<SEC-DOCUMENT>0001753926-23-000213.txt : 20230228
<SEC-HEADER>0001753926-23-000213.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228162601
ACCESSION NUMBER:		0001753926-23-000213
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTER PARFUMS INC
		CENTRAL INDEX KEY:			0000822663
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				133275609
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16469
		FILM NUMBER:		23685884

	BUSINESS ADDRESS:	
		STREET 1:		551 FIFTH AVE
		STREET 2:		STE 1500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10176
		BUSINESS PHONE:		2129832640

	MAIL ADDRESS:	
		STREET 1:		551 FIFTH AVENUE
		STREET 2:		STE 1500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10176

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JEAN PHILIPPE FRAGRANCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>g083417_10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ipar="http://interparfumsinc.com/20221231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2022_currency -->
<!-- Field: Set; Name: xdx; ID: xdx_034_ipar_interparfumsinc.com_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0000822663 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_07D_XDX_Z%2D%2D\XBRL JOB\2023\2023\Q1\02 February\Genesis\iXBRL__Inter Parfums, Inc.__31st December 2022__g083417__10K__FY\Out Bound\V2\Updated File\GFHg083417__Inter__Parfums____Inc.__2022__10%2DK__V2\g083245__10q.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_077_SO_Z%2D%2D\XBRL JOB\XBRL Team\Wasim\Training\14%2D02%2D2023\In Process\Rhishikesh\Last Q\n2574__x61%2D10q.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_063_USDEUR_0_iso4217%2D%2DEUR -->
<!-- Field: Set; Name: xdx; ID: xdx_06C_N_5_Number -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCentralIndexKey">0000822663</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0033" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0135" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0136" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLeasehold" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0207" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0298" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ipar:NetDerivativeInstrumentLossNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0616" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0617" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0649" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0811" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0813" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">P15Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0815" name="us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">P1Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl0817" name="us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">P12Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember" id="xdx2ixbrl0862" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">P7Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember" id="xdx2ixbrl0864" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">P50Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2022-12-31" id="xdx2ixbrl0868" name="us-gaap:LongTermDebtTerm">P10Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0913" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0915" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0918" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0920" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0933" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0935" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0938" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0940" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0957" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0959" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0967" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0969" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0972" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0979" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0982" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" id="xdx2ixbrl1040" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" id="xdx2ixbrl1061" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2022-12-31" id="xdx2ixbrl1083" decimals="0" unitRef="USD">7000000</ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_TrademarksMember" id="xdx2ixbrl1093" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P8Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_LicensingAgreementsMember" id="xdx2ixbrl1094" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P14Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_OtherIntangibleAssetsMember" id="xdx2ixbrl1095" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1096" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P14Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember" id="xdx2ixbrl1114" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember" id="xdx2ixbrl1116" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember" id="xdx2ixbrl1154" name="us-gaap:LineOfCreditFacilityExpirationDate1">2023-12-15</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember" id="xdx2ixbrl1183" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl1216" decimals="-3" scale="3" unitRef="USD">132902</ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2022-12-31" id="xdx2ixbrl1234" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">P5Y9M18D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_StockOptionMember" id="xdx2ixbrl1304" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P4Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_StockOptionMember" id="xdx2ixbrl1306" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember68792140" id="xdx2ixbrl1418" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1432" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P4Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1434" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1436" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember" id="xdx2ixbrl1475" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P0Y11M15D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember" id="xdx2ixbrl1483" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P2Y0M15D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ExercisePriceRangeThreeMember" id="xdx2ixbrl1488" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P3Y0M0D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ExercisePriceRangeFourMember" id="xdx2ixbrl1492" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P5Y10M6D</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeFourMember" id="xdx2ixbrl1493" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1495" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">P2Y7M13D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1500" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">P1Y10M17D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1512" name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">P3Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1557" decimals="INF" unitRef="Shares">31859417</ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1569" decimals="INF" unitRef="Shares">31835408</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_EliminationsMember" id="xdx2ixbrl1614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_custom_EliminationsMember" id="xdx2ixbrl1668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-12-31_custom_EliminationsMember" id="xdx2ixbrl1718" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31_custom_EliminationsMember" id="xdx2ixbrl1719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1797" decimals="-3" scale="3" unitRef="USD">194219</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1799" decimals="-3" scale="3" unitRef="USD">151019</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1801" decimals="-3" scale="3" unitRef="USD">69349</ix:nonFraction>
  <ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1" contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" id="xdx2ixbrl1968" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1" contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" id="xdx2ixbrl1982" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl2019" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl2020" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl2021" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember" id="xdx2ixbrl2068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember" id="xdx2ixbrl2075" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember" id="xdx2ixbrl2082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ipar-20221231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EmanuelUngarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipar:EmanuelUngarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DonnaKaranAndDKNYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DonnaKaranAndDKNYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RochasFashionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipar:RochasFashionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_RochasFashionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:RochasFashionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_currency_EUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SubtotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubtotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember_custom_RochasFashionBusinessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipar:RochasFashionBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DomesticSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ForeignSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LoansPayableTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LoansPayableTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansPayableTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LoansPayableThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LoansPayableThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansPayableThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-30_custom_LoansPayableOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OperatingLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:OperatingLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_StockOptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ipar:StockOptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_StockOptionMember68792140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-06-30_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InterparfumsSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_srt_NorthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CentralAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OtherSegmentCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OtherSegmentCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OtherSegmentCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RussiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RussiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RussiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UnitedKingdomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ForeignDerivedIntangibleIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000822663</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDEUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="N">
      <xbrli:measure>ipar:Number</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact002046" toRefs="Footnote002107"></ix:relationship>
  <ix:relationship fromRefs="Fact002053" toRefs="Footnote002107"></ix:relationship>
  <ix:relationship fromRefs="Fact002062" toRefs="Footnote002107"></ix:relationship>
  <ix:relationship fromRefs="Fact002069" toRefs="Footnote002108"></ix:relationship>
  <ix:relationship fromRefs="Fact002076" toRefs="Footnote002108"></ix:relationship>
  <ix:relationship fromRefs="Fact002083" toRefs="Footnote002108"></ix:relationship>
  <ix:relationship fromRefs="Fact002090" toRefs="Footnote002109"></ix:relationship>
  <ix:relationship fromRefs="Fact002097" toRefs="Footnote002109"></ix:relationship>
  <ix:relationship fromRefs="Fact002104" toRefs="Footnote002109"></ix:relationship>
  <ix:relationship fromRefs="Fact002045" toRefs="Footnote002110"></ix:relationship>
  <ix:relationship fromRefs="Fact002052" toRefs="Footnote002110"></ix:relationship>
  <ix:relationship fromRefs="Fact002060" toRefs="Footnote002110"></ix:relationship>
  <ix:relationship fromRefs="Fact002089" toRefs="Footnote002110"></ix:relationship>
  <ix:relationship fromRefs="Fact002096" toRefs="Footnote002110 Footnote002111"></ix:relationship>
  <ix:relationship fromRefs="Fact002103" toRefs="Footnote002110"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20220101__20221231_z8vsaTUBx4Nh"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Mark one)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--DocumentAnnualReport_c20220101__20221231_zAHpOvTPd8i9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></span>
<b>Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the fiscal year ended <span style="text-decoration: underline"><span id="xdx_90B_edei--DocumentPeriodEndDate_c20220101__20221231_zr3aKO8skhBj"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 31,
2022</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_edei--DocumentTransitionReport_c20220101__20221231_z9w4rcLniyCj"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span>
<b>Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the transition period from ________to _______.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file no. <span style="text-decoration: underline"><span id="xdx_90E_edei--EntityFileNumber_c20220101__20221231_zUJM5FRysru9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityFileNumber">0-16469</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b><i><span style="text-decoration: underline"><span id="xdx_903_edei--EntityRegistrantName_c20220101__20221231_z65mMHi23C37"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityRegistrantName">Inter
Parfums, Inc.</ix:nonNumeric></span></span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 50%; text-align: center"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20220101__20221231_z2opr3OaUVaf"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 49%; text-align: center"><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20220101__20221231_zs0ZljKJ1DX5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityTaxIdentificationNumber">13-3275609</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction of incorporation or organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span id="xdx_901_edei--EntityAddressAddressLine1_c20220101__20221231_zaPXdIb7M4ii"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine1">551 Fifth Avenue</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressCityOrTown_c20220101__20221231_ztu4kaM8EXh"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20220101__20221231_zSHxqfsVHwm4"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span id="xdx_90D_edei--EntityAddressPostalZipCode_c20220101__20221231_zyFLnuWVxboe"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressPostalZipCode">10176</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(Address of Principal Executive Offices)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Zip Code)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <span style="text-decoration: underline"><span id="xdx_906_edei--CityAreaCode_c20220101__20221231_zAgwusOL1ks3"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:CityAreaCode">212</ix:nonNumeric></span>.<span id="xdx_907_edei--LocalPhoneNumber_c20220101__20221231_zaPEMVXQbBeg"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:LocalPhoneNumber">983.2640</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 50%; text-align: center">Title of each class</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 49%; text-align: center">Name of exchange on which registered</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span id="xdx_903_edei--Security12bTitle_c20220101__20221231_zPwPISC7WQOc" title="Title of 12(b) Security"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:Security12bTitle">Common Stock, $.001 par value per share</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_905_edei--SecurityExchangeName_dxL_c20220101__20221231_zwJpEm8cuFwb" title="Security Exchange Name::XDX::NASDAQ"><span style="-sec-ix-hidden: xdx2ixbrl0033">The Nasdaq Stock Market</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20220101__20221231_zfo2Oh4f2SUe" title="Trading symbol" style="display: none; visibility: hidden"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:TradingSymbol">IPAR</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(g) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 50%; text-align: center">Title of each class</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 49%; text-align: center">Name of exchange on which registered</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center">None</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">None</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <span id="xdx_904_edei--EntityWellKnownSeasonedIssuer_c20220101__20221231_z9mRL28sy3gi"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityWellKnownSeasonedIssuer">Yes</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span>
No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant
is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
<span id="xdx_904_edei--EntityVoluntaryFilers_c20220101__20221231_znftVCaeuyD9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days: <span id="xdx_90F_edei--EntityCurrentReportingStatus_c20220101__20221231_zN4kl3ImVUx4"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span> No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;
232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
and post such files). <span id="xdx_90C_edei--EntityInteractiveDataCurrent_c20220101__20221231_zFVQONt3Zig5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span> No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; text-align: justify"><span id="xdx_908_edei--EntityFilerCategory_c20220101__20221231_zhz21A1JDim9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Large accelerated filer</ix:nonNumeric></span></td>
    <td style="width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td style="white-space: nowrap; width: 25%; text-align: justify">Accelerated filer</td>
    <td style="width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">Non-accelerated filer</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="white-space: nowrap; text-align: justify">Smaller reporting company</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntitySmallBusiness_c20220101__20221231_z0zuU7lnQ0L5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntitySmallBusiness">&#9744;</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify">Emerging growth company</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20220101__20221231_zyxUe1x7abRc"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared
or issued its audit report. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--IcfrAuditorAttestationFlag_c20220101__20221231_zLbyfuw8DIJ4"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Act). Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
<span id="xdx_903_edei--EntityShellCompany_c20220101__20221231_zAwVrZUY9945"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">State the aggregate market value of the
voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last
sold, or the average bid and asked price of such common equity, as of the last business day of the registrant&#8217;s most recently
completed second fiscal quarter. $<span id="xdx_90A_edei--EntityPublicFloat_iI_uUSD_c20220630_z6Ek5HUg48Ie"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,274,342,976</ix:nonFraction></span> of voting equity and $-0- of non-voting equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate the number of shares outstanding
of the registrant&#8217;s $.001 par value common stock as of the close of business on the latest practicable date February 28,
2023: <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20230228_zFWVqDcCY4x"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,109,360</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Documents Incorporated by Reference: None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="background-color: #CCEEFF">
    <td colspan="2" style="vertical-align: top; text-align: justify"><a href="#a001"><span style="font-size: 10pt">Forward
    Looking Statements</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">ii</span></td></tr>
<tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 8%; text-align: justify"><a href="#a002"><span style="font-size: 10pt"><b>PART I</b></span></a></td>
    <td style="vertical-align: top; width: 84%">&#160;</td>
    <td style="vertical-align: bottom; width: 8%; text-align: center"><span style="font-size: 10pt">1</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a003"><span style="font-size: 10pt">Item 1.</span></a></td>
    <td style="vertical-align: top"><a href="#a003"><span style="font-size: 10pt">Business</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">1</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a004"><span style="font-size: 10pt">Item 1A.</span></a></td>
    <td style="vertical-align: top"><a href="#a004"><span style="font-size: 10pt">Risk Factors</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">29</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a005"><span style="font-size: 10pt">Item 1B.</span></a></td>
    <td style="vertical-align: top"><a href="#a005"><span style="font-size: 10pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">37</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a006"><span style="font-size: 10pt">Item 2.</span></a></td>
    <td style="vertical-align: top"><a href="#a006"><span style="font-size: 10pt">Properties</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">38</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a007"><span style="font-size: 10pt">Item 3.</span></a></td>
    <td style="vertical-align: top"><a href="#a007"><span style="font-size: 10pt">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">38</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a008"><span style="font-size: 10pt">Item 4.</span></a></td>
    <td style="vertical-align: top"><a href="#a008"><span style="font-size: 10pt">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">38</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a009"><span style="font-size: 10pt"><b>PART II</b></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;39</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a010"><span style="font-size: 10pt">Item 5.</span></a></td>
    <td style="vertical-align: top"><a href="#a010"><span style="font-size: 10pt">Market for Registrant&#8217;s Common Equity,
    Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">39</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a011"><span style="font-size: 10pt">Item 6.</span></a></td>
    <td style="vertical-align: top"><a href="#a011"><span style="font-size: 10pt">RESERVED</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">40</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a012"><span style="font-size: 10pt">Item 7.</span></a></td>
    <td style="vertical-align: top"><a href="#a012"><span style="font-size: 10pt">Management&#8217;s Discussion and Analysis
    of Financial Condition and Results of Operations</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">41</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a013"><span style="font-size: 10pt">Item 7A.</span></a></td>
    <td style="vertical-align: top"><a href="#a013"><span style="font-size: 10pt">Quantitative and Qualitative Disclosures
    About Market Risk</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">52</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a014"><span style="font-size: 10pt">Item 8.</span></a></td>
    <td style="vertical-align: top"><a href="#a014"><span style="font-size: 10pt">Financial Statements and Supplementary Data</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">52</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a015"><span style="font-size: 10pt">Item 9.</span></a></td>
    <td style="vertical-align: top"><a href="#a015"><span style="font-size: 10pt">Changes in and Disagreements With Accountants
    on Accounting and Financial Disclosure</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">52</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a016"><span style="font-size: 10pt">Item 9A.</span></a></td>
    <td style="vertical-align: top"><a href="#a016"><span style="font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">52</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a017"><span style="font-size: 10pt">Item 9B.</span></a></td>
    <td style="vertical-align: top"><a href="#a017"><span style="font-size: 10pt">Other Information</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">53</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><b><a href="#a023">PART III</a></b></span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;54</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="#a024">Item 10.</a></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#a024">Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;54</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="#a025">Item 11.</a></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#a025">Executive Compensation</a></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;61</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="#a026">Item 12.</a></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#a026">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;76</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="#a027">Item 13.</a></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#a027">Certain Relationships and Related Transactions, and Director Independence</a></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;77</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="#a028">Item 14.</a></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#a028">Principal Accountant Fees and Services</a></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;78</td></tr>
<tr>
    <td style="vertical-align: top; background-color: white; text-align: justify">&#160;</td>
    <td style="vertical-align: top; background-color: white">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a018"><span style="font-size: 10pt"><b>PART IV</b></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">&#160;80</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a019"><span style="font-size: 10pt">Item 15.</span></a></td>
    <td style="vertical-align: top"><a href="#a019"><span style="font-size: 10pt">Exhibits and Financial Statement Schedules</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">80</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><a href="#a020"><span style="font-size: 10pt">Item 16.</span></a></td>
    <td style="vertical-align: top"><a href="#a020"><span style="font-size: 10pt">Form 10-K Summary</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">80</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td colspan="2" style="vertical-align: top; text-align: justify"><a href="#a021"><span style="font-size: 10pt"><b>FINANCIAL
    STATEMENTS</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-1</span></td></tr>
<tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td colspan="2" style="vertical-align: top; text-align: justify"><a href="#a022"><span style="font-size: 10pt"><b>SIGNATURES</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a001"></span>FORWARD LOOKING STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> This report includes
forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, and if incorporated by reference
into a registration statement under the Securities Act of 1933, as amended, within the meaning of Section 27A of such act. When
used in this report, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;will,&#8221; &#8220;should,&#8221;
&#8220;could,&#8221; &#8220;may,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221;
&#8220;potential,&#8221; or &#8220;continue&#8221; or similar expressions identify certain forward-looking statements. Although
we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give
no assurance that such plans, intentions or expectations will be achieved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actual results, performance
or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained
in this report. Important factors that could cause actual results to differ materially from our forward-looking statements are
set forth in this report, including under the heading &#8220;Risk Factors&#8221;. Such factors include: The effects of; our inability
to successfully integrate or manage any future acquisitions; continuation and renewal of existing licenses and similar agreements;
potential inability to obtain new licensing, arrangements or agreements for additional brands; potential reduction in sales of
our fragrance products due to reduced consumer confidence as the result of a prolonged economic downturn, recession or terrorist
attack in the United States, Europe or any of the other countries in which we do significant business; inflation; uncertainties
and deterioration in global credit markets could negatively impact suppliers, customers and consumers; re-emergence of COVID-19
and related governmental mandates, or outbreak of other disease, epidemic or pandemic, or similar public health threat,; inability
to protect our intellectual property rights; our business could be negatively impacted by social impact and sustainability matters;
potential liability for infringement of third party brand names; product liability claims; effectiveness of our sales and marketing
efforts and product acceptance by consumers; our dependence upon third party manufacturers and distributors; our dependence upon
existing management; competition in the fragrance industry; risks related to our foreign operations, currency fluctuation and international
tariff and trade barriers; compliance with governmental regulation; changing political conditions could adversely impact our business
and financial results; potential hacking and outages of our global information systems; seasonal variability of our business; our
ability to operate our business without infringing, and misappropriating or otherwise violating the intellectual property rights
of other parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These factors are not
intended to represent a complete list of the general or specific factors that may affect us. It should be recognized that other
factors, including general economic factors and business strategies, may be significant, and the factors set forth herein may affect
us to a greater extent than indicated. All forward-looking statements attributable to us or persons acting on our behalf are expressly
qualified in their entirety by the cautionary statements set forth in this report. Except as may be required by law, we undertake
no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a002"></span>PART I</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a003"></span>Item 1. Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General Business Development</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Founded in 1982, we
operate in the fragrance business, and manufacture, market and distribute a wide array of prestige fragrance, and fragrance related
products. Our worldwide headquarters and the office of our wholly-owned United States subsidiaries, Jean Philippe Fragrances, LLC
and Interparfums, USA LLC, are located at 551 Fifth Avenue, New York, New York 10176, and our telephone number is 212.983.2640.
We also have wholly-owned subsidiaries in Italy, subsidiary, Interparfums Italia Srl and Hong Kong, Inter Parfums USA Hong Kong
Limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our consolidated wholly-owned
subsidiary, Inter Parfums Holdings, S.A., and its majority owned subsidiary, Interparfums SA, maintain executive offices at 10
rue de Solf&#233;rino, 75007 Paris, France. Our telephone number in Paris is 331.5377.0000. Interparfums SA is the sole owner
of Interparfums Luxury Brands, Inc., a Delaware corporation, for distribution of prestige brands in the United States. Interparfums
SA is also the majority owner of Parfums Rochas Spain, SL, a Spanish limited liability company, which specializes in the distribution
of Rochas fragrances. In addition, Interparfums SA is also the sole owner of Interparfums (Suisse) Sarl, a company formed to hold
and manage certain brand names, and Interparfums Asia Pacific Pte., Ltd., an Asian sales and marketing office.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
listed on The Nasdaq Global Select Market under the trading symbol &#8220;IPAR&#8221;. The common shares of our subsidiary, Interparfums
SA, are traded on the Euronext.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities and
Exchange Commission (&#8220;SEC&#8221;) maintains an internet site at <span style="text-decoration: underline">http://www.sec.gov</span> that contains financial reports,
proxy and information statements, and other information regarding issuers that file electronically with the SEC. We maintain our
internet website at <span style="text-decoration: underline">www.interparfumsinc.com</span>, which is linked to the SEC internet site. You can obtain through our website,
free of charge, our annual reports on Form 10-K, quarterly reports on Form 10-Q, interactive data files, current reports on Form
8-K, beneficial ownership reports (Forms 3, 4 and 5) and amendments to those reports filed or furnished pursuant to Section 13(a)
of the Securities Exchange Act of 1934 as soon as reasonably practicable after they have been electronically filed with or furnished
to the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The following information
is qualified in its entirety by and should be read together with the more detailed information and audited financial statements,
including the related notes, contained or incorporated by reference in this report.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate in the fragrance
business and manufacture, market and distribute a wide array of fragrance and fragrance related products. We manage our business
in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced
and marketed by our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded
company as 28% of Interparfums SA shares trade on the Euronext.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is not
capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and
source our needed components from our suppliers. These components are either received and stored directly at our third-party fillers
or received at one of our distribution centers and then, based upon production needs, the components are sent to one of several
third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our fragrance products
focus on prestige brands, each with a devoted following. By concentrating in markets where the brands are best known, we have had
many successful product launches. We typically launch new fragrance families for our brands every few years, and more frequently
seasonal and limited edition fragrances are introduced as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The creation and marketing
of each product family is intimately linked with the brand&#8217;s name, its past and present positioning, customer base and, more
generally, the prevailing market atmosphere. Accordingly, we generally study the market for each proposed family of fragrance products
for almost a full year before we introduce any new product into the market. This study is intended to define the general position
of the fragrance family and more particularly its scent, bottle, packaging and appeal to the buyer. In our opinion, the unity of
these four elements of the marketing mix makes for a successful product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As with any business,
many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with
global reach and potential. As part of our strategy, we plan to continue to make investments in fast-growing markets and channels
to grow market share. We discuss in greater detail risk factors relating to our business in Item 1A of this Annual Report on Form
10-K for the fiscal year ended December 31, 2022, and the reports that we file from time to time with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>European Operations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We produce and distribute
our fragrance products primarily under license agreements with brand owners, and fragrance product sales through our European operations
represented approximately 68% of net sales for 2022. We have built a portfolio of prestige brands, which include <i>Boucheron,
Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont </i>and <i>Van Cleef &amp; Arpels</i>,
whose products are distributed in over 120 countries around the world. European operations will also become the exclusive worldwide
licensee for Lacoste fragrances on January 1, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>United States Operations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prestige brand fragrance
products are also produced and marketed through our United States operations, and represented approximately 32% of net sales for
the year ended December 31, 2022. These fragrance products are sold under trademarks owned by us or pursuant to license or other
agreements with the owners of brands, which include <i>Abercrombie &amp; Fitch, Anna Sui, Dunhill, Donna Karan, DKNY, Ferragamo,
Graff, GUESS, Hollister, MCM, Oscar de la Renta </i>and <i>Ungaro</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Developments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Lacoste</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2022, we
closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted to Interparfums SA for the
production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum
advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and
will last for 15 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Dunhill</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April 2022, we announced
that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce
and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory
for a limited time as is customary in the fragrance industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2021, we
closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the
production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising
expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last
for 10 years with a 5-year optional term, subject to certain conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the
management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian
subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the
license agreement was accounted for as an asset acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2021, we
also entered into a 10-year exclusive global licensing agreement with a 5-year optional term subject to certain conditions, with
Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under
the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments
as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances
and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum
advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established
and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant
loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc.
common stock valued at $5.0 million to the licensor. The exclusive license became effective on July 1, 2022, and we are planning
to launch new fragrances under these brands in 2024<b><i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls
for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge
on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion
trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains
an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fragrance Products</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are the owner of
the Rochas brand, and the Lanvin brand name and trademark for our class of trade. In addition, we have built a portfolio of licensed
prestige brands whereby we produce and distribute our prestige fragrance products under license agreements with brand owners. Under
license agreements, we obtain the right to use the brand name, create new fragrances and packaging, determine positioning and distribution,
and market and sell the licensed products, in exchange for the payment of royalties. Our rights under license agreements are also
generally subject to certain minimum sales requirements and advertising expenditures as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a percentage of
net sales, product sales for the Company&#8217;s largest brands were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">%</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our licenses expire
on the following dates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 30%"><b>Brand Name</b></td>
    <td style="width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; width: 69%"><b>Expiration Date</b></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Abercrombie &amp; Fitch</td>
    <td>&#160;</td>
    <td>Extends until either party terminates on 3 years&#8217; notice</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Anna Sui</td>
    <td>&#160;</td>
    <td>December 31, 2026, plus one 5-year optional term</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>bebe Stores</td>
    <td>&#160;</td>
    <td>June 30, 2023</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Boucheron</td>
    <td>&#160;</td>
    <td>December 31, 2025, plus a 5-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Coach</td>
    <td>&#160;</td>
    <td>June 30, 2026</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>DKNY</td>
    <td>&#160;</td>
    <td>December 31, 2032, plus a 5-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Donna Karan</td>
    <td>&#160;</td>
    <td>December 31, 2032, plus a 5-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Dunhill</td>
    <td>&#160;</td>
    <td>September 30, 2023</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Emanuel Ungaro</td>
    <td>&#160;</td>
    <td>December 31, 2031, plus a 5-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>French Connection</td>
    <td>&#160;</td>
    <td>December 31, 2027, plus a 10-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Graff</td>
    <td>&#160;</td>
    <td>December 31, 2026, plus 3 optional 3-year terms if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>GUESS</td>
    <td>&#160;</td>
    <td>December 31, 2033</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Hollister</td>
    <td>&#160;</td>
    <td>Extends until either party terminates on 3 years&#8217; notice</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Kate Spade</td>
    <td>&#160;</td>
    <td>June 30, 2030</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Jimmy Choo</td>
    <td>&#160;</td>
    <td>December 31, 2031</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Karl Lagerfeld</td>
    <td>&#160;</td>
    <td>October 31, 2032</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Lacoste*</td>
    <td>&#160;</td>
    <td>December 31, 2038</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>MCM</td>
    <td>&#160;</td>
    <td>December 31, 2030, plus 4 option years</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Moncler</td>
    <td>&#160;</td>
    <td>December 31, 2026, plus a 5-year optional term if certain conditions are met</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Montblanc</td>
    <td>&#160;</td>
    <td><p style="margin: 0pt 0">December 31, 2030</p>


</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Oscar de la Renta</td>
    <td>&#160;</td>
    <td>December 31, 2031, plus a 5-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Ferragamo</td>
    <td>&#160;</td>
    <td>December 31, 2031, plus a 5-year optional term if certain sales targets are met</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>S.T. Dupont</td>
    <td>&#160;</td>
    <td>December 31, 2023</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Van Cleef &amp; Arpels</td>
    <td>&#160;</td>
    <td>December 31, 2024</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*The Lacoste license commences on January
1, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the acquisition of the Lanvin brand names and trademarks for our class of trade, we granted the seller the right to repurchase
the brand names and trademarks on July 1, 2027 for &#8364;70 million (approximately $79 million) in accordance with an amendment
signed in 2021. In connection with such amendment, we also granted a license to the seller to develop and sell cosmetics other
than fragrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fragrance Portfolio</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Abercrombie &amp; Fitch&#8212; </b>In
2014, we entered into a worldwide license to create, produce and distribute new fragrances and fragrance related products under
the Abercrombie &amp; Fitch brand name. We distribute these fragrances in specialty stores, department stores and duty free shops,
and in the U.S., in select Abercrombie &amp; Fitch retail stores. Our initial men&#8217;s scent, <i>First Instinct</i> was launched
in 2016 followed by a women&#8217;s version in 2017. Since that time, we unveiled several new fragrances most notably the <i>Authentic
</i>and <i>Away </i>duos as well as brand extensions.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Abercrombie &amp; Fitch
Co. is a leading, global, omnichannel specialty retailer of apparel and accessories for men, women and kids. The iconic Abercrombie &amp; Fitch brand was born in 1892 and aims to make every day feel as exceptional as the start of a long weekend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anna
Sui&#8212;</b>In 2011, we entered into an exclusive worldwide fragrance license to create, produce and distribute fragrances and
fragrance related products under the Anna Sui brand. Anna Sui is one of New York&#8217;s most accomplished fashion designers known
for creating contemporary clothing inspired by vintage style that capture the brand&#8217;s very sweet feminine girly aspect,
combined with a touch of hipness and rock-and-roll. Today, Anna Sui has over 50 boutiques and her collection and products are
sold in 300 stores in over 30 countries, but her brand is by far most popular and well received throughout Asia. Over the past
decade, we have worked in partnership with Anna Sui and her creative team to build upon the brand&#8217;s customer appeal and
develop and market a family of fragrances including <i>Fantasia</i>, <i>Sui Dreams</i> and the newest scent, <i>Sky,</i> which
was ranked as the second best perfume launch of 2021 by WWD Japan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Boucheron&#8212; </b>In 2010, we entered
into an exclusive 15-year worldwide license agreement for the creation, development and distribution of fragrances and fragrance
related products under the Boucheron brand. For over a century, since becoming the first jeweler to open a boutique on Place Vend&#244;me
in 1893, Boucheron has embodied very high-end creation, luxury and French know-how. The mysterious and seductive collection of
Boucheron fragrances unquestionably continues this prestigious line of creations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Boucheron&#8217;s legacy
scents, <i>Femme</i> and <i>Homme</i>, and the legendary <i>Jaipur</i> perfume form the foundation of brand sales. Our team has
enriched the portfolio with <i>Quatre</i> for men and women, along with several special editions, a growing collection of unique
scents aptly named, <i>La Collection</i>, and <i>Serpent Boh&#232;me.</i> During 2022, we introduced a new men&#8217;s fragrance,
Boucheron <i>Singulier</i>, as well as still another addition to our Boucheron <i>Collection</i>. Currently, Boucheron operates
through several boutiques worldwide as well as an e-commerce site.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Coach</b>&#8212; In 2015, we entered
into an exclusive 11-year worldwide license to create, produce and distribute new men&#8217;s and women&#8217;s fragrances and
fragrance related products under the Coach brand name. We distribute these fragrances globally to department stores, specialty
stores and duty free shops, as well as in Coach retail stores.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Founded in 1941, Coach
is the ultimate American leather goods brand and has always been renowned for its quality craftsmanship. Now the luxury brand that
best embodies New York&#8217;s casual elegance, Coach also offers collections of ready-to-wear, lifestyle accessories and fragrances.
Its contemporary approach to luxury combines authenticity and innovation, exported worldwide thanks to its thoroughly American
non-conformist vision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2016, we launched
our first Coach fragrance, a women&#8217;s signature scent, and in 2017, a men&#8217;s scent, both of which became and remain top
selling prestige fragrances. Subsequent flankers and extensions have enlarged the Coach fragrance enterprise as have entirely new
collections, including <i>Coach Dreams</i> which debuted in early 2020, and its sister scent, <i>Dreams Sunset</i>, which debuted
in 2021. For 2022, we unveiled Coach <i>Wild Rose</i>, and Coach <i>Open Road</i>, a new fragrance for men. Coach is part of the Tapestry
house of brands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Donna Karan/DKNY&#8212; </b>In September
2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands, which took effect on July 1, 2022. The Donna Karan and DKNY brands, which draw
from the energy and attitude of New York City, are powerhouses in fashion and fragrance. These global lifestyle brands will make
excellent additions to our portfolio. With this agreement, we are gaining several well-established and valuable fragrance franchises,
most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around
the world. Upon joining our portfolio, these brands now rank among our largest. We are planning to launch new fragrances under
these brands in 2024. Donna Karan and DKNY are part of the G-III house of brands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dunhill&#8212; </b>Since 2012, we have
been the exclusive fragrance licensee whereby we create, produce and distribute fragrances and fragrance related products under
the Dunhill brand. Our rights under this license terminate on September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emanuel Ungaro&#8212; </b>In October
2021, we also entered into a 10-year exclusive global licensing agreement with Emanuel Ungaro for the creation, development and
distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. Founded in 1965 in Paris, the house
of Emanuel Ungaro is an icon of French refinement and haute couture. Its unique style is expressed through unquestioning sensuality,
purity of silhouette, flamboyant prints, and exquisite attention to details. Season after season, Emanuel Ungaro dared to be different,
combining unexpected yet sensual clashes of bright colors and prints with beautiful draping. Today Ungaro fragrances uphold the
same values of audacity and elegance, and the brand is best known and most prized internationally, and such presence will remain
our sales focus as we continue to produce and distribute the brand&#8217;s legacy scents, notably <i>Diva. </i>Beginning in 2023,
we plan to unveil a <i>Diva</i> brand extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Graff</b>&#8212; In 2018, we entered
into an exclusive, 8-year worldwide license agreement with London-based Graff for the creation, development and distribution of
fragrances under the Graff brand. The agreement has three 3-year automatic renewal options, potentially extending the license until
December 31, 2035.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since Laurence Graff
OBE founded the company in 1960, Graff has been dedicated to sourcing and crafting diamonds and gemstones of untold beauty and
rarity and transforming them into spectacular pieces of jewelry that move the heart and stir the soul. Throughout its rich history,
Graff has become the world leader for diamonds of rarity, magnitude and distinction. Each jewelry creation is designed and manufactured
in Graff&#8217;s London atelier, where master craftsmen employ techniques to emphasize the beauty of each individual stone. The
company remains a family business, overseen by Francois Graff, Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For Graff, a six-scent
collection for women, <i>Lesedi La Rona</i>, debuted exclusively at Harrods beginning in March 2020, which we further extended
through 2020 as a result of the mandatory store closings throughout that year. In 2021, a select market rollout began in the Middle
East, with limited luxury distribution to only the most exclusive, upmarket retail outlets. In 2021 and 2022, we added two new
scents to the <i>Lesedi La Rona</i> collection.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>GUESS</b>&#8212; In 2018, we entered
into an exclusive, 15-year worldwide license agreement with GUESS, Inc. for the creation, development and distribution of fragrances
under the GUESS brand.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Established in
1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand.&#160;GUESS, Inc. designs,
markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, footwear and other
related consumer products. GUESS products are distributed through branded GUESS stores as well as better department and specialty
stores around the world.&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We began selling GUESS
legacy scents in 2018. In 2019 the GUESS brand quickly became the largest within our U.S. operations, with legacy fragrances dominating
the sales mix. In 2019, we began shipments of <i>1981 Los Angeles</i> and <i>Seductive Noir</i>, both flankers of established scents,
which accelerated brand growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nearly three years
in the making, our first new blockbuster scent, <i>Bella Vita</i>, debuted for the GUESS brand both domestically and internationally
in 2021. In addition, <i>Effect,</i> a new men&#8217;s grooming line and fragrance collection was launched in 2021. <i>Uomo</i>,
a new men&#8217;s fragrance for GUESS, came to market in 2022 with a flanker debuting in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Hollister&#8212; </b>In 2014, we entered
into a worldwide license to create, produce and distribute new fragrances and fragrance related products under the Hollister brand
name. We distribute these fragrances in specialty stores, department stores and duty free shops, as well as select Hollister retail
stores in the U.S. In 2016 we launched our first men&#8217;s and women&#8217;s fragrance duo, <i>Wave </i>which led to flankers
and extensions as did subsequent fragrance families <i>Festival</i> and <i>Canyon Escape</i>. We have a new pillar debuting in
2023, <i>Feelin&#8217; Good</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The quintessential
apparel brand of the global teen consumer, Hollister celebrates the liberating spirit of the endless summer inside everyone. Inspired
by California&#8217;s laidback attitude, Hollister&#8217;s clothes are designed to be lived in and made your own, for wherever
life takes you.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Jimmy Choo&#8212;</b> In 2009, we entered
into an exclusive 12-year worldwide license agreement for the creation, development and distribution of fragrances and fragrance
related products under the Jimmy Choo brand, and in 2017, we extended the license agreement which now runs through December 31,
2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Jimmy Choo encompasses
a complete luxury accessories brand. Women&#8217;s shoes remain the core of the product offering, alongside handbags, small leather
goods, scarves, eyewear, belts, fragrance and men&#8217;s shoes. Jimmy Choo has a global store network encompassing more than 200
stores and is present in the most prestigious department and specialty stores worldwide. Jimmy Choo is part of the Capri Holdings
Limited luxury fashion group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our initial Jimmy Choo
fragrance was launched in 2011, a signature scent for women. In the decade that followed, Jimmy Choo has grown to become our second
largest brand with new pillars and flankers debuting regularly, both for men and women. Our newest women&#8217;s fragrance pillar,
<i>I Want Choo,</i> was launched in 2021 and for 2022, two flankers debuted, Jimmy Choo <i>Man Aqua </i>and <i>I Want Choo Forever</i>.
For 2023, Jimmy Choo <i>Rose Passion</i> is scheduled to be unveiled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Karl Lagerfeld&#8212; </b>In 2012, we
entered into a 20-year worldwide license agreement with Karl Lagerfeld B.V., the internationally renowned haute couture fashion
house, to create, produce and distribute fragrances under the Karl Lagerfeld brand.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the creative
direction of the late Karl Lagerfeld, one of the world&#8217;s most influential and iconic designers, the Lagerfeld Portfolio represents
a modern approach to distribution, an innovative digital strategy and a global 360 degree vision that reflects the designer&#8217;s
own style and soul. Karl Lagerfeld created the first fragrance that bears his name in 1978, and that legacy has expanded to include
several growing multi-scent collections, <i>Les Parfums Mati&#232;res </i>and more recently, <i>Karl Cities, </i>a new collection
featuring entries for New York, Paris, Hamburg, Tokyo and Vienna was unveiled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Kate Spade&#8212; </b>In 2019, we entered
into an exclusive, 11-year worldwide license agreement with Kate Spade to create, produce and distribute new perfumes and fragrance
related products under the Kate Spade brand which we distribute globally to department and specialty stores and duty free shops,
as well as in Kate Spade retail stores. Our first original scent, <i>Kate Spade New York</i>, debuted in January 2021 and for 2022,
we added a flanker to our line, <i>Kate Spade Sparkle</i>. Kate Spade <i>Cherie</i> debuted in early 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since its launch in
1993 with a collection of six essential handbags, Kate Spade has always stood for optimistic femininity. Today, the brand is a
global life and style house with handbags, ready-to-wear, jewelry, footwear, gifts, home d&#233;cor and more. Polished ease,
thoughtful details and a modern, sophisticated use of color&#8212;Kate Spade&#8217;s founding principles define a unique style
synonymous with joy. Under the vision of its creative director, the brand continues to celebrate confident women with a youthful
spirit. Kate Spade is part of the Tapestry house of brands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Lanvin&#8212; </b>In 2007, we acquired
the worldwide rights to the Lanvin brand names and international trademarks listed in Class 3, our class of trade. A synonym of
luxury and elegance, the Lanvin fashion house, founded in 1889 by Jeanne Lanvin, expanded into fragrances in the 1920s.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lanvin fragrances occupy
an important position in the selective distribution market in France, Eastern Europe and Asia, and we have several lines currently
in distribution, including <i>&#201;clat d&#8217;Arp&#232;ge</i>, <i>Lanvin L&#8217;Homme</i>, <i>Jeanne Lanvin, Modern Princess
</i>and <i>A Girl in Capri</i>. The <i>&#201;clat d&#8217;Arp&#232;ge </i>line accounts for almost 50% of brand sales. <i>Les
Fleurs de Lanvin, </i>a new floral fragrance collection, was released during the second half of 2021. For 2022, we unveiled a new
extension to our <i>&#201;clat d&#8217;Arp&#232;ge</i> line, <i>Mon &#201;clat</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>MCM&#8212; </b>In 2019, we entered into
an exclusive, 10-year worldwide license agreement with German luxury fashion house MCM for the creation, development and distribution
of fragrances and fragrance related products under the MCM brand. The agreement has a 4-year automatic renewal option, potentially
extending the license until December 31, 2034.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">MCM is a luxury lifestyle
goods and fashion house founded in 1976 with an attitude defined by the cultural Zeitgeist and its German heritage with a focus
on functional innovation, including the use of cutting-edge techniques. Today, through its association with music, art, travel
and technology, MCM embodies the bold, rebellious and aspirational. Always with an eye on the disruptive, the driving force behind
MCM centers on revolutionizing classic design with futuristic materials. MCM&#8217;s millennial and Gen Z audience is genderless,
ageless, empowered and unconstrained by rules and boundaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following through on
our plan to develop extraordinary fragrances that capture the creative spirit of MCM, our first new fragrance, <i>MCM</i>, was
released during the first quarter of 2021 to great, and somewhat unexpected success. We released a flanker in 2022, along with
a limited edition called <i>Graffiti</i>. Our distribution strategy encompasses MCM stores, high-end department stores and prestige
beauty retailers, with a geographic focus on Asia, the Americas and Europe. Our first ever men&#8217;s scent for the brand is debuting
in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Moncler&#8212; </b>In June 2020, we
entered into an exclusive, 5-year worldwide license agreement with a potential 5-year extension with Moncler for the creation,
development and distribution of fragrances under the Moncler brand. Moncler was founded at Monestier-de-Clermont, Grenoble, France,
in 1952 and is currently headquartered in Italy. Over the years, the brand has combined style with constant technological research
assisted by experts in activities linked to the world of the mountain. The Moncler outerwear collections marry the extreme demands
of nature with those of city life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
first fragrance for the Moncler brand has a revolutionary LED design, and the flask-shaped bottles of <i>Moncler Pour Femme</i>
and <i>Moncler Pour Homme</i> forge a powerful bond with the House Moncler&#8217;s alpine roots and pioneering spirit. This playful
and unique innovation enables its owner to write a personalized note that scrolls in red letters on the screen of the mirror bottle.
Our first fragrance was pre-launched in 250 select outlets in the second half of 2021, and was met with an excellent response.
The rollout to approximately 3,000 doors took place during 2022. Moncler will also launch a new collection in Q1 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Montblanc&#8212;</b>In 2010, we entered
into an exclusive license agreement to create, develop and distribute fragrances and fragrance related products under the Montblanc
brand. In 2015, we extended the agreement which now runs through December 31, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Montblanc has achieved
a world-renowned position in the luxury segment and has become a purveyor of exclusive products, which reflect today&#8217;s exacting
demands for timeless design, tradition and master craftsmanship. Through its leadership positions in writing instruments, watches
and leather goods, promising growth outlook in women&#8217;s jewelry, international retail footprint through its network of more
than 600 boutiques, high standards of product design and quality, Montblanc has grown to be our largest fragrance brand.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2011, we launched
our first new Montblanc fragrance, <i>Legend, </i>which quickly became our best-selling men&#8217;s line and has given rise to
a plethora of flankers including <i>Legend Night</i> and <i>Legend Spirit.</i> In 2014, we launched our second men&#8217;s line,
<i>Emblem </i>and like its predecessor, <i>Emblem</i> gave rise to brand extensions. In 2019, we unveiled Montblanc <i>Explorer</i>,
which has added flankers, most recently Montblanc <i>Explorer Ultra Blue</i>. The <i>Legend</i> continues, as in 2022, we introduced
a new flanker, Montblanc <i>Legend Red</i>. For 2023, extensions for the Montblanc signature scent for women and Explorer line for
men are in the pipeline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Oscar de la Renta&#8212;</b> In 2013,
we entered into an exclusive worldwide license to create, produce and distribute fragrances and fragrance related products under
the Oscar de la Renta brand. In 2019, the agreement was extended through December 31, 2031, with an additional five-year option
potentially extending the agreement through December 31, 2036. After taking over distribution of the brand&#8217;s legacy fragrances
in 2014, we introduced <i>Extraordinary </i>the following year. Oscar de la Renta <i>Bella Blanca</i> debuted in 2018, followed
by <i>Bella Rosa </i>and <i>Bella Essence </i>and soon to join them, <i>Bella Bouquet</i>. Debuting in 2021 was an entirely new
fragrance pillar, <i>Alibi</i> which welcomed a sister scent in 2022, <i>Alibi Eau de Toilette</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Oscar de la Renta is one of the world&#8217;s
leading luxury goods firms. The New York-based company was established in 1965, and encompasses a full line of women&#8217;s accessories,
bridal, children&#8217;s wear, fragrance, beauty and home goods, in addition to its internationally renowned signature women&#8217;s
ready to wear collection. Oscar de la Renta products are sold globally in fine department and specialty stores, www.oscardelarenta.com
and through wholesale channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Rochas</b>&#8212; In 2015, we acquired
the Rochas brand from The Procter &amp; Gamble Company. Founded by Marcel Rochas in 1925, the brand began as a fashion house and
expanded into perfumery in the 1950s under H&#233;l&#232;ne Rochas&#8217; direction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our first new fragrance
for Rochas, <i>Mademoiselle Rochas</i>, had a successful launch in 2017 in its traditional markets of France and Spain. Over the
next few years, we debuted flankers for legacy scents <i>Eau de Rochas</i> and <i>Mademoiselle Rochas, </i>plus others, and in
2018 we launched our first new men&#8217;s line, Rochas <i>Moustache</i>. <i>Byzance</i> debuted in early 2020 and <i>Rochas Girl</i>
in 2021, and the first flanker for both came to market in 2022 as well as one for <i>L&#8217;Homme Rochas.</i> Flankers for many
of these pillars debuted in 2022 with more to come in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Ferragamo&#8212; </b>In October 2021,
we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide 10-year license was granted
for the production and distribution of Ferragamo brand perfumes, with a 5-year optional term if certain conditions are met. Salvatore
Ferragamo S.p.A. is the parent company of the Salvatore Ferragamo Group, one of the world&#8217;s leaders in the luxury industry
and whose origins date back to 1927. Named after its founder, the brand still represents and lives by the original values of Salvatore
Ferragamo. The uniqueness and exclusivity of its creations, along with the perfect blend of style, creativity and innovation enriched
by the quality and superior craftsmanship of the &#8216;Made in Italy&#8217; tradition, have always been the hallmarks of the Salvatore
Ferragamo&#8217;s products notably shoes, leather goods, apparel, silk products and other accessories for men and women.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The current fragrance
lineup includes <i>Storie di Seta,</i> a collection of four refined, luminous olfactory works of art. Each fragrance is made with
rare, sustainable raw materials, and can be worn alone or in combination, creating a personalized multifaceted scent. The genderless
collection is comprised of four fragrances in four colors. Four exclusive motifs drawn from the House&#8217;s textile heritage
adorn each flacon. Established scents in the Ferragamo portfolio include <i>Ferragamo</i>, a collection of fragrances for men,
<i>Signoria</i>, a collection of fragrances for women, the <i>Tuscan Creations</i> series, the <i>Amo</i> series and the <i>Uomo
</i>series. New flankers are in the works for 2023 and 2024 with a major new pillar in the works for 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>S.T. Dupont&#8212;</b> In 1997, we signed
an exclusive worldwide license agreement with S.T. Dupont for the creation, manufacture and distribution of S.T. Dupont fragrances.
The license agreement had been renewed several times and is now renewed annually, without any material changes in terms and conditions.
S.T. Dupont is a French luxury goods house founded in 1872, which is known for its fine writing instruments, lighters and leather
goods. S.T. Dupont fragrances include <i>S.T. Dupont pour Femme</i>, <i>S.T. Dupont pour Homme, Pure</i> and <i>S.T. Dupont Collection.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Van Cleef &amp; Arpels&#8212; </b>In
2018, we renewed its license agreement for an additional six years with Van Cleef &amp; Arpels for the creation, development, and
distribution of fragrance products through December 2024. Our initial 12-year license agreement with Van Cleef &amp; Arpels was
signed in 2006.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Van Cleef &amp; Arpels
fragrances in current distribution include: <i>First </i>and <i>Collection Extraordinaire. </i>Sales of the <i>Collection Extraordinaire</i>
line have experienced continued growth since its debut. We continue to introduce new additions to the Van Cleef &amp; Arpels <i>Collection
Extraordinaire</i> assortment annually, including <i>Oud Blanc</i>, in 2020 and <i>R&#234;ve de Matiere </i>in 2021. <i>Patchouli
Blanc</i> is the new addition to the <i>Collection Extraordinaire</i>, released in 2022 with further additions coming in 2023.
Founded in 1896, Van Cleef &amp; Arpels is a French luxury jewelry company owned by Richemont Holdings Limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Strategy </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Focus on prestige
beauty brands</b>. Prestige beauty brands are expected to contribute significantly to our growth. We focus on developing and launching
quality fragrances utilizing internationally renowned brand names. By identifying and concentrating in the most receptive market
segments and territories where our brands are known, and executing highly targeted launches that capture the essence of the brand,
we have had a history of successful launches. Certain fashion designers and other licensors choose us as a partner, because our
Company&#8217;s size enables us to work more closely with them in the product development process as well as our successful track
record.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Grow portfolio brands
through new product development and marketing</b>. We grow through the creation of fragrance family extensions within the existing
brands in our portfolio. We regularly create a new family of fragrances for each brand in our portfolio. We frequently introduce
seasonal and limited edition fragrances as well. With new introductions, we leverage our ability and experience to gauge trends
in the market and further leverage the brand name into different product families in order to maximize sales and profit potential.
We have had success in introducing new fragrance families (sub-brands, flanker brands or flankers) within our brand franchises.
Furthermore, we promote the performance of our prestige fragrance operations through knowledge of the market, detailed analysis
of the image and potential of each brand name, and a highly professional approach to international distribution channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Continue to add
new brands to our portfolio, through new licenses or acquisitions.</b> Prestige brands are the core of our business, and we intend
to add new prestige beauty brands to our portfolio. Over the past 35 years, we have built our portfolio of well-known prestige
brands through acquisitions and new license agreements. We intend to further build on our success in prestige fragrances and pursue
new licenses and acquire new brands to strengthen our position in the prestige beauty market. To that end, in 2020, we signed a
new license for the Moncler brand. We also acquired a minority interest in Divabox, which owns the Origines-parfums online platform.
As a website of reference for all selective fragrance brands, Origines-parfums is a key French player in the online beauty market
recognized for its customer relationship expertise. This acquisition enhances the introduction of dedicated fragrance lines and
products designed to address a specific consumer demand for this distribution channel and accelerate our digital development. During
2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted
for the production and distribution of Ferragamo brand perfumes. In 2021, we also entered into a long-term global licensing agreement
for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands.
This exclusive license became effective in July 2022. During 2022, we closed a transaction agreement with Lacoste, whereby an exclusive
and worldwide license was granted to Interparfums SA for the production and distribution of Lacoste brand perfumes and cosmetics.
As of December 31, 2022, we had cash, cash equivalents and short-term investments of approximately $256 million, which we believe
should assist us in entering new brand licenses or outright acquisitions. We identify prestige brands that can be developed and
marketed into a full and varied product families and, with our technical knowledge and practical experience gained over time, take
licensed brand names through all phases of concept, development, manufacturing, marketing and distribution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Expand existing
portfolio into new categories</b>. We selectively broaden our product offering beyond the fragrance category and offer other fragrance
related products and personal care products under some of our existing brands. We believe such product offerings meet customer
needs, generate trial and further strengthen customer loyalty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Continue to build
global distribution footprint</b>. Our business is a global business, and we intend to continue to build our global distribution
footprint. In order to adapt to changes in the environment and our business, in addition to our arrangements with third party distributors
globally, we are operating distribution subsidiaries or divisions in the major markets of the United States, France, Italy and
Spain for distribution of prestige fragrances. We may look into future joint arrangements or acquire distribution companies within
other key markets to distribute certain of our prestige brands. While building a global distribution footprint is part of our long-term
strategy, we may need to make certain decisions based on the short-term needs of the business. We believe that in certain markets,
vertical integration of our distribution network may be one of the keys to future growth of our Company, and ownership of such
distribution should enable us to better serve our customers&#8217; needs in local markets and adapt more quickly as situations
may determine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Production and Supply</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The stages of the development
and production process for all fragrances are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Simultaneous discussions with perfume designers and creators (includes analysis of esthetic and olfactory trends, target clientele and market communication approach)</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Concept choice</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Produce mock-ups for final acceptance of bottles and packaging</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Receive bids from component suppliers (glass makers, plastic processors, printers, etc.) and packaging companies</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Choose suppliers</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Schedule production and packaging</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Issue component purchase orders</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Follow quality control procedures for incoming components; and</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Follow packaging and inventory control procedures.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Suppliers who assist us with product development
include, but are not limited to<b>:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Independent perfumery design companies (Aesthete, Carr&#233; Basset, PI Design, Cent Degres)</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Perfumers (IFF, Givaudan, Firmenich, Robertet, Takasago, Mane) who create a fragrance consistent with our expectations and, that of the fragrance designers and creators</td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#9679;</td>
    <td style="text-align: justify">Fillers (Voyant, CPFPI, Omega Packaging, Societe de Diffusion de Produits de Parfumerie, TSM Brands, ICR, Cosmint, Tatra, Arcade Beauty)</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bottle manufacturers (Pochet du
Courval, Verescence, Verreries Brosse, Bormioli Luigi, Stoelzle Masni&#232;res, Heinz), caps (Qualipac, ALBEA, RPC, Codiplas,
LF Beauty, Texen Group, S.A.R.L. J3P SBG Packaging Group), Pumps (Silgan Dispensing Systems Thomaston Corp, Aptar, Rexam) or boxes
(Autajon, Diamond Packaging, TPC Printing)&#160;</p></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Logistics (Bansard and Bollor&#233; Logistics for storage, order preparation and shipment)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Suppliers&#8217; accounts
for our European operations are primarily settled in euro and for our United States operations, suppliers&#8217; accounts are primarily
settled in U.S. dollars. For our European operations components for our prestige fragrances are purchased from many suppliers around
the world and are primarily manufactured in France.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For United States operations,
components for our prestige fragrances are sourced from many suppliers around the world and are primarily manufactured in the United
States and Italy. Additionally, we occasionally utilize third party manufacturers in China and Turkey.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Environmental, Social &amp; Governance
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Both our U.S. operations
and our European operations are good corporate citizens and take our responsibilities seriously. We comply with all applicable
laws, rules and regulations in general, and in particular with regard to chemicals and hazardous materials. Throughout our supply
chain, from procurement of components to distribution of finished products, we act responsibly and monitor and comply with all
legal requirements.&#160;While we do not own our manufacturing facilities, we set a high bar with our industrial partners by placing
an emphasis on quality, the use of good manufacturing practices and innovation, and encouraging them to build strong ESG programs
of their own. Like many of our industry competitors, we are applying a multifunctional and comprehensive approach in addressing
the issues of corporate, environmental and social responsibility and transparency, building off the UN Sustainable Development
Goals. Our European Operations have led the way on this initiative, but our US operations are actively catching up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>European Operations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Interparfums SA, our European operations
with their headquarters in Paris, has made further progress in the areas of environmental, social, and corporate governance (ESG)
based on the results of the 2022 campaign of the rating agency Ga&#239;a Research<sup>1</sup> which ranks the top performing companies
in this area.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 24%; padding-left: 6pt; text-align: justify">Campaign for Fiscal Year</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 23%; text-align: center">2020 for Fiscal 2019</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 23%; text-align: center">2021 for Fiscal 2020</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 30%; text-align: center">2022 for Fiscal Year 2021</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 6pt; text-align: justify">ESG Rating</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">69/100</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">76/100</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">81/100</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This score is calculated
on the basis of 140 criteria divided into 4 pillars: Environmental, Social, Governance and External Stakeholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA applies
a comprehensive approach in addressing the issues of corporate, environmental and social responsibility and transparency. It has
developed from one year to the next its corporate social responsibility (&#8220;CSR&#8221;) policy, implemented by its Operational
and Support Departments by involving all personnel, and has identified issues to be addressed in three key areas: its responsibilities
toward operational stakeholders, staff and the company. Social and societal values have been an important component of Interparfums
SA&#8217;s development for a number of years, exemplified notably by an attractive policy of employee benefits and solid relations
with its partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2022, Interparfums SA announced that it had retained the services of Muriel Buiatti, as its CSR Project Manager to assist
the CSR Executive Committee in achieving its goals. A graduate of the French Engineering School, Ecole Polytechnique, Ms. Buiatti
exercised various responsibilities, including research and development, at L&#8217;Or&#233;al for 13 years. After completing
her Master&#8217;s Degree in Sustainable Development, she founded Commenterre, which specializes in helping companies address
their CSR issues.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><sup>1</sup></span>
Ga&#239;a Research, a member of the EthiFinance Group is an extra-financial rating agency specializing in rating the ESG performance
of small and midsize companies and mid-cap companies listed on European markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To support its strategy,
at the beginning of 2021 and at the initiative of management, Interparfums SA created an CSR Executive Committee, consisting of
members of the Operations &amp; Supply Chain, Human Resources, Legal Affairs and Communications teams, tasked with formalizing
the company&#8217;s CSR strategy focusing on the following priorities, aligned with the UN Sustainable Development Goals:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">reinforce its status as a responsible employer, by notably creating a &#8220;Responsible Employer
Charter&#8221; and strengthening the employee training plan;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">reduce its environmental footprint, notably by adopting environmentally optimized design specifications
to reduce packaging and the introduction of recycled and recyclable materials for each product developed;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">strengthen its sustainable development approach by formalizing a code of business conduct and ethics
that is enforceable against operational stakeholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Environmental </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA does
not own its own manufacturing facilities, having chosen to support its industrial partners by placing an emphasis on quality, the
use of good manufacturing practices and innovation. The construction of a high quality environmentally certified warehouse in 2011
and sourcing in Europe more than 80% of its needs highlight the efforts undertaken in recent years. In addition, reflecting the
stakes in terms of protecting the planet, Interparfums SA now intends to also exercise an increasingly active role in contributing
to the environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">As part of its CSR
strategy, Interparfums SA has partnered with EcoVadis to assess the CSR performance of its supply chain and suppliers. EcoVadis
operates a global platform to assess corporate social responsibility and share performance data using their assessment method based
on international CSR standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">In 2022, 119 suppliers
were evaluated or were in the process of being evaluated, representing over 68% of Interparfums SA&#8217;s procurement activity.
As part of a continuous improvement process, Interparfums SA&#8217;s objective will be to monitor and encourage the CSR performance
of its suppliers in four major areas: the environment, social and human rights, ethics and responsible procurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">EcoVadis assessment
results:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">Number of suppliers evaluated</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">Average EcoVadis score</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">Average Environmental score</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">Average Labor and Human Rights score</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">Average Ethics score</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">Average Sustainable Procurement score</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">91</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">66.7</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">69.5</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">66.9</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">60.7</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">65.3</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">In addition, in 2022,
Interparfums SA has calculated its total carbon footprint in accordance with international standards, and namely the Green House
Gas Protocol (GHG Protocol) for the conversion of all emission sources into tons of CO<span style="font-family: Times New Roman, Times, Serif"><sub>2</sub></span>
equivalent and the Base Carbone<sup>&#174;</sup>, a public database of emission factors made available by the French Agency for
Ecological Transition (ADEME).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">2021 Carbon footprint: <b>174,930 tCO2e </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td>2021 Carbon intensity: <b>312 KgCO2e per &#8364; thousand of revenue </b>(in the low range of our industry)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>In tons CO<sub>2</sub> equivalent</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">Weight</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Scope 1 (gas and fuel energy consumption)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">226</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">0,1</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Scope 2 (electricity consumption)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0,0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Scope 3 (other indirect emissions)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174,675</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99,9</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,0</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Red"><img src="img001_v1.jpg" alt="(GRAPHIC)" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This first measurement is a crucial step before determining
a low carbon trajectory in accordance with the European green deal regulation which aims to be climate-neutral by 2050.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, Interparfums
SA complies with IS 22716, International Standards for Good Manufacturing Practices, with all aspects of the manufacturing process,
including receiving of raw materials and packaging materials, production and quality control. In this regulatory environment, regular
audit campaigns are carried out for all packaging plants by the quality department based on the ISO 22716 standard in place. The
ultimate purpose of these audits is to ensure that packaging service providers maintain a good level of traceability for their
activities. All plant activities were reviewed: receiving process for raw materials and packaging materials, manufacturing, packaging
and quality controls. These reports demonstrated that Interparfums SA&#8217;s subcontractors comply with ISO 22716 Good Manufacturing
Practices and in particular, traceability requirements for all perfume production operations. It is also in compliance with the EU
directive entitled Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals (&#8220;REACH&#8221;), which
governs and regulates the safe use of chemicals. Although not a manufacturer, per se, Interparfums SA has taken the initiative
and monitors its suppliers for compliance with REACH, and has commitments from each of them concerning &#8220;Substances of Very
High Concern&#8221; as listed in appendix XIV of REACH. No supplier of Interparfums SA has advised it of any such hazardous materials
in any of its products to date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA monitors
the outsourcing of the entire production process of its manufacturing partners with expertise and accountable leadership in their
respective areas. These include producers of juice, glass, caps and cardboard boxes and packaging companies. We take environmental
issues into account at each of these phases, and in particular regarding the choice of materials used for components, waste management
and reducing the carbon footprint. Moreover, all the alcohol used by Interparfums SA is from vegetal origin (essentially from beets).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td colspan="5" style="border: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>Proposing
    environmentally and socially responsible packaging</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom"><span style="font-size: 10pt">2021</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom"><span style="font-size: 10pt">2022</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom"><span style="font-size: 10pt">Target
    </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom"><span style="font-size: 10pt">Year</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Monitor:
    Monitor the EcoVadis scores of our suppliers</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Average
    score 65/100 </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Average
    score 66.7/100</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Average
    score &gt;70/100&#160; </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">2025</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Increase:
    Increase the PCR glass part of our packaging</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">47
    %</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">46
    %</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">60
    %</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">2025</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="5" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>Initiating
    a low-carbon trajectory</b></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reduce: Reduce scope 1, 2, 3 greenhouse gases emission intensity</p></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">-3%/year</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Neutrality</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">2040</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Contribute</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Define
    the appropriate regenerative agriculture program</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">One
    5 years program defined</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Sustainability &amp;
The Environment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At every stage of the
purchasing process, Interparfums SA seeks to determine the precise needs and considers the requirement of limiting sources of unnecessary
costs and a waste of resources:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">reducing waste, in particular at the phases of production, consumption and the end of the product
life;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">recycling flawed production, notably at the production phase;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">repairing palettes to increase their lifespan.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA regularly
monitors energy and water consumption indicators to assess possibilities for improving energy efficiencies in the area of lighting,
heating and air-conditioning for the entire warehousing site, for example by adjusting ventilation flows and using a program that
reduces heating and ventilation over weekends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With this objective,
measures are planned to automatically turn off lights in the warehouse when employees are taking outside breaks and maintain the
warehouse temperature at 11&#176;C (51&#176;Fahrenheit). These energy savings initiatives include measures providing for managing
the hours for reloading the electric forklifts during non-peak hours during the night, requiring low consumption for a maximum
of 280,000 kW instead of 600,000 kW during the day. Monthly reports on electricity consumption are prepared, allowing the company
to analyze the causes for overconsumption, when applicable, in order to take corrective actions as applicable. The measurement
of energy consumption highlighted stable levels for electricity and gas over the last four years, whereas water consumption has
on average declined marginally. Finally, in the spirit of contributing to protecting the environment, the company has installed
parking places at the logistic site for bicycles and electric recharging stations for cars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By strategically locating
its warehouse at the crossroads for its subcontractors, Interparfums SA has reduced distances for shipments of finished products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Measures undertaken
in collaboration with the warehouse and trade goods shipping manager, within the framework of the improvement and optimization
of shipments between production sites and the logistics platform have contributed to reducing the number of back-and-forth trips
for trucks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the area of transport
to distributors, Interparfums SA uses road transport for France and Europe and maritime transport for the Americas, Asia and the
Middle East. Use of air transport is very limited and reserved only for urgent situations where no other solutions are available.
Certain promotional materials manufactured in Asia are shipped directly to American distributors without being imported and stored
in France.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in 2018
Interparfums SA put into service a new warehouse located in Singapore to promote the use of short channels within the Asia Pacific
region. This warehouse makes it possible to maintain a permanent inventory in this region and, in this way, encourages the use
of maritime transport for goods shipped from France to Asia.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Measures to prevent
environmental risks and pollution involve firstly the choice of techniques and materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To reduce the impacts
of its activities, a water-soluble solution in part biodegradable that does not harm the environment is used in the coloring of
some of its bottles. For the remainder of the product lines, the coating process provides for the gradual elimination of solvent-based
coatings and the progressive adoption of hydro-coating for all the company&#8217;s products, in compliance with the law of 2005
for reducing emissions of Volatile Organic Compounds (VOC) in the air. In addition, certain sub-contractors for glass making have
electrostatic air filters to reduce dust and smoke emissions in addition to wastewater recycling.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA has,
in addition, eliminated thermosetting plastics from its line of bath and body care products in favor of recyclable plastic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To balance product
quality and aesthetics with environmental considerations, Interparfums SA takes care to reduce packaging volumes and select the
appropriate materials at each stage of production to ensure optimal conditions for their recycling or disposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The manufacture of
recyclable glass bottles includes a system for the recovery, crushing and remolding the waste. Indicators in place since 2013 for
tracking wastage have improved Interparfums SA&#8217;s ability to monitor wastage rates by glass bottle decorators. Its first objective
is to apply a continuous improvement approach and reduce rates of wastage over the long term. The second objective is to succeed
in reducing this wastage and reintroduce bottles back into the manufacturing cycle.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Interparfums
SA has adopted procedures for recovering waste from subcontractors originating from surplus production or components of discontinued
products. The recovered waste is then sorted for the purpose of their elimination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA has
also revised the bulk and secondary packaging (product boxes and perfume sets) in order to optimize the palletizing process, reduce
the purchase of cardboard packaging materials and reduce volumes transported by decreasing the amount of empty space. The company
henceforth requires a minimum number of palettes per truck.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Finally, cardboard
packaging materials for testers are 100% recyclable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Social</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Donations and sponsorship
initiatives:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Interparfums SA contributes to volunteer-sector organizations intervening in the areas of solidarity,
childhood, combating exclusion and promoting health, by providing financial assistance to support their projects and initiatives.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Since 2018, through the Givaudan Foundation,</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Interparfums provided support to five schools for the management of their libraries. </td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">In 2021, the program for the installation of school libraries continued in Sulawesi with a new
library in Moramo (South East Sulawesi), benefiting 1,040 children and 66 school teachers, and providing a total of 5,180 books.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">In 2021, &#8364;136,000 of charitable initiatives and donations were made by Interparfums SA.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Educational establishments:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">As part of its desire to share its experience and train future generations, Interparfums SA is
a regular contributor, particularly in the fields of marketing and finance, at different leading schools (business schools, Sciences
Po, &#201;cole sup&#233;rieure de parfumerie).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Interparfums SA also regularly welcomes and trains interns at Interparfums SA offices as well as
work-study contract beneficiaries.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assisting Local
Economies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Production facilities of Interparfums SA&#8217;s subcontractors as well as warehousing facilities
for finished products are located primarily in the Haute Normandie region of France. These activities contribute to developing
the local economy.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Interparfums SA provides support for patchouli-producing communities in Indonesia.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sustainable Development
Goals</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In line with Interparfums
SA&#8217;s Corporate Social Responsibility strategy, the main goals set by Interparfums SA are presented in the following table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Social
    Initiatives</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Current
    Situation</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Expected
    performance</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Deadline&#160;&#160;&#160;
    </span></b></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>Attracting,
    supporting and developing all talents</b></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">Attract:</p></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Write
    a Responsible Employer Charter</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Share
    the Responsible Employer Charter</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">2023</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Develop:
    Strengthen training</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">50%
    of the employees&#160;&#160;&#160;&#160;&#160; </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">70%
    of the employees</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">2025</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Develop
    : CSR training for employees</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">80%
    in 2 years</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">2023</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Diversify: Raising employee&#160;
        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;awareness about&#160; disabilities</p></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Once
    a year</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 10pt">Once
    a year&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Governance </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Interparfums SA only engages in recognized ethical practices.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">It has adopted the Middlenext Corporate Governance Code since 2010, which was revised in September
2016 and September 2021 to ensure effective governance.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Board of Directors &#8211; Interparfums SA has a Board of Directors consisting of 11 members, with
5 members being independent. It also intends to set up a committee of shareholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Director Ethics - in accordance with the new Middlenext Code Recommendation 2 reinforcing the management
of conflicts of interest, each Director declares before each meeting any potential conflicts of interest and, on an annual basis,
any actual or potential conflicts of interest between their obligations to Interparfums SA and their private interests, in particular
with respect to their other offices and functions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">In any event, the members of the Board shall refrain from participating in the proceedings and
voting on any matter in which they would be in a situation of real or potential conflict of interest.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Existence of a CSR Executive Committee</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">Audit committee consisting of 5 independent directors.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>United States Operations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the U.S. we are
also a good corporate citizen. Like our French subsidiary, Interparfums USA also retained Muriel Buiatti to advise and guide us
on our path to become a better corporate citizen, as we attempt to increase our efforts in ESG. Also, like our French subsidiary,
we are also not a true manufacturer, but we regularly monitor our subcontractors, suppliers and fillers for their compliance. In
addition, our subcontractors and fillers are subject to inspection and audit from our various licensors for compliance with all
aspects of law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Environmental</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with
a new product launch in 2023, Hollister <i>Feelin&#8217; Good</i>, this new fragrance highlights our ESG efforts we made in 2022:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Glass containing 10% PCR (post-consumer recycled) glass, and is 100% recyclable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Our folding cartons meet the requirements of SFI, the Sustainable Forestry Initiative, and are
100% recyclable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Liners are 100% recyclable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">All components sourced from North/South America &#8211; closer supply chain for Hollister brand
fragrances and are filled and warehoused in the United States.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, all folding
cartons for all licensed brands in United States operations now consist of FSC, the Forest Stewardship Council, or SFI certified
paper. We are also making efforts to regionally source components to filling and warehousing locations where practicable in order
to lessen shipping and thereby lower energy costs. For 2023 most giftsets will be reduced in format and size, and we have eliminated
plastic from the following branded gift sets completely, Abercrombie &amp; Fitch, Donna Karan, DKNY, Hollister, MCM and Oscar
de la Renta.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our largest filler
in the United States has been awarded Bronze status in 2022 from EcoVadis. One of our largest pump manufacturers is the recipient
of a 2021 Gold Medal from EcoVadis for Sustainability and a 2020 Bronze Medal from EcoVadis for its corporate social responsibility
rating, and a large glass bottle manufacturer was awarded gold metals from EcoVadis for its corporate social responsibility rating
two years in a row. In addition in 2021, a large glass bottle manufacturer that we utilize received an &#8220;A&#8221; rating for
leadership in corporate sustainability by CDP, a global environmental non-profit group, ranking &#8216;A&#8217; for tackling water
security and &#8216;A-&#8217; for leading effort against climate change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our U.S. operations,
we do not use any banned ingredients or components and use sustainable ingredients where practicable. Some componentry (glass/folding
cartons) is also recyclable where practicable. For example, our Abercrombie &amp; Fitch <i>Away </i>fragrance uses glass and folding
cartons that are 100% recyclable, and the carton liner is 100% recyclable and biodegradable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lastly, our product
development team works with our fragrance houses &#8211; all very sustainable in their own right &#8211; to incorporate sustainably
sourced ingredients in the fragrance oils used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to
our production operations complying with applicable law, our managers, supervisors and traffic coordinators in our New Jersey
distribution center undergo training in order for us to comply with Dangerous Goods Regulations. Compliance requires training
and certification to deal in hazardous materials to prevent damage to the environment. The two main certifications are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">International Maritime
Dangerous Goods (IMDG) Dangerous Goods Training &#8211; 3 year Certification for Ocean Shipment and International Air Transport
Association (IATA) Dangerous Goods Training &#8211; 2 year Certification for Global Air Shipments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, our distribution
center in New Jersey has in-rack sprinklers to accommodate our hazardous material products. Our fragrances, Class 9 &#8211; Consumer
Commodity ID8000, are registered with American Chemistry Council, Inc. (known in the chemicals industry as Chemtrec). Chemtrec
has a 24/7 hazardous materials emergency communications center, which provides immediate assistance for incidents involving hazardous
materials of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Social &amp; Governance</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have an Ethical
Code of Conduct, which governs our behavior in the following subject matters:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CSR &amp; Governance</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employer Values</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Social Values</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate Governance</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brand Initiatives</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Environment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dangerous Goods Regulations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>CSR &amp; Governance</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Introduction</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>Responsible
employment, corporate citizenship and governance practices have been an integral part of our values from day one</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>In
                                         our recent past, environmental practices were mainly based on Good Manufacturing Practices
                                         and U.S. sourcing. </td></tr>                                                                                                                                                <tr style="vertical-align: top">
<td>&#160;</td><td>&#9679;</td><td>Today, our aim is to elevate the issue of environmental responsibility</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Practices recognized in the areas of responsible
employment, social responsibility and governance</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Employer values: A responsible employer</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">An &#8220;Interparfums spirit&#8221; cultivating a sense of belonging #OneIP #OneTeam #OneDream</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">A proactive employee relations policy</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Social values: Long-standing practices</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Ethical conduct</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Close relations with our partners</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Governance values: Long-proven practices</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Quality of profiles, balance between independent/non-independent board members</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Following Inter Parfums, Inc. Board of Directors&#8217; Diversity Policy</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interparfums USA contributes to protecting
the environment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Application of Good Manufacturing Practices</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Audits of packaging service providers</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">U.S. sourcing: 64%</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A value chain from design to distribution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Approximately 40.5
    million bottles were shipped in 2022 throughout the globe</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Approximately 2.5 million gift sets are to be shipped per year, throughout the globe</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Working with U.S. packaging sites:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">6 fragrance filling and assembly sites</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">About 20 packaging component sites</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">A 150,000 sq. ft. warehouse and distribution facility in Dayton, New Jersey</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Points of sale all around the world</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Targets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Reinforcing our status as socially engaged and responsible employer</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Reinforcing our corporate governance practices</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Become an active contributor to protecting the environment</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recent Actions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Creation of working groups to integrate
an &#8220;optimized eco-design&#8221; component in products over their entire lifecycle</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Use of environmentally responsible materials</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Reducing weight and size of glass, cardboard and plastics</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Strengthening relations with design houses (natural products, sourcing, traceability)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Employer values
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current situation: A proactive employee
relations policy</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-standing fundamentals</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">A family-style management culture built on fostering close relations</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">An &#8220;Interparfums spirit&#8221; promoting a sense of belonging</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Ethical values based notably on respecting people</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Welcoming and sharing new ideas</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Job preservation</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Paid time off for vacation, sick days and personal days</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Workplace Quality of life</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Positions that encourage responsibility and autonomy</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Respecting a proper balance between business and private life</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Managing talent (appraisal interviews, training)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">A commitment to combating all forms of discrimination</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Paid
                                         sick leave benefits, including maternity leave and caring for a family member with a
                                         serious health condition</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A motivating compensation policy</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Compensation levels in line with market practice</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Savings plans in the form of 401K</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Available health insurance programs with multiple coverage options</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Stock option plans available for certain officers and high-level employees</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Targets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Formalizing employee relations practices through an employee Workplace Safety Committee</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><br />
<i>Social Values</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current situation: Recognized business
ethics</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Relations with brands under license agreements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">A focus on developing genuine partnerships through close and regular relations with the management
of each brand</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Developing products that respect the codes of each brand</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Dedicated Interparfums USA marketing teams</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Relations with customers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Long (or very long-term) relationships with distributors</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Taking into account the specific characteristics of each market and country</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Developing products in some cases specifically adapted to demands</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Sharing projects at a very early stage</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Relations with industrial partners</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Long or very long-term relationships with manufacturers in the sector</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Implementing guidelines on &#8220;Good Manufacturing Practices&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Supporting innovation</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Financial support (2020 pandemic)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Targets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Raising awareness of our partners about CSR challenges</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Corporate governance
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current situation: Long-proven practices</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">10 members: 6 independent directors (60%)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Audit Committee, Executive Compensation
Committee and Nominating Committee</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">3 members: 3 independent directors (100%)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Important Business Policies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Prohibition on fraud, bribes, kickbacks and other
benefits to suppliers and customers</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Prohibition on trading in the company&#8217;s securities
on the basis of non-public material information</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Requirement of Company-wide confidentiality for non-public
sensitive or proprietary information</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Prohibition on sexual harassment</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Prohibition on use of child labor and slave labor</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Targets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Consolidating our existing corporate governance practices</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Strengthening alignment with Inter Parfums, Inc. Board Diversity Policy</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Brand initiatives</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MCM</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>MCM EAU DE PARFUM</i> PACKAGING SUSTAINABILITY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Outer packaging is 100% recyclable and Forest Stewardship Council (FSC) certified</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">FSC sets standards for responsible forest management</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">FSC is the gold standard in forest certification</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Glass bottle is made from post-industrial recycled materials</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Only environmentally friendly ink and colorants were used for the bottle and carton</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">HOLLISTER</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">HOLLISTER <i>CANYON ESCAPE</i> named &#8220;GOOD FOR VEGAN&#8221;
by Sephora</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Hollister <i>Canyon Escape For Him</i> and Hollister <i>Canyon Escape For Her</i> meet the following
criteria:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Do not contain substances of animal origin (i.e., carmine, beeswax, honey, royal jelly, marine
collagen, lanolin, fish extract, musk, silk, gelatin, milk, keratin, etc.)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Formula has not been tested on animals</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Do not contain raw materials that have been tested on animals since March 11, 2009 for cosmetic
purposes</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ABERCROMBIE &amp; FITCH</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ABERCROMBIE &amp; FITCH <i>AWAY</i> PACKAGING
SUSTAINABILITY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Uses glass and folding cartons that are 100% recyclable</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Carton liner is 100% recyclable and biodegradable</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>The Environment </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Focus of 2022 work</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Today, Interparfums USA is pursuing an
environmental approach in the following areas</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Manufacturing of components</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">The design of fragrances (juice)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Industrial packaging</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Production of components</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Glass bottles: Reducing consumption of glass and systematic use of recycled glass for launches</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Packaging: Reducing consumption of cardboard, use of sustainable FSC-certified cardboard</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Gift sets: Use of FSC cardboard</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Design of fragrances (&#8220;juice&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>Continue close collaboration with fragrance houses to incorporate sustainably sourced ingredients in the fragrance oils used</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Industrial packaging</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Continue to work in close collaboration with EcoVadis Award Winning packaging service providers</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td style="text-align: justify">Our largest filler in the United States has been awarded Bronze status in 2022 from EcoVadis. One
of our largest pump manufacturers is the recipient of a 2021 Gold Medal from EcoVadis for Sustainability and a 2020 Bronze Medal
from EcoVadis for its corporate social responsibility rating, and a large glass bottle manufacturer was awarded gold metals from
EcoVadis for its corporate social responsibility rating two years in a row.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EcoVadis</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>A platform used by the main perfumes &amp; cosmetics industry players</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>4 pillars:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td>The environment</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td>Social &amp; Human Rights</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td>Ethics</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9675;</span></td><td>Responsible sourcing</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Targets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>Become an active contributor to protecting the environment as well as through our business partners</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As we continue in
our endeavors of responsible employment, corporate citizenship and governance practices, and continue to elevate the issue of environmental
responsibility, we will update our policies and procedures accordingly. As such, this Ethical Code of Conduct will be updated from
time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Marketing and Distribution</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are distributed
in over 120 countries around the world through a selective distribution network. For our international distribution, we either
contract with independent distribution companies specializing in luxury goods or distribute prestige products through our distribution
subsidiaries. In each country, we designate anywhere from one to three distributors on an exclusive basis for one or more of our
name brands. We also distribute our products through a variety of duty free operators, such as airports and airlines and select
vacation destinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As our business is
a global one, we intend to continue to build our global distribution footprint. For the distribution of brands within our European
based operations, we operate through our distribution subsidiaries or divisions in the major markets of the United States, France,
Italy and Spain, in addition to our arrangements with third party distributors globally. Our third party distributors vary in size
depending on the number of competing brands they represent. This extensive and diverse network together with our own distribution
subsidiaries provides us with a significant presence in over 120 countries around the world.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over 50% of our European
based prestige fragrance net sales are denominated in U.S. dollars. We address certain financial exposures through a controlled
program of risk management that includes the use of derivative financial instruments. We primarily enter into foreign currency
forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The business of our
European operations has become increasingly seasonal due to the timing of shipments by our distribution subsidiaries and divisions
to their customers, which are weighted to the second half of the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For our United States
operations, we distribute products to retailers and distributors in the United States as well as internationally, including duty
free and other travel-related retailers. We utilize our in-house sales team to reach our third party distributors and customers
outside the United States. In addition, the business of our United States operations has become increasingly seasonal as shipments
are weighted toward the second half of the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Competition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for prestige
fragrance products is highly competitive and sensitive to changing preferences and demands. The prestige fragrance industry is
highly concentrated around certain major players with resources far greater than ours. We compete with an original strategy, regular
and methodical development of quality fragrances for a growing portfolio of internationally renowned brand names.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Inventory</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We purchase raw materials
and component parts from suppliers based on internal estimates of anticipated need for finished goods, which enables us to meet
production requirements for finished goods. We generally ship products to customers within 72 hours of the receipt of their orders.
Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general
contractor and source our needed components from our suppliers. These components are received at one of our distribution centers
and then, based upon production needs, the components are sent to one of several third party fillers or directly to one of those
third party fillers, which manufacture the finished products for us and then deliver them to one of our distribution centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Product Liability</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our United States operations
maintain product liability coverage in an amount of $10.0 million, and our European operations maintain product liability coverage
in an amount of &#8364;20 million (approximately $21 million). Based on our experience, we believe this coverage is adequate and
covers substantially all of the exposure we may have with respect to our products. We have never been the subject of any material
product liability claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Government Regulation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Federal Food,
Drug and Cosmetic Act, fragrance products are regulated as cosmetics, and fragrances include perfumes, colognes and aftershave.
They must meet the same requirements for safety as other cosmetic ingredients. Compliance required of fragrance ingredients include
being safe for consumers when they are used according to labeled directions or as consumers customarily use them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Fair Packaging
and Labelling Act, companies and individuals who manufacture or market cosmetics have the legal responsibility to ensure the products
are safe and labelled according to the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our fragrance products
that are manufactured and marketed in Europe are also regulated as cosmetics and subject to EU Regulation 1223/2009, and after
Brexit, the United Kingdom regulation of The UK Schedule 34 to the Product Safety and Metrology Regulation 2019. As of the date
of this report, IP products are in compliance with these regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Trademarks</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for our
products depends to a significant extent upon the value associated with our trademarks and brand names. We have licenses or other
rights to use, or own, the material trademark and brand name rights used in connection with the packaging, marketing and distribution
of our major products both in the United States and in other countries where such products are principally sold. Therefore, trademark
and brand name protection are important to our business. Although most of the brand names we license, use or own are registered
in the United States and in certain foreign countries in which we operate, we may not be successful in asserting trademark or brand
name protection. In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same
extent as the laws of the United States. The costs required to protect our trademarks and brand names may be substantial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under various licenses
and other agreements, we have the right to use certain registered trademarks throughout the world for fragrance products. These
registered trademarks include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Abercrombie &amp; Fitch</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Anna Sui</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">bebe</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Boucheron</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Coach</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 48px">&#160;</td>
    <td style="text-align: justify; width: 24px">&#9679;</td>
    <td style="text-align: justify">Donna Karan and DKNY</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Dunhill</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#9679;</td>
    <td style="text-align: justify">Emanuel Ungaro</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">French Connection</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Graff</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#9679;</td>
    <td style="text-align: justify">GUESS</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Hollister</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Jimmy Choo</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Kate Spade</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Karl Lagerfeld</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">MCM</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Moncler</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#9679;</td>
    <td style="text-align: justify">Montblanc</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Oscar de la Renta</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Ferragamo</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#9679;</td>
    <td style="text-align: justify">S.T. Dupont</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Van Cleef &amp; Arpels</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we are the registered owner
of several trademarks for fragrance and beauty products, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Rochas</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Lanvin</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Intimate</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Aziza</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Human Capital</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31,
2022, we had 527 full-time employees worldwide. Of these, 306 are full-time employees of our European operations and its subsidiaries,
with 186 employees engaged in sales activities and 120 in administrative, production and marketing activities. Our United States
operations have 175 full-time employees, and of these, 51 are engaged in sales activities and 124 in administrative, production
and marketing activities. In addition, Interparfums Italia Srl, our wholly-owned subsidiary, has 46 full-time employees, with 21
engaged in sales activities and 25 in administrative, production and marketing activities. Other than for the employees of Interparfums
Italia Srl, we do not have collective bargaining agreements relating to any of our employees, and we believe the collective bargaining
agreement for our employees of Interparfums Italia Srl will not have a material adverse effect on our operations. We strive to
maintain an inclusive environment free from discrimination of any kind, including sexual or other discriminatory harassment and,
believe that our relationship with our employees is good.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goals for our employees Company-wide are</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">developing a team spirit and cross-functional collaboration;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">maintaining a high level of expertise;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">cultivating a culture that promotes our values of entrepreneurship, commitment, creativity and
passion;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">developing a respectful and inclusive work environment;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">ensuring equal opportunity employment;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">empowering employees to develop their skills and grow their careers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">promoting dialogue between employees and management;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">offering quality working conditions;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">preserving the health and safety of all;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 13.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: justify">maintaining a proper balance between professional and private life.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>United States Operations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our employees are one
of our most valuable assets, and fostering long-term relationships are beneficial to the continuity of our business. After experience
and expertise in the respective fields of employment, we look for dedication and loyalty among our employees, as we believe having
long-term staff members benefits our Company. All of our executive senior officers have been with us for more than twenty years
(other than our CFO who just joined our company in September 2022), and we have several senior and upper-level staff members, who
have also been with us long-term. These long-term executives and employees believe that our Company and their co-workers are an
extended family and share the same values of entrepreneurship, commitment, creativity and passion. Their efforts and dedication
are what allow our Company to prosper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Every year, United
States operations organizes two seminars over several days for all its global sales staff. This seminar provides an opportunity
to present all the Company&#8217;s brands and products and marketing strategies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The safety of our employees
is of paramount importance to us. In the early stages of the COVID-19 pandemic, we experienced brief closures at all of our locations,
and adapted to working remotely. Upon reopening, we implemented prevention protocols to minimize the spread of COVID-19 in our
workplaces. These protocols, which remain in place, are in compliance with the Centers for Disease Control guidelines and state
requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of our increasing
benefits of working at our United States operations, we provide a comprehensive benefits package (medical, dental, vision, long-term
disability, accidental death and dismemberment insurance and life insurance, 401-K, commuter benefits), allow Friday remote working
arrangements for our employees, have shorter hours on Fridays during the summer months, offer various gifts and &#8220;goodie bags&#8221;
during various times of the year, have made available food choices for purchase in our lunchroom in New York from the &#8220;Fra&#238;che
fridge,&#8221; and hold quarterly presentations showing financial results, updates on all departments, existing product lines,
as well as the development and launches of new products for all of our brands for all employees and consultants worldwide of United
States operations so that all are made aware of our operations, and invite comments from those in attendance at the presentations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Interparfums Italia
Srl</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The employees of our
wholly-owned Italian subsidiary, Interparfums Italia Srl, receive both benefits required under Italian law and certain additional
benefits that it provides. Below are employee benefits provided as required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Health insurance
for employees and family coverage</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Supplementary voluntary
severance plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Parental leave</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Study leave</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Training in health
and safety at work</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Paid time off</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9675; Implementation of
Covid anti-contagion measures and protocol</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums Italia
also provides these additional benefits for its employees:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Working remotely 2 days per
week</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Flexible working hours
(different start and end times for employees&#8217; workday)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Onboarding Process
&#8211; Welcome day (includes training on Company&#8217;s history and values, meeting with all teams, a gift and dinner with
the new hire&#8217;s team)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Welfare Plan &#8211;
&#8364;500 per year to each employee that can be used through a dedicated platform that encompasses a broad range of benefits and
services (transportation, education, health, culture and leisure time, supplementary pension, other fringe benefits)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Paid time off for medical checkups
- 10 hours per year</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Restaurant voucher to cover
lunch expenses (value of &#8364;8 per each day worked)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Mobile phone and unlimited
internet connection for specific category of employees (based on role)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following additional benefits
are also provided:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Event celebrations to actively
promote and build a sense of belonging</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; New office set up including
dining area to socialize and relax (free coffee, tea and biscuits)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Easter - Chocolate eggs
gift for charity purpose (AIL - Italian Association against Leukemia Lymphoma and Myeloma)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#9675; Christmas &#8211; Greeting
cards and gift sets baskets for charity purpose (ANT &#8211; Medical care at home for cancer patients)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>European Operations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA&#8217;s
employees constitute its most important contributor for creating value. For that reason, their professional fulfillment and motivation
are indispensable drivers for our development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a family-style
management culture that is close to its employees, everyone is free to share their ideas in a manner that respects the company&#8217;s
values. Management attaches great importance to ensuring that each employee fully understands and supports Interparfums SA&#8217;s
strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Through weekly memos
and regular information meetings on business developments and trends, employees are kept up-to-date on expectations of management
and the market. The organization&#8217;s flexibility largely made up of small teams facilitates its continuous adaptation to all
changes or evolving external conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This sharing of the
&#8220;Interparfums&#8221; spirit, also entails a commitment to and understanding of its ethical values by each employee, the fulfillment
of employees at work and compliance with good working conditions. This ethical commitment is formalized by a &#8220;Code of Good
Conduct&#8221; to which each employee subscribes, and that is focused in particular on health, safety, discipline, risk management,
preventing harassment, respecting individual freedoms, sensitive transactions, fraud and business confidentiality.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2017, Interparfums
SA adopted a Charter relating to the right to disconnect from digital devices that was accepted by each employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Every two to three
years, Interparfums SA organizes a seminar over several days for all its distributors from throughout the world. This seminar provides
an opportunity to present all the company&#8217;s brands and products, meet with all distributors and involve them in Interparfums
SA&#8217;s development while giving the distributors an opportunity to meet with staff with whom they work closely on a daily basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Human Resources
Department pays particular attention to ensuring equal opportunity and non-discrimination for each recruitment. Only skills, experience,
qualifications and the personality of the candidates are taken into account in the selection process for new employees. This diversity
in terms of profiles, culture, age and gender constitutes a decisive strength of its teams, the company&#8217;s most important
asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Women account for 72%
of Interparfums&#8217; workforce and 52% of management positions are occupied by women in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since 2019, Interparfums
SA has organized an annual disability awareness raising campaign. In 2021, employees were given an opportunity to participate role-playing
workshop designed to give them a first-hand perspective of a person with a disability (hearing, visual, psychological, motor).
Thanks to these opportunities for exchange, employees were able to talk about their all possible impediments and share their views
and experiences.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Through these awareness-raising
campaigns and local support from the Human Resources teams, two employees were accorded the status of employees with disabilities
through a specific procedure available in France for that purpose (Reconnaissance de la Qualit&#233; de Travailleur Handicap&#233;
or RQTH).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA also
participates indirectly in promoting the employment of persons with disabilities and combating exclusion discrimination. The company
has chosen to use a sheltered work enterprise to package its perfume boxes and a global communications agency called &#8220;Les
Papillons de Jour&#8221; to organize the European Week for the Employment of People with Disabilities (EWPD).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2021, the total
cost for these services amounted to &#8364;974,094.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Interparfums
SA has adopted action plans promoting the employment of seniors and equal opportunity between men and women.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Compensation and
wage increases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA has
a compensation policy as well as a system of job classifications and performance evaluations applied to all employees. These procedures
guarantee the principle of fairness as well as equal treatment of men and women employees. All employees benefit from a combination
of fixed and variable incentive compensation benefits linked to Interparfums SA&#8217;s performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Profit-sharing</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required by French
law, a statutory employee profit-sharing agreement was implemented in 2001. In April 2015, this agreement was amended to provide
more advantageous terms to employees, representing an important component of compensation and motivation for all staff and reviewed
every year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Savings plan and
pension plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All employees of Interparfums
SA benefit from a company savings plan which proposes several types of funds corresponding to the specific projects of each. Since
2017, it has adapted its plan by proposing an Interparfums stock ownership fund allowing employees to take advantage of the growth
of Interparfums&#8217; shares under favorable tax conditions. The amounts employees pay into this fund are supplemented by an important
contribution by the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a group
retirement savings plan (Plan d&#8217;Epargne Retraite Collectif or PERCOL) is available to employees as a vehicle for preparing
for their retirement and to which the company contributes significantly. Employees also can transfer a portion of their unused
annual vacation days into the Interparfums SA retirement savings plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Supplemental defined
contribution retirement plan contract (Article 83)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management employees
benefit from a supplemental defined-contribution retirement plan. Participation in this plan is mandatory. This individual plan
is funded by monthly employee and employer contributions, with the breakdown of these latter contributions freely determined. Interparfums
SA has decided to assist its employees in financing this supplemental retirement benefit, by assuming an important percentage of
these contributions itself.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a004"></span>Item 1A. Risk Factors. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should carefully
consider these material risk factors before you decide to purchase or sell shares of our common stock. These factors could cause
our future results to differ materially from those expressed or implied in forward-looking statements made by us. The trading price
of our common stock could decline due to any of these risks, and you may lose all or part of your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#9679;</td>
    <td style="text-align: justify"><b><span style="text-decoration: underline">Fragrance Business, Brand Names and Intellectual Property</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are dependent upon the continuation
and renewal of various licenses and other agreements for a significant portion of our sales, and the loss of one or more licenses
or agreements could have a material adverse effect on us.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our rights relating
to prestige fragrance brands, other than Lanvin and Rochas, are derived from licenses or other agreements from unaffiliated third
parties, and our business is dependent upon the continuation and renewal of such licenses and other agreements on terms favorable
to us. Each license or agreement is for a specific term and may have additional optional terms. Generally, each license is subject
to us making required royalty payments (which are subject to certain minimums), minimum advertising and promotional expenditures
and meeting minimum sales requirements. Other agreements are generally subject to meeting minimum sales requirements. Just as the
loss of a license or other significant agreement may have a material adverse effect on us, a renewal on less favorable terms may
also negatively impact us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>If we are unable to acquire or license
additional brands or obtain the required financing for these agreements and arrangements, then the growth of our business could
be impaired. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future expansion
through acquisitions or new product licenses or distribution arrangements, if any, will depend upon the capital resources and working
capital available to us. Further, we may be unable to obtain financing or credit that we may require for additional licenses, acquisitions
or other transactions. We may be unsuccessful in identifying, negotiating, financing and consummating such acquisitions or arrangements
on terms acceptable to us, or at all, which could hinder our ability to increase revenues and build our business. Just as the loss
of a license or other significant agreement may have a material adverse effect on us, our failure to acquire rights to new brands
may also negatively impact us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We may engage in future acquisitions
that we may not be able to successfully integrate or manage. These acquisitions may dilute our stockholders and cause us to incur
debt and assume contingent liabilities. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We continuously review
acquisition prospects that would complement our current product offerings, increase our size and geographic scope of operations
or otherwise offer growth and operating efficiency opportunities. The financing, if available, for any of these acquisitions could
significantly dilute our stockholders and/or result in an increase in our indebtedness. We may acquire or make investments in businesses
or products in the future, and such acquisitions may entail numerous integration risks and impose costs on us, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">difficulties in assimilating acquired operations or products, including the loss of key employees from acquired businesses</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">diversion of management&#8217;s attention from our core business</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">adverse effects on existing business relationships with suppliers and customers</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">risks of entering markets in which we have no or limited prior experience</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">dilutive issuances of equity securities</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">incurrence of substantial debt</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">assumption of contingent liabilities</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">incurrence of significant amortization expenses related to intangible assets and the potential impairment of acquired assets and</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">incurrence of significant immediate write-offs.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our failure to successfully
complete the integration of any acquired business could have a material adverse effect on our business, financial condition and
operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Joint arrangements or strategic alliances
in geographic markets in which we have limited, or no prior experience may expose us to additional risks.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review, and from
time to time may establish, arrangements and strategic alliances that we believe would complement our current product offerings,
increase the size and geographic scope of our operations or otherwise offer growth and operating efficiency opportunities. These
business relationships may require us to rely on the local expertise of our partners with respect to market development, sales,
local regulatory compliance and other matters. Further, there may be challenges with ensuring that such arrangements or strategic
alliances implement the appropriate internal controls to ensure compliance with the various laws and regulations applicable to
us as a U.S. public company. Accordingly, in addition to commercial and operational risk, these arrangements and strategic alliances
may entail risks such as reputational risk and regulatory compliance risk. In addition, there can be no assurance that we will
be able to identify suitable alliances or candidates, that we will be able to consummate any such alliances or arrangements on
favorable terms, or that we will realize the anticipated benefits of entering into any such alliances or arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>If we are unable to protect our intellectual
property rights, specifically trademarks and brand names, our ability to compete could be negatively impacted.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for our
products depends to a significant extent upon the value associated with trademarks and brand names that we license, use or own.
We have licenses or other rights to use, or own the material trademark and brand name rights in connection with the packaging,
marketing and distribution of our major products both in the United States and in other countries where such products are principally
sold. Therefore, trademark and brand name protection are important to our business. Although most of the brand names we license,
use or own are registered in the United States and in certain foreign countries in which we operate, we may not be successful in
asserting trademark or brand name protection. In addition, the laws of certain foreign countries may not protect our intellectual
property rights to the same extent as the laws of the United States. The costs required to protect our trademarks and brand names
may be substantial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I<b>f our intangible assets, such as trademarks
and licenses, become impaired, we may be required to record a significant non-cash charge to earnings which would negatively impact
our results of operations.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under United States
generally accepted accounting principles, we review our intangible assets, including our trademarks and licenses, for impairment
annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate the carrying
value of our intangible assets may not be fully recoverable. The carrying value of our intangible assets may not be recoverable
due to factors such as reduced estimates of future cash flows, including those associated with the specific brands to which intangibles
relate, or slower growth rates in our industry. Estimates of future cash flows are based on a long-term financial outlook of our
operations and the specific brands to which the intangible assets relate. However, actual performance in the near-term or long-term
could be materially different from these forecasts, which could impact future estimates and the recorded value of the intangibles.
Any significant impairment to our intangible assets would result in a significant charge to earnings in our financial statements
during the period in which the impairment is determined to exist.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The illegal distribution and sale by
third parties of counterfeit versions of the Company&#8217;s products or the unauthorized diversion by third parties of the Company&#8217;s
products could have an adverse effect on the Company&#8217;s revenues and a negative impact on the Company&#8217;s reputation and
business.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Third parties may illegally
distribute and sell counterfeit versions of the Company&#8217;s products. These counterfeit products may be inferior in terms of
quality and other characteristics compared to the Company&#8217;s authentic products and/or the counterfeit products could pose
safety risks that the Company&#8217;s authentic products would not otherwise present to consumers. Consumers could confuse counterfeit
products with the Company&#8217;s authentic products, which could damage or diminish the image, reputation and/or value of the
Company&#8217;s brands and cause consumers to refrain from purchasing the Company&#8217;s products in the future. In addition,
the sale of the Company&#8217;s prestige products through non-authorized &#8220;grey market&#8221; channels could damage or diminish
the image, reputation and/or value of the Company&#8217;s brands and could adversely affect the Company&#8217;s revenues and have
a negative impact on the Company&#8217;s reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our success depends on our ability to
operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and proprietary
rights of other parties.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our commercial success
depends at least in part on our ability to operate without infringing, misappropriating or otherwise violating the trademarks,
patents, copyrights and other proprietary rights of others. However, we cannot be certain that the conduct of our business does
not and will not infringe, misappropriate or otherwise violate such rights. Many companies have employed intellectual property
litigation as a way to gain a competitive advantage, and to the extent we gain greater visibility and market exposure, we may also
face a greater risk of being the subject of such litigation. For these and other reasons, third parties may allege that our products,
services or activities infringe, misappropriate or otherwise violate their trademark, patent, copyright or other proprietary rights.
Defending against allegations and litigation could be expensive, take significant time, divert management&#8217;s attention from
other business concerns, and delay getting our products to market. In addition, if we are found to be infringing, misappropriating
or otherwise violating third party trademark, patent, copyright or other proprietary rights, we may need to obtain a license, which
may not be available on commercially reasonable terms or at all, or redesign or rebrand our products, which may not be possible.
We may also be required to pay substantial damages or be subject to a court order prohibiting us and our customers from selling
certain products or engaging in certain activities. Our inability to operate our business without infringing, misappropriating
or otherwise violating the trademarks, patents, copyrights and proprietary rights of others could therefore have a material adverse
effect on our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><b>&#9679;</b></td>
    <td style="text-align: justify"><b><span style="text-decoration: underline">COVID-19 Pandemic and Economic Downturn</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Although in both 2022 and 2021 we weathered
the COVID-19 pandemic and its effects to date, if the pandemic reemerges, it may have a material adverse effect on our business,
results of operations, financial condition and cash flows.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The public health crisis
caused by the COVID-19 pandemic, its variants and the measures being taken by governments, businesses, including us, our suppliers,
our distributors, retailers and the public, to limit COVID-19&#8217;s spread, have had and we expect will continue to have, certain
negative impacts on our business including, but not limited to, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Deteriorating economic and political conditions in certain of our major markets affected by the COVID-19 pandemic, such as increased unemployment, decreases in disposable income, declines in consumer confidence, or economic slowdowns could cause a decrease in demand for our products.</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">We may be required to record significant impairment charges with respect to noncurrent assets, including trademarks, licenses and other intangible assets whose fair values may be negatively affected by the effects of re-emergence of the COVID-19 pandemic on our operations.</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Considerable uncertainty remains regarding the potential re-emergence of COVID-19 variants, including potential reinstatement of measures by various authorities and others in response to any such re-emergence. As we continue to monitor potential COVID-19 variant developments, including the impacts on our consumers, customers and suppliers, we take further measures as necessary to protect our business and our employees. Some of the actions we take could adversely impact our business, and there is no certainty that our actions will be sufficient to mitigate the risks and the impacts of a re-emergence of COVID-19 variants.</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Actions we may take, or decisions on potential actions that we did not take, as a consequence of a resurgence of a COVID-19 variant pandemic may result in claims or litigation against us.</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consumers may reduce discretionary purchases of our products
as a result of a general economic downturn. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that a high
degree of global economic uncertainty could have a further negative effect on consumer confidence, demand and spending. In addition,
we believe that consumer spending on beauty products is influenced by general economic conditions and the availability of discretionary
income. Accordingly, we may experience sustained periods of declines in sales during periods of economic downturn as it may affect
consumer purchasing patterns. In addition, a further general economic downturn may result in further reduced traffic in our customers&#8217;
stores which may, in turn, result in reduced net sales to our retail store customers. Any further material reduction in our sales
could have a material adverse effect on our business, financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>An outbreak of any other disease, epidemic
or pandemic, or similar public health threat on the scope of COVID-19, could have a material adverse impact on the Company&#8217;s
business, operating results and financial condition.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An outbreak of disease,
epidemic or pandemic, or similar public threat on the scope of COVID-19, or fear of such an event, that negatively impacts consumer
spending on our products could have a material adverse impact on the Company&#8217;s business, financial condition and operating
results. The extent and potential short and long-term impact of any other pandemic on the Company&#8217;s operational and financial
performance will depend on future developments, including the duration and spread of the outbreak, our customers&#8217; willingness
to travel and purchase our products, and the impact on our supply chain and the financial markets, all of which are highly uncertain
and cannot be predicted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#9679;</td>
    <td style="text-align: justify"><b><span style="text-decoration: underline">Global Operations</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are subject to risks related to our
foreign operations, and a disruption in our operations or supply chain could adversely affect our business and financial results.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate on a global
basis, with a substantial portion of our net sales and net income generated outside the United States, and we anticipate for the
foreseeable future that a substantial portion of our net sales and net income will be generated outside the United States. A substantial
portion of our cash, cash equivalents and short-term investments that result from these earnings remain outside the United States.
As a company engaged in manufacturing and distribution on a global scale, we are subject to many risks and uncertainties, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">changes in foreign laws, regulations and policies, including restrictions on trade, import and export license requirements, and tariffs and taxes, as well as changes in United States laws and regulations relating to foreign trade and investment; and</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">industrial accidents, environmental events, strikes and other labor disputes, disruptions in supply chain or information technology, loss or impairment of key manufacturing sites or suppliers, product quality control, safety, as well as natural disasters, adverse weather conditions, social, economic and geopolitical conditions, such as terrorist attacks, war or other military action and other external factors over which we have no control.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These risks could have
a material adverse effect on our business, prospects, results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terrorist attacks, acts of war or military
actions, other civil unrest or natural disasters may adversely affect territories in which we operate, and therefore affect our
business, financial condition and operating results. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Terrorist attacks such
as those that have previously occurred in Paris, France where we have our European headquarters, amongst other locations, and attempted
terrorist attacks, military responses to terrorist attacks, other military actions, or governmental action in response to or in
anticipation of a terrorist attack, or civil unrest as occurring in the Middle East, Ukraine and Africa or natural disasters, may
adversely affect prevailing economic conditions. These events could result in work stoppages, reduced consumer spending or reduced
demand for our products. These developments subject our worldwide operations to increased risks and, depending on their magnitude,
could reduce net sales and therefore could have a material adverse effect on our business, financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The loss of or disruption in our distribution
facilities could have a material adverse effect on our business, financial condition and operating results. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently have several
distribution facilities in Europe, China and the United States. The loss of any of those facilities, as well as the inventory stored
in those facilities, would require us to find replacement facilities and assets. In addition, acts of God, such as extreme weather
conditions, natural disasters and the like or terrorist attacks, could disrupt our distribution operations. If we cannot replace
our distribution capacity and inventory in a timely, cost-efficient manner, then such failure could have a material adverse effect
on our business, financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in foreign tax provisions, the
adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to being
subject to taxation in the United States, we are subject to income and other taxes in other foreign jurisdictions. Our effective
tax rate in the future could be adversely affected by changes to our operating structure, changes in the mix of earnings in countries
with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws and the
discovery of new information in the course of our tax return preparation process. From time to time, tax proposals are introduced
or considered by the United States Congress or the legislative bodies in foreign jurisdictions that could also affect our tax rate,
the carrying value of our deferred tax assets, or our other tax liabilities. Our tax liabilities are also affected by the amounts
we charge for inventory, services, licenses, funding, cross-jurisdictional transfer pricing, and other items in intercompany transactions.
A negative determination or ultimate disposition in any tax audit, changes in tax laws or tax rates, or the ability to utilize
our deferred tax assets could materially affect our tax provision, net income and cash flows in future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The international character of our business
renders us subject to fluctuation in foreign currency exchange rates and international trade tariffs, barriers and other restrictions.
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A substantial portion
of our European operations&#8217; net sales (over 50%) are sold in U.S. dollars. In an effort to reduce our exposure to foreign
currency exchange fluctuations, we engage in a controlled program of risk management that includes the use of derivative financial
instruments for all major currencies with which we operate. Despite such actions, fluctuations in foreign currency exchange rates
for the U.S. dollar, particularly with respect to the euro, could have a material adverse effect on our operating results. Possible
import, export, tariff and other trade barriers, which could be imposed by the United States, the European Union or other countries
might also have a material adverse effect on our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changing political conditions could
adversely impact our business and financial results.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Changes in the political
conditions in markets in which we manufacture, sell or distribute our products may be difficult to predict and may adversely affect
our business and financial results. In addition, results of elections, referendums or other political processes in certain markets
in which our products are manufactured, sold or distributed could create uncertainty regarding how existing governmental policies,
laws and regulations may change, including with respect to sanctions, taxes, the movement of goods, services, capital and people
between countries and other matters. The potential implications of such uncertainty, which include, among others, exchange rate
fluctuations, tariffs, trade barriers and market contraction, could adversely affect the Company&#8217;s business and financial
results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><b>&#9679;</b></td>
    <td style="width: 97%; text-align: justify"><b><span style="text-decoration: underline">Operational Risks</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are dependent upon Messrs. Jean Madar
and Philippe Benacin, and the loss of their services could harm our business.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Jean Madar, our Chairman
and Chief Executive Officer, and Philippe Benacin, our President, and Chief Executive Officer of Interparfums SA, are responsible
for day-to-day operations as well as major decisions. Termination of their relationships with us, whether through death, incapacity
or otherwise, could have a material adverse effect on our operations, and we cannot assure you that qualified replacements can
be found.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our reliance on third party manufacturers
could have a material adverse effect on us.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely on outside
sources to manufacture our fragrances and cosmetics. The failure of such third party manufacturers to deliver either compliant,
quality components or finished goods on a timely basis could have a material adverse effect on our business. Although we believe
there are alternate manufacturers available to supply our requirements, we cannot assure you that current or alternative sources
will be able to supply all of our demands on a timely basis. We do not intend to develop our own manufacturing capacity. As these
are third parties over whom we have little or no control, the failure of such third parties to provide components or finished goods
on a timely basis could have a material adverse effect on our business, financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our reliance on third party distributors
could have a material adverse effect on us.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We sell a substantial
percentage of our prestige fragrances through independent distributors specializing in luxury goods. Given the growing importance
of distribution, we have modified our distribution model by owning a controlling interest in certain of our distributors within
key markets. However, we have little or no control over third party distributors and the failure of such third parties to provide
services on a timely basis could have a material adverse effect on our business, financial condition and operating results. In
addition, if we replace existing third party distributors with new third party distributors or with our own distribution arrangements,
then transition issues could have a material adverse effect on our business, financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our business is subject to governmental
regulation, which could impact our operations.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Federal Food,
Drug and Cosmetic Act, fragrance products are regulated as cosmetics, and fragrances include perfumes, colognes and aftershave.
They must meet the same requirements for safety as other cosmetic ingredients. Compliance required of fragrance ingredients include
being safe for consumers when they are used according to labelled directions or as consumers customarily use them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Fair Packaging
and Labelling Act, companies and individuals who manufacture or market cosmetics have the legal responsibility to ensure the products
are safe and labelled according to the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our fragrance products
that are manufactured and marketed in Europe are also regulated as cosmetics and subject to EU Regulation 1223/2009, and after
Brexit, the United Kingdom regulation of The UK Schedule 34 to the Product Safety and Metrology Regulation 2019. As of the date
of this report, IP products are in compliance with these regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, we cannot
assure you that, should we use proscribed ingredients in our fragrance products that we develop or market, or develop or market
fragrance products with different ingredients, or should existing regulations or requirements be revised, we would not in the future
experience difficulty in complying with such requirements, which could have a material adverse effect on our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our business could be negatively impacted
by social impact and sustainability matters.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There continues to
be an increased focus from certain investors, customers, consumers, employees, and other stakeholders concerning social impact
and environmental matters. We are spending considerable time addressing social impact and sustainability matters, which are becoming
more prominent issues for certain of our institutional shareholders. From time to time, we may announce certain initiatives, including
goals and commitments, regarding environmental matters, packaging, responsible sourcing and corporate social responsibility. We
could fail, or be perceived to fail, in our achievement of such initiatives, or in accurately reporting our progress on such initiatives.
Such failures could be due to changes in distribution channels, new licenses or other acquisitions. Moreover, the standards by
which corporate social responsibility are measured are developing and evolving, and certain areas are subject to assumptions that
could change over time. In addition, we could be criticized for the scope of our initiatives or goals or perceived as not acting
responsibly in connection with these matters. Any of such matters could have a material adverse effect on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our business is subject to seasonal
variability.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is somewhat
seasonal due to the timing of shipments to our customers, which are weighted to the second half of the year. Accordingly, our financial
performance, sales, working capital requirements, cash flow and borrowings generally experience variability during the third and
fourth quarters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our business is subject to inflationary
pressures.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite significant
inflationary pressures that started during 2022 affecting many aspects of our business, especially increase component costs and
shipping, we were able to offset the effects of inflation during 2022 by increasing the prices of our products. Although we believe
inflation will continue to be a major factor in 2023, a further increase in sales prices should help to mitigate its impact to
some degree. However, we may not be able to continue increasing our prices indefinitely without causing a reduction in the number
of consumers with sufficient disposable income to buy our certain of our fragrance products, which could have a material adverse
effect on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><b>&#9679;</b></td>
    <td style="width: 97%; text-align: justify"><b><span style="text-decoration: underline">Fragrance Markets</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The success of our products is dependent
on public taste. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our revenues are substantially
dependent on the success of our products, which depends upon, among other matters, pronounced and rapidly changing public tastes,
factors which are difficult to predict and over which we have little, if any, control. In addition, we have to develop successful
marketing, promotional and sales programs in order to sell our fragrances and fragrance related products. If we are not able to
develop successful marketing, promotional and sales programs, then such failure will have a material adverse effect on our business,
financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are subject to extreme competition
in the fragrance industry. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for fragrance
products is highly competitive and sensitive to changing market preferences and demands. Many of our competitors in this market
are larger than we are and have greater financial resources than are available to us, potentially allowing them greater operational
flexibility. Our success in the prestige fragrance industry is dependent upon our ability to continue to generate original strategies
and develop quality products that are in accord with ongoing changes in the market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If there is insufficient
demand for our existing fragrance products, or if we do not develop future strategies and products that withstand competition or
if we are unsuccessful in competing on price terms, then we could experience a material adverse effect on our business, financial
condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in laws, regulations and policies
that affect our business could adversely affect our financial results. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is subject
to numerous laws, regulations and policies. Changes in the laws, regulations and policies, including the interpretation or enforcement
thereof, that affect, or will affect, our business, including changes in accounting standards, tax laws and regulations, environmental
or climate change laws, regulations or accords, trade rules and customs regulations, or increased cosmetics regulation, and the
outcome and expense of legal or regulatory proceedings, and any action we may take as a result could adversely affect our financial
results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><b>&#9679;</b></td>
    <td style="width: 97%; text-align: justify"><b><span style="text-decoration: underline">General Risk Factors</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our success depends, in part, on the
quality and safety of our products.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends,
in part, on the quality and safety of our products. If our products are found to be defective or unsafe, or if they otherwise fail
to meet our consumers&#8217; standards, then our relationships with customers or consumers could suffer, the appeal of one or more
of our brands could be diminished, and we could lose sales and/or become subject to liability claims, any of which could result
in a material adverse effect on our business, results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our failure to protect our reputation,
or the failure of our partners to protect their reputations, could have a material adverse effect on our brand images.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to maintain
our reputation is critical to our various brand images. Our reputation could be jeopardized if we fail to maintain high standards
for merchandise quality and integrity or if we, or the third parties with whom we do business, do not comply with regulations or
accepted practices. Any negative publicity about these types of concerns may reduce demand for our merchandise. Failure to comply
with ethical, social, product, labor and environmental standards, or related political considerations, such as animal testing,
could also jeopardize our reputation and potentially lead to various adverse consumer actions, including boycotts. Failure to comply
with local laws and regulations, including applicable U.S. trade sanctions, to maintain an effective system of internal controls
or to provide accurate and timely financial statement information could also hurt our reputation. We are also dependent on the
reputations of our brand partners and licensors, which can be affected by matters outside of our control. Damage to our reputation
or the reputations of our brand partners or licensors or loss of consumer confidence for any of these or other reasons could have
a material adverse effect on our results of operations, financial condition and cash flows, as well as require additional resources
to rebuild our reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our information systems and websites
may be susceptible to outages, hacking and other risks.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have information
systems that support our business processes, including product development, production, marketing, order processing, sales, distribution,
finance and intra-company communications. We also have Internet websites in the United States and Europe. These systems may be
susceptible to outages due to fire, floods, power loss, telecommunications failures, hacking and similar events. Despite the implementation
of network security measures, our systems may be vulnerable to computer viruses, hacking and similar disruptions from unauthorized
tampering. The occurrence of these or other events could disrupt or damage our information systems and adversely affect our business
and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The trading prices of our securities
periodically may rise or fall based on the accuracy of predictions of our earnings or other financial performance.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business planning
process is designed to maximize our long-term strength, growth and profitability, not to achieve an earnings target in any particular
fiscal quarter. We believe that this longer-term focus is in the best interests of our Company and our stockholders. At the same
time, however, we recognize that it may be helpful to provide investors with guidance as to our forecast of annual net sales and
diluted earnings per share. Accordingly, we provide guidance as to our expected annual net sales, and diluted earnings per share,
which is updated as appropriate throughout the year. While we generally provide updates to our guidance when we report our results
each fiscal quarter if called for, we assume no responsibility to update any of our forward-looking statements at such times or
otherwise. In addition, longer-term guidance that we may from time to time provide is based on goals that we believe, at the time
guidance is given, are reasonably attainable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In all of our public
statements when we make, or update, a forward-looking statement about our sales and/or earnings expectations or expectations regarding
other initiatives, we accompany such statements directly, or by reference to a public document, with a list of factors that could
cause our actual results to differ materially from those we expect. Such a list is included, among other places, in our earnings
press releases (by reference to our periodic filings with the Securities and Exchange Commission) and in our periodic filings with
the Securities and Exchange Commission (<i>e.g.,</i> in our reports on Form 10-K and Forms 10-Q). These and other factors may make
it difficult for outside observers, such as research analysts, to predict what our earnings will be in any given fiscal quarter
or year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Outside analysts and
investors have the right to make their own predictions of our financial results for any future period. Outside analysts, however,
have access to no more material information about our results or plans than any other public investor, and we do not endorse or
adopt their predictions as to our future performance. Nor do we assume any responsibility to correct the predictions of outside
analysts or others when they differ from our own internal expectations. If and when we announce actual results that differ from
those that outside analysts or others have been predicting, the market price of our securities could be affected. Investors who
rely on the predictions of outside analysts or others when making investment decisions with respect to our securities do so at
their own risk. We take no responsibility for any losses suffered as a result of such changes in the prices of our securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a005"></span>Item 1B. Unresolved Staff Comments.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a006"></span>Item 2. Properties </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>United States Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain our corporate
headquarters and United States operations in approximately 32,000 square feet with a term that expires on December 31, 2029, and
have been at the same location in New York City since 1992. We also have a 140,000 square foot distribution center in New Jersey,
and this lease expires on October 31, 2025. In addition, we maintain office space in Hong Kong with a lease that expires in June
2023, as well as a small leased distribution center in Hong Kong through December 2023. In October 2021 we leased office space
in Florence, Italy for a 6-year term with an option for an additional 6 years for Interparfums Italia Srl.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>European Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since March 2022, our
European operations have maintained their corporate headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris.
This is an office complex combining three buildings connected by two inner courtyards and consists of approximately 40,000 total
sq. ft. United States distribution operations for European operations maintain their headquarters in New York City, with a lease
that expires in May 2029. During 2022, we also purchased several small apartments at 96 rue de l&#8217;Universit&#233;, Paris
adjacent to the main office complex and have started the process of converting them into additional offices. A small office is
located Singapore for Asia-Pacific distribution by European operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, European
operations maintain an approximately 37,000 square meters (approximately 398,265 square feet) distribution center located in Criquebeuf
sur Seine, France, with a seven year term that expires May 2027 and an option to extend the term for an additional two years. Interparfums
SA also has several agreements for warehousing and distribution services which are renewed on an annual basis, as well as a one
with a service provider that expires in 2024. Fees payable are partially calculated based upon a percentage of sales, which is
customary in the industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe our office and warehouse facilities
are satisfactory for our present needs and those for the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a007"></span>Item 3. Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not a party
to any material lawsuits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a008"></span>Item 4. Mine Safety Disclosures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a009"></span>PART II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a010"></span>Item 5. Market for Registrant&#8217;s Common Equity, Related
Stockholder Matters and Issuer Purchases of Equity Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The Market for Our Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Company&#8217;s common stock, $.001
par value per share, is traded on The Nasdaq Global Select Market under the symbol &#8220;IPAR&#8221;. The following table sets
forth in dollars, the range of high and low closing prices for the past two fiscal years for our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 30%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Fiscal 2022</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 36%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">High Closing Price</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">Low Closing Price</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Fourth Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">99.35 </td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">74.26</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Third Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">86.78</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">70.02</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Second Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">89.45</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">64.74</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">First Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">106.82</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">80.22</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 30%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Fiscal 2021</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 36%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">High Closing Price</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">Low Closing Price</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Fourth Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">106.90 </td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">75.89</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Third Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">79.42</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">67.55</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">Second Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">77.95</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">69.96</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt">First Quarter</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">76.75</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; padding-left: 5.4pt">59.17</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of February 8, 2023, the number of record
holders, which include brokers and broker nominees, etc., of our common stock was 28. We believe there are approximately 32,436
beneficial owners of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Corporate Performance Graph</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following graph compares the performance
for the periods indicated in the graph of our common stock with the performance of the Nasdaq Market Index and the average performance
of a group of the Company&#8217;s peer corporations consisting of: CCA Industries, Inc., Colgate-Palmolive Co., Est&#233;e Lauder
Companies, Inc., Inter Parfums, Inc., Kimberly Clark Corp., Natural Health Trends Corp., Procter &amp; Gamble Co., Stephan Co.,
Summer Infant, Inc. and United Guardian, Inc. The graph assumes that the value of the investment in our common stock and each index
was $100 at the beginning of the period indicated in the graph, and that all dividends were reinvested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMPARISON OF 5 YEAR CUMULATIVE TOTAL
RETURN*</b><br />
Among Inter Parfums, Inc., the NASDAQ Composite Index,<br />
and a Peer Group</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="img002_v1.jpg" alt="" />&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">*$100 invested on 12/31/17 in stock or index, including reinvestment
of dividends. Fiscal year ending December 31.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Below is the list of the data points for
each year that corresponds to the lines on the above graph.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/17</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/18</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/19</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/20</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/21</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/22</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inter Parfums, Inc.</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>100.00</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>153.33</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>172.84</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>144.75</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>259.11</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>239.94</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NASDAQ Composite</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>100.00</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>97.16</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>132.81</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192.47</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>235.15</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>158.65</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peer Group</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>100.00</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>99.33</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>136.46</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>159.01</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>192.02</b></span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>171.79</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Dividends</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In April 2020, as a result of the uncertainties
raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend. In February
2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. In February 2022, the
Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share. Just recently, in February 2023 the Board
of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is
payable on March 31, 2023 to shareholders of record on March 15, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a011"></span>Item 6. [RESERVED] </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a012"></span><b>Item 7. Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We operate in the fragrance business, and
manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments,
European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by
our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as
28% of Interparfums SA shares trade on the NYSE Euronext.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We produce and distribute our European based
fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented
approximately 68%, 75% and 78% of net sales for 2022, 2021 and 2020, respectively. We have built a portfolio of prestige brands,
which include <i>Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont </i>and
<i>Van Cleef &amp; Arpels</i>, whose products are distributed in over 120 countries around the world.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Through our United States operations, we
also market fragrance and fragrance related products. United States operations represented 32%, 25% and 22% of net sales in 2022,
2021 and 2020, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners
of the <i>Abercrombie &amp; Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta </i>and
<i>Ungaro </i>brands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Substantially all of our prestige fragrance
brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses.
With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a percentage of net sales, product sales
for the Company&#8217;s largest brands were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 98%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Quarterly sales fluctuations are influenced
by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell
directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France and the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We grow our business and expand our shares
in two distinct ways. First, by adding new brands to our portfolio, either through new licenses or other arrangements or out-right
acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products
through advertising, merchandising and sampling, as well as by phasing out underperforming products, so we can devote greater resources
to those products with greater potential. The economics of developing, producing, launching and supporting products influence our
sales and operating performance each year. The introduction of new products may have some cannibalizing effect on sales of existing
products, which we take into account in our business planning.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business is not capital intensive, and
it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components
from our suppliers. These components are either received and stored directly at our third-party fillers or received at one of our
distribution centers and then, based upon production needs, the components are sent to one of several third party fillers, which
manufacture the finished product for us and then deliver them to one of our distribution centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As with any global business, many aspects
of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach
and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow
market share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our reported net sales are impacted by changes
in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively
affected by a strong dollar, because over 50% of net sales of our European operations are denominated in U.S. dollars, while almost
all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales
while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management
that includes the use of derivative financial instruments, and primarily enter into foreign currency forward exchange contracts
to reduce the effects of fluctuating foreign currency exchange rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Impact of COVID-19 Pandemic</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A novel strain of coronavirus (&#8220;COVID-19&#8221;)
surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In response, various national,
state, and local governments issued decrees prohibiting certain businesses from operating and certain classes of workers from reporting
to work. Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill
and caused a significant unfavorable impact on our results of operations in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Business significantly improved in the second
half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased online purchasing.
While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world has caused the temporary
re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains
curtailed in several jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 had significantly
restricted international travel, the travel retail business has picked up. We remain confident that travel retail will once again
be a source of growth over the long-term. Lastly, the improved economy has put significant strains on our supply chain causing
disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions
have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue
since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry
more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where
they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite
recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations,
financial position and cash flows through at least the first half of 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recent Important Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Lacoste</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2022, we
closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution
of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Dunhill</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April 2022, we announced
that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce
and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory
for a limited time as is customary in the fragrance industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2021, we
closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the
production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising
expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last
for 10 years with a 5-year optional term, subject to certain conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the
management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian
subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the
license agreement was accounted for as an asset acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2021, we
also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with
Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under
the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments
as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September 2021,
we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common
stock valued at $5.0 million to the licensor. The exclusive license became effective on July 1, 2022, and we are planning to launch
new fragrances under these brands in 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective January
1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction
in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas
fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark
after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an
option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Land
and Building Acquisition - Future Headquarters in Paris</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
April 2021, Interparfums SA, our 73% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de
Solf&#233;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings
connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
purchase price includes the complete renovation of the site. As of December 31, 2022, $148.1 million of the purchase price, including
approximately $4.4 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022. The purchase price has been allocated approximately $61.1 million to land and $87.0 million
to the building. The building, which was delivered on February&#160;28, 2022, includes the building structure, development of
the property, fa&#231;ade waterproofing, general and technical installations and interior fittings that will be depreciated
over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components.
Approximately $3.4 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The acquisition was
financed by a 10-year &#8364;120 million (approximately $128.0 million) bank loan which bears interest at one-month Euribor plus
0.75%. Approximately &#8364;80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate
of 2% per annum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Discussion of Critical Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We make estimates and assumptions in the
preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America.
Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following
discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial
condition and results of operations. These accounting policies generally require our management&#8217;s most difficult and subjective
judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Management
of the Company has discussed the selection of significant accounting policies and the effect of estimates with the Audit Committee
of the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Long-Lived Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We evaluate indefinite-lived intangible
assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change,
such as an unexpected decline in sales, that would more likely than not indicate that the carrying value of an indefinite-lived
intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires
a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations
are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.80%. The cash flow
projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense
levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are
more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that the assumptions we have
made in projecting future cash flows for the evaluations described above are reasonable. However, if future actual results do not
meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December 31, 2022 indefinite-lived intangible
assets aggregated $105.0 million. The following table presents the impact a change in the following significant assumptions would
have had on the calculated fair value in 2022 assuming all other assumptions remained constant:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">$ in millions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">Change</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">Increase
                                         (decrease) to fair value</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%">Weighted average cost of capital</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: center">+10%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(7.2</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average cost of capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">-10%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.1</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Future sales levels</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">+10%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9.7</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Future sales levels</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">-10%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(9.7</td><td style="text-align: left">)</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Intangible assets subject to amortization
are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable
intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future
cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our
projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is
recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment
charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of
assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions,
changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. In those cases
where we determine that the useful life of long-lived assets should be shortened, we would amortize the net book value in excess
of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby
increasing amortization expense. We believe that the assumptions we have made in projecting future cash flows for the evaluations
described above are reasonable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining the useful life of our Lanvin
brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3. The only factor that prevented us from determining
that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. &#8220;Any legal, regulatory, or
contractual provisions that may limit the useful life.&#8221; The existence of a repurchase option originally in 2025 and amended
to 2027, may limit the useful life of the Lanvin brand names and trademarks to the Company. However, this limitation would only
take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised,
then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our Company
and their useful life would be considered to be indefinite.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With respect to the application of ASC topic
350-30-35-8, the Lanvin brand names and trademarks would only have a finite life to our Company if the repurchase option were exercised,
and in applying ASC topic 350-30-35-8, we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation
to pay the exercise price and the Company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The
exercise price to be received (residual value) is well in excess of the carrying value of the Lanvin brand names and trademarks,
therefore no amortization is required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Quantitative Analysis</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the three-year period ended December
31, 2022, we have not made any material changes in our assumptions underlying these critical accounting policies or to the related
significant estimates. The results of our business underlying these assumptions have not differed significantly from our expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we believe the estimates we have made are proper and the related results of operations for the period are presented fairly in
all material respects, other assumptions could reasonably be justified that would change the amount of reported net sales, cost
of sales, and selling, general and administrative expenses as they relate to the provisions for anticipated sales returns, allowance
for doubtful accounts and inventory obsolescence reserves. For 2022, had these estimates been changed simultaneously by 5% in
either direction, our reported gross profit would have increased or decreased by approximately $0.8 million and selling, general
and administrative expenses would have changed by approximately $0.1 million. The collective impact of these changes on 2022 operating
income, net income attributable to Inter Parfums, Inc., and net income attributable to Inter Parfums, Inc. per diluted share would
be an increase or decrease of approximately $0.8 million, $0.5 million and $0.02, respectively.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Net Sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years
ended December 31,</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>(in millions)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>%
Change</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>%
Change</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2020</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">European based product sales </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">744.0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">12%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">663.2</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">57%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">422.9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States based product sales </td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">342.7</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">58%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">216.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">86%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">116.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total net sales </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,086.7</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">24%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">879.6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">63%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">539.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Net sales rebounded significantly in 2021,
as compared to 2020 for both European and United States based operations and continued to increase in 2022. At comparable foreign
currency exchange rates, net sales increased 30% in 2022, as compared to 2021. Net sales in 2020 reflected the negative impacts
of the COVID-19 pandemic on the beauty industry. Retail store closings, event cancellations and a shutdown of international air
travel brought our sales to a virtual standstill in early 2020. In the second half of 2020, business began rebounding thanks to
retail stores reopening and a robust e-commerce business conducted by our retail customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For European based operations, our largest
brands, Montblanc, Jimmy Choo and Coach grew 2022 sales by 15%, 23% and 18%, respectively, as compared to 2021. There were also
significant gains made by our mid-sized brands, including Van Cleef &amp; Arpels and Karl Lagerfeld. The year-over-year gains,
in both euro and dollars, are all the more impressive considering our new product pipeline was dominated by flankers and extensions.
However, we did bring to market several entirely new lines, including our first ever Moncler duo, Kate Spade <i>Sparkle, Singulier
</i>by Boucheron and <i>Open Road </i>and <i>Wild Rose</i> by Coach.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In 2021, GUESS became our fourth brand
with sales exceeding $100 million. Strong momentum on GUESS continued in 2022 with brand sales increasing another 24% as compared
to 2021. There were also significant gains made by our mid-sized brands, especially Abercrombie &amp; Fitch, Hollister and Oscar
de la Renta. Additionally, 2022 saw the first full year of sales of Ferragamo products and in the second half of 2022, we also
welcomed first time sales of our newest brands, Donna Karan/DKNY. Together, these new brands contributed to 38% growth of our
US operations.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are confident in our future as 2023
has many exciting developments for the Company. We have transitioned to a new modern enterprise resource planning system (ERP)
for our US operations which will enable us to operate more efficiently and offer more scale to absorb our newer brands We have
a solid line-up of new product launches in the pipeline for many of our brands. This includes the roll out of the Moncler <i>Collection
</i>in the first quarter and a <i>Duo </i>flanker in the third quarter, a launch of GUESS <i>Uomo Acqua </i>in the second quarter,
as well as <i>Bella Vita Paradiso</i> in the fourth quarter. Extensions of the Montblanc <i>Legend</i>, Jimmy Choo <i>Man</i>
and Jimmy Choo&#8217;s <i>I Want Choo</i>, debut in the first, second and third quarters, respectively. Also, in the third quarter,
we will unveil new men&#8217;s lines for Coach and Boucheron. Brand extensions and flankers are in the works for MCM, Abercrombie
&amp; Fitch, Hollister, Anna Sui, and Oscar de la Renta. In sum, 2023 has all the earmarks of another superb year as the growth
catalysts currently far outweigh the headwinds, most notably inflation and supply chain disruptions. Lastly, we have recently
announced the license agreement with Lacoste which will offer us another sizable building block of growth in 2024.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As in the past, we hope to benefit from
our strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. However,
we have no certainty that any new license or acquisition agreements will be consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Net Sales to
Customers by Region</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years ended December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2020</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in millions)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">431.9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">354.1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">193.5</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Western Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">259.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">147.1</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152.7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79.7</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46.8</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Eastern Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33.1</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32.5</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11.0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6.3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,086.7</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">879.6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">539.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our largest market, North America achieved
sales growth of 22% in 2022 compared to 2021, while Western Europe and Asia grew sales by 28% and 19% in 2022, respectively, compared
to 2021. Latin America and the Middle East also achieved top line growth of 24% and 44% in 2022, respectively compared to 2021.
Eastern Europe saw only moderate top line growth of 6% as compared to 2021 largely related to the war in Ukraine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Gross Margins</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2020</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in millions)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">European operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left">Net sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">744.0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">663.2</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">422.9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">236.9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">221.2</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">152.3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross margin</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">507.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">442.0</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">270.6</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross margin, as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64.0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">United States operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net sales</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">342.7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">216.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">116.1</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">155.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101.5</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">56.0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross margin</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">187.3</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">114.9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">60.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross margin, as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.8</td><td style="text-align: left">%</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For European based operations, gross profit
margin as a percentage of net sales was 68.2%, 66.6% and 64.0% in 2022, 2021 and 2020, respectively. Distribution in the United
States for European based operations is handled by a 100% owned subsidiary of Interparfums SA based in the United States. Therefore,
sales are made at a wholesale price rather than at an ex-factory price, resulting in higher gross margins. Net sales of our U.S.
based distribution subsidiary increased 16% in 2022, as compared to 2021, leading to favorable mix and giving rise to the increase
in gross margin in 2022 over both 2021 and 2020. We carefully monitor movements in foreign currency exchange rates as over 50%
of our European based operations net sales is denominated in U.S. dollars, while most of our costs are incurred in euro. From a
margin standpoint, a strong U.S. dollar has a positive effect on our gross margin while a weak U.S. dollar has a negative effect.
The average dollar/euro exchange rate was 1.05 in 2022, 1.18 in 2021, and 1.15 in 2020. Pricing action also enabled us to offset
inflationary pressures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For United States operations, gross profit
margin was 54.7%, 53.1% and 51.8% in 2022, 2021 and 2020, respectively. With a decline in sales in 2020, certain expenses such
as depreciation of tools and molds together with the distribution of point-of-sale materials exaggerated the decline in gross margin
for the year as a percentage of sales. The scale benefits coming from our significant growth in 2021 and 2022, combined with pricing
actions and favorable channel/brand mix, have enabled us to more than offset the impacts of inflation and thus expand gross margin
by 130 bps in 2021 and another 160 bps in 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Costs relating to purchase with purchase
and gift with purchase promotions are reflected in cost of sales, and aggregated $43.1 million, $36.9 million and $26.4 million
in 2022, 2021 and 2020, respectively, and represented 4.0%, 4.2% and 4.9% of net sales, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Generally, we do not bill customers for
shipping and handling costs and such costs, which aggregated $15.8 million, $10.0 million and $5.0 million in 2022, 2021 and 2020,
respectively, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our
Company&#8217;s gross margins may not be comparable to other companies, which may include these expenses as a component of cost
of goods sold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Selling, General &amp; Administrative
Expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years ended December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2020</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in millions)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">European Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Selling, general &amp; administrative expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">358.3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">327.5</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">210.6</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Selling, general &amp; administrative expenses as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49.8</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">United States Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Selling, general &amp; administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">134.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">79.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50.1</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Selling, general &amp; administrative expenses as a percent of net sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43.1</td><td style="text-align: left">%</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For European operations, selling, general
and administrative expenses increased 9% and 55% in 2022 and 2021, respectively, as compared to the corresponding prior year period,
and represented 48.2%, 49.4% and 49.8% of sales in 2022, 2021 and 2020, respectively as we were able to leverage our scale. As
discussed in more detail below, these fluctuations, which are in line with the fluctuations in sales for European operations, are
primarily from variations in promotion and advertising expenditures. For United States operations, selling, general and administrative
expenses increased 70% and 58% in 2022 and 2021, respectively, as compared to the corresponding prior year period and represented
39.1%, 36.5% and 43.1% of sales in 2022, 2021 and 2020, respectively. As discussed in more detail below, the increased selling,
general and administrative expenses as a percentage of net sales are primarily the result of increases in promotion and advertising
expenditures. Additionally, the US based operations increased expenses related to salaries and benefits as we build the organization
and infrastructure to support our new brands and future growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Promotion and advertising included in selling,
general and administrative expenses aggregated $212.4 million, $171.1 million and $91.7 million in 2022, 2021 and 2020, respectively.
Promotion and advertising as a percentage of sales represented 19.5%, 19.5% and 17.0% of net sales in 2022, 2021 and 2020, respectively.
Promotion and advertising programs were cut significantly in 2020 in response to market conditions. Promotion and advertising are
integral parts of our industry, and we continue to invest heavily in promotional spending to support new product launches and to
build brand awareness. We believe that our promotion and advertising efforts have had a beneficial effect on online net sales,
causing then to continue to grow strongly on a global basis. All of our brands have benefitted from newly launched and enhanced
e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to
develop and implement omnichannel concepts, the way brick-and-mortar stores and a business&#8217; online operations work in tandem,
and compelling content to deliver an integrated consumer experience. We anticipated that on a full year basis, future promotion
and advertising expenditures will aggregate approximately 21% of net sales, which is in line with pre-COVID historical averages.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Royalty expense included in selling, general
and administrative expenses aggregated $87.0 million, $68.9 million and $41.1 million in 2022, 2021 and 2020, respectively. Royalty
expense as a percentage of sales represented 8.0%, 7.8% and 7.6% of net sales in 2022, 2021 and 2020, respectively. The increases
in 2022 and 2021, as a percentage of sales, are directly related to new licenses and increased royalty-based product sales. As
a result of the COVID-19 pandemic, we reached agreements with most of our licensors to waive or significantly reduce minimum guaranteed
royalties for 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Service fees, which are fees paid within
our European operations to third parties relating to the activities of our distribution subsidiaries, aggregated $7.9 million,
$9.4 million and $6.8 million in 2022, 2021 and 2020, respectively. The 2022 and 2021 amounts are in line with and directly related
to fluctuations in sales within our U.S. distribution subsidiary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Income from Operations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result of the above analysis regarding
net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 17.9%, 16.8%
and 13.1% for the years ended December 31, 2022, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Other Income and Expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2022, to
finance the acquisition of the Lacoste trademark, the Company entered into a $53.3 million (&#8364;50 million) four-year loan agreement.
The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable
interest rate debt with a maximum rate of 2% per annum. Additionally, in April 2021, we completed the acquisition of the future
headquarters of Interparfums SA. The acquisition was financed by a 10-year &#8364;120 million (approximately $128 million) bank
loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately &#8364;80 million of the variable rate debt
was swapped for fixed interest rate debt. Long-term debt including current maturities aggregated $186.8 million, $148.8 million
and $24.7 million as of December 31, 2022, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We enter into foreign currency forward exchange
contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Due to the sizable swings in currency
rates during 2022, we went from recognizing a gain of $2.3 million in 2021 to a loss of $1.9 million in 2022. This accounts for
most of our fluctuation within Other income and expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Interest and investment income represents
interest earned on cash and cash equivalents and short-term investments. In 2022, short-term investments include approximately
$19.9 million of marketable equity securities of other companies in the luxury goods sector. Interest and investment income includes
approximately $3.1 million of unrealized gains on marketable equity securities. Given our strong balance sheet and cash position,
the increase in interest rates had a favorable impact on interest and investment income.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our effective income tax rate was 22.2%,
27.1% and 27.9% in 2022, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Income tax expense represents U.S. federal,
foreign, state and local income taxes. The effective rate differs from the federal statutory rate primarily due to the effect of
state and local income taxes, the tax impact of share-based compensation and the taxation of foreign income including tax settlements.
Our effective tax rate will change from year-to-year based on recurring and non-recurring factors including the geographical mix
of earnings, enacted tax legislation, state and local income taxes, the tax impact of share-based compensation, the interaction
of various global tax strategies and the impact from certain acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our effective income tax rate for European
operations was 25.2%, 30.6% and 29.7% in 2022, 2021 and 2020, respectively, as the French Prime Minister reduced the French corporate
income tax rate from approximately 33% to 25% over a three-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our effective income tax rate for U.S. operations
was 13.8%, 15.6% and 16.7% in 2022, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our effective tax rate differs from the
21% statutory rate due to state, local and foreign taxes, offset by benefits received from the exercise of stock options as well
as deductions we are allowed for a portion of our foreign derived intangible income. Additionally, in the third quarter of 2022,
our U.S. operations recognized a one-time tax benefit of $2.5 million associated with the 2021 Salvatore Ferragamo acquisition.
At the time of the acquisition, we had not recognized deferred tax benefits as there were uncertainties concerning its potential
recoverability; however, as of September 30, 2022, the recoverability was deemed likely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has determined that it has no
tax liability related global intangible low-taxed income (&#8220;GILTI&#8221;) as of December 31, 2022, 2021 and 2020. The Company
also estimated the effect of its foreign derived intangible income (&#8220;FDII&#8221;) and recorded a tax benefit of $1.5 million,
$0.6 million and $0.3 million as of December 31, 2022, 2021 and 2020, respectively. Share-based compensation resulted in a discrete
tax benefit of $0.8 million, $1.3 million and $0.4 million in 2022, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Net Income </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">(In thousands)</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Net income attributable to European operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">107,292</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">80,670</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">41,990</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.2in; padding-left: 0.2in">Net income attributable to United States operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">43,745</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">29,357</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,978</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.2in; padding-left: 0.2in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">151,037</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110,027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,968</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.2in; padding-left: 0.2in">Less: Net income attributable to the noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,099</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22,616</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,749</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income attributable to Inter Parfums, Inc.</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -13.5pt; padding-left: 13.5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Net income attributable to European operations
was $107.3 million, $80.7 million and $42.0 million in 2022, 2021 and 2020, respectively, while net income attributable to United
States operations was $43.7 million, $29.4 million and $8.0 million in 2022, 2021 and 2020, respectively. The fluctuations in net
income for both European operations and United States operations are directly related to the previous discussions concerning changes
in sales, gross profit margins, selling, general and administrative expenses, most of which were caused by the effects of the COVID-19
pandemic beginning in 2020 and the recovery in 2021 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The noncontrolling interest arises primarily
from our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares
trade on the Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European
operations and aggregated 27.9%, 28.0% and 28.1% of European operations net income in 2022, 2021 and 2020, respectively. Net margins
attributable to Inter Parfums, Inc. aggregated 11.1%, 9.9% and 7.1% in 2022, 2022 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our conservative financial tradition has
enabled us to amass significant cash balances. As of December 31, 2022, we had $256 million in cash, cash equivalents and short-term
investments, most of which are held in euro by our European operations and are readily convertible into U.S. dollars. We have not
had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term
investments. As of December 31, 2022, short-term investments include approximately $19.9 million of marketable equity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of December 31, 2022, working capital
aggregated $443 million, and we had a working capital ratio of 2.3 to 1. Approximately 80% of the Company&#8217;s total assets
are held by European operations including approximately $249 million of trademarks, licenses and other intangible assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company is party to a number of license
and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring
at various dates through 2039. In connection with certain of these license agreements, the Company is subject to minimum annual
advertising commitments, minimum annual royalties and other commitments. <i>See</i> Item 8. Financial Statements and Supplementary
Data &#8211; Note 12 &#8211; Commitments in this annual report on Form 10-K. Future advertising commitments are estimated based
on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal
periods and do not reflect the fact that our distributors share our advertising obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company hopes to continue to benefit
from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In
December 2022, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances
and fragrance-related products under the Lacoste brand. This new license takes effect January 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In September 2021, we entered into a long-term
global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the
Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty
payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance
franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer
base around the world. The exclusive license became effective on July 1, 2022, and we are planning to launch new fragrances under
these brands in 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In October 2021, we closed on a transaction
agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution
of Ferragamo brand perfumes. The license became effective in October 2021 and will last for 10 years with a 5-year optional term,
subject to certain conditions. With respect to the management and coordination of activities related to the license agreement,
the Company is operating through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo
on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition. The total cost
of the assets acquired net of liabilities assumed aggregated approximately $35.8 million. In connection with this acquisition,
we agreed to pay $17.0 million in equal annual installments of $1.7 million including interest imputed at 2.0%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Opportunities for external growth are regularly
examined, with the priority of maintaining the quality and homogeneous nature of our portfolio. However, we cannot assure you that
any new license or acquisition agreements will be consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cash provided by operating activities
aggregated $115.2 million, $119.6 million, and $65.0 million in 2022, 2021 and 2020, respectively. In 2022, working capital items
used $65.6 million in cash from operating activities, as compared to $13.7 million in 2021 and $7.3 million in 2020. Although,
from a cash flow perspective, accounts receivable is up approximately 37% from year-end 2021, the balance is reasonable based
upon fourth quarter 2022 record sales levels and reflects strong collection activity as day&#8217;s sales outstanding increased
slightly to 64 days in 2022, as compared to 61 days in 2022 and decreased significantly as compared to 86 days in 2020. From a
cash flow perspective, inventory levels are up 49% from year-end 2021. Inventory days on hand increased to 231 days in 2022, as
compared to 208 days in 2021, and 277 days in 2020 as we chose to protect service level in light of the COVID driven supply chain
disruptions.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cash flows used in investing activities
reflect the purchase and sales of short-term investments. These investments consist of certificates of deposit with maturities
greater than three months marketable equity securities and other contracts. At December 31, 2022, approximately $39 million of
certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business is not capital intensive as
we do not own any manufacturing facilities. On a full year basis, we generally spend less than $5.0 million on capital expenditures
including tools and molds needed to support our new product development calendar. Capital expenditures also include amounts for
office fixtures, computer equipment and industrial equipment needed at our distribution centers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In December 2022, to finance Interparfums
SA&#8217;s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (&#8364;50 million) four-year loan agreement.
The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable
interest rate debt with a maximum rate of 2% per annum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In April 2021, Interparfums SA completed
the acquisition of its future headquarters at 10 rue de Solf&#233;rino in the 7th arrondissement of Paris from the property developer.
This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total
sq. ft.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The $142 million purchase price is in line
with market value and includes the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price,
including approximately $3.1 million of acquisition costs, is included in building, equipment and leasehold improvements on the
accompanying balance sheet as of December 31, 2021. Approximately $8.8 million of cash held in escrow is included in other assets
on the accompanying balance sheet as of December 31, 2021. In 2022 this cash was released from escrow and there is no longer any
balance of cash outside of cash and cash equivalents on the accompanying balance sheet as of December 31, 2022. In addition, the
Company borrowed $17.0 million pursuant to a short-term loan equal to the VAT credit, and in July 2021, the $17.0 million VAT credit
was reimbursed by the French Tax Authorities and the loan was repaid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The acquisition was
financed by a 10-year &#8364;120 million (approximately $136 million) bank loan which bears interest at one-month Euribor plus 0.75%.
Approximately &#8364;80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2%
per annum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2020, the Company and Divabox, owner
of the Origines-parfums e-commerce platform for beauty products, signed a strategic agreement and equity investment pursuant to
which we acquired 25% of Divabox capital for $14 million through a capital increase. In connection with the acquisition, the Company
entered into a $13.4 million term loan, which was repaid in full in February 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our short-term financing requirements are
expected to be met by available cash on hand at December 31, 2022, cash generated by operations and short-term credit lines provided
by domestic and foreign banks. The principal credit facilities for 2022 consist of a $20.0 million unsecured revolving line of
credit provided by a domestic commercial bank and approximately $20 million in credit lines provided by a consortium of international
financial institutions. There were no balances due from short-term borrowings as of December 31, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In April 2020, as a result of the uncertainties
raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the quarterly cash dividend. In February
2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly and in February 2022,
our Board authorized a 100% increase in the annual dividend to $2.00 per share. In February 2023 the Board of Directors further
increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on March 31,
2023, to shareholders of record on March 15, 2023. Dividends paid, including dividends paid once per year to noncontrolling stockholders
of Interparfums SA, aggregated $79.8 million, $41.5 million and $21.1 million for the years ended December 31, 2022, 2021 and 2020,
respectively. The cash dividends to be paid in 2023 are not expected to have any significant impact on our financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that funds provided by or used
in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with
sufficient resources to meet all present and reasonably foreseeable future operating needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Inflation rates in the U.S. and foreign
countries in which we operate did not have a significant impact on operating results for the year ended December 31, 2022 as they
were either offset by price increases we passed onto our respective customers or operating efficiencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a013"></span>Item 7A. Quantitative and Qualitative Disclosures About Market
Risk.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>General</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We address certain financial exposures through
a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter
into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates.
We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Foreign Exchange Risk Management </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A general discussion relating to our policies
on foreign exchange risk management can be found in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and
Results of Operations&#8221; in Part II, Item 7 of our annual report on Form 10-K for the year ended December 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of December 31, 2022, we had foreign
currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $36.5 million which all
have maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial
institutions is remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Interest Rate Risk Management</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We mitigate interest rate risk by monitoring
interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate
debt should be swapped for fixed rate debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a014"></span>Item 8. Financial Statements and Supplementary Data</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The required financial statements commence
on page F-1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a015"></span><b>Item 9. Changes in and Disagreements
with Accountants on Accounting and Financial Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a016"></span>Item 9A. Controls and Procedures. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Evaluation of Disclosure Controls and Procedures </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Chief Executive Officer and Chief Financial
Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange
Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this annual report on Form 10-K (the &#8220;Evaluation Date&#8221;).
Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation
Date, our Company&#8217;s disclosure controls and procedures were effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Management&#8217;s Annual Report on Internal Control over
Financial Reporting</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The management of Inter Parfums, Inc. is
responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13(a)-15(f)
under the Securities Exchange Act of 1934. With the participation of the Chief Executive Officer and the Chief Financial Officer,
our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework
and criteria established in <i>Internal Control &#8211; Integrated Framework (2013)</i>, issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over
financial reporting was effective as of December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our independent auditor, Mazars USA LLP,
a registered public accounting firm, has issued its report on its audit of our internal control over financial reporting. This
report appears on page F-2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Changes in Internal Control Over Financial Reporting </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There has been no change in our internal
control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the
fourth quarter of 2022 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal
control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b><span id="a017"></span>Item 9B.</b></td><td><b>Other Information.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a023"></span>PART III</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a024"></span>Item 10. Directors, Executive Officers
and Corporate Governance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Executive Officers and Directors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this
report, our executive officers and directors were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 28%"><b>Name</b></td>
    <td style="vertical-align: top; width: 1%; text-align: justify"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 71%; text-align: justify"><b>Position</b></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Jean Madar</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Chairman of the Board, Chief Executive Officer of Inter Parfums, Inc. and Director General of Interparfums SA</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Philippe Benacin</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Vice Chairman of the Board, President of Inter Parfums, Inc. and Chief Executive Officer of Interparfums SA</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Michel Atwood</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director and Chief Financial Officer</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Philippe Santi</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director, Executive Vice President and Chief Financial Officer, Interparfums SA</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Fran&#231;ois Heilbronn</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Robert Bensoussan</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Patrick Cho&#235;l</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Michel Dyens</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Veronique Gabai-Pinsky</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>Gilbert Harrison</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Director</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>Frederic Garcia-Pelayo</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Executive Vice President and Chief Operating Officer of Interparfums SA</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our directors will
serve until the next annual meeting of stockholders and thereafter until their successors shall have been elected and qualified.
Messrs. Jean Madar and Philippe Benacin have a verbal agreement or understanding to vote their shares and the shares of their respective
holding companies in a like manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With the exception
of Mr. Benacin, the officers are elected annually by the directors and serve at the discretion of the board of directors. There
are no family relationships between executive officers or directors of our Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Board of Directors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors
has the responsibility for establishing broad corporate policies and for the overall performance of our Company. Although certain
directors are not involved in day-to-day operating details, members of the board of directors are kept informed of our business
by various reports and documents made available to them. Our board of directors held 18 meetings (or executed consents in lieu
thereof), including meetings of committees of the full board of directors during 2022, and all of the directors attended at least
75% of the meetings (or executed consents in lieu thereof) of the full board of directors and committees of which they were a member.
Our board of directors presently consists of ten (10) directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a Code
of Business Conduct that applies to our principal executive officer, principal financial officer, principal accounting officer
or controller, as well as other persons performing similar functions, and we agree to provide to any person without charge, upon
request, a copy of our Code of Business Conduct. Any person who requests a copy of our Code of Business Conduct should provide
their name and address in writing to: Inter Parfums, Inc., 551 Fifth Avenue, New York, NY 10176, Att.: Shareholder Relations. In
addition, our Code of Conduct is also maintained on our website, at www.interparfumsinc.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During 2022, our board of directors had
the following standing committees:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 48px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Audit Committee &#8211; The Audit Committee
    has the sole authority and is directly responsible for, the appointment, compensation and oversight of the work of the independent
    accountants employed by our company which prepare or issue audit reports for our company. During 2022, this committee consisted
    of Messrs. Heilbronn and Cho&#235;l, and Ms. Gabai-Pinsky. The charter of the Audit Committee is posted on our Company&#8217;s
    website.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not
have an &#8220;audit committee financial expert&#8221; within the definition of the applicable Securities and Exchange Commission
rules. Finding qualified nominees to serve as a director of a public company without the comparable financial resources of other
larger, more established companies has been challenging. In addition, despite the applicable Securities and Exchange Commission
rule which states that being named as the audit committee financial expert does not impose any greater duty, obligation or liability,
our company has been met with resistance from both present and former directors to being named as such, primarily due to potential
additional personal liability. However, as the result of the background, education and experience of the members of the Audit Committee,
our board of directors believes that such committee members are fully qualified to fulfill their obligations as members of the
Audit Committee. The Chair of the Audit Committee, Mr. Fran&#231;ois Heilbronn, is a graduate of Harvard Business School with
a Master of Business Administration degree and is currently the managing partner of the consulting firm of M.M. Friedrich, Heilbronn &amp; Fiszer which is specialized in business strategy and complex financial operations and investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 48px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Executive Compensation and Stock Option
    Committee &#8211; The Executive Compensation and Stock Option Committee oversees the compensation of our Company&#8217;s executives
    and administers our company&#8217;s stock option plans. During 2022, this committee consisted of Messrs. Heilbronn and Cho&#235;l,
    and Ms. Gabai-Pinsky. The charter of the Executive Compensation and Stock Option Committee is posted on our company&#8217;s
    website.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 48px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Nominating Committee &#8211; During 2022,
    this committee consisted of Messrs. Heilbronn and Cho&#235;l, and Ms. Gabai-Pinsky. The purpose of the Nominating Committee
    is to determine and recommend qualified persons to the Board of Directors who will be put forth as management&#8217;s slate
    of directors for vote of the Corporation&#8217;s stockholders, as well as to fill vacancies in the Board of Directors. The
    charter of the Nominating Committee is posted on our Company&#8217;s website.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a board
diversity policy, which provides that the selection of candidates for appointment to our board will be based on an overriding emphasis
on merit, but the Nominating Committee will seek to fill board vacancies by considering candidates that bring a diversity of background
and industry or related expertise to our board. The Nominating Committee is to consider an appropriate level of diversity having
regard for factors such as skills, business and other experience, education, gender, age, ethnicity and geographic location. A
copy of the board diversity policy is posted on our company&#8217;s website. In addition, Nasdaq has adopted a Board Diversity
Rule, which requires Nasdaq listed companies to publicly disclose board-level diversity statistics using a standardized template
during 2022. By the 2025 annual meeting, we will be required to disclose whether or not we have two directors that are diverse
under the applicable Nasdaq rule, and if not, then why not. We do not foresee any issue in complying with Nasdaq Board Diversity
Rule at this time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Nasdaq Board Diversity </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As required by the the Nasdaq Diversity
Rule, the board of directors of our company presently has one (1) member who self-identifies as a female and one (1) member who
identifies as Hispanic, which is in compliance with the Nasdaq Board Diversity rule. Below is the Nasdaq Board Diversity Matrix,
which shows the gender identity and demographic background of our board of directors as they have self-identified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td colspan="5" style="border: black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Board Diversity Matrix for &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INTER PARFUMS INC.</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of February 28, 2023</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td></tr>
<tr style="vertical-align: top; background-color: #BEBEBE">
    <td colspan="5" style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Total Number of Directors</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid">10</td></tr>
<tr style="vertical-align: top; background-color: #D9D9D9">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; width: 51%"><b>Part I: Gender Identity</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 12%"><b>Female</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 11%"><b>Male</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 13%"><b>Non-Binary</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 13%"><b>Did Not Disclose Gender</b></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Directors</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">1</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">9</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top; background-color: #D9D9D9">
    <td colspan="5" style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><b>Part II: Demographic Background</b></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">African American or Black</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Alaskan Native or American Indian</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Asian</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Hispanic or Latinx</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">1</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Native Hawaiian or Pacific Islander</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">White</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">1</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">8</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Two or More Races or Ethnicities</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">LGBTQ+</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Did Not Disclose Demographic Background</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">0</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Experience</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following sets
forth biographical information as to the business experience of each executive officer and director of our company for at least
the past five years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Jean Madar</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Jean Madar, age
62, a Director, has been the Chairman of the Board since our Company&#8217;s inception, and is a co-founder of our Company with
Mr. Philippe Benacin. From inception until December 1993 he was the President of our Company; in January 1994, he became Director
General of Interparfums SA, our Company&#8217;s subsidiary; and in January 1997, he became Chief Executive Officer of our Company.
Mr. Madar was previously the managing director of Interparfums SA, from September 1983 until June 1985. At such subsidiary, he
had the responsibility of overseeing the marketing operations of its foreign distribution, including market research analysis
and actual marketing campaigns. Mr. Madar graduated from The French University for Economic and Commercial Sciences (ESSEC) in
1983. We believe that Mr. Madar&#8217;s skills in guiding, leading and determining the strategic direction of our company since
its inception together with Mr. Benacin, in addition to his contacts in the fragrance and cosmetic industry, render him qualified
to serve as a member of our board of directors.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Philippe Benacin</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Benacin, age
64, a Director, is President of our Company and the Chief Executive Officer of Interparfums SA, has been the Vice Chairman of
the Board since September 1991, and is a co-founder of our Company with Mr. Madar. He was elected the Executive Vice President
in September 1991, Senior Vice President in April 1993, and President of the Company in January 1994. In addition, he has been
the President of our Company and Chief Executive Officer of Interparfums SA for more than the past five years. Mr. Benacin graduated
from The French University for Economic and Commercial Sciences (ESSEC) in 1983. In June 2014 Mr. Benacin was elected as a member
of the Supervisory Board of Vivendi, and Chairman of its Corporate Governance, Nominations and Remuneration Committee. We believe
that Mr. Benacin&#8217;s skills in guiding, leading and determining the strategic direction of our company since its inception
together with Mr. Madar, in addition to his contacts in the fragrance and cosmetic industry, render him qualified to serve as
a member of our board of directors.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Michel Atwood</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Atwood, age 53, became our Chief
Financial Officer on September 6, 2022, succeeding Mr. Russell Greenberg, the former Chief Financial Officer, who retired on that
same date. Mr. Atwood was first elected to our Board of Directors at the 2022 Annual Meeting held in September 2022.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From September
2018 through March 2022 while at Est&#233;e Lauder, Mr. Atwood had strategic oversight for the fragrance category across that
company and operational accountability for several of its fragrance brands. He also had senior level merger and acquisition (&#8220;M&amp;A&#8221;)
duties, including acquisition integration and brand divestitures/discontinuations. Over his nearly four years at Est&#233;e
Lauder, he also drove cross-brand synergies across research and development and supply chain for the fragrance category. From
February 2017 to August 2018, he was an independent consultant as an M&amp;A advisor on multiple fragrance license acquisitions
and also acted as a private investor.&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From 1995 to 2017,
Mr. Atwood has held several executive positions at Procter &amp; Gamble (&#8220;P&amp;G&#8221;) in France, Switzerland, Italy and
Germany. His final title at P&amp;G was Divisional CFO of Global Prestige Fragrances, leading a 90 member team, and ultimately
spearheading the divestiture of that division to Coty. Earlier he was CFO Global Markets &#8211; Prestige Fragrances, a business
generating over $2 billion in sales, where he headed a globally dispersed team of 60 people supporting the go-to-market organization
(affiliates, Travel Retail and distributors) of the Prestige Division. Before that, he was Global Prestige Director of Strategic
Planning, Licensing and Acquisition shaping and executing the overall business direction and licensing and acquisition strategy
of P&amp;G&#8217;s Global Fragrance and Premium skin and cosmetics businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Michel Atwood holds
a Master&#8217;s degree in Software Engineering from the Institut National des Sciences Appliqu&#233;es of Lyon, and a Master&#8217;s
in International Finance from HEC Paris, the prestigious French business school. He also earned the designation of Certified Management
Accountant from the Institute of Management Accountants. He has a truly international background, working/living in France, Switzerland,
the U.S., Canada, Turkey and Italy. We believe that Mr. Atwood&#8217;s skills and experience in accounting, international tax,
mergers and acquisitions, as well as his knowledge of the fragrance industry, render him qualified to serve as a member of our
board of directors.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Philippe Santi</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Philippe Santi, age
61, and a Director since December 1999, is the Executive Vice President and Chief Financial Officer of Interparfums SA. Mr. Santi,
who is a Certified Accountant and Statutory Auditor in France, has been the Chief Financial Officer of Interparfums SA since February
1995. Prior to February 1995, Mr. Santi was the Chief Financial Officer for Stryker France and an Audit Manager for Ernst and Young.
We believe that Mr. Santi&#8217;s skills in accounting and tax, as well as his knowledge of the fragrance industry and our Company&#8217;s
European operations, render him qualified to serve as a member of our board of directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Francois Heilbronn</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Heilbronn, age
61, a Director since 1988, an independent director and a member of the Audit Committee, Nominating Committee and the Executive
Compensation and Stock Option Committee, is a graduate of Harvard Business School with a Master of Business Administration degree
and is currently the managing partner of the consulting firm of M.M. Friedrich, Heilbronn &amp; Fiszer. He was formerly employed
by The Boston Consulting Group, Inc. from 1988 through 1992 as a manager. Mr. Heilbronn graduated from Institut d&#8217; Etudes
Politiques de Paris in June 1983. From 1984 to 1986, he worked as a financial analyst for Lazard Freres &amp; Co. In addition,
during 2009, Mr. Heilbronn became an Associate Professor in Business Strategy at Sciences Po, Paris, France. As the result of his
business and financial acumen, as well as his experience as managing partner of a business consulting firm in the area of mergers
and acquisitions of large international companies in retail, consumer goods and consumer services throughout the world, we believe
Mr. Heilbronn is qualified to serve as a member of our board of directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Robert Bensoussan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Robert Bensoussan,
age 65, has been a Director since March 1997, and is also an independent director. Mr. Bensoussan is the founder of Sirius Equity
Consultants, a retail and branded luxury goods investment company. To date, Mr. Bensoussan remains as an investor in Hapy Sweet
Bee Ltd, natural health food products,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">He was previously
Chairman of Cama&#239;eu, the French retail conglomerate, a board member of Celio International, the French retail conglomerate
and Vivarte representing the GLG hedge fund. In the latter part of 2019, Mr. Bensoussan resigned after 6 years as the only non-North
American board member of lululemon athletica Inc. Following the successful sale in 2021, Mr. Bensoussan stepped down from the
board of Feelunique.com, one of Europe&#8217;s largest online beauty retailers after serving 9 years.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">He is a member of the
Advisory Board of Pictet Bank Premium Brands Fund and sits on the board of Pronovias, the worldwide leader of wedding dresses.
Yonderland, Europe&#8217;s largest premium outdoor retailer and SNS, a prominent aspirational streetwear and entertainment hub.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Previously Mr.
Bensoussan was as director of, and had an indirect ownership interest in, J. Choo Limited until July 2011, and was CEO from 2001
to 2007, and was a member of the Board of Jimmy Choo Ltd, from 2001 to 2011, which had been a privately held luxury shoe wholesaler
and retailer.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe Mr. Bensoussan
is qualified to serve as a member of our board of directors due to his business and financial acumen, as well as his experience
in the retail and branded luxury goods market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patrick Cho&#235;l</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Cho&#235;l,
age 79, was appointed to the board of directors in June 2006 as an independent director, and is a member of the Audit Committee,
Nominating Committee and the Executive Compensation and Stock Option Committee. Mr. Cho&#235;l is a director of our majority-owned
subsidiary, Interparfums SA, a publicly held company, and Christian Dior a privately held company. For approximately 10 years,
through March 2004, Mr. Cho&#235;l was the President and CEO of two divisions of LVMH Moet Hennessy Louis Vuitton S.A., first
Parfums Christian Dior, a leading world-wide prestige beauty/fragrances business, and later, the LVMH Perfumes and Cosmetics Division,
which included such well-known brands as Parfums Christian Dior, Guerlain, and Parfums Givenchy, among others. Prior to such time,
for approximately 30 years, he held various executive positions at Unilever, including President and CEO of Elida Faberg&#233;
France and President and CEO of Chesebrough Pond&#8217;s USA. Because of this experience, especially in the prestige beauty business,
we believe that Mr. Cho&#235;l is qualified to serve as a member of our board of directors.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Michel Dyens</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Michel Dyens, age 82
and an independent director, is the Founder, Chairman and Chief Executive Officer of Michel Dyens &amp; Co., which he founded over
25 years ago. With headquarters in New York and Paris, Michel Dyens &amp; Co. is a leading independent investment banking firm
focused on mergers and acquisitions. Michel Dyens &amp; Co. has vast experience in luxury goods, beauty, spirits and other premium
branded consumer goods in which it has concluded numerous landmark deals. Michel Dyens &amp; Co. has advised in such deals as the
sale of the Grey Goose ultra-premium vodka brand to Bacardi, the acquisition of the luxury Swiss watchmaker Hublot by LVMH, the
sale of the Harry Winston to Aber Diamond Corporation and Boucheron to Kering. Michel Dyens &amp; Co. represented the owners of
Liaigre, the luxury furniture brand, in the sale to Symphony International and Navis Capital, and Casa Dragones, the ultra-premium
tequila, in the sale to BDT Partners (Byron Trott).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2021, Michel
Dyens &amp; Co. represented the owners of Buly, the luxury French fragrance and beauty brand, in the sale to LVMH and the owners
of Blissim, the French leader in beauty subscription e-commerce, and online beauty retail for an investment by Raise Investissement.
In addition, he has just sold We11done, the Korean contemporary fashion and lifestyle brand, to Sequoia Capital.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Michel Dyens
&amp; Co. was the exclusive advisor to Creed in the sale of the ultra-luxury fragrance company Creed BlackRock Long Term
Private Capital, and represented Mr. Chin Wook Lee, the founder and CEO of Dr. Jart+, in the sale of Have &amp; Be Co. Ltd.
to The Est&#233;e Lauder Companies. Michel Dyens &amp; Co. also advised the owner of the ultra-luxury fragrance brand By
Kilian, in the sale to Est&#233;e Lauder. Michel Dyens &amp; Co. advised the shareholders of the largest independent hair
color and hair care company in Brazil, Niely Cosmeticos in the sale of the company to L&#8217;Or&#233;al, as well as the
owner of the super-premium liqueur St-Germain in the sale of the brand to Bacardi, the Colomer Group (American Crew and
CND/Shellac brands) in its sale to Revlon, and Sidney Frank Importing Company in the sale of the company to Jaegermeister.
Other transactions include the sale of the Essie cosmetics business to L&#8217;Or&#233;al, the sale of TIGI (BedHead and
Catwalk brands) to Unilever, the luxury hair care brand Christophe Robin to The Hut Group, the thinning hair brand NIOXIN
Research Laboratories to Procter &amp; Gamble, John Frieda Professional Hair Care and Molton Brown to the Kao Corporation,
the Svedka vodka brand to Constellation Brands and Chambord liqueur to Brown-Forman.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the mission-driven
field, Michel Dyens &amp; Co. recently represented ClimateCare, a prominent UK carbon-offset business, in the sale to Averna Capital
and represented the founders of Caboo Paper Products a Vancouver, Canada-based tree-free household paper products brand, for an
investment by sustainability-focused venture capital firm Renewal Funds. Among other recent transactions, Michel Dyens &amp; Co.
recently represented the Fairtrade and organic coffee brand Ethical Bean Coffee in the sale to Kraft Heinz, and as well as Alter
Eco Americas, a leading organic chocolate brand, which we sold to NextWorld Evergreen.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In healthy and premium
food, Michel Dyens &amp; Co. represented the Fairtrade and organic coffee brand Ethical Bean Coffee in the sale to Kraft Heinz,
and as well as Alter Eco Americas, a leading organic chocolate brand, which it sold to NextWorld Evergreen.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From April 2004
to September 2014, Mr. Dyens was an independent director of Interparfums SA. We believe Mr. Dyens is qualified to serve as a member
of our board of directors thanks to his knowledge of our Company&#8217;s luxury business, his business and financial acumen, as
well as his experience in the luxury goods market.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Veronique Gabai-Pinsky</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms. Gabai-Pinsky,
age 57, was elected for the first time to our board in September 2017. She became a director of Interparfums SA in April 2017.
She is currently operating a startup specialty fragrance business, and a director of Lifetime Brands (Nasdaq: LCUT), which is
in the home goods business. She was President of Vera Wang Group from January 2016 through June 2018, after a year of consulting
with the company and she oversaw all product categories and markets. Prior to joining Vera Wang, from 2006 to December 2014, Ms.
Gabai-Pinsky was the Global President for Aramis and Designers Fragrances as well as Beauty Bank and Idea Bank at The Est&#233;e
Lauder Companies, reporting to the Chief Executive Officer of such company. During her tenure, Ms. Gabai-Pinsky developed and
ensured the growth of several beauty and skin care brands, including Lab Series for Men. She was highly instrumental in the evolution
of the fragrance category for such company, as she improved its overall business model, globally grew brands such as Donna Karan
and Michael Kors, evolved and harmonized the portfolio, divested dilutive brands and brought in Tory Burch, Zegna and Marni under
licenses. She ultimately actively participated in the acquisitions of Le Labo, Frederic Malle, and By Kilian and assisted in the
transformation of the long-term strategic direction of such company.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the earlier years
of her career, Ms. Gabai-Pinsky served as Vice President of Marketing and Communication for Guerlain, a division of LVMH Moet Hennessy
Louis Vuitton S.A., where she led the successful re-launch of Shalimar, the introduction of Aqua Allegoria, and contributed to
the re-focus of the beauty category around its pillars, Terracotta, Meteorites and Issima, while redesigning all communication
strategies and content. She started her career at L&#8217;Or&#233;al, and was also Vice President of Marketing for Giorgio Armani,
where she was instrumental in the overall development of its fragrance business by developing the successful Acqua di Gio for men
and introducing the Emporio Armani franchise. A graduate from ESSEC Business School in Paris, France, she has received several
awards, including Marketer of the Year by Women&#8217;s Wear Daily in December 2013.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms. Gabai-Pinksy
is an independent director, and is a member of the Audit Committee, Executive Compensation and Stock Option Committee and the
Nominating Committee of our Company. We believe Ms. Gabi-Pinsky is qualified to serve as a member of our board of directors due
to her more than 25 years of experience in the luxury, fashion, beauty and fragrance fields, success as a brand builder, creative
thinker, business acumen, and a broad understanding of consumers, brands and business models.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Gilbert Harrison</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Harrison, age 82,
an independent director, was appointed to our board in April 2018. Mr. Harrison has more than 50 years of experience in corporate
finance and strategic transactions, specializing in the consumer products space. He began his career in 1965 practicing corporate
and securities law in New York and Philadelphia. In 1971 he founded Financo, which he grew to become one of the leading independent
middle market transaction firms in the country. In 1985, Financo was acquired by Lehman Brothers, where the firm&#8217;s primary
efforts were focused on increasing its expertise in retail, apparel and other merchandising transactions of all types. At Lehman,
Mr. Harrison was Chairman of the Merchandising Group and on the firm&#8217;s Investment Banking Operating Committee while continuing
as Chairman of Financo, which was renamed the Middle Market Group of Lehman. In 1989, he re-acquired Financo from Lehman, re-establishing
Financo as one of the leading investment banking firms handling transactions and providing strategic advice in connection with
merchandising companies. Mr. Harrison retired as Chairman of Financo in December of 2017, after which he formed the Harrison Group,
a firm that provides consulting and financial advisory services to merchandising and products companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Harrison&#8217;s
other activities include his membership on the Advisory Council of the World Retail Congress, Shoptalk and the Financial Times
Business of Luxury Summit. Additionally, he has created a course on mergers and acquisitions at The Wharton School and has published
various articles and academic studies on the state of retailing and mergers and acquisitions, including a chapter in the book entitled,
&#8220;The Mergers and Acquisitions Handbook.&#8221; Mr. Harrison lectures throughout the country, including chairing seminars
for Retail Week as well as for the International Council of Shopping Centers, the National Retail Federation, Young President&#8217;s
Center, The Wharton Aresty Institute of Executive Education and The President&#8217;s Association of the American Management Association.
He also appears frequently on Bloomberg TV and CNBC as an expert on retail and apparel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Harrison received
a Bachelor of Science in Economics from The Wharton School of The University of Pennsylvania in 1962 and his Juris Doctor from
The University of Pennsylvania Law School in 1965. He is also Chairman of the Fashion Division of UJA, Treasurer and a Board member
of the Southampton Hospital, Director of the Peggy Guggenheim Collection, and former Board member of the Wharton School of the
University of Pennsylvania. We believe Mr. Harrison is qualified to serve as a member of our board of directors due to his tremendous
depth and breadth of knowledge about the merchandising and consumer industry, and he has a long track record of facilitating value-creating
transactions for companies in this sector. Mr. Harrison&#8217;s autobiography, <i>Deal Junky</i>, was published in January 2022.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Frederic Garcia-Pelayo</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Frederic Garcia-Pelayo,
age 61, has been with Interparfums SA for more than the past 20 years. He is currently the Executive Vice President and Chief Operating
Officer of Interparfums SA, and was previously the Director of its Luxury and Fashion division beginning in March 2005. He was
also previously the Director of Marketing and Distribution for Perfume and Cosmetics and was first named Executive Vice President
in 2004.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Section 16(a) Beneficial Ownership
Reporting Compliance</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based solely upon a
review of Forms 3, 4 and 5 and any amendments to such forms furnished to us, and written representations from various reporting
persons furnished to us, we are not aware of any reporting person who has failed to file the reports required to be filed under
Section 16(a) of the Securities Exchange Act of 1934 on a timely basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a025"></span>Item 11. Executive Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Discussion and Analysis</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The executive compensation
and stock option committee of our board of directors is comprised entirely of independent directors and oversees all elements of
compensation (base salary, annual bonus, long-term incentives and perquisites) of our company&#8217;s executive officers and administers
our company&#8217;s stock option plans, other than the non-employee directors stock option plan, which is self-executing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The objectives of our
compensation program are designed to strike a balance between offering sufficient compensation to either retain existing or attract
new executives on the one hand, and maintaining compensation at reasonable levels on the other hand. We do not have the resources
comparable to the cosmetic giants in our industry, and, accordingly, cannot afford to pay excessive executive compensation. In
furtherance of these objectives, our executive compensation packages generally include a base salary, as well as annual incentives
tied to individual performance and long-term incentives tied to our operating performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2022 and
prior years, Mr. Madar, the Chairman and Chief Executive Officer, took the initiative after discussions with Mr. Russell Greenberg,
the former Executive Vice President, Chief Financial Officer and board member, and recommended executive compensation levels for
executives for United States operations. Mr. Benacin, the Chief Executive Officer of Interparfums SA, took the initiative after
discussions with Philippe Santi, the Chief Financial Officer of Interparfums SA, and recommended executive compensation levels
for executives for European operations. The recommendations are presented to the compensation committee for its consideration,
and the compensation committee makes a final determination regarding salary adjustments and annual award amounts to executives,
including Jean Madar and Philippe Benacin. Messrs. Madar and Benacin are not present during deliberations or determination of
their executive compensation by the compensation committee. Further, Messrs. Madar and Benacin, in addition to being executive
officers and directors, are our largest beneficial shareholders, and therefore, their interests are aligned with our shareholder
base in keeping executive compensation at a reasonable level.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation committee
was pleased that the most recent shareholder advisory vote on executive compensation held at our last annual meeting of shareholders
in September 2022 overwhelmingly approved the compensation policies and decisions of the compensation committee. The compensation
committee has determined to continue its present compensation policies in order to determine similar future decisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our compensation
committee believes that individual executive compensation is at a level comparable with executives in other companies of similar
size and stage of development that operate in the fragrance industry, and takes into account our company&#8217;s performance as
well as our own strategic goals. Further, the compensation committee believes that its present policies to date, with its emphasis
on rewarding performance, has served to focus the efforts of our executives, which in turn has permitted our company to weather
the COVID-19 pandemic, supply chain disruptions and geopolitical turmoil in certain parts of the world, which resulted in the
Company&#8217;s record results for 2022. During 2022, the members of such committee consisted of Messrs. Heilbronn and Cho&#235;l,
and Ms. Gabai-Pinsky.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Elements of Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation of
our executive officers is generally comprised of base salaries, including a fee paid to the holding companies of each of Messrs.
Madar and Benacin, annual cash bonuses and long-term equity incentive awards. In determining specific components of compensation,
the compensation committee considers individual performance, level of responsibility, skills and experience, other compensation
awards or arrangements and overall company performance. The compensation committee reviews and approves all elements of compensation
for all of our executive officers taking into consideration recommendations from the Chief Executive Officer of our company and
the Chief Executive Officer of Interparfums SA, as well as information regarding compensation levels at competitors in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our named executive
officers have all been with the Company for more than the past ten (10) years, other than Mr. Atwood who joined our Company in
September 2022, with Messrs. Madar and Benacin being founders of the Company. As Messrs. Madar and Greenberg, the former Chief
Financial Officer and Executive Vice President for United States operations, and Benacin and Santi for European operations, were
most familiar with the individual performance, level of responsibility, skills and experience of each executive officer in their
respective operating segments, the compensation committee relies upon the information provided by such executive officers in determining
individual performance, level of responsibility, skills and experience of each executive officer.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation committee
views the competitive marketplace very broadly, which would include executive officers from both public and privately held companies
in general, including fashion and beauty companies, but not limited to the peer companies contained in the corporate performance
graph contained in our annual report. Generally, rather than tie the compensation committee&#8217;s determination of compensation
proposals to any specific peer companies, the members of our committee have used their business experience, judgment and knowledge
to review the executive compensation proposals recommended to them by Mr. Madar for United States operations and Mr. Benacin for
European operations. As such, as a general rule the compensation committee did not determine the need to benchmark of any material
item of compensation or overall compensation. However, in connection with the salary increase to Mr. Madar that occurred in February
2020, surveys of both peer companies and companies with comparable market capitalizations were used by the compensation committee
as one of the factors in reaching such determination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The members of the
compensation committee have extensive experience and business acumen and are well qualified in determining the appropriateness
of executive compensation levels. Mr. Heilbronn is a managing partner of a business consulting firm in the area of mergers and
acquisitions of large international companies in retail, consumer goods and consumer services throughout the world. Mr. Cho&#235;l
previously worked as President and Chief Executive Officer of two divisions of LVMH Moet Hennessy Louis Vuitton S.A., which included
such well-known brands as Parfums Christian Dior, Guerlain, and Parfums Givenchy. Mr. Cho&#235;l has also been President and CEO
of both Elida Faberg&#233; France and Chesebrough Ponds USA. Ms. Gabai-Pinsky, the final committee member, has executive experience
as the former President of Vera Wang Group, as well as the Global President for Aramis and Designers Fragrances in addition to
Beauty Bank and Idea Bank at The Est&#233;e Lauder Companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Base Salary</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Base salaries for executive
officers are initially determined by evaluating the responsibilities of the position held and the experience of the individual,
and by reference to the competitive marketplace for executive talent. Base salaries for executive officers are reviewed on an annual
basis, and adjustments are determined by evaluating our operating performance, the performance of each executive officer, as well
as whether the nature of the responsibilities of the executive has changed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As stated above,
as Messrs. Madar and Greenberg for United States operations, and Messrs. Benacin and Santi for European operations, were most
familiar with the individual performance, level of responsibility, skills and experience of each executive officer in their respective
segments, the committee relied upon the information provided by such executive officers in determining individual performance,
level of responsibility, skills and experience of each executive officer.&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For executive officers
of United States operations, the bulk of their annual compensation is in base salary including a fee paid to the holding company
for Mr. Madar for services rendered outside the United States. However, for executive officers of European operations base salary
comprises a smaller percentage of overall compensation. We have paid a lower percentage of overall compensation in the form of
base salary to executive officers of European operations for several years, principally because European operations historically
have had higher profitability than United States operations, and European operations are run differently from United States operations
by the Chief Executive Officer of European operations, Mr. Benacin. As the result of this historically higher profitability, European
operations have had the ability to pay higher bonus compensation in addition to base salary. As bonus compensation is and has historically
been discretionary, no targets were set in order to maintain flexibility. Further, if results of operations for European operations
were not satisfactory (again, no target amounts were set to maintain flexibility), then bonus compensation, as well as overall
compensation could be lowered without otherwise affecting base salary. Finally, by keeping annual bonus compensation at a higher
percentage of overall compensation and base salary at a lower percentage, our company benefits because the base amount for annual
salary adjustments would be smaller.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the impact
of COVID-19 on executive compensation in 2020 and 2021, please see our Annual Report on Form 10-K for the fiscal year ended December
31, 2021, under Item 11, <b>Item 11. Executive Compensation, <i>Compensation Discussion and Analysis</i></b>, <i>Covid-19 Impact</i>,
which is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2022, Mr. Benacin
received a base salary of $756,000, (included an increase of &#8364;12,000 but due to the foreign currency conversion this is showing
as a decrease when compared to 2021), and Mr. Benacin&#8217;s holding company received $250,000 paid by the Company&#8217;s United
States operations, which is included the calculation of his base salary. This same consulting fee has been paid for more than
each of the past three years, in accordance with the consulting agreement with Mr. Benacin&#8217;s holding company, which provides
for review on an annual basis of the amount of compensation payable to such company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2021, although
Mr. Benacin received the same base salary as he did in 2020, his salary was affected by foreign currency conversion rates and was
$804,000 for 2021. For 2020, Mr. Benacin received a modest increase in base salary of $14,000 to $789,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation committee
considered the following salient factors in authorizing payment to Mr. Benacin&#8217;s holding company&#8212; services rendered
to United States operations for several years by Mr. Benacin in connection with licensing and distribution of international brands,
as well as future services to be performed by Mr. Benacin internationally relating to licensing and distribution of international
brands for United States operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As Mr. Benacin values
the services of two named executive officers of Interparfums SA, Mr. Philippe Santi, Executive Vice President and the Chief Financial
Officer, and Mr. Frederic Garcia-Pelayo, Executive Vice President and Chief Operating Officer, equally, their base salaries, as
well as their bonus compensation discussed below, have been in lockstep.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2022, the base
salary of each of Messrs. Santi and Garcia-Pelayo was &#8364;432,000, and increase of &#8364;24,000. For 2021, the base salary of
each of Messrs. Santi and Garcia-Pelayo was &#8364;408,000, as no executive officer received any increase in base salary due the
continuing impact of the COVID-19 pandemic. However, the base salaries of Messrs. Santi and Garcia-Pelayo in 2021 were affected
by foreign currency conversion rates and were both $483,000 for 2021. For 2020, each of Messrs. Santi and Garcia-Pelayo received
an increase in base salary of $14,000 to $470,000. Increases in prior years were awarded primarily to reward these two executive
officers for their contributions in European Operations achieving increases in both the sales and earnings. The compensation committee
considered the recommendations of Mr. Benacin, results of operations for the year, as well as the services performed for European
operations by Messrs. Santi and Garcia-Pelayo in authorizing these salary levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A different approach
is taken for United States operations as that segment is smaller and less profitable. A more significant base salary is paid in
order to attract and retain employees with the skills and talents needed to run the operation with a lesser emphasis placed on
bonuses. Neither of the executive officers for United States operations have employment agreements (although Mr. Madar&#8217;s
personal holding company has a consulting agreement that provides for review on an annual basis of the amount of compensation payable
to such company), as we believe that having flexibility in structuring annual base salary is a benefit, which permits us to act
quickly to meet a changing economic environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As previously reported,
from 2013 until 2019 the annual aggregate base salary paid to Mr. Madar individually and fees paid to his holding company remained
unchanged at $630,000, which was substantially below the amounts indicated by two surveys of chief executive officer salaries
for 2019 (collectively the &#8220;CEO Salary Surveys&#8221;). The CEO Salary Surveys indicated that the annual and median average
CEO salaries for peer companies (excluding the Madar salary) were $2,854,656 and $1,540,000, respectively, and $2,604,346 and
$1,750,000 for comparable market capitalization companies, respectively. In recognition of the efforts of Mr. Madar and his holding
company as one of the prime causes for our substantial increase in net sales and net income, as well as market capitalization
from 2014 through 2019, thus substantially increasing shareholder value, on February 4, 2020 the Committee jointly authorized
the aggregate annual increase in Mr. Madar&#8217;s base salary by $600,000 to $1.23 million effective as of January 1, 2020. For
2022 and 2021, Mr. Madar did not receive any increase in base salary.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Russell Greenberg,
the former Executive Vice President and Chief Financial Officer, received a $30,000 increase in base salary for 2022 to $750,000
on an annualized basis, also did not have any salary increase for 2021, when his base salary remained at $720,000. Previously,
he had received the same $30,000 increase in base salary for 2020 and 2019. In connection with the previous increases in salary,
the Compensation Committee considered the following material factors in granting Mr. Greenberg his salary increases: his individual
performance, level of responsibility, skill and experience, as well as the recommendation of the Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Atwood, who
became the Chief Financial Officer in September 2022 after the retirement of Mr. Greenberg, was granted a $500,000 annual base
salary, as well as a signing bonus of $100,000 that was paid in September 2022. An additional bonus of $50,000 was also paid in
December 2022 for the September-December period. The Compensation Committee considered the following material factors in approving
the base salary and guaranteed annual bonus of Mr. Atwood for 2022: his individual performances, level of responsibilities, skill
and experience with other companies in the fragrance and cosmetic industry, as well as the recommendation of the Chief Executive
Officer.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Bonus Compensation/Annual
Incentives</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recognition
of the Company&#8217;s turnaround from the effects of the COVID-19 pandemic, supply chain disruptions and geopolitical turmoil
in 2022 and record results in 2022, and after the recommendations of Messrs. Madar and Benacin, the compensation committee determined
that Mr. Benacin receive a bonus of $211,000. Also, in recognition of record results in 2021 while dealing with the effects of
the COVID-19 pandemic, supply chain disruptions and geopolitical turmoil, and after the recommendations of Messrs. Madar and Benacin,
the compensation committee determined that Mr. Benacin receive a bonus of $166,000. For 2020 Mr. Benacin, the chief decision maker
for European operations, proposed and the compensation committee concurred in the payment of discretionary bonus compensation
of $131,000. Discretionary bonus compensation for Mr. Benacin has been approximately 28%, 30% and 17% of his base salary in 2022,
2021 and 2020, respectively.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Compensation
Committee agreed with the recommendation of Mr. Benacin and the contributions made by Messrs. Santi and Garcia-Pelayo to the Company&#8217;s
success and growth. Bonus compensation for Messrs. Santi and Garcia-Pelayo have remained in lockstep, and each was awarded a discretionary
bonus of $437,000, $378,000 and $296,000 in 2022, 2021 and 2020, respectively, or 96%, 78% and 63%of their base salary for those
years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A different approach
is taken for United States operations as that segment is smaller and less profitable. As discussed above, a more significant base
salary is paid in order to attract and retain employees with the skills and talents needed to run United States operations with
a lesser emphasis placed on bonuses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2022, as Mr.
Greenberg retired, he did not receive a discretionary bonus. In 2021, although Mr. Greenberg did not receive any increase in base
salary due to the continuing impact of the COVID-19 pandemic, he did receive a discretionary bonus of $70,000 based upon the recommendation
of the Chief Executive Officer. Mr. Greenberg was paid a discretionary bonus of $35,000 in 2020 and $50,000 for each of the several
years prior thereto. The Compensation Committee considered the following material factors in granting Mr. Greenberg his bonuses:
his individual performance, level of responsibility, skill and experience, as well as the recommendation of the Chief Executive
Officer.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Atwood, who
became the Chief Financial Officer in September 2022 after the retirement of Mr. Greenberg, received a sign on bonus of $100,000.
His compensation arrangement also entitles him to a guaranteed annual bonus of $100,000, as well as a $100,000 bonus based upon
achieving certain milestones. For 2022, Mr. Atwood received his $100,000 sign on bonus and $50,000 pro-rated performance bonus
related to the September-December period. The Compensation Committee considered the same factor in granting these two bonuses
as in approving his initial annualized salary.</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Madar, the Chief
Executive Officer has not received any cash bonus in the past three years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required by French
law, Interparfums SA maintains its own profit sharing plan for all French employees who have completed three months of service,
including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Interparfums SA.
Benefits are calculated based upon a percentage of taxable income of Interparfums SA and allocated to employees based upon salary.
The maximum amount payable per year per employee is approximately $32,485.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Calculation of the
total annual benefits contribution is made according to the following formula:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">67% of (Interparfums SA net income,
less 2.5% of shareholders&#8217; equity without net income for the year) times a fraction, the numerator of which is wages, and
the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization
expenses + interest expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Contribution to individual
employees is then made pro rata based upon their individual salaries for the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Long-Term Incentives</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock Options</i>.
In prior years, we had linked long-term incentives with corporate performance through the grant of stock options. However, no
options were granted in 2021 or 2020 to either employees of United States operations or European operations, as other compensation
arrangements were being considered as part of a review of the executive compensation strategy. In December 2022, at the recommendation
of the Chief Executive Officer, the Compensation Committee authorized the grant of a stock option to purchase 5,000 shares to
Mr. Atwood at the fair market value on the date of grant as part of his long-term incentives. Unless the market price of our common
stock increases, Mr. Atwood will have no tangible benefit from this option. Thus, the option holder is provided with the additional
incentive to increase individual performance with the ultimate goal of increasing our overall performance. We believe that enhanced
executive incentives that result in increased corporate performance tend to build company loyalty. No other stock option grants
were made to other executive officers in 2022, including Messrs. Jean Madar and Philippe Benacin.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Interparfums SA
Stock Compensation Plans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>2022 Free Share
Plan &#8211; </i>On March 16, 2022, the Board of Interparfums SA (&#8220;IPSA&#8221;) decided to grant 88,400 free shares of its
capital stock to all of the IPSA&#8217;s employees and corporate officers having more than 6 months seniority at the grant date.
The free shares are to be issued in June 2025. Issuance of those shares are based on satisfaction of performance conditions, relating
to the 2024 IPSA sales for 50% of the shares and 2024 operating income for the balance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IPSA used the services
of third party to assist them in the valuation of the plan, with the calculations and assumptions as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">Management expects the rate of staff turnover to be 12%,</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">Using the Monte Carlo method, management expects the performance rate to be 80% on the consolidated
sales and 80.8% on the consolidated operating income.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the above
assumptions, the total expenses related to this plan is valued at $3.3 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31,
2022:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">63,281 shares of IPSA Capital
                                         Stock, representing $3.0 million were purchased in the open market and allocated to this
                                         plan.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">$1.0 million of
expense was recorded (or $1.2 million including social contributions).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>2019 Plan</i>
&#8211; In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with
no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate
performance conditions. The shares, subject to adjustment for stock splits, were distributed in June 2022. Under this plan in
June 2022, Messrs. Benacin, Madar, Garcia Pelayo and Santi received 4,000 shares each (5,857 shares as adjusted for stock splits).</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2020, the performance
conditions were modified effecting 96 employees. As of December 31, 2021, the number of shares to be distributed, after forfeited
shares and adjusted for stock splits, increased to 172,343. The increase in shares anticipated to be distributed were transferred
from treasury shares at the Interparfums SA level. The modification resulted in a revised cost of the grant to approximately $4.6
million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the 2019 Plan referred to above, an incentive plan was established by Interparfums SA for certain employees of Interparfums Luxury
Brands, Inc. (&#8220;IPLB&#8221;), Interparfums Singapore (&#8220;IP Singapore&#8221;) and Inter Parfums, Inc. The proposed incentive
plan would not provide shares but rather, would give a cash payment or bonus (&#8220;incentive&#8221; or &#8220;award&#8221;) that
mirrors the shares that Interparfums SA employees will receive. An aggregate of 42,140 &#8220;phantom&#8221; shares have been awarded
in 2022, with Mr. Greenberg being awarded 1,000 of such &#8220;phantom&#8221; shares, all subject to adjustment for stock splits,
with a value of approximately $69,839.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock Appreciation
Rights</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our stock option plans
authorize us to grant stock appreciation rights, or SARs. A SAR represents a right to receive the appreciation in value, if any,
of our common stock over the base value of the SAR. To date, we have not granted any SARs under our plans. While the compensation
committee currently does not plan to grant any SARs under our plans, it may choose to do so in the future as part of a review of
the executive compensation strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Restricted Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not in
the past, and we do not have any future plans to grant restricted stock to our executive officers. However, while the compensation
committee currently does not plan to authorize any restricted stock plans, the compensation committee may choose to do so in the
future as part of a review of the executive compensation strategy. Our French operating subsidiary, Interparfums, SA, however,
has instituted its 2022 and 2019 Stock Compensation Plans as discussed above.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2022, each of Messrs.
Benacin and Garcia-Pelayo received an automobile allowance of $11,372.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>No Stock Ownership
Guidelines</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not require any
minimum level of stock ownership by any of our executive officers. As stated above, Messrs. Madar and Benacin, are our largest
beneficial shareholders, which aligns their interests with our shareholder base in keeping executive compensation at a reasonable
level.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Retirement and Pension
Plans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a 401(k)
plan for United States operations. Commencing in October 2021 we started matching the first $6,000 of contribution for each employee,
as we have determined that base compensation together with annual bonuses, are sufficient incentives to retain talented employees.
Our European operations maintain a pension plan for its employees as required by French law. For each of 2022, 2021and 2020, each
of Messrs. Benacin, Santi and Garcia-Pelayo received an increase of $16,006, $17,773 and $17,500, respectively, in their value
of deferred compensation earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee Report</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have reviewed and
discussed with management the Compensation Discussion and Analysis provisions to be included in this Annual Report on Form 10-K
for fiscal year ended December 31, 2022 and the proxy statement for the upcoming annual meeting of shareholders. Based on this
review and discussion, we recommend to the board of directors that the Compensation Discussion and Analysis referred to above be
included in this Annual Report on Form 10-K as well as the proxy statement for the upcoming annual meeting of shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Francois Heilbronn</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patrick Cho&#235;l and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Veronique Gabai-Pinsky</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth a summary of all compensation awarded to, earned by or paid to our &#8220;named executive officers,&#8221; who are our
principal executive officer, our principal financial officer, and each of the three most highly compensated executive officers
of our company. This table covers all such compensation during fiscal years ended December 31, 2022, December 31, 2021 and December
31, 2020. For all compensation related matters disclosed in the summary compensation table, and elsewhere where applicable, all
amounts paid in euro have been converted to U.S. dollars at the average rate of exchange in each year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="19" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>SUMMARY
    COMPENSATION TABLE</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Name
    and Principal Position</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Year</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Salary</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Bonus</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Stock</b><br />
    <b>Awards</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Option</b><br />
    <b>Awards</b><br />
    <b>($)(1)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-Equity</b><br />
    <b>Incentive Plan Compensation</b><br />
    <b>($)(2)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Change
    in</b><br />
    <b>Pension Value</b><br />
    <b>and</b><br />
    <b>Nonqualified</b><br />
    <b>Deferred</b><br />
    <b>Compensation</b><br />
    <b>Earnings</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>All
    Other</b><br />
    <b>Compensation</b><br />
    <b>($)(3)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b><br />
    <b>($)</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 22%; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Jean
    Madar,</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,230,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,230,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chairman and</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,230,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,230,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chief Executive
    Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,230,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,230,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Russell Greenberg,
    (4)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">750,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">750,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chief Financial
    Officer and</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">720,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">70,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">790,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Executive Vice President</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">720,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">35,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">755,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Michel Atwood (5)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">161,218</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">150,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101,814</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">413,032</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chief Financial
    Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Philippe Benacin,
    President Inter</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">755,440</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">210,600</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16,006</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11,372</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">993,418</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Parfums, Inc., Chief
    Executive</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">803,504</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">165,578</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">999,589</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Officer of Interparfums
    SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">788,808</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">130,673</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,434</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">949,415</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Philippe Santi,
    Executive Vice</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">454,896</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">436,995</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16,006</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">907,897</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">President and Chief
    Financial</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">482,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">378,464</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">878,739</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Officer, Interparfums
    SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">469,730</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">295,596</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">782,826</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fr&#233;d&#233;ric
    Garcia-Pelayo,</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">454,896</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">436,995</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16,006</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11,372</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">919,269</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Executive Vice President
    and</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">482,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">378,464</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,733</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,774</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">891,513</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chief Operating
    Officer Interparfums SA</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">469,730</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">295,596</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-0-</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,980</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">791,806</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">1</td>
    <td style="text-align: justify">Amounts reflected under Option Awards represent the grant date fair values in 2022, 2021 and 2020 based on the fair value of stock option awards using a Black-Scholes option pricing model. The assumptions used in this model are detailed in Footnote 13 to the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022 and filed with the SEC.</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">2</td>
    <td style="text-align: justify">As required by French law, Interparfums SA maintains its own profit sharing plan for all French employees who have completed three months of service, including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Interparfums SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and are allocated to employees based upon salary. The maximum amount payable per year is approximately $32,485.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Calculation of total
annual benefits contribution is made according to the following formula:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">67% of (Interparfums SA net income,
less 2.5% of shareholders&#8217; equity without net income for the year) times a fraction, the numerator of which is wages, and
the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization
expenses + interest expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Contribution to individual
employees is then made pro rata based upon their individual salaries for the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">3</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">The following table identifies (i) perquisites
    and other personal benefits provided to our named executive officers in fiscal 2022, and quantifies those required by SEC
    rules to be quantified and (ii) all other compensation that is required by SEC rules to be separately identified and quantified.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">4</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Greenberg retired in September
        2022.</p></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">5</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Atwood replaced Mr. Greenberg
        on September 6, 2022. His base salary was prorated from $500,000, annually.</p></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name and Principal Position</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Perquisites</b></span><br />
    <span style="font-size: 10pt"><b>and other</b></span><br />
    <span style="font-size: 10pt"><b>Personal</b></span><br />
    <span style="font-size: 10pt"><b>Benefits</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Personal</b></span><br />
    <span style="font-size: 10pt"><b>Automobile</b></span><br />
    <span style="font-size: 10pt"><b>Expense</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Lodging</b></span><br />
    <span style="font-size: 10pt"><b>Expense</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Total</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><span style="font-size: 10pt">Jean Madar, Chairman </span><br />
    <span style="font-size: 10pt">Chief Executive Officer</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Russell Greenberg, Chief Financial</span><br />
    <span style="font-size: 10pt">Officer and Executive Vice</span><br />
    <span style="font-size: 10pt">President</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Philippe Benacin, President of Inter </span><br />
    <span style="font-size: 10pt">Parfums, Inc. and Chief Executive</span><br />
    <span style="font-size: 10pt">Officer of Interparfums SA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11,372</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11,372</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Philippe Santi, </span><br />
    <span style="font-size: 10pt">Executive Vice President and Chief</span><br />
    <span style="font-size: 10pt">Financial Officer, Interparfums SA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo, </span><br />
    <span style="font-size: 10pt">Executive Vice President and </span><br />
    <span style="font-size: 10pt">Chief Operating Officer, </span><br />
    <span style="font-size: 10pt">Interparfums SA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11,372</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11,372</span></td>
    <td>&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Plan Based Awards</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets certain information relating to each grant of an award made by our company to the executive officers of our company listed
in the Summary Compensation Table during the past fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="26" style="border-bottom: black 1pt solid; text-align: center"><b>Grants of Plan-Based Awards</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td>
    <td><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><b>Name</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Grant Date</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><b>Estimated Future Payouts Under </b><br />
<b>Non-Equity Incentive Plan Awards</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><b>Estimated Future Payouts Under </b><br />
<b>Equity Incentive Plan Awards</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>All Other Stock Awards: </b><br />
<b>Number of Shares of Stock or</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>All Other Option Awards: </b><br />
<b>Number of Securities Underlying</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Exercise or Base Price of Option</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Closing</b></td>
    <td style="text-align: center"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Threshold ($)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Target </b><br />
<b>($)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Maximum ($)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Threshold (#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Target (#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Maximum (#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Units</b><br />
<b>(#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Options</b><br />
<b>(#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Awards </b><br />
<b>($/Sh)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Price </b><br />
<b>($/Sh)</b></td>
    <td style="text-align: center"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 9%">Jean Madar</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 6%; text-align: center">NA</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">NA</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right">NA</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Russell Greenberg</td>
    <td>&#160;</td>
    <td style="text-align: center">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michel</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atwood&#160;</p></td>
    <td>&#160;</td>
    <td style="text-align: center">07/22/2022</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">100,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">100,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">100,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">- 0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michel</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atwood&#160;</p></td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/202</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">$97.84</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">$96.52</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Philippe Benacin</td>
    <td>&#160;</td>
    <td style="text-align: center">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Philippe Santi</td>
    <td>&#160;</td>
    <td style="text-align: center">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>Fr&#233;d&#233;ric Garcia-Pelayo</td>
    <td>&#160;</td>
    <td style="text-align: center">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Interparfums SA
Stock Compensation Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets certain information relating to each grant of an award made by Interparfums SA to the executive officers of our company listed
in the Summary Compensation Table during the past fiscal year. Equity awards relate to the shares of Interparfums SA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="26" style="border-bottom: black 1pt solid; text-align: center"><b>Grants of Plan-Based Awards</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td>
    <td><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><b>Name</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Grant Date</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><b>Estimated Future Payouts Under </b><br />
<b>Non-Equity Incentive Plan Awards</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><b>Estimated Future Payouts Under </b><br />
<b>Equity Incentive Plan Awards</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>All Other Stock Awards: </b><br />
<b>Number of Shares of Stock or</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>All Other Option Awards: </b><br />
<b>Number of Securities Underlying</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Exercise or Base Price of Option</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Closing</b></td>
    <td style="text-align: center"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Threshold ($)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Target </b><br />
<b>($)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Maximum ($)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Threshold (#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Target (#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Maximum (#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Units</b><br />
<b>(#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Options</b><br />
<b>(#)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Awards </b><br />
<b>($/Sh)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Price </b><br />
<b>($/Sh)</b></td>
    <td style="text-align: center"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Jean Madar</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: center">3/16/22</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right">NA</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right">NA</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right">NA</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 6%; text-align: right">3,000</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 6%; text-align: right">-0-</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 6%; text-align: right">49,89 &#8364;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Russell Greenberg</td>
    <td>&#160;</td>
    <td style="text-align: center">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michel</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atwood&#160;</p></td>
    <td>&#160;</td>
    <td style="padding-bottom: 8pt; text-align: center">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Philippe Benacin</td>
    <td>&#160;</td>
    <td style="text-align: center">3/16/22</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">3,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Philippe Santi</td>
    <td>&#160;</td>
    <td style="text-align: center">3/16/22</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">6,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">49,89 &#8364;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Philippe Santi</td>
    <td>&#160;</td>
    <td style="text-align: center">12/31/22</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">32,485</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fr&#233;d&#233;ric Garcia-Pelayo</td>
    <td>&#160;</td>
    <td style="text-align: center">3/16/22</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">6,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">49,89 &#8364;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Fr&#233;d&#233;ric Garcia-Pelayo</td>
    <td>&#160;</td>
    <td style="text-align: center">12/31/22</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">32,485</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">-0-</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">NA</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NA means not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Interparfums SA
Profit Sharing Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also as discussed above
and required by French law, Inter Parfums, SA maintains its own profit sharing plan for all French employees who have completed
three months of service, including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer
of Inter Parfums, SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and allocated to employees
based upon salary. The maximum amount payable per year per employee is approximately $32,485.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Calculation of total
annual benefits contribution is made according to the following formula:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">67% of (Interparfums
SA net income, less 2.5% of shareholders equity without net income for the year) times a fraction, the numerator of which is wages,
and the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization
expenses + interest expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets certain information relating to each grant of a non-equity award made by Interparfums SA to the executive officers of our
company listed in the Summary Compensation Table during the past fiscal year. Equity awards relate to the shares of Interparfums
SA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>Outstanding Equity Awards at Fiscal
Year-End</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth certain information relating to outstanding equity awards of our Company held by the executive officers listed in the
Summary Compensation Table as of December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td colspan="17" style="border-bottom: black 1pt solid; text-align: center"><b>Option Awards</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5pt"><b>Name</b></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Number of</b><br />
    <b>Securities</b><br />
    <b>Underlying</b><br />
    <b>Unexercised</b><br />
    <b>Options (#)</b><br />
    <b>Exercisable<sup>(1)</sup></b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Number of</b><br />
    <b>Securities</b><br />
    <b>Underlying</b><br />
    <b>Unexercised</b><br />
    <b>Options (#)</b><br />
    <b>Unexercisable</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Equity Incentive</b><br />
    <b>Plan Awards:</b><br />
    <b>Number of</b><br />
    <b>Securities</b><br />
    <b>Underlying</b><br />
    <b>Unexercised</b><br />
    <b>Unearned</b><br />
    <b>Options (#)</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Option</b><br />
    <b>Exercise</b><br />
    <b>Price ($)</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Option</b><br />
    <b>Expiration</b><br />
    <b>Date</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 23%; padding-left: 5pt">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;Jean Madar</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">25,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">43.80</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/29/23</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">20,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">65.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">15,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">10,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">73.09</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/25</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">Russell Greenberg</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">15,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43.80</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/29/23</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">65.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">10,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">73.09</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/25</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5pt">Michel Atwood</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">97.84</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/28</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;Philippe Benacin</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">25,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">43.80</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/29/23</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">20,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">5,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">65.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">15,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">10,000</td>
    <td><sup>(2)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">73.09</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/25</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;Philippe Santi</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">1,200</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">43.80</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/29/23</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">800</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">800</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">46.903</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">1/18/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">2,400</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">2,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">65.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">4,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">4,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><p style="margin: 0pt 0">0</p>

</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">73.09</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/25</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;Fr&#233;d&#233;ric Garcia-Pelayo</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">2,400</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">43.80</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/29/23</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">800</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">800</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">46.903</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">1/18/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">4,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">2,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">65.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/24</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">4,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">4,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">0</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">73.09</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">12/30/25</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[<i>Footnotes from table above</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">1</td>
    <td style="text-align: justify">All options expire 6 years from the date of grant, and vest 20% each year commencing one year after the date of grant.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">2</td>
    <td style="text-align: justify">Options are held in the name of personal holding company.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets certain information relating to outstanding equity awards granted by Interparfums SA, our majority-owned French subsidiary
which has its shares traded on the NYSE Euronext, held by the executive officers of our company listed in the Summary Compensation
Table as of the end of the past fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</b><br />
<b>OF INTERPARFUMS SA</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="17" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Option Awards</b></span></td>
    <td>&#160;</td>
    <td colspan="12" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Stock Awards</b></span></td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number of Securities
    Underlying Unexercised Options (#) Exercisable)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number of Securities
    Underlying Unexercised Options (#) Unexercisable</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Equity Incentive
    Plan Awards: Number of Securities Underlying Unexercised Unearned</b></span><br />
    <span style="font-size: 10pt"><b>Options (#)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Option</b></span><br />
    <span style="font-size: 10pt"><b>Exercise</b></span><br />
    <span style="font-size: 10pt"><b>Price ($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Option Expiration</b></span><br />
    <span style="font-size: 10pt"><b>Date</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number of Shares
    or Units of Stock that Have Not Vested (#)(1)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Market Value
    of Shares or Units of Stock that Have Not Vested ($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Equity Incentive
    Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Equity Incentive Plan Awards:
    Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested($)</b></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 10%; padding-left: 9pt"><span style="font-size: 10pt">Jean Madar</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: right"><span style="font-size: 10pt">0</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">3,000</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-size: 10pt">175,640</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Russell Greenberg</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Michel</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Atwood</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Philippe Benacin</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">3,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">175,640</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Philippe Santi</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">6,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">351,281</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">6,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">175,640</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1 Estimated number of shares are to be
issued only to the extent that the performance conditions have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2 As of December 31, 2022, the closing
price of Interparfums SA as reported by Euronext was 55.60 euros, and the exchange rate was 1.053 U.S. dollars to 1 euro.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Option Exercises and Stock Vested</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth certain information relating to each option exercise affected during the past fiscal year, and each vesting of stock,
including restricted stock, restricted stock units and similar instruments of our company during the past fiscal year, for the
executive officers of our company listed in the Summary Compensation Table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OPTION EXERCISES AND STOCK VESTED</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Option Awards</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Stock Awards</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number</b></span><br />
    <span style="font-size: 10pt"><b>of Shares</b></span><br />
    <span style="font-size: 10pt"><b>Acquired on</b></span><br />
    <span style="font-size: 10pt"><b>Exercise</b></span><br />
    <span style="font-size: 10pt"><b>(#)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Value </b></span><br />
    <span style="font-size: 10pt"><b>Realized on</b></span><br />
    <span style="font-size: 10pt"><b>Exercise</b></span><br />
    <span style="font-size: 10pt"><b>($)<sup>1</sup></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number</b></span><br />
    <span style="font-size: 10pt"><b>of Shares</b></span><br />
    <span style="font-size: 10pt"><b>Acquired on</b></span><br />
    <span style="font-size: 10pt"><b>Vesting</b></span><br />
    <span style="font-size: 10pt"><b>(#)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Value</b></span><br />
    <span style="font-size: 10pt"><b>Realized On</b></span><br />
    <span style="font-size: 10pt"><b>Vesting</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 51%; padding-left: 9pt"><span style="font-size: 10pt">Jean Madar</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-size: 10pt">19,000</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-size: 10pt">1,230,315</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Russell Greenberg</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">60,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2,475,744</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Michel Atwood</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Philippe Benacin</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">19,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,191,374</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Philippe Santi</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">199,588</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,200</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">82,973</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Footnotes from table above]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">1</td>
    <td style="text-align: justify">Total value realized on exercise of options in dollars is based upon the difference between the fair market value of the common stock on the date of exercise, and the exercise price of the option.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regarding Interparfums
SA, our majority-owned French subsidiary which has its shares traded on the Euronext, no options were exercised during the past
fiscal year, and there was no vesting of stock, including restricted stock, restricted stock units and similar instruments during
the past fiscal year, for the executive officers of our company listed in the Summary Compensation Table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pension Benefits</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth certain information relating to payment of benefits in connection with retirement plans during the past fiscal year,
for the executive officers of our company listed in the Summary Compensation Table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PENSION BENEFITS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Plan Name</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number</b></span><br />
    <span style="font-size: 10pt"><b>of Years</b></span><br />
    <span style="font-size: 10pt"><b>Credited</b></span><br />
    <span style="font-size: 10pt"><b>Service </b></span><br />
    <span style="font-size: 10pt"><b>(#)</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Present</b></span><br />
    <span style="font-size: 10pt"><b>Value of</b></span><br />
    <span style="font-size: 10pt"><b>Accumulated</b></span><br />
    <span style="font-size: 10pt"><b>Benefit* </b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Payments</b></span><br />
    <span style="font-size: 10pt"><b>During</b></span><br />
    <span style="font-size: 10pt"><b>Last Fiscal</b></span><br />
    <span style="font-size: 10pt"><b>Year </b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 32%; padding-left: 9pt"><span style="font-size: 10pt">Jean Madar</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Russell Greenberg</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Michel Atwood</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 9pt"><span style="font-size: 10pt">Philippe Benacin</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Inter Parfums SA Pension Plan</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">331,239</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-size: 10pt">16,006</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; padding-left: 9pt"><span style="font-size: 10pt">Philippe Santi</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Inter Parfums SA Pension Plan</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">321,239</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-size: 10pt">16,006</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 9pt"><span style="font-size: 10pt">Fr&#233;d&#233;ric Garcia-Pelayo</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Inter Parfums SA Pension Plan</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">NA</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">321,239</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-size: 10pt">16,006</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">*</td>
    <td style="text-align: justify">Does not include any contributions made by prior employers, or individually by the recipients as such information is confidential under French law.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interparfums SA maintains
a pension plan for all of its employees, including all executive officers. The calculation of commitments for severance benefits
involves estimating the probable present value of projected benefit obligations. This projected benefit obligations are then prorated
to take into account seniority of the employees of Interparfums SA on the calculation date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In calculating benefits,
the following assumptions were applied:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">-</td>
    <td style="text-align: justify">voluntary retirement at age 65;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">-</td>
    <td style="text-align: justify">a rate of 45% for employer payroll contributions for all employees;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">-</td>
    <td style="text-align: justify">a 3% average annual salary increase;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">-</td>
    <td style="text-align: justify">an annual rate of turnover for all employees under 55 years of age and nil above;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">-</td>
    <td style="text-align: justify">the TH 00-02 mortality table for men and the TF 00-02 mortality table for women;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">-</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">a discount rate of 3.8%.</span></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The normal retirement age is 65 years,
but employees, including Messrs. Benacin, Santi and Garcia-Pelayo, can collect reduced benefits if they retire at age 62.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nonqualified Deferred Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not maintain
any nonqualified deferred compensation plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>CEO Pay Ratio</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required by Section
953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing the
following information about the relationship of the annual total compensation of our mean employee and the annual total compensation
of Mr. Jean Madar, Chief Executive Officer (the &#8220;CEO&#8221;):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2022, our last
completed fiscal year:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 24px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Our median employee&#8217;s compensation
    was $66,402</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">Our Chief Executive Officer&#8217;s total 2022 compensation was $2,460,315</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 24px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Accordingly, our 2022 CEO to Median Employee
    Pay Ratio was 37.05 to 1</span></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This pay ratio is a
reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records. We identified
our median employee using our total employee population as of December 31, 2022 by applying a consistently applied compensation
measure across our global employee population. For our consistently applied compensation measure, we used all compensation, including
actual base salary, bonuses, commissions, and any overtime paid during the 12-month period ending December 31, 2022. We did not
use any material estimates, assumptions, adjustments or statistical sampling to determine the worldwide median employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC rules for identifying
the median compensated employee and calculating the pay ratio based on that employee&#8217;s annual total compensation allow companies
to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect
their compensation practices. As such, the pay ratio reported by other companies may not be comparable to the pay ratio reported
above, as other companies may have different employment and compensation practices and may utilize different methodologies, exclusions,
estimates and assumptions in calculating their own pay ratios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Employment and
Consulting Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see our Annual
Report on Form 10-K for the year ended December 31, 2021, Item 11 under the heading &#8220;<b><i>Employment and Consulting Agreements</i></b>&#8221;
for a material terms of the employment agreement with Philippe Benacin, individually, and the consulting agreements with, and fees
and stock options previously granted to, Philippe Benacin Holding SAS and Jean Madar Holding SAS, which is incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Compensation
of Directors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth certain information relating to the compensation for each of our directors who is not an executive officer of our Company
named in the Summary Compensation Table for the past fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>DIRECTOR COMPENSATION</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fees Earned or Paid in Cash</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)</b></p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Stock</b></span><br />
    <span style="font-size: 10pt"><b>Awards</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Option</b></span><br />
    <span style="font-size: 10pt"><b>Awards</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Non-Equity
    Incentive Plan Compensation</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Change in</b></span><br />
    <span style="font-size: 10pt"><b>Pension Value</b></span><br />
    <span style="font-size: 10pt"><b>and Nonqualified Deferred Compensation Earnings</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>All Other Compensation</b></span><br />
    <span style="font-size: 10pt"><b>($)<sup>1</sup></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Total</b></span><br />
    <span style="font-size: 10pt"><b>($)</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 29%; padding-left: 9pt"><span style="font-size: 10pt">Francois Heilbronn<sup>2</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">15,000</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">30,544</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 7%; text-align: right"><span style="font-size: 10pt">45,544</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Robert Bensoussan<sup>3</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">30,544</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">66,480</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">115,024</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Patrick Cho&#235;l<sup>4</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">15,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">30,544</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">13,246</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">58,790</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Michel Dyens<sup>5</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">21,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">30,544</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">51,544</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Veronique Gabai-Pinsky<sup>6</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">30,544</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">84,308</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">132,852</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Gilbert Harrison<sup>7</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">30,544</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">120,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">168,544</span></td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Footnotes from table above]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">1.</td>
    <td style="text-align: justify">Represents gain from exercise of stock options, except for Mr. Harrison, which consists of a $120,000 payment made in 2022 to the company controlled by Mr. Harrison in connection with the acquisition of the Donna Karan license. See &#8220;Fee for Director&#8217;s Company&#8221; in Item 13, Certain Relationships and Related Transactions, and Director Independence, in this annual report on Form 10-K.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">2.</td>
    <td style="text-align: justify">As of the end of the last fiscal year, Mr. Heilbronn held options to purchase an aggregate of 6,500 shares of our common stock.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">3.</td>
    <td style="text-align: justify">As of the end of the last fiscal year, Mr. Bensoussan held options to purchase an aggregate of 7,500 shares of our common stock.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">4.</td>
    <td style="text-align: justify">As of the end of the last fiscal year, Mr. Cho&#235;l held options to purchase an aggregate of 5,750 shares of our common stock.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">5.</td>
    <td style="text-align: justify">As of the end of the last fiscal year, Mr. Dyens held options to purchase an aggregate of 6,500 shares of our common stock.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">6.</td>
    <td style="text-align: justify">As of the end of the last fiscal year, Ms. Gabai-Pinsky held options to purchase an aggregate of 7,500 shares of our common stock.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">7.</td>
    <td style="text-align: justify">As of the end of the last fiscal year, Mr. Harrison held options to purchase an aggregate of 7,500 shares of our common stock.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All nonemployee directors
receive $6,000 for each board meeting at which they participate in person, and $3,000 for each meeting held by conference telephone.
In addition, the annual fee for each member of the audit committee is $8,000. The compensation for the nonemployee directors remained
the same for 2021 and 2022, except for Mr. Harrison. During 2021, a company owned by Mr. Harrison received a fee equal to $300,000,
in connection with the Donna Karan license agreement, which is effective on July 1, 2022. A payment of $120,000 was made in 2021
to Mr. Harrison&#8217;s company, $120,000 was paid one year later in 2022, and $60,000 will be paid one year thereafter in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a stock
option plan for our nonemployee or independent directors. The purpose of this plans is to assist us in attracting and retaining
key directors who are responsible for continuing the growth and success of our company. Under such plan, until 2022 options to
purchase 1,500 shares are granted on each February 1st to all nonemployee directors for as long as each is a nonemployee director
on such date. However, if a nonemployee director does not attend certain of the board meetings, then such option grants are reduced
according to a schedule. However, our board of directors cancelled the automatic grant of options to the nonemployee directors
effective with the grant that had been scheduled for February 1, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After discussions Mr.
Atwood had with certain financial consultants relating to potential compensation plans in lieu of stock option grants to the Company&#8217;s
independent directors, and consultation between Messrs. Madar and Atwood, it was determined that the most favorable way for the
nonemployee directors to be compensated was to amend the 2016 Stock Option Plan to reinstate the automatic grant of stock options
previously provided to nonemployee directors, commencing with a new automatic grant on the last business day of 2022, December
30, and continuing on the last business day of each year thereafter, subject to the approval of the shareholders of this Corporation
at the 2023 annual meeting of shareholders. The automatic option grants to independent directors were approved by the Board of
Directors with the following changes: Reinstatement of the automatic grant of nonqualified stock options to all nonemployee directors
was made without any discretion on the part of the Executive Compensation and Stock Option Committee, with the right to purchase
1,500 shares of the our common stock under our 2016 Stock Option Plan, as amended (the &#8220;2016 Stock Option Plan&#8221;), at
the purchase per share on the date of grant equal to the fair market value as determined in accordance with the 2016 Stock Option
Plan, each exercisable for a six (6) year period; provided that, such options shall vest and become exercisable to purchase shares
of Common Stock as follows: 20% one year after the date of grant, and then 20% on each of the second, third, fourth and fifth consecutive
years from the date of grant on a cumulative basis, so that each option shall become fully vested and exercisable on the first
day of the sixth year from the date of grant, with the automatic grant date to commence on the last business day of this year,
December 30, 2022 and continuing on the last business day of each year thereafter, in lieu of the grant date on each February 1<sup>st</sup>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><br />
<b><span id="a026"></span>Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth information with respect to the beneficial ownership of our common stock by (a) each person we know to be the beneficial
owner of more than 5% of our outstanding common stock, (b) our executive officers and directors and (c) all of our directors and
officers as a group. Messrs. Madar and Benacin own 99.99% of their respective personal holding companies. As of February 28, 2023,
we had 32,109,360 shares of common stock outstanding.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name and Address of Beneficial Owner</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Amount of</b></span><br />
    <span style="font-size: 10pt"><b>Beneficial</b></span><br />
    <span style="font-size: 10pt"><b>Ownership<sup>1</sup></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Approximate</b></span><br />
    <span style="font-size: 10pt"><b>Percent of</b></span><br />
    <span style="font-size: 10pt"><b>Class</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 75%"><span style="font-size: 10pt">Jean Madar</span><br />
    <span style="font-size: 10pt">c/o Interparfums SA</span><br />
    <span style="font-size: 10pt">10 rue de Solf&#233;rino</span><br />
    <span style="font-size: 10pt">75007 Paris, France</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">7,116,741</span></td>
    <td style="width: 1%"><span style="font-size: 10pt"><sup>2</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">22.2</span></td>
    <td style="width: 1%; text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Philippe Benacin</span><br />
    <span style="font-size: 10pt">c/o Interparfums SA</span><br />
    <span style="font-size: 10pt">10 rue de Solf&#233;rino</span><br />
    <span style="font-size: 10pt">75007 Paris, France</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">6,906,064</span></td>
    <td><span style="font-size: 10pt"><sup>3</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">21.5</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Michel Atwood</span><br />
    <span style="font-size: 10pt">c/o Inter Parfums, Inc.</span><br />
    <span style="font-size: 10pt">551 Fifth Avenue</span><br />
    <span style="font-size: 10pt">New York, NY 10176</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 2pt">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">NA</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Philippe Santi</span><br />
    <span style="font-size: 10pt">Interparfums SA</span><br />
    <span style="font-size: 10pt">10 rue de Solf&#233;rino</span><br />
    <span style="font-size: 10pt">75008, Paris, France</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">800</span></td>
    <td><span style="font-size: 10pt"><sup>4</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Francois Heilbronn</span><br />
    <span style="font-size: 10pt">60 Avenue de Breteuil</span><br />
    <span style="font-size: 10pt">75007 Paris, France</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">28,938</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>5</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Robert Bensoussan</span><br />
    <span style="font-size: 10pt">c/o Sirius Equity LLP</span><br />
    <span style="font-size: 10pt">52 Brook Street</span><br />
    <span style="font-size: 10pt">W1K 5DS London, UK</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">10,375</span></td>
    <td><span style="font-size: 10pt"><sup>6</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 73%"><span style="font-size: 10pt">Patrick Cho&#235;l</span><br />
    <span style="font-size: 10pt">140 Rue de Grenelle</span><br />
    <span style="font-size: 10pt">75007, Paris, France</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><span style="font-size: 10pt">7,125</span></td>
    <td style="width: 1%"><span style="font-size: 10pt"><sup>7</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="width: 1%; text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Michel Dyens</span><br />
    <span style="font-size: 10pt">Michel Dyens &amp; Co.</span><br />
    <span style="font-size: 10pt">17 Avenue Montaigne</span><br />
    <span style="font-size: 10pt">75007 Paris, France</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">7,875</span></td>
    <td><span style="font-size: 10pt"><sup>8</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Veronique Gabai-Pinsky</span><br />
    <span style="font-size: 10pt">200 East End Avenue</span><br />
    <span style="font-size: 10pt">New York, NY 10128</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2,875</span></td>
    <td><span style="font-size: 10pt"><sup>9</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Gilbert Harrison</span><br />
    <span style="font-size: 10pt">Harrison Group</span><br />
    <span style="font-size: 10pt">745 Fifth Avenue, Suite 514</span><br />
    <span style="font-size: 10pt">New York, NY 10151</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4,875</span></td>
    <td><span style="font-size: 10pt"><sup>10</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Frederic Garcia-Pelayo</span><br />
    <span style="font-size: 10pt">Interparfums SA</span><br />
    <span style="font-size: 10pt">10 rue de Solf&#233;rino</span><br />
    <span style="font-size: 10pt">75008, Paris, France</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">12,000</span></td>
    <td><span style="font-size: 10pt"><sup>11</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">Less than 1</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Blackrock, Inc.</span><br />
    <span style="font-size: 10pt">55 East 52<sup>nd</sup> Street</span><br />
    <span style="font-size: 10pt">New York, NY 10055 </span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2,789,318</span></td>
    <td><span style="font-size: 10pt"><sup>12</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">8.8</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">The Vanguard Group</span><br />
    <span style="font-size: 10pt">100 Vanguard Blvd.</span><br />
    <span style="font-size: 10pt">Malvern, PA 19355</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,983,427</span></td>
    <td><span style="font-size: 10pt"><sup>13</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">6.2</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">All Directors and Officers</span><br />
    <span style="font-size: 10pt">(As a Group 10 Persons)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">14,097,668</span></td>
    <td><span style="font-size: 10pt"><sup>14</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">43.7</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">%</span></td></tr>
</table>





<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>1</sup></td>
    <td style="text-align: justify">All shares of common stock are directly held with sole voting power and sole power to dispose, unless otherwise stated. Options which are exercisable within 60 days are included in beneficial ownership calculations. </td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><sup>2</sup></td>
    <td style="text-align: justify">Consists of 24,400 shares held directly, 7,032,341 shares held indirectly through Jean Madar Holding SAS, a personal holding company, and options to purchase 60,000 shares.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>3</sup></td>
    <td style="text-align: justify">Consists of 6,846,064 shares held indirectly through Philippe Benacin Holding SAS, a personal holding company, and options to purchase 60,000 shares.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>4</sup></td>
    <td style="text-align: justify">Consists of shares of common stock underlying options for Mr. Santi.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>5</sup></td>
    <td style="text-align: justify">Consists of 26,063 shares held directly and options to purchase 2,875 shares for Mr. Heilbronn.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>6</sup></td>
    <td style="text-align: justify">Consists of 7,500 shares held directly and options to purchase 2,875 shares for Mr. Bensoussan.</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><sup>7</sup></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Consists of 4,250 shares held directly and
    options to purchase 2,825 shares for Mr. Cho&#235;l.</span></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>8</sup></td>
    <td style="text-align: justify">Consists of 5,000 shares held directly and options to purchase 2,875 shares for Mr. Dyens.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>9</sup></td>
    <td style="text-align: justify">Consists of shares of common stock underlying options for Ms. Gabai-Pinsky.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>10</sup></td>
    <td style="text-align: justify">Consists of shares of common stock underlying options for Mr. Harrison.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>11</sup></td>
    <td style="text-align: justify">Consists of shares of common stock underlying options for Mr. Garcia-Pelayo.</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><sup>12</sup></td>
    <td style="text-align: justify">Information based upon Schedule 13G of Blackrock, Inc. dated January 25, 2023 as filed with the Securities and Exchange Commission.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><sup>13</sup></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Information based upon Schedule 13G Amendment 5 of The Vanguard Group, an investment advisor, dated February 9, 2023 as filed with the Securities and Exchange Commission.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><sup>14</sup></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Consists of 13,945,618 shares held directly
    or indirectly, and options to purchase 152,050 shares.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth certain information as of the end of our last fiscal year regarding all equity compensation plans that provide for the
award of equity securities or the grant of options, warrants or rights to purchase our equity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Compensation Plan Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Plan category</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number of</b></span><br />
    <span style="font-size: 10pt"><b>securities to</b></span><br />
    <span style="font-size: 10pt"><b>be issued</b></span><br />
    <span style="font-size: 10pt"><b>upon</b></span><br />
    <span style="font-size: 10pt"><b>exercise of</b></span><br />
    <span style="font-size: 10pt"><b>outstanding</b></span><br />
    <span style="font-size: 10pt"><b>options,</b></span><br />
    <span style="font-size: 10pt"><b>warrants and</b></span><br />
    <span style="font-size: 10pt"><b>rights</b></span><br />
    <span style="font-size: 10pt"><b>(a)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Weighted-average</b></span><br />
    <span style="font-size: 10pt"><b>exercise price of</b></span><br />
    <span style="font-size: 10pt"><b>outstanding</b></span><br />
    <span style="font-size: 10pt"><b>options, warrants</b></span><br />
    <span style="font-size: 10pt"><b>and rights</b></span><br />
    <span style="font-size: 10pt"><b>(b)</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number of</b></span><br />
    <span style="font-size: 10pt"><b>securities</b></span><br />
    <span style="font-size: 10pt"><b>remaining</b></span><br />
    <span style="font-size: 10pt"><b>available for</b></span><br />
    <span style="font-size: 10pt"><b>future issuance</b></span><br />
    <span style="font-size: 10pt"><b>under equity</b></span><br />
    <span style="font-size: 10pt"><b>compensation</b></span><br />
    <span style="font-size: 10pt"><b>plans</b></span><br />
    <span style="font-size: 10pt"><b>(excluding</b></span><br />
    <span style="font-size: 10pt"><b>securities</b></span><br />
    <span style="font-size: 10pt"><b>reflected in</b></span><br />
    <span style="font-size: 10pt"><b>column (a)) </b></span><br />
    <span style="font-size: 10pt"><b>(c)</b></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%; padding-left: 9pt"><span style="font-size: 10pt">Equity compensation plans approved by security
    holders</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">441,580</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">$67.30</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">558,975</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Equity compensation plans not approved by security holders</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">N/A</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">-0-</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><span style="font-size: 10pt">Total</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">&#160;441,580</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">&#160;$67.30</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">&#160;558,975</span></td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a027"></span>Item 13. Certain Relationships and Related
Transactions, and Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Transactions with European Subsidiaries</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also provide
(or had provided on our behalf) certain financial, accounting and legal services for Interparfums SA, and during 2022, 2021 and
2020 fees for such services were $491,300, $443,625 and $450,750, respectively.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September 2021,
Interparfums Luxury Brands, Inc., an indirect majority-owned subsidiary of the Company, loaned the Company $24 million, which is
repayable in 12 equal monthly payments with interest at 2% per annum commencing on January 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2021, Inter
Parfums USA, LLC, a United States subsidiary, renewed a license agreement for five years that was initially signed in 2012 on the
same terms with Interparfums Suisse (SARL), a Swiss subsidiary of Interparfums SA, for the right to sell amenities under the Lanvin
brand name to luxury hotels, cruise lines and airlines in return for royalty payments as are customary in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September 2022,
Interparfums Luxury Brands, Inc. loaned the Company $10 million, which is repayable in one lump sum on June 30, 2023 with interest
at 3.5% per annum. In addition, the $2 million payment due on September 30, 2022 by the Company against the loan made in September
2021 was postponed to January 31, 2023 together with interest at 2% per annum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fee for Director&#8217;s Company
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the acquisition of the Donna Karan license, which became effective on July 1, 2022 as discussed above, we agreed to pay to a company
controlled by Mr. Gilbert Harrison, a director, the sum of $300,000, payable over time, with $120,000 paid in 2021, $120,000 paid
one year later in 2022 and $60,000 due two years later in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Consulting Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see our Annual
Report on Form 10-K for the year ended December 31, 2021, Item 11 under the heading &#8220;<b><i>Employment and Consulting Agreements</i></b>&#8221;
for a material terms of the employment agreement with Philippe Benacin, individually, and the consulting agreements with, and fees
and stock options previously granted to, Philippe Benacin Holding SAS and Jean Madar Holding SAS, which is incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Procedures for Approval of Related
Person Transactions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Transactions between
related persons, such as between an executive officer or director and our company, or any company or person controlled by such
officer or director, are required to be approved by our Audit Committee of our board of directors. Our Audit Committee Charter
contains such explicit authority, as required by the applicable rules of The Nasdaq Stock Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following are our
directors who are independent directors within the applicable rules of The Nasdaq Stock Market:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Francois Heilbronn&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Robert Bensoussan&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patrick Cho&#235;l&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Michel Dyens&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Veronique Gabai-Pinsky&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gilbert Harrison</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We follow and comply
with the independent director definitions as provided by The Nasdaq Stock Market rules in determining the independence of our directors,
which are posted on our company&#8217;s website. In addition, such rules are also available on The Nasdaq Stock Market&#8217;s
website. In addition, The Nasdaq Stock Market maintains more stringent rules relating to director independence for the members
of our Audit Committee, and the members of our Audit Committee, Messrs. Heilbronn and Cho&#235;l, as well as Ms. Gabai-Pinsky,
are independent within the meaning of those rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Board Leadership Structure and Risk
Management</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see our Annual
Report on Form 10-K for the year ended December 31, 2021, <b>Item 13. Certain Relationships and Related Transactions, and Director
Independence,</b> under the heading &#8220;<b><i>Board Leadership Structure and Risk Management</i></b>,&#8221; for prior disclosure
on this topic, which is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a028"></span>Item 14. Principal Accountant Fees and
Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following sets
forth the fees billed to us by Mazars USA LLP, as well as discusses the services provided for the past two fiscal years, fiscal
years ended December 31, 2022 and December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
billed by Mazars USA LLP and its affiliate, Mazars S.A. for audit services and review of the financial statements contained in
our Quarterly Reports on Form 10-Q were $1.4 million and $1.2 and million for 2022 and 2021, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit-Related Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
USA LLP did not bill us for any audit-related services during 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tax Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
USA did not bill us in 2022 for any tax services. Tax services billed to us during 2021 was $49,300.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>All Other Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
S.A. billed us $6,000 and $3,000 for other services during 2022 and 2021, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit Committee Pre-Approval Policies
and Procedures</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
has the sole authority for the appointment, compensation and oversight of the work of our independent accountants, who prepare
or issue an audit report for us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the first quarter
of 2022, the audit committee authorized the following non-audit services to be performed by Mazars USA LLP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">We authorized the engagement of Mazars USA LLP if deemed necessary to provide tax consultation in the ordinary course of business for fiscal year ended December 31, 2022.</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">We authorized the engagement of Mazars USA LLP if deemed necessary to provide tax consultation as may be required on a project by project basis that would not be considered in the ordinary course of business, up to a $10,000 fee limit per project (or &#8364;10,000 in the case of Interparfums SA), subject to an aggregate fee limit of $50,000 for fiscal year ended December 31, 2022. If we require further tax services from Mazars USA LLP, then the approval of the audit committee must be obtained.</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">We authorized the engagement of Mazars USA LLP if deemed necessary to provide attestation or other services as may be required on a project by project basis that would not be considered in the ordinary course of business, up to a $10,000 fee limit per project (or &#8364;10,000 in the case of Interparfums SA), subject to an aggregate fee limit of $50,000 for fiscal year ended December 31, 2022. If we require further tax services from Mazars USA LLP, then the approval of the audit committee must be obtained.</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">If we require other services by Mazars USA LLP on an expedited basis such that obtaining pre-approval of the audit committee is not practicable, then the Chairman of the Committee has authority to grant the required pre-approvals for all such services.</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">We imposed a cap of $100,000 on the fees that Mazars USA LLP can charge for services on an expedited basis that are approved by the Chairman without obtaining full audit committee approval.</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify">&#9679;</td>
    <td style="text-align: justify">None of the non-audit services of either of the Company&#8217;s auditors had the pre-approval requirement waived in accordance with Rule 2-01(c)(7)(i)(C) of Regulation S-X.</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a018"></span>PART IV</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a019"></span>Item 15. Exhibits, Financial Statement
Schedules</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 91%; padding-left: 9pt; text-align: justify">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><b>Page</b></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-align: justify">(<b>a)(1) Financial Statements annexed hereto</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-align: justify"><a href="#b001">Report of Independent Registered Public Accounting Firm</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-2</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-align: justify">Audited Financial Statements:</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b002">Consolidated Balance Sheets as of December 31, 2022 and 2021</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-5</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b003">Consolidated Statements of Income for each of the years in the three-year period ended December 31, 2022</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-6</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b004">Consolidated Statements of Comprehensive Income for each of the years in the three-year period ended December 31, 2022</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-7</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b005">Consolidated Statements of Changes in Shareholders&#8217; Equity for each of the years in the three-year period ended December 31, 2022</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-8</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b006">Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2022</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-9</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 0.25in; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b007">Notes to Consolidated Financial Statements</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-10</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-align: justify"><b>(a)(2) Financial Statement Schedule:</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-align: justify"><a href="#b008">Schedule II &#8211; Valuation and Qualifying Accounts</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-34</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-align: justify"><b>(a)(3) Exhibits </b>&#8211; The list of exhibits is contained in the
    Exhibit Index, which follows the signature page of this report.</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a020"></span>Item 16. Form 10-K Summary</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="a021"></span>INTER PARFUMS,
INC. AND SUBSIDIARIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Consolidated Financial Statements and Schedule</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Index</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: left; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Page</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left; font-weight: bold; width: 95%">&#160;</td>
    <td style="text-align: right; font-weight: bold; width: 3%">&#160;</td>
    <td style="width: 2%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><a href="#b001"><span style="font-size: 10pt">Report of Independent Registered Public Accounting Firm</span></a></td>
    <td style="text-align: right"><span style="font-size: 10pt">F-2</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 0.125in"><span style="font-size: 10pt">(<i>Mazars USA LLP, New York, New York, PCAOB ID <span id="xdx_909_edei--AuditorFirmId_c20220101__20221231_zPVlp5OWSgQe"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorFirmId">339</ix:nonNumeric></span></i>)</span></td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">Audited Financial Statements:</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; padding-left: 0.125in"><a href="#b002">Consolidated Balance Sheets as of December 31, 2022, and 2021</a></td>
    <td style="text-align: right">F-5</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; padding-left: 0.125in"><a href="#b003">Consolidated Statements of Income for each of the years in the three-year period ended December 31, 2022,</a></td>
    <td style="text-align: right">F-6</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; padding-left: 0.125in"><a href="#b004">Consolidated Statements of Comprehensive Income for each of the years in the three-year period ended December 31, 2022,</a></td>
    <td style="text-align: right">F-7</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; padding-left: 0.125in"><a href="#b005">Consolidated Statements of Changes in Shareholders&#8217; Equity for each of the years in the three-year period ended December 31, 2022,</a></td>
    <td style="text-align: right">F-8</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; padding-left: 0.125in"><a href="#b006">Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2022,</a></td>
    <td style="text-align: right">F-9</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in"><a href="#b007">Notes to Consolidated Financial Statements</a></td>
    <td style="text-align: right">F-10</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; font-weight: bold">Financial Statement Schedule:</td>
    <td style="text-align: right; font-weight: bold">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in; font-weight: bold">&#160;</td>
    <td style="text-align: right; font-weight: bold">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-indent: 0in"><a href="#b008">Schedule II &#8211; Valuation and Qualifying Accounts</a></td>
    <td style="text-align: right">F-34</td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: Page; Sequence: 84; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><b><span id="b001"></span>REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>To Shareholders and the Board of Directors
of&#160;Inter Parfums, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinions on the Financial Statements
and Internal Control over Financial Reporting </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Inter Parfums, Inc. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, and the related consolidated
statements of income, comprehensive income, shareholders' equity, and cash flows for each of the years in the three-year period
ended December 31, 2021, and the related notes and the schedule listed in the Index in Item 15(a)(2) (collectively referred to
as the &#8220;financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of
December 31, 2022, based on criteria established in Internal Control - Integrated Framework: (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our opinion, the consolidated financial
statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31,
2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended December
31, 2022, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the
Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based
on criteria established in <i>Internal Control - Integrated Framework: (2013)</i> issued by COSO.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s management is responsible
for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment
of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report
on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial
statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about
whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal
control over financial reporting was maintained in all material respects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits of the consolidated financial
statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements,
whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a
test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating
the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of
the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding
of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the
design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Definition and Limitations of Internal
Control over Financial Reporting </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A company&#8217;s internal control over
financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles.
A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements
in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only
in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect
on the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Audit Matter</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The critical audit matter communicated
below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required
to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated
financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of the critical
audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not,
by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts
or disclosures to which it relates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Notes 1 and 8 to the consolidated
financial statements, the Company&#8217;s consolidated indefinite and finite - life intangible assets balance was $291 million
at December 31, 2022. Indefinite lived intangible assets principally consist of trademarks and finite-lived intangible assets represent
fees to acquire or enter into a license.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Those intangible assets are tested for
impairment as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">Indefinite - life intangible assets are tested for impairment at least annually at the reporting
unit level or more frequently when events occur, or circumstances change. The evaluation requires a comparison of the estimated
fair value of the asset to the carrying value of the asset. The fair value is estimated based upon discounted future cash flow
projections. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.</td></tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify">Finite - life intangible assets are tested for impairment testing whenever events or changes in
circumstances indicate that the carrying amount of the asset may not be recoverable. If impairment indicators exist, the undiscounted
future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset.
If the projection of undiscounted cash flows is less than the carrying value of a finite-lived intangible asset, an impairment
charge would be recorded.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The determination of the future cash flows
of the intangible assets requires management to make significant estimates and assumptions related to forecasts of future revenues,
operating margins, and discount rates. As disclosed by management, changes in these assumptions could have a significant impact
on the future cash flows and therefore, on the amount of any impairment charge. The determination of an impairment indicator on
the finite - life intangible assets requires management judgments and involves assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We identified the impairment assessment
of intangible assets as a critical audit matter as auditing management&#8217;s judgments regarding the evaluation of impairment
indicators, forecasts of future revenue, operating margin, and the discount rate to be applied involve a high degree of subjectivity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary procedures we performed to
address this critical audit matter included:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; Reviewing the analysis of the identification
of impairment evidence for each indefinite and finite-life asset based on three indicators (sales analysis, new products launches,
and payment of minimum guarantees), and then corroborating that analysis with external information and evidence obtained in other
areas of the audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; Testing the effectiveness of controls
relating to management&#8217;s impairment tests, including controls over the impairment indicators and determination of the future
cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; In testing management&#8217;s process
for determining the future cash flows we evaluated the reasonableness of management&#8217;s forecasts of future revenue and operating
margin by performing a retrospective review in comparing these forecasts to historical operating results, evaluating whether the
assumptions used were reasonable considering current information as well as future expectations, and using additional evidence
obtained in other areas of the audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9658; Utilizing a valuation specialist
to assist in auditing the discount rate. It includes evaluating whether the assumptions used were reasonable by comparing to third
party market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mazars USA LLP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ <span id="xdx_909_edei--AuditorName_c20220101__20221231_zwjoVLpCTQqk"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorName">Mazars USA LLP</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company's auditor
since 2004.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_909_edei--AuditorLocation_c20220101__20221231_z4E1plsDCK1b"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorLocation">New York, New York</ix:nonNumeric></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February 28, 2023</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b002"></span>Consolidated Balance Sheets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, and 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_pn3n3_zPgYG8BOQ8Rk" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20221231_zDzE6EJN9ync" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_zwsp9DbmTvEe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AssetsAbstract_iB_zomdajJVUZ65" style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; padding-left: 0.125in; text-indent: -0.125in">Assets</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AssetsCurrentAbstract_i01B_zfKSzZfqZqgb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CashEquivalentsAtCarryingValue_i02I_maACz2d8_zRGFycAjXdgh" style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-left: 0.375in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104,713</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,613</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--ShortTermInvestments_i02I_maACz2d8_zJuBjHhRMrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160,014</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_maACz2d8_ziHTLsDl3iy8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197,584</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,281</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--InventoryNet_i02I_maACz2d8_zmQi2WcvkcJg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">289,984</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OtherReceivablesNetCurrent_i02I_maACz2d8_zqHTyhKDWgeg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Receivables, other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,803</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,308</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherAssetsCurrent_i02I_maACz2d8_zcIp3MAxk5j8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,650</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,375</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeTaxesReceivable_i02I_maACz2d8_z9IyVNGK3yjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Income taxes receivable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesReceivable" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AssetsCurrent_i01TI_mtACz2d8_maAzIiT_z6Sr1iCvMFQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1.5in; text-indent: -0.125in">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">787,724</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">709,715</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAzIiT_zvjAwW6vCV2l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Property, equipment and leasehold improvements, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,722</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149,352</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maAzIiT_zkq9l8R3ng36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Right-of-use assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,964</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,728</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maAzIiT_zHoV4gtZcD6k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Trademarks, licenses and other intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290,853</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,047</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_maAzIiT_zRpH3KgoaLk5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,936</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OtherAssetsNoncurrent_i01I_maAzIiT_zgAUKnUGpq79" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,120</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,586</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--Assets_iTI_mtAzIiT_zzdjhiaVE9db" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1.5in; text-indent: -0.125in">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,308,542</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,145,364</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zCRCd6Y87Jma" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center; padding-left: 0.125in">Liabilities and Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i01B_zoaldOyPsF28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LongTermDebtCurrent_i02I_maLCzUvp_z8ocFkN5DbP3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,911</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzUvp_z8mlK7ztw6nh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Current portion of lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,296</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,014</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccountsPayableCurrent_i02I_maLCzUvp_zgCpqnIpMP6l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accounts payable - trade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">88,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81,980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCzUvp_zAu5Vjf6kOGj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">213,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,677</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DividendsPayableCurrent_i02I_maLCzUvp_zqcHKKs07MH7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Income taxes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,715</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,328</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzUvp_maLASEz1gX_z74J41sSngHa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 1.5in; text-indent: -0.125in">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160; &#160;<ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">344,567</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244,910</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_i01I_maLASEz1gX_zPLzAwrgFGzl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Long&#8211;term debt, less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,494</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132,902</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLASEz1gX_zEFrYFGzkZl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Lease liabilities, less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,335</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,220</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EquityAbstract_i01B_zdvBXq9hP6K1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--StockholdersEquityAbstract_i02B_zSIWYucnqHp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Inter Parfums, Inc. shareholders&#8217; equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PreferredStockValue_i03I_maSEzHBp_zgw8v3sOSCMi" style="vertical-align: bottom; background-color: White">
  <td style="padding-left: 0.5in; text-indent: -0.125in">Preferred stock, $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20211231_zN4GPp2OgzXb" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20221231_zUcOwJeeKhz6"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value. Authorized <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20211231_zUr3QPc0AACe" title="Preferred stock, authorized"><span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20221231_zChNwgFO4BVe" title="Preferred stock, authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares:<br />
<span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pid_dn_uShares_c20211231_z05OaoPYor4l" title="Preferred stock, issued"><span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_dn_uShares_c20221231_zfidNItUEtYi" title="Preferred stock, issued"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></span></span> issued</td>
  <td>&#160;<br />
&#160;</td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
  <td style="text-align: right">&#160;<br />
<span style="-sec-ix-hidden: xdx2ixbrl0135">&#8212;</span></td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
  <td>&#160;<br />
&#160;</td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
  <td style="text-align: right">&#160;<br />
<span style="-sec-ix-hidden: xdx2ixbrl0136">&#8212;</span></td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
</tr>
<tr id="xdx_408_eus-gaap--CommonStockValue_i03I_maSEzHBp_z4ZNQ26FyMR7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
  <td style="padding-left: 0.5in; text-indent: -0.125in">Common stock, $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20211231_z5RdDV6opEsk" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20221231_zycoVH9nSjCd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value. Authorized <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20211231_z7H6bzYPAmg3" title="Common stock, authorized"><span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20221231_z0XTbYKM6kIc" title="Common stock, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares:<br />
outstanding, <span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20221231_zjNhDxCjseRl" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,967,300</ix:nonFraction></span> and <span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20211231_zns5EPYXEiyh" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,830,420</ix:nonFraction></span> shares on December 31, 2022, and 2021, respectively</td>
  <td>&#160;<br />
&#160;</td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
  <td style="text-align: right">&#160;<br />
<ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
  <td>&#160;<br />
&#160;</td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
  <td style="text-align: right">&#160;<br />
<ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td>
  <td style="text-align: left">&#160;<br />
&#160;</td>
</tr>
<tr id="xdx_40A_eus-gaap--AdditionalPaidInCapital_i03I_maSEzHBp_zyfCKy8Flz1j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90,186</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,132</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--RetainedEarningsAccumulatedDeficit_i03I_maSEzHBp_zS9j1ymTb2Mk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Retained earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">620,095</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">560,663</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i03I_maSEzHBp_zq8nXpIp8yGi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5in; text-indent: -0.125in">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56,056</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--TreasuryStockValue_i03NI_di_msSEzHBp_zK3ePEgeoGql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.5in; text-indent: -0.125in">Treasury stock, at cost, <span id="xdx_907_eus-gaap--TreasuryStockShares_iI_pid_uShares_c20211231_zWEqSjWq7Dyl"><span id="xdx_905_eus-gaap--TreasuryStockShares_iI_pid_uShares_c20221231_zBxWqNrjpVL1"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,864,805</ix:nonFraction></ix:nonFraction></span></span> common shares on December 31, 2022, and 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,475</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,475</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_409_eus-gaap--StockholdersEquity_i03TI_mtSEzHBp_maSEIPAzQvE_zQaVoIDR0HYd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 1.5in; text-indent: -0.125in">Total Inter Parfums, Inc. shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">616,782</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571,920</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--MinorityInterest_i03I_maSEIPAzQvE_zTubP5UoRao3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171,364</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,412</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i03TI_mtSEIPAzQvE_maLASEz1gX_zD0VOK9qzpd7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75in; text-indent: -0.125in">Total equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">788,146</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738,332</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtLASEz1gX_zQqjhVNDNXB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1.5in; text-indent: -0.125in">Total liabilities and equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,308,542</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,145,364</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">See accompanying notes to consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b003"></span>Consolidated Statements of Income</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Years ended December 31, 2022, 2021, and
2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_113_pn3n3_zIRl6oTj7kcc" summary="xdx: Statement - Consolidated Statements of Income" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_zS8QC8vF25ge" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20211231_zlzQ4HiYYw7j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20200101__20201231_zOG6n2iXEST" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_maGPzj5S_z3cBC6v3Blwk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,086,653</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">879,516</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,009</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CostOfGoodsAndServicesSold_msGPzj5S_z4OtwPqwHWA6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">392,231</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">322,614</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208,278</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--GrossProfit_iT_mtGPzj5S_maOILzCSY_zPBmRnf4TeFh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1.25in; text-indent: -0.125in">Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">694,422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">556,902</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">330,731</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--SellingGeneralAndAdministrativeExpense_msOILzCSY_zaT0EwLIwaJ7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Selling, general, and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">492,370</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">406,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">260,648</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ImpairmentOfLeasehold_msOILzCSY_zluDP9OSgFk4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Impairment loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfLeasehold" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,749</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfLeasehold" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,393</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0207">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingIncomeLoss_iT_mtOILzCSY_z00shAb5ZLUg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 1pt">Income from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">194,303</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148,050</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70,083</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z2B0StpdxWag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Other expenses (income):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InterestExpense_i01_msNIEzxCb_z445ToTa0anh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,599</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,825</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01N_di_maNIEzxCb_zk9v5aZOz8Re" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Loss (gain) on foreign currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,921</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,338</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,178</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InvestmentIncomeInterestAndDividend_i01N_di_maNIEzxCb_zMGUQeEgHGU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest and investment income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,486</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,403</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,865</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01N_di_maNIEzxCb_zDh2qtdVqVx9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other loss (income)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">49</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">549</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzxCb_zKxR2V1UeWE6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; visibility: hidden">&#160;Nonoperating Income (Expense)</span> </td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">83</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,969</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">734</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_maCzNc9_zRquFQgAXCX9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Income before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">194,219</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,349</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_msCzNc9_zjupMKEZH3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,182</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,992</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,381</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProfitLoss_iT_mtCzNc9_maCzUSG_zemnpME4SVHa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 1.25in; text-indent: -0.125in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,037</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_msCzUSG_zVpEyvnfOnma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Less: Net income attributable to the
    noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,099</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,616</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,749</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--NetIncomeLoss_iT_mtCzUSG_zxPjy0KxRi71" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Net income attributable to Inter Parfums, Inc.</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120,938</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--EarningsPerShareBasicAbstract_iB_zEQE4dURpWVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_ztwbb0J7IG94" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_z30pUBM39m0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zsxUOol4sSW9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Weighted average number of shares outstanding:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_z1MdTx4UmQ2k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,859,417</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,676,796</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,536,659</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_uShares_zkNTN2JnuZik" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,988,753</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,835,408</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,654,544</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--CommonStockDividendsPerShareDeclared_pid_zGu7UllUMIm3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Dividends declared per share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">See accompanying notes to consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b004"></span><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b><br />
Consolidated Statements of Comprehensive Income<br />
Years ended December 31, 2022, 2021, and 2020<br />
(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_pn3n3_zjWDTfVe2nhc" summary="xdx: Statement - Consolidated Statements of Comprehensive Income" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_z7qYJLLA285a" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20210101__20211231_z5YpUSJo5ub7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20200101__20201231_zlR7lak6K3yh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ProfitLoss_maCINOTzhbH_zAi63ltPe9v1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Net income</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,037</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_iB_zPjVBx3WsCYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Other comprehensive income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_i01_maOCILFzmZM_maOCILBzOCP_zw4fuTN6Hlu3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net derivative instrument income (loss), &#160;net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,356</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,367</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_i01N_di_msOCILBzOCP_z7skerRMmo4f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Transfer of OCI into earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0298">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_i01_maOCILBzOCP_zUfMmhsJMck6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"><p style="margin-top: 0; margin-bottom: 0">Translation
adjustments, net of tax&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,683</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42,967</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,912</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeLossBeforeTax_i01T_maCINOTzhbH_mtOCILBzOCP_zCWrRvXmKxna" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"><b style="display: none; visibility: hidden">Other comprehensive income (loss), before tax</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,335</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44,334</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,841</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_i01_maCINOTzmwc_z6FmOsQfgpJ1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Comprehensive income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124,702</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,693</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97,809</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_iB_zI0YtxAfdz2g" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Comprehensive income attributable to noncontrolling interests:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_i01_maCINOTze56_zWrXQmkAOzC6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,099</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,749</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_i01_maCINOTze56_zuq4cAp6pJQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net derivative instrument income (loss), &#160;net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_i01N_di_msCINOTze56_zeL902bY2Uvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Translation adjustments, net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,358</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,524</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,004</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_i01T_mtCINOTze56_msCINOTzmwc_zbYo6ebMrxTf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"><b style="display: none; visibility: hidden">Comprehensive income (loss), net of tax, atributable
    to noncontrolling interest</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,388</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,717</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,734</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_mtCINOTzmwc_zmWMsfsZy6b1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Comprehensive income attributable to Inter Parfums Inc.</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103,314</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,976</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,075</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">See accompanying notes to consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b005"></span><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b><br />
Consolidated Statements of Changes in Shareholders&#8217; Equity<br />
Years ended December 31, 2022, 2021, and 2020<br />
(In thousands except share and per share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_114_pn3n3_zhLk0f2VryDb" summary="xdx: Statement - Consolidated Statements of Changes in Shareholder&apos;s Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Common stock, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyGPAAlkhh23" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zS23bQXN91T" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCfQh3sI8Tz2" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Shares issued upon exercise of stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvHeIG2ZfYrc" title="Shares issued upon exercise of stock options" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_d0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9JEXt1b3D2e" title="Shares issued upon exercise of stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHe40LXCKfW8" title="Shares issued upon exercise of stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Common stock, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkl7Iu3IjQ16" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztJ5zKrnn6t1" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2jSu7mh6a6g" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Additional paid-in capital, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zZnQEvn1AqOj" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,132</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zCpg4ACdkd6a" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75,708</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zePfKBYA5fe3" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70,664</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Shares issued upon exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zSIiWFI46dtl" title="Shares issued upon exercise of stock options" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zopsKjvjafZ4" title="Shares issued upon exercise of stock options" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zhJJlNH77hVe" title="Shares issued upon exercise of stock options" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,771</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_znveIH24bv5b" title="Share-based compensation" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,355</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zo307XkCQjXg" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,566</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zLTixnXxPWR5" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,711</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Purchase of subsidiary shares from noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zSS8HSxbm8Ti" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zVQUndJWQ4Vd" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_iN_di0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_znkJzPmw1chb" title="Purchase of subsidiary shares from noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Shares issued for license acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zIYfoSU1bp7f" title="Shares issued for license acquisition" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_z8uuNXQxulfa" title="Shares issued for license acquisition" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zGi3wh5MOnU4" title="Shares issued for license acquisition" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0381">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Transfer of subsidiary shares purchased</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zJt3jbOhYkDa" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,305</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zkG7HYR1JoS5" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">535</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zQM1eqxzXub8" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">562</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Additional paid-in capital, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zYkI0qwyTtBj" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90,186</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zMEvsk2rLXwj" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,132</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zsbh3TROGNqi" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75,708</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Retained earnings, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zJCDT0HzGDZb" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">560,663</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zhMMriMMphGi" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z7xmdXetdMqf" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">474,637</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ProfitLoss_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zkbCnfkddQVg" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ProfitLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zqQQ94HEgPld" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zQZG1iANNZU" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DividendsCash_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zp45DFMrlVta" title="Dividends, Cash" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63,743</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DividendsCash_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZ3G4GR1KAN" title="Dividends, Cash" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,690</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DividendsCash_iN_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHzFdzOxVn7k" title="Dividends, Cash" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,406</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Share-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zuRAFChHkUGd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,237</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zcXTB4ZfgiRd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,375</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zzcYZvh9K0Qc" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,117</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Retained earnings, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDJs3jKGutuj" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">620,095</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zxAfRAFpfrIf" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">560,663</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z6fpEHHAexd1" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503,567</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Accumulated other comprehensive loss, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zwJsSjsXyUce" title="Beginning Balance" style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zem4HJHZ7gml" title="Beginning Balance" style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zqZH3OfEBZ3c" title="Beginning Balance" style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,853</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency translation adjustment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zWku6rvWaem5" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,325</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zVm9RZaOdiMa" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,443</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zTPrMqoi83oi" title="Foreign currency translation adjustment, net of tax" style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,908</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Transfer from other comprehensive income into earnings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DebtSecuritiesAvailableForSaleTransferToTradingLoss_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_z2evefqZWsri" title="Transfer from other comprehensive income into earnings" style="text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DebtSecuritiesAvailableForSaleTransferToTradingLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zyEVMRiuK1ha" title="Transfer from other comprehensive income into earnings" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0436">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DebtSecuritiesAvailableForSaleTransferToTradingLoss_iN_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zDTCgyZDFkpa" title="Transfer from other comprehensive income into earnings" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Net derivative instrument income (loss), net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetDerivativeInstrumentLossNetOfTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_ziEJ3TQutk6e" title="Net derivative instrument loss, net of tax" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:NetDerivativeInstrumentLossNetOfTax" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,709</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--NetDerivativeInstrumentLossNetOfTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zTwOIqLC5Umf" title="Net derivative instrument loss, net of tax" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:NetDerivativeInstrumentLossNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--NetDerivativeInstrumentLossNetOfTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zU9unKGPbhe1" title="Net derivative instrument loss, net of tax" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0444">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Accumulated other comprehensive loss, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zWePoY6LUZM8" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56,056</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zCHB5dtqIvbj" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedOtherComprehensiveIncomeMember_zDOv1MRWnOx9" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255); visibility: hidden">
    <td style="display: none; font-weight: bold; text-align: left; padding-bottom: 1pt; visibility: hidden">Treasury stock, beginning and end of year</td><td style="display: none; padding-bottom: 1pt; visibility: hidden">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_98E_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zVtvMBFUzwy2" title="Beginning Balance" style="border-bottom: Black 1pt solid; display: none; text-align: right; visibility: hidden">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left; visibility: hidden">)</td><td style="display: none; padding-bottom: 1pt; visibility: hidden">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zZRT7N8Tvhue" title="Beginning Balance" style="border-bottom: Black 1pt solid; display: none; text-align: right; visibility: hidden">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left; visibility: hidden">)</td><td style="display: none; padding-bottom: 1pt; visibility: hidden">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_98E_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zVQwT719xQoj" title="Beginning Balance" style="border-bottom: Black 1pt solid; display: none; text-align: right; visibility: hidden">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left; visibility: hidden">)</td></tr>
<tr style="display: none; visibility: hidden; vertical-align: bottom; background-color: White">
    <td style="display: none; visibility: hidden; vertical-align: middle; text-align: left">Net income</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; visibility: hidden; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zgfe7aevvePe" style="display: none; visibility: hidden; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span>&#160;</td><td style="display: none; visibility: hidden; text-align: left">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; visibility: hidden; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProfitLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zCD97U9RdLdg" style="display: none; visibility: hidden; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">-</span>&#160;</td><td style="display: none; visibility: hidden; text-align: left">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; visibility: hidden; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ProfitLoss_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zTO639qgXq6k" style="display: none; visibility: hidden; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span>&#160;</td><td style="display: none; visibility: hidden; text-align: left">&#160;</td></tr>
<tr style="visibility: hidden; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="visibility: hidden; vertical-align: middle; text-align: left"><b style="visibility: hidden">Treasury stock, beginning and end of year</b></td><td style="visibility: hidden">&#160;</td>
    <td style="visibility: hidden; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zf0P0d11eUC3" title="Ending Balance" style="visibility: hidden; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="visibility: hidden; text-align: left">)</td><td style="visibility: hidden">&#160;</td>
    <td style="visibility: hidden; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zm5WwYsD3yje" title="Ending Balance" style="visibility: hidden; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="visibility: hidden; text-align: left">)</td><td style="visibility: hidden">&#160;</td>
    <td style="visibility: hidden; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zDM1buqugnck" title="Ending Balance" style="visibility: hidden; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,475</ix:nonFraction></td><td style="visibility: hidden; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="visibility: hidden; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Noncontrolling interest, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zF7sqKxeWSw6" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zdtCpjz8mRR6" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,615</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zpKh5NRtVPO2" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,994</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_ze79jPCpQwIa" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,099</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ProfitLoss_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zLJsD0AqbzUb" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ProfitLoss_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zzbmM8tmcu23" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,749</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency translation adjustment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zsRKD8OVMTo" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,358</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z4Dxh8v5VQrk" title="Foreign currency translation adjustment, net of tax" style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,524</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zuIJnKPsjsp9" title="Foreign currency translation adjustment, net of tax" style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,004</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net derivative instrument income (loss), net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--NetDerivativeInstrumentLossNetOfTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zkj7Ehj65QZb" title="Net derivative instrument loss, net of tax" style="text-align: right"><ix:nonFraction name="ipar:NetDerivativeInstrumentLossNetOfTax" contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--NetDerivativeInstrumentLossNetOfTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z3b0q0MSUEna" title="Net derivative instrument loss, net of tax" style="text-align: right">(<ix:nonFraction name="ipar:NetDerivativeInstrumentLossNetOfTax" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--NetDerivativeInstrumentLossNetOfTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zkmD892Hw1zk" title="Net derivative instrument loss, net of tax" style="text-align: right">(<ix:nonFraction name="ipar:NetDerivativeInstrumentLossNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DividendsCash_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_znWxj3nEADPj" title="Dividends" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,056</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DividendsCash_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z8gfq1hlkKfi" title="Dividends" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,836</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DividendsCash_iN_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zUtQM0jNajLh" title="Dividends" style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">324</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zyYFsntGqUS" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">282</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zrXxTsLtsatl" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">293</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zfCMBqUl1P7e" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Transfer of subsidiary shares purchased</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zHpnEjSLryr2" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">98</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zb7rno3PjI65" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">791</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--TransferOfSubsidiarySharesPurchasedToTreasuryShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zKFWi3GPxdoe" title="Transfer of subsidiary shares purchased" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares" contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">139</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">Noncontrolling interest, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z5Oo9YnvH0df" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171,364</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zSnfdvO5f7H5" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,412</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zourXzYL4DO2" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,615</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255); visibility: hidden">
    <td style="display: none; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_986_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20220101__20221231_zxWUAt7FXlxa" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738,332</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_986_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20210101__20211231_zQZADUflNMH" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">702,450</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_986_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_c20200101__20201231_zsTliPVuO2Tk" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">608,998</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255); visibility: hidden">
    <td style="display: none; padding-left: 0.125in; text-indent: -0.125in; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_981_eus-gaap--ProfitLoss_c20220101__20221231_zLjVr24gtFOd" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,037</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_981_eus-gaap--ProfitLoss_c20210101__20211231_zQYygy7w6H1c" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_982_eus-gaap--ProfitLoss_c20200101__20201231_zRIOICbcQZa2" style="display: none; text-align: right; visibility: hidden"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Total equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20220101__20221231_z8mCnwdtgLR9" title="Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">788,146</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20210101__20211231_zavw4l8VBAu8" title="Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738,332</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_c20200101__20201231_zUDuAm2EexN7" title="Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">702,450</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span id="b006"></span><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b><br />
Consolidated Statements of Cash Flows<br />
Years ended December 31, 2022, 2021, and 2020<br />
(In thousands)</p>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_30F_112_pn3n3_znmC2jpNa8Y9" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49B_20220101__20221231_zBdPZDZ46gW7" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_499_20210101__20211231_zTVboB6aY08d" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20200101__20201231_z6CM9zaC2tn9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z2z1WCcEXX84" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows from operating activities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProfitLoss_i01_maNCPBUzatk_zmxMJdrjUMR7" style="vertical-align: bottom; background-color: white">
    <td style="width: 61%; padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,037</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,027</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,968</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_ztOl0BiH6FUa" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments to reconcile net income to net cash provided by operating activities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUz5ay_maNCPBUzatk_zewwGEH3rClb" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization including impairment loss</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,539</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,698</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,067</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_405_ecustom--ProvisionForDoubtfulAccounts1_i02_maNCPBUz5ay_maNCPBUzatk_zII6k2Amn1Cl" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for doubtful accounts</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ipar:ProvisionForDoubtfulAccounts1" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,353</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ipar:ProvisionForDoubtfulAccounts1" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">853</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ipar:ProvisionForDoubtfulAccounts1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ShareBasedCompensation_i02_maNCPBUz5ay_maNCPBUzatk_zjoN4MvZWrq7" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncash stock compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,143</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,853</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,029</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_di_msNCPBUz5ay_msNCPBUzatk_z4UG9mW1s0Mf" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share of income of equity investment</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">49</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">549</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--ProvisionForLoanLeaseAndOtherLosses_i02_maNCPBUz5ay_maNCPBUzatk_zFcNuqQLpML6" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease expense</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,980</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,302</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,483</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_maNCPBUz5ay_maNCPBUzatk_zgWxwlbYMLv8" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax expense (benefit)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,604</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">465</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">581</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfDerivatives_i02N_di_msNCPBUz5ay_msNCPBUzatk_zeMpFkrYkyU9" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of derivatives</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ipar:ChangeInFairValueOfDerivatives" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">227</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ipar:ChangeInFairValueOfDerivatives" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">65</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ipar:ChangeInFairValueOfDerivatives" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_z2oPcGAexDy" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.5in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz5ay_msNCPBUzatk_zvdc4jpGZdjg" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 45pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,640</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,395</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,157</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msNCPBUz5ay_msNCPBUzatk_zXFgUInsuk25" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 45pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98,297</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,815</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,333</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i03N_di_msNCPBUz5ay_msNCPBUzatk_zqztmRWvOb5g" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 45pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,651</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,725</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,176</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUz5ay_maNCPBUzatk_ze6E5O4oNJVa" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 45pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,795</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,503</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,421</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz5ay_maNCPBUzatk_z2Op6i8gR4f3" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 45pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued expenses</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">106,857</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103,046</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">32,239</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedTaxesPayable_i03_maNCPBUz5ay_maNCPBUzatk_zVe6WUnqtOZ7" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 45pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes, net</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,952</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,698</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,279</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i03T_mtNCPBUzatk_maCCERCzVMC_zReoVjRFP209" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.75in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash provided by operating activities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115,150</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,586</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64,993</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zcfRcj9PRxZa" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows from investing activities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PaymentsToAcquireInvestments_i01N_di_msNCPBUz5VJ_zqZJGg20tSH1" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases of short-term investments</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,038</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,691</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,582</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromSaleMaturityAndCollectionsOfInvestments_i01_maNCPBUz5VJ_z0tYxRlEcoYb" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from sale of short-term investments</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">896</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,644</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,513</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz5VJ_zUMvGgHnglok" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase of property, equipment and leasehold improvements</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,756</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,274</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,011</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msNCPBUz5VJ_zIsMCgRPUzP1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for intangible assets acquired</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98,865</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,545</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,251</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsToAcquireEquityMethodInvestments_i01N_di_msNCPBUz5VJ_zWwOxFneYTW7" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase of equity investment</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0616">&#8212;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0617">&#8212;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,998</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz5VJ_maCCERCzVMC_zkOeQ4qwc1T8" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.75in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash used in investing activities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">132,763</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">187,866</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,329</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zAnHIqaSwU87" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows from financing activities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RepaymentsOfLongTermDebt_i01N_di_msNCPBUzXpQ_z7kJZnSuYuw3" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment of long-term debt</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,861</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,056</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,725</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_i01_maNCPBUzXpQ_z5HsU822LRd9" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from issuance of long-term debt</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,492</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157,382</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,438</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzXpQ_zDxrornOdRwc" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from exercise of options</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,003</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,393</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,771</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsOfDividendsCommonStock_i01N_di_msNCPBUzXpQ_zxl67GPwqYJ4" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends paid</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63,743</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,690</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,805</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msNCPBUzXpQ_zrIGjpnZ9Mg4" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends paid to noncontrolling interests</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,056</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,836</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">324</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToMinorityShareholders_i01N_di_msNCPBUzXpQ_zJk3H47N1Ci1" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase of subsidiary shares from noncontrolling interests</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,403</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#8212;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0650">&#8212;</span></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzXpQ_maCCERCzVMC_zIQu02KQHCmk" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.75in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash provided by (used in) financing activities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">45,568</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,193</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">18,645</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01_maCCERCzVMC_zNJLWSmVvSr5" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of exchange rate changes on cash</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">493</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,207</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,245</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_i01T_mtCCERCzVMC_z8Cce3PzFTSa" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.75in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net increase (decrease) in cash and cash equivalents</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">63,674</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,294</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,264</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zdy2LpTDiXL8" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents &#8211; beginning of year</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168,387</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169,681</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133,417</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zqXUeP1IjoT5" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents &#8211; end of year</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104,713</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168,387</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169,681</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_ecustom--SupplementalDisclosureOfCashFlowInformationAbstract_iB_zPypaGnp73Ck" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental disclosures of cash flow information:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SupplementalCashFlowInformationAbstract_i01B_zWVRj3jFrBne" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid for:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestPaidNet_i02_zDb3DSADV7S5" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 27pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,468</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,105</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxesPaid_i02_zpGKrL7euR63" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 27pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,492</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,497</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,772</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">See accompanying notes to consolidated financial statements.</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="b007"></span>Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zd1EKIHGXhJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>(1)</b></td><td id="xdx_828_znbAHDBviiWh" style="text-align: justify"><b>The Company and its Significant Accounting Policies</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zNT0b1hpSc">Business of the Company</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries
(the &#8220;Company&#8221;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" title="Concentration risk percentage" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" title="Concentration risk percentage" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" title="Concentration risk percentage" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10%
or more of consolidated net sales.</p>

</ix:nonNumeric><p id="xdx_852_zkLqrsGkJApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zAi7NibSjYo">Basis of Preparation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The
consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">72</ix:nonFraction></span>% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances
and transactions have been eliminated</span>.</p>

</ix:nonNumeric><p id="xdx_858_zhK8rh8t0VFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_zxhhk0ZXFq5">Management Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.</p>

</ix:nonNumeric><p id="xdx_850_zBwbKroun2Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_z6rIV82Xvpje">Foreign Currency Translation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#8217; equity.</p>

</ix:nonNumeric><p id="xdx_85D_z8zurES5J9S2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zQ2usvaXHXs5">Cash and Cash Equivalents
and Short-Term Investments</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.</p>

</ix:nonNumeric><p id="xdx_85D_zZPquTcOQRla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_zml6eL2CVYk2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_z54XD0qTeT8k" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_z23c51MuGg22" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><p id="xdx_230_zXkBtUpi1Brf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zk35vTCmqE36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_z8G2oRvLoVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_232_zccb3HKdtoma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_233_zR7H7fOkKiWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>

<ix:exclude><p id="xdx_237_zUZHA4GIiGmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zbpNXfQ5UYnk">Accounts Receivable</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.7</ix:nonFraction> million</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.2</ix:nonFraction> million</span> as of December 31, 2022, and 2021, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#8217;s financial position, as well as previously established
buying patterns.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_850_zeVmfblcJqaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zB6czE4UKP8b">Inventories</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor
and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound
freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#8217;s customers.</p>

</ix:nonNumeric><p id="xdx_859_z8E6H25uy7b6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_z8KfMRukTmb">Derivatives</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#8217;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p>

</ix:nonNumeric><p id="xdx_85A_zBXJO3IV73i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zjzUiz8tMvX9">Property, Equipment
and Leasehold Improvements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.</p>

</ix:nonNumeric><p id="xdx_859_zEts96VpM581" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zi2k1cwo7voh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div id="xdx_23D_zJdvVsHFPT6d" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zM1y073xiTxb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><p id="xdx_233_zaXOJqcS5h7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_z8dxRpJF0H75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zuIqExhFOkqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_237_zAJkgp6oQCyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_23B_zFMstMsM4Bsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>

<ix:exclude><p id="xdx_238_zbAZ6NOqyTEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zftBm8SvL7Bd">Long-Lived Assets</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.8</ix:nonFraction></span>% and <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.47</ix:nonFraction></span>% in 2022 and 2021, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p>

</ix:nonNumeric><p id="xdx_850_zz1nwOS3naq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_866_zn7swQC93rge">Revenue Recognition</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in
either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable,
collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms.
Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#8217;
freight and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-01-012022-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">15.8</ix:nonFraction> million</span>, $1<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numunitdecimalin" decimals="0" unitRef="USD">0.0</ix:nonFraction> million</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.0</ix:nonFraction> million</span>
in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements
of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue
concentration of credit risk. No one customer represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>% or more of net sales in 2022, 2021 or 2020.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div id="xdx_231_zllqS3yoyU4f" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div id="xdx_239_zpWDznEEbCNk" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zYIF8sRtWtu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><p id="xdx_231_zcgDRIDIaO2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_z2KWWZI6tbRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_z8lWn0W9fzQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_233_zwwvh6t93VAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_23A_zKXqROWH7Wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>

<ix:exclude><p id="xdx_236_zUvJ73Ag2YFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RevenueRecognitionSalesReturns"><p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_znG0d2ejty9j">Sales Returns</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $<span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiability" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">8.6</ix:nonFraction> million</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.1</ix:nonFraction> million</span> at December 31, 2022 and 2021, respectively, and
the amounts recognized for the rights to recover products was $<span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products"><ix:nonFraction name="us-gaap:ContractWithCustomerRightToRecoverProduct" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.2</ix:nonFraction> million</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products"><ix:nonFraction name="us-gaap:ContractWithCustomerRightToRecoverProduct" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.9</ix:nonFraction> million</span> at December 31, 2022 and 2021, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p>

</ix:nonNumeric><p id="xdx_850_zIceJJmoSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RevenueRecognitionAllowances"><p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpZS8YHNN1fl">Payments to Customers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.</p>

</ix:nonNumeric><p id="xdx_857_zXoMw6n70mia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zIZybcTPiYQ3">Advertising and Promotion</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">212.4</ix:nonFraction> million</span>, $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">171.1</ix:nonFraction> million</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">91.7</ix:nonFraction> million</span> for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">43.1</ix:nonFraction> million</span>, $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">36.9</ix:nonFraction> million</span> and $<span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost"><ix:nonFraction name="us-gaap:MarketingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">26.4</ix:nonFraction> million</span>
in 2022, 2021 and 2020, respectively.</p>

</ix:nonNumeric><p id="xdx_854_zH3jODrKQ9K8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zqec8gj621I2">Package Development
Costs</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.</p>

</ix:nonNumeric><p id="xdx_853_zOZeg8z2S3Xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:LessorLeasesPolicyTextBlock"><p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zxkrSXeufu6">Operating Leases</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p>

</ix:nonNumeric><p id="xdx_85F_zrc4W7gVcqB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_z9w7mF9udvQl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div id="xdx_23A_zRz4oOYzGnP9" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zTkaZ2CYimok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><p id="xdx_23C_zILxymbpw8k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zEmEXXOxdKda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_znvYtTNXWmDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_23F_z3rmhb3DJCsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_233_zRV6Fm0GkXxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>

<ix:exclude><p id="xdx_238_zecjmV3virYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zSbdHovAxh91">License Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#8217; trademarks. The licenses typically have an initial term of approximately <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0811">5</span></span> to <span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0813">15</span></span> years, and are potentially
renewable subject to the Company&#8217;s compliance with the license agreement provisions. The remaining terms, excluding potential
renewal periods, range from approximately <span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">1</span></span> to <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">12</span></span> years. Under each license, the Company is required to pay royalties in the range
of <span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>% to <span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% to the licensor, at least annually, based on net sales to third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.</p>

</ix:nonNumeric><p id="xdx_85B_zh64ekd6mbY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zWZrltbKXMm6">Income Taxes</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets
assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset
will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued
interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p>

</ix:nonNumeric><p id="xdx_85D_zixJEyMNLdl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ConsolidationSubsidiaryStockIssuancesPolicy"><p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86D_ziVu2DnrRlH1">Issuance of Common Stock
by Consolidated Subsidiary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company&#8217;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#8217;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.</p>

</ix:nonNumeric><p id="xdx_854_zakTrhiCpMz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RepurchaseAgreementsCollateralPolicy"><p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_861_zOSRLpHtTRY4">Treasury Stock</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize
share repurchases of the Company&#8217;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.</p>

</ix:nonNumeric><p id="xdx_859_zckO1rZ36bOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_814_ztK0Ho48JQCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ipar:ImpactOfCOVID19PandemicTextBlock"><p id="xdx_80B_ecustom--ImpactOfCOVID19PandemicTextBlock_zmuAy07zyRm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(2)</td><td id="xdx_823_zTZ7NfolXM2g">Impact of COVID-19 Pandemic</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A novel strain of coronavirus
(&#8220;COVID-19&#8221;) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In
response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain
classes of workers from reporting to work.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Retail store closings, event
cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable
impact on our results of operations in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Business significantly improved
in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased
online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world
has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international
air travel remains curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19
has significantly restricted international travel, the travel retail business is beginning to pick up. Lastly, the improved economy
has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport
goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger
or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in
larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers
and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin
lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might
continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first
half of 2023.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_z4GAOYWVwyJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(3)</td><td id="xdx_820_zvvCe9AfJeN1">Recent Agreements</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Lacoste</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, we closed a
transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution
of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Dunhill</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2022, we announced that
the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and
sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory
for a limited time as is customary in the fragrance industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zPmZGSXimOF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><p id="xdx_23C_zpMa60aLS1Z3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_z6dWYaNJbMBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zjvbozg24qoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_238_zaQ2XAcrKAp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zTd3COeXOuRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_235_z7IV4r4Hz5va" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_239_zevJxkL8aa69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>

<ix:exclude><p id="xdx_230_zGrwy5D2iG1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, <span id="xdx_901_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--EmanuelUngarMember_z7orWVKIZK91" title="Description of recent agreement"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_EmanuelUngarMember" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">we also entered
into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro
Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro
brand.</ix:nonNumeric></span> Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary
in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered
into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zGE1fIms7cI" title="Shares issue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_custom_DonnaKaranAndDKNYMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">65,342</ix:nonFraction></span> shares of Inter Parfums, Inc. common
stock valued at $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zP05Z3DKOrIh" title="Shares value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_custom_DonnaKaranAndDKNYMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span>.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new
fragrances under these brands in 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective January 1, 2021,
<span id="xdx_90D_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_z1l2yFbEEYbc" title="Description of recent agreement"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RochasFashionMember" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in
royalties to be received. As a result, in the first quarter of 2021, we took a $<span id="xdx_903_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20210331__dei--LegalEntityAxis__custom--RochasFashionMember_zYTSjFo1J7o5" title="Impairment Charge on Reclassified Assets"><ix:nonFraction name="us-gaap:ImpairmentChargeOnReclassifiedAssets" contextRef="From2021-01-012021-03-31_custom_RochasFashionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.4</ix:nonFraction> million</span> impairment charge on our Rochas fashion
trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after
an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option
for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span title="Description of recent agreement">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Land
and Building Acquisition - Future Headquarters in Paris</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
April 2021, Interparfums SA, our <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z4n07UjPSSTf" title="Ownership percentage"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2021-04-30_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">73</ix:nonFraction></span>% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de
Solf&#233;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings
connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
purchase price includes the complete renovation of the site. As of December 31, 2022, $<span id="xdx_904_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231_z5jptVveA3dg" title="Purchase price, period cost"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">148.1</ix:nonFraction> million</span> of the purchase price, including
approximately $<span id="xdx_90F_eus-gaap--AcquisitionCosts_dm_c20220101__20221231_zKT9pTNyaDc6" title="Acquisition costs, period cost"><ix:nonFraction name="us-gaap:AcquisitionCosts" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.4</ix:nonFraction> million</span> of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022. The purchase price has been allocated approximately $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zDCgyiyNbLfc" title="Purchase price, period cost"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-01-012022-12-31_us-gaap_LandMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">61.1</ix:nonFraction> million</span> to land and $<span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zLQLzk0FdM0j" title="Purchase price, period cost"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-01-012022-12-31_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">87.0</ix:nonFraction> million</span>
to the building. The building, which was delivered on February&#160;28, 2022, includes the building structure, development of
the property, fa&#231;ade waterproofing, general and technical installations and interior fittings that will be depreciated
over a range of <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zGe7YQOs4dY3" title="Depreciated over a range::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl0862">7</span></span> to <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zZmef4g63Fse" title="Depreciated over a range::XDX::P50Y"><span style="-sec-ix-hidden: xdx2ixbrl0864">50</span></span> years. The Company has elected to depreciate the building cost based on the useful lives of its components.
Approximately $<span id="xdx_905_eus-gaap--EscrowDeposit_iI_dm_c20221231_zKMnXiE3mdkl" title="Cash held in escrow is included in other assets"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.4</ix:nonFraction> million</span> of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
acquisition was financed by a <span id="xdx_903_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_z4VGt2LRdjB2" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0868">10</span></span>-year &#8364;<span id="xdx_906_eus-gaap--LineOfCredit_iI_pn6n6_uUSDEUR_c20221231_zKVvzG0WcZaf" title="Long-term line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USDEUR">120</ix:nonFraction></span> million (approximately $<span id="xdx_900_eus-gaap--LineOfCredit_iI_dm_c20221231_zfoF6FEzvm3c" title="Long-term line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">128.0</ix:nonFraction> million</span>) bank loan which bears interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateTerms_c20220101__20221231_zCDYNEZyZR4h" title="Description of debt instrument interest rate terms"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="us-gaap:DebtInstrumentInterestRateTerms">one-month
Euribor plus 0.75%</ix:nonNumeric></span>. Approximately &#8364;<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zsMdkVzocId9" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_currency_EUR" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USDEUR">80</ix:nonFraction></span> million of the variable rate debt was swapped for variable interest rate debt with
a maximum rate of 2% per annum.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_812_zdOb21Fjq7fk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_z2H4TVyUgGs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(4)</td><td id="xdx_82C_zONtxktEjTW7">Inventories</td></tr></table>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden">Schedule of inventories</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Raw materials and component parts</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146,772</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">111,312</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143,212</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,602</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">289,984</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,914</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

</ix:nonNumeric><p id="xdx_8A6_zJnpHd5uesY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Overhead included in inventory
aggregated $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zcpC9lIdwDT5" title="Cost of Goods Sold, Overhead"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2022-01-012022-12-31_us-gaap_ProductMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.4</ix:nonFraction> million</span> and $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zawROXE2RwDh"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2021-01-012021-12-31_us-gaap_ProductMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.7</ix:nonFraction> million</span> as of December 31, 2022 and 2021, respectively. Included in inventories is an inventory
reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales
forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated
events may be established. Inventory reserves aggregated $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_dm_c20221231_zRYbMeXh3tEl" title="Inventory Valuation Reserves"><ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">11.4</ix:nonFraction> million</span> and $<span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_zTjfvkqnMGke" title="Inventory Valuation Reserves"><ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">15.8</ix:nonFraction> million</span> as of December 31, 2022 and 2021, respectively.</p>

</ix:nonNumeric><p id="xdx_81E_zC7Ut7szeqzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_z5WnGP2HTJMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(5)</td><td id="xdx_82B_zewNog1Z67i7">Fair Value of Financial Instruments</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br /> Active Markets for<br /> Identical Assets<br /> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br /> Observable<br /> Inputs<br /> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br /> Unobservable<br /> Inputs<br /> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White">
    <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,833</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,861</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130,174</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">798</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,758</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0913">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,758</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,189</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,189</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;<b style="display: none; visibility: hidden">Total Assets</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,780</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,861</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,122</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">798</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zCymZ2Bq9gLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zOUa0wrieTo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zaFlNfuypQf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zGtUEyI4cyn6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zuvsIQYqVPa6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_z2FyF88yWBF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_238_za2gKgGJw8Zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_233_z1A5ayU1K50g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_23B_zS1HjceEGyf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">

<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br /> Active Markets for<br /> Identical Assets<br /> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br /> Observable<br /> Inputs<br /> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br /> Unobservable<br /> Inputs<br /> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White">
    <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Short-term investments</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160,014</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160,014</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,982</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,982</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">234</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0977">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">234</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,811</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0982">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,811</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

</ix:nonNumeric><p id="xdx_8A0_zd20yXHgXpb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of cash and
cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable,
other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments.
The carrying amount of loans payable approximates fair value as the variable interest rates on the Company&#8217;s indebtedness
approximate current market rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Foreign currency forward exchange
contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net
present value of the swaps using third party quotes from financial institutions.</p>

</ix:nonNumeric><p id="xdx_812_z0rPmDNrJoHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p id="xdx_801_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zpsKbcjSP5Fc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(6)</td><td id="xdx_823_z5OyFdJ7Zwd3">Derivative Financial Instruments</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into foreign
currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction
for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged
item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the
change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item.
The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and
excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward
difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign
currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued,
and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted
transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period
earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23A_z1wbGL9FIEya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zatE9Z2Jzhml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zztOvhzHNeY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_230_zIQQVtaIKSj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_z2sTNQ3nYrm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_233_z05SKPnG6Fqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zbY35fRRbUcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_23E_z0Su6R4b7AJ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Gains and losses in derivatives
designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as
hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial
in each of the years in the three-year period ended December 31, 2022. Interest expense includes a gain of $<span id="xdx_902_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_z0Th4GfsSfD2" title="Loan amount"><ix:nonFraction name="us-gaap:DerivativeNotionalAmount" contextRef="AsOf2022-12-31_us-gaap_ForeignExchangeContractMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">6.3</ix:nonFraction> million</span> and $<span id="xdx_908_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zLFSfFgqCEA8" title="Loan amount"><ix:nonFraction name="us-gaap:DerivativeNotionalAmount" contextRef="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction>
million</span> in 2022 and 2021, respectively, resulting from an interest rate swap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments
are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap
is included in other assets on the accompanying balance sheet for the period ended December 31, 2022 and was included in long-term
debt on the accompanying balance sheet for the period ended December 31, 2021. The valuation of foreign currency forward exchange
contracts at December 31, 2022 and December 31, 2021, resulted in an asset and is included in other current assets on the accompanying
balance sheets.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2022, the Company
had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $<span id="xdx_907_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zzciTf9stfI8" title="Foreign currency contracts, liability, fair value disclosure"><ix:nonFraction name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_ForeignExchangeContractMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">36.5</ix:nonFraction> million</span>,
which all have maturities of less than one year.</p>

</ix:nonNumeric><p id="xdx_816_zf6mBTVFtBF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zzPgk7acn2Uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(7)</td><td id="xdx_829_z4yVTpn8yy73">Property, Equipment and Leasehold Improvements</td></tr></table>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" title="Equipment and leasehold improvements" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148,137</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" title="Equipment and leasehold improvements" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,131</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" title="Equipment and leasehold improvements" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,689</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" title="Equipment and leasehold improvements" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,036</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" title="Equipment and leasehold improvements" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,293</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" title="Equipment and leasehold improvements" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,082</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210,119</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">190,249</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" title="Less accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,397</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" title="Less accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,897</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" title="Property, Plant and Equipment, Net, Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166,722</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" title="Property, Plant and Equipment, Net, Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149,352</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

</ix:nonNumeric><p id="xdx_8A3_zznwfvvUieqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Depreciation and amortization
expense was $<span id="xdx_908_eus-gaap--Depreciation_dm_c20220101__20221231_zCM1bM8qcIdf" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">7.5</ix:nonFraction> million</span>, $<span id="xdx_90B_eus-gaap--Depreciation_dm_c20210101__20211231_zwixaZb6pDr7" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.4</ix:nonFraction> million</span> and $<span id="xdx_903_eus-gaap--Depreciation_dm_c20200101__20201231_z5iqMiT4q11j" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">3.8</ix:nonFraction> million</span> in 2022, 2021, and 2020, respectively.</p>

</ix:nonNumeric><p id="xdx_812_zWu6Mir78IP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>


<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z7h8bft4ZVJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(8)</td><td id="xdx_822_zz9hd6R2SV27">Trademarks, Licenses and Other Intangible Assets</td></tr></table>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross<br /> Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br /> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book<br /> Value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" title="Gross Amount" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,022</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" title="Accumulated Amortization" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1040">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" title="Net Book Value" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,022</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,203</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63,535</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,849</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,921</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,928</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264,351</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,520</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,831</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">369,373</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,520</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290,853</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross <br /> Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated <br /> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book <br /> Value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" title="Gross Amount" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,712</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" title="Accumulated Amortization" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1061">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" title="Net Book Value" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,712</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,820</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,752</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,286</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,396</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,775</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,588</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,187</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171,277</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,942</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_SubtotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94,335</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290,989</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,942</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,047</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

</ix:nonNumeric><p id="xdx_8A1_zeQ09ycLVty5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was
$<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_dm_c20220101__20221231_ziBicTVGvRNe"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">6.8</ix:nonFraction> million</span>, $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRSgahoBzRde"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.9</ix:nonFraction> million</span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zrrZnnOOg6Eh"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.3</ix:nonFraction> million</span> in 2022, 2021 and 2020, respectively. Amortization expense is expected to approximate
$<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dxL_c20221231_zXscZXrnUoki" title="2023::XDX::7000000"><span style="-sec-ix-hidden: xdx2ixbrl1083">7.0</span></span> million in 2023, $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20221231_zMd0BL1SBgxe" title="2024"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">13.3</ix:nonFraction> million</span> in 2024, $<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_dm_c20221231_z9ERUTqKJJYe" title="2025"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">12.3</ix:nonFraction> million</span> in 2025, $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_dm_c20221231_zabK9mHOHGNh" title="2026"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_dm_c20221231_z8WZ84eTOJFa" title="2027"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">10.5</ix:nonFraction></ix:nonFraction> million</span></span> in 2026 and 2027. The weighted average amortization
period for trademarks, licenses and other intangible assets with finite lives are <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_znS4kMqpChN3" title="Amortization period::XDX::P8Y"><span style="-sec-ix-hidden: xdx2ixbrl1093">18 </span></span>years, <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ztClFyOdnMkg" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1094">14</span></span> years and <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVDNwAWPVYoh" title="::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1095">2</span></span> years, respectively,
and <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231_zsIvae8lf0k8" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1096">14</span></span> years on average.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company reviews intangible
assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may
not be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $<span id="xdx_903_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zhTMH5ORxlr2" title="Impairment charge"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">6.8</ix:nonFraction> million</span> and $<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zWWEb43iMPY5"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.4</ix:nonFraction> million</span>
in 2022 and 2021, respectively, relating to our Rochas fashion business and an impairment charge for trademarks with indefinite
useful lives of $<span id="xdx_907_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionBusinessMember_zlHEFoRLvQY4"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember_custom_RochasFashionBusinessMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.9</ix:nonFraction> million</span> in 2022 relating to our Intimate trademark. The fair values used in our evaluations are estimated
based upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zeFmOx2jwC1f" title="Weighted average cost of capital"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.80</ix:nonFraction></span>%, <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z1vX5T2FQCJi"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.47</ix:nonFraction></span>%, and <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z4MGmXYlzuB6"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.99</ix:nonFraction></span>% as of December
31, 2022, 2021 and 2020, respectively. The cash flow projections are based upon a number of assumptions, including, future sales
levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or
changes in consumer acceptance of our products which are more subjective in nature. The Company believes that the assumptions
it has made in projecting future cash flows for the evaluations described above are reasonable and currently no other impairment
indicators exist for our indefinite-lived assets. However, if future actual results do not meet our expectations, the Company
may be required to record an impairment charge, the amount of which could be material to our results of operations.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zHGmc9Nfoink" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zlGYZNi6Z5oe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zH0SwNX8IIr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zBh4ctYFP8d9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_238_zLeuCQFIIIe1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zzpy6u479Qr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z7fOzjhq7Cfa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_234_z4IyJ4I8SAJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of trademarks, licenses
and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license
or the intangible assets estimated useful life which range from <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zWGvEvWj4cxb" title="Amortization period::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1114">three</span></span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z0j651Fi1xv6" title="Amortization period::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl1116">twenty years</span></span>. If the residual value of a finite life intangible
asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for
impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Trademarks (finite lives)
primarily represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to
repurchase the brand names and trademarks on July 1, 2027 for &#8364;70 million (approximately $<span id="xdx_904_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20221231_z72Xc9HoRtKl"><ix:nonFraction name="us-gaap:IndefiniteLivedLicenseAgreements" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">7</ix:nonFraction>
5</span> million) (residual value) in accordance with an amendment signed in 2021. Because the residual value of the intangible
asset exceeds its carrying value, the asset is not being amortized.</p>

</ix:nonNumeric><p id="xdx_81A_z4LQycR1G54d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zfFpH5PpqeDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(9)</td><td><span id="xdx_824_zBsQzl8NGjl">Accrued Expenses</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zk4nlSz7Fm3e">Accrued expenses consist of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Advertising liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,338</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,215</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Salary (including bonus and related taxes)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,128</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,993</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,532</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,154</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due vendors (not yet invoiced)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:DueVendorsNotYetInvoiced" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:DueVendorsNotYetInvoiced" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,707</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retirement reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,234</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Refund (return) liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CustomerRefundLiabilityCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CustomerRefundLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,128</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,149</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,246</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><b style="display: none; visibility: hidden">Total</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">213,621</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136,677</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A7_z3YQAjvVt3Rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in">&#160;</p>

</ix:nonNumeric><p id="xdx_811_zXdeTrCYeQEb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zWWvHPes4W7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(10)</td><td><span id="xdx_823_zVsRs3VmVzEf">Loans Payable &#8211; Banks</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Loans payable &#8211; banks consist
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its domestic
subsidiaries have available a $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zSvSlrua0U5b" title="Line of credit, maximum borrowing amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-12-31_custom_DomesticSubsidiariesMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">20</ix:nonFraction> million</span> unsecured revolving line of credit due on demand, which bears interest at the daily Secured
Overnight Financing Rate (&#8220;SOFR&#8221;) plus <span id="xdx_90B_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYLPXJapi36a" title="Basis spread over variable interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="From2022-01-012022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% (the SOFR was <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zf2wEZRDgLT3" title="Variable rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.3</ix:nonFraction></span>% as of December 31, 2022). The line of credit which has
a maturity date of <span id="xdx_90D_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zOIGxK6Ah7y7" title="::XDX::2023-12-15"><span style="-sec-ix-hidden: xdx2ixbrl1154">December 15, 2023</span></span>, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines of
credit were zero as of December 31, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s foreign subsidiaries
have available credit lines, including several bank overdraft facilities totaling approximately $<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zOTqYWKWmLyl"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-12-31_custom_ForeignSubsidiariesMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">20</ix:nonFraction></span> million. These credit lines
bear interest at EURIBOR plus between <span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zoZlAWLpGPic" title="Basis spread over variable interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span>% and <span id="xdx_90E_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_z5O2OZQtFDba" title="Basis spread over variable interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.9</ix:nonFraction></span>% (EURIBOR was minus <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zqXxBh8x2uIi" title="Variable rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.576</ix:nonFraction></span>% at December 31, 2022). Borrowings outstanding pursuant
to these bank overdraft facilities were zero as of December 31, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As there were no borrowings outstanding
as of December 31, 2022 and 2021, there is no weighted average interest rate on short-term borrowings as of December 31, 2022 and
2021.</p>

</ix:nonNumeric><p id="xdx_81D_zWGtCRPC0pbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div id="xdx_23E_zoPAyQZxUTQj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div id="xdx_23D_zN27OEsoN7u1" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p id="xdx_238_zHuwECSEx0yg" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_235_zYlLu9iQ25h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p id="xdx_234_zOvtyQuwSgI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p id="xdx_231_zOKtT2n4U5A" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p id="xdx_23B_z6XHOiXRFVMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p id="xdx_23B_zbMspC4oudF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p id="xdx_23C_z76VShY5sz96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p id="xdx_238_zTEaJ4vQtRy1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>


<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zXDC79Sujj8c" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(11)</td><td><span id="xdx_826_zpKuRONIxAV8">Long-Term Debt</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B6_zftsybzXQda9">Long-term debt consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">53.3</ix:nonFraction></span> million payable in <span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">48</ix:nonFraction></span> equal monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.1</ix:nonFraction> million</span> beginning in December 2022, bearing interest at one-month Euribor plus <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.825</ix:nonFraction></span>%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" title="Loan payable" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,061</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1183">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">135.9</ix:nonFraction></span> million payable in <span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2022-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">120</ix:nonFraction></span> equal monthly installments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.1</ix:nonFraction> million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.75</ix:nonFraction></span>%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124,375</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">15.0</ix:nonFraction></span> million payable in <span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">14</ix:nonFraction></span> equal annual installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.1</ix:nonFraction> million</span> beginning in January 2020 including interest imputed at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.1</ix:nonFraction></span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,569</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">17</ix:nonFraction></span> million payable in <span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments"><ix:nonFraction name="ipar:NumberOfInstallment" contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">10</ix:nonFraction></span> equal annual installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="-3" scale="9" unitRef="USD">1.7</ix:nonFraction> million</span> beginning in October 2021 including interest imputed at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></span>% per annum</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" title="Loan payable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,332</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,859</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,041</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148,803</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" title="Less current maturities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,547</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" title="Less current maturities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,911</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151,494</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" title="::XDX::132902" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1216">132,892</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

</ix:nonNumeric><p id="xdx_8A8_z5HmvadJDHEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, to finance
Interparfums SA&#8217;s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (&#8364;<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zQT8YHh7sZk7"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USDEUR">50</ix:nonFraction></span> million) four-year
loan agreement. <span id="xdx_908_eus-gaap--LongTermDebtDescription_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zo0dolFaZI1g" title="Debt description"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_LoansPayableMember" name="us-gaap:LongTermDebtDescription">The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was
swapped for variable interest rate debt with a maximum rate of 2% per annum.</ix:nonNumeric></span> The swap is a hedged derivative instrument and is
therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, to finance the
acquisition of Interparfums SA&#8217;s future corporate headquarters, the Company entered into a $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z8Fs8D40OnTe"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-04-30_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">128.0</ix:nonFraction> million</span> (&#8364;<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zAjWWQRyuBv2"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-04-30_custom_LoansPayableOneMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USDEUR">120</ix:nonFraction></span> million)
ten-year credit agreement.<span id="xdx_90E_eus-gaap--LongTermDebtDescription_c20210401__20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zaZaVlRPeZS" title="Debt description"> <ix:nonNumeric contextRef="From2021-04-012021-04-30_custom_LoansPayableOneMember" name="us-gaap:LongTermDebtDescription">Approximately $85.3 million (&#8364;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum.</ix:nonNumeric> </span>The swap is a derivative instrument and is therefore recorded at fair value
and changes in fair value are reflected in the accompanying consolidated statements of income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Maturities of long-term debt
subsequent to December 31, 2022 are approximately $<span id="xdx_907_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20221231_zXSKH0X9ZWa5" title="Long-term Debt, Maturities, 2021"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">30.4</ix:nonFraction> million</span> in 2023 and $<span id="xdx_909_eus-gaap--LongTermDebtDescription_c20220101__20221231_zZdNR4ZToCMj" title="Long term debt maturity, description"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="us-gaap:LongTermDebtDescription">28.7 million per year thereafter through 2033.</ix:nonNumeric></span></p>

</ix:nonNumeric><p id="xdx_817_zRf7Hzmy94ui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_237_zULlVZJO5d7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p id="xdx_237_zzDhmj2lnNEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p id="xdx_23F_z6jqxqn5b4Uf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>


<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zTwr7Ra7eKO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(12)</td><td><span id="xdx_822_zv6FdTOer5w7">Commitments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Leases</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices,
warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing
leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized
at the lease commencement date based on the present value of lease payments over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining lease asset value,
the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on
the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option
is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available
at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the
weighted average remaining lease term was <span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20221231_zYWOvqd8k7Z" title="Weighted average remaining lease term::XDX::P5Y9M18D"><span style="-sec-ix-hidden: xdx2ixbrl1234">5.8</span></span> years and the weighted average discount rate used to determine the operating lease
liability was <span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OperatingLeaseMember_zmmFrMrS3QQ3" title="Operating lease, weighted average discount rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-12-31_custom_OperatingLeaseMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.6</ix:nonFraction></span>%. Rental expense related to operating leases was $<span id="xdx_906_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20220101__20221231_zDmGhOiSjPBb" title="Operating lease of related to rental expenses"><ix:nonFraction name="ipar:OperatingLeaseOfRelatedToRentalExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">5.6</ix:nonFraction> million</span>, $<span id="xdx_90C_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20210101__20211231_zOpXgtuxey95" title="Operating lease of related to rental expenses"><ix:nonFraction name="ipar:OperatingLeaseOfRelatedToRentalExpenses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">8.2</ix:nonFraction> million</span>, and $<span id="xdx_90D_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20200101__20201231_z6e3ua44YPd5" title="Operating lease of related to rental expenses"><ix:nonFraction name="ipar:OperatingLeaseOfRelatedToRentalExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">6.2</ix:nonFraction> million</span> for the years ended
December 31, 2022, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $<span id="xdx_90C_eus-gaap--OperatingLeasePayments_dm_c20220101__20221231_zOycA2qmyVT8" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.9</ix:nonFraction> million</span>
and noncash additions to operating lease assets totaled $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_dm_c20220101__20221231_zCokZCjQiWch" title="Noncash additions to operating lease assets"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.3</ix:nonFraction> million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock"><p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B6_zJZSArOFca1k">Maturities of lease liabilities
subsequent to December 31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" title="2023" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,723</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" title="2024" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" title="2025" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,847</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,049</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">2027</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,060</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Thereafter</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,913</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" title="Gross Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,563</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><span style="font-size: 10pt">Less imputed interest (based on
    2.6%</span> weighted-average discount rate)</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" title="Less imputed interest (based on 2.6% weighted-average discount rate)" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,932</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" title="Net Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="ipar:LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,631</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

</ix:nonNumeric><p id="xdx_8AD_zy90NeZibwc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"></p>

<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div id="xdx_23E_zXsOZ5VBmu7b" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div id="xdx_23C_ziP8wPutUYi7" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red">&#160;</p>

<ix:exclude><p id="xdx_235_zd2KqAcXM483" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:exclude><p id="xdx_237_zjJrMWnJ0cI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_23B_zvOGJCpgWrk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_234_zC50ficD2Pxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">License Agreements</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock"><p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</ix:nonNumeric></span> In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, <span id="xdx_8B6_zLKFQSlOwCib">minimum annual royalties and other commitments as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands) </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" title="2023" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInNextTwelveMonths" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">217,852</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" title="2024" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInSecondYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">224,201</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" title="2025" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInThirdYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218,047</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInFourthYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">139,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueInFifthYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132,502</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thereafter</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherCommitmentDueAfterFifthYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">986,434</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherCommitment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,918,384</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></p>

</ix:nonNumeric><p id="xdx_8AB_zqW0gUZLUbSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 40.5pt; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future advertising commitments
are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration
for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations.
Royalty expense included in selling, general, and administrative expenses, aggregated $<span id="xdx_906_eus-gaap--RoyaltyExpense_dm_c20220101__20221231_zJ4Vw88JOFd" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">87.0</ix:nonFraction> million</span>, $<span id="xdx_900_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zEFGKRKYN0Kl" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">68.9</ix:nonFraction> million</span> and $<span id="xdx_90B_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zKT2XSaeLDt6" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">41.1</ix:nonFraction> million</span>,
in 2022, 2021 and 2020, respectively, and represented <span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231_zja2h94g7ujk" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.0</ix:nonFraction></span>%, <span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zfGTtDuPHMu" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.8</ix:nonFraction></span>% and <span id="xdx_907_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zAIxykTL3msl" title="Royalty expense, percentage of net sales"><ix:nonFraction name="ipar:RoyaltyExpenseNetSalesPercentage" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.6</ix:nonFraction></span>% of net sales for the years ended December 31, 2022, 2021
and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z0xEZThRjPSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(13)</td><td><span id="xdx_824_z4QG4D9JjvZj">Equity</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Share-Based Payments</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains a stock
option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide
for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and
vest over a <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbUkuxEy131l" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1304">four</span></span> to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUm5qZQr8np4" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1306">five</span></span>-year period. The fair value of shares vested aggregated $<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiTTmRm9Ryg"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.3</ix:nonFraction> million</span>, $<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNTy7pkKCtLa" title="Fair value of shares vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.4</ix:nonFraction> million</span> and $<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqrJtdNf4GM"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.7</ix:nonFraction> million</span> in
2022, 2021 and 2020, respectively. <span style="font-family: Times New Roman, Times, Serif">Compensation cost, net of estimated
forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated
based on historic trends. </span>It is generally the Company&#8217;s policy to issue new shares upon exercise of stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zFjpmdCfOPe7">The following table sets forth
information with respect to nonvested options for 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Nonvested options &#8211; beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" title="Nonvested options - beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">209,510</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" title="Weighted Average Grant Date Fair Value, beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.45</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nonvested options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" title="Nonvested options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">62,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" title="Weighted Average Grant Date Fair Value, granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.36</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" title="Nonvested options vested or forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" title="Weighted Average Grant Date Fair Value, vested or forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.93</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options &#8211; end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" title="Nonvested options - end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168,730</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" title="Weighted Average Grant Date Fair Value, end of year" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.31</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_z2lp4EWwj9ta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div id="xdx_237_zpqQpjuaqfdb" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div id="xdx_230_zhWoUUvzA266" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zGmzpOU8SbTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zfgKJ2MJe0f2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zmU1sQbwhZta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zBSYF6OYsWP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_233_zaiBjR5iN5ck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_23F_zBwOS8pFexq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_23D_ziiVjECSoCE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zaFiKtjKr3b5">The effect of share-based payment
expenses decreased income statement line items as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Income before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" title="Income before income taxes" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,143</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" title="Income before income taxes" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,850</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" title="Income before income taxes" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,030</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" title="Net income attributable to Inter Parfums, Inc." style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,036</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" title="Net income attributable to Inter Parfums, Inc." style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" title="Net income attributable to Inter Parfums, Inc." style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,040</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" title="Diluted earnings per share attributable to Inter Parfums, Inc" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" title="Diluted earnings per share attributable to Inter Parfums, Inc" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" title="Diluted earnings per share attributable to Inter Parfums, Inc" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zmgo6RZltrt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z10lqP2NV1bl">The following table summarizes
stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Shares under option -&#160;beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" title="Options shares under option - beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">524,900</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" title="Weighted average exercise price shares under option - beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">57.58</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" title="Options shares under option - beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">713,210</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" title="Weighted average exercise price shares under option - beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.74</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">815,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">49.89</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" title="Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">62,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" title="Weighted average exercise price options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">97.84</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" title="Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" title="Weighted average exercise price options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">62.18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" title="Options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">69.11</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Options exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" title="Options exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">136,880</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" title="Weighted average exercise price options exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">43.86</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" title="Options exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,490</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" title="Weighted average exercise price options exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.46</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" title="Options exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,570</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">28.99</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Options forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" title="Options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,440</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" title="Weighted average exercise price options forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">67.65</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" title="Options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,820</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" title="Weighted average exercise price options forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">62.57</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" title="Options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,020</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">58.38</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Shares under option - end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" title="Options shares under option - end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">441,580</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" title="Weighted average exercise price shares under option - end of year" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">67.30</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" title="Options shares under option - end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">524,900</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" title="Weighted average exercise price shares under option - end of year" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">57.58</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">713,210</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.74</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_8A7_zMusYQdqpD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2022, options
for <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zRbzGPHLcDW9" title="Number of shares available for grant (in shares)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">558,975</ix:nonFraction></span> shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zPczbZ4CHEe9" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">13.0</ix:nonFraction>
million</span> as of December 31, 2022 and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zrJOO8xEv2Zk" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-12-31_custom_StockOptionOneMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.7</ix:nonFraction> million</span>,
which will be recognized over the next <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20220101__20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zNds05itzyhh" title="Term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1418">five</span></span> years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted average fair values
of options granted by Inter Parfums, Inc. during 2022, 2021 and 2020 were $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3ts39aUaVf" title="Weighted average grant date fair value (in dollars per share)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.36</ix:nonFraction></span>, $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqCA6fheI8Gb" title="Weighted average grant date fair value (in dollars per share)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.35</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGXHMgADgBg2" title="Weighted average grant date fair value (in dollars per share)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.16</ix:nonFraction></span> per share, respectively, on
the date of grant using the Black-Scholes option pricing model to calculate the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zZGs8M9wlPE9">The assumptions used in the Black-Scholes
pricing model are set forth in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">26</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average expected option life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" title="Weighted-average expected option life::XDX::P4Y" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">4.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" title="Weighted-average expected option life::XDX::P5Y" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1434">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" title="Weighted-average expected option life::XDX::P5Y" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1436">5.0 years</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.4</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AB_zjBkLAW2FMue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div id="xdx_231_z6yaK7NomAAj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zc4udghQp6Ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zhZhQODDorad" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zRIlYXUklach" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zOuQRyK3rxf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_230_zZ0HZmwBsZu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zgqaSRnLppC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_236_zIIwNjj2Z8Ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_23B_zy9uD0sneCc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Expected volatility is estimated
based on historic volatility of the Company&#8217;s common stock. The expected term of the option is estimated based on historic
data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend
yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout
ratio as a percentage of earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"><p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zZTZ2TudDlj9">Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Proceeds from stock options exercised</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,003</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,393</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,771</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tax benefits</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intrinsic value of stock options exercised</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,873</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zXo8dwKlRsok" style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B1_zT9VrNCHVHH3">The following table summarizes
additional stock option information as of December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding weighted average remaining contractual life</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options exercisable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: center"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40.15</ix:nonFraction></span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">46.90</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" title="Options outstanding" style="width: 22%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,460</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"><span style="-sec-ix-hidden: xdx2ixbrl1475">0.96</span></span> years</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" title="Options exercisable" style="width: 22%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">101,860</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt">$<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">62.18</ix:nonFraction></span> - $<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">69.11</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" title="Options outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">139,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"><span style="-sec-ix-hidden: xdx2ixbrl1483">2.04</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" title="Options exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,210</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">73.09</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">136,220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1488">3.00</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">73,780</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">$<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">97.84</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2022-12-31_custom_ExercisePriceRangeFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">62,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"><span style="-sec-ix-hidden: xdx2ixbrl1492">5.85</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1493">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Totals</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">441,580</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"><span style="-sec-ix-hidden: xdx2ixbrl1495">2.62</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">272,850</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"></p>

</ix:nonNumeric><p id="xdx_8A2_zbPfi6PqJBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the
weighted average exercise price of options exercisable was $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uUSDPShares_c20221231_ztPpZ95AvzX" title="Weighted average exercise price of options exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">59.46</ix:nonFraction></span> and the weighted average remaining contractual life of options
exercisable is <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20220101__20221231_zEGDcIwT5I72" title="Weighted average remaining contractual life of options exercisable::XDX::P1Y10M17D"><span style="-sec-ix-hidden: xdx2ixbrl1500">1.88</span></span> years. The aggregate intrinsic value of options exercisable at December 31, 2022 is $<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_dm_c20221231_zWPFWaH7sF3f" title="Aggregate intrinsic value of options exercisable"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">10.1</ix:nonFraction> million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2018, Interparfums
SA approved a plan to grant an aggregate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zolqUtSNVf35" title="Adjusted for stock splits (in shares)"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,600</ix:nonFraction></span> shares of its stock to employees with no performance condition requirement,
and an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zKV5xx7gtrzh" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,000</ix:nonFraction></span> shares to officers and managers, subject to certain corporate performance conditions. The corporate
performance conditions were met and therefore in June 2022, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220627__20220630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zmz0K9mMiMia" title="Shares adjusted for stock splits"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" contextRef="From2022-06-272022-06-30_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">211,955</ix:nonFraction></span> shares, adjusted for stock splits, were distributed. The aggregate
cost of the grant of approximately $<span id="xdx_908_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_dm_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zpMHa71JZO72" title="Recognized as compensation cost"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.8</ix:nonFraction> million</span> was recognized as compensation cost on a straight-line basis over the requisite
<span id="xdx_909_eus-gaap--DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_dxL_c20220101__20221231_zn6Zy3HzEP4i" title="Straight line basis over the requisite::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1512">three</span></span>-year service period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z5VzzvkQvQA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zYnVQXNRm1S4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zoQgK5fG2DL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zd13pDhjg5y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_232_zLOlqJCdkYr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_233_zsFAh5YGEq94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_234_zAatW0HMC7Od" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zYmO4DD5Shc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_233_zsAGiTP8Ps51" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2022, Interparfums SA
approved an additional plan to grant an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z6WQrzRaEvP4"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2022-03-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">88,400</ix:nonFraction></span> shares to all Interparfums SA employees and corporate officers having
more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment
for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the grant had
been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The
estimated number of shares to be distributed of <span id="xdx_904_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z4xDvfHemfK7" title="Number of share distributed"><ix:nonFraction name="us-gaap:DistributionMadeToLimitedPartnerUnitDistribution" contextRef="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,062</ix:nonFraction></span> has been determined taking into account employee turnover. The aggregate
cost of the grant of approximately $<span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20220101__20221231__srt--OwnershipAxis__custom--InterparfumsSAMember_z7xoxRrTw8na"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" contextRef="From2022-01-012022-12-31_custom_InterparfumsSAMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.1</ix:nonFraction> million</span> will be recognized as compensation cost on a straight-line basis over the requisite
three and a quarter year service period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Similar to the December 2018
plan, in order to avoid dilution of the Company&#8217;s ownership of Interparfums SA, all shares distributed or to be distributed
pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During
the year ended December 31, 2022, the Company acquired <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zvzvYImHjQzh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,281</ix:nonFraction></span> shares at an aggregate cost of $<span id="xdx_902_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn6n6_c20220101__20221231_z1yhgjJBhuJ3" title="Aggregate cost"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">3.0</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zq82NAWaxztj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All share purchases and issuances
have been classified as equity transactions on the accompanying balance sheet.</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Dividends</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2019, our Board of
Directors authorized a <span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_zq1BtKsWXw1j" title="Percentage of increase in annual dividend"><ix:nonFraction name="ipar:PercentageOfIncreaseInAnnualDividend" contextRef="From2019-10-012019-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% increase in the annual dividend to $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zT4bsZb7yhz"><ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.32</ix:nonFraction></span> per share on an annual basis. In April 2020, as a result of
the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash
dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly.
In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share and in February 2023,
the Board of Directors further increased the annual dividend to $<span id="xdx_90C_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zn5dEgZpNPql" title="Dividends payable, amount per share (in dollars per share)"><ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" contextRef="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.50</ix:nonFraction></span> per share. The next quarterly cash dividend of $<span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3H9aLSa9j2g" title="Dividends payable, amount per share (in Dollars per share)"><ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" contextRef="AsOf2023-03-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.625</ix:nonFraction></span> per
share is payable on March 31, 2023 to shareholders of record on March 15, 2023.</p>

</ix:nonNumeric><p id="xdx_81E_zwZolvM0grya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zx5E95p2u826" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><b>(14)</b></td><td id="xdx_82C_zg2XEdxMVec8" style="text-align: justify"><b>Net Income Attributable to Inter Parfums, Inc. Common Shareholders</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net income attributable to Inter
Parfums, Inc. per common share (&#8220;basic EPS&#8221;) is computed by dividing net income attributable to Inter Parfums, Inc.
by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution
(&#8220;diluted EPS&#8221;), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding
assuming the exercise of dilutive stock options using the treasury stock method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zVhudg1jze4e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zYcbzp8nkgD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zyjeTgYCKLHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zg0C5KGz7Kre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_231_zoaxmaQNDTy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zc0D1HwrocZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zo1Egh11pASk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_233_ziRcDPFhELub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_233_zkKUhf45j2Jc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_z0oWgrF1Exze">The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" title="Numerator for diluted earnings per share (in dollars)" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120,938</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" title="Numerator for diluted earnings per share (in dollars)" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" title="Numerator for diluted earnings per share (in dollars)" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" title="Weighted average shares::XDX::31859417" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1557">31,859,417</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" title="Weighted average shares" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,676,796</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" title="Weighted average shares" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,536,659</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" title="Stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">129,336</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" title="Stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">158,612</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" title="Stock options" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117,885</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" title="Denominator for diluted earnings per share::XDX::31835408" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1569">31,988,753</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" title="Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,835,408</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" title="Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,654,544</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.
    common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" title="Basic (in dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" title="Basic (in dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" title="Basic (in dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" title="Diluted (in dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" title="Diluted (in dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" title="Diluted (in dollars per share)" style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A9_zbK4fmd08pt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Not included in the above computations
is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zg2q9bpdlHmj" title="Antidilutive securities excluded from computation of earnings per share, amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,000</ix:nonFraction></span>, <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zZ3Omt4U4Yj3" title="Antidilutive securities excluded from computation of earnings per share, amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">175,000</ix:nonFraction></span>, and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_zIqUqAS4cqsk" title="Antidilutive securities excluded from computation of earnings per share, amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,000</ix:nonFraction></span>
shares of common stock for 2022, 2021, and 2020, respectively.</p>

</ix:nonNumeric><p id="xdx_81C_ziY5EQ8WCvi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zGZBHf28LoC8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><b>(15)</b></td><td id="xdx_82C_zH7uC5DUdNy3" style="text-align: justify"><b>Segments and Geographic Areas</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company <span style="font-family: Times New Roman, Times, Serif">manufactures
and distributes one product line, fragrances and fragrance related products. The Company</span> manages its business in two segments,
European based operations and United States based operations. The European assets are located, and operations are primarily conducted,
in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B9_zpH2kTnlYawl">Information on the Company&#8217;s
operations by segments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">342,644</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216,559</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">117,489</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">744,075</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">663,290</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">422,947</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations of intercompany
    sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">66</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">333</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,427</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,086,653</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">879,516</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,009</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,745</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,359</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,942</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,193</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,241</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120,938</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Depreciation and amortization expense including
    impairment loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,355</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,835</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,354</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,184</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,863</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,713</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,539</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,698</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,067</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td>Interest and investment income:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,769</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,526</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2022-01-012022-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">349</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,486</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,403</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,865</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">636</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">604</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" title="Interest expense" style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" title="Interest expense" style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,315</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" title="Interest expense" style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,496</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" title="Interest expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">349</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" title="Interest expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" title="Interest expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" title="Interest expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,599</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" title="Interest expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,825</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" title="Interest expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,970</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,590</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,607</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,782</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,182</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,992</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,381</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zfEM318ve1e2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zpoZ3MMzJ2u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zFh0xMZ5xVn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zmB6btH8JSL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_231_zbUZzQmbkxdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_238_zejMk2AttRta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zR2Cm3QHHYSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_235_zwkV0Vh3AZI2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">278,090</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">247,703</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,316</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,052,004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">931,735</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">758,812</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,552</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,074</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,983</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,308,542</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,145,364</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">890,145</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Additions to long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,004</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,438</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,563</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,259</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,756</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">141,274</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AdditionsToOtherAssetsAmount" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,263</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,539</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63,094</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,656</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">423,999</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,033</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">217,766</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">485,538</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">397,127</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">258,422</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,906</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">870</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">886</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,066</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,106</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,159</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,936</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,041</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A3_z3AfBJKqYq4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">United States export sales were
approximately $<span id="xdx_906_eus-gaap--Revenues_dm_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z9mKYeG4Bxvg" title="Revenue from export sales"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">169.1</ix:nonFraction> million</span>, $<span id="xdx_90C_eus-gaap--Revenues_dm_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zRk6SmlGxoJf" title="Revenue from export sales"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">126.2</ix:nonFraction> million</span> and $<span id="xdx_908_eus-gaap--Revenues_dm_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z12uafZ15sJ3" title="Revenue from export sales"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">71.5</ix:nonFraction> million</span> in 2022, 2021 and 2020, respectively. <span>Consolidated net sales to
customers by region are as follows:</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden">Consolidated net sales to customers by region are as follows:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" title="Net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_srt_NorthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">431,900</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" title="Net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_srt_NorthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">354,100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" title="Net sales" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_srt_NorthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">193,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">333,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">128,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_custom_CentralAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_custom_OtherSegmentCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31_custom_OtherSegmentCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,400</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_OtherSegmentCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,300</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,086,700</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">879,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_ztRhsXR8V6Q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zDMAokYGm4Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_z4ZYHiQN2gWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zGgOuYrjkPy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zffB9P3i9BX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_239_zv2KAawsiGSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_233_zyRsik7uOY92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_239_zMv79c4p4hsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B7_z7FpI55o74vh">Consolidated net sales to customers in major countries
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" title="Revenue from Contract with Customer, Including Assessed Tax" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_UnitedStatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">420,900</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" title="Revenue from Contract with Customer, Including Assessed Tax" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_UnitedStatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">351,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" title="Revenue from Contract with Customer, Including Assessed Tax" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_UnitedStatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">187,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>France</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_FranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_FranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_FranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Russia</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_RussiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,964</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_RussiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_RussiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_UnitedKingdomMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_UnitedKingdomMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_UnitedKingdomMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zpCmLcFFUQ57" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_813_z5FLP2qbAnS8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zEzULplDcgK7" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(16)</td><td id="xdx_821_zrAktrtcrZrl">Income Taxes</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries
file income tax returns in the U.S. federal, and various states and foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed its uncertain
tax positions and determined that it has no material uncertain tax position at December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z7VnI34zzwX8">The components of income before
income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">U.S. operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" title="U.S. operations" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" title="U.S. operations" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,742</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" title="U.S. operations" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,577</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" title="Foreign operations" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143,969</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" title="Foreign operations" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116,277</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" title="Foreign operations" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,772</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" title="Income before income taxes::XDX::194219" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1797">194,219</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" title="Income before income taxes::XDX::151019" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1799">151,019</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" title="Income before income taxes::XDX::69349" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">69,349</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zMdKdsLj6jH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zcy74h7kGdd5">The provision for current and
deferred income tax expense (benefit) consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Current:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; padding-left: 0.125in">Federal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" title="Federal" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,829</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" title="Federal" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,825</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" title="Federal" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,685</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">State and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" title="State and local" style="text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">658</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" title="State and local" style="text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">518</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" title="State and local" style="text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,458</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,164</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,024</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" title="Current income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,945</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" title="Current income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,507</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" title="Current income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,799</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" title="Federal" style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">802</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" title="Federal" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" title="Federal" style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">State and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" title="State and local" style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">49</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" title="State and local" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" title="State and local" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,912</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">530</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" title="Foreign" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">753</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" title="Deferred income tax expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,763</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" title="Deferred income tax expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">515</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" title="Deferred income tax expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">582</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" title="Total income tax expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,182</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" title="Total income tax expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,992</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" title="Total income tax expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,381</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8AA_zu1mvlECuEsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z2yGRbqn3r7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zvVZu1jDR25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zMvDkY0F6Gjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zq6GUQZ9YJV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_231_zyLmQ6S4jeh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_z7lL4TaNeJd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<ix:exclude><p id="xdx_23E_zAt4LRdbxH64" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_230_zUvC4rVvwMz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_zp6bQ94sbp35">The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,292</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Inventory and accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:DeferredTaxAssetsInventoryAndAccountsReceivable" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:DeferredTaxAssetsInventoryAndAccountsReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,508</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Profit sharing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,871</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,787</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Stock option compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">716</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">732</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of inventory profit elimination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,342</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,112</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">266</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">407</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Total gross deferred tax assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,838</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,582</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,075</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,256</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities (long-term):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Building expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ipar:DeferredTaxLiabilitiesBuildingExpenses" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,356</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ipar:DeferredTaxLiabilitiesBuildingExpenses" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,082</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Trademarks and licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,160</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,551</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Unrealized gain on marketable equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,745</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">436</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">655</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">251</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,916</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,320</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,159</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,936</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A9_zi5Iazzkwjqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Valuation allowances have been
provided for deferred tax assets relating to foreign net operating loss carry-forwards as future profitable operations from certain
foreign subsidiaries might not be sufficient to realize the full amount of the deferred tax assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other valuation allowances
have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future
taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company estimated of the
effect of global intangible low-taxed income (&#8220;GILTI&#8221;) and has determined that it has no tax liability related to GILTI
as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of foreign derived intangible income (&#8220;FDII&#8221;)
and recorded a tax benefit of approximately $<span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_z2RduZVyNBx2"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_custom_ForeignDerivedIntangibleIncomeMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.5</ix:nonFraction> million</span>, $<span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zEdLfbzCw8lk"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.9</ix:nonFraction> million</span> and $<span id="xdx_90A_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zsIXtt16Baih"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">0.3</ix:nonFraction> million</span> as of December 31, 2022, 2021 and 2020,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is no longer subject
to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zvX6PMykLvpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_z2GUBvxvSPeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zsyZwhoW8yw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zzFbwylADarj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p></ix:exclude>

<ix:exclude><p id="xdx_234_zCibS8hZyA7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zpCe3eUXTk7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p></ix:exclude>

<ix:exclude><p id="xdx_231_zhqj62Iluae8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zhkm5ueVYNTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p></ix:exclude>


<ix:exclude><p id="xdx_23B_zFeRNBa5DiLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z8w289QLD5Z9">Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Statutory rates</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and local taxes, net of Federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Windfall benefit from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.4</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.9</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Benefit of Foreign Derived Intangible Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.8</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.6</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.4</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Effect of foreign taxes greater than U.S. statutory rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.625in">Effective rates</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22.2</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.1</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.9</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">%</td></tr>

</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A7_z0csr17AQpCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

</ix:nonNumeric><p id="xdx_811_zDWqXtVRMVYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ComprehensiveIncomeNoteTextBlock"><p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zggFcT5jBCP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(17)</td><td><span id="xdx_820_z08Cgu9j1Gii">Accumulated Other Comprehensive Loss</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8B6_zdI2PfJTcWk4">The components of accumulated other
comprehensive loss consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" title="Net derivative instruments, beginning of year" style="width: 10%; text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1" contextRef="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" title="Net derivative instruments, beginning of year" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1968">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" title="Net derivative instruments, beginning of year" style="width: 10%; text-align: right"><ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1" contextRef="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" title="Net derivative instrument gain (loss), net of tax" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2022-01-012022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,701</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" title="Net derivative instrument gain (loss), net of tax" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" title="Net derivative instrument gain (loss), net of tax" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" title="Net derivative instruments, end of year" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1" contextRef="AsOf2022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,709</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" title="Net derivative instruments, end of year" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1" contextRef="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">992</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" title="Net derivative instruments, end of year" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1982">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cumulative translation adjustments, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" title="Cumulative translation adjustments, beginning of year" style="text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2" contextRef="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,440</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" title="Cumulative translation adjustments, beginning of year" style="text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2" contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" title="Cumulative translation adjustments, beginning of year" style="text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2" contextRef="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,905</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" title="Translation adjustments" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,325</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" title="Translation adjustments" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,443</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" title="Translation adjustments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,908</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" title="Cumulative translation adjustments, end of year" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2" contextRef="AsOf2022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,765</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" title="Cumulative translation adjustments, end of year" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2" contextRef="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,440</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" title="Cumulative translation adjustments, end of year" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2" contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" title="Accumulated other comprehensive loss" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56,056</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" title="Accumulated other comprehensive loss" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,432</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,997</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2pt">)</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></p>

</ix:nonNumeric><p id="xdx_8A5_z6Qdw7p9XLe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

</ix:nonNumeric><p id="xdx_81F_zRTyd4oexmdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"></p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zameMs2bbq29" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div id="xdx_23C_zidiagNtBgs1" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p id="xdx_23B_zAlwxxIqW49i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p id="xdx_23E_z1e3je5u3PY7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Notes to Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p id="xdx_230_zPrdgiMCTU9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 31, 2022, 2021 and 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p id="xdx_236_zRO4kIDGF0X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands except share and per share
data)</p>


<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_z0NbJg2VBBYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(18)</td><td><span id="xdx_820_zOpk2joaSrZ8">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</span></td></tr></table>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"><p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120,938</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2019">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2020">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120,938</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,411</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,219</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

</ix:nonNumeric><p id="xdx_8A6_zlQaVNVUJMd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red">&#160;</p>

</ix:nonNumeric><p id="xdx_813_z4AxBvnHqWHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock"><p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_zwaHVFtCoXM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(19)</td><td><span id="xdx_82D_zPzQ3HIOQUij">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zWO24NCWEtHj">The following table summarizes
cash and cash equivalents as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-family: Courier New, Courier, Monospace; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br />
 2021</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 77%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" title="Cash and cash equivalents per balance sheet" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,613</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" title="Cash held in escrow included in other assets (see note 3)::XDX::168387" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ipar:CashHeldInEscrowIncludedInOtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,774</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Cash and cash equivalents per balance sheet::XDX::168387" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" title="Cash and cash equivalents per statement of cash flows::XDX::168387" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168,387</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_z5GK5tdRTIOa" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_81B_z6fyx3f7Tghf" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"><p id="xdx_80D_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zfjmJJOx1YB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_829_zQO6hwDTuQBc" style="display: none; visibility: hidden">&#160;Schedule II - Valuation and Qualifying Accounts</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Schedule II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<ix:exclude><p id="xdx_23B_zZmIwljmg7Rl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="b008"></span>INTER PARFUMS, INC. AND SUBSIDIARIES</b></p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SummaryOfValuationAllowanceTextBlock"><p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden">Schedule of Valuation and Qualifying Accounts</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Valuation and Qualifying Accounts</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Column A</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column B</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column C</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column D</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column E</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additions</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(1)</td><td style="font-weight: bold; text-align: left"></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(2)</td><td style="font-weight: bold; text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance
    at</b></span><br /> <span style="font-size: 10pt"><b>beginning of</b></span><br /> <span style="font-size: 10pt"><b>period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged
    to</b></span><br /> <span style="font-size: 10pt"><b>costs and</b></span><br /> <span style="font-size: 10pt"><b>expenses</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged
    to</b></span><br /> <span style="font-size: 10pt"><b>other</b></span><br /> <span style="font-size: 10pt"><b>accounts &#8211;</b></span><br />
    <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Deductions</b></span><br />
    <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance
    at</b></span><br /> <span style="font-size: 10pt"><b>end of period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in">Allowance for doubtful accounts:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 3%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,247</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,353</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" title="Charged to other accounts describe" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember" id="Fact002045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,134</ix:nonFraction></td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember" id="Fact002046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,044</ix:nonFraction></td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2022-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,690</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2020-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">877</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right">(<ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember" id="Fact002052" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">843</ix:nonFraction></td><td colspan="2" style="text-align: left">)(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember" id="Fact002053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,336</ix:nonFraction></td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,247</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2019-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" title="Charged to costs and expenses" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember" id="Fact002060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">381</ix:nonFraction></td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" title="Deductions describe" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember" id="Fact002062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,107</ix:nonFraction></td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2020-12-31_us-gaap_AllowanceForCreditLossMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,550</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Allowance for sales returns, net of inventory:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,997</ix:nonFraction>	</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2068">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember" id="Fact002069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,829</ix:nonFraction></td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2022-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,410</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2020-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,042</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2075">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember" id="Fact002076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,042</ix:nonFraction></td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,242</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2019-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,587</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,978</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember" id="Fact002083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,323</ix:nonFraction></td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2020-12-31_us-gaap_SalesReturnsAndAllowancesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,242</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Inventory reserve:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,777</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,742</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right">(<ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember" id="Fact002089" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">378</ix:nonFraction></td><td colspan="2" style="text-align: left">)(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember" id="Fact002090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,710</ix:nonFraction></td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2022-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,431</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2020-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,371</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,217</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember" id="Fact002096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,041</ix:nonFraction></td><td colspan="2" style="text-align: left">(d)(e)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember" id="Fact002097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,852</ix:nonFraction></td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,777</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" title="Balance at beginning of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2019-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,909</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,212</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember" id="Fact002103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">616</ix:nonFraction></td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember" id="Fact002104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,366</ix:nonFraction></td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" title="Balance at end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2020-12-31_us-gaap_InventoryValuationReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,371</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left">(a)</td><td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify"><ix:footnote id="Footnote002107" xml:lang="en-US">Write-off of bad debts.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left">(b)</td><td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify"><ix:footnote id="Footnote002108" xml:lang="en-US">Write-off of sales returns.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left">(c)</td><td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify"><ix:footnote id="Footnote002109" xml:lang="en-US">Disposal of inventory</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left">(d)</td><td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify"><ix:footnote id="Footnote002110" xml:lang="en-US">Foreign currency translation adjustment</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left">(e)</td><td id="xdx_F19_z623xCp9iOT7" style="text-align: justify"><ix:footnote id="Footnote002111" xml:lang="en-US">Inventory reserves acquired of $7,639</ix:footnote></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A7_zbYGZKrqekt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying reports of independent registered public accounting
firm.</p>

</ix:nonNumeric><p id="xdx_815_zLI0r4D4t1m2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a022"></span>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of Section 13 or 15 (d) of the
Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">Inter Parfums, Inc.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 57%">&#160;</td>
    <td style="width: 2%">By: </td>
    <td style="border-bottom: black 1pt solid; width: 41%">&#160;/s/ Jean Madar </td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">Jean Madar, Chief Executive Officer</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">Date: February 28, 2023</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the
dates indicated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 30%; text-align: center"><span style="font-size: 10pt">Signature</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 41%; text-align: center"><span style="font-size: 10pt">Title</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 25%; text-align: center"><span style="font-size: 10pt">Date</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;/s/ Jean Madar</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chairman of the Board of Directors</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Jean Madar</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">and Chief Executive Officer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 28, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;/s/ Michel Atwood</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Michel Atwood</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Financial Officer and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 28, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;/s/ Philippe Benacin</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Philippe Benacin</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;/s/ Philippe Santi</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Philippe Santi</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                                         Fran&#231;ois Heilbronn</span></p>


</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Fran&#231;ois Heilbronn</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">/s/&#160;Robert Bensoussan</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Robert Bensoussan</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">/s/ Patrick Cho&#235;l</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Patrick Cho&#235;l</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Michel Dyens</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February __, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">/s/ Veronique Gabai-Pinsky</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Veronique Gabai-Pinsky</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">/s/ Gilbert Harrison</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Gilbert Harrison</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">February 24, 2023</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 118; Options: NewSection; Value: 81 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">Exhibit Index</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2017:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 8%"><span style="font-size: 10pt">10.166</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 91%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577418001852/s109206_ex10-166.htm"><span style="font-size: 10pt">Form
    of Option Agreement for Options Granted to Executive Officers on December 29, 2017 with Schedule of Option Holders and Options
    Granted</span></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.167</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577418001852/s109206_ex10-167.htm"><span style="font-size: 10pt">Form
    of Option Agreement for Options Granted to Executive Officers on January 19, 2018 with Schedule of Option Holders and Options
    Granted</span></a></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2018:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.156</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-156.htm"><span style="font-size: 10pt">Consulting
    Agreement with Jean Madar Holding SAS</span></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 8%; text-align: justify"><span style="font-size: 10pt">10.168</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 91%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-168.htm"><span style="font-size: 10pt">Eighth
    Modification of Lease for portions of 551 5<sup>th</sup> Avenue, New York, NY</span></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.168.1</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-1681.htm"><span style="font-size: 10pt">Exhibits
    to Eighth Modification of Lease for portions of 551 5<sup>th</sup> Avenue, New York, NY</span></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.169</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-169.htm"><span style="font-size: 10pt">Fourth
    Amendment to Lease for 60 Stults Road, South Brunswick, NJ</span></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.171</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000161577419003459/s116268_ex10-171.htm"><span style="font-size: 10pt">Form
    of Option Agreement for Options Granted to Executive Officers on December 31, 2018 with Schedule of Option Holders and Options
    Granted</span></a></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following document
previously filed with the Commission is incorporated by reference to the Company&#8217;s Current Report on Form 8-K as filed on
February 7, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 8%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 91%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">10.171</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020002946/f8k020420ex10-171_inter.htm"><span style="font-size: 10pt">Form
    of Amendment to Consulting Agreement for Jean Madar Holding SAS</span></a></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 119; Value: 81 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2019:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 8%"><b>Exhibit No.</b></td>
    <td style="width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: black 1pt solid; width: 91%"><b>Description</b></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>10.160</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-160_interpar.htm">Consulting
    Agreement with Philippe Benacin Holding SAS</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.1.1</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1i_interpar.htm">Restated
    Certificate of Incorporation dated September 3, 1987</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.1.2</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1ii_interpar.htm">Amendment
    to Restated Certificate of Incorporation dated July 31, 1992</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.1.3</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1iii_interpar.htm">Amendment
    to Restated Certificate of Incorporation dated July 9, 1993</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.1.4</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1iv_interpar.htm">Amendment
    to Restated Certificate of Incorporation, as amended, dated July 13, 1999</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.1.5</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1v_interpar.htm">Amendment
    to Restated Certificate of Incorporation, as amended, dated July 12, 2000</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.1.6</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-1vi_interpar.htm">Amendment
    to Restated Certificate of Incorporation dated August 6, 2004</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.3</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-3_interpar.htm">Articles
    of Incorporation of Inter Parfums Holdings, S.A.</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.3.1</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-3i_interpar.htm">Articles
    of Incorporation of Inter Parfums Holdings, S.A. (English translation)</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.4</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-4_interpar.htm">Articles
    of Incorporation of Interparfums SA</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">3.4.1</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex3-4i_interpar.htm">Articles
    of Incorporation of Interparfums SA (English translation)</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">10.25</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-25_interpar.htm">Employment
    Agreement between the Company and Philippe Benacin dated July 29, 1991</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">10.26</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-26_interpar.htm">Lease
    for portion of 15th Floor, 551 Fifth Avenue, New York, New York</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">10.61</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-61_interpar.htm">Lease
    for 60 Stults Road, South Brunswick, NJ between Forsgate Industrial Complex, LP, and Jean Philippe Fragrances, Inc. dated
    July 10, 1995</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify">10.61.1</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-61i_interpar.htm">Third
    Amendment to Lease for 60 Stults Road, South Brunswick, NJ</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">10.172</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-172_interpar.htm">Form
    of Option Agreement for Options Granted to Executive Officers on December 31, 2019 with Schedule of Option Holders and Options
    Granted</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">10.173</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000121390020005153/f10k2019ex10-173_inter.htm">Lease
    for Interparfums SA Distribution Center <i>(confidential information in this exhibit was omitted)</i></a></td></tr>
</table>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
previously filed with the Commission are incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2020:</p>



<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%"><span style="font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 1%; text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">23</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify"><a href="g083417_ex23.htm"><span style="font-size: 10pt">Consent of Mazars USA LLP</span></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">31.1</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex31-1.htm">Certification Required by Rule 13a-14 of Chief Executive Officer</a></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">31.2</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex31-2.htm">Certification Required by Rule 13a-14 of Chief Financial Officer</a></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">32.1</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex32-1.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">32.2</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex32-2.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">101</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">Interactive data files</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 120; Value: 81 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following documents previously filed
with the Commission are incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended
December 31, 2021:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">4.33</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/822663/000175392622000273/g082622_ex4-33.htm"><span style="font-size: 10pt">2016 Stock Option Plan</span></a></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">21</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex21.htm">List of Subsidiaries</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">23</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex23.htm">Consent of Mazars USA LLP</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">31.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex31-1.htm">Certification Required by Rule 13a-14 of Chief Executive Officer</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">31.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex31-2.htm">Certification Required by Rule 13a-14 of Chief Financial Officer</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">32.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex32-1.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">32.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="g083417_ex32-2.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exhibits Filed and Attached to this report:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following documents are filed with
this report, the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 6%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 85%"><span style="font-size: 10pt"><b>Description</b></span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 7%"><span style="font-size: 10pt"><b>Page Nos.</b></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">21</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="g083417_ex21.htm">List of Subsidiaries</a></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">23</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="g083417_ex23.htm">Consent of Mazars USA LLP</a></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">31.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="g083417_ex31-1.htm">Certification Required by Rule 13a-14 of Chief Executive Officer</a></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">31.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="g083417_ex31-2.htm">Certification Required by Rule 13a-14 of Chief Financial Officer</a></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">32.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="g083417_ex32-1.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">32.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="g083417_ex32-2.htm">Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer</a></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>




<!-- Field: Page; Sequence: 121; Value: 81 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="margin: 0"></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>g083417_ex21.htm
<DESCRIPTION>EXHIBIT 21
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 21</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIST OF SUBSIDIARIES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter Parfums Holdings, S.A.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums SA</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Philippe Fragrances, LLC</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums, USA LLC</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP Beauty, Inc.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parfums Rochas Spain, SL</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spain</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums (Suisse) Sarl</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums Luxury Brands, Inc.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums Asia Pacific Pte., Ltd.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Republic of Singapore</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter Parfums USA Hong Kong Limited</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interstellar Brands LLC</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Divabox SAS</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interparfums Italia Srl</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italy</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>g083417_ex23.htm
<DESCRIPTION>EXHIBIT 23
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the incorporation by reference in this
Annual Report on Form 10-K of Inter Parfums, Inc. and subsidiaries and Subsidiaries for the year ended December 31, 2022 of our
reports dated February 28, 2023 included in its Registration Statements on Form S-8 (No. 333-136988 and No. 333-216705) dated February
28, 2023 relating to the consolidated financial statements and consolidated financial statement schedules and internal controls
for the three years ended 2022 listed in Item 15(a)(2).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mazars USA LLP</FONT></TD>
    <TD STYLE="width: 65%; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February 28, 2023</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>g083417_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CERTIFICATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Jean Madar, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. I have reviewed this annual report on Form 10-K of Inter
Parfums, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. Based on my knowledge, the financial statements, and other
financial information included in this annual report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. The registrant&rsquo;s other certifying officer(s) and I
are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">b) Designed such internal control over financial reporting,
or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">c) Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures as of the end of the period covered by this report based upon such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">d) Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s
internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. The registrant&rsquo;s other certifying officer(s) and I
have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">a) all significant deficiencies and material weaknesses
in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: February 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s /Jean Madar</FONT></TD>
    <TD STYLE="width: 65%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar, Chief Executive Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>g083417_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Michel Atwood, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. I have reviewed this annual report on Form 10-K of Inter
Parfums, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. Based on my knowledge, the financial statements, and other
financial information included in this annual report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. The registrant&rsquo;s other certifying officer(s) and I
are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">b) Designed such internal control over financial reporting,
or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">c) Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures as of the end of the period covered by this report based upon such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">d) Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s
internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. The registrant&rsquo;s other certifying officer(s) and I
have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">a) all significant deficiencies and material weaknesses
in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: February 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s /Michel Atwood</FONT></TD>
    <TD STYLE="width: 65%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michel Atwood </FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and </FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accounting Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>g083417_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby certifies, in accordance
with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter
Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on Form 10-K for the year ended December 31, 2022, fully complies
with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report
fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 28, 2023</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jean Madar</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jean Madar,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A signed original of this written statement
required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>g083417_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby certifies, in accordance
with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter
Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on Form 10-K for the year ended December 31, 2022, fully complies
with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report
fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 28, 2023</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michel Atwood</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michel Atwood,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President, </FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and </FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accounting Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A signed original of this written statement
required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img001_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img001_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ^0)\ P$1  (1 0,1 ?_$ /$  0  !@,!
M       ! @,&!P@$!0D* 0$  00# 0               @$#! 4&!P@)$
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M2 !#D#CVZB8>''0.(CH4-> =@94#*[,":^,_@5)W6;E/ >Y^)2^:H::=WVZ
M(@8X"/+_ #=1 VHZ>#7*2-$N#^%:X8>6E*^ZHM:UH:T>BT8>!1%L@(ZB34?
M/,;@/C#RN _*&4R-[7M_^*&TKC@.@#@/(J=FS(8Z=1QJ?&INX2T$!( @;3F
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M.[5KZ3B'CG!8F-CBNTV[E3G$?[T_*!CCIH.1[WN\NV[WMUV<KXVPV4+BQI-
M7"1X))P;PIS4.Z+NK?W*[/OK:UE=<:C.SM7"AHUT;' !IS/XUY4\2\:.F7XK
MG6_<NLFH46VS\18:O>=Q0J4QMX>GMF:-;C"RJ[11>(<(E2EF2[-), 45<&5
MX@(^'._MX]R7=M9=V0U>UG@;J44)>"',S.<,<3VE7> $$#D%YN[O^_WO2U/O
M1.@:I;W!TQTV0@]H6M;TXQY?)3@OK"L>X5(I@1HW.W5JJ&E7)6$<%@FXV)+(
M/C@!BM6(OG*'G2XE_HDU'3CIGB/3M%U?6&.?I-K<7+6-S.[*-\F4=+L@-!X2
MO?>I;AV_HV4:O?V5JYYHT33Q1EQZ 'N:2?%X%=B#E)P7G2,)B:Z ?3R#<"F
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MPY6:-%T4U-0YQ !$.+C9\QC8[M8!+(TN8QSP'.;Q! -#CRP->E<CBWK9SYQ
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MZ8',<2V9KVR]GE+'!Q..(:<2,.-*+%VW'5BRLT0JRAX*][NST(\FS6AY4JQ
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M]SLN_CF9-9R6]Q#,]S*QR-< 64S5H:@"HQ(Q6^L=RPS.?'?-?;NCM^V)D:6
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MJ#,&-#8BSJEH  H3FQ&!/.M? N.V6T[K1YI+[;\K6:C+*3)VAS-Q(K1I80,
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M2$A,1?) ,3UV/C)>+>3#HR"R)"I<K@Q3IGS27>[+.ZB=!K$)DM#()&AI+2"
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MR&ME1G;;3Z_(6^NIR#4JZ";:6<M';QDX:"<2@9%8 #34HAKG2&K/W+LV_O\
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MH&S=*'AVA'J^/Y7&7/6'R/<,#4U]X#\BF>H0^E"*^^**;W0NFGC_ -C=*#B
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MKF,[:)-RAJW\V W8'*'9;=IT_;F0%N7)E%2*\^./'''\2S1K48%!",>.%/\
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M(1X7+=@?_P"3[CI\_I0<C)I,1&9MQ=OPP'K#^FG2I#4)PW%L8]P*([)P0?\
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MQ^G\'OJO]T:B7.<&6]74_P"#'A2O#J^'W@@[9P0ZZR-HXAR_^TTT&@?)H]
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ME"81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(J:W_-F_\GP@':8
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M<.=&O-/">K@$S,XU"Y1]Z*89BR=,7$U).I)9Z@A!QE?E7%D14C!*64!Y"&:
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M"8<CPVH%*A^4LH>/ID\<.2\&WOW;]]77?;/O%TH_MN:Y[42!\0=B[T2TN,G
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MPG7+C&6^@235^3XF:N7E3AA1>Q.ZK^Z;?NYTIN]VN_N1MFP2@TSB@ 9VE/\
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M$PB81,(F$3")A$PB81,(F$3")A$PB@8= $=-?D\?SY4<5%Q :2>"X2JFHAS
M*? /Z1=3&U#R0#4"F'_RLPBPR2YVM>6-XTJKKI8H6 /D8U[L!F('XROF8^+!
M\-OJSZD^I!+=C::,C+_39F$A8..AW<]&12M,>1S%HT=JN&DRX22!E(KI'<"N
MV[PW#02ZFU#VWW!=^?=YL[:9V_KS8[74+>.2KW,:73E\SWY3U0[JAPI4N\ 7
M@W[R'<KWE[WW0W5]NSSW6F32QEL3#)D@#8(V%P#7N'6(/!K<>97N=T<[36S8
M[IPV?VKO,JWE;73*G'0\TZ;.#OVIGR" "LBU?+E*JY1:F/W95.4G,!== SRQ
MO'6;'7-R76J6$(AMIWU:&T \= UO'CP7KSN]T._T/:5MI6KN,]];M +W5J#3
MAB7'WUM/G%US-,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3"+$N^VTE=WWVBOVT%K,HG 7^N2%=?N42D.X9 ]1,5!^V(
MI_='<,7($5(4_D&$FAM0$0S>[9W'=;1UZVW)9"MQ:29@* U!!8X8@@5:XBM*
MCB,5QK>&V[3=^VKO;=ZXMM[MC6DBN!:]KP<*'BT+RSZ*OA9[;= 5PMV_EDWF
MD+JZCZ?,1Q7TO$,*]!5NO*K-Y69EW2J;QVH[=G:QB8"(G31(4H@4@<PZ]X=Z
M'?QJG?#IEGMNUL1! '@N&<.,CRT-YTR"I<>JZ@KP  7G[NL^[WM[N9UB^W/=
M7CI)3#1A ?U&M<9/1  <11O$.)IQ-37=+ISZ^^F3JKM]FH^R6XA;58JFS2D9
M:.6@IN',,8LJ=L238*RC!LF_9"Z3$G.00X^#Q]5;J[L]\;.L(=3UVVABM)'4
MJV9C\<:"C22.%>C#BNW-G=[VPM]7+]/V]<SR7K2?3A>P&F/%P X+=$IM3&#7
M70 \ !VZYP1K@YQH<*+L@.QR\PI\FI)A$PB81,(F$3")A$PB81,(F$3"*F81
M VA1\'9IV?+KD79Q3(*BN)4007EI=C3A3WU146 A#B<W A3&,;@ :%#41$?!
MH 8DJQKI*]4#@KC87.8 ZA-<?%[B^:_XYUUZNJW:-HVFUS^_U_9M=+^]E=L)
M.>B)60O7I,!;QTV\KKIL\+RIE K5+F324U$3")@USUY]VK3>[2ZT>XGW7274
M@9"X%LA/9Y!EIV=* D'PUKCR7BC[TVK=ZECJUC%LQYALG0--08,9 ^3$]K4\
M W#$>!>O_P /A[O++](VSCW?XLG[25ZZ/I5:<.<TZNW3=NRQ3B:,8YU322D4
M1 5A.8QC'$=1$>.=$=Z\&W(.\'4F;68UNB";Z,93AU6YAUZN]/-2N*]%=S<V
MXI>[;2KC=#R_7Y+4&9W4-22:'J ,]&GH@!;K]TF)BF$OE%$1*.H\!$-!X .@
MZYUTUC6N+AQ=QY^2O#W%V2YC7D.-:@U%"1Y:<?=JJF24DPB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(I#@(@ %#PAQ\
M0!J.O@[=-/X<H2YHJT5*HYN9M*T_VK!?4=LPCU!;*;E[..Y9[7V^X%7DH$)J
M/,07$>NZ2'S=?NS&+WK8KDI>^3X=XEJ77CG(MI:[)M7<EMN*(-F?;R-=V;JY
M3E->(X5%5QG=N@'=NA7.@S2.MXY8GM;(VA=5S'LX5'#-7$C&F*\:_AM_"EW/
MZ/=[I_>?=:\5M:/BJW)P4%%U==ZFG()OE&ZKF1F%E%0($>T:M]2(G( E4#GX
M &>A^^3[P%CWD:#!H6CZ?&U\C@.J9"X'-6@#H8\2<*XBE1S!7E[N,^[OJ7=A
MN&XUS5[Z1UJQI(S-C:",E"3EF?2E>) Y+U$V[Z^>D'=#<YYM!0M]:98[ZV%5
M-*%:+/R>?N&IA3>-8N0=,&\;*.&I] ,1!90VH\ '0=.D=3[K=^:%HS-?U/3+
MF+2Y14..5U!3-BUKB\"F.+0%Z)TGO/[O-:UA^W]*U:VFUMA.:,9AP<&X/<T,
M<<Q H'DK<3O"<.(\>SR3:_-IKG PX$9@#3Q$?C"Y\7-:X-)Q*F 0'LU_A 0_
MC ,D<$#@[@HZX0$%,*J81,(F$3")A$PB81!'3B.":"J*05"AQ$1T_P#DF^CC
MEEUQ"VF9U*_A[GNJH!)H.*H**IZCY0@/*/\ 1-J %XF'LUT .W$D;P[M<SA&
M!P%2/'AA_L46/C,P8,I?XQ7Q+Y;/C+]6?6-M5U 56G[;3EUVPVTCHR.E*M.5
M=O))-K_9G?)YXVD'J*"R4EY@H4$DV*0\YC"(B&HY[7^[[LSNVUS;KKW<-Q:G
M4'L!<).P<6'/(,H$C7%O5#3R)S5.%*>#/O&[\[T-"W>RPV[;79TOMG#-'ZP
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M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"*!NP?R#D7^B?$JCBJ!_Z/Y
M_B#)P^@L2Y],>-3D[?X,@?UI\2N1IX3?Y>/,.W_7O\?G5Z3T4\.7;G]8SW?R
M*,7 JD/A_*.6[KBSW/QA68_SO=50.POY/IS*N?U9\:O0?JPIR]IOX/Y<F/0;
MXE<=P"GPHIA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
I")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img002_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img002_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!2@(P P$1  (1 0,1 ?_$ ,@  0 " @,! 0$
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M#M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M,8>@?/@$\8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@$"\6_\N>E/\-ZM_=:& 3U@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 0+Q;_RYZ4_PWJO]UH8
M!/6 , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8! O%O_+GI3_#>J_W6A@$]8 P!@# & , 8 P!@# & , 8 P!@# &
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MS6>\/=4SZ3A%MOG8<&<S<.2MVA'1$RN:W!N#'3J[5PF(&4 [HQ?]W@&^\H
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MU(SXL'(KQPTBJF8#)J:UJATS!Y&(>*;F*8.O0>@E' )\P!@# & , 8 P!@#
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M9G#BRN(>\R$1'R',+?-?=D%'C/J2P$'I6V+Y#W02W+L6*]PD8T\%F+-4'AP
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MK-=-:))V.&V;3XG86M[$PBW"0&:66,9Q%BO];L9&#1;W/92;)F,<O7U!T$,
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M!:.-A8:&3!&(B8R*2*7T E&L&K%,"]"!Z0(U22*!>B9?#IT_=#Z, ]/ & ,
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M4C8D#&4;4^F,51$K2)8 F@D0 $_K/^]@%^, 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8!%.\6.T)/46PXW2QJXGM21JLNQHRMN?OHNMH6!VU.@R7EW\;'R
MK]LT1.?U"=)NJ<!#J!1P#6W;^,'(V6XY/M&5/1_'RI6%O5ZXC5]M--H3 W:*
MV11))&WT3:,C((:L;N9J>A-DM4YY4BJOMN71UBFZ%6. @;7*J:R&K%=-<4XM
M&VF@XDUH1A%EW$,E818H#,IQ*[E)!RM&DD?<! ZA"',D!1,4!ZA@'O8 P!@&
ML;FUVP:!SBV+K2WWS=N\JK3*Q($3V9I2OVHLCJC<%71K=RKZ4,[K=A1DDM=3
M;E&YN$'TS7!8/).,.=JZ!50K-TRWX64>'YA\JU]17IOC59HU#(A=A756*S3N
M]J%F%3;+%4U39="%C23R:\GKR-]N=P,N&I?T][FM,BO6-JJDIJVMI/9*4XV2
MC"Z47=2I254U[=MDK7Q!U5:]T<=]X*.K7"6'C'7;?5]<5V ?P[6GK1%SCX>,
MD$;"P>0+^7>F8M81$&HMGS,"")A4!3J'21CYN31R?(\NY=S,Y/#CCW.7[D;9
MW;H;=K4W*;3;<EMT2BGU(4\6B7"XG 5Q[?'X69'(KV_-OA7VU&3ENUAM?5:*
M3?7=\")%NW5K*:VXVV9L#</(W;=7AK9+WZFZ(VKL*"N6G:)=YMFHP>V*MB]I
M2>UEB(MEC SBY*U2$''F'U-62)O'(.'75B8;Q;(QOO\ I+L6%UG6Z&/>FK:U
M*&R,W.+<'==&V]1]JM22)6=.6;:YI]FJ611?.NOI7.W&DITRVRW=M1FE-PI=
M5<Y+6<)=4_6XY=OG3?&C8JNR:K:=GW&1B*?.ZXU9!;"EZC)5W1NM+/9FEPL.
MOM7IUND56;"O2EBCVZQE)]]/2**3=-L@Z2:D!'+&GD<NKCK<"4NY;D+%C=?)
M?G70PJYU8E=CCMKVT0LFDX5PG9)J=\[9QC)0<C"JR.0CG.5D:*[LBZ%"DW3#
M(RY;LJ]*6Z;LNEKKOLE"M2FJ851G).]?3Y?_ $"&0280-Q;_ ,N>E/\ #>K?
MW6A@$]8 P!@# & , _@Y=-F39=X\<(-&C9(Z[ETZ530;MT$BB=19==4Q4DDD
MR@(F,80* >/7 -3NTN\1QQ8W"8U!Q.J>SNX)OJ(.X9/-><38)K;J?6Y9/UE2
M:;&W[,/(C1U 2%<GI6^)FUGB >(MC")0,!&J6E^[WS%61>[ZY :X[<FFGQ@5
M6TKQ*8-]Q\DG\<HF #&VWDSLF*;T2JO#]1!3[-U!51+Q*F^,( K@%H>/?:IX
M.<<;2&RZYIQMLG=ZB@KO>0G(*<F=][S>.S)*HJND-B;/=V*5K@*I+J%%O#!&
MLRE4,4J)0,(8!;[9>CM/;E^I/YKZUINPAK1Y!2OFMD$QF3PQY4C5.3&-.\24
M.T%^FQ1!;T"'N D7U=?2& 8-7>(/%RI6&$ME:T%JJ&LM:?\ UI7IQC38=*2A
M9+X9RS!_&.?AA49/"M'BJ8*)B4X$4, #T$< L;@# & , 8 P!@# & <=0^7Z
ML A;>>[X/1U7B)9[!SMSM=RLS"B:RUQ5 CAMFQ[]+-7[^.J\":8?1<,S,G&1
M3Q^^>/7+=G&Q;%T[74*B@<< I<GW$E]2R(+\TJCH;C[KV3O=AU[%[;U_RNA]
MT4.GVB 9'?J5?>[JU:KT1)ZFMBZ;==$Z;5M8H9F\1!NYE$EG#,CD# )[OJ]L
MY"UN*!K/>5AY,[!;1:\P:D\3--;CY*RXL416(507^HZ-9ZRW,X<(^V0%I!+]
MX0,;TI_OX!7SEUR=[Q6\=?:"D>V]PYL6G37^4EI[9LWRD?:3JUHJ-*B7S,L+
M%.(UWLBXO*98+LR6.JF!ZI9%F:9#)N$6RH@( =>.?"KN'Q7+&6Y>6K7O;DX\
M7/9DY!)[DL;5UR=YE<@[#K1@O _6>MJ?LV^6O15(T]$R3*.7_P"$@X%>+2>G
M(Y%NKT.F8#9IRUXB3?*U.F1S7EMROXU5VN%FDK%#<8+I0M>NMAM9D(XOP]CM
ML]K2Y72(-'HL3IMUH.0BG")7*IB*%6]M5,"M%)[+/!RM6.O7.ZM.1'(*Y5:1
M83,+8>2'+3DCN+X:<C%TG3.:4K=EV6:E.I)%R@0Y3J1A@((?N 7J/4#9M8:%
M1[=]6?:RG5:T?4BOQ$-]HZ]$3@Q+CT>W\1&_6;-U\"O[?[OK2])NGAUZ8!3?
MD/VQ>"G*&51M>U..],2V0Q!K]3;DUN:5T[NZ!58K*.&"L-N#5,C3]A-"LUUC
MB5+ZP,W,550ATSIJ*$,!5Y#M[\[]$$,3A]W3MIOJX@LH9CJ[G?JFH\LJZT8E
M%0S&&C=G5R3TCNYLW9$]#<KF4G)UTHW( K&67ZKF _JCMKOH:W16;V[AYV_>
M3!F9C)HSNG.66X./KFP()&])'IJ;M'C]M9K673PIP.+3[02:;<2F+\2J'I.(
M'Z!YR]T,'P01NRI?!E!,5J-C3YT\5CZS!T9,!^+^O5'*.Q!@"*&Z&7^R7QO0
M!$&0^ "!3;F5R?[K$95-2["VYI'M[< -=P&ZJ2Y<[8WMRSO>^XJE2CM5Y%P[
MNRPM8T]H>M.8TT@X*(^JRL@4%1-(# 8PX!2CDDEQ'Y'Z0V XY<]\*@<[MN2K
M-JAKOC+I/;>L=!<<WELDK-%I0%=B-&:KN<YL';+QN8Z*+=&S66=!VX RGPQ?
M<*DF!]=.K:/3M=:^J%-H53KM(JL%7XIE$5BJPL=7H**;ILD !NQB(ILT8LTR
MC_LD3*'7S\< S_ & , 8 P!@# & , 8 P!@# & , 8 P!@# & , ?+Y?JP#C
MI\OU?T8!S@# & , 8 P!@# & 0+Q;_RYZ4_PWJO]UH8!/6 , 8 P##KYL*B:
MMK$I==DW&LT.H0C91Y+6:W3<=7X2/;I%]1U'4E)N&S5( #R 3=1'P !' -15
MA[KUMW[(.J1VQ>-UJY8S1W#J+/OFZ?66J>*U4D$#KHG>2-TEV!+1=V;=9L8H
MD@V*A%!]/I< 4WK #\\;VO-P\GY!M;NZ#RDMN_V/N@]:\6-0+RFFN)L$J9PU
M7*RFZC7Y$MDVU\*5BF4%+/(R*(B=;THD*H)0 VQ:HTSJ;15.B-?::US3-84F
M!9H,(>L4>NQ=;AH]HV2(BB@W8Q;9L@0B::8 'A\V 29^? & , 8 P!@# & ,
M 8!QUP#@YR$(90Y@*0@&,<YA I2%* B8QC#T I2@'41' *G3W.WA]7-N5/0K
M[D+K9YN6[RP0E<UO7)D;?:G,F*9U10?QM30FU(%---,1.J_%JB3P]1PZAU C
M+E_N'G+3K%7J/Q"T'IBW&L,(_>R.XM];4D*K1*9)-U4BIL5*-6XHUHN+@&8J
M.130D6("5(2^L.OJ #Y\]I;DY9[7=5/E-1.8I.:G(#AOR,HC#5W%OC[HYKIW
MCK:-N[FC[]Q[?5N+V;<6;RR[ 4K55O4^::<H3CQHTCFJXJII (J% @B:[;=Z
MY-;_ .WG=]^<?[!Q=BI1YKU'EVML77NG[G*W#DY1)R1V>V?1^TCEM\XZ?[I;
MUGX*S+MR0K%55/VBJ.3.R$*!];^A^$_%'C'8KS;]#:$UEK"V;*E5YF\V:J52
M)BYZROG"IEU!DI5NV(\6;%5.(D1]?M)]?W2A@%I/E\OFP!@# & , 8!QTP#G
M ..GR_9@'YGC%E((F;/VC5\W,)3&;O&Z+E 3$$#%,*2Y#IB)3  AX> A@'E$
MJE73.11.MP":B9@.0Y(>.*<ARB!BG(8&P&*8I@Z@(#X8![X>'@'D& , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8! O%O_+G
MI3_#>J_W6A@$]8 P"-MJ[BU9HZHR5]V_?ZKKJGQ*"CA]/VR89Q#%--(OJ.5,
MSE0AW*W3R32*=0WS . :E)/N3<AN6,@[J/;$XYR-\@B.E(^2Y7[[9RNOM!PY
MDEU6SM>IQSM%O9-C.V:J(B!6I"(G*8!ZB& 9!1^TG&[+ML3M_N'[IMW,_9K%
M4LA'TJ=46KG'BF/#&!0&U6U1'*I1+Q%H/[I%GQ5%3^D#&#K@&W>N5BN4^&95
MZIP,16H*.2(@PAX*.:14:S1( %*FW9,DD6Z10*'S%# /=P!@# & , 8 P!@#
M & , K!R6YE\:^(4+&S/(+:D!0AGO>+6H-T9=_:+2LW$A%6];KD<DZE9=8AU
M"E'VDQ*43!U$.N 4WUMW#=[\B=ETR-T)PCVK$Z#?VF,:7'D5R#<--0P2%46=
M)A(2M*IDL(6:RR LA$S4@@0JJBB8"'B(8!@?-%UQ3Y;;;G]$RO)O>%DN&CM=
MVZRW_AWQIN<U 2.P%8)=J_=1%P5KR*:CV<<)N&[-&-4=)&.BL/AT.(X!'&A.
M*FU3\?XM]PLXK:J[8^PWU]<D?6#==.A-M[9<Z]4(512R))H"Z4C;C**B/K0D
M%S%+UZC@&PIMP/U7.;QH?)K;$W=]H[OHE8K\/%2,Q:)5CKZ.FX=F=![:H#6;
M!PE6H>6EUUCG6,!% $! O3H& 2KMCB/QIWC3837NTM,4>TTFMVT+Y ULT8,/
M&Q-R!C-QOVC9)U]:).C*&8V1^F90#=3 Z4Z]1'K@$,USMB\#*G9*Y;H#C51F
M%CJ4Y&6:N2@N[0[5B)^&<%>1<JT2?3[EN#MBZ(!TS&(;H(8!?' & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8!_(ZZ*1DR**IIG6/[2)5#E(990"&4%-(IA RA_;()N@=1Z (_-A:OHO737
M]GW_ *NJ_P 1^GX:Z?XG].H>6/AJ#CU!F/0'/7\^$]?0QJ=#JII]!44(3KU$
M/68I>O3SZ=1\>F9,D"<65T#\=-* 19(X_P N*L'0JA##X1B #X 8< ]'>W)'
M1/&2DR&Q=][4I>K*?&$,9>7M\ZPB$U3@ B1LR1<K$</WBXAT311*=10P@!0$
M< U8K<]N:'-0#1';9XUN*OK"3.=FGS1Y:1TOKW6:351-4 G]9ZI<((;)VHDF
M;T&14*U91JX&Z@Z , E74_:;UNK98C;?-/9]ZYU[QCWJTNUF-Q'0:ZBI\DNK
M[Y6^O=(QAAI\6RBC"9)JK(A)O/: !,IZO' -KC%@RC&;:/C6;2.8,T2-VC%B
MW2:-&J"10*DBW;($31113*  !2E  # /UX P!@# & , 8 Z_+_3_ *L 8!P)
M@ !$1Z '41$1  \//Q'P#I@$![0Y4<;M*R=>A=L;RU=0)JV6"#JM:A[1=(&)
ME9RPV220B82(C(]T]([=O9!^Y(1,A""(]1'R 1P"#^<')/?W'^N4\_'_ (^Q
M&YYFX.9=I)6FZ[7I&I=7:R28IL!:2MYG[-))RZ[5^9Z<4DXQD^5'X<Q3 43$
M]0&J6M[GY-["Y@Z[T9R8Y\1U:VBD:)O!N*G!#35HMU>9Q*[09N%9[CW[9821
MCXF$F&@ F599G&(.1-T*KX@. 7T=-.5W*J/V)95>)NI^*^UJ&Y4K_&W<O(N.
MH.[K2E'NY84[/.-ZM39-_*5./D8YHFHW1&3:JKJ'(*A  @X!G+OM^%W#$<>9
M/E[O;:.ZMC:(<S<RL[HD[+Z0UA?K/(VII8X2;MNN:G+/',NM3FL:V8L4EY51
MJ=(%3JHF,J )@7H@-=T&J3%@L58I%1KEAML@I+6N=@ZW#Q,S9I55)!!63L$F
MP9H/9F051:IE.LX.HJ8J90$W@& 9E@# & , 8 P!@# & , 8 P!@# & , 8
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M_3@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MI<MSHKE+65=#E[G3!QK<NKCJ3L[,R>0G59DS;G5*N6L?;OE5_"E=MT[TJO\
MXI6[G7^!H]'2'"GCMQWN]EV'JRG2419K*QD(<JLO<;A:HVIUZ7FPLTQ5=<0E
MFFY:'UM4YBQE"0=QD&BP8N'A0642,H &SK3EY-'&OBH3D\63JWN7NLL6/"56
M/&RV6MED,>N<J\>$Y.-,)2C6HIM%7;@XMW(KE9P2RD['%+VUPG<XROLA4M*X
M67RC&5UD8J=KBG.4FB!^8';E8\K-]:(Y(PO)??''+:7'R"M,!2YG32.JG23E
MM;G+9:56EVVR]<WU)54S9 [7HD"2:C5=5-0IRG, QR651XJ]KQQ,WWA_S0VM
MS.Y,;CN&F-<LD]?Z^MD=HF$UO"1\_"';O8Y",HFH*I+$2,5SU,J5X#A84R>Z
MH<"@& ;T#)E/X*%*<O\ ]4Q0$ ^;Y^N ?F48,E3E559M%%"].BAVR)S@ >0
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MO9(F9905 -_#=LW:I^TV01;I!Y)H))I$+^8B92D#]6 ?WP#CIX_L_+]. <X
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , @7BW_ESTI_AO5?[K0P">L 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP#C,:?<"JDSPDXNS_(F%Y6RNG:F[WM 1+F(C[R=B4'GMN#E-\:Y:A_PCN61
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 0+Q;_RYZ4_PWJO]UH8!/6
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# .
M.H?2& <X P"!>+?^7/2G^&]5_NM# )ZP!@# & , 8 P!@# & , 8 P!@# &
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M8\^9M7R-J?5:H,1$ 4H&)'K*5DS\P&ZF%V]6'R$, R?[;=Q7[D>.WXBV+^C
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M 9Z#S*RBSG9=C3VT8\9Z?\R%%<9K]:DFG^E/4\OXQ'_0W6UQ<<.W-R9TI_\
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M< [" #X" "'T"'T>7ZL = Z]>@=?+KT\>GY\ YP!@# & , 8 P!@' @ ].H
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M%,AO$Q""(>0B4!Z?K# .1(00Z"4HAY]!* A^KITP !2@'I I0+]   !^H/#
M.WE@# & , 8 P!@#  @ ^ AU#Z!P#J)"&Z>HA3=/+J4!Z?FZAX8 ]!1#TB4H
ME^CH'3P_)TZ8!Q[:?3I[9.G7KT])>G7Z>G3IUP#L!2E#H4 *'T   'Z@P#G
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M)Z1^_5I'[&/_ ' &^2<9-@W.5XHZY>\HM1\Z]*\,+OI^H;=&Q:_E7VZVJ[N
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M4S?1@%=-:=T'M[[CO4%K'5W+S2-ZV#9GHQL!4:[;FSZ:EGX 8PM&30A ,LL
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MVBN4FU9796UM"T+CEK%=R^2GXQA!3L-&;6LMIF;%$O7L(R]A-^@S3]@3 <J
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M>O\ P^W^('Y_ZOS?ZP\_R?LS1?#[?;_AH9^/V^VO^8^?YOD/R_3F?B_M]O\
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C/B'\H_7Y_-A&7_D<&\P_;Y?HS'Q?V?V_\1]WV^W_  U/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>ipar-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9qw5o7xRiXgen8uEZ3ZcSaSOCaOdz511uZlBtWlwHXn6nysnHoK5+yX2FJAWgWsL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ipar="http://interparfumsinc.com/20221231" elementFormDefault="qualified" targetNamespace="http://interparfumsinc.com/20221231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://interparfumsinc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfIncome" id="StatementsOfIncome">
	  <link:definition>00000004 - Statement - Consolidated Statements of Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" id="StatementsOfComprehensiveIncome">
	  <link:definition>00000005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
	  <link:definition>00000006 - Statement - Consolidated Statements of Changes in Shareholder's Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" id="CompanyAndItsSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - The Company and its Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" id="ImpactOfCovid-19Pandemic">
	  <link:definition>00000009 - Disclosure - Impact of COVID-19 Pandemic</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/RecentAgreements" id="RecentAgreements">
	  <link:definition>00000010 - Disclosure - Recent Agreements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Inventories" id="Inventories">
	  <link:definition>00000011 - Disclosure - Inventories</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
	  <link:definition>00000012 - Disclosure - Fair Value of Financial Instruments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" id="DerivativeFinancialInstruments">
	  <link:definition>00000013 - Disclosure - Derivative Financial Instruments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" id="PropertyEquipmentAndLeaseholdImprovements">
	  <link:definition>00000014 - Disclosure - Property, Equipment and Leasehold Improvements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" id="TrademarksLicensesAndOtherIntangibleAssets">
	  <link:definition>00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccruedExpenses" id="AccruedExpenses">
	  <link:definition>00000016 - Disclosure - Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/LoansPayableBanks" id="LoansPayableBanks">
	  <link:definition>00000017 - Disclosure - Loans Payable &#8211; Banks</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebt" id="Long-termDebt">
	  <link:definition>00000018 - Disclosure - Long-Term Debt</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Commitments" id="Commitments">
	  <link:definition>00000019 - Disclosure - Commitments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Equity" id="Equity">
	  <link:definition>00000020 - Disclosure - Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" id="NetIncomeAttributableToInterParfumsInc.CommonShareholders">
	  <link:definition>00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" id="SegmentsAndGeographicAreas">
	  <link:definition>00000022 - Disclosure - Segments and Geographic Areas</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000023 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" id="AccumulatedOtherComprehensiveLoss">
	  <link:definition>00000024 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" id="NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest">
	  <link:definition>00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" id="ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows">
	  <link:definition>00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" id="ScheduleIi-ValuationAndQualifyingAccounts">
	  <link:definition>00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" id="CompanyAndItsSignificantAccountingPoliciesPolicies">
	  <link:definition>00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" id="CompanyAndItsSignificantAccountingPoliciesTables">
	  <link:definition>00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000030 - Disclosure - Inventories (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
	  <link:definition>00000031 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" id="PropertyEquipmentAndLeaseholdImprovementsTables">
	  <link:definition>00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" id="TrademarksLicensesAndOtherIntangibleAssetsTables">
	  <link:definition>00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
	  <link:definition>00000034 - Disclosure - Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebtTables" id="Long-termDebtTables">
	  <link:definition>00000035 - Disclosure - Long-Term Debt (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CommitmentsTables" id="CommitmentsTables">
	  <link:definition>00000036 - Disclosure - Commitments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/EquityTables" id="EquityTables">
	  <link:definition>00000037 - Disclosure - Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" id="NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables">
	  <link:definition>00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" id="SegmentsAndGeographicAreasTables">
	  <link:definition>00000039 - Disclosure - Segments and Geographic Areas (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000040 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" id="AccumulatedOtherComprehensiveLossTables">
	  <link:definition>00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" id="NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables">
	  <link:definition>00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" id="ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables">
	  <link:definition>00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" id="ScheduleIi-ValuationAndQualifyingAccountsTables">
	  <link:definition>00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" id="ScheduleOfLanvinBrandNameForOurClassDetails">
	  <link:definition>00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" id="CompanyAndItsSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" id="RecentAgreementsDetailsNarrative">
	  <link:definition>00000047 - Disclosure - Recent Agreements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" id="ScheduleOfInventoriesDetails">
	  <link:definition>00000048 - Disclosure - Schedule of inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" id="InventoriesDetailsNarrative">
	  <link:definition>00000049 - Disclosure - Inventories (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" id="ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails">
	  <link:definition>00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" id="DerivativeFinancialInstrumentsDetailsNarrative">
	  <link:definition>00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" id="ScheduleOfEquipmentAndLeaseholdImprovementsDetails">
	  <link:definition>00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" id="PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative">
	  <link:definition>00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" id="ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails">
	  <link:definition>00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" id="TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" id="AccruedExpensesConsistOfFollowingDetails">
	  <link:definition>00000056 - Disclosure - Accrued expenses consist of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" id="Long-termDebtConsistsOfFollowingDetails">
	  <link:definition>00000057 - Disclosure - Long-term debt consists of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" id="LoansPayableBanksDetailsNarrative">
	  <link:definition>00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" id="Long-termDebtDetailsNarrative">
	  <link:definition>00000059 - Disclosure - Long-Term Debt (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" id="MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails">
	  <link:definition>00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" id="MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails">
	  <link:definition>00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" id="CommitmentsDetailsNarrative">
	  <link:definition>00000062 - Disclosure - Commitments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" id="FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details">
	  <link:definition>00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" id="EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails">
	  <link:definition>00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" id="FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details">
	  <link:definition>00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" id="AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails">
	  <link:definition>00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" id="ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails">
	  <link:definition>00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" id="FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details">
	  <link:definition>00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
	  <link:definition>00000069 - Disclosure - Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" id="ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails">
	  <link:definition>00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" id="NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative">
	  <link:definition>00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" id="InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails">
	  <link:definition>00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" id="NetSalesToCustomersByRegionAreAsFollowsDetails">
	  <link:definition>00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" id="NetSalesToCustomersInMajorCountriesAreAsFollowsDetails">
	  <link:definition>00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" id="SegmentsAndGeographicAreasDetailsNarrative">
	  <link:definition>00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" id="ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails">
	  <link:definition>00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" id="ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails">
	  <link:definition>00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" id="TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails">
	  <link:definition>00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" id="DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails">
	  <link:definition>00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000080 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" id="ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails">
	  <link:definition>00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" id="ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails">
	  <link:definition>00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" id="FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details">
	  <link:definition>00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" id="ScheduleOfValuationAndQualifyingAccountsDetails">
	  <link:definition>00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ipar-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="ipar_ProductSalesConcentrationRiskMember" name="ProductSalesConcentrationRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_MontblancMember" name="MontblancMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_JanvinMember" name="JanvinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_JimmyChooMember" name="JimmyChooMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CoachMember" name="CoachMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_GUESSMember" name="GUESSMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_InterparfumsSASubsidiaryMember" name="InterparfumsSASubsidiaryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EmanuelUngarMember" name="EmanuelUngarMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DonnaKaranAndDKNYMember" name="DonnaKaranAndDKNYMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RochasFashionMember" name="RochasFashionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_SubtotalMember" name="SubtotalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RochasFashionBusinessMember" name="RochasFashionBusinessMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DomesticSubsidiariesMember" name="DomesticSubsidiariesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LondonInterbankOfferedRateMember" name="LondonInterbankOfferedRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ForeignSubsidiariesMember" name="ForeignSubsidiariesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EuroInterbankOfferedRateMember" name="EuroInterbankOfferedRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LoansPayableOneMember" name="LoansPayableOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LoansPayableTwoMember" name="LoansPayableTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LoansPayableThreeMember" name="LoansPayableThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OperatingLeaseMember" name="OperatingLeaseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_StockOptionOneMember" name="StockOptionOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_InterparfumsSAMember" name="InterparfumsSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EliminationsMember" name="EliminationsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CentralAndSouthAmericaMember" name="CentralAndSouthAmericaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherSegmentCountryMember" name="OtherSegmentCountryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_UnitedStatesMember" name="UnitedStatesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_FranceMember" name="FranceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RussiaMember" name="RussiaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_UnitedKingdomMember" name="UnitedKingdomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ForeignDerivedIntangibleIncomeMember" name="ForeignDerivedIntangibleIncomeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" name="AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" name="TransferOfSubsidiarySharesPurchasedToTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_NetDerivativeInstrumentLossNetOfTax" name="NetDerivativeInstrumentLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ProvisionForDoubtfulAccounts1" name="ProvisionForDoubtfulAccounts1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ChangeInFairValueOfDerivatives" name="ChangeInFairValueOfDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_SupplementalDisclosureOfCashFlowInformationAbstract" name="SupplementalDisclosureOfCashFlowInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DisclosureImpactOfCovid19PandemicAbstract" name="DisclosureImpactOfCovid19PandemicAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ImpactOfCOVID19PandemicTextBlock" name="ImpactOfCOVID19PandemicTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" name="DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" name="ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" name="ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RoyaltyExpenseNetSalesPercentage" name="RoyaltyExpenseNetSalesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DueVendorsNotYetInvoiced" name="DueVendorsNotYetInvoiced" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_NumberOfInstallment" name="NumberOfInstallment" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" name="LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" name="LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OperatingLeaseOfRelatedToRentalExpenses" name="OperatingLeaseOfRelatedToRentalExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_PercentageOfIncreaseInAnnualDividend" name="PercentageOfIncreaseInAnnualDividend" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" name="DeferredTaxAssetsInventoryAndAccountsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredTaxLiabilitiesBuildingExpenses" name="DeferredTaxLiabilitiesBuildingExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" name="DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" name="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" name="AccumulatedOtherComprehensiveIncomeLossNetOfTax1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" name="AccumulatedOtherComprehensiveIncomeLossNetOfTax2" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CashHeldInEscrowIncludedInOtherAssets" name="CashHeldInEscrowIncludedInOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_SalvatoreFerragamoMember" name="SalvatoreFerragamoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_InventoryMember" name="InventoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherAssetMember" name="OtherAssetMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OfficersAndManagersMember" name="OfficersAndManagersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_SalvatoreFerragamoSAMember" name="SalvatoreFerragamoSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_NetIncomeLossAttributableToNoncontrollingInterest1" name="NetIncomeLossAttributableToNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1" name="OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1" name="OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OperatingLeasesRentExpenseNet1" name="OperatingLeasesRentExpenseNet1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_InvestmentIncomeInterestAndDividend1" name="InvestmentIncomeInterestAndDividend1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1" name="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" name="CashAndCashEquivalentsPerStatementOfCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DiscriptionOfRecentAgreement" name="DiscriptionOfRecentAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_AnnaSuiCorpMember" name="AnnaSuiCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_CashHeldInEscrow" name="CashHeldInEscrow" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_STDupontMember" name="STDupontMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_GlobalSettlementAgreementMember" name="GlobalSettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" name="OperatingLeasesFutureMinimumPaymentsDueInSixYears" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_Covid19Description" name="Covid19Description" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_RevaluationResultedInReductionOfCostDescription" name="RevaluationResultedInReductionOfCostDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_UnrealizedGainOnMarketableEquitySecurities" name="UnrealizedGainOnMarketableEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_BuildingExpenses" name="BuildingExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_EURMember" name="EURMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_USDMember" name="USDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ScheduleOfInventoryCurrentTableTextBlock1" name="ScheduleOfInventoryCurrentTableTextBlock1" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest" name="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs" name="OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne" name="OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1" name="OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1" name="ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossBeforeTax1" name="OtherComprehensiveIncomeLossBeforeTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1" name="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1" name="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ComprehensiveIncomeNetOfTax1" name="ComprehensiveIncomeNetOfTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract" name="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_DeferredIncomeTaxExpenseBenefit1" name="DeferredIncomeTaxExpenseBenefit1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_IncomeLossFromEquityMethodInvestments1" name="IncomeLossFromEquityMethodInvestments1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1" name="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_IncreaseDecreaseInAccountsReceivable1" name="IncreaseDecreaseInAccountsReceivable1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_IncreaseDecreaseInAccruedTaxesPayable1" name="IncreaseDecreaseInAccruedTaxesPayable1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_IncreaseDecreaseInInventories1" name="IncreaseDecreaseInInventories1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_IncreaseDecreaseInOperatingLeaseLiability1" name="IncreaseDecreaseInOperatingLeaseLiability1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_ScheduleOfValuationAndQualifyingAccountsTableTextBlock" name="ScheduleOfValuationAndQualifyingAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ipar_USExportMember" name="USExportMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>ipar-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://interparfumsinc.com/role/Cover" xlink:href="ipar-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheets" xlink:href="ipar-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:href="ipar-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfIncome" xlink:href="ipar-20221231.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:href="ipar-20221231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="ipar-20221231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:href="ipar-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:href="ipar-20221231.xsd#ImpactOfCovid-19Pandemic" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreements" xlink:href="ipar-20221231.xsd#RecentAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Inventories" xlink:href="ipar-20221231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:href="ipar-20221231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:href="ipar-20221231.xsd#DerivativeFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpenses" xlink:href="ipar-20221231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanks" xlink:href="ipar-20221231.xsd#LoansPayableBanks" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebt" xlink:href="ipar-20221231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Commitments" xlink:href="ipar-20221231.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Equity" xlink:href="ipar-20221231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreas" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxes" xlink:href="ipar-20221231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="ipar-20221231.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:href="ipar-20221231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" xlink:href="ipar-20221231.xsd#ScheduleIi-ValuationAndQualifyingAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesTables" xlink:href="ipar-20221231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="ipar-20221231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:href="ipar-20221231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtTables" xlink:href="ipar-20221231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsTables" xlink:href="ipar-20221231.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityTables" xlink:href="ipar-20221231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreasTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:href="ipar-20221231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="ipar-20221231.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:href="ipar-20221231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:href="ipar-20221231.xsd#ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:href="ipar-20221231.xsd#ScheduleOfLanvinBrandNameForOurClassDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:href="ipar-20221231.xsd#RecentAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:href="ipar-20221231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:href="ipar-20221231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="ipar-20221231.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="ipar-20221231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#AccruedExpensesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:href="ipar-20221231.xsd#Long-termDebtConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:href="ipar-20221231.xsd#LoansPayableBanksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:href="ipar-20221231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:href="ipar-20221231.xsd#MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:href="ipar-20221231.xsd#MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:href="ipar-20221231.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:href="ipar-20221231.xsd#FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:href="ipar-20221231.xsd#EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:href="ipar-20221231.xsd#AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:href="ipar-20221231.xsd#ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:href="ipar-20221231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:href="ipar-20221231.xsd#ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:href="ipar-20221231.xsd#InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreasDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:href="ipar-20221231.xsd#ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:href="ipar-20221231.xsd#DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipar-20221231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:href="ipar-20221231.xsd#ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfValuationAndQualifyingAccountsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaapIncomeTaxesReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapIncomeTaxesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="loc_us-gaapImpairmentOfLeasehold" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapImpairmentOfLeasehold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaapReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholder&apos;s Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ProvisionForDoubtfulAccounts1" xlink:label="loc_iparProvisionForDoubtfulAccounts1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_iparProvisionForDoubtfulAccounts1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:label="loc_us-gaapProvisionForLoanLeaseAndOtherLosses" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ChangeInFairValueOfDerivatives" xlink:label="loc_iparChangeInFairValueOfDerivatives" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_iparChangeInFairValueOfDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="loc_us-gaapProceedsFromSaleMaturityAndCollectionsOfInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - The Company and its Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:title="00000009 - Disclosure - Impact of COVID-19 Pandemic" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreements" xlink:title="00000010 - Disclosure - Recent Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:title="00000012 - Disclosure - Fair Value of Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:title="00000013 - Disclosure - Derivative Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:title="00000014 - Disclosure - Property, Equipment and Leasehold Improvements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:title="00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpenses" xlink:title="00000016 - Disclosure - Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanks" xlink:title="00000017 - Disclosure - Loans Payable &#8211; Banks" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebt" xlink:title="00000018 - Disclosure - Long-Term Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Commitments" xlink:title="00000019 - Disclosure - Commitments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Equity" xlink:title="00000020 - Disclosure - Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:title="00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:title="00000022 - Disclosure - Segments and Geographic Areas" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:title="00000024 - Disclosure - Accumulated Other Comprehensive Loss" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:title="00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:title="00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" xlink:title="00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:title="00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesTables" xlink:title="00000030 - Disclosure - Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:title="00000031 - Disclosure - Fair Value of Financial Instruments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:title="00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:title="00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:title="00000034 - Disclosure - Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtTables" xlink:title="00000035 - Disclosure - Long-Term Debt (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsTables" xlink:title="00000036 - Disclosure - Commitments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityTables" xlink:title="00000037 - Disclosure - Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:title="00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:title="00000039 - Disclosure - Segments and Geographic Areas (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:title="00000040 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:title="00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:title="00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:title="00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:title="00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:title="00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:title="00000047 - Disclosure - Recent Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:title="00000048 - Disclosure - Schedule of inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:title="00000049 - Disclosure - Inventories (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:title="00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:title="00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:title="00000056 - Disclosure - Accrued expenses consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaapAccruedAdvertisingCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedAdvertisingCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DueVendorsNotYetInvoiced" xlink:label="loc_iparDueVendorsNotYetInvoiced" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_iparDueVendorsNotYetInvoiced" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapCustomerRefundLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapCustomerRefundLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:title="00000057 - Disclosure - Long-term debt consists of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:title="00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:title="00000059 - Disclosure - Long-Term Debt (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:title="00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:title="00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:title="00000062 - Disclosure - Commitments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:title="00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:title="00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:title="00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:title="00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:title="00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:title="00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:title="00000069 - Disclosure - Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:title="00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:title="00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:title="00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:title="00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" xlink:title="00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:title="00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:title="00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:title="00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:title="00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000080 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:title="00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:title="00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:title="00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" xlink:title="00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>ipar-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://interparfumsinc.com/role/Cover" xlink:href="ipar-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheets" xlink:href="ipar-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:href="ipar-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfIncome" xlink:href="ipar-20221231.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:href="ipar-20221231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="ipar-20221231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:href="ipar-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:href="ipar-20221231.xsd#ImpactOfCovid-19Pandemic" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreements" xlink:href="ipar-20221231.xsd#RecentAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Inventories" xlink:href="ipar-20221231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:href="ipar-20221231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:href="ipar-20221231.xsd#DerivativeFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpenses" xlink:href="ipar-20221231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanks" xlink:href="ipar-20221231.xsd#LoansPayableBanks" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebt" xlink:href="ipar-20221231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Commitments" xlink:href="ipar-20221231.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Equity" xlink:href="ipar-20221231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreas" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxes" xlink:href="ipar-20221231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="ipar-20221231.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:href="ipar-20221231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" xlink:href="ipar-20221231.xsd#ScheduleIi-ValuationAndQualifyingAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesTables" xlink:href="ipar-20221231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="ipar-20221231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:href="ipar-20221231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtTables" xlink:href="ipar-20221231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsTables" xlink:href="ipar-20221231.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityTables" xlink:href="ipar-20221231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreasTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:href="ipar-20221231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="ipar-20221231.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:href="ipar-20221231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:href="ipar-20221231.xsd#ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:href="ipar-20221231.xsd#ScheduleOfLanvinBrandNameForOurClassDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:href="ipar-20221231.xsd#RecentAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:href="ipar-20221231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:href="ipar-20221231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="ipar-20221231.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="ipar-20221231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#AccruedExpensesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:href="ipar-20221231.xsd#Long-termDebtConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:href="ipar-20221231.xsd#LoansPayableBanksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:href="ipar-20221231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:href="ipar-20221231.xsd#MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:href="ipar-20221231.xsd#MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:href="ipar-20221231.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:href="ipar-20221231.xsd#FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:href="ipar-20221231.xsd#EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:href="ipar-20221231.xsd#AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:href="ipar-20221231.xsd#ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:href="ipar-20221231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:href="ipar-20221231.xsd#ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:href="ipar-20221231.xsd#InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreasDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:href="ipar-20221231.xsd#ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:href="ipar-20221231.xsd#DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipar-20221231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:href="ipar-20221231.xsd#ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfValuationAndQualifyingAccountsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholder&apos;s Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:label="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleTransferToTradingLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleTransferToTradingLoss_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NetDerivativeInstrumentLossNetOfTax" xlink:label="loc_iparNetDerivativeInstrumentLossNetOfTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparNetDerivativeInstrumentLossNetOfTax_80" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - The Company and its Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:title="00000009 - Disclosure - Impact of COVID-19 Pandemic" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreements" xlink:title="00000010 - Disclosure - Recent Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:title="00000012 - Disclosure - Fair Value of Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:title="00000013 - Disclosure - Derivative Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:title="00000014 - Disclosure - Property, Equipment and Leasehold Improvements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:title="00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpenses" xlink:title="00000016 - Disclosure - Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanks" xlink:title="00000017 - Disclosure - Loans Payable &#8211; Banks" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebt" xlink:title="00000018 - Disclosure - Long-Term Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Commitments" xlink:title="00000019 - Disclosure - Commitments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Equity" xlink:title="00000020 - Disclosure - Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:title="00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:title="00000022 - Disclosure - Segments and Geographic Areas" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:title="00000024 - Disclosure - Accumulated Other Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:title="00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:title="00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" xlink:title="00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:title="00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesTables" xlink:title="00000030 - Disclosure - Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:title="00000031 - Disclosure - Fair Value of Financial Instruments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:title="00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:title="00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:title="00000034 - Disclosure - Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtTables" xlink:title="00000035 - Disclosure - Long-Term Debt (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsTables" xlink:title="00000036 - Disclosure - Commitments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityTables" xlink:title="00000037 - Disclosure - Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:title="00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:title="00000039 - Disclosure - Segments and Geographic Areas (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:title="00000040 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:title="00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:title="00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:title="00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:title="00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:title="00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ProductSalesConcentrationRiskMember" xlink:label="loc_iparProductSalesConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_iparProductSalesConcentrationRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_MontblancMember" xlink:label="loc_iparMontblancMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparMontblancMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_JimmyChooMember" xlink:label="loc_iparJimmyChooMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparJimmyChooMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CoachMember" xlink:label="loc_iparCoachMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparCoachMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_GUESSMember" xlink:label="loc_iparGUESSMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparGUESSMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis" xlink:label="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueConcentrationOfRiskDisclosureItemsDomain" xlink:label="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" xlink:to="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueConcentrationOfRiskDisclosureItemsDomain" xlink:label="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" xlink:to="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_JanvinMember" xlink:label="loc_iparJanvinMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain" xlink:to="loc_iparJanvinMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:label="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" xlink:label="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:to="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" xlink:label="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:to="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditRiskMember" xlink:label="loc_us-gaapCreditRiskMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" xlink:to="loc_us-gaapCreditRiskMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability" xlink:label="loc_us-gaapContractWithCustomerRefundLiability_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRefundLiability_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:label="loc_us-gaapContractWithCustomerRightToRecoverProduct_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRightToRecoverProduct_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMarketingExpense_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage_170" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:title="00000047 - Disclosure - Recent Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EmanuelUngarMember" xlink:label="loc_iparEmanuelUngarMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_iparEmanuelUngarMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionMember" xlink:label="loc_iparRochasFashionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_iparRochasFashionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DonnaKaranAndDKNYMember" xlink:label="loc_iparDonnaKaranAndDKNYMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparDonnaKaranAndDKNYMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionMember" xlink:label="loc_iparRochasFashionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparRochasFashionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currencyEUR_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:label="loc_us-gaapImpairmentChargeOnReclassifiedAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapImpairmentChargeOnReclassifiedAssets_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts" xlink:label="loc_us-gaapAcquisitionCosts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquisitionCosts_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapEscrowDeposit_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapLongTermDebtTerm_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapLineOfCredit_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:title="00000048 - Disclosure - Schedule of inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:title="00000049 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaapAssetsFairValueDisclosureAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:label="loc_us-gaapInterestRateFairValueHedgeDerivativeAtFairValueNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:to="loc_us-gaapInterestRateFairValueHedgeDerivativeAtFairValueNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:label="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:to="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract_90" xlink:to="loc_us-gaapAssetsFairValueDisclosure_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue" xlink:label="loc_us-gaapForeignCurrencyFairValueHedgeLiabilityAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapForeignCurrencyFairValueHedgeLiabilityAtFairValue_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:label="loc_us-gaapInterestRateDerivativeLiabilitiesAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInterestRateDerivativeLiabilitiesAtFairValue_90" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaapDerivativeNotionalAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeNotionalAmount_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:title="00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:title="00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SubtotalMember" xlink:label="loc_iparSubtotalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_iparSubtotalMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionBusinessMember" xlink:label="loc_iparRochasFashionBusinessMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_iparRochasFashionBusinessMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="loc_us-gaapIndefiniteLivedLicenseAgreements_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIndefiniteLivedLicenseAgreements_160" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:title="00000056 - Disclosure - Accrued expenses consist of the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:title="00000057 - Disclosure - Long-term debt consists of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLoansPayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableTwoMember" xlink:label="loc_iparLoansPayableTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableThreeMember" xlink:label="loc_iparLoansPayableThreeMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableThreeMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NumberOfInstallment" xlink:label="loc_iparNumberOfInstallment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_iparNumberOfInstallment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_150" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:title="00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DomesticSubsidiariesMember" xlink:label="loc_iparDomesticSubsidiariesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparDomesticSubsidiariesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ForeignSubsidiariesMember" xlink:label="loc_iparForeignSubsidiariesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparForeignSubsidiariesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LondonInterbankOfferedRateMember" xlink:label="loc_iparLondonInterbankOfferedRateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparLondonInterbankOfferedRateMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EuroInterbankOfferedRateMember" xlink:label="loc_iparEuroInterbankOfferedRateMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparEuroInterbankOfferedRateMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_80" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:title="00000059 - Disclosure - Long-Term Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLoansPayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtDescription" xlink:label="loc_us-gaapLongTermDebtDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtDescription_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:title="00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:title="00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:title="00000062 - Disclosure - Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeaseMember" xlink:label="loc_iparOperatingLeaseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparOperatingLeaseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeaseOfRelatedToRentalExpenses" xlink:label="loc_iparOperatingLeaseOfRelatedToRentalExpenses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_iparOperatingLeaseOfRelatedToRentalExpenses_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseCost_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapRoyaltyExpense_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:title="00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:title="00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember" xlink:label="loc_us-gaapOperatingIncomeLossMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapOperatingIncomeLossMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:title="00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:title="00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:title="00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:title="00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeOneMember" xlink:label="loc_iparExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeTwoMember" xlink:label="loc_iparExercisePriceRangeTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeTwoMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeThreeMember" xlink:label="loc_iparExercisePriceRangeThreeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeThreeMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeFourMember" xlink:label="loc_iparExercisePriceRangeFourMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeFourMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_150" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:title="00000069 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapStockOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_StockOptionOneMember" xlink:label="loc_iparStockOptionOneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_iparStockOptionOneMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EmployeesMember" xlink:label="loc_iparEmployeesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_iparEmployeesMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSAMember" xlink:label="loc_iparInterparfumsSAMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSAMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_220" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_220" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_220" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_220" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_220" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_220" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_220" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockSplits_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockSplits_220" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_220" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_220" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionMadeToLimitedPartnerUnitDistribution" xlink:label="loc_us-gaapDistributionMadeToLimitedPartnerUnitDistribution_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDistributionMadeToLimitedPartnerUnitDistribution_220" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense_220" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_PercentageOfIncreaseInAnnualDividend" xlink:label="loc_iparPercentageOfIncreaseInAnnualDividend_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparPercentageOfIncreaseInAnnualDividend_220" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="loc_us-gaapDividendsPayableAmountPerShare_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDividendsPayableAmountPerShare_220" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:title="00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:title="00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:title="00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EliminationsMember" xlink:label="loc_iparEliminationsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparEliminationsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInterestExpense_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets_250" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionsToOtherAssetsAmount" xlink:label="loc_us-gaapAdditionsToOtherAssetsAmount_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAdditionsToOtherAssetsAmount_250" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNoncurrentAssets_250" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet_250" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember" xlink:label="loc_srtAsiaMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MiddleEastMember" xlink:label="loc_us-gaapMiddleEastMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapMiddleEastMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CentralAndSouthAmericaMember" xlink:label="loc_iparCentralAndSouthAmericaMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparCentralAndSouthAmericaMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherSegmentCountryMember" xlink:label="loc_iparOtherSegmentCountryMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparOtherSegmentCountryMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_220" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:title="00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnitedStatesMember" xlink:label="loc_iparUnitedStatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedStatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_FranceMember" xlink:label="loc_iparFranceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparFranceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RussiaMember" xlink:label="loc_iparRussiaMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparRussiaMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnitedKingdomMember" xlink:label="loc_iparUnitedKingdomMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedKingdomMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" xlink:title="00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:title="00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:title="00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:title="00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:title="00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000080 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ForeignDerivedIntangibleIncomeMember" xlink:label="loc_iparForeignDerivedIntangibleIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_iparForeignDerivedIntangibleIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:title="00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:label="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:label="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax1_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:label="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax2_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax2_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_180" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:title="00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:title="00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" xlink:title="00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srtValuationAndQualifyingAccountsDisclosureTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_srtValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaapValuationAllowancesAndReservesTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureTable" xlink:to="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaapValuationAllowancesAndReservesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:to="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaapValuationAllowancesAndReservesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:to="loc_us-gaapValuationAllowancesAndReservesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaapAllowanceForCreditLossMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapAllowanceForCreditLossMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaapSalesReturnsAndAllowancesMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapSalesReturnsAndAllowancesMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserveMember" xlink:label="loc_us-gaapInventoryValuationReserveMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapInventoryValuationReserveMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="loc_us-gaapValuationAllowancesAndReservesChargedToOtherAccounts_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesChargedToOtherAccounts_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaapValuationAllowancesAndReservesDeductions_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesDeductions_220" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>ipar-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ProductSalesConcentrationRiskMember" xlink:label="ipar_ProductSalesConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ProductSalesConcentrationRiskMember" xlink:to="ipar_ProductSalesConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ProductSalesConcentrationRiskMember_lbl" xml:lang="en-US">Product Sales Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_MontblancMember" xlink:label="ipar_MontblancMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_MontblancMember" xlink:to="ipar_MontblancMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_MontblancMember_lbl" xml:lang="en-US">Montblanc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis" xlink:label="us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis" xlink:to="us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis_lbl" xml:lang="en-US">Concentration of Credit or Market Risk [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_JanvinMember" xlink:label="ipar_JanvinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_JanvinMember" xlink:to="ipar_JanvinMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_JanvinMember_lbl" xml:lang="en-US">Janvin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_JimmyChooMember" xlink:label="ipar_JimmyChooMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_JimmyChooMember" xlink:to="ipar_JimmyChooMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_JimmyChooMember_lbl" xml:lang="en-US">Jimmy Choo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CoachMember" xlink:label="ipar_CoachMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CoachMember" xlink:to="ipar_CoachMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CoachMember_lbl" xml:lang="en-US">Coach [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_GUESSMember" xlink:label="ipar_GUESSMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GUESSMember" xlink:to="ipar_GUESSMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_GUESSMember_lbl" xml:lang="en-US">G U E S S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="ipar_InterparfumsSASubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InterparfumsSASubsidiaryMember" xlink:to="ipar_InterparfumsSASubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_InterparfumsSASubsidiaryMember_lbl" xml:lang="en-US">Interparfums SA Subsidiary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:label="us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:to="us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis_lbl" xml:lang="en-US">Servicing Assets and Servicing Liabilities Risk [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditRiskMember" xlink:label="us-gaap_CreditRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditRiskMember" xlink:to="us-gaap_CreditRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditRiskMember_lbl" xml:lang="en-US">Credit Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xml:lang="en-US">Licensing Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EmanuelUngarMember" xlink:label="ipar_EmanuelUngarMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EmanuelUngarMember" xlink:to="ipar_EmanuelUngarMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EmanuelUngarMember_lbl" xml:lang="en-US">Emanuel Ungar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DonnaKaranAndDKNYMember" xlink:label="ipar_DonnaKaranAndDKNYMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DonnaKaranAndDKNYMember" xlink:to="ipar_DonnaKaranAndDKNYMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DonnaKaranAndDKNYMember_lbl" xml:lang="en-US">Donna Karan and DKNY [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionMember" xlink:label="ipar_RochasFashionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RochasFashionMember" xlink:to="ipar_RochasFashionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RochasFashionMember_lbl" xml:lang="en-US">Rochas Fashion [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="currency_EUR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US">Euro Member Countries, Euro</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US">Product [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignExchangeContractMember" xlink:to="us-gaap_ForeignExchangeContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignExchangeContractMember_lbl" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="us-gaap_IndefinitelivedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:to="us-gaap_IndefinitelivedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefinitelivedIntangibleAssetsMember_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SubtotalMember" xlink:label="ipar_SubtotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SubtotalMember" xlink:to="ipar_SubtotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_SubtotalMember_lbl" xml:lang="en-US">Subtotal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionBusinessMember" xlink:label="ipar_RochasFashionBusinessMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RochasFashionBusinessMember" xlink:to="ipar_RochasFashionBusinessMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RochasFashionBusinessMember_lbl" xml:lang="en-US">Rochas Fashion Business [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DomesticSubsidiariesMember" xlink:label="ipar_DomesticSubsidiariesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DomesticSubsidiariesMember" xlink:to="ipar_DomesticSubsidiariesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DomesticSubsidiariesMember_lbl" xml:lang="en-US">Domestic Subsidiaries [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LondonInterbankOfferedRateMember" xlink:label="ipar_LondonInterbankOfferedRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LondonInterbankOfferedRateMember" xlink:to="ipar_LondonInterbankOfferedRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LondonInterbankOfferedRateMember_lbl" xml:lang="en-US">London Interbank Offered Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ForeignSubsidiariesMember" xlink:label="ipar_ForeignSubsidiariesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignSubsidiariesMember" xlink:to="ipar_ForeignSubsidiariesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ForeignSubsidiariesMember_lbl" xml:lang="en-US">Foreign Subsidiaries [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EuroInterbankOfferedRateMember" xlink:label="ipar_EuroInterbankOfferedRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EuroInterbankOfferedRateMember" xlink:to="ipar_EuroInterbankOfferedRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EuroInterbankOfferedRateMember_lbl" xml:lang="en-US">Euro Interbank Offered Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="us-gaap_LoansPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableMember_lbl" xml:lang="en-US">Loans Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableOneMember" xlink:label="ipar_LoansPayableOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableOneMember" xlink:to="ipar_LoansPayableOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LoansPayableOneMember_lbl" xml:lang="en-US">Loans Payable One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableTwoMember" xlink:label="ipar_LoansPayableTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableTwoMember" xlink:to="ipar_LoansPayableTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LoansPayableTwoMember_lbl" xml:lang="en-US">Loans Payable Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableThreeMember" xlink:label="ipar_LoansPayableThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableThreeMember" xlink:to="ipar_LoansPayableThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LoansPayableThreeMember_lbl" xml:lang="en-US">Loans Payable Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeaseMember" xlink:label="ipar_OperatingLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeaseMember" xlink:to="ipar_OperatingLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_OperatingLeaseMember_lbl" xml:lang="en-US">Operating Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_StockOptionOneMember" xlink:label="ipar_StockOptionOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_StockOptionOneMember" xlink:to="ipar_StockOptionOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_StockOptionOneMember_lbl" xml:lang="en-US">Stock Option One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EmployeesMember" xlink:label="ipar_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EmployeesMember" xlink:to="ipar_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSAMember" xlink:label="ipar_InterparfumsSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InterparfumsSAMember" xlink:to="ipar_InterparfumsSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_InterparfumsSAMember_lbl" xml:lang="en-US">interparfums S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember" xlink:label="us-gaap_OperatingIncomeLossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLossMember" xlink:to="us-gaap_OperatingIncomeLossMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLossMember_lbl" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeOneMember" xlink:label="ipar_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeOneMember" xlink:to="ipar_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeTwoMember" xlink:label="ipar_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeTwoMember" xlink:to="ipar_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeThreeMember" xlink:label="ipar_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeThreeMember" xlink:to="ipar_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeFourMember" xlink:label="ipar_ExercisePriceRangeFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeFourMember" xlink:to="ipar_ExercisePriceRangeFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ExercisePriceRangeFourMember_lbl" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EliminationsMember" xlink:label="ipar_EliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EliminationsMember" xlink:to="ipar_EliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EliminationsMember_lbl" xml:lang="en-US">Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember" xlink:label="srt_NorthAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US">North America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember" xlink:label="srt_AsiaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaMember_lbl" xml:lang="en-US">Asia [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MiddleEastMember" xlink:label="us-gaap_MiddleEastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MiddleEastMember_lbl" xml:lang="en-US">Middle East [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CentralAndSouthAmericaMember" xlink:label="ipar_CentralAndSouthAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CentralAndSouthAmericaMember" xlink:to="ipar_CentralAndSouthAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CentralAndSouthAmericaMember_lbl" xml:lang="en-US">Central and South America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherSegmentCountryMember" xlink:label="ipar_OtherSegmentCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherSegmentCountryMember" xlink:to="ipar_OtherSegmentCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_OtherSegmentCountryMember_lbl" xml:lang="en-US">Other Segment Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnitedStatesMember" xlink:label="ipar_UnitedStatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedStatesMember" xlink:to="ipar_UnitedStatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_UnitedStatesMember_lbl" xml:lang="en-US">United States [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_FranceMember" xlink:label="ipar_FranceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FranceMember" xlink:to="ipar_FranceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_FranceMember_lbl" xml:lang="en-US">France [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RussiaMember" xlink:label="ipar_RussiaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RussiaMember" xlink:to="ipar_RussiaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RussiaMember_lbl" xml:lang="en-US">Russia [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnitedKingdomMember" xlink:label="ipar_UnitedKingdomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedKingdomMember" xlink:to="ipar_UnitedKingdomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_UnitedKingdomMember_lbl" xml:lang="en-US">United Kingdom [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ForeignDerivedIntangibleIncomeMember" xlink:label="ipar_ForeignDerivedIntangibleIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignDerivedIntangibleIncomeMember" xlink:to="ipar_ForeignDerivedIntangibleIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ForeignDerivedIntangibleIncomeMember_lbl" xml:lang="en-US">Foreign Derived Intangible Income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:label="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:to="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_lbl" xml:lang="en-US">Accumulated Defined Benefit Plans Net Derivative Instruments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="us-gaap_AllowanceForCreditLossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossMember" xlink:to="us-gaap_AllowanceForCreditLossMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossMember_lbl" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="us-gaap_SalesReturnsAndAllowancesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesReturnsAndAllowancesMember" xlink:to="us-gaap_SalesReturnsAndAllowancesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesReturnsAndAllowancesMember_lbl" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserveMember" xlink:label="us-gaap_InventoryValuationReserveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserveMember" xlink:to="us-gaap_InventoryValuationReserveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserveMember_lbl" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Receivables, other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xml:lang="en-US">Income taxes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, equipment and leasehold improvements, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Trademarks, licenses and other intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable - trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long&#8211;term debt, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liabilities, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Inter Parfums, Inc. shareholders&#8217; equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.001 par value. Authorized 1,000,000 shares: none issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value. Authorized 100,000,000 shares: outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Inter Parfums, Inc. shareholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross margin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="us-gaap_ImpairmentOfLeasehold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLeasehold" xlink:to="us-gaap_ImpairmentOfLeasehold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLeasehold_lbl" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other expenses (income):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Loss (gain) on foreign currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest and investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other loss (income)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">&#160;&#160;Nonoperating Income (Expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net income attributable to the noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income attributable to Inter Parfums, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Net income attributable to Inter Parfums, Inc. common shareholders:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Dividends declared per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive income:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_lbl" xml:lang="en-US">Net derivative instrument income (loss), &#160;net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_lbl" xml:lang="en-US">Transfer of OCI into earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Translation adjustments, net of tax&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax_lbl" xml:lang="en-US">Other comprehensive income (loss), before tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net derivative instrument income (loss), &#160;net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Translation adjustments, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive income (loss), net of tax, atributable to noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income attributable to Inter Parfums Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Shares issued upon exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xml:lang="en-US">Purchase of subsidiary shares from noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Shares issued for license acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:label="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:to="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_lbl" xml:lang="en-US">Transfer of subsidiary shares purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCash_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xml:lang="en-US">Foreign currency translation adjustment, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss_lbl" xml:lang="en-US">Transfer from other comprehensive income into earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss_2_lbl" xml:lang="en-US">Transfer from other comprehensive income into earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NetDerivativeInstrumentLossNetOfTax" xlink:label="ipar_NetDerivativeInstrumentLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NetDerivativeInstrumentLossNetOfTax" xlink:to="ipar_NetDerivativeInstrumentLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_NetDerivativeInstrumentLossNetOfTax_lbl" xml:lang="en-US">Net derivative instrument loss, net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization including impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ProvisionForDoubtfulAccounts1" xlink:label="ipar_ProvisionForDoubtfulAccounts1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ProvisionForDoubtfulAccounts1" xlink:to="ipar_ProvisionForDoubtfulAccounts1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ProvisionForDoubtfulAccounts1_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Noncash stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Share of income of equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:label="us-gaap_ProvisionForLoanLeaseAndOtherLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:to="us-gaap_ProvisionForLoanLeaseAndOtherLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForLoanLeaseAndOtherLosses_lbl" xml:lang="en-US">Lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ChangeInFairValueOfDerivatives" xlink:label="ipar_ChangeInFairValueOfDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ChangeInFairValueOfDerivatives" xlink:to="ipar_ChangeInFairValueOfDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ipar_ChangeInFairValueOfDerivatives_lbl" xml:lang="en-US">Change in fair value of derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xml:lang="en-US">Income taxes, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Purchases of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property, equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Payment for intangible assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US">Purchase of equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayment of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US">Dividends paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Dividends paid to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US">Purchase of subsidiary shares from noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents &#8211; beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents &#8211; end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:label="ipar_SupplementalDisclosureOfCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="ipar_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Cash paid for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">The Company and its Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DisclosureImpactOfCovid19PandemicAbstract" xlink:label="ipar_DisclosureImpactOfCovid19PandemicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DisclosureImpactOfCovid19PandemicAbstract" xlink:to="ipar_DisclosureImpactOfCovid19PandemicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DisclosureImpactOfCovid19PandemicAbstract_lbl" xml:lang="en-US">Impact Of Covid-19 Pandemic</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ImpactOfCOVID19PandemicTextBlock" xlink:label="ipar_ImpactOfCOVID19PandemicTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ImpactOfCOVID19PandemicTextBlock" xlink:to="ipar_ImpactOfCOVID19PandemicTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ImpactOfCOVID19PandemicTextBlock_lbl" xml:lang="en-US">Impact of COVID-19 Pandemic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Recent Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property, Equipment and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Trademarks, Licenses and Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Loans Payable &#8211; Banks</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityAbstract_2_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Income Attributable to Inter Parfums, Inc. Common Shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segments and Geographic Areas</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:label="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:to="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_lbl" xml:lang="en-US">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Business of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Preparation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Management Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents and Short-Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Equipment and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionSalesReturns" xlink:label="us-gaap_RevenueRecognitionSalesReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionSalesReturns" xlink:to="us-gaap_RevenueRecognitionSalesReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionSalesReturns_lbl" xml:lang="en-US">Sales Returns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAllowances" xlink:label="us-gaap_RevenueRecognitionAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionAllowances" xlink:to="us-gaap_RevenueRecognitionAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionAllowances_lbl" xml:lang="en-US">Payments to Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising and Promotion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Package Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="us-gaap_LessorLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorLeasesPolicyTextBlock" xlink:to="us-gaap_LessorLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LessorLeasesPolicyTextBlock_lbl" xml:lang="en-US">Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">License Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" xlink:label="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" xlink:to="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy_lbl" xml:lang="en-US">Issuance of Common Stock by Consolidated Subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepurchaseAgreementsCollateralPolicy" xlink:label="us-gaap_RepurchaseAgreementsCollateralPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepurchaseAgreementsCollateralPolicy" xlink:to="us-gaap_RepurchaseAgreementsCollateralPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepurchaseAgreementsCollateralPolicy_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedule of lanvin brand name for our class</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value, assets measured on recurring basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:to="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock_lbl" xml:lang="en-US">Schedule of trademarks, licenses and other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Accrued expenses consist of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Long-term debt consists of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" xlink:label="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" xlink:to="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_lbl" xml:lang="en-US">Maturities of lease liabilities subsequent to December 31, 2022 are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_lbl" xml:lang="en-US">minimum annual royalties and other commitments as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">The following table sets forth information with respect to nonvested options for 2022:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">The effect of share-based payment expenses decreased income statement line items as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">The assumptions used in the Black-Scholes pricing model are set forth in the following table:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:label="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:to="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_lbl" xml:lang="en-US">Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">The following table summarizes additional stock option information as of December 31, 2022:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Information on the Company&#8217;s operations by segments is as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">Consolidated net sales to customers by region are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xml:lang="en-US">Consolidated net sales to customers in major countries are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">The components of income before income taxes consist of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">The provision for current and deferred income tax expense (benefit) consists of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">The components of accumulated other comprehensive loss consist of the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xml:lang="en-US">Schedule of net income attributable to transfers from the noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xml:lang="en-US">The following table summarizes cash and cash equivalents as of December 31, 2021:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Ownership percentage in Interparfums SA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowances for sales returns and doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average cost of capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Shipping and handling costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability" xlink:label="us-gaap_ContractWithCustomerRefundLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerRefundLiability" xlink:to="us-gaap_ContractWithCustomerRefundLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerRefundLiability_lbl" xml:lang="en-US">Contract with customer, refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:label="us-gaap_ContractWithCustomerRightToRecoverProduct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:to="us-gaap_ContractWithCustomerRightToRecoverProduct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerRightToRecoverProduct_lbl" xml:lang="en-US">Contract with customer, right to recover products</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingExpense" xlink:label="us-gaap_MarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingExpense" xlink:to="us-gaap_MarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingExpense_lbl" xml:lang="en-US">Customer incentives cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">License agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_lbl" xml:lang="en-US">License agreement renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="ipar_RoyaltyExpenseNetSalesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RoyaltyExpenseNetSalesPercentage" xlink:to="ipar_RoyaltyExpenseNetSalesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_RoyaltyExpenseNetSalesPercentage_lbl" xml:lang="en-US">Royalty expense, percentage of net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xml:lang="en-US">Description of recent agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Shares issue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Shares value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:label="us-gaap_ImpairmentChargeOnReclassifiedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:to="us-gaap_ImpairmentChargeOnReclassifiedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentChargeOnReclassifiedAssets_lbl" xml:lang="en-US">Impairment Charge on Reclassified Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_2_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Purchase price, period cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts" xlink:label="us-gaap_AcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquisitionCosts" xlink:to="us-gaap_AcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquisitionCosts_lbl" xml:lang="en-US">Acquisition costs, period cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Depreciated over a range</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EscrowDeposit_lbl" xml:lang="en-US">Cash held in escrow is included in other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm" xlink:label="us-gaap_LongTermDebtTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTerm" xlink:to="us-gaap_LongTermDebtTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTerm_lbl" xml:lang="en-US">Long-term debt, term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Long-term line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xml:lang="en-US">Description of debt instrument interest rate terms</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrument, face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and component parts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:to="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xml:lang="en-US">Cost of Goods Sold, Overhead</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US">Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:label="us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:to="us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_lbl" xml:lang="en-US">Interest rate swaps</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:label="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:to="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue_lbl" xml:lang="en-US">Foreign currency forward exchange contracts accounted for using hedge accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">&#160;Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue" xlink:label="us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue" xlink:to="us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue_lbl" xml:lang="en-US">Foreign currency forward exchange contracts not accounted for using hedge accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_lbl" xml:lang="en-US">Foreign currency forward exchange contracts not accounted for using hedge accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:label="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:to="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_lbl" xml:lang="en-US">Interest rate swaps</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="us-gaap_DerivativeNotionalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeNotionalAmount" xlink:to="us-gaap_DerivativeNotionalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeNotionalAmount_lbl" xml:lang="en-US">Loan amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xml:lang="en-US">Foreign currency contracts, liability, fair value disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Net, Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation and amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net Book Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Impairment charge</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="us-gaap_IndefiniteLivedLicenseAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedLicenseAgreements" xlink:to="us-gaap_IndefiniteLivedLicenseAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedLicenseAgreements_lbl" xml:lang="en-US">Indefinite-Lived License Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="us-gaap_AccruedAdvertisingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedAdvertisingCurrent" xlink:to="us-gaap_AccruedAdvertisingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedAdvertisingCurrent_lbl" xml:lang="en-US">Advertising liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Salary (including bonus and related taxes)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrent" xlink:to="us-gaap_AccruedRoyaltiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xml:lang="en-US">Royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DueVendorsNotYetInvoiced" xlink:label="ipar_DueVendorsNotYetInvoiced" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DueVendorsNotYetInvoiced" xlink:to="ipar_DueVendorsNotYetInvoiced_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DueVendorsNotYetInvoiced_lbl" xml:lang="en-US">Due vendors (not yet invoiced)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:label="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:to="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_lbl" xml:lang="en-US">Retirement reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="us-gaap_CustomerRefundLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRefundLiabilityCurrent" xlink:to="us-gaap_CustomerRefundLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRefundLiabilityCurrent_lbl" xml:lang="en-US">Refund (return) liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NumberOfInstallment" xlink:label="ipar_NumberOfInstallment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NumberOfInstallment" xlink:to="ipar_NumberOfInstallment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_NumberOfInstallment_lbl" xml:lang="en-US">Number of installments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Installment amount (in Dollars)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest per annum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Loan payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Less current maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit, maximum borrowing amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Basis spread over variable interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Variable rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtDescription" xlink:to="us-gaap_LongTermDebtDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtDescription_lbl" xml:lang="en-US">Long term debt maturity, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">Long-term Debt, Maturities, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Gross Total</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" xlink:label="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" xlink:to="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_lbl" xml:lang="en-US">Less imputed interest (based on 2.6% weighted-average discount rate)</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" xlink:label="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" xlink:to="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_lbl" xml:lang="en-US">Net Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement" xlink:label="us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement" xlink:to="us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_lbl" xml:lang="en-US">License agreement, expiration description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="us-gaap_OtherCommitmentDueInSecondYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondYear" xlink:to="us-gaap_OtherCommitmentDueInSecondYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInSecondYear_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="us-gaap_OtherCommitmentDueInThirdYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInThirdYear" xlink:to="us-gaap_OtherCommitmentDueInThirdYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInThirdYear_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="us-gaap_OtherCommitmentDueInFourthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFourthYear" xlink:to="us-gaap_OtherCommitmentDueInFourthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInFourthYear_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="us-gaap_OtherCommitmentDueInFifthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFifthYear" xlink:to="us-gaap_OtherCommitmentDueInFifthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueInFifthYear_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="us-gaap_OtherCommitmentDueAfterFifthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueAfterFifthYear" xlink:to="us-gaap_OtherCommitmentDueAfterFifthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCommitmentDueAfterFifthYear_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitment" xlink:to="us-gaap_OtherCommitment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitment_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xml:lang="en-US">Operating lease, weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeaseOfRelatedToRentalExpenses" xlink:label="ipar_OperatingLeaseOfRelatedToRentalExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeaseOfRelatedToRentalExpenses" xlink:to="ipar_OperatingLeaseOfRelatedToRentalExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_OperatingLeaseOfRelatedToRentalExpenses_lbl" xml:lang="en-US">Operating lease of related to rental expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Noncash additions to operating lease assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Royalty expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Nonvested options - beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Nonvested options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Nonvested options vested or forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, vested or forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Nonvested options - end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income attributable to Inter Parfums, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted earnings per share attributable to Inter Parfums, Inc</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options shares under option - beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price shares under option - beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Options shares under option - end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price shares under option - end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Weighted-average expected stock-price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted-average expected option life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted-average risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Weighted-average dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xml:lang="en-US">Proceeds from stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xml:lang="en-US">Tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value of stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Exercise price range (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options outstanding weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair value of shares vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price of options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted average remaining contractual life of options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Adjusted for stock splits (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits_lbl" xml:lang="en-US">Shares adjusted for stock splits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xml:lang="en-US">Recognized as compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xml:lang="en-US">Straight line basis over the requisite</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionMadeToLimitedPartnerUnitDistribution" xlink:label="us-gaap_DistributionMadeToLimitedPartnerUnitDistribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionMadeToLimitedPartnerUnitDistribution" xlink:to="us-gaap_DistributionMadeToLimitedPartnerUnitDistribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DistributionMadeToLimitedPartnerUnitDistribution_lbl" xml:lang="en-US">Number of share distributed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_lbl" xml:lang="en-US">Aggregate cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_PercentageOfIncreaseInAnnualDividend" xlink:label="ipar_PercentageOfIncreaseInAnnualDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_PercentageOfIncreaseInAnnualDividend" xlink:to="ipar_PercentageOfIncreaseInAnnualDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_PercentageOfIncreaseInAnnualDividend_lbl" xml:lang="en-US">Percentage of increase in annual dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="us-gaap_DividendsPayableAmountPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl" xml:lang="en-US">Dividends payable, amount per share (in Dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Numerator for diluted earnings per share (in dollars)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic (in dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_3_lbl" xml:lang="en-US">Diluted (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2_lbl" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_2_lbl" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_3_lbl" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_Assets_3_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionsToOtherAssetsAmount" xlink:label="us-gaap_AdditionsToOtherAssetsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionsToOtherAssetsAmount" xlink:to="us-gaap_AdditionsToOtherAssetsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionsToOtherAssetsAmount_lbl" xml:lang="en-US">Additions to Other Assets, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets" xlink:label="us-gaap_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenue from export sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">U.S. operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Current income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xml:lang="en-US">Deferred income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Total income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Net deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Foreign net operating loss carry-forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:label="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:to="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_lbl" xml:lang="en-US">Inventory and accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Profit sharing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock option compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Effect of inventory profit elimination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total gross deferred tax assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xml:lang="en-US">Deferred tax liabilities (long-term):</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:label="ipar_DeferredTaxLiabilitiesBuildingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:to="ipar_DeferredTaxLiabilitiesBuildingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DeferredTaxLiabilitiesBuildingExpenses_lbl" xml:lang="en-US">Building expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xml:lang="en-US">Trademarks and licenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:label="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:to="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_lbl" xml:lang="en-US">Unrealized gain on marketable equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local taxes, net of Federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_lbl" xml:lang="en-US">Windfall benefit from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Benefit of Foreign Derived Intangible Income</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:label="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:to="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_lbl" xml:lang="en-US">Effect of foreign taxes greater than U.S. statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_lbl" xml:lang="en-US">Net derivative instruments, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US">Net derivative instrument gain (loss), net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_2_lbl" xml:lang="en-US">Net derivative instruments, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_lbl" xml:lang="en-US">Cumulative translation adjustments, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xml:lang="en-US">Translation adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_2_lbl" xml:lang="en-US">Cumulative translation adjustments, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_lbl" xml:lang="en-US">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_lbl" xml:lang="en-US">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract_2_lbl" xml:lang="en-US">Following Table Summarizes Cash And Cash Equivalents As Of December 31 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents per balance sheet</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:label="ipar_CashHeldInEscrowIncludedInOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:to="ipar_CashHeldInEscrowIncludedInOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_CashHeldInEscrowIncludedInOtherAssets_lbl" xml:lang="en-US">Cash held in escrow included in other assets (see note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents per statement of cash flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US">Balance at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US">Charged to costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xml:lang="en-US">Charged to other accounts describe</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US">Deductions describe</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_2_lbl" xml:lang="en-US">Balance at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SalvatoreFerragamoMember" xlink:label="ipar_SalvatoreFerragamoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SalvatoreFerragamoMember" xlink:to="ipar_SalvatoreFerragamoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_SalvatoreFerragamoMember_doc" xml:lang="en-US">The element represents salvatore ferragamo member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InventoryMember" xlink:label="ipar_InventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InventoryMember" xlink:to="ipar_InventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_InventoryMember_doc" xml:lang="en-US">The element represents inventory member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherAssetMember" xlink:label="ipar_OtherAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherAssetMember" xlink:to="ipar_OtherAssetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherAssetMember_doc" xml:lang="en-US">The element represents other asset member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EmanuelUngarMember" xlink:to="ipar_EmanuelUngarMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EmanuelUngarMember_doc" xml:lang="en-US">The element represents emanuel ungar member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DonnaKaranAndDKNYMember" xlink:to="ipar_DonnaKaranAndDKNYMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DonnaKaranAndDKNYMember_doc" xml:lang="en-US">The element represents donna karan and dkny member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InterparfumsSASubsidiaryMember" xlink:to="ipar_InterparfumsSASubsidiaryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_InterparfumsSASubsidiaryMember_doc" xml:lang="en-US">The element represents interparfums sa subsidiary member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EmployeesMember" xlink:to="ipar_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EmployeesMember_doc" xml:lang="en-US">The element represents employees member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OfficersAndManagersMember" xlink:label="ipar_OfficersAndManagersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OfficersAndManagersMember" xlink:to="ipar_OfficersAndManagersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OfficersAndManagersMember_doc" xml:lang="en-US">The element represents officers and managers member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:to="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares_doc" xml:lang="en-US">The element represents transfer of subsidiary shares purchased to treasury shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InterparfumsSAMember" xlink:to="ipar_InterparfumsSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_InterparfumsSAMember_doc" xml:lang="en-US">The element represents interparfums s a member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SalvatoreFerragamoSAMember" xlink:label="ipar_SalvatoreFerragamoSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SalvatoreFerragamoSAMember" xlink:to="ipar_SalvatoreFerragamoSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_SalvatoreFerragamoSAMember_doc" xml:lang="en-US">The element represents salvatore ferragamo s a member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NetIncomeLossAttributableToNoncontrollingInterest1" xlink:label="ipar_NetIncomeLossAttributableToNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NetIncomeLossAttributableToNoncontrollingInterest1" xlink:to="ipar_NetIncomeLossAttributableToNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_NetIncomeLossAttributableToNoncontrollingInterest1_doc" xml:lang="en-US">The element represents net income loss attributable to noncontrolling interest1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1" xlink:label="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1" xlink:to="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToNoncontrollingInterest1_doc" xml:lang="en-US">The element represents other comprehensive income derivatives qualifying as hedges tax portion attributable to noncontrolling interest1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1" xlink:label="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1" xlink:to="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest1_doc" xml:lang="en-US">The element represents other comprehensive income derivatives qualifying as hedges net of tax portion attributable to noncontrolling interest1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeasesRentExpenseNet1" xlink:label="ipar_OperatingLeasesRentExpenseNet1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeasesRentExpenseNet1" xlink:to="ipar_OperatingLeasesRentExpenseNet1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OperatingLeasesRentExpenseNet1_doc" xml:lang="en-US">The element represents operating leases rent expense net1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InvestmentIncomeInterestAndDividend1" xlink:label="ipar_InvestmentIncomeInterestAndDividend1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_InvestmentIncomeInterestAndDividend1" xlink:to="ipar_InvestmentIncomeInterestAndDividend1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_InvestmentIncomeInterestAndDividend1_doc" xml:lang="en-US">The element represents investment income interest and dividend1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1" xlink:label="ipar_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1" xlink:to="ipar_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax1_doc" xml:lang="en-US">The element represents other comprehensive income loss reclassification adjustment from a o c i on derivatives net of tax1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:to="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_doc" xml:lang="en-US">The element represents reconciliation of cash and cash equivalents to the statement of cash flows text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_MontblancMember" xlink:to="ipar_MontblancMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_MontblancMember_doc" xml:lang="en-US">The element represents montblanc member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_JimmyChooMember" xlink:to="ipar_JimmyChooMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_JimmyChooMember_doc" xml:lang="en-US">The element represents jimmy choo member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CoachMember" xlink:to="ipar_CoachMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CoachMember_doc" xml:lang="en-US">The element represents coach member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GUESSMember" xlink:to="ipar_GUESSMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_GUESSMember_doc" xml:lang="en-US">The element represents g u e s s member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:to="ipar_CashHeldInEscrowIncludedInOtherAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CashHeldInEscrowIncludedInOtherAssets_doc" xml:lang="en-US">Cash held in escrow included in other assets.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CashAndCashEquivalentsPerStatementOfCashFlows" xlink:label="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashAndCashEquivalentsPerStatementOfCashFlows" xlink:to="ipar_CashAndCashEquivalentsPerStatementOfCashFlows_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CashAndCashEquivalentsPerStatementOfCashFlows_doc" xml:lang="en-US">Cash and cash equivalents per statement of cash flows.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RoyaltyExpenseNetSalesPercentage" xlink:to="ipar_RoyaltyExpenseNetSalesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RoyaltyExpenseNetSalesPercentage_doc" xml:lang="en-US">The element represents royalty expense net sales percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ImpactOfCOVID19PandemicTextBlock" xlink:to="ipar_ImpactOfCOVID19PandemicTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ImpactOfCOVID19PandemicTextBlock_doc" xml:lang="en-US">The element represents impact of c o v i d19 pandemic text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:to="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_doc" xml:lang="en-US">The element represents accumulated defined benefit plans net derivative instruments member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DiscriptionOfRecentAgreement" xlink:label="ipar_DiscriptionOfRecentAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DiscriptionOfRecentAgreement" xlink:to="ipar_DiscriptionOfRecentAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DiscriptionOfRecentAgreement_doc" xml:lang="en-US">The element represents discription of recent agreement.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AnnaSuiCorpMember" xlink:label="ipar_AnnaSuiCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AnnaSuiCorpMember" xlink:to="ipar_AnnaSuiCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_AnnaSuiCorpMember_doc" xml:lang="en-US">This member stans for anna SuiCorp.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RochasFashionMember" xlink:to="ipar_RochasFashionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RochasFashionMember_doc" xml:lang="en-US">This member stans for rochas fashion.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CashHeldInEscrow" xlink:label="ipar_CashHeldInEscrow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CashHeldInEscrow" xlink:to="ipar_CashHeldInEscrow_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CashHeldInEscrow_doc" xml:lang="en-US">Cash held in escrow.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_STDupontMember" xlink:label="ipar_STDupontMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_STDupontMember" xlink:to="ipar_STDupontMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_STDupontMember_doc" xml:lang="en-US">The element represents s t dupont member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_GlobalSettlementAgreementMember" xlink:label="ipar_GlobalSettlementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_GlobalSettlementAgreementMember" xlink:to="ipar_GlobalSettlementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_GlobalSettlementAgreementMember_doc" xml:lang="en-US">This member stans for global settlement agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:to="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredTaxAssetsInventoryAndAccountsReceivable_doc" xml:lang="en-US">The element represents deferred tax assets inventory and accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DueVendorsNotYetInvoiced" xlink:to="ipar_DueVendorsNotYetInvoiced_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DueVendorsNotYetInvoiced_doc" xml:lang="en-US">The element represents due vendors not yet invoiced.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignDerivedIntangibleIncomeMember" xlink:to="ipar_ForeignDerivedIntangibleIncomeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ForeignDerivedIntangibleIncomeMember_doc" xml:lang="en-US">The element represents foreign derived intangible income member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DomesticSubsidiariesMember" xlink:to="ipar_DomesticSubsidiariesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DomesticSubsidiariesMember_doc" xml:lang="en-US">The element represents domestic subsidiaries member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LondonInterbankOfferedRateMember" xlink:to="ipar_LondonInterbankOfferedRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LondonInterbankOfferedRateMember_doc" xml:lang="en-US">The element represents london interbank offered rate member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ForeignSubsidiariesMember" xlink:to="ipar_ForeignSubsidiariesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ForeignSubsidiariesMember_doc" xml:lang="en-US">The element represents foreign subsidiaries member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EuroInterbankOfferedRateMember" xlink:to="ipar_EuroInterbankOfferedRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EuroInterbankOfferedRateMember_doc" xml:lang="en-US">The element represents euro interbank offered rate member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EliminationsMember" xlink:to="ipar_EliminationsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EliminationsMember_doc" xml:lang="en-US">This member stans for eliminations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableOneMember" xlink:to="ipar_LoansPayableOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LoansPayableOneMember_doc" xml:lang="en-US">The element represents loans payable one member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableTwoMember" xlink:to="ipar_LoansPayableTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LoansPayableTwoMember_doc" xml:lang="en-US">The element represents loans payable two member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LoansPayableThreeMember" xlink:to="ipar_LoansPayableThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LoansPayableThreeMember_doc" xml:lang="en-US">The element represents loans payable three member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NumberOfInstallment" xlink:to="ipar_NumberOfInstallment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_NumberOfInstallment_doc" xml:lang="en-US">The element represents number of installment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_CentralAndSouthAmericaMember" xlink:to="ipar_CentralAndSouthAmericaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_CentralAndSouthAmericaMember_doc" xml:lang="en-US">The element represents central and south america member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherSegmentCountryMember" xlink:to="ipar_OtherSegmentCountryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherSegmentCountryMember_doc" xml:lang="en-US">The element represents other segment country member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedStatesMember" xlink:to="ipar_UnitedStatesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_UnitedStatesMember_doc" xml:lang="en-US">The element represents united states member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FranceMember" xlink:to="ipar_FranceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_FranceMember_doc" xml:lang="en-US">The element represents france member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RussiaMember" xlink:to="ipar_RussiaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RussiaMember_doc" xml:lang="en-US">The element represents russia member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnitedKingdomMember" xlink:to="ipar_UnitedKingdomMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_UnitedKingdomMember_doc" xml:lang="en-US">The element represents united kingdom member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeOneMember" xlink:to="ipar_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeOneMember_doc" xml:lang="en-US">The element represents exercise price range one member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeFiveMember" xlink:label="ipar_ExercisePriceRangeFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeFiveMember" xlink:to="ipar_ExercisePriceRangeFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeFiveMember_doc" xml:lang="en-US">The element represents exercise price range five member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeFourMember" xlink:to="ipar_ExercisePriceRangeFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeFourMember_doc" xml:lang="en-US">The element represents exercise price range four member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeThreeMember" xlink:to="ipar_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">The element represents exercise price range three member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" xlink:label="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears" xlink:to="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OperatingLeasesFutureMinimumPaymentsDueInSixYears_doc" xml:lang="en-US">The element represents operating leases future minimum payments due in six years.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_Covid19Description" xlink:label="ipar_Covid19Description" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_Covid19Description" xlink:to="ipar_Covid19Description_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_Covid19Description_doc" xml:lang="en-US">The element represents covid19 description.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RevaluationResultedInReductionOfCostDescription" xlink:label="ipar_RevaluationResultedInReductionOfCostDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RevaluationResultedInReductionOfCostDescription" xlink:to="ipar_RevaluationResultedInReductionOfCostDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RevaluationResultedInReductionOfCostDescription_doc" xml:lang="en-US">The element represents revaluation resulted in reduction of cost description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_PercentageOfIncreaseInAnnualDividend" xlink:to="ipar_PercentageOfIncreaseInAnnualDividend_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_PercentageOfIncreaseInAnnualDividend_doc" xml:lang="en-US">The element represents percentage of increase in annual dividend.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_StockOptionOneMember" xlink:to="ipar_StockOptionOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_StockOptionOneMember_doc" xml:lang="en-US">The element represents stock option one member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnrealizedGainOnMarketableEquitySecurities" xlink:label="ipar_UnrealizedGainOnMarketableEquitySecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_UnrealizedGainOnMarketableEquitySecurities" xlink:to="ipar_UnrealizedGainOnMarketableEquitySecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_UnrealizedGainOnMarketableEquitySecurities_doc" xml:lang="en-US">The element represents unrealized gain on marketable equity securities.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_BuildingExpenses" xlink:label="ipar_BuildingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_BuildingExpenses" xlink:to="ipar_BuildingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_BuildingExpenses_doc" xml:lang="en-US">The element represents building expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_SubtotalMember" xlink:to="ipar_SubtotalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_SubtotalMember_doc" xml:lang="en-US">The element represents subtotal member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EURMember" xlink:label="ipar_EURMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EURMember" xlink:to="ipar_EURMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EURMember_doc" xml:lang="en-US">The element represents e u r member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_USDMember" xlink:label="ipar_USDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_USDMember" xlink:to="ipar_USDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_USDMember_doc" xml:lang="en-US">The element represents u s d member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ScheduleOfInventoryCurrentTableTextBlock1" xlink:label="ipar_ScheduleOfInventoryCurrentTableTextBlock1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ScheduleOfInventoryCurrentTableTextBlock1" xlink:to="ipar_ScheduleOfInventoryCurrentTableTextBlock1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ScheduleOfInventoryCurrentTableTextBlock1_doc" xml:lang="en-US">The element represents schedule of inventory current table text block1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:to="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_doc" xml:lang="en-US">The element represents effective income tax rate reconciliation at federal statutory income tax rate1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:label="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears" xlink:to="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_FiniteLivedIntangibleAssetsAmortizationExpenseAfterTwoYears_doc" xml:lang="en-US">The element represents finite lived intangible assets amortization expense after two years.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:to="ipar_DeferredTaxLiabilitiesBuildingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredTaxLiabilitiesBuildingExpenses_doc" xml:lang="en-US">The element represents deferred tax liabilities building expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:to="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_doc" xml:lang="en-US">The element represents deferred tax liabilities unrealized gain on marketable equity securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" xlink:to="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_doc" xml:lang="en-US">The element represents less imputed interest based on2.6 weightedaverage discount rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" xlink:to="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_doc" xml:lang="en-US">The element represents lessee operating lease liability payments due net total.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ProductSalesConcentrationRiskMember" xlink:to="ipar_ProductSalesConcentrationRiskMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ProductSalesConcentrationRiskMember_doc" xml:lang="en-US">The element represents product sales concentration risk member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_JanvinMember" xlink:to="ipar_JanvinMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_JanvinMember_doc" xml:lang="en-US">The element represents janvin member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeaseOfRelatedToRentalExpenses" xlink:to="ipar_OperatingLeaseOfRelatedToRentalExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OperatingLeaseOfRelatedToRentalExpenses_doc" xml:lang="en-US">The element represents operating lease of related to rental expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_NetDerivativeInstrumentLossNetOfTax" xlink:to="ipar_NetDerivativeInstrumentLossNetOfTax_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_NetDerivativeInstrumentLossNetOfTax_doc" xml:lang="en-US">The element represents net derivative instrument loss net of tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" xlink:to="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_doc" xml:lang="en-US">The element represents schedule of maturities of lease liabilities subsequent table text block.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest" xlink:label="ipar_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest" xlink:to="ipar_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxsPortionAttributableToNoncontrollingInterest_doc" xml:lang="en-US">The element represents other comprehensive income foreign currency transaction and translation adjustment net of taxs portion attributable to noncontrolling interest.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs" xlink:label="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs" xlink:to="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxs_doc" xml:lang="en-US">The element represents other comprehensive income loss derivative excluded component increase decrease after adjustments and taxs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ExercisePriceRangeTwoMember" xlink:to="ipar_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">The element represents exercise price range two member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne" xlink:label="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne" xlink:to="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxAbstractOne_doc" xml:lang="en-US">The element represents other comprehensive income loss derivative excluded component increase decrease after adjustments and tax abstract one.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1" xlink:label="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1" xlink:to="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax1_doc" xml:lang="en-US">The element represents other comprehensive income loss derivative excluded component increase decrease after adjustments and tax.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1" xlink:label="ipar_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1" xlink:to="ipar_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent1_doc" xml:lang="en-US">The element represents reclassification from aoci current period net of tax attributable to parent1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1" xlink:label="ipar_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1" xlink:to="ipar_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1_doc" xml:lang="en-US">The element represents other comprehensive income loss foreign currency transaction and translation adjustment net of tax1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossBeforeTax1" xlink:label="ipar_OtherComprehensiveIncomeLossBeforeTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossBeforeTax1" xlink:to="ipar_OtherComprehensiveIncomeLossBeforeTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossBeforeTax1_doc" xml:lang="en-US">The element represents other comprehensive income loss before tax1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1" xlink:label="ipar_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1" xlink:to="ipar_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest1_doc" xml:lang="en-US">The element represents other comprehensive income loss net of tax portion attributable to noncontrolling interest1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1" xlink:label="ipar_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1" xlink:to="ipar_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest1_doc" xml:lang="en-US">The element represents comprehensive income net of tax attributable to noncontrolling interest1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ComprehensiveIncomeNetOfTax1" xlink:label="ipar_ComprehensiveIncomeNetOfTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ComprehensiveIncomeNetOfTax1" xlink:to="ipar_ComprehensiveIncomeNetOfTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ComprehensiveIncomeNetOfTax1_doc" xml:lang="en-US">The element represents comprehensive income net of tax1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract" xlink:label="ipar_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract" xlink:to="ipar_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease1Abstract_doc" xml:lang="en-US">The element represents other comprehensive income loss net of tax period increase decrease1 abstract.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredIncomeTaxExpenseBenefit1" xlink:label="ipar_DeferredIncomeTaxExpenseBenefit1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_DeferredIncomeTaxExpenseBenefit1" xlink:to="ipar_DeferredIncomeTaxExpenseBenefit1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_DeferredIncomeTaxExpenseBenefit1_doc" xml:lang="en-US">The element represents deferred income tax expense benefit1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_IncomeLossFromEquityMethodInvestments1" xlink:label="ipar_IncomeLossFromEquityMethodInvestments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_IncomeLossFromEquityMethodInvestments1" xlink:to="ipar_IncomeLossFromEquityMethodInvestments1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_IncomeLossFromEquityMethodInvestments1_doc" xml:lang="en-US">The element represents income loss from equity method investments1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1" xlink:label="ipar_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1" xlink:to="ipar_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1_doc" xml:lang="en-US">The element represents increase decrease in accounts payable and accrued liabilities1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_IncreaseDecreaseInAccountsReceivable1" xlink:label="ipar_IncreaseDecreaseInAccountsReceivable1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_IncreaseDecreaseInAccountsReceivable1" xlink:to="ipar_IncreaseDecreaseInAccountsReceivable1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_IncreaseDecreaseInAccountsReceivable1_doc" xml:lang="en-US">The element represents increase decrease in accounts receivable1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_IncreaseDecreaseInAccruedTaxesPayable1" xlink:label="ipar_IncreaseDecreaseInAccruedTaxesPayable1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_IncreaseDecreaseInAccruedTaxesPayable1" xlink:to="ipar_IncreaseDecreaseInAccruedTaxesPayable1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_IncreaseDecreaseInAccruedTaxesPayable1_doc" xml:lang="en-US">The element represents increase decrease in accrued taxes payable1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_IncreaseDecreaseInInventories1" xlink:label="ipar_IncreaseDecreaseInInventories1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_IncreaseDecreaseInInventories1" xlink:to="ipar_IncreaseDecreaseInInventories1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_IncreaseDecreaseInInventories1_doc" xml:lang="en-US">The element represents increase decrease in inventories1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_IncreaseDecreaseInOperatingLeaseLiability1" xlink:label="ipar_IncreaseDecreaseInOperatingLeaseLiability1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_IncreaseDecreaseInOperatingLeaseLiability1" xlink:to="ipar_IncreaseDecreaseInOperatingLeaseLiability1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_IncreaseDecreaseInOperatingLeaseLiability1_doc" xml:lang="en-US">The element represents increase decrease in operating lease liability1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ScheduleOfValuationAndQualifyingAccountsTableTextBlock" xlink:label="ipar_ScheduleOfValuationAndQualifyingAccountsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ScheduleOfValuationAndQualifyingAccountsTableTextBlock" xlink:to="ipar_ScheduleOfValuationAndQualifyingAccountsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ScheduleOfValuationAndQualifyingAccountsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of valuation and qualifying accounts table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ProvisionForDoubtfulAccounts1" xlink:to="ipar_ProvisionForDoubtfulAccounts1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ProvisionForDoubtfulAccounts1_doc" xml:lang="en-US">The element represents provision for doubtful accounts1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ChangeInFairValueOfDerivatives" xlink:to="ipar_ChangeInFairValueOfDerivatives_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_ChangeInFairValueOfDerivatives_doc" xml:lang="en-US">The element represents change in fair value of derivatives.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_OperatingLeaseMember" xlink:to="ipar_OperatingLeaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_OperatingLeaseMember_doc" xml:lang="en-US">The element represents operating lease member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_RochasFashionBusinessMember" xlink:to="ipar_RochasFashionBusinessMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_RochasFashionBusinessMember_doc" xml:lang="en-US">The element represents rochas fashion business member.</link:label>
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_USExportMember" xlink:label="ipar_USExportMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_USExportMember" xlink:to="ipar_USExportMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_USExportMember_doc" xml:lang="en-US">The element represents us export member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_doc" xml:lang="en-US">The element represents accumulated other comprehensive income loss net of tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_doc" xml:lang="en-US">The element represents accumulated other comprehensive income loss net of tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_4_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_2_lbl" xml:lang="en-US">Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2_lbl" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2_lbl" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCash_2_lbl" xml:lang="en-US">Dividends, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_ChangeInFairValueOfDerivatives" xlink:to="ipar_ChangeInFairValueOfDerivatives_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_ChangeInFairValueOfDerivatives_3_lbl" xml:lang="en-US">Change in Fair Value of Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToMinorityShareholders_2_lbl" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_2_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_2_lbl" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:to="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_2_lbl" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" xlink:to="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_3_lbl" xml:lang="en-US">Less Imputed Interest Based on2.6 Weighted Average Discount Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="us-gaap_OtherCommitmentDueInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInSecondYear" xlink:to="us-gaap_OtherCommitmentDueInSecondYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInSecondYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInThirdYear" xlink:to="us-gaap_OtherCommitmentDueInThirdYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInThirdYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFourthYear" xlink:to="us-gaap_OtherCommitmentDueInFourthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInFourthYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInFifthYear" xlink:to="us-gaap_OtherCommitmentDueInFifthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInFifthYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueAfterFifthYear" xlink:to="us-gaap_OtherCommitmentDueAfterFifthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueAfterFifthYear_2_lbl" xml:lang="en-US">Other Commitment, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_2_lbl" xml:lang="en-US">Long-Lived Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1_4_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:to="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2_4_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Net Of Tax [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_3_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>ipar-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://interparfumsinc.com/role/Cover" xlink:href="ipar-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheets" xlink:href="ipar-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:href="ipar-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfIncome" xlink:href="ipar-20221231.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:href="ipar-20221231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="ipar-20221231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:href="ipar-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:href="ipar-20221231.xsd#ImpactOfCovid-19Pandemic" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreements" xlink:href="ipar-20221231.xsd#RecentAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Inventories" xlink:href="ipar-20221231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:href="ipar-20221231.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:href="ipar-20221231.xsd#DerivativeFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpenses" xlink:href="ipar-20221231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanks" xlink:href="ipar-20221231.xsd#LoansPayableBanks" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebt" xlink:href="ipar-20221231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Commitments" xlink:href="ipar-20221231.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Equity" xlink:href="ipar-20221231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreas" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxes" xlink:href="ipar-20221231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="ipar-20221231.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:href="ipar-20221231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" xlink:href="ipar-20221231.xsd#ScheduleIi-ValuationAndQualifyingAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesTables" xlink:href="ipar-20221231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="ipar-20221231.xsd#FairValueOfFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:href="ipar-20221231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtTables" xlink:href="ipar-20221231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsTables" xlink:href="ipar-20221231.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityTables" xlink:href="ipar-20221231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreasTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:href="ipar-20221231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="ipar-20221231.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:href="ipar-20221231.xsd#ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:href="ipar-20221231.xsd#ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:href="ipar-20221231.xsd#ScheduleOfLanvinBrandNameForOurClassDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:href="ipar-20221231.xsd#CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:href="ipar-20221231.xsd#RecentAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:href="ipar-20221231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:href="ipar-20221231.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:href="ipar-20221231.xsd#ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="ipar-20221231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="ipar-20221231.xsd#PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:href="ipar-20221231.xsd#TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#AccruedExpensesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:href="ipar-20221231.xsd#Long-termDebtConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:href="ipar-20221231.xsd#LoansPayableBanksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:href="ipar-20221231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:href="ipar-20221231.xsd#MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:href="ipar-20221231.xsd#MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:href="ipar-20221231.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:href="ipar-20221231.xsd#FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:href="ipar-20221231.xsd#EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:href="ipar-20221231.xsd#AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:href="ipar-20221231.xsd#ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:href="ipar-20221231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:href="ipar-20221231.xsd#ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:href="ipar-20221231.xsd#NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:href="ipar-20221231.xsd#InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" xlink:href="ipar-20221231.xsd#SegmentsAndGeographicAreasDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:href="ipar-20221231.xsd#ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:href="ipar-20221231.xsd#TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:href="ipar-20221231.xsd#DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipar-20221231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:href="ipar-20221231.xsd#ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:href="ipar-20221231.xsd#ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:href="ipar-20221231.xsd#FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:type="simple" />
    <link:roleRef roleURI="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" xlink:href="ipar-20221231.xsd#ScheduleOfValuationAndQualifyingAccountsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaapIncomeTaxesReceivable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIncomeTaxesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="loc_us-gaapImpairmentOfLeasehold" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapImpairmentOfLeasehold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" xlink:title="00000005 - Statement - Consolidated Statements of Comprehensive Income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaapReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Changes in Shareholder&apos;s Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:label="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparTransferOfSubsidiarySharesPurchasedToTreasuryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleTransferToTradingLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleTransferToTradingLoss_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleTransferToTradingLoss_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NetDerivativeInstrumentLossNetOfTax" xlink:label="loc_iparNetDerivativeInstrumentLossNetOfTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_iparNetDerivativeInstrumentLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ProvisionForDoubtfulAccounts1" xlink:label="loc_iparProvisionForDoubtfulAccounts1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_iparProvisionForDoubtfulAccounts1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:label="loc_us-gaapProvisionForLoanLeaseAndOtherLosses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ChangeInFairValueOfDerivatives" xlink:label="loc_iparChangeInFairValueOfDerivatives" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_iparChangeInFairValueOfDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="loc_us-gaapProceedsFromSaleMaturityAndCollectionsOfInvestments" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:label="loc_iparSupplementalDisclosureOfCashFlowInformationAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_iparSupplementalDisclosureOfCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparSupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - The Company and its Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" xlink:title="00000009 - Disclosure - Impact of COVID-19 Pandemic">
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DisclosureImpactOfCovid19PandemicAbstract" xlink:label="loc_iparDisclosureImpactOfCovid19PandemicAbstract" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ImpactOfCOVID19PandemicTextBlock" xlink:label="loc_iparImpactOfCOVID19PandemicTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureImpactOfCovid19PandemicAbstract" xlink:to="loc_iparImpactOfCOVID19PandemicTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreements" xlink:title="00000010 - Disclosure - Recent Agreements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstruments" xlink:title="00000012 - Disclosure - Fair Value of Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstruments" xlink:title="00000013 - Disclosure - Derivative Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" xlink:title="00000014 - Disclosure - Property, Equipment and Leasehold Improvements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" xlink:title="00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpenses" xlink:title="00000016 - Disclosure - Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanks" xlink:title="00000017 - Disclosure - Loans Payable &#8211; Banks">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebt" xlink:title="00000018 - Disclosure - Long-Term Debt">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Commitments" xlink:title="00000019 - Disclosure - Commitments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Equity" xlink:title="00000020 - Disclosure - Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" xlink:title="00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreas" xlink:title="00000022 - Disclosure - Segments and Geographic Areas">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:title="00000024 - Disclosure - Accumulated Other Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaapComprehensiveIncomeNoteTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNoteTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" xlink:title="00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" xlink:title="00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:label="loc_iparReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_iparReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" xlink:title="00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" xlink:title="00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionSalesReturns" xlink:label="loc_us-gaapRevenueRecognitionSalesReturns" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionSalesReturns" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAllowances" xlink:label="loc_us-gaapRevenueRecognitionAllowances" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="loc_us-gaapLessorLeasesPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLessorLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy" xlink:label="loc_us-gaapConsolidationSubsidiaryStockIssuancesPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationSubsidiaryStockIssuancesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepurchaseAgreementsCollateralPolicy" xlink:label="loc_us-gaapRepurchaseAgreementsCollateralPolicy" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRepurchaseAgreementsCollateralPolicy" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesTables" xlink:title="00000030 - Disclosure - Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" xlink:title="00000031 - Disclosure - Fair Value of Financial Instruments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" xlink:title="00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" xlink:title="00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock" xlink:label="loc_us-gaapScheduleOfImpairedIntangibleAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfImpairedIntangibleAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesTables" xlink:title="00000034 - Disclosure - Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtTables" xlink:title="00000035 - Disclosure - Long-Term Debt (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsTables" xlink:title="00000036 - Disclosure - Commitments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" xlink:label="loc_iparScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_iparScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:label="loc_srtContractualObligationFiscalYearMaturityScheduleTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_srtContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityTables" xlink:title="00000037 - Disclosure - Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:label="loc_us-gaapCashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" xlink:title="00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" xlink:title="00000039 - Disclosure - Segments and Geographic Areas (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesTables" xlink:title="00000040 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:title="00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" xlink:title="00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" xlink:title="00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)">
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" xlink:title="00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" xlink:title="00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ProductSalesConcentrationRiskMember" xlink:label="loc_iparProductSalesConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_iparProductSalesConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_MontblancMember" xlink:label="loc_iparMontblancMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparMontblancMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_JimmyChooMember" xlink:label="loc_iparJimmyChooMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparJimmyChooMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CoachMember" xlink:label="loc_iparCoachMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparCoachMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_GUESSMember" xlink:label="loc_iparGUESSMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_iparGUESSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis" xlink:label="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueConcentrationOfRiskDisclosureItemsDomain" xlink:label="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsAxis" xlink:to="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_JanvinMember" xlink:label="loc_iparJanvinMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueConcentrationOfRiskDisclosureItemsDomain" xlink:to="loc_iparJanvinMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:label="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" xlink:label="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis" xlink:to="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditRiskMember" xlink:label="loc_us-gaapCreditRiskMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain" xlink:to="loc_us-gaapCreditRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtRangeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability" xlink:label="loc_us-gaapContractWithCustomerRefundLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRefundLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRightToRecoverProduct" xlink:label="loc_us-gaapContractWithCustomerRightToRecoverProduct" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRightToRecoverProduct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" xlink:title="00000047 - Disclosure - Recent Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EmanuelUngarMember" xlink:label="loc_iparEmanuelUngarMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_iparEmanuelUngarMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionMember" xlink:label="loc_iparRochasFashionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_iparRochasFashionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DonnaKaranAndDKNYMember" xlink:label="loc_iparDonnaKaranAndDKNYMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparDonnaKaranAndDKNYMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionMember" xlink:label="loc_iparRochasFashionMember_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparRochasFashionMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtOwnershipAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtCurrencyAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:label="loc_us-gaapImpairmentChargeOnReclassifiedAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapImpairmentChargeOnReclassifiedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts" xlink:label="loc_us-gaapAcquisitionCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapLongTermDebtTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" xlink:title="00000048 - Disclosure - Schedule of inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InventoriesDetailsNarrative" xlink:title="00000049 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" xlink:title="00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaapAssetsFairValueDisclosureAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:label="loc_us-gaapInterestRateFairValueHedgeDerivativeAtFairValueNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:to="loc_us-gaapInterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:label="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:to="loc_us-gaapForeignCurrencyFairValueHedgeAssetAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue" xlink:label="loc_us-gaapForeignCurrencyFairValueHedgeLiabilityAtFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyFairValueHedgeLiabilityAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:label="loc_us-gaapInterestRateDerivativeLiabilitiesAtFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInterestRateDerivativeLiabilitiesAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaapDerivativeNotionalAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeNotionalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" xlink:title="00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" xlink:title="00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_SubtotalMember" xlink:label="loc_iparSubtotalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_iparSubtotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:label="loc_us-gaapIndefinitelivedIntangibleAssetsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapIndefinitelivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RochasFashionBusinessMember" xlink:label="loc_iparRochasFashionBusinessMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_iparRochasFashionBusinessMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="loc_us-gaapIndefiniteLivedLicenseAgreements" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIndefiniteLivedLicenseAgreements" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" xlink:title="00000056 - Disclosure - Accrued expenses consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaapAccruedAdvertisingCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedAdvertisingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DueVendorsNotYetInvoiced" xlink:label="loc_iparDueVendorsNotYetInvoiced" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_iparDueVendorsNotYetInvoiced" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapCustomerRefundLiabilityCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapCustomerRefundLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" xlink:title="00000057 - Disclosure - Long-term debt consists of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLoansPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableTwoMember" xlink:label="loc_iparLoansPayableTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableThreeMember" xlink:label="loc_iparLoansPayableThreeMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_NumberOfInstallment" xlink:label="loc_iparNumberOfInstallment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_iparNumberOfInstallment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" xlink:title="00000058 - Disclosure - Loans Payable &#8211; Banks (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DomesticSubsidiariesMember" xlink:label="loc_iparDomesticSubsidiariesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparDomesticSubsidiariesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ForeignSubsidiariesMember" xlink:label="loc_iparForeignSubsidiariesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_iparForeignSubsidiariesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LondonInterbankOfferedRateMember" xlink:label="loc_iparLondonInterbankOfferedRateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparLondonInterbankOfferedRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EuroInterbankOfferedRateMember" xlink:label="loc_iparEuroInterbankOfferedRateMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_iparEuroInterbankOfferedRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" xlink:title="00000059 - Disclosure - Long-Term Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLoansPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LoansPayableOneMember" xlink:label="loc_iparLoansPayableOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_iparLoansPayableOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtDescription" xlink:label="loc_us-gaapLongTermDebtDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" xlink:title="00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate" xlink:label="loc_iparLessImputedInterestBasedOn2.6WeightedaverageDiscountRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_iparLessImputedInterestBasedOn2.6WeightedaverageDiscountRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal" xlink:label="loc_iparLesseeOperatingLeaseLiabilityPaymentsDueNetTotal" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_iparLesseeOperatingLeaseLiabilityPaymentsDueNetTotal" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" xlink:title="00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaapOtherCommitmentDueInSecondYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInSecondYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaapOtherCommitmentDueInThirdYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInThirdYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaapOtherCommitmentDueInFourthYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInFourthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaapOtherCommitmentDueInFifthYear" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInFifthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaapOtherCommitmentDueAfterFifthYear" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentDueAfterFifthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaapOtherCommitment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/CommitmentsDetailsNarrative" xlink:title="00000062 - Disclosure - Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeaseMember" xlink:label="loc_iparOperatingLeaseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_iparOperatingLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OperatingLeaseOfRelatedToRentalExpenses" xlink:label="loc_iparOperatingLeaseOfRelatedToRentalExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_iparOperatingLeaseOfRelatedToRentalExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RoyaltyExpenseNetSalesPercentage" xlink:label="loc_iparRoyaltyExpenseNetSalesPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_iparRoyaltyExpenseNetSalesPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" xlink:title="00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" xlink:title="00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember" xlink:label="loc_us-gaapOperatingIncomeLossMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapOperatingIncomeLossMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" xlink:title="00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" xlink:title="00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" xlink:title="00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="loc_us-gaapDeferredTaxExpenseFromStockOptionsExercised" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapDeferredTaxExpenseFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" xlink:title="00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeOneMember" xlink:label="loc_iparExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeTwoMember" xlink:label="loc_iparExercisePriceRangeTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeThreeMember" xlink:label="loc_iparExercisePriceRangeThreeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ExercisePriceRangeFourMember" xlink:label="loc_iparExercisePriceRangeFourMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_iparExercisePriceRangeFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/EquityDetailsNarrative" xlink:title="00000069 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapStockOptionMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_StockOptionOneMember" xlink:label="loc_iparStockOptionOneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_iparStockOptionOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSASubsidiaryMember" xlink:label="loc_iparInterparfumsSASubsidiaryMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_iparInterparfumsSASubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EmployeesMember" xlink:label="loc_iparEmployeesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_iparEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_srtOwnershipAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_InterparfumsSAMember" xlink:label="loc_iparInterparfumsSAMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_iparInterparfumsSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockSplits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionMadeToLimitedPartnerUnitDistribution" xlink:label="loc_us-gaapDistributionMadeToLimitedPartnerUnitDistribution" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDistributionMadeToLimitedPartnerUnitDistribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_PercentageOfIncreaseInAnnualDividend" xlink:label="loc_iparPercentageOfIncreaseInAnnualDividend" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_iparPercentageOfIncreaseInAnnualDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="loc_us-gaapDividendsPayableAmountPerShare" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="loc_us-gaapDividendsPayableAmountPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" xlink:title="00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" xlink:title="00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" xlink:title="00000072 - Disclosure - Information on the Company&#8217;s operations by segments is as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EliminationsMember" xlink:label="loc_iparEliminationsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapInterestExpense_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionsToOtherAssetsAmount" xlink:label="loc_us-gaapAdditionsToOtherAssetsAmount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAdditionsToOtherAssetsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember" xlink:label="loc_srtNorthAmericaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtNorthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember" xlink:label="loc_srtAsiaMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MiddleEastMember" xlink:label="loc_us-gaapMiddleEastMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapMiddleEastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CentralAndSouthAmericaMember" xlink:label="loc_iparCentralAndSouthAmericaMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparCentralAndSouthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_OtherSegmentCountryMember" xlink:label="loc_iparOtherSegmentCountryMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_iparOtherSegmentCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" xlink:title="00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnitedStatesMember" xlink:label="loc_iparUnitedStatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedStatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_FranceMember" xlink:label="loc_iparFranceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparFranceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_RussiaMember" xlink:label="loc_iparRussiaMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparRussiaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_UnitedKingdomMember" xlink:label="loc_iparUnitedKingdomMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_iparUnitedKingdomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" xlink:title="00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" xlink:title="00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" xlink:title="00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" xlink:title="00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredTaxAssetsInventoryAndAccountsReceivable" xlink:label="loc_iparDeferredTaxAssetsInventoryAndAccountsReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_iparDeferredTaxAssetsInventoryAndAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredTaxLiabilitiesBuildingExpenses" xlink:label="loc_iparDeferredTaxLiabilitiesBuildingExpenses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_iparDeferredTaxLiabilitiesBuildingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOtherFiniteLivedAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:label="loc_iparDeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_iparDeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" xlink:title="00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:label="loc_iparEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_iparEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000080 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_ForeignDerivedIntangibleIncomeMember" xlink:label="loc_iparForeignDerivedIntangibleIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_iparForeignDerivedIntangibleIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" xlink:title="00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:label="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_iparAccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:label="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1" xlink:label="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax1_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:label="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2" xlink:label="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax2_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_iparAccumulatedOtherComprehensiveIncomeLossNetOfTax2_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" xlink:title="00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" xlink:title="00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)">
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:label="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ipar-20221231.xsd#ipar_CashHeldInEscrowIncludedInOtherAssets" xlink:label="loc_iparCashHeldInEscrowIncludedInOtherAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_iparCashHeldInEscrowIncludedInOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iparDisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" xlink:title="00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srtValuationAndQualifyingAccountsDisclosureTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_srtValuationAndQualifyingAccountsDisclosureTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureTable" xlink:to="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaapValuationAllowancesAndReservesTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureTable" xlink:to="loc_us-gaapValuationAllowancesAndReservesTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaapValuationAllowancesAndReservesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:to="loc_us-gaapValuationAllowancesAndReservesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaapAllowanceForCreditLossMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapAllowanceForCreditLossMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaapSalesReturnsAndAllowancesMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapSalesReturnsAndAllowancesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserveMember" xlink:label="loc_us-gaapInventoryValuationReserveMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapInventoryValuationReserveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="loc_us-gaapValuationAllowancesAndReservesChargedToOtherAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaapValuationAllowancesAndReservesDeductions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672461776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-16469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Inter
Parfums, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000822663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3275609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">551 Fifth Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">983.2640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading symbol</a></td>
<td class="text">IPAR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,274,342,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,109,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Mazars USA LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672646160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 104,713<span></span>
</td>
<td class="nump">$ 159,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">150,833<span></span>
</td>
<td class="nump">160,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">197,584<span></span>
</td>
<td class="nump">159,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">289,984<span></span>
</td>
<td class="nump">198,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Receivables, other</a></td>
<td class="nump">28,803<span></span>
</td>
<td class="nump">10,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">15,650<span></span>
</td>
<td class="nump">21,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">787,724<span></span>
</td>
<td class="nump">709,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and leasehold improvements, net</a></td>
<td class="nump">166,722<span></span>
</td>
<td class="nump">149,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">27,964<span></span>
</td>
<td class="nump">33,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Trademarks, licenses and other intangible assets, net</a></td>
<td class="nump">290,853<span></span>
</td>
<td class="nump">214,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">11,159<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">24,120<span></span>
</td>
<td class="nump">30,586<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,308,542<span></span>
</td>
<td class="nump">1,145,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">28,547<span></span>
</td>
<td class="nump">15,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td>
<td class="nump">5,296<span></span>
</td>
<td class="nump">6,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">88,388<span></span>
</td>
<td class="nump">81,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">213,621<span></span>
</td>
<td class="nump">136,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">8,715<span></span>
</td>
<td class="nump">4,328<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">344,567<span></span>
</td>
<td class="nump">244,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long&#8211;term debt, less current portion</a></td>
<td class="nump">151,494<span></span>
</td>
<td class="nump">132,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, less current portion</a></td>
<td class="nump">24,335<span></span>
</td>
<td class="nump">29,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Inter Parfums, Inc. shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value. Authorized 1,000,000 shares: none issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value. Authorized 100,000,000 shares: outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">90,186<span></span>
</td>
<td class="nump">87,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">620,095<span></span>
</td>
<td class="nump">560,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(56,056)<span></span>
</td>
<td class="num">(38,432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021</a></td>
<td class="num">(37,475)<span></span>
</td>
<td class="num">(37,475)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Inter Parfums, Inc. shareholders&#8217; equity</a></td>
<td class="nump">616,782<span></span>
</td>
<td class="nump">571,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">171,364<span></span>
</td>
<td class="nump">166,412<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">788,146<span></span>
</td>
<td class="nump">738,332<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 1,308,542<span></span>
</td>
<td class="nump">$ 1,145,364<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671794320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">31,967,300<span></span>
</td>
<td class="nump">31,830,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">9,864,805<span></span>
</td>
<td class="nump">9,864,805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672478144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,086,653<span></span>
</td>
<td class="nump">$ 879,516<span></span>
</td>
<td class="nump">$ 539,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">392,231<span></span>
</td>
<td class="nump">322,614<span></span>
</td>
<td class="nump">208,278<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">694,422<span></span>
</td>
<td class="nump">556,902<span></span>
</td>
<td class="nump">330,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expenses</a></td>
<td class="nump">492,370<span></span>
</td>
<td class="nump">406,459<span></span>
</td>
<td class="nump">260,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLeasehold', window );">Impairment loss</a></td>
<td class="nump">7,749<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">194,303<span></span>
</td>
<td class="nump">148,050<span></span>
</td>
<td class="nump">70,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">3,599<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Loss (gain) on foreign currency</a></td>
<td class="nump">1,921<span></span>
</td>
<td class="num">(2,338)<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and investment income</a></td>
<td class="num">(5,486)<span></span>
</td>
<td class="num">(3,403)<span></span>
</td>
<td class="num">(2,865)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other loss (income)</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">&#160;&#160;Nonoperating Income (Expense)</a></td>
<td class="nump">83<span></span>
</td>
<td class="num">(2,969)<span></span>
</td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">194,219<span></span>
</td>
<td class="nump">151,019<span></span>
</td>
<td class="nump">69,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">43,182<span></span>
</td>
<td class="nump">40,992<span></span>
</td>
<td class="nump">19,381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">151,037<span></span>
</td>
<td class="nump">110,027<span></span>
</td>
<td class="nump">49,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to the noncontrolling interest</a></td>
<td class="nump">30,099<span></span>
</td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">11,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 120,938<span></span>
</td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net income attributable to Inter Parfums, Inc. common shareholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 3.78<span></span>
</td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">31,859,417<span></span>
</td>
<td class="nump">31,676,796<span></span>
</td>
<td class="nump">31,536,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">31,988,753<span></span>
</td>
<td class="nump">31,835,408<span></span>
</td>
<td class="nump">31,654,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share</a></td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLeasehold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLeasehold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671765152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 151,037<span></span>
</td>
<td class="nump">$ 110,027<span></span>
</td>
<td class="nump">$ 49,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax', window );">Net derivative instrument income (loss), &#160;net of tax</a></td>
<td class="nump">2,356<span></span>
</td>
<td class="num">(1,367)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Transfer of OCI into earnings</a></td>
<td class="nump">992<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Translation adjustments, net of tax&#160;</a></td>
<td class="num">(29,683)<span></span>
</td>
<td class="num">(42,967)<span></span>
</td>
<td class="nump">47,912<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income (loss), before tax</a></td>
<td class="num">(26,335)<span></span>
</td>
<td class="num">(44,334)<span></span>
</td>
<td class="nump">47,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">124,702<span></span>
</td>
<td class="nump">65,693<span></span>
</td>
<td class="nump">97,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income attributable to noncontrolling interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">30,099<span></span>
</td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">11,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Net derivative instrument income (loss), &#160;net of tax</a></td>
<td class="nump">647<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Translation adjustments, net of tax</a></td>
<td class="num">(9,358)<span></span>
</td>
<td class="num">(11,524)<span></span>
</td>
<td class="nump">14,004<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income (loss), net of tax, atributable to noncontrolling interest</a></td>
<td class="nump">21,388<span></span>
</td>
<td class="nump">10,717<span></span>
</td>
<td class="nump">25,734<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Inter Parfums Inc.</a></td>
<td class="nump">$ 103,314<span></span>
</td>
<td class="nump">$ 54,976<span></span>
</td>
<td class="nump">$ 72,075<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341667022848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholder's Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 70,664<span></span>
</td>
<td class="nump">$ 474,637<span></span>
</td>
<td class="num">$ (39,853)<span></span>
</td>
<td class="num">$ (37,475)<span></span>
</td>
<td class="nump">$ 140,994<span></span>
</td>
<td class="nump">$ 608,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Shares issued upon exercise of stock options</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,711<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued for license acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares', window );">Transfer of subsidiary shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">49,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NetDerivativeInstrumentLossNetOfTax', window );">Net derivative instrument loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">75,708<span></span>
</td>
<td class="nump">503,567<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">(37,475)<span></span>
</td>
<td class="nump">166,615<span></span>
</td>
<td class="nump">702,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Shares issued upon exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued for license acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares', window );">Transfer of subsidiary shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(791)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">110,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,836)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NetDerivativeInstrumentLossNetOfTax', window );">Net derivative instrument loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">87,132<span></span>
</td>
<td class="nump">560,663<span></span>
</td>
<td class="num">(38,432)<span></span>
</td>
<td class="num">(37,475)<span></span>
</td>
<td class="nump">166,412<span></span>
</td>
<td class="nump">738,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Shares issued upon exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">2,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued for license acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares', window );">Transfer of subsidiary shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">30,099<span></span>
</td>
<td class="nump">151,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss', window );">Transfer from other comprehensive income into earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NetDerivativeInstrumentLossNetOfTax', window );">Net derivative instrument loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 90,186<span></span>
</td>
<td class="nump">$ 620,095<span></span>
</td>
<td class="num">$ (56,056)<span></span>
</td>
<td class="num">$ (37,475)<span></span>
</td>
<td class="nump">$ 171,364<span></span>
</td>
<td class="nump">$ 788,146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_NetDerivativeInstrumentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents net derivative instrument loss net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_NetDerivativeInstrumentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents transfer of subsidiary shares purchased to treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss recognized in earnings from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) to investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671638304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 151,037<span></span>
</td>
<td class="nump">$ 110,027<span></span>
</td>
<td class="nump">$ 49,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization including impairment loss</a></td>
<td class="nump">22,539<span></span>
</td>
<td class="nump">12,698<span></span>
</td>
<td class="nump">9,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_ProvisionForDoubtfulAccounts1', window );">Provision for doubtful accounts</a></td>
<td class="nump">2,353<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Noncash stock compensation</a></td>
<td class="nump">3,143<span></span>
</td>
<td class="nump">2,853<span></span>
</td>
<td class="nump">3,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of income of equity investment</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses', window );">Lease expense</a></td>
<td class="nump">4,980<span></span>
</td>
<td class="nump">7,302<span></span>
</td>
<td class="nump">5,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense (benefit)</a></td>
<td class="num">(3,604)<span></span>
</td>
<td class="num">(465)<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_ChangeInFairValueOfDerivatives', window );">Change in fair value of derivatives</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(59,640)<span></span>
</td>
<td class="num">(45,395)<span></span>
</td>
<td class="nump">13,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(98,297)<span></span>
</td>
<td class="num">(49,815)<span></span>
</td>
<td class="nump">19,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(13,651)<span></span>
</td>
<td class="num">(16,725)<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(4,795)<span></span>
</td>
<td class="num">(7,503)<span></span>
</td>
<td class="num">(5,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">106,857<span></span>
</td>
<td class="nump">103,046<span></span>
</td>
<td class="num">(32,239)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Income taxes, net</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="nump">2,698<span></span>
</td>
<td class="num">(3,279)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">115,150<span></span>
</td>
<td class="nump">119,586<span></span>
</td>
<td class="nump">64,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(1,038)<span></span>
</td>
<td class="num">(55,691)<span></span>
</td>
<td class="num">(7,582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">896<span></span>
</td>
<td class="nump">10,644<span></span>
</td>
<td class="nump">11,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, equipment and leasehold improvements</a></td>
<td class="num">(33,756)<span></span>
</td>
<td class="num">(141,274)<span></span>
</td>
<td class="num">(11,011)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payment for intangible assets acquired</a></td>
<td class="num">(98,865)<span></span>
</td>
<td class="num">(1,545)<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(13,998)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(132,763)<span></span>
</td>
<td class="num">(187,866)<span></span>
</td>
<td class="num">(22,329)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(19,861)<span></span>
</td>
<td class="num">(43,056)<span></span>
</td>
<td class="num">(13,725)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">52,492<span></span>
</td>
<td class="nump">157,382<span></span>
</td>
<td class="nump">13,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">6,003<span></span>
</td>
<td class="nump">5,393<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(63,743)<span></span>
</td>
<td class="num">(31,690)<span></span>
</td>
<td class="num">(20,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Dividends paid to noncontrolling interests</a></td>
<td class="num">(16,056)<span></span>
</td>
<td class="num">(9,836)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchase of subsidiary shares from noncontrolling interests</a></td>
<td class="num">(4,403)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(45,568)<span></span>
</td>
<td class="nump">78,193<span></span>
</td>
<td class="num">(18,645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(493)<span></span>
</td>
<td class="num">(11,207)<span></span>
</td>
<td class="nump">12,245<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(63,674)<span></span>
</td>
<td class="num">(1,294)<span></span>
</td>
<td class="nump">36,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents &#8211; beginning of year</a></td>
<td class="nump">168,387<span></span>
</td>
<td class="nump">169,681<span></span>
</td>
<td class="nump">133,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents &#8211; end of year</a></td>
<td class="nump">104,713<span></span>
</td>
<td class="nump">168,387<span></span>
</td>
<td class="nump">169,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash paid for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 38,492<span></span>
</td>
<td class="nump">$ 40,497<span></span>
</td>
<td class="nump">$ 21,772<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ProvisionForDoubtfulAccounts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents provision for doubtful accounts1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ProvisionForDoubtfulAccounts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLeaseAndOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341677953216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">The Company and its Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zd1EKIHGXhJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.5in; text-align: left"><b>(1)</b></td><td id="xdx_828_znbAHDBviiWh" style="text-align: justify"><b>The Company and its Significant Accounting Policies</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zNT0b1hpSc">Business of the Company</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries
(the &#8220;Company&#8221;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage">21</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right">17</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right">11</td><td style="text-align: left">%</td></tr>
</table>


<p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10%
or more of consolidated net sales.</p>

<p id="xdx_852_zkLqrsGkJApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zAi7NibSjYo">Basis of Preparation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The
consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA">72</span>% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances
and transactions have been eliminated</span>.</p>

<p id="xdx_858_zhK8rh8t0VFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_zxhhk0ZXFq5">Management Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.</p>

<p id="xdx_850_zBwbKroun2Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_z6rIV82Xvpje">Foreign Currency Translation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#8217; equity.</p>

<p id="xdx_85D_z8zurES5J9S2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zQ2usvaXHXs5">Cash and Cash Equivalents
and Short-Term Investments</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.</p>

<p id="xdx_85D_zZPquTcOQRla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>





<p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zbpNXfQ5UYnk">Accounts Receivable</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts">4.7 million</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts">2.2 million</span> as of December 31, 2022, and 2021, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#8217;s financial position, as well as previously established
buying patterns.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_850_zeVmfblcJqaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zB6czE4UKP8b">Inventories</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor
and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound
freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#8217;s customers.</p>

<p id="xdx_859_z8E6H25uy7b6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_z8KfMRukTmb">Derivatives</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#8217;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p>

<p id="xdx_85A_zBXJO3IV73i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zjzUiz8tMvX9">Property, Equipment
and Leasehold Improvements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.</p>

<p id="xdx_859_zEts96VpM581" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>





<p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zftBm8SvL7Bd">Long-Lived Assets</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital">9.8</span>% and <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital">7.47</span>% in 2022 and 2021, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p>

<p id="xdx_850_zz1nwOS3naq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_866_zn7swQC93rge">Revenue Recognition</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in
either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable,
collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms.
Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#8217;
freight and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs">15.8 million</span>, $1<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs">0.0 million</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs">5.0 million</span>
in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements
of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue
concentration of credit risk. No one customer represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage">10</span></span></span>% or more of net sales in 2022, 2021 or 2020.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>





<p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_znG0d2ejty9j">Sales Returns</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $<span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability">8.6 million</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability">5.1 million</span> at December 31, 2022 and 2021, respectively, and
the amounts recognized for the rights to recover products was $<span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products">3.2 million</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products">1.9 million</span> at December 31, 2022 and 2021, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p>

<p id="xdx_850_zIceJJmoSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpZS8YHNN1fl">Payments to Customers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.</p>

<p id="xdx_857_zXoMw6n70mia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zIZybcTPiYQ3">Advertising and Promotion</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs">212.4 million</span>, $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs">171.1 million</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs">91.7 million</span> for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost">43.1 million</span>, $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost">36.9 million</span> and $<span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost">26.4 million</span>
in 2022, 2021 and 2020, respectively.</p>

<p id="xdx_854_zH3jODrKQ9K8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zqec8gj621I2">Package Development
Costs</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.</p>

<p id="xdx_853_zOZeg8z2S3Xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zxkrSXeufu6">Operating Leases</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p>

<p id="xdx_85F_zrc4W7gVcqB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>





<p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zSbdHovAxh91">License Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#8217; trademarks. The licenses typically have an initial term of approximately <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0811">5</span></span> to <span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0813">15</span></span> years, and are potentially
renewable subject to the Company&#8217;s compliance with the license agreement provisions. The remaining terms, excluding potential
renewal periods, range from approximately <span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">1</span></span> to <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">12</span></span> years. Under each license, the Company is required to pay royalties in the range
of <span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales">6</span>% to <span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales">10</span>% to the licensor, at least annually, based on net sales to third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.</p>

<p id="xdx_85B_zh64ekd6mbY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zWZrltbKXMm6">Income Taxes</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets
assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset
will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued
interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p>

<p id="xdx_85D_zixJEyMNLdl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86D_ziVu2DnrRlH1">Issuance of Common Stock
by Consolidated Subsidiary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company&#8217;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#8217;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.</p>

<p id="xdx_854_zakTrhiCpMz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_861_zOSRLpHtTRY4">Treasury Stock</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize
share repurchases of the Company&#8217;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.</p>

<p id="xdx_859_zckO1rZ36bOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341768291584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impact of COVID-19 Pandemic<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DisclosureImpactOfCovid19PandemicAbstract', window );"><strong>Impact Of Covid-19 Pandemic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_ImpactOfCOVID19PandemicTextBlock', window );">Impact of COVID-19 Pandemic</a></td>
<td class="text"><p id="xdx_80B_ecustom--ImpactOfCOVID19PandemicTextBlock_zmuAy07zyRm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td id="xdx_823_zTZ7NfolXM2g">Impact of COVID-19 Pandemic</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A novel strain of coronavirus
(&#8220;COVID-19&#8221;) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In
response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain
classes of workers from reporting to work.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Retail store closings, event
cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable
impact on our results of operations in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Business significantly improved
in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased
online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world
has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international
air travel remains curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19
has significantly restricted international travel, the travel retail business is beginning to pick up. Lastly, the improved economy
has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport
goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger
or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in
larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers
and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin
lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might
continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first
half of 2023.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureImpactOfCovid19PandemicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureImpactOfCovid19PandemicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ImpactOfCOVID19PandemicTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents impact of c o v i d19 pandemic text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ImpactOfCOVID19PandemicTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341677927280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Recent Agreements</a></td>
<td class="text"><p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_z4GAOYWVwyJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td id="xdx_820_zvvCe9AfJeN1">Recent Agreements</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Lacoste</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, we closed a
transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution
of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Dunhill</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2022, we announced that
the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and
sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory
for a limited time as is customary in the fragrance industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, <span id="xdx_901_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--EmanuelUngarMember_z7orWVKIZK91" title="Description of recent agreement">we also entered
into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro
Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro
brand.</span> Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary
in our industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered
into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zGE1fIms7cI" title="Shares issue">65,342</span> shares of Inter Parfums, Inc. common
stock valued at $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zP05Z3DKOrIh" title="Shares value">5</span>.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new
fragrances under these brands in 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective January 1, 2021,
<span id="xdx_90D_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_z1l2yFbEEYbc" title="Description of recent agreement">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in
royalties to be received. As a result, in the first quarter of 2021, we took a $<span id="xdx_903_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20210331__dei--LegalEntityAxis__custom--RochasFashionMember_zYTSjFo1J7o5" title="Impairment Charge on Reclassified Assets">2.4 million</span> impairment charge on our Rochas fashion
trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after
an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option
for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span title="Description of recent agreement">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Land
and Building Acquisition - Future Headquarters in Paris</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
April 2021, Interparfums SA, our <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z4n07UjPSSTf" title="Ownership percentage">73</span>% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de
Solf&#233;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings
connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
purchase price includes the complete renovation of the site. As of December 31, 2022, $<span id="xdx_904_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231_z5jptVveA3dg" title="Purchase price, period cost">148.1 million</span> of the purchase price, including
approximately $<span id="xdx_90F_eus-gaap--AcquisitionCosts_dm_c20220101__20221231_zKT9pTNyaDc6" title="Acquisition costs, period cost">4.4 million</span> of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022. The purchase price has been allocated approximately $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zDCgyiyNbLfc" title="Purchase price, period cost">61.1 million</span> to land and $<span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zLQLzk0FdM0j" title="Purchase price, period cost">87.0 million</span>
to the building. The building, which was delivered on February&#160;28, 2022, includes the building structure, development of
the property, fa&#231;ade waterproofing, general and technical installations and interior fittings that will be depreciated
over a range of <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zGe7YQOs4dY3" title="Depreciated over a range::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl0862">7</span></span> to <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zZmef4g63Fse" title="Depreciated over a range::XDX::P50Y"><span style="-sec-ix-hidden: xdx2ixbrl0864">50</span></span> years. The Company has elected to depreciate the building cost based on the useful lives of its components.
Approximately $<span id="xdx_905_eus-gaap--EscrowDeposit_iI_dm_c20221231_zKMnXiE3mdkl" title="Cash held in escrow is included in other assets">3.4 million</span> of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
acquisition was financed by a <span id="xdx_903_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_z4VGt2LRdjB2" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0868">10</span></span>-year &#8364;<span id="xdx_906_eus-gaap--LineOfCredit_iI_pn6n6_uUSDEUR_c20221231_zKVvzG0WcZaf" title="Long-term line of credit">120</span> million (approximately $<span id="xdx_900_eus-gaap--LineOfCredit_iI_dm_c20221231_zfoF6FEzvm3c" title="Long-term line of credit">128.0 million</span>) bank loan which bears interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateTerms_c20220101__20221231_zCDYNEZyZR4h" title="Description of debt instrument interest rate terms">one-month
Euribor plus 0.75%</span>. Approximately &#8364;<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zsMdkVzocId9" title="Debt instrument, face amount">80</span> million of the variable rate debt was swapped for variable interest rate debt with
a maximum rate of 2% per annum.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341677953216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_z2H4TVyUgGs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(4)</td><td id="xdx_82C_zONtxktEjTW7">Inventories</td></tr></table>

<p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden">Schedule of inventories</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Raw materials and component parts</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">146,772</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">111,312</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,602</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">198,914</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<p id="xdx_8A6_zJnpHd5uesY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Overhead included in inventory
aggregated $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zcpC9lIdwDT5" title="Cost of Goods Sold, Overhead">3.4 million</span> and $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zawROXE2RwDh">3.7 million</span> as of December 31, 2022 and 2021, respectively. Included in inventories is an inventory
reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales
forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated
events may be established. Inventory reserves aggregated $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_dm_c20221231_zRYbMeXh3tEl" title="Inventory Valuation Reserves">11.4 million</span> and $<span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_zTjfvkqnMGke" title="Inventory Valuation Reserves">15.8 million</span> as of December 31, 2022 and 2021, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675901712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_z5WnGP2HTJMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(5)</td><td id="xdx_82B_zewNog1Z67i7">Fair Value of Financial Instruments</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White">
    <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">150,833</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">19,861</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">130,174</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">798</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0913">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;<b style="display: none; visibility: hidden">Total Assets</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">158,780</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,861</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,122</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>






















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">

<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White">
    <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Short-term investments</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0977">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0982">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<p id="xdx_8A0_zd20yXHgXpb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of cash and
cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable,
other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments.
The carrying amount of loans payable approximates fair value as the variable interest rates on the Company&#8217;s indebtedness
approximate current market rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Foreign currency forward exchange
contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net
present value of the swaps using third party quotes from financial institutions.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672807088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p id="xdx_801_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zpsKbcjSP5Fc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(6)</td><td id="xdx_823_z5OyFdJ7Zwd3">Derivative Financial Instruments</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into foreign
currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction
for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged
item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the
change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item.
The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and
excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward
difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign
currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued,
and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted
transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period
earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Gains and losses in derivatives
designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as
hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial
in each of the years in the three-year period ended December 31, 2022. Interest expense includes a gain of $<span id="xdx_902_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_z0Th4GfsSfD2" title="Loan amount">6.3 million</span> and $<span id="xdx_908_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zLFSfFgqCEA8" title="Loan amount">0.2
million</span> in 2022 and 2021, respectively, resulting from an interest rate swap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments
are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap
is included in other assets on the accompanying balance sheet for the period ended December 31, 2022 and was included in long-term
debt on the accompanying balance sheet for the period ended December 31, 2021. The valuation of foreign currency forward exchange
contracts at December 31, 2022 and December 31, 2021, resulted in an asset and is included in other current assets on the accompanying
balance sheets.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2022, the Company
had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $<span id="xdx_907_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zzciTf9stfI8" title="Foreign currency contracts, liability, fair value disclosure">36.5 million</span>,
which all have maturities of less than one year.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672764672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Equipment and Leasehold Improvements</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zzPgk7acn2Uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(7)</td><td id="xdx_829_z4yVTpn8yy73">Property, Equipment and Leasehold Improvements</td></tr></table>

<p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">148,137</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">136,131</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" style="text-align: right" title="Equipment and leasehold improvements">59,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" style="text-align: right" title="Equipment and leasehold improvements">52,036</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,293</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,082</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right">210,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right">190,249</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">43,397</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">40,897</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">166,722</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">149,352</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<p id="xdx_8A3_zznwfvvUieqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Depreciation and amortization
expense was $<span id="xdx_908_eus-gaap--Depreciation_dm_c20220101__20221231_zCM1bM8qcIdf" title="Depreciation and amortization expense">7.5 million</span>, $<span id="xdx_90B_eus-gaap--Depreciation_dm_c20210101__20211231_zwixaZb6pDr7" title="Depreciation and amortization expense">4.4 million</span> and $<span id="xdx_903_eus-gaap--Depreciation_dm_c20200101__20201231_z5iqMiT4q11j" title="Depreciation and amortization expense">3.8 million</span> in 2022, 2021, and 2020, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675901712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trademarks, Licenses and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Trademarks, Licenses and Other Intangible Assets</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z7h8bft4ZVJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(8)</td><td id="xdx_822_zz9hd6R2SV27">Trademarks, Licenses and Other Intangible Assets</td></tr></table>

<p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book<br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1040">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right">41,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right">64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right">41,203</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right">205,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right">63,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right">141,700</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right">17,849</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right">14,921</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right">2,928</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right">264,351</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right">185,831</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right">369,373</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right">290,853</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross <br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated <br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book <br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1061">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right">43,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right">68</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right">43,752</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right">109,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right">62,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right">47,396</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right">17,775</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right">14,588</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right">3,187</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right">171,277</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right">94,335</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right">290,989</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right">214,047</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<p id="xdx_8A1_zeQ09ycLVty5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was
$<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_dm_c20220101__20221231_ziBicTVGvRNe">6.8 million</span>, $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRSgahoBzRde">5.9 million</span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zrrZnnOOg6Eh">5.3 million</span> in 2022, 2021 and 2020, respectively. Amortization expense is expected to approximate
$<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dxL_c20221231_zXscZXrnUoki" title="2023::XDX::7000000"><span style="-sec-ix-hidden: xdx2ixbrl1083">7.0</span></span> million in 2023, $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20221231_zMd0BL1SBgxe" title="2024">13.3 million</span> in 2024, $<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_dm_c20221231_z9ERUTqKJJYe" title="2025">12.3 million</span> in 2025, $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_dm_c20221231_zabK9mHOHGNh" title="2026"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_dm_c20221231_z8WZ84eTOJFa" title="2027">10.5 million</span></span> in 2026 and 2027. The weighted average amortization
period for trademarks, licenses and other intangible assets with finite lives are <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_znS4kMqpChN3" title="Amortization period::XDX::P8Y"><span style="-sec-ix-hidden: xdx2ixbrl1093">18 </span></span>years, <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ztClFyOdnMkg" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1094">14</span></span> years and <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVDNwAWPVYoh" title="::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1095">2</span></span> years, respectively,
and <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231_zsIvae8lf0k8" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1096">14</span></span> years on average.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company reviews intangible
assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may
not be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $<span id="xdx_903_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zhTMH5ORxlr2" title="Impairment charge">6.8 million</span> and $<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zWWEb43iMPY5">2.4 million</span>
in 2022 and 2021, respectively, relating to our Rochas fashion business and an impairment charge for trademarks with indefinite
useful lives of $<span id="xdx_907_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionBusinessMember_zlHEFoRLvQY4">0.9 million</span> in 2022 relating to our Intimate trademark. The fair values used in our evaluations are estimated
based upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zeFmOx2jwC1f" title="Weighted average cost of capital">9.80</span>%, <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z1vX5T2FQCJi">7.47</span>%, and <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z4MGmXYlzuB6">6.99</span>% as of December
31, 2022, 2021 and 2020, respectively. The cash flow projections are based upon a number of assumptions, including, future sales
levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or
changes in consumer acceptance of our products which are more subjective in nature. The Company believes that the assumptions
it has made in projecting future cash flows for the evaluations described above are reasonable and currently no other impairment
indicators exist for our indefinite-lived assets. However, if future actual results do not meet our expectations, the Company
may be required to record an impairment charge, the amount of which could be material to our results of operations.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of trademarks, licenses
and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license
or the intangible assets estimated useful life which range from <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zWGvEvWj4cxb" title="Amortization period::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1114">three</span></span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z0j651Fi1xv6" title="Amortization period::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl1116">twenty years</span></span>. If the residual value of a finite life intangible
asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for
impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Trademarks (finite lives)
primarily represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to
repurchase the brand names and trademarks on July 1, 2027 for &#8364;70 million (approximately $<span id="xdx_904_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20221231_z72Xc9HoRtKl">7
5</span> million) (residual value) in accordance with an amendment signed in 2021. Because the residual value of the intangible
asset exceeds its carrying value, the asset is not being amortized.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675987776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zfFpH5PpqeDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(9)</td><td><span id="xdx_824_zBsQzl8NGjl">Accrued Expenses</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zk4nlSz7Fm3e">Accrued expenses consist of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Advertising liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">42,338</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">31,215</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Salary (including bonus and related taxes)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,993</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,532</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,154</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due vendors (not yet invoiced)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,707</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retirement reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,234</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Refund (return) liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,128</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,149</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,246</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><b style="display: none; visibility: hidden">Total</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">213,621</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">136,677</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_8A7_z3YQAjvVt3Rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675982992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Payable &#8211; Banks<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loans Payable &#8211; Banks</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zWWvHPes4W7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(10)</td><td><span id="xdx_823_zVsRs3VmVzEf">Loans Payable &#8211; Banks</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Loans payable &#8211; banks consist
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its domestic
subsidiaries have available a $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zSvSlrua0U5b" title="Line of credit, maximum borrowing amount">20 million</span> unsecured revolving line of credit due on demand, which bears interest at the daily Secured
Overnight Financing Rate (&#8220;SOFR&#8221;) plus <span id="xdx_90B_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYLPXJapi36a" title="Basis spread over variable interest rate">2</span>% (the SOFR was <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zf2wEZRDgLT3" title="Variable rate">4.3</span>% as of December 31, 2022). The line of credit which has
a maturity date of <span id="xdx_90D_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zOIGxK6Ah7y7" title="::XDX::2023-12-15"><span style="-sec-ix-hidden: xdx2ixbrl1154">December 15, 2023</span></span>, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines of
credit were zero as of December 31, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s foreign subsidiaries
have available credit lines, including several bank overdraft facilities totaling approximately $<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zOTqYWKWmLyl">20</span> million. These credit lines
bear interest at EURIBOR plus between <span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zoZlAWLpGPic" title="Basis spread over variable interest rate">0.6</span>% and <span id="xdx_90E_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_z5O2OZQtFDba" title="Basis spread over variable interest rate">0.9</span>% (EURIBOR was minus <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zqXxBh8x2uIi" title="Variable rate">0.576</span>% at December 31, 2022). Borrowings outstanding pursuant
to these bank overdraft facilities were zero as of December 31, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As there were no borrowings outstanding
as of December 31, 2022 and 2021, there is no weighted average interest rate on short-term borrowings as of December 31, 2022 and
2021.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675397312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zXDC79Sujj8c" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(11)</td><td><span id="xdx_826_zpKuRONIxAV8">Long-Term Debt</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B6_zftsybzXQda9">Long-term debt consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj">53.3</span> million payable in <span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments">48</span> equal monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)">1.1 million</span> beginning in December 2022, bearing interest at one-month Euribor plus <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum">0.825</span>%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" style="width: 10%; text-align: right" title="Loan payable">52,061</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1183">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i">135.9</span> million payable in <span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments">120</span> equal monthly installments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26">1.1 million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf">0.75</span>%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right">104,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right">124,375</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf">15.0</span> million payable in <span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments">14</span> equal annual installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh">1.1 million</span> beginning in January 2020 including interest imputed at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum">4.1</span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right">9,890</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right">10,569</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6">17</span> million payable in <span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments">10</span> equal annual installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8">1.7 million</span> beginning in October 2021 including interest imputed at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum">2.0</span>% per annum</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable">13,332</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right">13,859</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right">180,041</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right">148,803</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">28,547</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">15,911</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">151,494</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" style="border-bottom: Black 2.5pt double; text-align: right" title="::XDX::132902"><span style="-sec-ix-hidden: xdx2ixbrl1216">132,892</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<p id="xdx_8A8_z5HmvadJDHEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, to finance
Interparfums SA&#8217;s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (&#8364;<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zQT8YHh7sZk7">50</span> million) four-year
loan agreement. <span id="xdx_908_eus-gaap--LongTermDebtDescription_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zo0dolFaZI1g" title="Debt description">The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was
swapped for variable interest rate debt with a maximum rate of 2% per annum.</span> The swap is a hedged derivative instrument and is
therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, to finance the
acquisition of Interparfums SA&#8217;s future corporate headquarters, the Company entered into a $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z8Fs8D40OnTe">128.0 million</span> (&#8364;<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zAjWWQRyuBv2">120</span> million)
ten-year credit agreement.<span id="xdx_90E_eus-gaap--LongTermDebtDescription_c20210401__20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zaZaVlRPeZS" title="Debt description"> Approximately $85.3 million (&#8364;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum. </span>The swap is a derivative instrument and is therefore recorded at fair value
and changes in fair value are reflected in the accompanying consolidated statements of income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Maturities of long-term debt
subsequent to December 31, 2022 are approximately $<span id="xdx_907_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20221231_zXSKH0X9ZWa5" title="Long-term Debt, Maturities, 2021">30.4 million</span> in 2023 and $<span id="xdx_909_eus-gaap--LongTermDebtDescription_c20220101__20221231_zZdNR4ZToCMj" title="Long term debt maturity, description">28.7 million per year thereafter through 2033.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672764672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zTwr7Ra7eKO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(12)</td><td><span id="xdx_822_zv6FdTOer5w7">Commitments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Leases</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices,
warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing
leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized
at the lease commencement date based on the present value of lease payments over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining lease asset value,
the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on
the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option
is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available
at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the
weighted average remaining lease term was <span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20221231_zYWOvqd8k7Z" title="Weighted average remaining lease term::XDX::P5Y9M18D"><span style="-sec-ix-hidden: xdx2ixbrl1234">5.8</span></span> years and the weighted average discount rate used to determine the operating lease
liability was <span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OperatingLeaseMember_zmmFrMrS3QQ3" title="Operating lease, weighted average discount rate">2.6</span>%. Rental expense related to operating leases was $<span id="xdx_906_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20220101__20221231_zDmGhOiSjPBb" title="Operating lease of related to rental expenses">5.6 million</span>, $<span id="xdx_90C_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20210101__20211231_zOpXgtuxey95" title="Operating lease of related to rental expenses">8.2 million</span>, and $<span id="xdx_90D_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20200101__20201231_z6e3ua44YPd5" title="Operating lease of related to rental expenses">6.2 million</span> for the years ended
December 31, 2022, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $<span id="xdx_90C_eus-gaap--OperatingLeasePayments_dm_c20220101__20221231_zOycA2qmyVT8" title="Operating lease payments">4.9 million</span>
and noncash additions to operating lease assets totaled $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_dm_c20220101__20221231_zCokZCjQiWch" title="Noncash additions to operating lease assets">0.3 million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B6_zJZSArOFca1k">Maturities of lease liabilities
subsequent to December 31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" style="width: 10%; text-align: right" title="2023">5,723</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" style="text-align: right" title="2024">5,971</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" style="text-align: right" title="2025">4,847</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" style="text-align: right" title="2026">4,049</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">2027</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" style="text-align: right" title="2027">4,060</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Thereafter</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">6,913</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total">31,563</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><span style="font-size: 10pt">Less imputed interest (based on
    2.6%</span> weighted-average discount rate)</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest (based on 2.6% weighted-average discount rate)">(1,932</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Total">29,631</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<p id="xdx_8AD_zy90NeZibwc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">License Agreements</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, <span id="xdx_8B6_zLKFQSlOwCib">minimum annual royalties and other commitments as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands) </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" style="width: 10%; text-align: right" title="2023">217,852</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" style="text-align: right" title="2024">224,201</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" style="text-align: right" title="2025">218,047</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" style="text-align: right" title="2026">139,348</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" style="text-align: right" title="2027">132,502</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thereafter</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">986,434</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,918,384</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/>

<p id="xdx_8AB_zqW0gUZLUbSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 40.5pt; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future advertising commitments
are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration
for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations.
Royalty expense included in selling, general, and administrative expenses, aggregated $<span id="xdx_906_eus-gaap--RoyaltyExpense_dm_c20220101__20221231_zJ4Vw88JOFd" title="Royalty expense">87.0 million</span>, $<span id="xdx_900_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zEFGKRKYN0Kl" title="Royalty expense">68.9 million</span> and $<span id="xdx_90B_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zKT2XSaeLDt6" title="Royalty expense">41.1 million</span>,
in 2022, 2021 and 2020, respectively, and represented <span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231_zja2h94g7ujk" title="Royalty expense, percentage of net sales">8.0</span>%, <span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zfGTtDuPHMu" title="Royalty expense, percentage of net sales">7.8</span>% and <span id="xdx_907_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zAIxykTL3msl" title="Royalty expense, percentage of net sales">7.6</span>% of net sales for the years ended December 31, 2022, 2021
and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676855264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z0xEZThRjPSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(13)</td><td><span id="xdx_824_z4QG4D9JjvZj">Equity</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Share-Based Payments</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains a stock
option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide
for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and
vest over a <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbUkuxEy131l" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1304">four</span></span> to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUm5qZQr8np4" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1306">five</span></span>-year period. The fair value of shares vested aggregated $<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiTTmRm9Ryg">1.3 million</span>, $<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNTy7pkKCtLa" title="Fair value of shares vested">1.4 million</span> and $<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqrJtdNf4GM">1.7 million</span> in
2022, 2021 and 2020, respectively. <span style="font-family: Times New Roman, Times, Serif">Compensation cost, net of estimated
forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated
based on historic trends. </span>It is generally the Company&#8217;s policy to issue new shares upon exercise of stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zFjpmdCfOPe7">The following table sets forth
information with respect to nonvested options for 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Nonvested options &#8211; beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" style="width: 10%; text-align: right" title="Nonvested options - beginning of year">209,510</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" style="width: 10%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year">13.45</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nonvested options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" style="text-align: right" title="Nonvested options granted">62,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted">20.36</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(102,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited">12.93</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options &#8211; end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options - end of year">168,730</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year">16.31</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_z2lp4EWwj9ta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>






<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zaFiKtjKr3b5">The effect of share-based payment
expenses decreased income statement line items as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Income before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" style="width: 10%; text-align: right" title="Income before income taxes">3,143</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" style="width: 10%; text-align: right" title="Income before income taxes">2,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" style="width: 10%; text-align: right" title="Income before income taxes">3,030</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">1,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,040</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A1_zmgo6RZltrt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z10lqP2NV1bl">The following table summarizes
stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Shares under option -&#160;beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">524,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">57.58</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">713,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">52.74</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right">815,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right">49.89</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" style="text-align: right" title="Options granted">62,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" style="text-align: right" title="Weighted average exercise price options granted">97.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" style="text-align: right" title="Weighted average exercise price options granted">62.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right">69.11</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Options exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" style="text-align: right" title="Options exercised">(136,880</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" style="text-align: right" title="Weighted average exercise price options exercised">43.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" style="text-align: right" title="Options exercised">(156,490</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" style="text-align: right" title="Weighted average exercise price options exercised">34.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" style="text-align: right" title="Options exercised">(95,570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right">28.99</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Options forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(8,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" style="text-align: right" title="Weighted average exercise price options forfeited">67.65</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(40,820</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" style="text-align: right" title="Weighted average exercise price options forfeited">62.57</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(16,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right">58.38</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Shares under option - end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">441,580</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" style="text-align: right" title="Weighted average exercise price shares under option - end of year">67.30</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">524,900</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" style="text-align: right" title="Weighted average exercise price shares under option - end of year">57.58</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right">713,210</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right">52.74</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_8A7_zMusYQdqpD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2022, options
for <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zRbzGPHLcDW9" title="Number of shares available for grant (in shares)">558,975</span> shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zPczbZ4CHEe9" title="Aggregate intrinsic value of options outstanding">13.0
million</span> as of December 31, 2022 and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zrJOO8xEv2Zk" title="Aggregate intrinsic value of options outstanding">2.7 million</span>,
which will be recognized over the next <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20220101__20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zNds05itzyhh" title="Term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1418">five</span></span> years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted average fair values
of options granted by Inter Parfums, Inc. during 2022, 2021 and 2020 were $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3ts39aUaVf" title="Weighted average grant date fair value (in dollars per share)">20.36</span>, $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqCA6fheI8Gb" title="Weighted average grant date fair value (in dollars per share)">11.35</span> and $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGXHMgADgBg2" title="Weighted average grant date fair value (in dollars per share)">12.16</span> per share, respectively, on
the date of grant using the Black-Scholes option pricing model to calculate the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zZGs8M9wlPE9">The assumptions used in the Black-Scholes
pricing model are set forth in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average expected option life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" style="text-align: right" title="Weighted-average expected option life::XDX::P4Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">4.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1434">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1436">5.0 years</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.4</td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.5</td><td style="text-align: left">%</td></tr>
</table>


<p id="xdx_8AB_zjBkLAW2FMue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Expected volatility is estimated
based on historic volatility of the Company&#8217;s common stock. The expected term of the option is estimated based on historic
data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend
yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout
ratio as a percentage of earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zZTZ2TudDlj9">Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Proceeds from stock options exercised</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">6,003</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,393</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,771</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tax benefits</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intrinsic value of stock options exercised</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,873</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zXo8dwKlRsok" style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p>

<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B1_zT9VrNCHVHH3">The following table summarizes
additional stock option information as of December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding weighted average remaining contractual life</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options exercisable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: center"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1">40.15</span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)">46.90</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" style="width: 22%; text-align: right" title="Options outstanding">103,460</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"><span style="-sec-ix-hidden: xdx2ixbrl1475">0.96</span></span> years</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" style="width: 22%; text-align: right" title="Options exercisable">101,860</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt">$<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8">62.18</span> - $<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm">69.11</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" style="text-align: right" title="Options outstanding">139,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"><span style="-sec-ix-hidden: xdx2ixbrl1483">2.04</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" style="text-align: right" title="Options exercisable">97,210</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb">73.09</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right">136,220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1488">3.00</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right">73,780</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">$<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi">97.84</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right">62,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"><span style="-sec-ix-hidden: xdx2ixbrl1492">5.85</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1493">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Totals</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right">441,580</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"><span style="-sec-ix-hidden: xdx2ixbrl1495">2.62</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right">272,850</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"/>

<p id="xdx_8A2_zbPfi6PqJBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the
weighted average exercise price of options exercisable was $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uUSDPShares_c20221231_ztPpZ95AvzX" title="Weighted average exercise price of options exercisable">59.46</span> and the weighted average remaining contractual life of options
exercisable is <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20220101__20221231_zEGDcIwT5I72" title="Weighted average remaining contractual life of options exercisable::XDX::P1Y10M17D"><span style="-sec-ix-hidden: xdx2ixbrl1500">1.88</span></span> years. The aggregate intrinsic value of options exercisable at December 31, 2022 is $<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_dm_c20221231_zWPFWaH7sF3f" title="Aggregate intrinsic value of options exercisable">10.1 million</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2018, Interparfums
SA approved a plan to grant an aggregate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zolqUtSNVf35" title="Adjusted for stock splits (in shares)">26,600</span> shares of its stock to employees with no performance condition requirement,
and an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zKV5xx7gtrzh" title="Aggregate intrinsic value of options outstanding">133,000</span> shares to officers and managers, subject to certain corporate performance conditions. The corporate
performance conditions were met and therefore in June 2022, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220627__20220630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zmz0K9mMiMia" title="Shares adjusted for stock splits">211,955</span> shares, adjusted for stock splits, were distributed. The aggregate
cost of the grant of approximately $<span id="xdx_908_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_dm_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zpMHa71JZO72" title="Recognized as compensation cost">4.8 million</span> was recognized as compensation cost on a straight-line basis over the requisite
<span id="xdx_909_eus-gaap--DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_dxL_c20220101__20221231_zn6Zy3HzEP4i" title="Straight line basis over the requisite::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1512">three</span></span>-year service period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>






















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2022, Interparfums SA
approved an additional plan to grant an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z6WQrzRaEvP4">88,400</span> shares to all Interparfums SA employees and corporate officers having
more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment
for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the grant had
been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The
estimated number of shares to be distributed of <span id="xdx_904_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z4xDvfHemfK7" title="Number of share distributed">85,062</span> has been determined taking into account employee turnover. The aggregate
cost of the grant of approximately $<span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20220101__20221231__srt--OwnershipAxis__custom--InterparfumsSAMember_z7xoxRrTw8na">4.1 million</span> will be recognized as compensation cost on a straight-line basis over the requisite
three and a quarter year service period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Similar to the December 2018
plan, in order to avoid dilution of the Company&#8217;s ownership of Interparfums SA, all shares distributed or to be distributed
pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During
the year ended December 31, 2022, the Company acquired <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zvzvYImHjQzh">63,281</span> shares at an aggregate cost of $<span id="xdx_902_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn6n6_c20220101__20221231_z1yhgjJBhuJ3" title="Aggregate cost">3.0</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Dividends</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2019, our Board of
Directors authorized a <span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_zq1BtKsWXw1j" title="Percentage of increase in annual dividend">20</span>% increase in the annual dividend to $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zT4bsZb7yhz">1.32</span> per share on an annual basis. In April 2020, as a result of
the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash
dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly.
In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share and in February 2023,
the Board of Directors further increased the annual dividend to $<span id="xdx_90C_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zn5dEgZpNPql" title="Dividends payable, amount per share (in dollars per share)">2.50</span> per share. The next quarterly cash dividend of $<span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3H9aLSa9j2g" title="Dividends payable, amount per share (in Dollars per share)">0.625</span> per
share is payable on March 31, 2023 to shareholders of record on March 15, 2023.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675869824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. Common Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Attributable to Inter Parfums, Inc. Common Shareholders</a></td>
<td class="text"><p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zx5E95p2u826" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><b>(14)</b></td><td id="xdx_82C_zg2XEdxMVec8" style="text-align: justify"><b>Net Income Attributable to Inter Parfums, Inc. Common Shareholders</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net income attributable to Inter
Parfums, Inc. per common share (&#8220;basic EPS&#8221;) is computed by dividing net income attributable to Inter Parfums, Inc.
by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution
(&#8220;diluted EPS&#8221;), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding
assuming the exercise of dilutive stock options using the treasury stock method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>






















<p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_z0oWgrF1Exze">The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">120,938</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">87,411</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">38,219</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" style="text-align: right" title="Weighted average shares::XDX::31859417"><span style="-sec-ix-hidden: xdx2ixbrl1557">31,859,417</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" style="text-align: right" title="Weighted average shares">31,676,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" style="text-align: right" title="Weighted average shares">31,536,659</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">129,336</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">158,612</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">117,885</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share::XDX::31835408"><span style="-sec-ix-hidden: xdx2ixbrl1569">31,988,753</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,835,408</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,654,544</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.
    common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" style="text-align: right" title="Basic (in dollars per share)">3.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" style="text-align: right" title="Basic (in dollars per share)">2.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" style="text-align: right" title="Basic (in dollars per share)">1.21</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" style="text-align: right" title="Diluted (in dollars per share)">3.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" style="text-align: right" title="Diluted (in dollars per share)">2.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" style="text-align: right" title="Diluted (in dollars per share)">1.21</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_8A9_zbK4fmd08pt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Not included in the above computations
is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zg2q9bpdlHmj" title="Antidilutive securities excluded from computation of earnings per share, amount">38,000</span>, <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zZ3Omt4U4Yj3" title="Antidilutive securities excluded from computation of earnings per share, amount">175,000</span>, and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_zIqUqAS4cqsk" title="Antidilutive securities excluded from computation of earnings per share, amount">450,000</span>
shares of common stock for 2022, 2021, and 2020, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675869824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Areas<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments and Geographic Areas</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zGZBHf28LoC8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><b>(15)</b></td><td id="xdx_82C_zH7uC5DUdNy3" style="text-align: justify"><b>Segments and Geographic Areas</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company <span style="font-family: Times New Roman, Times, Serif">manufactures
and distributes one product line, fragrances and fragrance related products. The Company</span> manages its business in two segments,
European based operations and United States based operations. The European assets are located, and operations are primarily conducted,
in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B9_zpH2kTnlYawl">Information on the Company&#8217;s
operations by segments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right">342,644</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right">216,559</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right">117,489</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right">744,075</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right">663,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right">422,947</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations of intercompany
    sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right">(66</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right">(333</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right">(1,427</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right">1,086,653</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right">879,516</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right">539,009</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right">43,745</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right">29,359</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right">7,942</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right">77,193</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right">57,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right">30,241</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right">183</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Depreciation and amortization expense including
    impairment loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right">6,355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right">3,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right">3,354</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right">16,184</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right">8,863</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right">5,713</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right">22,539</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right">12,698</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right">9,067</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td>Interest and investment income:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right">66</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right">3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right">24</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right">5,769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right">3,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right">2,971</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right">5,486</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right">3,403</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right">2,865</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right">1,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right">636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right">604</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" style="text-align: right" title="Interest expense">2,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" style="text-align: right" title="Interest expense">2,315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" style="text-align: right" title="Interest expense">1,496</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">3,599</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">2,825</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">1,970</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right">6,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right">5,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right">1,590</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right">36,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right">35,607</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right">17,782</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right">43,182</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right">40,992</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right">19,381</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right">278,090</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right">247,703</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right">141,316</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right">1,052,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right">931,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right">758,812</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right">(21,552</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right">(34,074</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right">(9,983</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right">1,308,542</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right">1,145,364</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right">890,145</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Additions to long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right">2,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right">2,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right">1,004</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right">31,438</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right">138,563</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right">11,259</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right">33,756</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right">141,274</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right">12,263</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right">61,539</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right">63,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right">40,656</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right">423,999</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right">334,033</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right">217,766</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right">485,538</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right">397,127</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right">258,422</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right">2,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right">870</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right">886</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right">8,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right">7,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right">7,106</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right">8,041</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_8A3_z3AfBJKqYq4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">United States export sales were
approximately $<span id="xdx_906_eus-gaap--Revenues_dm_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z9mKYeG4Bxvg" title="Revenue from export sales">169.1 million</span>, $<span id="xdx_90C_eus-gaap--Revenues_dm_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zRk6SmlGxoJf" title="Revenue from export sales">126.2 million</span> and $<span id="xdx_908_eus-gaap--Revenues_dm_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z12uafZ15sJ3" title="Revenue from export sales">71.5 million</span> in 2022, 2021 and 2020, respectively. <span>Consolidated net sales to
customers by region are as follows:</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden">Consolidated net sales to customers by region are as follows:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" style="width: 10%; text-align: right" title="Net sales">431,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" style="width: 10%; text-align: right" title="Net sales">354,100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" style="width: 10%; text-align: right" title="Net sales">193,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right">333,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right">271,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right">180,200</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right">152,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right">128,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right">79,700</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right">87,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right">61,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right">46,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right">69,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right">56,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right">32,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right">8,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right">6,300</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right">1,086,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right">879,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right">539,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_ztRhsXR8V6Q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B7_z7FpI55o74vh">Consolidated net sales to customers in major countries
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">420,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">351,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">187,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>France</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right">44,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right">44,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right">37,600</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Russia</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right">33,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right">43,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right">14,100</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right">37,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right">38,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right">24,600</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zpCmLcFFUQ57" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675842960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zEzULplDcgK7" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(16)</td><td id="xdx_821_zrAktrtcrZrl">Income Taxes</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries
file income tax returns in the U.S. federal, and various states and foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed its uncertain
tax positions and determined that it has no material uncertain tax position at December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z7VnI34zzwX8">The components of income before
income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">U.S. operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" style="width: 10%; text-align: right" title="U.S. operations">50,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" style="width: 10%; text-align: right" title="U.S. operations">34,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" style="width: 10%; text-align: right" title="U.S. operations">9,577</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">143,969</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">116,277</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">59,772</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::194219"><span style="-sec-ix-hidden: xdx2ixbrl1797">194,219</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::151019"><span style="-sec-ix-hidden: xdx2ixbrl1799">151,019</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::69349"><span style="-sec-ix-hidden: xdx2ixbrl1801">69,349</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zMdKdsLj6jH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zcy74h7kGdd5">The provision for current and
deferred income tax expense (benefit) consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Current:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; padding-left: 0.125in">Federal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" style="width: 10%; text-align: right" title="Federal">6,829</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" style="width: 10%; text-align: right" title="Federal">4,825</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" style="width: 10%; text-align: right" title="Federal">1,685</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">State and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" style="text-align: right" title="State and local">658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" style="text-align: right" title="State and local">518</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" style="text-align: right" title="State and local">90</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">39,458</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">36,164</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">17,024</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">46,945</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">41,507</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">18,799</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" style="text-align: right" title="Federal">(802</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" style="text-align: right" title="Federal">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" style="text-align: right" title="Federal">(215</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">State and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" style="text-align: right" title="State and local">(49</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" style="text-align: right" title="State and local">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" style="text-align: right" title="State and local">44</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(2,912</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(530</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">753</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(3,763</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(515</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">582</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">43,182</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">40,992</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">19,381</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_8AA_zu1mvlECuEsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>






<p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_zp6bQ94sbp35">The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">554</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,292</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Inventory and accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,508</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Profit sharing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,787</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Stock option compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">732</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of inventory profit elimination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,342</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,112</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">266</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">407</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Total gross deferred tax assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,838</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(554</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,582</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,075</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,256</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities (long-term):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Building expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,356</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,082</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Trademarks and licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,551</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Unrealized gain on marketable equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,745</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(436</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(655</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(251</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,916</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,320</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_8A9_zi5Iazzkwjqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Valuation allowances have been
provided for deferred tax assets relating to foreign net operating loss carry-forwards as future profitable operations from certain
foreign subsidiaries might not be sufficient to realize the full amount of the deferred tax assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other valuation allowances
have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future
taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company estimated of the
effect of global intangible low-taxed income (&#8220;GILTI&#8221;) and has determined that it has no tax liability related to GILTI
as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of foreign derived intangible income (&#8220;FDII&#8221;)
and recorded a tax benefit of approximately $<span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_z2RduZVyNBx2">1.5 million</span>, $<span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zEdLfbzCw8lk">0.9 million</span> and $<span id="xdx_90A_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zsIXtt16Baih">0.3 million</span> as of December 31, 2022, 2021 and 2020,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is no longer subject
to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>






















<p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z8w289QLD5Z9">Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Statutory rates</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and local taxes, net of Federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Windfall benefit from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.9</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Benefit of Foreign Derived Intangible Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.8</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Effect of foreign taxes greater than U.S. statutory rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.5</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.2</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.625in">Effective rates</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">22.2</td><td style="text-align: left; padding-bottom: 2pt">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">27.1</td><td style="text-align: left; padding-bottom: 2pt">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">27.9</td><td style="text-align: left; padding-bottom: 2pt">%</td></tr>

</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p id="xdx_8A7_z0csr17AQpCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675895552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zggFcT5jBCP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(17)</td><td><span id="xdx_820_z08Cgu9j1Gii">Accumulated Other Comprehensive Loss</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8B6_zdI2PfJTcWk4">The components of accumulated other
comprehensive loss consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">(992</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1968">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">52</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">2,701</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(52</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">1,709</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"><span style="-sec-ix-hidden: xdx2ixbrl1982">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cumulative translation adjustments, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(37,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(5,997</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(39,905</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(20,325</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(31,443</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">33,908</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(57,765</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(37,440</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(5,997</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(56,056</td><td style="text-align: left; padding-bottom: 2pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(38,432</td><td style="text-align: left; padding-bottom: 2pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right">(5,997</td><td style="text-align: left; padding-bottom: 2pt">)</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/>

<p id="xdx_8A5_z6Qdw7p9XLe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676855264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</a></td>
<td class="text"><p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_z0NbJg2VBBYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(18)</td><td><span id="xdx_820_zOpk2joaSrZ8">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</span></td></tr></table>

<p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">120,938</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">87,411</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">38,219</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2019">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2020">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<p id="xdx_8A6_zlQaVNVUJMd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675801328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract', window );"><strong>Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock', window );">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</a></td>
<td class="text"><p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_zwaHVFtCoXM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(19)</td><td><span id="xdx_82D_zPzQ3HIOQUij">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zWO24NCWEtHj">The following table summarizes
cash and cash equivalents as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-family: Courier New, Courier, Monospace; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/>
 2021</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 77%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" style="width: 12%; text-align: right" title="Cash and cash equivalents per balance sheet">159,613</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" style="border-bottom: Black 1pt solid; text-align: right" title="Cash held in escrow included in other assets (see note 3)::XDX::168387">8,774</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Cash and cash equivalents per balance sheet::XDX::168387">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash and cash equivalents per statement of cash flows::XDX::168387">168,387</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_z5GK5tdRTIOa" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents reconciliation of cash and cash equivalents to the statement of cash flows text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676855264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><p id="xdx_80D_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zfjmJJOx1YB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_829_zQO6hwDTuQBc" style="display: none; visibility: hidden">&#160;Schedule II - Valuation and Qualifying Accounts</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Schedule II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>



<p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden">Schedule of Valuation and Qualifying Accounts</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Valuation and Qualifying Accounts</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Column A</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column B</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column C</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column D</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column E</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additions</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(1)</td><td style="font-weight: bold; text-align: left"/><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(2)</td><td style="font-weight: bold; text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance
    at</b></span><br/> <span style="font-size: 10pt"><b>beginning of</b></span><br/> <span style="font-size: 10pt"><b>period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged
    to</b></span><br/> <span style="font-size: 10pt"><b>costs and</b></span><br/> <span style="font-size: 10pt"><b>expenses</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged
    to</b></span><br/> <span style="font-size: 10pt"><b>other</b></span><br/> <span style="font-size: 10pt"><b>accounts &#8211;</b></span><br/>
    <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Deductions</b></span><br/>
    <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance
    at</b></span><br/> <span style="font-size: 10pt"><b>end of period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in">Allowance for doubtful accounts:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 3%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" style="text-align: right" title="Balance at beginning of period">2,247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right">2,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" style="text-align: right" title="Charged to other accounts describe">1,134</td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right">1,044</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" style="text-align: right" title="Balance at end of period">4,690</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" style="text-align: right" title="Balance at beginning of period">5,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right">877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right">(843</td><td colspan="2" style="text-align: left">)(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right">3,336</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" style="text-align: right" title="Balance at end of period">2,247</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" style="text-align: right" title="Balance at beginning of period">2,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" style="text-align: right" title="Charged to costs and expenses">4,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right">381</td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" style="text-align: right" title="Deductions describe">2,107</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" style="text-align: right" title="Balance at end of period">5,550</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Allowance for sales returns, net of inventory:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" style="text-align: right" title="Balance at beginning of period">3,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right">4,997	</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2068">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right">2,829</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" style="text-align: right" title="Balance at end of period">5,410</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" style="text-align: right" title="Balance at beginning of period">2,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right">3,042</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2075">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right">2,042</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" style="text-align: right" title="Balance at end of period">3,242</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" style="text-align: right" title="Balance at beginning of period">2,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right">1,978</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right">2,323</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" style="text-align: right" title="Balance at end of period">2,242</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Inventory reserve:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" style="text-align: right" title="Balance at beginning of period">15,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right">8,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right">(378</td><td colspan="2" style="text-align: left">)(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right">12,710</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" style="text-align: right" title="Balance at end of period">11,431</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" style="text-align: right" title="Balance at beginning of period">9,371</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right">8,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right">7,041</td><td colspan="2" style="text-align: left">(d)(e)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right">8,852</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" style="text-align: right" title="Balance at end of period">15,777</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" style="text-align: right" title="Balance at beginning of period">4,909</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right">7,212</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right">616</td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right">3,366</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" style="text-align: right" title="Balance at end of period">9,371</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left">(a)</td><td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify">Write-off of bad debts.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left">(b)</td><td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify">Write-off of sales returns.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left">(c)</td><td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify">Disposal of inventory</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left">(d)</td><td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify">Foreign currency translation adjustment</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left">(e)</td><td id="xdx_F19_z623xCp9iOT7" style="text-align: justify">Inventory reserves acquired of $7,639</td>
</tr></table>

<p id="xdx_8A7_zbYGZKrqekt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying reports of independent registered public accounting
firm.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666716944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Business of the Company</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zNT0b1hpSc">Business of the Company</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries
(the &#8220;Company&#8221;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage">21</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right">17</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right">11</td><td style="text-align: left">%</td></tr>
</table>


<p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10%
or more of consolidated net sales.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zAi7NibSjYo">Basis of Preparation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The
consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA">72</span>% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances
and transactions have been eliminated</span>.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Management Estimates</a></td>
<td class="text"><p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_zxhhk0ZXFq5">Management Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_z6rIV82Xvpje">Foreign Currency Translation</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#8217; equity.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents and Short-Term Investments</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zQ2usvaXHXs5">Cash and Cash Equivalents
and Short-Term Investments</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zbpNXfQ5UYnk">Accounts Receivable</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts">4.7 million</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts">2.2 million</span> as of December 31, 2022, and 2021, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#8217;s financial position, as well as previously established
buying patterns.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zB6czE4UKP8b">Inventories</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor
and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound
freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#8217;s customers.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_z8KfMRukTmb">Derivatives</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#8217;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Equipment and Leasehold Improvements</a></td>
<td class="text"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zjzUiz8tMvX9">Property, Equipment
and Leasehold Improvements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zftBm8SvL7Bd">Long-Lived Assets</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital">9.8</span>% and <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital">7.47</span>% in 2022 and 2021, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_866_zn7swQC93rge">Revenue Recognition</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in
either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable,
collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms.
Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#8217;
freight and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs">15.8 million</span>, $1<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs">0.0 million</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs">5.0 million</span>
in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements
of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue
concentration of credit risk. No one customer represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage">10</span></span></span>% or more of net sales in 2022, 2021 or 2020.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>





<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSalesReturns', window );">Sales Returns</a></td>
<td class="text"><p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_znG0d2ejty9j">Sales Returns</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $<span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability">8.6 million</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability">5.1 million</span> at December 31, 2022 and 2021, respectively, and
the amounts recognized for the rights to recover products was $<span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products">3.2 million</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products">1.9 million</span> at December 31, 2022 and 2021, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAllowances', window );">Payments to Customers</a></td>
<td class="text"><p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpZS8YHNN1fl">Payments to Customers</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising and Promotion</a></td>
<td class="text"><p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zIZybcTPiYQ3">Advertising and Promotion</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs">212.4 million</span>, $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs">171.1 million</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs">91.7 million</span> for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost">43.1 million</span>, $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost">36.9 million</span> and $<span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost">26.4 million</span>
in 2022, 2021 and 2020, respectively.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Package Development Costs</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zqec8gj621I2">Package Development
Costs</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Operating Leases</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zxkrSXeufu6">Operating Leases</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">License Agreements</a></td>
<td class="text"><p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zSbdHovAxh91">License Agreements</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#8217; trademarks. The licenses typically have an initial term of approximately <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0811">5</span></span> to <span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0813">15</span></span> years, and are potentially
renewable subject to the Company&#8217;s compliance with the license agreement provisions. The remaining terms, excluding potential
renewal periods, range from approximately <span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">1</span></span> to <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">12</span></span> years. Under each license, the Company is required to pay royalties in the range
of <span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales">6</span>% to <span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales">10</span>% to the licensor, at least annually, based on net sales to third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zWZrltbKXMm6">Income Taxes</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets
assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset
will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued
interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy', window );">Issuance of Common Stock by Consolidated Subsidiary</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86D_ziVu2DnrRlH1">Issuance of Common Stock
by Consolidated Subsidiary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company&#8217;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#8217;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementsCollateralPolicy', window );">Treasury Stock</a></td>
<td class="text"><p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_861_zOSRLpHtTRY4">Treasury Stock</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize
share repurchases of the Company&#8217;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569618-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepurchaseAgreementsCollateralPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy with regard to collateral required and collateral rights on securities sold under agreements to repurchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepurchaseAgreementsCollateralPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for sales allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675901712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of lanvin brand name for our class</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#8217;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#8217;s largest brands were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%">Montblanc</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage">21</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jimmy Choo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right">18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right">16</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Coach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right">16</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right">17</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>GUESS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right">12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right">11</td><td style="text-align: left">%</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672826864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden">Schedule of inventories</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Raw materials and component parts</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">146,772</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">111,312</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,602</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">198,914</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675998352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of fair value, assets measured on recurring basis</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White">
    <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">150,833</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">19,861</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">130,174</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">798</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0913">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;<b style="display: none; visibility: hidden">Total Assets</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">158,780</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,861</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,122</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>






















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">

<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White">
    <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Short-term investments</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0977">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0982">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8212;</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675871824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of equipment and leasehold improvements</a></td>
<td class="text"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">148,137</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">136,131</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" style="text-align: right" title="Equipment and leasehold improvements">59,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" style="text-align: right" title="Equipment and leasehold improvements">52,036</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,293</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,082</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right">210,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right">190,249</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">43,397</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">40,897</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">166,722</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">149,352</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671660672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trademarks, Licenses and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock', window );">Schedule of trademarks, licenses and other intangible assets</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book<br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1040">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right">41,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right">64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right">41,203</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right">205,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right">63,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right">141,700</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right">17,849</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right">14,921</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right">2,928</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right">264,351</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right">185,831</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right">369,373</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right">290,853</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross <br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated <br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book <br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1061">&#8212;</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trademarks (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right">43,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right">68</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right">43,752</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses (finite lives)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right">109,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right">62,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right">47,396</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right">17,775</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right">14,588</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right">3,187</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right">171,277</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right">94,335</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right">290,989</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right">214,047</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675953312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued expenses consist of the following:</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zk4nlSz7Fm3e">Accrued expenses consist of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Advertising liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">42,338</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">31,215</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Salary (including bonus and related taxes)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,993</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,532</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,154</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due vendors (not yet invoiced)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,707</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retirement reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,234</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Refund (return) liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,128</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,149</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,246</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><b style="display: none; visibility: hidden">Total</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">213,621</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">136,677</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671742240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term debt consists of the following:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B6_zftsybzXQda9">Long-term debt consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj">53.3</span> million payable in <span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments">48</span> equal monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)">1.1 million</span> beginning in December 2022, bearing interest at one-month Euribor plus <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum">0.825</span>%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" style="width: 10%; text-align: right" title="Loan payable">52,061</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1183">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i">135.9</span> million payable in <span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments">120</span> equal monthly installments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26">1.1 million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf">0.75</span>%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right">104,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right">124,375</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf">15.0</span> million payable in <span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments">14</span> equal annual installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh">1.1 million</span> beginning in January 2020 including interest imputed at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum">4.1</span>% per annum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right">9,890</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right">10,569</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6">17</span> million payable in <span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments">10</span> equal annual installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8">1.7 million</span> beginning in October 2021 including interest imputed at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum">2.0</span>% per annum</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable">13,332</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right">13,859</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right">180,041</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right">148,803</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">28,547</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">15,911</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">151,494</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" style="border-bottom: Black 2.5pt double; text-align: right" title="::XDX::132902"><span style="-sec-ix-hidden: xdx2ixbrl1216">132,892</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341669979584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock', window );">Maturities of lease liabilities subsequent to December 31, 2022 are as follows:</a></td>
<td class="text"><p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B6_zJZSArOFca1k">Maturities of lease liabilities
subsequent to December 31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" style="width: 10%; text-align: right" title="2023">5,723</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" style="text-align: right" title="2024">5,971</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" style="text-align: right" title="2025">4,847</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" style="text-align: right" title="2026">4,049</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">2027</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" style="text-align: right" title="2027">4,060</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Thereafter</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">6,913</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total">31,563</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><span style="font-size: 10pt">Less imputed interest (based on
    2.6%</span> weighted-average discount rate)</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest (based on 2.6% weighted-average discount rate)">(1,932</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Total">29,631</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">minimum annual royalties and other commitments as follows:</a></td>
<td class="text"><p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, <span id="xdx_8B6_zLKFQSlOwCib">minimum annual royalties and other commitments as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands) </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" style="width: 10%; text-align: right" title="2023">217,852</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" style="text-align: right" title="2024">224,201</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" style="text-align: right" title="2025">218,047</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" style="text-align: right" title="2026">139,348</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" style="text-align: right" title="2027">132,502</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thereafter</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">986,434</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,918,384</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of maturities of lease liabilities subsequent table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341757667712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">The following table sets forth information with respect to nonvested options for 2022:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zFjpmdCfOPe7">The following table sets forth
information with respect to nonvested options for 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Nonvested options &#8211; beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" style="width: 10%; text-align: right" title="Nonvested options - beginning of year">209,510</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" style="width: 10%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year">13.45</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nonvested options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" style="text-align: right" title="Nonvested options granted">62,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted">20.36</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(102,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited">12.93</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options &#8211; end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options - end of year">168,730</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year">16.31</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">The effect of share-based payment expenses decreased income statement line items as follows:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zaFiKtjKr3b5">The effect of share-based payment
expenses decreased income statement line items as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Income before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" style="width: 10%; text-align: right" title="Income before income taxes">3,143</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" style="width: 10%; text-align: right" title="Income before income taxes">2,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" style="width: 10%; text-align: right" title="Income before income taxes">3,030</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">1,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,040</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z10lqP2NV1bl">The following table summarizes
stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b>&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Shares under option -&#160;beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">524,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">57.58</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">713,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">52.74</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right">815,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right">49.89</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" style="text-align: right" title="Options granted">62,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" style="text-align: right" title="Weighted average exercise price options granted">97.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" style="text-align: right" title="Weighted average exercise price options granted">62.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right">69.11</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;Options exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" style="text-align: right" title="Options exercised">(136,880</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" style="text-align: right" title="Weighted average exercise price options exercised">43.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" style="text-align: right" title="Options exercised">(156,490</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" style="text-align: right" title="Weighted average exercise price options exercised">34.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" style="text-align: right" title="Options exercised">(95,570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right">28.99</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Options forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(8,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" style="text-align: right" title="Weighted average exercise price options forfeited">67.65</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(40,820</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" style="text-align: right" title="Weighted average exercise price options forfeited">62.57</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(16,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right">58.38</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">&#160;Shares under option - end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">441,580</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" style="text-align: right" title="Weighted average exercise price shares under option - end of year">67.30</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">524,900</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" style="text-align: right" title="Weighted average exercise price shares under option - end of year">57.58</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right">713,210</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right">52.74</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">The assumptions used in the Black-Scholes pricing model are set forth in the following table:</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zZGs8M9wlPE9">The assumptions used in the Black-Scholes
pricing model are set forth in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average expected option life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" style="text-align: right" title="Weighted-average expected option life::XDX::P4Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">4.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1434">5.0 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1436">5.0 years</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.4</td><td style="text-align: left">%</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.5</td><td style="text-align: left">%</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock', window );">Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zZTZ2TudDlj9">Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Proceeds from stock options exercised</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">6,003</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,393</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,771</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tax benefits</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intrinsic value of stock options exercised</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,873</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">The following table summarizes additional stock option information as of December 31, 2022:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B1_zT9VrNCHVHH3">The following table summarizes
additional stock option information as of December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding weighted average remaining contractual life</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options exercisable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: center"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1">40.15</span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)">46.90</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" style="width: 22%; text-align: right" title="Options outstanding">103,460</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"><span style="-sec-ix-hidden: xdx2ixbrl1475">0.96</span></span> years</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" style="width: 22%; text-align: right" title="Options exercisable">101,860</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt">$<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8">62.18</span> - $<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm">69.11</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" style="text-align: right" title="Options outstanding">139,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"><span style="-sec-ix-hidden: xdx2ixbrl1483">2.04</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" style="text-align: right" title="Options exercisable">97,210</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb">73.09</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right">136,220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1488">3.00</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right">73,780</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">$<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi">97.84</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right">62,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"><span style="-sec-ix-hidden: xdx2ixbrl1492">5.85</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1493">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">Totals</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right">441,580</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"><span style="-sec-ix-hidden: xdx2ixbrl1495">2.62</span></span> years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right">272,850</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675899280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_z0oWgrF1Exze">The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">120,938</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">87,411</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">38,219</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" style="text-align: right" title="Weighted average shares::XDX::31859417"><span style="-sec-ix-hidden: xdx2ixbrl1557">31,859,417</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" style="text-align: right" title="Weighted average shares">31,676,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" style="text-align: right" title="Weighted average shares">31,536,659</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">129,336</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">158,612</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">117,885</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share::XDX::31835408"><span style="-sec-ix-hidden: xdx2ixbrl1569">31,988,753</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,835,408</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,654,544</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.
    common shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" style="text-align: right" title="Basic (in dollars per share)">3.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" style="text-align: right" title="Basic (in dollars per share)">2.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" style="text-align: right" title="Basic (in dollars per share)">1.21</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" style="text-align: right" title="Diluted (in dollars per share)">3.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" style="text-align: right" title="Diluted (in dollars per share)">2.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" style="text-align: right" title="Diluted (in dollars per share)">1.21</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675892448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Areas (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Information on the Company&#8217;s operations by segments is as follows:</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B9_zpH2kTnlYawl">Information on the Company&#8217;s
operations by segments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right">342,644</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right">216,559</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right">117,489</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right">744,075</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right">663,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right">422,947</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations of intercompany
    sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right">(66</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right">(333</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right">(1,427</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right">1,086,653</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right">879,516</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right">539,009</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right">43,745</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right">29,359</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right">7,942</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right">77,193</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right">57,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right">30,241</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right">183</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Depreciation and amortization expense including
    impairment loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right">6,355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right">3,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right">3,354</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right">16,184</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right">8,863</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right">5,713</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right">22,539</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right">12,698</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right">9,067</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td>Interest and investment income:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right">66</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right">3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right">24</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right">5,769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right">3,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right">2,971</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right">5,486</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right">3,403</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right">2,865</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right">1,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right">636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right">604</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" style="text-align: right" title="Interest expense">2,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" style="text-align: right" title="Interest expense">2,315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" style="text-align: right" title="Interest expense">1,496</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">3,599</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">2,825</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">1,970</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right">6,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right">5,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right">1,590</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right">36,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right">35,607</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right">17,782</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right">43,182</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right">40,992</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right">19,381</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right">278,090</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right">247,703</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right">141,316</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right">1,052,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right">931,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right">758,812</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right">(21,552</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right">(34,074</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right">(9,983</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right">1,308,542</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right">1,145,364</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right">890,145</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Additions to long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right">2,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right">2,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right">1,004</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right">31,438</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right">138,563</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right">11,259</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right">33,756</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right">141,274</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right">12,263</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total long-lived assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right">61,539</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right">63,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right">40,656</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right">423,999</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right">334,033</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right">217,766</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right">485,538</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right">397,127</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right">258,422</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right">2,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right">870</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right">886</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right">8,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right">7,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right">7,106</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right">8,041</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Consolidated net sales to customers by region are as follows:</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;<span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden">Consolidated net sales to customers by region are as follows:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">North America</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" style="width: 10%; text-align: right" title="Net sales">431,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" style="width: 10%; text-align: right" title="Net sales">354,100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" style="width: 10%; text-align: right" title="Net sales">193,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Europe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right">333,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right">271,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right">180,200</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Asia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right">152,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right">128,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right">79,700</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Middle East</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right">87,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right">61,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right">46,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Central and South America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right">69,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right">56,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right">32,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right">8,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right">6,300</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right">1,086,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right">879,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right">539,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Consolidated net sales to customers in major countries are as follows:</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B7_z7FpI55o74vh">Consolidated net sales to customers in major countries
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">420,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">351,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">187,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>France</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right">44,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right">44,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right">37,600</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Russia</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right">33,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right">43,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right">14,100</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right">37,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right">38,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right">24,600</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671819328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">The components of income before income taxes consist of the following:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z7VnI34zzwX8">The components of income before
income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">U.S. operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" style="width: 10%; text-align: right" title="U.S. operations">50,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" style="width: 10%; text-align: right" title="U.S. operations">34,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" style="width: 10%; text-align: right" title="U.S. operations">9,577</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">143,969</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">116,277</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">59,772</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::194219"><span style="-sec-ix-hidden: xdx2ixbrl1797">194,219</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::151019"><span style="-sec-ix-hidden: xdx2ixbrl1799">151,019</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::69349"><span style="-sec-ix-hidden: xdx2ixbrl1801">69,349</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">The provision for current and deferred income tax expense (benefit) consists of the following:</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zcy74h7kGdd5">The provision for current and
deferred income tax expense (benefit) consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Current:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 61%; padding-left: 0.125in">Federal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" style="width: 10%; text-align: right" title="Federal">6,829</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" style="width: 10%; text-align: right" title="Federal">4,825</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" style="width: 10%; text-align: right" title="Federal">1,685</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">State and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" style="text-align: right" title="State and local">658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" style="text-align: right" title="State and local">518</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" style="text-align: right" title="State and local">90</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">39,458</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">36,164</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">17,024</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">46,945</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">41,507</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">18,799</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" style="text-align: right" title="Federal">(802</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" style="text-align: right" title="Federal">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" style="text-align: right" title="Federal">(215</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">State and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" style="text-align: right" title="State and local">(49</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" style="text-align: right" title="State and local">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" style="text-align: right" title="State and local">44</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(2,912</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(530</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">753</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(3,763</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(515</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">582</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in">Total income tax expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">43,182</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">40,992</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">19,381</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_zp6bQ94sbp35">The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">554</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,292</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Inventory and accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,508</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Profit sharing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,787</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Stock option compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">732</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of inventory profit elimination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,342</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,112</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">266</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">407</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Total gross deferred tax assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,838</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(554</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,582</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,075</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,256</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities (long-term):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Building expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,356</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,082</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Trademarks and licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,551</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Unrealized gain on marketable equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,745</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(436</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(655</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(251</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,916</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,320</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z8w289QLD5Z9">Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Statutory rates</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and local taxes, net of Federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Windfall benefit from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.9</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Benefit of Foreign Derived Intangible Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.8</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Effect of foreign taxes greater than U.S. statutory rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.5</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.2</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.625in">Effective rates</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">22.2</td><td style="text-align: left; padding-bottom: 2pt">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">27.1</td><td style="text-align: left; padding-bottom: 2pt">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">27.9</td><td style="text-align: left; padding-bottom: 2pt">%</td></tr>

</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676011088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">The components of accumulated other comprehensive loss consist of the following:</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8B6_zdI2PfJTcWk4">The components of accumulated other
comprehensive loss consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">(992</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1968">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">52</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">2,701</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(52</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">1,709</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"><span style="-sec-ix-hidden: xdx2ixbrl1982">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cumulative translation adjustments, beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(37,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(5,997</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(39,905</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(20,325</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(31,443</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">33,908</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(57,765</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(37,440</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(5,997</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(56,056</td><td style="text-align: left; padding-bottom: 2pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(38,432</td><td style="text-align: left; padding-bottom: 2pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right">(5,997</td><td style="text-align: left; padding-bottom: 2pt">)</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672785888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Schedule of net income attributable to transfers from the noncontrolling interest</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">120,938</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">87,411</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">38,219</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2019">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2020">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">&#8212;</span></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676027904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract', window );"><strong>Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">The following table summarizes cash and cash equivalents as of December 31, 2021:</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zWO24NCWEtHj">The following table summarizes
cash and cash equivalents as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="font-family: Courier New, Courier, Monospace; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/>
 2021</b></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 77%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" style="width: 12%; text-align: right" title="Cash and cash equivalents per balance sheet">159,613</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" style="border-bottom: Black 1pt solid; text-align: right" title="Cash held in escrow included in other assets (see note 3)::XDX::168387">8,774</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Cash and cash equivalents per balance sheet::XDX::168387">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash and cash equivalents per statement of cash flows::XDX::168387">168,387</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672791024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of Valuation and Qualifying Accounts</a></td>
<td class="text"><p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden">Schedule of Valuation and Qualifying Accounts</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Valuation and Qualifying Accounts</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Column A</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column B</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column C</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column D</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column E</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additions</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(1)</td><td style="font-weight: bold; text-align: left"/><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(2)</td><td style="font-weight: bold; text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance
    at</b></span><br/> <span style="font-size: 10pt"><b>beginning of</b></span><br/> <span style="font-size: 10pt"><b>period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged
    to</b></span><br/> <span style="font-size: 10pt"><b>costs and</b></span><br/> <span style="font-size: 10pt"><b>expenses</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged
    to</b></span><br/> <span style="font-size: 10pt"><b>other</b></span><br/> <span style="font-size: 10pt"><b>accounts &#8211;</b></span><br/>
    <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Deductions</b></span><br/>
    <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance
    at</b></span><br/> <span style="font-size: 10pt"><b>end of period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in">Allowance for doubtful accounts:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 3%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" style="text-align: right" title="Balance at beginning of period">2,247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right">2,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" style="text-align: right" title="Charged to other accounts describe">1,134</td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right">1,044</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" style="text-align: right" title="Balance at end of period">4,690</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" style="text-align: right" title="Balance at beginning of period">5,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right">877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right">(843</td><td colspan="2" style="text-align: left">)(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right">3,336</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" style="text-align: right" title="Balance at end of period">2,247</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" style="text-align: right" title="Balance at beginning of period">2,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" style="text-align: right" title="Charged to costs and expenses">4,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right">381</td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" style="text-align: right" title="Deductions describe">2,107</td><td style="text-align: left">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" style="text-align: right" title="Balance at end of period">5,550</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Allowance for sales returns, net of inventory:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" style="text-align: right" title="Balance at beginning of period">3,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right">4,997	</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2068">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right">2,829</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" style="text-align: right" title="Balance at end of period">5,410</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" style="text-align: right" title="Balance at beginning of period">2,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right">3,042</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2075">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right">2,042</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" style="text-align: right" title="Balance at end of period">3,242</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" style="text-align: right" title="Balance at beginning of period">2,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right">1,978</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right">2,323</td><td style="text-align: left">(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" style="text-align: right" title="Balance at end of period">2,242</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Inventory reserve:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" style="text-align: right" title="Balance at beginning of period">15,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right">8,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right">(378</td><td colspan="2" style="text-align: left">)(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right">12,710</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" style="text-align: right" title="Balance at end of period">11,431</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" style="text-align: right" title="Balance at beginning of period">9,371</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right">8,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right">7,041</td><td colspan="2" style="text-align: left">(d)(e)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right">8,852</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" style="text-align: right" title="Balance at end of period">15,777</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" style="text-align: right" title="Balance at beginning of period">4,909</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right">7,212</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right">616</td><td colspan="2" style="text-align: left">(d)</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right">3,366</td><td style="text-align: left">(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" style="text-align: right" title="Balance at end of period">9,371</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left">(a)</td><td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify">Write-off of bad debts.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left">(b)</td><td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify">Write-off of sales returns.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left">(c)</td><td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify">Disposal of inventory</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left">(d)</td><td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify">Foreign currency translation adjustment</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left">(e)</td><td id="xdx_F19_z623xCp9iOT7" style="text-align: justify">Inventory reserves acquired of $7,639</td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666717648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of lanvin brand name for our class (Details) - Product Sales Concentration Risk [Member] - Janvin [Member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=ipar_ProductSalesConcentrationRiskMember', window );">Montblanc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=ipar_ProductSalesConcentrationRiskMember', window );">Jimmy Choo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=ipar_ProductSalesConcentrationRiskMember', window );">Coach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=ipar_ProductSalesConcentrationRiskMember', window );">G U E S S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ipar_ProductSalesConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ipar_ProductSalesConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_MontblancMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_MontblancMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis=ipar_JanvinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis=ipar_JanvinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_JimmyChooMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_JimmyChooMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_CoachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_CoachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_GUESSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ipar_GUESSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341667061888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and its Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for sales returns and doubtful accounts</a></td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Shipping and handling costs</a></td>
<td class="nump">392,231,000<span></span>
</td>
<td class="nump">322,614,000<span></span>
</td>
<td class="nump">$ 208,278,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Contract with customer, refund liability</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRightToRecoverProduct', window );">Contract with customer, right to recover products</a></td>
<td class="nump">3,200,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">212,400,000<span></span>
</td>
<td class="nump">171,100,000<span></span>
</td>
<td class="nump">91,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Customer incentives cost</a></td>
<td class="nump">$ 43,100,000<span></span>
</td>
<td class="nump">$ 36,900,000<span></span>
</td>
<td class="nump">$ 26,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.80%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">License agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension', window );">License agreement renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">License agreement term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension', window );">License agreement renewal term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Credit Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Shipping and handling costs</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average cost of capital</a></td>
<td class="nump">9.80%<span></span>
</td>
<td class="nump">7.47%<span></span>
</td>
<td class="nump">6.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums SA Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage in Interparfums SA</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_RoyaltyExpenseNetSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents royalty expense net sales percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_RoyaltyExpenseNetSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRightToRecoverProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to recover product from customer on settling refund liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRightToRecoverProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis=us-gaap_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis=us-gaap_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341667076336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Agreements (Details Narrative)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase price, period cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition costs, period cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Cash held in escrow is included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,000,000.0<span></span>
</td>
<td class="nump">&#8364; 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Description of debt instrument interest rate terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-month
Euribor plus 0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciated over a range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciated over a range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">50 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase price, period cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase price, period cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums SA Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_DonnaKaranAndDKNYMember', window );">Donna Karan and DKNY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issue | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_RochasFashionMember', window );">Rochas Fashion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentChargeOnReclassifiedAssets', window );">Impairment Charge on Reclassified Assets</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ipar_EmanuelUngarMember', window );">Emanuel Ungar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Description of recent agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">we also entered
into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro
Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro
brand.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ipar_RochasFashionMember', window );">Rochas Fashion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Description of recent agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in
royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion
trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after
an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option
for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentChargeOnReclassifiedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 44<br> -URI https://asc.fasb.org/extlink&amp;oid=29634951&amp;loc=d3e1756-110224<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2459-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentChargeOnReclassifiedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_DonnaKaranAndDKNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_DonnaKaranAndDKNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_RochasFashionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_RochasFashionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ipar_EmanuelUngarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ipar_EmanuelUngarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ipar_RochasFashionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ipar_RochasFashionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670361984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and component parts</a></td>
<td class="nump">$ 146,772<span></span>
</td>
<td class="nump">$ 111,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">143,212<span></span>
</td>
<td class="nump">87,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 289,984<span></span>
</td>
<td class="nump">$ 198,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676821056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldOverhead', window );">Cost of Goods Sold, Overhead</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indirect cost incurred related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341665997824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair value, assets measured on recurring basis (Details) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">$ 150,833<span></span>
</td>
<td class="nump">$ 160,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Interest rate swaps</a></td>
<td class="nump">6,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="nump">1,189<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="nump">158,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">19,861<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Interest rate swaps</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="nump">19,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">130,174<span></span>
</td>
<td class="nump">160,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Interest rate swaps</a></td>
<td class="nump">6,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="nump">1,189<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="nump">138,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">798<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Interest rate swaps</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue', window );">Foreign currency forward exchange contracts accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">&#160;Total Assets</a></td>
<td class="nump">798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Foreign currency forward exchange contracts not accounted for using hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivatives designated as interest rate fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672708736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments (Details Narrative) - Foreign Exchange Contract [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Loan amount</a></td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts, liability, fair value disclosure</a></td>
<td class="nump">$ 36,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341665889184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of equipment and leasehold improvements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">$ 210,119<span></span>
</td>
<td class="nump">$ 190,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">43,397<span></span>
</td>
<td class="nump">40,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net, Total</a></td>
<td class="nump">166,722<span></span>
</td>
<td class="nump">149,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">148,137<span></span>
</td>
<td class="nump">136,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">59,689<span></span>
</td>
<td class="nump">52,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and leasehold improvements</a></td>
<td class="nump">$ 2,293<span></span>
</td>
<td class="nump">$ 2,082<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341675885664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666966784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of trademarks, licenses and other intangible assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">$ 369,373<span></span>
</td>
<td class="nump">$ 290,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">78,520<span></span>
</td>
<td class="nump">76,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">290,853<span></span>
</td>
<td class="nump">214,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">205,235<span></span>
</td>
<td class="nump">109,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">63,535<span></span>
</td>
<td class="nump">62,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">141,700<span></span>
</td>
<td class="nump">47,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">17,849<span></span>
</td>
<td class="nump">17,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">14,921<span></span>
</td>
<td class="nump">14,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">2,928<span></span>
</td>
<td class="nump">3,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">Indefinite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">105,022<span></span>
</td>
<td class="nump">119,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">105,022<span></span>
</td>
<td class="nump">119,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Finite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">41,267<span></span>
</td>
<td class="nump">43,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">41,203<span></span>
</td>
<td class="nump">43,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ipar_SubtotalMember', window );">Subtotal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">264,351<span></span>
</td>
<td class="nump">171,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">78,520<span></span>
</td>
<td class="nump">76,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">$ 185,831<span></span>
</td>
<td class="nump">$ 94,335<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ipar_SubtotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ipar_SubtotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671717184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trademarks, Licenses and Other Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">12,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">$ 10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedLicenseAgreements', window );">Indefinite-Lived License Agreements</a></td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average cost of capital</a></td>
<td class="nump">9.80%<span></span>
</td>
<td class="nump">7.47%<span></span>
</td>
<td class="nump">6.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">Indefinite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">Indefinite-Lived Intangible Assets [Member] | Rochas Fashion Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ipar_RochasFashionBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ipar_RochasFashionBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666721488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued expenses consist of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedAdvertisingCurrent', window );">Advertising liabilities</a></td>
<td class="nump">$ 42,338<span></span>
</td>
<td class="nump">$ 31,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Salary (including bonus and related taxes)</a></td>
<td class="nump">21,128<span></span>
</td>
<td class="nump">19,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">26,532<span></span>
</td>
<td class="nump">19,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DueVendorsNotYetInvoiced', window );">Due vendors (not yet invoiced)</a></td>
<td class="nump">105,869<span></span>
</td>
<td class="nump">45,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent', window );">Retirement reserves</a></td>
<td class="nump">8,001<span></span>
</td>
<td class="nump">10,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Refund (return) liability</a></td>
<td class="nump">8,604<span></span>
</td>
<td class="nump">5,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,149<span></span>
</td>
<td class="nump">5,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 213,621<span></span>
</td>
<td class="nump">$ 136,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DueVendorsNotYetInvoiced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents due vendors not yet invoiced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DueVendorsNotYetInvoiced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedAdvertisingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedAdvertisingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670655520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt consists of the following: (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 180,041,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148,803,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current maturities</a></td>
<td class="nump">28,547,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,911,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total</a></td>
<td class="nump">151,494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,902,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 53,300,000<span></span>
</td>
<td class="nump">&#8364; 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">0.825%<span></span>
</td>
<td class="nump">0.825%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 52,061,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember', window );">Loans Payable One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 135,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,000,000.0<span></span>
</td>
<td class="nump">&#8364; 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 104,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableTwoMember', window );">Loans Payable Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 9,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableThreeMember', window );">Loans Payable Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_NumberOfInstallment', window );">Number of installments | Number</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment amount (in Dollars)</a></td>
<td class="nump">$ 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest per annum</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable</a></td>
<td class="nump">$ 13,332,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,859,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_NumberOfInstallment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents number of installment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_NumberOfInstallment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672744256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Payable &#8211; Banks (Details Narrative)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember', window );">Domestic Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum borrowing amount</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember', window );">Domestic Subsidiaries [Member] | London Interbank Offered Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread over variable interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Variable rate</a></td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of Credit Facility, Expiration Date</a></td>
<td class="text">Dec. 15,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum borrowing amount</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member] | Euro Interbank Offered Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Variable rate</a></td>
<td class="nump">0.576%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member] | Euro Interbank Offered Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread over variable interest rate</a></td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember', window );">Foreign Subsidiaries [Member] | Euro Interbank Offered Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread over variable interest rate</a></td>
<td class="nump">0.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_DomesticSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ipar_LondonInterbankOfferedRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ipar_LondonInterbankOfferedRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ipar_ForeignSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ipar_EuroInterbankOfferedRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ipar_EuroInterbankOfferedRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672749456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Details Narrative)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtDescription', window );">Long term debt maturity, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">28.7 million per year thereafter through 2033.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-term Debt, Maturities, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,300,000<span></span>
</td>
<td class="nump">&#8364; 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtDescription', window );">Long term debt maturity, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was
swapped for variable interest rate debt with a maximum rate of 2% per annum.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember', window );">Loans Payable One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 128,000,000.0<span></span>
</td>
<td class="nump">$ 135,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtDescription', window );">Long term debt maturity, description</a></td>
<td class="text">Approximately $85.3 million (&#8364;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ipar_LoansPayableOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670940832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 5,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">5,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">4,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">4,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Gross Total</a></td>
<td class="nump">31,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate', window );">Less imputed interest (based on 2.6% weighted-average discount rate)</a></td>
<td class="num">(1,932)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal', window );">Net Total</a></td>
<td class="nump">$ 29,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less imputed interest based on2.6 weightedaverage discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents lessee operating lease liability payments due net total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676731136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>minimum annual royalties and other commitments as follows: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement', window );">License agreement, expiration description</a></td>
<td class="text">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 217,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondYear', window );">2024</a></td>
<td class="nump">224,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInThirdYear', window );">2025</a></td>
<td class="nump">218,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFourthYear', window );">2026</a></td>
<td class="nump">139,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFifthYear', window );">2027</a></td>
<td class="nump">132,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">986,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Total</a></td>
<td class="nump">$ 1,918,384<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the entity's intent or ability to renew or extend the arrangement related to an intangible asset and how that affects expected future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=SL5742995-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671679536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_OperatingLeaseOfRelatedToRentalExpenses', window );">Operating lease of related to rental expenses</a></td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Noncash additions to operating lease assets</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">$ 87,000,000.0<span></span>
</td>
<td class="nump">$ 68,900,000<span></span>
</td>
<td class="nump">$ 41,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_RoyaltyExpenseNetSalesPercentage', window );">Royalty expense, percentage of net sales</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.80%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_OperatingLeaseMember', window );">Operating Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_OperatingLeaseOfRelatedToRentalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents operating lease of related to rental expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_OperatingLeaseOfRelatedToRentalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_RoyaltyExpenseNetSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents royalty expense net sales percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_RoyaltyExpenseNetSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ipar_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341676716736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth information with respect to nonvested options for 2022: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested options - beginning of year</a></td>
<td class="nump">209,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, beginning of year</a></td>
<td class="nump">$ 13.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Nonvested options granted</a></td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, granted</a></td>
<td class="nump">$ 20.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Nonvested options vested or forfeited</a></td>
<td class="num">(102,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, vested or forfeited</a></td>
<td class="nump">$ 12.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested options - end of year</a></td>
<td class="nump">168,730<span></span>
</td>
<td class="nump">209,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, end of year</a></td>
<td class="nump">$ 16.31<span></span>
</td>
<td class="nump">$ 13.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671599264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The effect of share-based payment expenses decreased income statement line items as follows: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 194,219<span></span>
</td>
<td class="nump">$ 151,019<span></span>
</td>
<td class="nump">$ 69,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 120,938<span></span>
</td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Inter Parfums, Inc</a></td>
<td class="nump">$ 3.78<span></span>
</td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember', window );">Operating Income (Loss) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 3,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 2,036<span></span>
</td>
<td class="nump">$ 1,880<span></span>
</td>
<td class="nump">$ 2,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Inter Parfums, Inc</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670462368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options shares under option - beginning of year</a></td>
<td class="nump">524,900<span></span>
</td>
<td class="nump">713,210<span></span>
</td>
<td class="nump">815,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price shares under option - beginning of year</a></td>
<td class="nump">$ 57.58<span></span>
</td>
<td class="nump">$ 52.74<span></span>
</td>
<td class="nump">$ 49.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price options granted</a></td>
<td class="nump">$ 97.84<span></span>
</td>
<td class="nump">$ 62.18<span></span>
</td>
<td class="nump">$ 69.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
<td class="num">(136,880)<span></span>
</td>
<td class="num">(156,490)<span></span>
</td>
<td class="num">(95,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price options exercised</a></td>
<td class="nump">$ 43.86<span></span>
</td>
<td class="nump">$ 34.46<span></span>
</td>
<td class="nump">$ 28.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited</a></td>
<td class="num">(8,440)<span></span>
</td>
<td class="num">(40,820)<span></span>
</td>
<td class="num">(16,020)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price options forfeited</a></td>
<td class="nump">$ 67.65<span></span>
</td>
<td class="nump">$ 62.57<span></span>
</td>
<td class="nump">$ 58.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options shares under option - end of year</a></td>
<td class="nump">441,580<span></span>
</td>
<td class="nump">524,900<span></span>
</td>
<td class="nump">713,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price shares under option - end of year</a></td>
<td class="nump">$ 67.30<span></span>
</td>
<td class="nump">$ 57.58<span></span>
</td>
<td class="nump">$ 52.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341674515936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted-average expected stock-price volatility</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected option life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Weighted-average dividend yield</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670758416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="nump">$ 6,003<span></span>
</td>
<td class="nump">$ 5,393<span></span>
</td>
<td class="nump">$ 2,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised', window );">Tax benefits</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options exercised</a></td>
<td class="nump">$ 6,760<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="nump">$ 2,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxExpenseFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341665847232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes additional stock option information as of December 31, 2022: (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">441,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">2 years 7 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">272,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeOneMember', window );">Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">103,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">101,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeTwoMember', window );">Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">139,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">97,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeThreeMember', window );">Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">136,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="nump">73,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeFourMember', window );">Exercise Price Range Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 97.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">62,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">5 years 10 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 40.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in dollars per share) | $ / shares</a></td>
<td class="nump">62.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 46.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">11 months 15 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price range (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 69.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life</a></td>
<td class="text">2 years 15 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ipar_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341665559984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price of options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life of options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Straight line basis over the requisite</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_PercentageOfIncreaseInAnnualDividend', window );">Percentage of increase in annual dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=ipar_InterparfumsSAMember', window );">interparfums S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums SA Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockSplits', window );">Shares adjusted for stock splits</a></td>
<td class="nump">211,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Recognized as compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember', window );">Interparfums SA Subsidiary [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Adjusted for stock splits (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DistributionMadeToLimitedPartnerUnitDistribution', window );">Number of share distributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember', window );">Stock Option One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.36<span></span>
</td>
<td class="nump">$ 11.35<span></span>
</td>
<td class="nump">$ 12.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_PercentageOfIncreaseInAnnualDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents percentage of increase in annual dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_PercentageOfIncreaseInAnnualDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionMadeToLimitedPartnerUnitDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of units distributed for payment of a unit distribution to unit-holder of limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionMadeToLimitedPartnerUnitDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=128088960&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126965701&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of a stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ipar_InterparfumsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ipar_InterparfumsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ipar_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ipar_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341673501664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Numerator for diluted earnings per share (in dollars)</a></td>
<td class="nump">$ 120,938<span></span>
</td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares</a></td>
<td class="nump">31,859,417<span></span>
</td>
<td class="nump">31,676,796<span></span>
</td>
<td class="nump">31,536,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Stock options</a></td>
<td class="nump">129,336<span></span>
</td>
<td class="nump">158,612<span></span>
</td>
<td class="nump">117,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings per share</a></td>
<td class="nump">31,988,753<span></span>
</td>
<td class="nump">31,835,408<span></span>
</td>
<td class="nump">31,654,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 3.78<span></span>
</td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671740352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">175,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666221792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information on the Company&#8217;s operations by segments is as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 1,086,653<span></span>
</td>
<td class="nump">$ 879,516<span></span>
</td>
<td class="nump">$ 539,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">120,938<span></span>
</td>
<td class="nump">87,411<span></span>
</td>
<td class="nump">38,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">22,539<span></span>
</td>
<td class="nump">12,698<span></span>
</td>
<td class="nump">9,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">5,486<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">2,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="num">(5,486)<span></span>
</td>
<td class="num">(3,403)<span></span>
</td>
<td class="num">(2,865)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">3,599<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(3,599)<span></span>
</td>
<td class="num">(2,825)<span></span>
</td>
<td class="num">(1,970)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">43,182<span></span>
</td>
<td class="nump">40,992<span></span>
</td>
<td class="nump">19,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,308,542<span></span>
</td>
<td class="nump">1,145,364<span></span>
</td>
<td class="nump">890,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="num">(1,308,542)<span></span>
</td>
<td class="num">(1,145,364)<span></span>
</td>
<td class="num">(890,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionsToOtherAssetsAmount', window );">Additions to Other Assets, Amount</a></td>
<td class="nump">33,756<span></span>
</td>
<td class="nump">141,274<span></span>
</td>
<td class="nump">12,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">485,538<span></span>
</td>
<td class="nump">397,127<span></span>
</td>
<td class="nump">258,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">11,159<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">8,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">342,644<span></span>
</td>
<td class="nump">216,559<span></span>
</td>
<td class="nump">117,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">43,745<span></span>
</td>
<td class="nump">29,359<span></span>
</td>
<td class="nump">7,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">6,355<span></span>
</td>
<td class="nump">3,835<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,100)<span></span>
</td>
<td class="num">(636)<span></span>
</td>
<td class="num">(604)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">6,920<span></span>
</td>
<td class="nump">5,336<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">278,090<span></span>
</td>
<td class="nump">247,703<span></span>
</td>
<td class="nump">141,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="num">(278,090)<span></span>
</td>
<td class="num">(247,703)<span></span>
</td>
<td class="num">(141,316)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionsToOtherAssetsAmount', window );">Additions to Other Assets, Amount</a></td>
<td class="nump">2,318<span></span>
</td>
<td class="nump">2,711<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">61,539<span></span>
</td>
<td class="nump">63,094<span></span>
</td>
<td class="nump">40,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">2,906<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">744,075<span></span>
</td>
<td class="nump">663,290<span></span>
</td>
<td class="nump">422,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">77,193<span></span>
</td>
<td class="nump">57,869<span></span>
</td>
<td class="nump">30,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">16,184<span></span>
</td>
<td class="nump">8,863<span></span>
</td>
<td class="nump">5,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">5,769<span></span>
</td>
<td class="nump">3,526<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="num">(5,769)<span></span>
</td>
<td class="num">(3,526)<span></span>
</td>
<td class="num">(2,971)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,848<span></span>
</td>
<td class="nump">2,315<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,848)<span></span>
</td>
<td class="num">(2,315)<span></span>
</td>
<td class="num">(1,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">36,262<span></span>
</td>
<td class="nump">35,607<span></span>
</td>
<td class="nump">17,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,052,004<span></span>
</td>
<td class="nump">931,735<span></span>
</td>
<td class="nump">758,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="num">(1,052,004)<span></span>
</td>
<td class="num">(931,735)<span></span>
</td>
<td class="num">(758,812)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionsToOtherAssetsAmount', window );">Additions to Other Assets, Amount</a></td>
<td class="nump">31,438<span></span>
</td>
<td class="nump">138,563<span></span>
</td>
<td class="nump">11,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">423,999<span></span>
</td>
<td class="nump">334,033<span></span>
</td>
<td class="nump">217,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">8,253<span></span>
</td>
<td class="nump">7,066<span></span>
</td>
<td class="nump">7,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_EliminationsMember', window );">Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment Income, Interest and Dividend</a></td>
<td class="num">(349)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(349)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">21,552<span></span>
</td>
<td class="nump">34,074<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="num">(21,552)<span></span>
</td>
<td class="num">(34,074)<span></span>
</td>
<td class="num">(9,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionsToOtherAssetsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of significant additions in the period in other assets (current, noncurrent, or unclassified).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionsToOtherAssetsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_EliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_EliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670969552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated net sales to customers by region are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,086,700<span></span>
</td>
<td class="nump">$ 879,500<span></span>
</td>
<td class="nump">$ 539,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">431,900<span></span>
</td>
<td class="nump">354,100<span></span>
</td>
<td class="nump">193,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">333,400<span></span>
</td>
<td class="nump">271,600<span></span>
</td>
<td class="nump">180,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">152,700<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">79,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember', window );">Middle East [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">87,800<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
<td class="nump">46,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_CentralAndSouthAmericaMember', window );">Central and South America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">69,900<span></span>
</td>
<td class="nump">56,400<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ipar_OtherSegmentCountryMember', window );">Other Segment Country [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_MiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_CentralAndSouthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_CentralAndSouthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ipar_OtherSegmentCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ipar_OtherSegmentCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666745728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated net sales to customers in major countries are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 1,086,653<span></span>
</td>
<td class="nump">$ 879,516<span></span>
</td>
<td class="nump">$ 539,009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedStatesMember', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">420,900<span></span>
</td>
<td class="nump">351,300<span></span>
</td>
<td class="nump">187,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_FranceMember', window );">France [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">44,800<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">37,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_RussiaMember', window );">Russia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">33,964<span></span>
</td>
<td class="nump">43,400<span></span>
</td>
<td class="nump">14,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedKingdomMember', window );">United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 37,900<span></span>
</td>
<td class="nump">$ 38,500<span></span>
</td>
<td class="nump">$ 24,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_FranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_FranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_RussiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_RussiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedKingdomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ipar_UnitedKingdomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341665703376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Areas (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from export sales</a></td>
<td class="nump">$ 1,086,700,000<span></span>
</td>
<td class="nump">$ 879,500,000<span></span>
</td>
<td class="nump">$ 539,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from export sales</a></td>
<td class="nump">$ 169,100,000<span></span>
</td>
<td class="nump">$ 126,200,000<span></span>
</td>
<td class="nump">$ 71,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670756976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The components of income before income taxes consist of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="nump">$ 50,250<span></span>
</td>
<td class="nump">$ 34,742<span></span>
</td>
<td class="nump">$ 9,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign operations</a></td>
<td class="nump">143,969<span></span>
</td>
<td class="nump">116,277<span></span>
</td>
<td class="nump">59,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 194,219<span></span>
</td>
<td class="nump">$ 151,019<span></span>
</td>
<td class="nump">$ 69,349<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672653344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The provision for current and deferred income tax expense (benefit) consists of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 6,829<span></span>
</td>
<td class="nump">$ 4,825<span></span>
</td>
<td class="nump">$ 1,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">658<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">39,458<span></span>
</td>
<td class="nump">36,164<span></span>
</td>
<td class="nump">17,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense</a></td>
<td class="nump">46,945<span></span>
</td>
<td class="nump">41,507<span></span>
</td>
<td class="nump">18,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(802)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(49)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(2,912)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income tax expense</a></td>
<td class="num">(3,763)<span></span>
</td>
<td class="num">(515)<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 43,182<span></span>
</td>
<td class="nump">$ 40,992<span></span>
</td>
<td class="nump">$ 19,381<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666818976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Net deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign net operating loss carry-forwards</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">$ 1,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DeferredTaxAssetsInventoryAndAccountsReceivable', window );">Inventory and accounts receivable</a></td>
<td class="nump">3,880<span></span>
</td>
<td class="nump">4,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Profit sharing</a></td>
<td class="nump">2,871<span></span>
</td>
<td class="nump">3,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock option compensation</a></td>
<td class="nump">716<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Effect of inventory profit elimination</a></td>
<td class="nump">9,342<span></span>
</td>
<td class="nump">5,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets, net</a></td>
<td class="nump">17,629<span></span>
</td>
<td class="nump">15,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(554)<span></span>
</td>
<td class="num">(3,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">17,075<span></span>
</td>
<td class="nump">12,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities (long-term):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DeferredTaxLiabilitiesBuildingExpenses', window );">Building expenses</a></td>
<td class="num">(1,356)<span></span>
</td>
<td class="num">(1,082)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Trademarks and licenses</a></td>
<td class="num">(2,160)<span></span>
</td>
<td class="num">(2,551)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities', window );">Unrealized gain on marketable equity securities</a></td>
<td class="num">(1,745)<span></span>
</td>
<td class="num">(436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(655)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(5,916)<span></span>
</td>
<td class="num">(4,320)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 11,159<span></span>
</td>
<td class="nump">$ 7,936<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DeferredTaxAssetsInventoryAndAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets inventory and accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DeferredTaxAssetsInventoryAndAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DeferredTaxLiabilitiesBuildingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax liabilities building expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DeferredTaxLiabilitiesBuildingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax liabilities unrealized gain on marketable equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670473168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory rates</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of Federal benefit</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends', window );">Windfall benefit from exercise of stock options</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Benefit of Foreign Derived Intangible Income</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1', window );">Effect of foreign taxes greater than U.S. statutory rates</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective rates</a></td>
<td class="nump">22.20%<span></span>
</td>
<td class="nump">27.10%<span></span>
</td>
<td class="nump">27.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents effective income tax rate reconciliation at federal statutory income tax rate1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend paid to employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670812032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="num">$ (2,912,000)<span></span>
</td>
<td class="num">$ (530,000)<span></span>
</td>
<td class="nump">$ 753,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ipar_ForeignDerivedIntangibleIncomeMember', window );">Foreign Derived Intangible Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ipar_ForeignDerivedIntangibleIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ipar_ForeignDerivedIntangibleIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341672678832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The components of accumulated other comprehensive loss consist of the following: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (56,056)<span></span>
</td>
<td class="num">$ (38,432)<span></span>
</td>
<td class="num">$ (5,997)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember', window );">Accumulated Defined Benefit Plans Net Derivative Instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1', window );">Net derivative instruments, beginning of year</a></td>
<td class="num">(992)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Net derivative instrument gain (loss), net of tax</a></td>
<td class="nump">2,701<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1', window );">Net derivative instruments, end of year</a></td>
<td class="nump">1,709<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2', window );">Cumulative translation adjustments, beginning of year</a></td>
<td class="num">(37,440)<span></span>
</td>
<td class="num">(5,997)<span></span>
</td>
<td class="num">(39,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Translation adjustments</a></td>
<td class="num">(20,325)<span></span>
</td>
<td class="num">(31,443)<span></span>
</td>
<td class="nump">33,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2', window );">Cumulative translation adjustments, end of year</a></td>
<td class="num">$ (57,765)<span></span>
</td>
<td class="num">$ (37,440)<span></span>
</td>
<td class="num">$ (5,997)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents accumulated other comprehensive income loss net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents accumulated other comprehensive income loss net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341666760064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of net income attributable to transfers from the noncontrolling interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Inter Parfums, Inc.</a></td>
<td class="nump">$ 120,938<span></span>
</td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet', window );">Decrease in Inter Parfums, Inc.&#8217;s additional paid-in capital for subsidiary share transactions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet', window );">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</a></td>
<td class="nump">$ 120,938<span></span>
</td>
<td class="nump">$ 87,411<span></span>
</td>
<td class="nump">$ 38,219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the total net income attributable to the parent for the period and the effect of net changes during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not result in a deconsolidation of the subsidiary from the consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not arise in a deconsolidation of the subsidiary from the consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341671646672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract', window );"><strong>Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents per balance sheet</a></td>
<td class="nump">$ 159,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ipar_CashHeldInEscrowIncludedInOtherAssets', window );">Cash held in escrow included in other assets (see note 3)</a></td>
<td class="nump">8,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents per statement of cash flows</a></td>
<td class="nump">$ 168,387<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_CashHeldInEscrowIncludedInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash held in escrow included in other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_CashHeldInEscrowIncludedInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ipar_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140341670949472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,247<span></span>
</td>
<td class="nump">$ 5,550<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,353<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to other accounts describe</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,134<span></span>
</td>
<td class="num">(843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions describe</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">3,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,690<span></span>
</td>
<td class="nump">2,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember', window );">Sales Returns and Allowances [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,242<span></span>
</td>
<td class="nump">2,242<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,997<span></span>
</td>
<td class="nump">3,042<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to other accounts describe</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions describe</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">2,829<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,410<span></span>
</td>
<td class="nump">3,242<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember', window );">SEC Schedule, 12-09, Reserve, Inventory [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,777<span></span>
</td>
<td class="nump">9,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,742<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to other accounts describe</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(378)<span></span>
</td>
<td class="nump">7,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions describe</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">12,710<span></span>
</td>
<td class="nump">8,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,431<span></span>
</td>
<td class="nump">$ 15,777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,371<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Foreign currency translation adjustment</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Write-off of bad debts.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Write-off of sales returns.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Inventory reserves acquired of $7,639</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Disposal of inventory</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>g083417_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:ipar="http://interparfumsinc.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ipar-20221231.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:MontblancMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:JimmyChooMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:CoachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ipar:GUESSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ipar:ProductSalesConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueConcentrationOfRiskDisclosureItemsAxis">ipar:JanvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis">us-gaap:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EmanuelUngarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipar:EmanuelUngarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DonnaKaranAndDKNYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DonnaKaranAndDKNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RochasFashionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipar:RochasFashionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_RochasFashionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:RochasFashionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-30_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_ForeignExchangeContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SubtotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubtotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ipar:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember_custom_RochasFashionBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ipar:RochasFashionBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DomesticSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:LondonInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:DomesticSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ForeignSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ipar:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ipar:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LoansPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoansPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LoansPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoansPayableThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LoansPayableThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansPayableThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2021-04-012021-04-30_custom_LoansPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ipar:LoansPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OperatingLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ipar:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_StockOptionOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ipar:StockOptionOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_StockOptionMember68792140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2022-06-272022-06-30_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InterparfumsSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ipar:InterparfumsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ipar:InterparfumsSASubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ipar:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2019-10-012019-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ipar:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:EliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_srt_NorthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CentralAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:CentralAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OtherSegmentCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OtherSegmentCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OtherSegmentCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ipar:OtherSegmentCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UnitedStatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnitedStatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UnitedStatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:FranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RussiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RussiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RussiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:RussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UnitedKingdomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ipar:UnitedKingdomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ForeignDerivedIntangibleIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ipar:ForeignDerivedIntangibleIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000822663</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="USDEUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="N">
        <measure>ipar:Number</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-12-31">0000822663</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-12-31">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:SecurityExchangeName contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0033">NASDAQ</dei:SecurityExchangeName>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0135"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0298"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <ipar:NetDerivativeInstrumentLossNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0616"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0617"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0811">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0813">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension
      contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0815">P1Y</us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension
      contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl0817">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      id="xdx2ixbrl0862">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      id="xdx2ixbrl0864">P50Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LongTermDebtTerm contextRef="AsOf2022-12-31" id="xdx2ixbrl0868">P10Y</us-gaap:LongTermDebtTerm>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0913"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0915"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0918"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0920"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0933"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0935"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0938"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0940"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0957"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0959"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0967"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0969"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0972"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0977"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0979"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0982"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0984"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      id="xdx2ixbrl1040"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      id="xdx2ixbrl1061"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="xdx2ixbrl1083"
      unitRef="USD">7000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2022-01-012022-12-31_us-gaap_TrademarksMember"
      id="xdx2ixbrl1093">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2022-01-012022-12-31_us-gaap_LicensingAgreementsMember"
      id="xdx2ixbrl1094">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2022-01-012022-12-31_us-gaap_OtherIntangibleAssetsMember"
      id="xdx2ixbrl1095">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1096">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      id="xdx2ixbrl1114">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      id="xdx2ixbrl1116">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2022-01-012022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember"
      id="xdx2ixbrl1154">2023-12-15</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_us-gaap_LoansPayableMember"
      id="xdx2ixbrl1183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="xdx2ixbrl1216"
      unitRef="USD">132902000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-12-31" id="xdx2ixbrl1234">P5Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_StockOptionMember"
      id="xdx2ixbrl1304">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_StockOptionMember"
      id="xdx2ixbrl1306">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember68792140"
      id="xdx2ixbrl1418">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1432">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1434">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1436">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember"
      id="xdx2ixbrl1475">P0Y11M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-012022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember"
      id="xdx2ixbrl1483">P2Y0M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-012022-12-31_custom_ExercisePriceRangeThreeMember"
      id="xdx2ixbrl1488">P3Y0M0D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-012022-12-31_custom_ExercisePriceRangeFourMember"
      id="xdx2ixbrl1492">P5Y10M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeFourMember"
      id="xdx2ixbrl1493"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1495">P2Y7M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1500">P1Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1 contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl1512">P3Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      id="xdx2ixbrl1557"
      unitRef="Shares">31859417</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="xdx2ixbrl1569"
      unitRef="Shares">31835408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_EliminationsMember"
      id="xdx2ixbrl1614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_custom_EliminationsMember"
      id="xdx2ixbrl1668"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2022-12-31_custom_EliminationsMember"
      id="xdx2ixbrl1718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2021-12-31_custom_EliminationsMember"
      id="xdx2ixbrl1719"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      id="xdx2ixbrl1797"
      unitRef="USD">194219000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="xdx2ixbrl1799"
      unitRef="USD">151019000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      id="xdx2ixbrl1801"
      unitRef="USD">69349000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1
      contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      id="xdx2ixbrl1968"
      unitRef="USD"
      xsi:nil="true"/>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1
      contextRef="AsOf2020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      id="xdx2ixbrl1982"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl2019"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl2020"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl2021"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      id="xdx2ixbrl2068"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      id="xdx2ixbrl2075"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      id="xdx2ixbrl2082"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2022-01-01to2022-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-12-31">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2022-01-01to2022-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2022-01-01to2022-12-31">0-16469</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-12-31">Inter Parfums, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-12-31">13-3275609</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-12-31">551 Fifth Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-12-31">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-12-31">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-12-31">10176</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-12-31">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-12-31">983.2640</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-01-01to2022-12-31">Common Stock, $.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-01to2022-12-31">IPAR</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2022-01-01to2022-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-12-31">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-12-31">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2022-01-01to2022-12-31">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-12-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1274342976</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-02-28" decimals="INF" unitRef="Shares">32109360</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="From2022-01-01to2022-12-31">339</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2022-01-01to2022-12-31">Mazars USA LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2022-01-01to2022-12-31">New York, New York</dei:AuditorLocation>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">104713000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">159613000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">150833000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">160014000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">197584000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">159281000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">289984000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">198914000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">28803000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">10308000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">15650000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">21375000</us-gaap:OtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">157000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">210000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">787724000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">709715000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">166722000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">149352000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">27964000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">33728000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">290853000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">214047000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">11159000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7936000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">24120000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">30586000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1308542000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1145364000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">28547000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">15911000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">5296000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">6014000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">88388000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">81980000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">213621000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">136677000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">8715000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4328000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">344567000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">244910000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">151494000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">132902000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">24335000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">29220000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">31967300</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">31830420</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">32000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">32000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">90186000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">87132000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">620095000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">560663000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-56056000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-38432000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">9864805</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">9864805</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">37475000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">37475000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">616782000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">571920000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">171364000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">166412000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">788146000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">738332000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1308542000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1145364000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">1086653000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">879516000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">539009000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">392231000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">322614000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">208278000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">694422000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">556902000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">330731000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">492370000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">406459000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">260648000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">7749000</us-gaap:ImpairmentOfLeasehold>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2393000</us-gaap:ImpairmentOfLeasehold>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">194303000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">148050000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">70083000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">3599000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2825000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1970000</us-gaap:InterestExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-1921000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2338000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-2178000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">5486000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">3403000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2865000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:OtherIncome
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-49000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">53000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">549000</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-83000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2969000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-734000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">194219000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">151019000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">69349000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">43182000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">40992000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">19381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">151037000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">30099000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">22616000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11749000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">120938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">3.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">31859417</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">31676796</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31536659</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">31988753</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">31835408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31654544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">151037000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">2356000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-1367000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-19000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-992000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">52000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-29683000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-42967000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">47912000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-26335000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-44334000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">47841000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">124702000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">65693000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">97809000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">30099000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">22616000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11749000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">647000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-375000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-19000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">9358000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">11524000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-14004000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">21388000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">10717000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">25734000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">103314000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">54976000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">72075000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">87132000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">75708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">70664000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">6004000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">5393000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">2771000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1355000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1566000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1711000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-4305000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-535000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">562000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">90186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">87132000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">75708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">560663000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">503567000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">474637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">120938000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:ProfitLoss>
    <us-gaap:DividendsCash
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">63743000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">31690000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">10406000</us-gaap:DividendsCash>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">2237000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">1375000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">1117000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">620095000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">560663000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">503567000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-38432000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-5997000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-39853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-20325000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-31443000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">33908000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">992000</us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">52000</us-gaap:DebtSecuritiesAvailableForSaleTransferToTradingLoss>
    <ipar:NetDerivativeInstrumentLossNetOfTax
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">1709000</ipar:NetDerivativeInstrumentLossNetOfTax>
    <ipar:NetDerivativeInstrumentLossNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-992000</ipar:NetDerivativeInstrumentLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-56056000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-38432000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-5997000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-37475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166412000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166615000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">140994000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">30099000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">22616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">11749000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-9358000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-11524000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">14004000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <ipar:NetDerivativeInstrumentLossNetOfTax
      contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">647000</ipar:NetDerivativeInstrumentLossNetOfTax>
    <ipar:NetDerivativeInstrumentLossNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-375000</ipar:NetDerivativeInstrumentLossNetOfTax>
    <ipar:NetDerivativeInstrumentLossNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-19000</ipar:NetDerivativeInstrumentLossNetOfTax>
    <us-gaap:DividendsCash
      contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">16056000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">9836000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">324000</us-gaap:DividendsCash>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-282000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-293000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">350000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2022-01-012022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-98000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-791000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares
      contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-139000</ipar:TransferOfSubsidiarySharesPurchasedToTreasuryShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">171364000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166412000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">166615000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">738332000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">702450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">608998000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">151037000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">788146000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">738332000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">702450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">151037000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">110027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49968000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">22539000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">12698000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">9067000</us-gaap:DepreciationDepletionAndAmortization>
    <ipar:ProvisionForDoubtfulAccounts1
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">2353000</ipar:ProvisionForDoubtfulAccounts1>
    <ipar:ProvisionForDoubtfulAccounts1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">853000</ipar:ProvisionForDoubtfulAccounts1>
    <ipar:ProvisionForDoubtfulAccounts1
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">4824000</ipar:ProvisionForDoubtfulAccounts1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">3143000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2853000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">3029000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-49000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">53000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">549000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">4980000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">7302000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">5483000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-3604000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-465000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">581000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <ipar:ChangeInFairValueOfDerivatives
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-227000</ipar:ChangeInFairValueOfDerivatives>
    <ipar:ChangeInFairValueOfDerivatives
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-65000</ipar:ChangeInFairValueOfDerivatives>
    <ipar:ChangeInFairValueOfDerivatives
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">137000</ipar:ChangeInFairValueOfDerivatives>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">59640000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">45395000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-13157000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">98297000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">49815000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-19333000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">13651000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">16725000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-1176000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-4795000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-7503000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-5421000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">106857000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">103046000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-32239000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">3952000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2698000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-3279000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">115150000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">119586000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">64993000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">1038000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">55691000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">7582000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">896000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">10644000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11513000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">33756000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">141274000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">11011000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">98865000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">1545000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1251000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13998000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-132763000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-187866000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-22329000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">19861000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">43056000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13725000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">52492000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">157382000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13438000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">6003000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">5393000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2771000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">63743000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">31690000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">20805000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">16056000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">9836000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">324000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">4403000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-45568000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">78193000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-18645000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-493000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-11207000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">12245000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-63674000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-1294000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">36264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">168387000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">169681000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">133417000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">104713000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">168387000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">169681000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">2987000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2468000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1105000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">38492000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">40497000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">21772000</us-gaap:IncomeTaxesPaid>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zd1EKIHGXhJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.5in; text-align: left"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_828_znbAHDBviiWh" style="text-align: justify"&gt;&lt;b&gt;The Company and its Significant Accounting Policies&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zNT0b1hpSc"&gt;Business of the Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inter Parfums, Inc. and its subsidiaries
(the &#x201c;Company&#x201d;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#x2019;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#x2019;s largest brands were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden"&gt;Schedule of lanvin brand name for our class&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%"&gt;Montblanc&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Jimmy Choo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Coach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;GUESS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;No other brand represented 10%
or more of consolidated net sales.&lt;/p&gt;

&lt;p id="xdx_852_zkLqrsGkJApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86E_zAi7NibSjYo"&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-size: 10pt; color: windowtext"&gt;The
consolidated financial statements include the accounts of the Company and its subsidiaries, including &lt;span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA"&gt;72&lt;/span&gt;% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.&lt;/span&gt; &lt;span style="font-size: 10pt"&gt;All material intercompany balances
and transactions have been eliminated&lt;/span&gt;.&lt;/p&gt;

&lt;p id="xdx_858_zhK8rh8t0VFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zxhhk0ZXFq5"&gt;Management Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.&lt;/p&gt;

&lt;p id="xdx_850_zBwbKroun2Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_z6rIV82Xvpje"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#x2019; equity.&lt;/p&gt;

&lt;p id="xdx_85D_z8zurES5J9S2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_868_zQ2usvaXHXs5"&gt;Cash and Cash Equivalents
and Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.&lt;/p&gt;

&lt;p id="xdx_85D_zZPquTcOQRla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;





&lt;p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_zbpNXfQ5UYnk"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts"&gt;4.7 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts"&gt;2.2 million&lt;/span&gt; as of December 31, 2022, and 2021, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#x2019;s financial position, as well as previously established
buying patterns.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_850_zeVmfblcJqaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zB6czE4UKP8b"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor
and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound
freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#x2019;s customers.&lt;/p&gt;

&lt;p id="xdx_859_z8E6H25uy7b6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_z8KfMRukTmb"&gt;Derivatives&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#x2019;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.&lt;/p&gt;

&lt;p id="xdx_85A_zBXJO3IV73i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zjzUiz8tMvX9"&gt;Property, Equipment
and Leasehold Improvements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.&lt;/p&gt;

&lt;p id="xdx_859_zEts96VpM581" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;





&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86E_zftBm8SvL7Bd"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of &lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital"&gt;9.8&lt;/span&gt;% and &lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital"&gt;7.47&lt;/span&gt;% in 2022 and 2021, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.&lt;/p&gt;

&lt;p id="xdx_850_zz1nwOS3naq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_866_zn7swQC93rge"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in
either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable,
collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms.
Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#x2019;
freight and handling charges. All shipping and handling costs, which aggregated $&lt;span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs"&gt;15.8 million&lt;/span&gt;, $1&lt;span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs"&gt;0.0 million&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs"&gt;5.0 million&lt;/span&gt;
in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements
of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue
concentration of credit risk. No one customer represented &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;% or more of net sales in 2022, 2021 or 2020.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;





&lt;p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_znG0d2ejty9j"&gt;Sales Returns&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $&lt;span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability"&gt;8.6 million&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability"&gt;5.1 million&lt;/span&gt; at December 31, 2022 and 2021, respectively, and
the amounts recognized for the rights to recover products was $&lt;span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products"&gt;3.2 million&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products"&gt;1.9 million&lt;/span&gt; at December 31, 2022 and 2021, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.&lt;/p&gt;

&lt;p id="xdx_850_zIceJJmoSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zpZS8YHNN1fl"&gt;Payments to Customers&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.&lt;/p&gt;

&lt;p id="xdx_857_zXoMw6n70mia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_860_zIZybcTPiYQ3"&gt;Advertising and Promotion&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $&lt;span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs"&gt;212.4 million&lt;/span&gt;, $&lt;span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs"&gt;171.1 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs"&gt;91.7 million&lt;/span&gt; for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $&lt;span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost"&gt;43.1 million&lt;/span&gt;, $&lt;span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost"&gt;36.9 million&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost"&gt;26.4 million&lt;/span&gt;
in 2022, 2021 and 2020, respectively.&lt;/p&gt;

&lt;p id="xdx_854_zH3jODrKQ9K8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_zqec8gj621I2"&gt;Package Development
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.&lt;/p&gt;

&lt;p id="xdx_853_zOZeg8z2S3Xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_zxkrSXeufu6"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

&lt;p id="xdx_85F_zrc4W7gVcqB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;





&lt;p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zSbdHovAxh91"&gt;License Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#x2019; trademarks. The licenses typically have an initial term of approximately &lt;span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;5&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0813"&gt;15&lt;/span&gt;&lt;/span&gt; years, and are potentially
renewable subject to the Company&#x2019;s compliance with the license agreement provisions. The remaining terms, excluding potential
renewal periods, range from approximately &lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0815"&gt;1&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;12&lt;/span&gt;&lt;/span&gt; years. Under each license, the Company is required to pay royalties in the range
of &lt;span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales"&gt;6&lt;/span&gt;% to &lt;span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales"&gt;10&lt;/span&gt;% to the licensor, at least annually, based on net sales to third parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.&lt;/p&gt;

&lt;p id="xdx_85B_zh64ekd6mbY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_860_zWZrltbKXMm6"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets
assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset
will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued
interest and penalties are included within the related tax asset or liability in the accompanying financial statements.&lt;/p&gt;

&lt;p id="xdx_85D_zixJEyMNLdl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86D_ziVu2DnrRlH1"&gt;Issuance of Common Stock
by Consolidated Subsidiary&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The difference between the Company&#x2019;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#x2019;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.&lt;/p&gt;

&lt;p id="xdx_854_zakTrhiCpMz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_861_zOSRLpHtTRY4"&gt;Treasury Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Board of Directors may authorize
share repurchases of the Company&#x2019;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.&lt;/p&gt;

&lt;p id="xdx_859_zckO1rZ36bOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zNT0b1hpSc"&gt;Business of the Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inter Parfums, Inc. and its subsidiaries
(the &#x201c;Company&#x201d;) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance
related products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#x2019;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#x2019;s largest brands were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden"&gt;Schedule of lanvin brand name for our class&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%"&gt;Montblanc&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Jimmy Choo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Coach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;GUESS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;No other brand represented 10%
or more of consolidated net sales.&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Substantially all of our prestige
fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal
of such licenses. With respect to the Company&#x2019;s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand
names. As a percentage of net sales, product sales for the Company&#x2019;s largest brands were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden"&gt;Schedule of lanvin brand name for our class&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%"&gt;Montblanc&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Jimmy Choo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Coach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right"&gt;17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;GUESS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_JimmyChooMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_CoachMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_ProductSalesConcentrationRiskMember_custom_GUESSMember_custom_JanvinMember"
      decimals="INF"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86E_zAi7NibSjYo"&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-size: 10pt; color: windowtext"&gt;The
consolidated financial statements include the accounts of the Company and its subsidiaries, including &lt;span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA"&gt;72&lt;/span&gt;% owned Interparfums SA,
a subsidiary whose stock is publicly traded in France.&lt;/span&gt; &lt;span style="font-size: 10pt"&gt;All material intercompany balances
and transactions have been eliminated&lt;/span&gt;.&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember"
      decimals="INF"
      unitRef="Pure">0.72</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zxhhk0ZXFq5"&gt;Management Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Management makes assumptions
and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States
of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial
statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near
term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these
notes to the consolidated financial statements.&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_z6rIV82Xvpje"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For foreign subsidiaries with
operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates.
Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation
adjustments are accumulated in a separate component of shareholders&#x2019; equity.&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_868_zQ2usvaXHXs5"&gt;Cash and Cash Equivalents
and Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All highly liquid investments
purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments
which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable
equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company
conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with
large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions
outside the United States and are readily convertible into U.S. dollars.&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_zbpNXfQ5UYnk"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accounts receivable represent
payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which
are estimated to be uncollectible, which aggregated $&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts"&gt;4.7 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts"&gt;2.2 million&lt;/span&gt; as of December 31, 2022, and 2021, respectively.
Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries
of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.
We generally grant credit based upon our analysis of the customer&#x2019;s financial position, as well as previously established
buying patterns.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">4700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2200000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86B_zB6czE4UKP8b"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories, including promotional
merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net
realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor
and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound
freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company&#x2019;s customers.&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_z8KfMRukTmb"&gt;Derivatives&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All derivative instruments are
recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage
a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset
or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period
of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that
accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value.
For cash flow hedges, the effective portion of the derivative&#x2019;s gain or loss is initially reported in equity (as a component
of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during
which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported
in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting
treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zjzUiz8tMvX9"&gt;Property, Equipment
and Leasehold Improvements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property, equipment and leasehold
improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using
the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter
of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently
purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools
and molds, is included in cost of sales.&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86E_zftBm8SvL7Bd"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Indefinite-lived intangible assets
principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment
at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected
decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may
not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the
estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based
upon discounted future cash flow projections using a weighted average cost of capital of &lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital"&gt;9.8&lt;/span&gt;% and &lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital"&gt;7.47&lt;/span&gt;% in 2022 and 2021, respectively.
The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating
expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products
which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment
charge is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Intangible assets subject to
amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount
of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset,
the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value
of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no
impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible
asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.098</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0747</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_866_zn7swQC93rge"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company sells its products
to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts
represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries
are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in
either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable,
collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms.
Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers&#x2019;
freight and handling charges. All shipping and handling costs, which aggregated $&lt;span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs"&gt;15.8 million&lt;/span&gt;, $1&lt;span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs"&gt;0.0 million&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs"&gt;5.0 million&lt;/span&gt;
in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements
of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue
concentration of credit risk. No one customer represented &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"&gt;&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"&gt;&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;% or more of net sales in 2022, 2021 or 2020.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;





</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-01-012022-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">15800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-012021-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">0.00</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">5000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_CreditRiskMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueRecognitionSalesReturns contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_znG0d2ejty9j"&gt;Sales Returns&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Generally, the Company does not
permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized
and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns
based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory
levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The
types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers,
store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products.
The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries
to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund
liability associated with estimated returns was $&lt;span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability"&gt;8.6 million&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability"&gt;5.1 million&lt;/span&gt; at December 31, 2022 and 2021, respectively, and
the amounts recognized for the rights to recover products was $&lt;span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products"&gt;3.2 million&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products"&gt;1.9 million&lt;/span&gt; at December 31, 2022 and 2021, respectively.
The physical condition and marketability of returned products are the major factors we consider in estimating realizable value.
Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably,
from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.&lt;/p&gt;

</us-gaap:RevenueRecognitionSalesReturns>
    <us-gaap:ContractWithCustomerRefundLiability contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">8600000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRefundLiability contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">5100000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRightToRecoverProduct contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3200000</us-gaap:ContractWithCustomerRightToRecoverProduct>
    <us-gaap:ContractWithCustomerRightToRecoverProduct contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1900000</us-gaap:ContractWithCustomerRightToRecoverProduct>
    <us-gaap:RevenueRecognitionAllowances contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zpZS8YHNN1fl"&gt;Payments to Customers&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company records revenues
generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and
gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers
based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.&lt;/p&gt;

</us-gaap:RevenueRecognitionAllowances>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_860_zIZybcTPiYQ3"&gt;Advertising and Promotion&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Advertising and promotional costs
are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling,
general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses
were $&lt;span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs"&gt;212.4 million&lt;/span&gt;, $&lt;span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs"&gt;171.1 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs"&gt;91.7 million&lt;/span&gt; for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase
and gift with purchase promotions that are reflected in cost of sales aggregated $&lt;span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost"&gt;43.1 million&lt;/span&gt;, $&lt;span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost"&gt;36.9 million&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost"&gt;26.4 million&lt;/span&gt;
in 2022, 2021 and 2020, respectively.&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">212400000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">171100000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">91700000</us-gaap:AdvertisingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">43100000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">36900000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">26400000</us-gaap:MarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_864_zqec8gj621I2"&gt;Package Development
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Package development costs associated
with new products and redesigns of existing product packaging are expensed as incurred.&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:LessorLeasesPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_862_zxkrSXeufu6"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases its offices
and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company
currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets
and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86A_zSbdHovAxh91"&gt;License Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s license agreements
generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using
the licensors&#x2019; trademarks. The licenses typically have an initial term of approximately &lt;span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;5&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0813"&gt;15&lt;/span&gt;&lt;/span&gt; years, and are potentially
renewable subject to the Company&#x2019;s compliance with the license agreement provisions. The remaining terms, excluding potential
renewal periods, range from approximately &lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0815"&gt;1&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;12&lt;/span&gt;&lt;/span&gt; years. Under each license, the Company is required to pay royalties in the range
of &lt;span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales"&gt;6&lt;/span&gt;% to &lt;span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales"&gt;10&lt;/span&gt;% to the licensor, at least annually, based on net sales to third parties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In certain cases, the Company
may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance
business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Most license agreements require
minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities.
Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued
at the time these costs are incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, the Company is exposed
to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business
is dependent upon the continuation and renewal of such licenses.&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2022-01-012022-12-31_srt_MinimumMember_us-gaap_LicensingAgreementsMember"
      decimals="INF"
      unitRef="Pure">0.06</ipar:RoyaltyExpenseNetSalesPercentage>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2022-01-012022-12-31_srt_MaximumMember_us-gaap_LicensingAgreementsMember"
      decimals="INF"
      unitRef="Pure">0.10</ipar:RoyaltyExpenseNetSalesPercentage>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_860_zWZrltbKXMm6"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for income
taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets
assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included
in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not
that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset
will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued
interest and penalties are included within the related tax asset or liability in the accompanying financial statements.&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiaryStockIssuancesPolicy contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_86D_ziVu2DnrRlH1"&gt;Issuance of Common Stock
by Consolidated Subsidiary&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The difference between the Company&#x2019;s
share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company&#x2019;s investment deemed
sold, is reflected as an equity adjustment in the consolidated balance sheets.&lt;/p&gt;

</us-gaap:ConsolidationSubsidiaryStockIssuancesPolicy>
    <us-gaap:RepurchaseAgreementsCollateralPolicy contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_861_zOSRLpHtTRY4"&gt;Treasury Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Board of Directors may authorize
share repurchases of the Company&#x2019;s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase
Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within
the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general
corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the
cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any
time without notice.&lt;/p&gt;

</us-gaap:RepurchaseAgreementsCollateralPolicy>
    <ipar:ImpactOfCOVID19PandemicTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80B_ecustom--ImpactOfCOVID19PandemicTextBlock_zmuAy07zyRm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(2)&lt;/td&gt;&lt;td id="xdx_823_zTZ7NfolXM2g"&gt;Impact of COVID-19 Pandemic&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;A novel strain of coronavirus
(&#x201c;COVID-19&#x201d;) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In
response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain
classes of workers from reporting to work.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Retail store closings, event
cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable
impact on our results of operations in 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Business significantly improved
in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased
online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world
has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international
air travel remains curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19
has significantly restricted international travel, the travel retail business is beginning to pick up. Lastly, the improved economy
has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport
goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger
or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in
larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers
and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin
lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might
continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first
half of 2023.&lt;/p&gt;

</ipar:ImpactOfCOVID19PandemicTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_z4GAOYWVwyJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(3)&lt;/td&gt;&lt;td id="xdx_820_zvvCe9AfJeN1"&gt;Recent Agreements&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Lacoste&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In December 2022, we closed a
transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution
of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Dunhill&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In April 2022, we announced that
the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and
sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory
for a limited time as is customary in the fragrance industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Salvatore Ferragamo &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In October 2021, we closed on
a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production
and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years
with a 5-year optional term, subject to certain conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;With respect to the management
and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary
based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement
was accounted for as an asset acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Emanuel Ungaro&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In October 2021, &lt;span id="xdx_901_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--EmanuelUngarMember_z7orWVKIZK91" title="Description of recent agreement"&gt;we also entered
into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro
Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro
brand.&lt;/span&gt; Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary
in our industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Donna Karan and DKNY &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In September 2021, we entered
into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related
products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures
and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable
fragrance franchises, most notably Donna Karan &lt;i&gt;Cashmere Mist&lt;/i&gt; and DKNY &lt;i&gt;Be Delicious&lt;/i&gt;, as well as a significant loyal
consumer base around the world. In connection with the grant of license, we issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zGE1fIms7cI" title="Shares issue"&gt;65,342&lt;/span&gt; shares of Inter Parfums, Inc. common
stock valued at $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zP05Z3DKOrIh" title="Shares value"&gt;5&lt;/span&gt;.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new
fragrances under these brands in 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Rochas Fashion&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Effective January 1, 2021,
&lt;span id="xdx_90D_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_z1l2yFbEEYbc" title="Description of recent agreement"&gt;we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in
royalties to be received. As a result, in the first quarter of 2021, we took a $&lt;span id="xdx_903_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20210331__dei--LegalEntityAxis__custom--RochasFashionMember_zYTSjFo1J7o5" title="Impairment Charge on Reclassified Assets"&gt;2.4 million&lt;/span&gt; impairment charge on our Rochas fashion
trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after
an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option
for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span title="Description of recent agreement"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Land
and Building Acquisition - Future Headquarters in Paris&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
April 2021, Interparfums SA, our &lt;span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z4n07UjPSSTf" title="Ownership percentage"&gt;73&lt;/span&gt;% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de
Solf&#xe9;rino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings
connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
purchase price includes the complete renovation of the site. As of December 31, 2022, $&lt;span id="xdx_904_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231_z5jptVveA3dg" title="Purchase price, period cost"&gt;148.1 million&lt;/span&gt; of the purchase price, including
approximately $&lt;span id="xdx_90F_eus-gaap--AcquisitionCosts_dm_c20220101__20221231_zKT9pTNyaDc6" title="Acquisition costs, period cost"&gt;4.4 million&lt;/span&gt; of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022. The purchase price has been allocated approximately $&lt;span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zDCgyiyNbLfc" title="Purchase price, period cost"&gt;61.1 million&lt;/span&gt; to land and $&lt;span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zLQLzk0FdM0j" title="Purchase price, period cost"&gt;87.0 million&lt;/span&gt;
to the building. The building, which was delivered on February&#160;28, 2022, includes the building structure, development of
the property, fa&#xe7;ade waterproofing, general and technical installations and interior fittings that will be depreciated
over a range of &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zGe7YQOs4dY3" title="Depreciated over a range::XDX::P7Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0862"&gt;7&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zZmef4g63Fse" title="Depreciated over a range::XDX::P50Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;50&lt;/span&gt;&lt;/span&gt; years. The Company has elected to depreciate the building cost based on the useful lives of its components.
Approximately $&lt;span id="xdx_905_eus-gaap--EscrowDeposit_iI_dm_c20221231_zKMnXiE3mdkl" title="Cash held in escrow is included in other assets"&gt;3.4 million&lt;/span&gt; of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying
balance sheet as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
acquisition was financed by a &lt;span id="xdx_903_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_z4VGt2LRdjB2" title="Long-term debt, term::XDX::P10Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0868"&gt;10&lt;/span&gt;&lt;/span&gt;-year &#x20ac;&lt;span id="xdx_906_eus-gaap--LineOfCredit_iI_pn6n6_uUSDEUR_c20221231_zKVvzG0WcZaf" title="Long-term line of credit"&gt;120&lt;/span&gt; million (approximately $&lt;span id="xdx_900_eus-gaap--LineOfCredit_iI_dm_c20221231_zfoF6FEzvm3c" title="Long-term line of credit"&gt;128.0 million&lt;/span&gt;) bank loan which bears interest at &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateTerms_c20220101__20221231_zCDYNEZyZR4h" title="Description of debt instrument interest rate terms"&gt;one-month
Euribor plus 0.75%&lt;/span&gt;. Approximately &#x20ac;&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zsMdkVzocId9" title="Debt instrument, face amount"&gt;80&lt;/span&gt; million of the variable rate debt was swapped for variable interest rate debt with
a maximum rate of 2% per annum.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="From2022-01-012022-12-31_custom_EmanuelUngarMember">we also entered
into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro
Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro
brand.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_custom_DonnaKaranAndDKNYMember"
      decimals="INF"
      unitRef="Shares">65342</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_custom_DonnaKaranAndDKNYMember"
      decimals="-6"
      unitRef="USD">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="From2022-01-012022-12-31_custom_RochasFashionMember">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in
royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion
trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after
an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option
for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:ImpairmentChargeOnReclassifiedAssets
      contextRef="From2021-01-012021-03-31_custom_RochasFashionMember"
      decimals="0"
      unitRef="USD">2400000</us-gaap:ImpairmentChargeOnReclassifiedAssets>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2021-04-30_custom_InterparfumsSASubsidiaryMember"
      decimals="INF"
      unitRef="Pure">0.73</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">148100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:AcquisitionCosts
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">4400000</us-gaap:AcquisitionCosts>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-01-012022-12-31_us-gaap_LandMember"
      decimals="0"
      unitRef="USD">61100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-01-012022-12-31_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">87000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:EscrowDeposit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3400000</us-gaap:EscrowDeposit>
    <us-gaap:LineOfCredit contextRef="AsOf2022-12-31" decimals="-6" unitRef="USDEUR">120000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">128000000.0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2022-01-01to2022-12-31">one-month
Euribor plus 0.75%</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_currency_EUR"
      decimals="-6"
      unitRef="USDEUR">80000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_z2H4TVyUgGs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(4)&lt;/td&gt;&lt;td id="xdx_82C_zONtxktEjTW7"&gt;Inventories&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden"&gt;Schedule of inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Raw materials and component parts&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;146,772&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;111,312&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143,212&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,602&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Inventories&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;289,984&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;198,914&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;p id="xdx_8A6_zJnpHd5uesY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Overhead included in inventory
aggregated $&lt;span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zcpC9lIdwDT5" title="Cost of Goods Sold, Overhead"&gt;3.4 million&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zawROXE2RwDh"&gt;3.7 million&lt;/span&gt; as of December 31, 2022 and 2021, respectively. Included in inventories is an inventory
reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales
forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated
events may be established. Inventory reserves aggregated $&lt;span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_dm_c20221231_zRYbMeXh3tEl" title="Inventory Valuation Reserves"&gt;11.4 million&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_zTjfvkqnMGke" title="Inventory Valuation Reserves"&gt;15.8 million&lt;/span&gt; as of December 31, 2022 and 2021, respectively.&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden"&gt;Schedule of inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Raw materials and component parts&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;146,772&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;111,312&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143,212&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,602&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Inventories&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;289,984&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;198,914&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">146772000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">111312000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">143212000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">87602000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">289984000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">198914000</us-gaap:InventoryNet>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2022-01-012022-12-31_us-gaap_ProductMember"
      decimals="0"
      unitRef="USD">3400000</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2021-01-012021-12-31_us-gaap_ProductMember"
      decimals="0"
      unitRef="USD">3700000</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">11400000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15800000</us-gaap:InventoryValuationReserves>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_z5WnGP2HTJMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(5)&lt;/td&gt;&lt;td id="xdx_82B_zewNog1Z67i7"&gt;Fair Value of Financial Instruments&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden"&gt;Schedule of fair value, assets measured on recurring basis&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Measurements at December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Quoted Prices in&lt;br/&gt; Active Markets for&lt;br/&gt; Identical Assets&lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Short-term investments&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;150,833&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;19,861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;130,174&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;798&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Interest rate swaps&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,758&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0913"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,758&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0915"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Foreign currency forward exchange contracts accounted for using hedge accounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,189&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0918"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,189&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;b style="display: none; visibility: hidden"&gt;Total Assets&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;158,780&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,861&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;138,122&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;798&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Foreign currency forward exchange contracts not accounted for using hedge accounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0933"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Total liabilities&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;

&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Measurements at December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Quoted Prices in&lt;br/&gt; Active Markets for&lt;br/&gt; Identical Assets&lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Short-term investments&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"&gt;160,014&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"&gt;160,014&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0959"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign currency forward exchange contracts accounted for using hedge accounting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0967"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Foreign currency forward exchange contracts not accounted for using hedge accounting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0972"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Interest rate swaps&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(234&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(234&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0979"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Total liabilities&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,811&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0982"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,811&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

&lt;p id="xdx_8A0_zd20yXHgXpb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The carrying amount of cash and
cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable,
other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments.
The carrying amount of loans payable approximates fair value as the variable interest rates on the Company&#x2019;s indebtedness
approximate current market rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Foreign currency forward exchange
contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net
present value of the swaps using third party quotes from financial institutions.&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following tables present
our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value
hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden"&gt;Schedule of fair value, assets measured on recurring basis&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Measurements at December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Quoted Prices in&lt;br/&gt; Active Markets for&lt;br/&gt; Identical Assets&lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Short-term investments&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;150,833&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;19,861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;130,174&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;798&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Interest rate swaps&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,758&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0913"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,758&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0915"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Foreign currency forward exchange contracts accounted for using hedge accounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,189&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0918"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,189&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;b style="display: none; visibility: hidden"&gt;Total Assets&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;158,780&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,861&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;138,122&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;798&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Foreign currency forward exchange contracts not accounted for using hedge accounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0933"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Total liabilities&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;

&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Measurements at December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Quoted Prices in&lt;br/&gt; Active Markets for&lt;br/&gt; Identical Assets&lt;br/&gt; (Level 1)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Significant&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Short-term investments&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"&gt;160,014&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"&gt;160,014&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0959"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign currency forward exchange contracts accounted for using hedge accounting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0967"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,982&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Foreign currency forward exchange contracts not accounted for using hedge accounting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0972"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Interest rate swaps&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(234&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(234&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0979"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Total liabilities&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,811&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0982"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,811&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">150833000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">19861000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">130174000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      unitRef="USD">798000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">6758000</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">6758000</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">1189000</us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">1189000</us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">158780000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">19861000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">138122000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      unitRef="USD">798000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">68000</us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">68000</us-gaap:ForeignCurrencyFairValueHedgeLiabilityAtFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">68000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">68000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">160014000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">160014000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">1982000</us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">1982000</us-gaap:ForeignCurrencyFairValueHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">63000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">63000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">234000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">234000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">1811000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">1811000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_801_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zpsKbcjSP5Fc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(6)&lt;/td&gt;&lt;td id="xdx_823_z5OyFdJ7Zwd3"&gt;Derivative Financial Instruments&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company enters into foreign
currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally
to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction
for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged
item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the
change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item.
The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and
excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward
difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign
currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued,
and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted
transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period
earnings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Gains and losses in derivatives
designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as
hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial
in each of the years in the three-year period ended December 31, 2022. Interest expense includes a gain of $&lt;span id="xdx_902_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_z0Th4GfsSfD2" title="Loan amount"&gt;6.3 million&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zLFSfFgqCEA8" title="Loan amount"&gt;0.2
million&lt;/span&gt; in 2022 and 2021, respectively, resulting from an interest rate swap.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All derivative instruments
are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap
is included in other assets on the accompanying balance sheet for the period ended December 31, 2022 and was included in long-term
debt on the accompanying balance sheet for the period ended December 31, 2021. The valuation of foreign currency forward exchange
contracts at December 31, 2022 and December 31, 2021, resulted in an asset and is included in other current assets on the accompanying
balance sheets.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;At December 31, 2022, the Company
had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $&lt;span id="xdx_907_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zzciTf9stfI8" title="Foreign currency contracts, liability, fair value disclosure"&gt;36.5 million&lt;/span&gt;,
which all have maturities of less than one year.&lt;/p&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="AsOf2022-12-31_us-gaap_ForeignExchangeContractMember"
      decimals="-5"
      unitRef="USD">6300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="AsOf2021-12-31_us-gaap_ForeignExchangeContractMember"
      decimals="-5"
      unitRef="USD">200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_ForeignExchangeContractMember"
      decimals="0"
      unitRef="USD">36500000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zzPgk7acn2Uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(7)&lt;/td&gt;&lt;td id="xdx_829_z4yVTpn8yy73"&gt;Property, Equipment and Leasehold Improvements&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden"&gt;Schedule of equipment and leasehold improvements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Land and Building (construction in progress)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" style="width: 10%; text-align: right" title="Equipment and leasehold improvements"&gt;148,137&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" style="width: 10%; text-align: right" title="Equipment and leasehold improvements"&gt;136,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" style="text-align: right" title="Equipment and leasehold improvements"&gt;59,689&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" style="text-align: right" title="Equipment and leasehold improvements"&gt;52,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;2,293&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;2,082&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right"&gt;210,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right"&gt;190,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;43,397&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;40,897&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;166,722&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;149,352&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;p id="xdx_8A3_zznwfvvUieqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Depreciation and amortization
expense was $&lt;span id="xdx_908_eus-gaap--Depreciation_dm_c20220101__20221231_zCM1bM8qcIdf" title="Depreciation and amortization expense"&gt;7.5 million&lt;/span&gt;, $&lt;span id="xdx_90B_eus-gaap--Depreciation_dm_c20210101__20211231_zwixaZb6pDr7" title="Depreciation and amortization expense"&gt;4.4 million&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--Depreciation_dm_c20200101__20201231_z5iqMiT4q11j" title="Depreciation and amortization expense"&gt;3.8 million&lt;/span&gt; in 2022, 2021, and 2020, respectively.&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden"&gt;Schedule of equipment and leasehold improvements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Land and Building (construction in progress)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" style="width: 10%; text-align: right" title="Equipment and leasehold improvements"&gt;148,137&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" style="width: 10%; text-align: right" title="Equipment and leasehold improvements"&gt;136,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" style="text-align: right" title="Equipment and leasehold improvements"&gt;59,689&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" style="text-align: right" title="Equipment and leasehold improvements"&gt;52,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;2,293&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements"&gt;2,082&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right"&gt;210,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right"&gt;190,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;43,397&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;40,897&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;166,722&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total"&gt;149,352&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">148137000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">136131000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_EquipmentMember"
      decimals="-3"
      unitRef="USD">59689000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_EquipmentMember"
      decimals="-3"
      unitRef="USD">52036000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="USD">2293000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="USD">2082000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">210119000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">190249000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">43397000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">40897000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">166722000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">149352000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">7500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">4400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3800000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z7h8bft4ZVJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(8)&lt;/td&gt;&lt;td id="xdx_822_zz9hd6R2SV27"&gt;Trademarks, Licenses and Other Intangible Assets&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden"&gt;Schedule of trademarks, licenses and other intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated&lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book&lt;br/&gt; Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount"&gt;105,022&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1040"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value"&gt;105,022&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right"&gt;41,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right"&gt;41,203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right"&gt;205,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right"&gt;63,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right"&gt;141,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right"&gt;17,849&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,921&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,928&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right"&gt;264,351&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right"&gt;78,520&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right"&gt;185,831&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.625in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;369,373&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right"&gt;78,520&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right"&gt;290,853&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross &lt;br/&gt; Amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated &lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book &lt;br/&gt; Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1061"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right"&gt;43,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right"&gt;43,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right"&gt;109,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right"&gt;62,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right"&gt;47,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right"&gt;17,775&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,588&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,187&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right"&gt;171,277&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right"&gt;94,335&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.625in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right"&gt;290,989&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right"&gt;214,047&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

&lt;p id="xdx_8A1_zeQ09ycLVty5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Amortization expense was
$&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_dm_c20220101__20221231_ziBicTVGvRNe"&gt;6.8 million&lt;/span&gt;, $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRSgahoBzRde"&gt;5.9 million&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zrrZnnOOg6Eh"&gt;5.3 million&lt;/span&gt; in 2022, 2021 and 2020, respectively. Amortization expense is expected to approximate
$&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dxL_c20221231_zXscZXrnUoki" title="2023::XDX::7000000"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;7.0&lt;/span&gt;&lt;/span&gt; million in 2023, $&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20221231_zMd0BL1SBgxe" title="2024"&gt;13.3 million&lt;/span&gt; in 2024, $&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_dm_c20221231_z9ERUTqKJJYe" title="2025"&gt;12.3 million&lt;/span&gt; in 2025, $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_dm_c20221231_zabK9mHOHGNh" title="2026"&gt;&lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_dm_c20221231_z8WZ84eTOJFa" title="2027"&gt;10.5 million&lt;/span&gt;&lt;/span&gt; in 2026 and 2027. The weighted average amortization
period for trademarks, licenses and other intangible assets with finite lives are &lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_znS4kMqpChN3" title="Amortization period::XDX::P8Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;18 &lt;/span&gt;&lt;/span&gt;years, &lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ztClFyOdnMkg" title="::XDX::P14Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;14&lt;/span&gt;&lt;/span&gt; years and &lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVDNwAWPVYoh" title="::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;2&lt;/span&gt;&lt;/span&gt; years, respectively,
and &lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231_zsIvae8lf0k8" title="::XDX::P14Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;14&lt;/span&gt;&lt;/span&gt; years on average.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company reviews intangible
assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may
not be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $&lt;span id="xdx_903_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zhTMH5ORxlr2" title="Impairment charge"&gt;6.8 million&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AssetImpairmentCharges_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zWWEb43iMPY5"&gt;2.4 million&lt;/span&gt;
in 2022 and 2021, respectively, relating to our Rochas fashion business and an impairment charge for trademarks with indefinite
useful lives of $&lt;span id="xdx_907_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionBusinessMember_zlHEFoRLvQY4"&gt;0.9 million&lt;/span&gt; in 2022 relating to our Intimate trademark. The fair values used in our evaluations are estimated
based upon discounted future cash flow projections using a weighted average cost of capital of &lt;span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zeFmOx2jwC1f" title="Weighted average cost of capital"&gt;9.80&lt;/span&gt;%, &lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z1vX5T2FQCJi"&gt;7.47&lt;/span&gt;%, and &lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z4MGmXYlzuB6"&gt;6.99&lt;/span&gt;% as of December
31, 2022, 2021 and 2020, respectively. The cash flow projections are based upon a number of assumptions, including, future sales
levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or
changes in consumer acceptance of our products which are more subjective in nature. The Company believes that the assumptions
it has made in projecting future cash flows for the evaluations described above are reasonable and currently no other impairment
indicators exist for our indefinite-lived assets. However, if future actual results do not meet our expectations, the Company
may be required to record an impairment charge, the amount of which could be material to our results of operations.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The cost of trademarks, licenses
and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license
or the intangible assets estimated useful life which range from &lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zWGvEvWj4cxb" title="Amortization period::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1114"&gt;three&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z0j651Fi1xv6" title="Amortization period::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1116"&gt;twenty years&lt;/span&gt;&lt;/span&gt;. If the residual value of a finite life intangible
asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for
impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Trademarks (finite lives)
primarily represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to
repurchase the brand names and trademarks on July 1, 2027 for &#x20ac;70 million (approximately $&lt;span id="xdx_904_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20221231_z72Xc9HoRtKl"&gt;7
5&lt;/span&gt; million) (residual value) in accordance with an amendment signed in 2021. Because the residual value of the intangible
asset exceeds its carrying value, the asset is not being amortized.&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden"&gt;Schedule of trademarks, licenses and other intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated&lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book&lt;br/&gt; Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount"&gt;105,022&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1040"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value"&gt;105,022&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right"&gt;41,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right"&gt;41,203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right"&gt;205,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right"&gt;63,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right"&gt;141,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right"&gt;17,849&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,921&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,928&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right"&gt;264,351&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right"&gt;78,520&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right"&gt;185,831&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.625in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;369,373&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right"&gt;78,520&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right"&gt;290,853&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross &lt;br/&gt; Amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated &lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book &lt;br/&gt; Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-bottom: 1pt"&gt;Trademarks (indefinite lives)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1061"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value"&gt;119,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trademarks (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right"&gt;43,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right"&gt;68&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right"&gt;43,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses (finite lives)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right"&gt;109,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right"&gt;62,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right"&gt;47,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other intangible assets (finite lives)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right"&gt;17,775&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right"&gt;14,588&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,187&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right"&gt;171,277&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right"&gt;94,335&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.625in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right"&gt;290,989&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;76,942&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right"&gt;214,047&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;

</us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">105022000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">105022000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">41267000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">64000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">41203000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">205235000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">63535000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">141700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">17849000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">14921000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">2928000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">264351000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">78520000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">185831000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">369373000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">78520000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">290853000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">119712000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">119712000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">43820000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">68000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">43752000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">109682000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">62286000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">47396000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">17775000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">14588000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="-3"
      unitRef="USD">3187000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">171277000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">76942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_SubtotalMember"
      decimals="-3"
      unitRef="USD">94335000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">290989000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">76942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">214047000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">6800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">5300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">13300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">12300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">10500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">10500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">6800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2021-01-012021-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">2400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2022-01-012022-12-31_us-gaap_IndefinitelivedIntangibleAssetsMember_custom_RochasFashionBusinessMember"
      decimals="0"
      unitRef="USD">900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0980</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0747</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2020-12-31_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">0.0699</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:IndefiniteLivedLicenseAgreements contextRef="AsOf2022-12-31" decimals="-6" unitRef="USD">7000000</us-gaap:IndefiniteLivedLicenseAgreements>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zfFpH5PpqeDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(9)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zBsQzl8NGjl"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_zk4nlSz7Fm3e"&gt;Accrued expenses consist of the
following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Advertising liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;42,338&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;31,215&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Salary (including bonus and related taxes)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,532&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due vendors (not yet invoiced)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retirement reserves&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Refund (return) liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,149&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,246&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;213,621&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;136,677&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_8A7_z3YQAjvVt3Rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_zk4nlSz7Fm3e"&gt;Accrued expenses consist of the
following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Advertising liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;42,338&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;31,215&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Salary (including bonus and related taxes)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,532&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due vendors (not yet invoiced)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retirement reserves&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Refund (return) liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,149&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,246&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b style="display: none; visibility: hidden"&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;213,621&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;136,677&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedAdvertisingCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">42338000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedAdvertisingCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">31215000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">21128000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">19993000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">26532000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">19154000</us-gaap:AccruedRoyaltiesCurrent>
    <ipar:DueVendorsNotYetInvoiced contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">105869000</ipar:DueVendorsNotYetInvoiced>
    <ipar:DueVendorsNotYetInvoiced contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">45707000</ipar:DueVendorsNotYetInvoiced>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">8001000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">10234000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">8604000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5128000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1149000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5246000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">213621000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">136677000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zWWvHPes4W7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(10)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_823_zVsRs3VmVzEf"&gt;Loans Payable &#x2013; Banks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Loans payable &#x2013; banks consist
of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its domestic
subsidiaries have available a $&lt;span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zSvSlrua0U5b" title="Line of credit, maximum borrowing amount"&gt;20 million&lt;/span&gt; unsecured revolving line of credit due on demand, which bears interest at the daily Secured
Overnight Financing Rate (&#x201c;SOFR&#x201d;) plus &lt;span id="xdx_90B_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYLPXJapi36a" title="Basis spread over variable interest rate"&gt;2&lt;/span&gt;% (the SOFR was &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zf2wEZRDgLT3" title="Variable rate"&gt;4.3&lt;/span&gt;% as of December 31, 2022). The line of credit which has
a maturity date of &lt;span id="xdx_90D_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zOIGxK6Ah7y7" title="::XDX::2023-12-15"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;December 15, 2023&lt;/span&gt;&lt;/span&gt;, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines of
credit were zero as of December 31, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s foreign subsidiaries
have available credit lines, including several bank overdraft facilities totaling approximately $&lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zOTqYWKWmLyl"&gt;20&lt;/span&gt; million. These credit lines
bear interest at EURIBOR plus between &lt;span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zoZlAWLpGPic" title="Basis spread over variable interest rate"&gt;0.6&lt;/span&gt;% and &lt;span id="xdx_90E_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_z5O2OZQtFDba" title="Basis spread over variable interest rate"&gt;0.9&lt;/span&gt;% (EURIBOR was minus &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zqXxBh8x2uIi" title="Variable rate"&gt;0.576&lt;/span&gt;% at December 31, 2022). Borrowings outstanding pursuant
to these bank overdraft facilities were zero as of December 31, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As there were no borrowings outstanding
as of December 31, 2022 and 2021, there is no weighted average interest rate on short-term borrowings as of December 31, 2022 and
2021.&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-12-31_custom_DomesticSubsidiariesMember"
      decimals="-6"
      unitRef="USD">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2022-01-012022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_LondonInterbankOfferedRateMember_custom_DomesticSubsidiariesMember"
      decimals="INF"
      unitRef="Pure">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-12-31_custom_ForeignSubsidiariesMember"
      decimals="-6"
      unitRef="USD">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.006</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="From2022-01-012022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.009</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_EuroInterbankOfferedRateMember_custom_ForeignSubsidiariesMember"
      decimals="INF"
      unitRef="Pure">0.00576</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zXDC79Sujj8c" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(11)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zpKuRONIxAV8"&gt;Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8B6_zftsybzXQda9"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;$&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj"&gt;53.3&lt;/span&gt; million payable in &lt;span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments"&gt;48&lt;/span&gt; equal monthly installments of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)"&gt;1.1 million&lt;/span&gt; beginning in December 2022, bearing interest at one-month Euribor plus &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum"&gt;0.825&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" style="width: 10%; text-align: right" title="Loan payable"&gt;52,061&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1183"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;$&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i"&gt;135.9&lt;/span&gt; million payable in &lt;span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments"&gt;120&lt;/span&gt; equal monthly installments of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26"&gt;1.1 million&lt;/span&gt; beginning in April 2021, bearing interest at one-month Euribor plus &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf"&gt;0.75&lt;/span&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right"&gt;104,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right"&gt;124,375&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;$&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf"&gt;15.0&lt;/span&gt; million payable in &lt;span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments"&gt;14&lt;/span&gt; equal annual installments of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh"&gt;1.1 million&lt;/span&gt; beginning in January 2020 including interest imputed at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum"&gt;4.1&lt;/span&gt;% per annum&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right"&gt;9,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right"&gt;10,569&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;$&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6"&gt;17&lt;/span&gt; million payable in &lt;span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments"&gt;10&lt;/span&gt; equal annual installments of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8"&gt;1.7 million&lt;/span&gt; beginning in October 2021 including interest imputed at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum"&gt;2.0&lt;/span&gt;% per annum&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable"&gt;13,332&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right"&gt;13,859&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right"&gt;180,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right"&gt;148,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Less current maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities"&gt;28,547&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities"&gt;15,911&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;151,494&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" style="border-bottom: Black 2.5pt double; text-align: right" title="::XDX::132902"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1216"&gt;132,892&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

&lt;p id="xdx_8A8_z5HmvadJDHEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In December 2022, to finance
Interparfums SA&#x2019;s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (&#x20ac;&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zQT8YHh7sZk7"&gt;50&lt;/span&gt; million) four-year
loan agreement. &lt;span id="xdx_908_eus-gaap--LongTermDebtDescription_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zo0dolFaZI1g" title="Debt description"&gt;The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was
swapped for variable interest rate debt with a maximum rate of 2% per annum.&lt;/span&gt; The swap is a hedged derivative instrument and is
therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In April 2021, to finance the
acquisition of Interparfums SA&#x2019;s future corporate headquarters, the Company entered into a $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z8Fs8D40OnTe"&gt;128.0 million&lt;/span&gt; (&#x20ac;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zAjWWQRyuBv2"&gt;120&lt;/span&gt; million)
ten-year credit agreement.&lt;span id="xdx_90E_eus-gaap--LongTermDebtDescription_c20210401__20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zaZaVlRPeZS" title="Debt description"&gt; Approximately $85.3 million (&#x20ac;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum. &lt;/span&gt;The swap is a derivative instrument and is therefore recorded at fair value
and changes in fair value are reflected in the accompanying consolidated statements of income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Maturities of long-term debt
subsequent to December 31, 2022 are approximately $&lt;span id="xdx_907_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20221231_zXSKH0X9ZWa5" title="Long-term Debt, Maturities, 2021"&gt;30.4 million&lt;/span&gt; in 2023 and $&lt;span id="xdx_909_eus-gaap--LongTermDebtDescription_c20220101__20221231_zZdNR4ZToCMj" title="Long term debt maturity, description"&gt;28.7 million per year thereafter through 2033.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8B6_zftsybzXQda9"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;$&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj"&gt;53.3&lt;/span&gt; million payable in &lt;span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments"&gt;48&lt;/span&gt; equal monthly installments of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)"&gt;1.1 million&lt;/span&gt; beginning in December 2022, bearing interest at one-month Euribor plus &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum"&gt;0.825&lt;/span&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" style="width: 10%; text-align: right" title="Loan payable"&gt;52,061&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1183"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;$&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i"&gt;135.9&lt;/span&gt; million payable in &lt;span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments"&gt;120&lt;/span&gt; equal monthly installments of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26"&gt;1.1 million&lt;/span&gt; beginning in April 2021, bearing interest at one-month Euribor plus &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf"&gt;0.75&lt;/span&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right"&gt;104,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right"&gt;124,375&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;$&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf"&gt;15.0&lt;/span&gt; million payable in &lt;span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments"&gt;14&lt;/span&gt; equal annual installments of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh"&gt;1.1 million&lt;/span&gt; beginning in January 2020 including interest imputed at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum"&gt;4.1&lt;/span&gt;% per annum&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right"&gt;9,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right"&gt;10,569&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;$&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6"&gt;17&lt;/span&gt; million payable in &lt;span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments"&gt;10&lt;/span&gt; equal annual installments of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8"&gt;1.7 million&lt;/span&gt; beginning in October 2021 including interest imputed at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum"&gt;2.0&lt;/span&gt;% per annum&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable"&gt;13,332&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right"&gt;13,859&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right"&gt;180,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right"&gt;148,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Less current maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities"&gt;28,547&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities"&gt;15,911&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;151,494&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" style="border-bottom: Black 2.5pt double; text-align: right" title="::XDX::132902"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1216"&gt;132,892&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember"
      decimals="-5"
      unitRef="USD">53300000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember"
      decimals="INF"
      unitRef="N">48</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_us-gaap_LoansPayableMember"
      decimals="-3"
      unitRef="USD">1100000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember"
      decimals="INF"
      unitRef="Pure">0.00825</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember"
      decimals="-3"
      unitRef="USD">52061000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_custom_LoansPayableOneMember"
      decimals="-5"
      unitRef="USD">135900000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2022-12-31_custom_LoansPayableOneMember"
      decimals="INF"
      unitRef="N">120</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_LoansPayableOneMember"
      decimals="-3"
      unitRef="USD">1100000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_LoansPayableOneMember"
      decimals="INF"
      unitRef="Pure">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_LoansPayableOneMember"
      decimals="-3"
      unitRef="USD">104758000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_LoansPayableOneMember"
      decimals="-3"
      unitRef="USD">124375000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember"
      decimals="-6"
      unitRef="USD">15000000.0</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember"
      decimals="INF"
      unitRef="N">14</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_LoansPayableTwoMember"
      decimals="-3"
      unitRef="USD">1100000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember"
      decimals="INF"
      unitRef="Pure">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_LoansPayableTwoMember"
      decimals="-3"
      unitRef="USD">9890000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_LoansPayableTwoMember"
      decimals="-3"
      unitRef="USD">10569000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember"
      decimals="-6"
      unitRef="USD">17000000</us-gaap:DebtInstrumentFaceAmount>
    <ipar:NumberOfInstallment
      contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember"
      decimals="INF"
      unitRef="N">10</ipar:NumberOfInstallment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_LoansPayableThreeMember"
      decimals="-3"
      unitRef="USD">1700000000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember"
      decimals="INF"
      unitRef="Pure">0.020</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_LoansPayableThreeMember"
      decimals="-3"
      unitRef="USD">13332000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_LoansPayableThreeMember"
      decimals="-3"
      unitRef="USD">13859000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">180041000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">148803000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">28547000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">15911000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">151494000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_us-gaap_LoansPayableMember"
      decimals="-6"
      unitRef="USDEUR">50000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtDescription contextRef="From2022-01-012022-12-31_us-gaap_LoansPayableMember">The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was
swapped for variable interest rate debt with a maximum rate of 2% per annum.</us-gaap:LongTermDebtDescription>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-04-30_custom_LoansPayableOneMember"
      decimals="0"
      unitRef="USD">128000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-04-30_custom_LoansPayableOneMember"
      decimals="-6"
      unitRef="USDEUR">120000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtDescription contextRef="From2021-04-012021-04-30_custom_LoansPayableOneMember">Approximately $85.3 million (&#x20ac;80.0 million) of the variable rate debt was swapped for variable
interest rate debt with maximum rate of 2% per annum.</us-gaap:LongTermDebtDescription>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">30400000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtDescription contextRef="From2022-01-01to2022-12-31">28.7 million per year thereafter through 2033.</us-gaap:LongTermDebtDescription>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zTwr7Ra7eKO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(12)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_822_zv6FdTOer5w7"&gt;Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;Leases&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases its offices,
warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing
leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized
at the lease commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In determining lease asset value,
the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on
the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option
is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available
at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2022, the
weighted average remaining lease term was &lt;span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20221231_zYWOvqd8k7Z" title="Weighted average remaining lease term::XDX::P5Y9M18D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;5.8&lt;/span&gt;&lt;/span&gt; years and the weighted average discount rate used to determine the operating lease
liability was &lt;span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OperatingLeaseMember_zmmFrMrS3QQ3" title="Operating lease, weighted average discount rate"&gt;2.6&lt;/span&gt;%. Rental expense related to operating leases was $&lt;span id="xdx_906_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20220101__20221231_zDmGhOiSjPBb" title="Operating lease of related to rental expenses"&gt;5.6 million&lt;/span&gt;, $&lt;span id="xdx_90C_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20210101__20211231_zOpXgtuxey95" title="Operating lease of related to rental expenses"&gt;8.2 million&lt;/span&gt;, and $&lt;span id="xdx_90D_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20200101__20201231_z6e3ua44YPd5" title="Operating lease of related to rental expenses"&gt;6.2 million&lt;/span&gt; for the years ended
December 31, 2022, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $&lt;span id="xdx_90C_eus-gaap--OperatingLeasePayments_dm_c20220101__20221231_zOycA2qmyVT8" title="Operating lease payments"&gt;4.9 million&lt;/span&gt;
and noncash additions to operating lease assets totaled $&lt;span id="xdx_90A_eus-gaap--OperatingLeaseCost_dm_c20220101__20221231_zCokZCjQiWch" title="Noncash additions to operating lease assets"&gt;0.3 million&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B6_zJZSArOFca1k"&gt;Maturities of lease liabilities
subsequent to December 31, 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" style="width: 10%; text-align: right" title="2023"&gt;5,723&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" style="text-align: right" title="2024"&gt;5,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" style="text-align: right" title="2025"&gt;4,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" style="text-align: right" title="2026"&gt;4,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;2027&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" style="text-align: right" title="2027"&gt;4,060&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;6,913&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total"&gt;31,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Less imputed interest (based on
    2.6%&lt;/span&gt; weighted-average discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest (based on 2.6% weighted-average discount rate)"&gt;(1,932&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Total"&gt;29,631&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

&lt;p id="xdx_8AD_zy90NeZibwc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;License Agreements&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description"&gt;The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.&lt;/span&gt; In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, &lt;span id="xdx_8B6_zLKFQSlOwCib"&gt;minimum annual royalties and other commitments as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;(In thousands) &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" style="width: 10%; text-align: right" title="2023"&gt;217,852&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" style="text-align: right" title="2024"&gt;224,201&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" style="text-align: right" title="2025"&gt;218,047&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" style="text-align: right" title="2026"&gt;139,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" style="text-align: right" title="2027"&gt;132,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;986,434&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;1,918,384&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/&gt;

&lt;p id="xdx_8AB_zqW0gUZLUbSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 40.5pt; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Future advertising commitments
are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration
for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations.
Royalty expense included in selling, general, and administrative expenses, aggregated $&lt;span id="xdx_906_eus-gaap--RoyaltyExpense_dm_c20220101__20221231_zJ4Vw88JOFd" title="Royalty expense"&gt;87.0 million&lt;/span&gt;, $&lt;span id="xdx_900_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zEFGKRKYN0Kl" title="Royalty expense"&gt;68.9 million&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zKT2XSaeLDt6" title="Royalty expense"&gt;41.1 million&lt;/span&gt;,
in 2022, 2021 and 2020, respectively, and represented &lt;span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231_zja2h94g7ujk" title="Royalty expense, percentage of net sales"&gt;8.0&lt;/span&gt;%, &lt;span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zfGTtDuPHMu" title="Royalty expense, percentage of net sales"&gt;7.8&lt;/span&gt;% and &lt;span id="xdx_907_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zAIxykTL3msl" title="Royalty expense, percentage of net sales"&gt;7.6&lt;/span&gt;% of net sales for the years ended December 31, 2022, 2021
and 2020, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2022-12-31_custom_OperatingLeaseMember"
      decimals="INF"
      unitRef="Pure">0.026</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <ipar:OperatingLeaseOfRelatedToRentalExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">5600000</ipar:OperatingLeaseOfRelatedToRentalExpenses>
    <ipar:OperatingLeaseOfRelatedToRentalExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">8200000</ipar:OperatingLeaseOfRelatedToRentalExpenses>
    <ipar:OperatingLeaseOfRelatedToRentalExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">6200000</ipar:OperatingLeaseOfRelatedToRentalExpenses>
    <us-gaap:OperatingLeasePayments
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">4900000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">300000</us-gaap:OperatingLeaseCost>
    <ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B6_zJZSArOFca1k"&gt;Maturities of lease liabilities
subsequent to December 31, 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" style="width: 10%; text-align: right" title="2023"&gt;5,723&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" style="text-align: right" title="2024"&gt;5,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" style="text-align: right" title="2025"&gt;4,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" style="text-align: right" title="2026"&gt;4,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;2027&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" style="text-align: right" title="2027"&gt;4,060&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;6,913&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total"&gt;31,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Less imputed interest (based on
    2.6%&lt;/span&gt; weighted-average discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest (based on 2.6% weighted-average discount rate)"&gt;(1,932&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Total"&gt;29,631&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;

</ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">5723000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">5971000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">4847000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">4049000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">4060000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">6913000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">31563000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <ipar:LessImputedInterestBasedOn2.6WeightedaverageDiscountRate contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1932000</ipar:LessImputedInterestBasedOn2.6WeightedaverageDiscountRate>
    <ipar:LesseeOperatingLeaseLiabilityPaymentsDueNetTotal contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">29631000</ipar:LesseeOperatingLeaseLiabilityPaymentsDueNetTotal>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description"&gt;The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.&lt;/span&gt; In connection with certain of these license agreements, the Company is subject to minimum
annual advertising commitments, &lt;span id="xdx_8B6_zLKFQSlOwCib"&gt;minimum annual royalties and other commitments as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;(In thousands) &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" style="width: 10%; text-align: right" title="2023"&gt;217,852&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" style="text-align: right" title="2024"&gt;224,201&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" style="text-align: right" title="2025"&gt;218,047&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" style="text-align: right" title="2026"&gt;139,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" style="text-align: right" title="2027"&gt;132,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;986,434&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;1,918,384&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/&gt;

</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement contextRef="From2022-01-01to2022-12-31">The Company is party to a number
of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products
expiring at various dates through 2033.</us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement>
    <us-gaap:OtherCommitmentDueInNextTwelveMonths contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">217852000</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <us-gaap:OtherCommitmentDueInSecondYear contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">224201000</us-gaap:OtherCommitmentDueInSecondYear>
    <us-gaap:OtherCommitmentDueInThirdYear contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">218047000</us-gaap:OtherCommitmentDueInThirdYear>
    <us-gaap:OtherCommitmentDueInFourthYear contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">139348000</us-gaap:OtherCommitmentDueInFourthYear>
    <us-gaap:OtherCommitmentDueInFifthYear contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">132502000</us-gaap:OtherCommitmentDueInFifthYear>
    <us-gaap:OtherCommitmentDueAfterFifthYear contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">986434000</us-gaap:OtherCommitmentDueAfterFifthYear>
    <us-gaap:OtherCommitment contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1918384000</us-gaap:OtherCommitment>
    <us-gaap:RoyaltyExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">87000000.0</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">68900000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">41100000</us-gaap:RoyaltyExpense>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.080</ipar:RoyaltyExpenseNetSalesPercentage>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.078</ipar:RoyaltyExpenseNetSalesPercentage>
    <ipar:RoyaltyExpenseNetSalesPercentage
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.076</ipar:RoyaltyExpenseNetSalesPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z0xEZThRjPSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(13)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_z4QG4D9JjvZj"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;Share-Based Payments&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company maintains a stock
option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide
for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and
vest over a &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbUkuxEy131l" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1304"&gt;four&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUm5qZQr8np4" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;five&lt;/span&gt;&lt;/span&gt;-year period. The fair value of shares vested aggregated $&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiTTmRm9Ryg"&gt;1.3 million&lt;/span&gt;, $&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNTy7pkKCtLa" title="Fair value of shares vested"&gt;1.4 million&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqrJtdNf4GM"&gt;1.7 million&lt;/span&gt; in
2022, 2021 and 2020, respectively. &lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation cost, net of estimated
forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated
based on historic trends. &lt;/span&gt;It is generally the Company&#x2019;s policy to issue new shares upon exercise of stock options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BB_zFjpmdCfOPe7"&gt;The following table sets forth
information with respect to nonvested options for 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Grant Date Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Nonvested options &#x2013; beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" style="width: 10%; text-align: right" title="Nonvested options - beginning of year"&gt;209,510&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" style="width: 10%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year"&gt;13.45&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Nonvested options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" style="text-align: right" title="Nonvested options granted"&gt;62,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted"&gt;20.36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Nonvested options vested or forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited"&gt;(102,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited"&gt;12.93&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Nonvested options &#x2013; end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options - end of year"&gt;168,730&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year"&gt;16.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_z2lp4EWwj9ta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;






&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B7_zaFiKtjKr3b5"&gt;The effect of share-based payment
expenses decreased income statement line items as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Income before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" style="width: 10%; text-align: right" title="Income before income taxes"&gt;3,143&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" style="width: 10%; text-align: right" title="Income before income taxes"&gt;2,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" style="width: 10%; text-align: right" title="Income before income taxes"&gt;3,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net income attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;2,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;1,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Diluted earnings per share attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zmgo6RZltrt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_z10lqP2NV1bl"&gt;The following table summarizes
stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Shares under option -&#160;beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" style="width: 10%; text-align: right" title="Options shares under option - beginning of year"&gt;524,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"&gt;57.58&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" style="width: 10%; text-align: right" title="Options shares under option - beginning of year"&gt;713,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"&gt;52.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right"&gt;815,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right"&gt;49.89&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" style="text-align: right" title="Options granted"&gt;62,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" style="text-align: right" title="Weighted average exercise price options granted"&gt;97.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" style="text-align: right" title="Weighted average exercise price options granted"&gt;62.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right"&gt;69.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" style="text-align: right" title="Options exercised"&gt;(136,880&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" style="text-align: right" title="Weighted average exercise price options exercised"&gt;43.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" style="text-align: right" title="Options exercised"&gt;(156,490&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" style="text-align: right" title="Weighted average exercise price options exercised"&gt;34.46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" style="text-align: right" title="Options exercised"&gt;(95,570&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right"&gt;28.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Options forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(8,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" style="text-align: right" title="Weighted average exercise price options forfeited"&gt;67.65&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(40,820&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" style="text-align: right" title="Weighted average exercise price options forfeited"&gt;62.57&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(16,020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right"&gt;58.38&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Shares under option - end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year"&gt;441,580&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" style="text-align: right" title="Weighted average exercise price shares under option - end of year"&gt;67.30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year"&gt;524,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" style="text-align: right" title="Weighted average exercise price shares under option - end of year"&gt;57.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;713,210&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right"&gt;52.74&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_8A7_zMusYQdqpD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;At December 31, 2022, options
for &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zRbzGPHLcDW9" title="Number of shares available for grant (in shares)"&gt;558,975&lt;/span&gt; shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zPczbZ4CHEe9" title="Aggregate intrinsic value of options outstanding"&gt;13.0
million&lt;/span&gt; as of December 31, 2022 and unrecognized compensation cost related to stock options outstanding aggregated $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zrJOO8xEv2Zk" title="Aggregate intrinsic value of options outstanding"&gt;2.7 million&lt;/span&gt;,
which will be recognized over the next &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20220101__20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zNds05itzyhh" title="Term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1418"&gt;five&lt;/span&gt;&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The weighted average fair values
of options granted by Inter Parfums, Inc. during 2022, 2021 and 2020 were $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3ts39aUaVf" title="Weighted average grant date fair value (in dollars per share)"&gt;20.36&lt;/span&gt;, $&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqCA6fheI8Gb" title="Weighted average grant date fair value (in dollars per share)"&gt;11.35&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGXHMgADgBg2" title="Weighted average grant date fair value (in dollars per share)"&gt;12.16&lt;/span&gt; per share, respectively, on
the date of grant using the Black-Scholes option pricing model to calculate the fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B0_zZGs8M9wlPE9"&gt;The assumptions used in the Black-Scholes
pricing model are set forth in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Weighted-average expected stock-price volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average expected option life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" style="text-align: right" title="Weighted-average expected option life::XDX::P4Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1432"&gt;4.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1434"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1436"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AB_zjBkLAW2FMue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Expected volatility is estimated
based on historic volatility of the Company&#x2019;s common stock. The expected term of the option is estimated based on historic
data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend
yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout
ratio as a percentage of earnings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zZTZ2TudDlj9"&gt;Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Proceeds from stock options exercised&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;6,003&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;5,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;2,771&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Tax benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Intrinsic value of stock options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zXo8dwKlRsok" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B1_zT9VrNCHVHH3"&gt;The following table summarizes
additional stock option information as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise prices&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options outstanding&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options outstanding weighted average remaining contractual life&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options exercisable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1"&gt;40.15&lt;/span&gt; - $&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)"&gt;46.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" style="width: 22%; text-align: right" title="Options outstanding"&gt;103,460&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;0.96&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" style="width: 22%; text-align: right" title="Options exercisable"&gt;101,860&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8"&gt;62.18&lt;/span&gt; - $&lt;span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm"&gt;69.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" style="text-align: right" title="Options outstanding"&gt;139,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1483"&gt;2.04&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" style="text-align: right" title="Options exercisable"&gt;97,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;$&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb"&gt;73.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right"&gt;136,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1488"&gt;3.00&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right"&gt;73,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;$&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi"&gt;97.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right"&gt;62,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1492"&gt;5.85&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1493"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right"&gt;441,580&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1495"&gt;2.62&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right"&gt;272,850&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"/&gt;

&lt;p id="xdx_8A2_zbPfi6PqJBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2022, the
weighted average exercise price of options exercisable was $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uUSDPShares_c20221231_ztPpZ95AvzX" title="Weighted average exercise price of options exercisable"&gt;59.46&lt;/span&gt; and the weighted average remaining contractual life of options
exercisable is &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20220101__20221231_zEGDcIwT5I72" title="Weighted average remaining contractual life of options exercisable::XDX::P1Y10M17D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1500"&gt;1.88&lt;/span&gt;&lt;/span&gt; years. The aggregate intrinsic value of options exercisable at December 31, 2022 is $&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_dm_c20221231_zWPFWaH7sF3f" title="Aggregate intrinsic value of options exercisable"&gt;10.1 million&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In December 2018, Interparfums
SA approved a plan to grant an aggregate of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zolqUtSNVf35" title="Adjusted for stock splits (in shares)"&gt;26,600&lt;/span&gt; shares of its stock to employees with no performance condition requirement,
and an aggregate of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zKV5xx7gtrzh" title="Aggregate intrinsic value of options outstanding"&gt;133,000&lt;/span&gt; shares to officers and managers, subject to certain corporate performance conditions. The corporate
performance conditions were met and therefore in June 2022, &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220627__20220630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zmz0K9mMiMia" title="Shares adjusted for stock splits"&gt;211,955&lt;/span&gt; shares, adjusted for stock splits, were distributed. The aggregate
cost of the grant of approximately $&lt;span id="xdx_908_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_dm_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zpMHa71JZO72" title="Recognized as compensation cost"&gt;4.8 million&lt;/span&gt; was recognized as compensation cost on a straight-line basis over the requisite
&lt;span id="xdx_909_eus-gaap--DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_dxL_c20220101__20221231_zn6Zy3HzEP4i" title="Straight line basis over the requisite::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;three&lt;/span&gt;&lt;/span&gt;-year service period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In March 2022, Interparfums SA
approved an additional plan to grant an aggregate of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z6WQrzRaEvP4"&gt;88,400&lt;/span&gt; shares to all Interparfums SA employees and corporate officers having
more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment
for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of the grant had
been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The
estimated number of shares to be distributed of &lt;span id="xdx_904_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z4xDvfHemfK7" title="Number of share distributed"&gt;85,062&lt;/span&gt; has been determined taking into account employee turnover. The aggregate
cost of the grant of approximately $&lt;span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20220101__20221231__srt--OwnershipAxis__custom--InterparfumsSAMember_z7xoxRrTw8na"&gt;4.1 million&lt;/span&gt; will be recognized as compensation cost on a straight-line basis over the requisite
three and a quarter year service period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Similar to the December 2018
plan, in order to avoid dilution of the Company&#x2019;s ownership of Interparfums SA, all shares distributed or to be distributed
pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During
the year ended December 31, 2022, the Company acquired &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zvzvYImHjQzh"&gt;63,281&lt;/span&gt; shares at an aggregate cost of $&lt;span id="xdx_902_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn6n6_c20220101__20221231_z1yhgjJBhuJ3" title="Aggregate cost"&gt;3.0&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;Dividends&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In October 2019, our Board of
Directors authorized a &lt;span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_zq1BtKsWXw1j" title="Percentage of increase in annual dividend"&gt;20&lt;/span&gt;% increase in the annual dividend to $&lt;span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zT4bsZb7yhz"&gt;1.32&lt;/span&gt; per share on an annual basis. In April 2020, as a result of
the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash
dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly.
In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share and in February 2023,
the Board of Directors further increased the annual dividend to $&lt;span id="xdx_90C_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zn5dEgZpNPql" title="Dividends payable, amount per share (in dollars per share)"&gt;2.50&lt;/span&gt; per share. The next quarterly cash dividend of $&lt;span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3H9aLSa9j2g" title="Dividends payable, amount per share (in Dollars per share)"&gt;0.625&lt;/span&gt; per
share is payable on March 31, 2023 to shareholders of record on March 15, 2023.&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BB_zFjpmdCfOPe7"&gt;The following table sets forth
information with respect to nonvested options for 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Shares &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Grant Date Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Nonvested options &#x2013; beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" style="width: 10%; text-align: right" title="Nonvested options - beginning of year"&gt;209,510&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" style="width: 10%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year"&gt;13.45&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Nonvested options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" style="text-align: right" title="Nonvested options granted"&gt;62,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted"&gt;20.36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Nonvested options vested or forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited"&gt;(102,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited"&gt;12.93&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Nonvested options &#x2013; end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options - end of year"&gt;168,730&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year"&gt;16.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">209510</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">13.45</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">62000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">20.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">102780</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">12.93</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">168730</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">16.31</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B7_zaFiKtjKr3b5"&gt;The effect of share-based payment
expenses decreased income statement line items as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Income before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" style="width: 10%; text-align: right" title="Income before income taxes"&gt;3,143&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" style="width: 10%; text-align: right" title="Income before income taxes"&gt;2,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" style="width: 10%; text-align: right" title="Income before income taxes"&gt;3,030&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net income attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;2,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;1,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Diluted earnings per share attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">3143000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">2850000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">3030000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">2036000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">1880000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="-3"
      unitRef="USD">2040000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-12-31_us-gaap_OperatingIncomeLossMember"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_z10lqP2NV1bl"&gt;The following table summarizes
stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Shares under option -&#160;beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" style="width: 10%; text-align: right" title="Options shares under option - beginning of year"&gt;524,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"&gt;57.58&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" style="width: 10%; text-align: right" title="Options shares under option - beginning of year"&gt;713,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"&gt;52.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right"&gt;815,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right"&gt;49.89&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" style="text-align: right" title="Options granted"&gt;62,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" style="text-align: right" title="Weighted average exercise price options granted"&gt;97.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" style="text-align: right" title="Weighted average exercise price options granted"&gt;62.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" style="text-align: right" title="Options granted"&gt;9,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right"&gt;69.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" style="text-align: right" title="Options exercised"&gt;(136,880&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" style="text-align: right" title="Weighted average exercise price options exercised"&gt;43.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" style="text-align: right" title="Options exercised"&gt;(156,490&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" style="text-align: right" title="Weighted average exercise price options exercised"&gt;34.46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" style="text-align: right" title="Options exercised"&gt;(95,570&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right"&gt;28.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Options forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(8,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" style="text-align: right" title="Weighted average exercise price options forfeited"&gt;67.65&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(40,820&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" style="text-align: right" title="Weighted average exercise price options forfeited"&gt;62.57&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited"&gt;(16,020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right"&gt;58.38&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;Shares under option - end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year"&gt;441,580&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" style="text-align: right" title="Weighted average exercise price shares under option - end of year"&gt;67.30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year"&gt;524,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" style="text-align: right" title="Weighted average exercise price shares under option - end of year"&gt;57.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;713,210&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right"&gt;52.74&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">524900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">57.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">713210</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">52.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">815800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">49.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">62000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">97.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">62.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">69.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">136880</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">43.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">156490</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">34.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">95570</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">28.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">8440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">67.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">40820</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">62.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">16020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">58.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">441580</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">67.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">524900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">57.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">713210</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">52.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2022-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">558975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-12-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">13000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-12-31_custom_StockOptionOneMember"
      decimals="0"
      unitRef="USD">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">20.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">11.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B0_zZGs8M9wlPE9"&gt;The assumptions used in the Black-Scholes
pricing model are set forth in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Weighted-average expected stock-price volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average expected option life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" style="text-align: right" title="Weighted-average expected option life::XDX::P4Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1432"&gt;4.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1434"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1436"&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BA_zZTZ2TudDlj9"&gt;Proceeds, tax benefits and intrinsic
value related to stock options exercised were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Proceeds from stock options exercised&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;6,003&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;5,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;2,771&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Tax benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Intrinsic value of stock options exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">6003000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">5393000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2771000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">800000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">1300000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">400000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">6760000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">7800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2873000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B1_zT9VrNCHVHH3"&gt;The following table summarizes
additional stock option information as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise prices&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options outstanding&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options outstanding weighted average remaining contractual life&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options exercisable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1"&gt;40.15&lt;/span&gt; - $&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)"&gt;46.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" style="width: 22%; text-align: right" title="Options outstanding"&gt;103,460&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;0.96&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" style="width: 22%; text-align: right" title="Options exercisable"&gt;101,860&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8"&gt;62.18&lt;/span&gt; - $&lt;span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm"&gt;69.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" style="text-align: right" title="Options outstanding"&gt;139,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1483"&gt;2.04&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" style="text-align: right" title="Options exercisable"&gt;97,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;$&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb"&gt;73.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right"&gt;136,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1488"&gt;3.00&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right"&gt;73,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;$&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi"&gt;97.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right"&gt;62,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1492"&gt;5.85&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1493"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right"&gt;441,580&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1495"&gt;2.62&lt;/span&gt;&lt;/span&gt; years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right"&gt;272,850&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"/&gt;

</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="USDPShares">40.15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="USDPShares">46.90</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="Shares">103460</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      unitRef="Shares">101860</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31_srt_MinimumMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="USDPShares">62.18</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31_srt_MaximumMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="USDPShares">69.11</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="Shares">139900</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      unitRef="Shares">97210</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="USDPShares">73.09</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="Shares">136220</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      unitRef="Shares">73780</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      unitRef="USDPShares">97.84</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2022-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      unitRef="Shares">62000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">441580</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">272850</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">59.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">10100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">26600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2018-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">133000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="From2022-06-272022-06-30_custom_InterparfumsSASubsidiaryMember"
      decimals="INF"
      unitRef="Shares">211955</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember"
      decimals="0"
      unitRef="USD">4800000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2022-03-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">88400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DistributionMadeToLimitedPartnerUnitDistribution
      contextRef="From2022-01-012022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">85062</us-gaap:DistributionMadeToLimitedPartnerUnitDistribution>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="From2022-01-012022-12-31_custom_InterparfumsSAMember"
      decimals="0"
      unitRef="USD">4100000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2022-12-31_custom_InterparfumsSASubsidiaryMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">63281</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="-6"
      unitRef="USD">3000000.0</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <ipar:PercentageOfIncreaseInAnnualDividend
      contextRef="From2019-10-012019-10-31"
      decimals="INF"
      unitRef="Pure">0.20</ipar:PercentageOfIncreaseInAnnualDividend>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2019-10-31"
      decimals="INF"
      unitRef="USDPShares">1.32</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2021-02-28_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      unitRef="USDPShares">2.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="AsOf2023-03-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">0.625</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zx5E95p2u826" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(14)&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_82C_zg2XEdxMVec8" style="text-align: justify"&gt;&lt;b&gt;Net Income Attributable to Inter Parfums, Inc. Common Shareholders&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Net income attributable to Inter
Parfums, Inc. per common share (&#x201c;basic EPS&#x201d;) is computed by dividing net income attributable to Inter Parfums, Inc.
by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution
(&#x201c;diluted EPS&#x201d;), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding
assuming the exercise of dilutive stock options using the treasury stock method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;






















&lt;p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B7_z0oWgrF1Exze"&gt;The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Numerator for diluted earnings per share&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)"&gt;120,938&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)"&gt;87,411&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)"&gt;38,219&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" style="text-align: right" title="Weighted average shares::XDX::31859417"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1557"&gt;31,859,417&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" style="text-align: right" title="Weighted average shares"&gt;31,676,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" style="text-align: right" title="Weighted average shares"&gt;31,536,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Effect of dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options"&gt;129,336&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options"&gt;158,612&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options"&gt;117,885&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share::XDX::31835408"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1569"&gt;31,988,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share"&gt;31,835,408&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share"&gt;31,654,544&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc.
    common shareholders:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" style="text-align: right" title="Basic (in dollars per share)"&gt;3.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" style="text-align: right" title="Basic (in dollars per share)"&gt;2.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" style="text-align: right" title="Basic (in dollars per share)"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" style="text-align: right" title="Diluted (in dollars per share)"&gt;3.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" style="text-align: right" title="Diluted (in dollars per share)"&gt;2.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" style="text-align: right" title="Diluted (in dollars per share)"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_8A9_zbK4fmd08pt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Not included in the above computations
is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase &lt;span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zg2q9bpdlHmj" title="Antidilutive securities excluded from computation of earnings per share, amount"&gt;38,000&lt;/span&gt;, &lt;span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zZ3Omt4U4Yj3" title="Antidilutive securities excluded from computation of earnings per share, amount"&gt;175,000&lt;/span&gt;, and &lt;span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_zIqUqAS4cqsk" title="Antidilutive securities excluded from computation of earnings per share, amount"&gt;450,000&lt;/span&gt;
shares of common stock for 2022, 2021, and 2020, respectively.&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B7_z0oWgrF1Exze"&gt;The reconciliation between the
numerators and denominators of the basic and diluted EPS computations is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Numerator for diluted earnings per share&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)"&gt;120,938&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)"&gt;87,411&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)"&gt;38,219&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Weighted average shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" style="text-align: right" title="Weighted average shares::XDX::31859417"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1557"&gt;31,859,417&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" style="text-align: right" title="Weighted average shares"&gt;31,676,796&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" style="text-align: right" title="Weighted average shares"&gt;31,536,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Effect of dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options"&gt;129,336&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options"&gt;158,612&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options"&gt;117,885&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share::XDX::31835408"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1569"&gt;31,988,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share"&gt;31,835,408&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share"&gt;31,654,544&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc.
    common shareholders:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" style="text-align: right" title="Basic (in dollars per share)"&gt;3.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" style="text-align: right" title="Basic (in dollars per share)"&gt;2.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" style="text-align: right" title="Basic (in dollars per share)"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.5in; text-indent: -0.125in"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" style="text-align: right" title="Diluted (in dollars per share)"&gt;3.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" style="text-align: right" title="Diluted (in dollars per share)"&gt;2.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" style="text-align: right" title="Diluted (in dollars per share)"&gt;1.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">120938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">31676796</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31536659</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">129336</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">158612</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">117885</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">31835408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31654544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">3.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">2.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">38000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">175000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">450000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zGZBHf28LoC8" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(15)&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_82C_zH7uC5DUdNy3" style="text-align: justify"&gt;&lt;b&gt;Segments and Geographic Areas&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company &lt;span style="font-family: Times New Roman, Times, Serif"&gt;manufactures
and distributes one product line, fragrances and fragrance related products. The Company&lt;/span&gt; manages its business in two segments,
European based operations and United States based operations. The European assets are located, and operations are primarily conducted,
in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B9_zpH2kTnlYawl"&gt;Information on the Company&#x2019;s
operations by segments is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Net sales:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right"&gt;342,644&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right"&gt;216,559&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right"&gt;117,489&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right"&gt;744,075&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right"&gt;663,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right"&gt;422,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations of intercompany
    sales&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(66&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right"&gt;(333&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,427&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,086,653&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;879,516&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right"&gt;539,009&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc.:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right"&gt;43,745&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right"&gt;29,359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right"&gt;7,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right"&gt;77,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right"&gt;57,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right"&gt;30,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1614"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right"&gt;183&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right"&gt;120,938&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation and amortization expense including
    impairment loss:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right"&gt;6,355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right"&gt;3,835&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right"&gt;3,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right"&gt;16,184&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right"&gt;8,863&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right"&gt;5,713&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right"&gt;22,539&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,698&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,067&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Interest and investment income:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right"&gt;66&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right"&gt;3&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right"&gt;24&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right"&gt;5,769&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right"&gt;3,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right"&gt;2,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right"&gt;(349&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right"&gt;(130&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,486&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,403&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,865&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right"&gt;1,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right"&gt;636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right"&gt;604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" style="text-align: right" title="Interest expense"&gt;2,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" style="text-align: right" title="Interest expense"&gt;2,315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" style="text-align: right" title="Interest expense"&gt;1,496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense"&gt;(349&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense"&gt;(126&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense"&gt;(130&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense"&gt;3,599&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense"&gt;2,825&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense"&gt;1,970&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income tax expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right"&gt;6,920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right"&gt;5,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right"&gt;1,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right"&gt;36,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right"&gt;35,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right"&gt;17,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1668"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;43,182&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;40,992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,381&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Total assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right"&gt;278,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right"&gt;247,703&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right"&gt;141,316&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right"&gt;1,052,004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right"&gt;931,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right"&gt;758,812&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right"&gt;(21,552&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right"&gt;(34,074&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,983&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,308,542&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,145,364&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right"&gt;890,145&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Additions to long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right"&gt;2,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right"&gt;2,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right"&gt;1,004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right"&gt;31,438&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right"&gt;138,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right"&gt;11,259&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,756&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right"&gt;141,274&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,263&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Total long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right"&gt;61,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right"&gt;63,094&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right"&gt;40,656&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right"&gt;423,999&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right"&gt;334,033&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right"&gt;217,766&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;485,538&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;397,127&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right"&gt;258,422&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right"&gt;2,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right"&gt;870&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right"&gt;886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right"&gt;8,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right"&gt;7,066&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right"&gt;7,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1718"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1719"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,159&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;8,041&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_8A3_z3AfBJKqYq4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;United States export sales were
approximately $&lt;span id="xdx_906_eus-gaap--Revenues_dm_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z9mKYeG4Bxvg" title="Revenue from export sales"&gt;169.1 million&lt;/span&gt;, $&lt;span id="xdx_90C_eus-gaap--Revenues_dm_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zRk6SmlGxoJf" title="Revenue from export sales"&gt;126.2 million&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--Revenues_dm_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z12uafZ15sJ3" title="Revenue from export sales"&gt;71.5 million&lt;/span&gt; in 2022, 2021 and 2020, respectively. &lt;span&gt;Consolidated net sales to
customers by region are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden"&gt;Consolidated net sales to customers by region are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;North America&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" style="width: 10%; text-align: right" title="Net sales"&gt;431,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" style="width: 10%; text-align: right" title="Net sales"&gt;354,100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" style="width: 10%; text-align: right" title="Net sales"&gt;193,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right"&gt;333,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right"&gt;271,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right"&gt;180,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Asia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right"&gt;152,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right"&gt;128,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right"&gt;79,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Middle East&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right"&gt;87,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right"&gt;61,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right"&gt;46,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Central and South America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right"&gt;69,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right"&gt;56,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right"&gt;32,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right"&gt;11,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right"&gt;8,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right"&gt;6,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,086,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right"&gt;879,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;539,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_ztRhsXR8V6Q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8B7_z7FpI55o74vh"&gt;Consolidated net sales to customers in major countries
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;420,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;351,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;187,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;France&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right"&gt;44,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right"&gt;44,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right"&gt;37,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Russia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right"&gt;33,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right"&gt;43,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right"&gt;14,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right"&gt;37,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right"&gt;38,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right"&gt;24,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zpCmLcFFUQ57" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8B9_zpH2kTnlYawl"&gt;Information on the Company&#x2019;s
operations by segments is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Net sales:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right"&gt;342,644&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right"&gt;216,559&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right"&gt;117,489&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right"&gt;744,075&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right"&gt;663,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right"&gt;422,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations of intercompany
    sales&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(66&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right"&gt;(333&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,427&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,086,653&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;879,516&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right"&gt;539,009&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc.:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right"&gt;43,745&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right"&gt;29,359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right"&gt;7,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right"&gt;77,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right"&gt;57,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right"&gt;30,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1614"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right"&gt;183&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right"&gt;120,938&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation and amortization expense including
    impairment loss:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right"&gt;6,355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right"&gt;3,835&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right"&gt;3,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right"&gt;16,184&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right"&gt;8,863&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right"&gt;5,713&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right"&gt;22,539&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,698&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,067&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Interest and investment income:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right"&gt;66&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right"&gt;3&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right"&gt;24&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right"&gt;5,769&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right"&gt;3,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right"&gt;2,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right"&gt;(349&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right"&gt;(130&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,486&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,403&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,865&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right"&gt;1,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right"&gt;636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right"&gt;604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" style="text-align: right" title="Interest expense"&gt;2,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" style="text-align: right" title="Interest expense"&gt;2,315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" style="text-align: right" title="Interest expense"&gt;1,496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense"&gt;(349&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense"&gt;(126&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense"&gt;(130&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense"&gt;3,599&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense"&gt;2,825&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense"&gt;1,970&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income tax expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right"&gt;6,920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right"&gt;5,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right"&gt;1,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right"&gt;36,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right"&gt;35,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right"&gt;17,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1668"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;43,182&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;40,992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,381&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Total assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right"&gt;278,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right"&gt;247,703&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right"&gt;141,316&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right"&gt;1,052,004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right"&gt;931,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right"&gt;758,812&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right"&gt;(21,552&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right"&gt;(34,074&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,983&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,308,542&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,145,364&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right"&gt;890,145&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Additions to long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right"&gt;2,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right"&gt;2,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right"&gt;1,004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right"&gt;31,438&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right"&gt;138,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right"&gt;11,259&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,756&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right"&gt;141,274&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,263&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Total long-lived assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right"&gt;61,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right"&gt;63,094&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right"&gt;40,656&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right"&gt;423,999&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right"&gt;334,033&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right"&gt;217,766&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;485,538&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;397,127&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right"&gt;258,422&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right"&gt;2,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right"&gt;870&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right"&gt;886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right"&gt;8,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right"&gt;7,066&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right"&gt;7,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1718"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1719"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,159&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;8,041&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">342644000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">216559000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">117489000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">744075000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">663290000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">422947000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-66000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-333000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-1427000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">1086653000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">879516000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">539009000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">43745000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">29359000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">7942000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">77193000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">57869000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">30241000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">183000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">36000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">120938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">6355000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">3835000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">3354000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">16184000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">8863000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5713000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">22539000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">12698000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">9067000</us-gaap:DepreciationAndAmortization>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">66000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">3000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">24000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5769000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">3526000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">2971000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2022-01-012022-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">349000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">126000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">130000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">5486000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">3403000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2865000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">636000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">604000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">2848000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">2315000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">1496000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">349000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">126000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">130000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">3599000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2825000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1970000</us-gaap:InterestExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">6920000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">5336000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">1590000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">36262000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">35607000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">17782000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">9000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">43182000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">40992000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">19381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_country_US"
      decimals="-3"
      unitRef="USD">278090000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">247703000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_country_US"
      decimals="-3"
      unitRef="USD">141316000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">1052004000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">931735000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">758812000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">21552000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">34074000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">9983000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1308542000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1145364000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">890145000</us-gaap:Assets>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      unitRef="USD">2318000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="-3"
      unitRef="USD">2711000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="-3"
      unitRef="USD">1004000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">31438000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">138563000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">11259000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">33756000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">141274000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:AdditionsToOtherAssetsAmount
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">12263000</us-gaap:AdditionsToOtherAssetsAmount>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_country_US"
      decimals="-3"
      unitRef="USD">61539000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">63094000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2020-12-31_country_US"
      decimals="-3"
      unitRef="USD">40656000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">423999000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">334033000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">217766000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">485538000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">397127000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">258422000</us-gaap:NoncurrentAssets>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2022-12-31_country_US"
      decimals="-3"
      unitRef="USD">2906000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">870000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2020-12-31_country_US"
      decimals="-3"
      unitRef="USD">886000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">8253000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">7066000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">7106000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2020-12-31_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">11159000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7936000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">8041000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="0"
      unitRef="USD">169100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="0"
      unitRef="USD">126200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="0"
      unitRef="USD">71500000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden"&gt;Consolidated net sales to customers by region are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;North America&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" style="width: 10%; text-align: right" title="Net sales"&gt;431,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" style="width: 10%; text-align: right" title="Net sales"&gt;354,100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" style="width: 10%; text-align: right" title="Net sales"&gt;193,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Europe&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right"&gt;333,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right"&gt;271,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right"&gt;180,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Asia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right"&gt;152,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right"&gt;128,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right"&gt;79,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Middle East&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right"&gt;87,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right"&gt;61,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right"&gt;46,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Central and South America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right"&gt;69,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right"&gt;56,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right"&gt;32,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right"&gt;11,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right"&gt;8,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right"&gt;6,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,086,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right"&gt;879,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;539,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_srt_NorthAmericaMember"
      decimals="-3"
      unitRef="USD">431900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_srt_NorthAmericaMember"
      decimals="-3"
      unitRef="USD">354100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_srt_NorthAmericaMember"
      decimals="-3"
      unitRef="USD">193500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">333400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">271600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">180200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">152700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">128000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">79700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_us-gaap_MiddleEastMember"
      decimals="-3"
      unitRef="USD">87800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_us-gaap_MiddleEastMember"
      decimals="-3"
      unitRef="USD">61000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_us-gaap_MiddleEastMember"
      decimals="-3"
      unitRef="USD">46800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_custom_CentralAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">69900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_CentralAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">56400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_CentralAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">32500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_custom_OtherSegmentCountryMember"
      decimals="-3"
      unitRef="USD">11000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_OtherSegmentCountryMember"
      decimals="-3"
      unitRef="USD">8400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OtherSegmentCountryMember"
      decimals="-3"
      unitRef="USD">6300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">1086700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">879500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">539000000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span id="xdx_8B7_z7FpI55o74vh"&gt;Consolidated net sales to customers in major countries
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;420,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;351,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax"&gt;187,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;France&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right"&gt;44,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right"&gt;44,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right"&gt;37,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Russia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right"&gt;33,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right"&gt;43,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right"&gt;14,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right"&gt;37,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right"&gt;38,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right"&gt;24,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_UnitedStatesMember"
      decimals="-3"
      unitRef="USD">420900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_UnitedStatesMember"
      decimals="-3"
      unitRef="USD">351300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_UnitedStatesMember"
      decimals="-3"
      unitRef="USD">187300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_FranceMember"
      decimals="-3"
      unitRef="USD">44800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_FranceMember"
      decimals="-3"
      unitRef="USD">44000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_FranceMember"
      decimals="-3"
      unitRef="USD">37600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_RussiaMember"
      decimals="-3"
      unitRef="USD">33964000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_RussiaMember"
      decimals="-3"
      unitRef="USD">43400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_RussiaMember"
      decimals="-3"
      unitRef="USD">14100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_UnitedKingdomMember"
      decimals="-3"
      unitRef="USD">37900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_UnitedKingdomMember"
      decimals="-3"
      unitRef="USD">38500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_UnitedKingdomMember"
      decimals="-3"
      unitRef="USD">24600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zEzULplDcgK7" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(16)&lt;/td&gt;&lt;td id="xdx_821_zrAktrtcrZrl"&gt;Income Taxes&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company and its subsidiaries
file income tax returns in the U.S. federal, and various states and foreign jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company assessed its uncertain
tax positions and determined that it has no material uncertain tax position at December 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_z7VnI34zzwX8"&gt;The components of income before
income taxes consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;U.S. operations&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" style="width: 10%; text-align: right" title="U.S. operations"&gt;50,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" style="width: 10%; text-align: right" title="U.S. operations"&gt;34,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" style="width: 10%; text-align: right" title="U.S. operations"&gt;9,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Foreign operations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;143,969&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;116,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;59,772&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::194219"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1797"&gt;194,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::151019"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1799"&gt;151,019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::69349"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1801"&gt;69,349&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zMdKdsLj6jH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_zcy74h7kGdd5"&gt;The provision for current and
deferred income tax expense (benefit) consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 61%; padding-left: 0.125in"&gt;Federal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" style="width: 10%; text-align: right" title="Federal"&gt;6,829&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" style="width: 10%; text-align: right" title="Federal"&gt;4,825&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" style="width: 10%; text-align: right" title="Federal"&gt;1,685&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;State and local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" style="text-align: right" title="State and local"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" style="text-align: right" title="State and local"&gt;518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" style="text-align: right" title="State and local"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;39,458&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;36,164&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;17,024&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;46,945&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;41,507&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;18,799&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" style="text-align: right" title="Federal"&gt;(802&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" style="text-align: right" title="Federal"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" style="text-align: right" title="Federal"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;State and local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" style="text-align: right" title="State and local"&gt;(49&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" style="text-align: right" title="State and local"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" style="text-align: right" title="State and local"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;(2,912&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;(530&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;753&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;(3,763&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;(515&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;582&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in"&gt;Total income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense"&gt;43,182&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense"&gt;40,992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense"&gt;19,381&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_8AA_zu1mvlECuEsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;






&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BE_zp6bQ94sbp35"&gt;The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Net deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign net operating loss carry-forwards&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;554&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,292&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Inventory and accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Profit sharing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,871&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,787&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Stock option compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;732&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Effect of inventory profit elimination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;266&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;407&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in"&gt;Total gross deferred tax assets, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,629&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(554&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,582&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17,075&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,256&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax liabilities (long-term):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Building expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,356&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,082&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Trademarks and licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,160&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,551&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Unrealized gain on marketable equity securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,745&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(436&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(655&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(251&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,916&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,320&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,159&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_8A9_zi5Iazzkwjqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Valuation allowances have been
provided for deferred tax assets relating to foreign net operating loss carry-forwards as future profitable operations from certain
foreign subsidiaries might not be sufficient to realize the full amount of the deferred tax assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;No other valuation allowances
have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future
taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company estimated of the
effect of global intangible low-taxed income (&#x201c;GILTI&#x201d;) and has determined that it has no tax liability related to GILTI
as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of foreign derived intangible income (&#x201c;FDII&#x201d;)
and recorded a tax benefit of approximately $&lt;span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_z2RduZVyNBx2"&gt;1.5 million&lt;/span&gt;, $&lt;span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zEdLfbzCw8lk"&gt;0.9 million&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zsIXtt16Baih"&gt;0.3 million&lt;/span&gt; as of December 31, 2022, 2021 and 2020,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company is no longer subject
to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;






















&lt;p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BE_z8w289QLD5Z9"&gt;Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Statutory rates&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State and local taxes, net of Federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Windfall benefit from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Benefit of Foreign Derived Intangible Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Effect of foreign taxes greater than U.S. statutory rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.625in"&gt;Effective rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;22.2&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27.1&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27.9&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;%&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p id="xdx_8A7_z0csr17AQpCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_z7VnI34zzwX8"&gt;The components of income before
income taxes consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;U.S. operations&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" style="width: 10%; text-align: right" title="U.S. operations"&gt;50,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" style="width: 10%; text-align: right" title="U.S. operations"&gt;34,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" style="width: 10%; text-align: right" title="U.S. operations"&gt;9,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Foreign operations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;143,969&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;116,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations"&gt;59,772&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::194219"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1797"&gt;194,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::151019"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1799"&gt;151,019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::69349"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1801"&gt;69,349&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">50250000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">34742000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">9577000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">143969000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">116277000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">59772000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BF_zcy74h7kGdd5"&gt;The provision for current and
deferred income tax expense (benefit) consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 61%; padding-left: 0.125in"&gt;Federal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" style="width: 10%; text-align: right" title="Federal"&gt;6,829&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" style="width: 10%; text-align: right" title="Federal"&gt;4,825&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" style="width: 10%; text-align: right" title="Federal"&gt;1,685&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;State and local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" style="text-align: right" title="State and local"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" style="text-align: right" title="State and local"&gt;518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" style="text-align: right" title="State and local"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;39,458&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;36,164&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;17,024&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;46,945&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;41,507&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense"&gt;18,799&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" style="text-align: right" title="Federal"&gt;(802&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" style="text-align: right" title="Federal"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" style="text-align: right" title="Federal"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;State and local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" style="text-align: right" title="State and local"&gt;(49&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" style="text-align: right" title="State and local"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" style="text-align: right" title="State and local"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;(2,912&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;(530&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign"&gt;753&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;(3,763&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;(515&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense"&gt;582&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in"&gt;Total income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense"&gt;43,182&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense"&gt;40,992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense"&gt;19,381&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">6829000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">4825000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1685000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">658000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">518000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">90000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">39458000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">36164000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">17024000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">46945000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">41507000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">18799000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-802000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">4000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-215000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-49000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">11000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">44000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-2912000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-530000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">753000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-3763000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-515000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">582000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">43182000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">40992000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">19381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BE_zp6bQ94sbp35"&gt;The tax effects of temporary
differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Net deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign net operating loss carry-forwards&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;554&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,292&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Inventory and accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Profit sharing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,871&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,787&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Stock option compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;732&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Effect of inventory profit elimination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;266&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;407&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in"&gt;Total gross deferred tax assets, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,629&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(554&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,582&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17,075&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,256&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax liabilities (long-term):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Building expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,356&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,082&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Trademarks and licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,160&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,551&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Unrealized gain on marketable equity securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,745&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(436&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(655&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(251&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,916&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,320&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,159&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,936&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">554000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">1292000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <ipar:DeferredTaxAssetsInventoryAndAccountsReceivable contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">3880000</ipar:DeferredTaxAssetsInventoryAndAccountsReceivable>
    <ipar:DeferredTaxAssetsInventoryAndAccountsReceivable contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4508000</ipar:DeferredTaxAssetsInventoryAndAccountsReceivable>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">2871000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">3787000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">716000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">732000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">9342000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">5112000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">266000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">407000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">17629000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">15838000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">554000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">3582000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">17075000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">12256000</us-gaap:DeferredTaxAssetsNet>
    <ipar:DeferredTaxLiabilitiesBuildingExpenses contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-1356000</ipar:DeferredTaxLiabilitiesBuildingExpenses>
    <ipar:DeferredTaxLiabilitiesBuildingExpenses contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-1082000</ipar:DeferredTaxLiabilitiesBuildingExpenses>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">2160000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2551000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-1745000</ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities>
    <ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-436000</ipar:DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-655000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-251000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">5916000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4320000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">11159000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7936000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_custom_ForeignDerivedIntangibleIncomeMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31_custom_ForeignDerivedIntangibleIncomeMember"
      decimals="0"
      unitRef="USD">900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_custom_ForeignDerivedIntangibleIncomeMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BE_z8w289QLD5Z9"&gt;Differences between the United
States federal statutory income tax rate and the effective income tax rate were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Statutory rates&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State and local taxes, net of Federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Windfall benefit from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Benefit of Foreign Derived Intangible Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Effect of foreign taxes greater than U.S. statutory rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.625in"&gt;Effective rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;22.2&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27.1&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27.9&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;%&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.031</ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1>
    <ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.074</ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1>
    <ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.075</ipar:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.222</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.271</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.279</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zggFcT5jBCP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(17)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_z08Cgu9j1Gii"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_8B6_zdI2PfJTcWk4"&gt;The components of accumulated other
comprehensive loss consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Net derivative instruments, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"&gt;(992&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1968"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"&gt;52&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net derivative instrument loss, net of tax&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;2,701&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(52&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net derivative instruments, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"&gt;1,709&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"&gt;(992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1982"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cumulative translation adjustments, beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" style="text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(37,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" style="text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(5,997&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" style="text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(39,905&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments"&gt;(20,325&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments"&gt;(31,443&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments"&gt;33,908&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cumulative translation adjustments, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(57,765&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(37,440&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(5,997&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated other comprehensive loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss"&gt;(56,056&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss"&gt;(38,432&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;(5,997&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/&gt;

&lt;p id="xdx_8A5_z6Qdw7p9XLe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span id="xdx_8B6_zdI2PfJTcWk4"&gt;The components of accumulated other
comprehensive loss consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left"&gt;Net derivative instruments, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"&gt;(992&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1968"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"&gt;52&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net derivative instrument loss, net of tax&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;2,701&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax"&gt;(52&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net derivative instruments, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"&gt;1,709&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"&gt;(992&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1982"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cumulative translation adjustments, beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" style="text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(37,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" style="text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(5,997&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" style="text-align: right" title="Cumulative translation adjustments, beginning of year"&gt;(39,905&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Translation adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments"&gt;(20,325&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments"&gt;(31,443&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments"&gt;33,908&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cumulative translation adjustments, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(57,765&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(37,440&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year"&gt;(5,997&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated other comprehensive loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss"&gt;(56,056&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss"&gt;(38,432&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;(5,997&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/&gt;

</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1
      contextRef="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-992000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1
      contextRef="AsOf2019-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">52000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2022-01-012022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">2701000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2021-01-012021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-992000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2020-01-012020-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-52000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1
      contextRef="AsOf2022-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">1709000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1
      contextRef="AsOf2021-12-31_custom_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember"
      decimals="-3"
      unitRef="USD">-992000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax1>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-37440000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-5997000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-39905000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-20325000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-31443000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">33908000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-57765000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-37440000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2>
    <ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-3"
      unitRef="USD">-5997000</ipar:AccumulatedOtherComprehensiveIncomeLossNetOfTax2>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-56056000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-38432000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-5997000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_z0NbJg2VBBYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(18)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_zOpk2joaSrZ8"&gt;Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden"&gt;Schedule of net income attributable to transfers from the noncontrolling interest&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;120,938&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Decrease in Inter Parfums, Inc.&#x2019;s additional paid-in capital for subsidiary share transactions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2019"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2020"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2021"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;120,938&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;p id="xdx_8A6_zlQaVNVUJMd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red"&gt;&#160;&lt;/p&gt;

</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden"&gt;Schedule of net income attributable to transfers from the noncontrolling interest&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Net income attributable to Inter Parfums, Inc.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;120,938&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Decrease in Inter Parfums, Inc.&#x2019;s additional paid-in capital for subsidiary share transactions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2019"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2020"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2021"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;120,938&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;87,411&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,219&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;

</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">120938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:NetIncomeLoss>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">120938000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">87411000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">38219000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet>
    <ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_zwaHVFtCoXM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 0.5in"&gt;(19)&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82D_zPzQ3HIOQUij"&gt;Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BB_zWO24NCWEtHj"&gt;The following table summarizes
cash and cash equivalents as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Courier New, Courier, Monospace; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31,&lt;br/&gt;
 2021&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 77%; text-align: left"&gt;Cash and cash equivalents per balance sheet&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" style="width: 12%; text-align: right" title="Cash and cash equivalents per balance sheet"&gt;159,613&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash held in escrow included in other assets (see note 3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" style="border-bottom: Black 1pt solid; text-align: right" title="Cash held in escrow included in other assets (see note 3)::XDX::168387"&gt;8,774&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Cash and cash equivalents per balance sheet::XDX::168387"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents per statement of cash flows&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash and cash equivalents per statement of cash flows::XDX::168387"&gt;168,387&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_z5GK5tdRTIOa" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BB_zWO24NCWEtHj"&gt;The following table summarizes
cash and cash equivalents as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Courier New, Courier, Monospace; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31,&lt;br/&gt;
 2021&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 77%; text-align: left"&gt;Cash and cash equivalents per balance sheet&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" style="width: 12%; text-align: right" title="Cash and cash equivalents per balance sheet"&gt;159,613&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash held in escrow included in other assets (see note 3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" style="border-bottom: Black 1pt solid; text-align: right" title="Cash held in escrow included in other assets (see note 3)::XDX::168387"&gt;8,774&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Cash and cash equivalents per balance sheet::XDX::168387"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents per statement of cash flows&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash and cash equivalents per statement of cash flows::XDX::168387"&gt;168,387&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">159613000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ipar:CashHeldInEscrowIncludedInOtherAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">8774000</ipar:CashHeldInEscrowIncludedInOtherAssets>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">168387000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80D_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zfjmJJOx1YB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_829_zQO6hwDTuQBc" style="display: none; visibility: hidden"&gt;&#160;Schedule II - Valuation and Qualifying Accounts&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"&gt;&lt;b&gt;Schedule II&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden"&gt;Schedule of Valuation and Qualifying Accounts&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Valuation and Qualifying Accounts&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center"&gt;Column A&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column B&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column C&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column D&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column E&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Additions&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(1)&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(2)&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Balance
    at&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;beginning of&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Charged
    to&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;costs and&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Charged
    to&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;accounts &#x2013;&lt;/b&gt;&lt;/span&gt;&lt;br/&gt;
    &lt;span style="font-size: 10pt"&gt;&lt;b&gt;describe&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Deductions&lt;/b&gt;&lt;/span&gt;&lt;br/&gt;
    &lt;span style="font-size: 10pt"&gt;&lt;b&gt;describe&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Balance
    at&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;end of period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for doubtful accounts:&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 3%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" style="text-align: right" title="Balance at beginning of period"&gt;2,247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right"&gt;2,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" style="text-align: right" title="Charged to other accounts describe"&gt;1,134&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right"&gt;1,044&lt;/td&gt;&lt;td style="text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" style="text-align: right" title="Balance at end of period"&gt;4,690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" style="text-align: right" title="Balance at beginning of period"&gt;5,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right"&gt;877&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right"&gt;(843&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;)(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right"&gt;3,336&lt;/td&gt;&lt;td style="text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" style="text-align: right" title="Balance at end of period"&gt;2,247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" style="text-align: right" title="Balance at beginning of period"&gt;2,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" style="text-align: right" title="Charged to costs and expenses"&gt;4,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right"&gt;381&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" style="text-align: right" title="Deductions describe"&gt;2,107&lt;/td&gt;&lt;td style="text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" style="text-align: right" title="Balance at end of period"&gt;5,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for sales returns, net of inventory:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" style="text-align: right" title="Balance at beginning of period"&gt;3,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right"&gt;4,997	&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2068"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right"&gt;2,829&lt;/td&gt;&lt;td style="text-align: left"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" style="text-align: right" title="Balance at end of period"&gt;5,410&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" style="text-align: right" title="Balance at beginning of period"&gt;2,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right"&gt;3,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2075"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right"&gt;2,042&lt;/td&gt;&lt;td style="text-align: left"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" style="text-align: right" title="Balance at end of period"&gt;3,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" style="text-align: right" title="Balance at beginning of period"&gt;2,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right"&gt;1,978&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2082"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right"&gt;2,323&lt;/td&gt;&lt;td style="text-align: left"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" style="text-align: right" title="Balance at end of period"&gt;2,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Inventory reserve:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" style="text-align: right" title="Balance at beginning of period"&gt;15,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right"&gt;8,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right"&gt;(378&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;)(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right"&gt;12,710&lt;/td&gt;&lt;td style="text-align: left"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" style="text-align: right" title="Balance at end of period"&gt;11,431&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" style="text-align: right" title="Balance at beginning of period"&gt;9,371&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right"&gt;8,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right"&gt;7,041&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)(e)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right"&gt;8,852&lt;/td&gt;&lt;td style="text-align: left"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" style="text-align: right" title="Balance at end of period"&gt;15,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" style="text-align: right" title="Balance at beginning of period"&gt;4,909&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right"&gt;7,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right"&gt;616&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right"&gt;3,366&lt;/td&gt;&lt;td style="text-align: left"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" style="text-align: right" title="Balance at end of period"&gt;9,371&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left"&gt;(a)&lt;/td&gt;&lt;td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify"&gt;Write-off of bad debts.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left"&gt;(b)&lt;/td&gt;&lt;td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify"&gt;Write-off of sales returns.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left"&gt;(c)&lt;/td&gt;&lt;td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify"&gt;Disposal of inventory&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left"&gt;(d)&lt;/td&gt;&lt;td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify"&gt;Foreign currency translation adjustment&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left"&gt;(e)&lt;/td&gt;&lt;td id="xdx_F19_z623xCp9iOT7" style="text-align: justify"&gt;Inventory reserves acquired of $7,639&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A7_zbYGZKrqekt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;See accompanying reports of independent registered public accounting
firm.&lt;/p&gt;

</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden"&gt;Schedule of Valuation and Qualifying Accounts&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;Valuation and Qualifying Accounts&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;(In thousands)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center"&gt;Column A&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column B&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column C&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column D&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Column E&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Additions&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(1)&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(2)&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Balance
    at&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;beginning of&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Charged
    to&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;costs and&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Charged
    to&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;accounts &#x2013;&lt;/b&gt;&lt;/span&gt;&lt;br/&gt;
    &lt;span style="font-size: 10pt"&gt;&lt;b&gt;describe&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Deductions&lt;/b&gt;&lt;/span&gt;&lt;br/&gt;
    &lt;span style="font-size: 10pt"&gt;&lt;b&gt;describe&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Balance
    at&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;end of period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for doubtful accounts:&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 3%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" style="text-align: right" title="Balance at beginning of period"&gt;2,247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right"&gt;2,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" style="text-align: right" title="Charged to other accounts describe"&gt;1,134&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right"&gt;1,044&lt;/td&gt;&lt;td style="text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" style="text-align: right" title="Balance at end of period"&gt;4,690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" style="text-align: right" title="Balance at beginning of period"&gt;5,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right"&gt;877&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right"&gt;(843&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;)(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right"&gt;3,336&lt;/td&gt;&lt;td style="text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" style="text-align: right" title="Balance at end of period"&gt;2,247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" style="text-align: right" title="Balance at beginning of period"&gt;2,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" style="text-align: right" title="Charged to costs and expenses"&gt;4,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right"&gt;381&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" style="text-align: right" title="Deductions describe"&gt;2,107&lt;/td&gt;&lt;td style="text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" style="text-align: right" title="Balance at end of period"&gt;5,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for sales returns, net of inventory:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" style="text-align: right" title="Balance at beginning of period"&gt;3,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right"&gt;4,997	&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2068"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right"&gt;2,829&lt;/td&gt;&lt;td style="text-align: left"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" style="text-align: right" title="Balance at end of period"&gt;5,410&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" style="text-align: right" title="Balance at beginning of period"&gt;2,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right"&gt;3,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2075"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right"&gt;2,042&lt;/td&gt;&lt;td style="text-align: left"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" style="text-align: right" title="Balance at end of period"&gt;3,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" style="text-align: right" title="Balance at beginning of period"&gt;2,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right"&gt;1,978&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2082"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right"&gt;2,323&lt;/td&gt;&lt;td style="text-align: left"&gt;(b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" style="text-align: right" title="Balance at end of period"&gt;2,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Inventory reserve:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" style="text-align: right" title="Balance at beginning of period"&gt;15,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right"&gt;8,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right"&gt;(378&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;)(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right"&gt;12,710&lt;/td&gt;&lt;td style="text-align: left"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" style="text-align: right" title="Balance at end of period"&gt;11,431&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" style="text-align: right" title="Balance at beginning of period"&gt;9,371&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right"&gt;8,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right"&gt;7,041&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)(e)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right"&gt;8,852&lt;/td&gt;&lt;td style="text-align: left"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" style="text-align: right" title="Balance at end of period"&gt;15,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Year ended December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" style="text-align: right" title="Balance at beginning of period"&gt;4,909&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right"&gt;7,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right"&gt;616&lt;/td&gt;&lt;td colspan="2" style="text-align: left"&gt;(d)&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right"&gt;3,366&lt;/td&gt;&lt;td style="text-align: left"&gt;(c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" style="text-align: right" title="Balance at end of period"&gt;9,371&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left"&gt;(a)&lt;/td&gt;&lt;td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify"&gt;Write-off of bad debts.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left"&gt;(b)&lt;/td&gt;&lt;td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify"&gt;Write-off of sales returns.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left"&gt;(c)&lt;/td&gt;&lt;td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify"&gt;Disposal of inventory&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left"&gt;(d)&lt;/td&gt;&lt;td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify"&gt;Foreign currency translation adjustment&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left"&gt;(e)&lt;/td&gt;&lt;td id="xdx_F19_z623xCp9iOT7" style="text-align: justify"&gt;Inventory reserves acquired of $7,639&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">2247000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">2353000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact002045"
      unitRef="USD">1134000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2022-01-012022-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact002046"
      unitRef="USD">1044000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2022-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">4690000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2020-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">5550000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">877000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact002052"
      unitRef="USD">-843000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2021-01-012021-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact002053"
      unitRef="USD">3336000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">2247000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2019-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">2452000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">4824000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact002060"
      unitRef="USD">381000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2020-01-012020-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact002062"
      unitRef="USD">2107000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2020-12-31_us-gaap_AllowanceForCreditLossMember"
      decimals="-3"
      unitRef="USD">5550000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2021-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">3242000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">4997000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2022-01-012022-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      id="Fact002069"
      unitRef="USD">2829000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2022-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">5410000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2020-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">2242000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">3042000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2021-01-012021-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      id="Fact002076"
      unitRef="USD">2042000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2021-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">3242000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2019-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">2587000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">1978000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2020-01-012020-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      id="Fact002083"
      unitRef="USD">2323000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2020-12-31_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-3"
      unitRef="USD">2242000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2021-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">15777000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">8742000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      id="Fact002089"
      unitRef="USD">-378000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2022-01-012022-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      id="Fact002090"
      unitRef="USD">12710000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2022-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">11431000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2020-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">9371000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">8217000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      id="Fact002096"
      unitRef="USD">7041000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2021-01-012021-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      id="Fact002097"
      unitRef="USD">8852000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2021-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">15777000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2019-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">4909000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">7212000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      id="Fact002103"
      unitRef="USD">616000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="From2020-01-012020-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      id="Fact002104"
      unitRef="USD">3366000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="AsOf2020-12-31_us-gaap_InventoryValuationReserveMember"
      decimals="-3"
      unitRef="USD">9371000</us-gaap:ValuationAllowancesAndReservesBalance>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact002046"
          xlink:label="Fact002046"
          xlink:type="locator"/>
        <link:footnote id="Footnote002107" xlink:label="Footnote002107" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Write-off of bad debts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002046"
          xlink:to="Footnote002107"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002053"
          xlink:label="Fact002053"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002053"
          xlink:to="Footnote002107"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002062"
          xlink:label="Fact002062"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002062"
          xlink:to="Footnote002107"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002069"
          xlink:label="Fact002069"
          xlink:type="locator"/>
        <link:footnote id="Footnote002108" xlink:label="Footnote002108" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Write-off of sales returns.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002069"
          xlink:to="Footnote002108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002076"
          xlink:label="Fact002076"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002076"
          xlink:to="Footnote002108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002083"
          xlink:label="Fact002083"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002083"
          xlink:to="Footnote002108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002090"
          xlink:label="Fact002090"
          xlink:type="locator"/>
        <link:footnote id="Footnote002109" xlink:label="Footnote002109" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Disposal of inventory</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002090"
          xlink:to="Footnote002109"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002097"
          xlink:label="Fact002097"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002097"
          xlink:to="Footnote002109"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002104"
          xlink:label="Fact002104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002104"
          xlink:to="Footnote002109"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002045"
          xlink:label="Fact002045"
          xlink:type="locator"/>
        <link:footnote id="Footnote002110" xlink:label="Footnote002110" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002045"
          xlink:to="Footnote002110"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002052"
          xlink:label="Fact002052"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002052"
          xlink:to="Footnote002110"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002060"
          xlink:label="Fact002060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002060"
          xlink:to="Footnote002110"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002089"
          xlink:label="Fact002089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002089"
          xlink:to="Footnote002110"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002096"
          xlink:label="Fact002096"
          xlink:type="locator"/>
        <link:footnote id="Footnote002111" xlink:label="Footnote002111" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Inventory reserves acquired of $7,639</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002096"
          xlink:to="Footnote002110"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002096"
          xlink:to="Footnote002111"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002103"
          xlink:label="Fact002103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002103"
          xlink:to="Footnote002110"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>100
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[E&LZF)60X MM3*U(@3@@T) MF"VV22B5W3)%J.1&JQ81<UJ!K"E5MYS4&0
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M)&8';%D0V\=#[LR4*+N6&H.8(1#S:#C,OA6->)3C /,#P#P(\'>'"0KP<:'
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MG1N;C6Y8859QHB4^99BGXY$HE. LI1I2<DLY+1(@$R.GR/LQE5#H##1+*/]
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MYHLKSIX UVCE35^T@]E:*_IEH^?]07+UME1V<G'+&L&JLL@E+<"#5']J4J4
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M2<GJ]G)+<U71-$"]7S,F7VYT \.QU^)_4$L#!!0    ( #N#7%9@[!@P@@0
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MJ1468/Y?":'?!M9 <XLT_0=02P,$%     @ .X-<5L58NO6]"0  1%<  !@
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6RUG%USV[@5AO\*1]UINS.KB #X
MF=J>2<2O7.S6$V=W+SJ]H"588D.16A*RDW]?4&)$X4.P*1_?V))]\!P0? F
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MGOI8>V(M=BVK-WUCWH--41U^Y]_Z@3AI@/&9!KAO@*4&Q#O3@/0-B)S!/]/
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ME*D%2?9F,I@)VDH=0'G8A TI()P38KA,AM+DJ&0 G[L4RDK.(*ZF(QI.$"F
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M%UIAZBYB:!NI:RQ0=KA0EOP'*@GI+C&V\'4*D=TC6)Y+ORZ1/O$&>(L;8$:
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MO4@/XNE=_T:ZE3(@-RUQE(WV$O6;CV"K^#Y=V "&QI]KI)$<"V!_:6UH/MA
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MS /Q@8-<>OOFG7YG1BU +]TD;IBC48^K[6D[[%_4,^Y6O/ZE<,OU$NWA0[Y
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M3JO42E&K;0_3'ARX"58-IK9IVGW]KB&AJ91FFK2'D&O[GN-S??%ALI'J01<
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M_L*N\\VR$,K&.ET?@DE!+53WY(^'>W@2,$I>"&"' -;J[E[4JKSFCL\F1N_
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MF;1<]'YC[2-RYZVQ#5Q(U4CG9DE3Z+GEBM3U<5:IY'*JF VOMCHG3:,DQ4Q
MY1N<Y-D!WO-H9_1M<Z&'^8)#?/4^XNLX6[>[:J6S\ET+]W0[U?C<VONGW/:[
MUI4I<**(O\\-DBA(=ZV3[_61]?I&960SHZ$^)S\D*MDNE@27),&A=RW<FS<5
MJH6;JM1LLJU--WJVN]O!/>GFU4Z]F_JWKB8UE#@G4_M*>*"Z2=HMC&S<])I*
M0[/0B?;:45D%.I]+:38+ZV#[=V;\'U!+ P04    "  [@UQ68%M*V.H%   =
M#0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6R-5UMOVS84?M>O(+QN
M2 %!MBZ^94F I%VQ BU6I+L\#'N@)=HB2I$:2<7)?OV^0]FRTJ7)7A**Y#G\
MSOG.S1=[8[^X6@C/[ANEW>6D]KX]GTY=68N&N\2T0N-D:VS#/3[M;NI:*W@5
MA!HUS6:SQ;3A4D^N+L+>)WMU83JOI!:?+'-=TW#[<".4V5].TLEQXU;N:D\;
MTZN+EN_$9^%_:S]9?$T'+95LA';2:&;%]G)RG9[?%'0_7/A=BKT;K1E9LC'F
M"WV\KRXG,P(DE"@]:>#X=R?>"*5($6#\?= Y&9XDP?'ZJ/U=L!VV;+@3;XSZ
M0U:^OIRL)JP26]XI?VOV/XN#/7/25QKEPE^V[^_.LPDK.^=-<Q &@D;J_C^_
M/_AA)+":?4,@.PAD 7?_4$#YEGM^=6'-GEFZ#6VT"*8&:8"3FDCY["U.)>3\
MU1O3--+#R]Y=3#T4TO:T/ C?],+9-X33C'TTVM>._:0K43U6, 62 4YVA'.3
M/:OQK2@3EJ<QRV99]HR^?# O#_KRE\UC7%?L#>!*O1.ZE,*QM]*5RKC."O;G
M]<9YBQCYZRDW](\43S]">7/N6EZ*RPD2PPE[)R97/WR7+F8_/F-",9A0/*?]
M)8:>%7X:VEF:O69CSWP0B&O'?JT%;;=</S#5;TF<FNU6EL+%T9Y;49N.]LF7
M=Z*6I<(!,AK.X_ L5^J!X0]DV!ZG-8,(*Q5W3FZEJ!B'NE983B0<WD@>O5MV
MU@(3U-2XJPUBW0L+Q6PK-0=M>A<])5<)7$-^$.8MX.%ART$T&<@D />O,8XO
M78J62D+"?GF,!?"<.$2*V2BYXW3-!2.L*,U.RW]$%4&'Q].]2 D_(ISZARJ
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ML'0!YUL#I@X?],#PB^CJ7U!+ P04    "  [@UQ6P>Q&_D$)   _%@  &0
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M'QH8S;9B&/:!ELX6$4G42"I._OV.E*S(:^*@&/9%XLO=<\_=D<=;'+BXEP6
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MDHS-2J0P]?"8#.@U>+/79U$_O#@AJ]?*ZIUB_^]RG&0]K+D;#=ZP?XG'ON;
M4EQ6$J0U3"WP+OV%*8)UTF>PDF"IPHFQY(\N;*%*[ "%7(X[/T%H!O1G,*PK
M5'.,B[7M4&VIP!$-8><S]J0,=+$6='-9(8W5=44:?#:'92$ELA']$_&]8MW1
MB+,W:+P^&_*(7Z"5\.,L3J7/)#02Q2/C_B",=C3=!,>3&C"#-GJ$T-$.NHW?
MN6X.B8!6"VG(IDZ4_<*+?321;CSP>[W02?!'HP$9\<@?A0GJ^7J8AW5YZ,<\
M<;X1PF.TXAA!PW]2L9]*-QGX@WY#]5))Y_)EY=F!RF,IDKX?)GU7C6X\]'MQ
M4YDVHT-W)=AK8Q7HI6O6]!_5TC8=K5UMWX/+I@W^=6\>DT]"X[$:5L("H>'Y
M(/&8;AIT,[%JY9KB7%ELL<[,\4T#30ZXOU#*[B84H'TE9W\ 4$L#!!0    (
M #N#7%:A(3?UT (  &8'   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM
M;+U574_;,!1][Z^X"A/:I(Y\M- ";:46-HT'4 7[T#3MP4EN&HO8SFR'LG^_
MZR3-@+757K:7Q';N/?><:^=XLE;ZWN2(%AY%(<W4RZTMSWS?)#D*9HY4B9*^
M9$H+9FFJ5[XI-;*T3A*%'P7!B2\8E]YL4J\M]6RB*EMPB4L-IA*"Z9\++-1Z
MZH7>9N&6KW+K%OS9I&0KO$/[J5QJFOD=2LH%2L.5!(W9U)N'9XNABZ\#/G-<
MFR=C<$IBI>[=Y"J=>H$CA 4FUB$P>CW@!1:% R(:/UI,KROI$I^.-^CO:^VD
M)68&+U3QA:<VGWIC#U+,6%786[7^@*V>8X>7J,+43UBWL8$'266L$FTR,1!<
M-F_VV/;A;Q*B-B&J>3>%:I:7S++91*LU:!=-:&Y02ZVSB1R7;E/NK*:OG/+L
M[(;V_4HF2B#,K=4\KBR+"P2K:-FBAB73625,WT4= 9,I?-1,F@RU@4PK 39'
MN%$$(:U6!>&OFDPT=N);HN@*^4E+9]'0B7;0"2.X)J#<P#N98OH<P"=MG<!H
M(W 1[46\1*(]"/L0!5&T!V_0-6Q0XPUV-6R[5/@VCXW5=,B^;U/=8 ZW8[H?
M[\R4+,&I1W^60?V WNSP(#P)SO<P'G:,A_O0__\6[Z6S7>SK</P&_BE1N",_
M2RN"4QE(JL2;2NQ%)?LGHGR.R%O$WE=D&M"=4Z!3AB(FBG32>NZDN>,6ND?0
MN]E=;)NL5Q!&0?]T,*;1>-0?AB$-!N-^%)[VJ PYKT'"VY9[>#".PM&Y 9:F
MW)D>*Z!D/'U+X0DKN:4Y^3@Y<&QXRLF$P>1,8R.:U3YIH$:)SE^^>Q<YDRML
MVK*G@;NVZD5C=S1UGWS8]C/X3[Q/H%[5#F\@496TC0UVJ]TE,F^\\W=X<P-=
M,[WBU( ",TH-CD;''NC&U9N)567MI+&RY,OU,*>+$+4+H.^94G8S<06ZJW7V
M"U!+ P04    "  [@UQ6-%G=S9\"  "C!@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6RU54UOVS ,O?=7$-XPK$!0?R1-TBP)T*0MMD/1HNVVLV+3
ML5!9<B6EZ?;K1\F.YP%INL-VL2F*?.2CY.?I5NE'4R!:>"F%-+.@L+::A*%)
M"RR9.5$52MK)E2Z9I:5>AZ;2R#*?5(HPB:)A6#(N@_G4^V[U?*HV5G")MQK,
MIBR9_K% H;:S( YVCCN^+JQSA/-IQ=9XC_9K=:MI%;8H&2]1&JXD:,QGP7D\
M60Q<O _XQG%K.C8X)BNE'MWB2S8+(M<0"DRM0V#T>L8E"N& J(VG!C-H2[K$
MKKU#O_+<B<N*&5PJ\9UGMI@%XP RS-E&V#NU_8P-GU.'ERIA_!.V=>SH-(!T
M8ZPJFV3JH.2R?K.79@Z=A''T2D+2)"2^[[J0[_*"63:?:K4%[:()S1F>JL^F
MYKATAW)O->URRK/S.TR53+G@S ])Y;!DI@ FL]JX?-KP9R906@-6@2T0[BVS
M2.=BV^@K.EHS#2WUXU##M*F]J&LGK]2.$[A6TA8&+F6&V9\ (1%IV20[-HOD
M(.(%IB?0CWN01$ER *_?3J?O\?I_-YV;AN_YOND\J,YD;MZ:3%UWL+^N^Q(G
MIF(IS@+ZU SJ9PSF'][%P^C3 5:#EM7@$/I_/O.#M?<S^QB?'<._ZPH>:"]7
M@FPNUV#92F"C.OPGFJ-TA^L-[. RXY#H%F&Y0KV[2?'DJ.LZ6KZ:7Z'3",%D
M2@6]IKZ'^/2L-XS[=5:!(@,N 4WJ#HW+5&SHZCN7(D::.C!(0!\-(DAE$?K'
M,.Z-1H,WJIKN*'Q$[D=!]8?C7G\\@GT7)^P(1XEZ[>710*HVTM8:TGI;!3ZO
MA>=W>"W?UTRON30@,*?4Z,0)GJXEL5Y857D96BE+HN;-@OXBJ%T [>>*Z#8+
M5Z#]+\U_ 5!+ P04    "  [@UQ6$9RVH#L$  ! "@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6RM5MMNVT80?>=7#)@@D #:(I>42#F2 ,EV43\$
M<&,T05'T84F.)#;D+K.[M.R_[^SJ$KFUI1;HBS1[F7/FPIF=R4:J;WJ-:."I
MJ86>^FMCVJO!0!=K;+B^E"T*.EE*U7!#2[4:Z%8A+YU24P]8&(X&#:^$/YNX
MO7LUF\C.U)7 >P6Z:QJNGA=8R\W4C_S]QN=JM39V8S";M'R%#VA^;>\5K08'
ME+)J4.A*"E"XG/KSZ&J1V/ONPI<*-_I(!NM)+N4WN[@KIWYH#<(:"V,1./T]
MXC76M04B,[[O,/T#I54\EO?H/SG?R9><:[R6]=>J-.NIG_E0XI)WM?DL-S_C
MSI^AQ2MDK=TO;+9W1R,?BDX;V>R4R8*F$MM__K2+PY%"%KZAP'8*S-F])7)6
MWG##9Q,E-Z#L;4*S@G/5:9-QE;!)>3"*3BO2,[,'RG+9U0AW=W !7WC=\6VT
M1 F_=+RNEL^56,&\*&0GC)X,#)%:U4&Q(UAL"=@;!!&#3U*8M89;46+Y$F!
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MQ#6->*CL!3I?2FGV"TMP&!IG?P%02P,$%     @ .X-<5I,'6PPS%P  U44
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M$*4S+^#\D;1\%W**-/V>'3-LT.8^K!4L#_XOFQ5)9I&M+6<&YQ1[Q<-1R>'
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M;;-Y\ OQL5 7##".:L =YR!P7I@US+QY4/'OQ"V2!,DI\BM9BCB2Q &)76&
M-EP(3;QI\D(;?&6P>0;VA&/*\HMKLJ0@:TDP@K6T8[F!_C4]$Y)DL]9M;\G;
M_]5KB.5,A5H'@=G@6_9;).:O64];TD>+E_+2DF8BH$8<)C9P.&'=4 "&Q%L.
MJUZ0<X)ZT='Z>(^M\9Z3P%B-=O*)+.$#I$(>@ M [DBJR(N</M76WH#H"*9T
M\V5>(*&+-"PB0MAAI/KHX5S]@3UUT#? CKNRU&,#.1/I6B#Y1VI<7#H!2A==
M8#9H]6TT*%2&%/&M/<971!J&\4[T#+Z5SF.@1"SIL"+Z&(J,RY-(4,/!@0X)
M]@9/3,KZI_'%&#:.J,5R- .#[!.D02USO2L[S176%_/GZMG\\3,4CP\X1O#D
M3ZEL9K<,<9#FXH"O\40@<@96.(B=3=WL6/8F9$4J&9D(2Z#")U]NR8DZ)B>7
MZY0\OQ0R:^8S-!GD?V'J&?N9OIE@O[N5B?,1!:M/L+Z$K(!_2^'\(#R2YX30
M#?'A6)*RL21=ALIX.'/,]P4"V4(C,YXT#AP7UUO[)[YF"0\E @[A"8#1-U/$
M",&G3[],3N;)@=VX18[8HE6"UHB3DI4ZNBN.4[HT%)OT4T.3QV*Z.>,#!)ZH
M_R"AVZFZS?0LQSM1CDP]<C'.5)5D:$-;14:;+%"DD##4D>!SCX!!BXB1E!0R
M)"222$;S8RD64IQ"BIQ+J((:<*-]/F1/Z,7 "WA,%-L_2*GFZC>2 NOIC)GS
M+"8:%4Q3Q6$,MZFAFZ-=5>7&VSZ&*NC]$&&2K#$"\I@>45><;0G=&/&EU0T/
MBH2/&EZXO)=4L8;,,.E$FL*5M)F;7.)HS6R<;QY7S#*?&#&];6$(1SGCT0G&
M>-\%)CIQWH&5##1EM=IX+T;+YJR.Z_)SJ/7Z;!WLV2SS>=20H6#%C254%&PM
M0TBDT;%,.S9/CF'E#I\'Z^2/0[Q3R";H#:'F0EII.-W%$ 4$S[-_AU1QM';D
M83%TK386D67<+]L$:\A:-, 9@%G1\_F$?$PPC[E7M$;P+VVTDDI%$!L?XH<,
M'T^#Y%SE<PKHAIESKBL2/GZ%/*<[FH1>/"$/&K+0Y_/S^/E)\GEQKJ:,R]!A
MLIAN#A'9_R#,.6I6[C!>_1S:$6:C?']@8[:##'4#$\6B8JR/DWL4Q-,FKG^U
M>SC]&;M5%G,1D#@%-T#Q^84C5N7:AS:<!"'(BI0%B6-/D9P%CN8X0^\X6BH.
M]65#H:6,O$87J._8NB;9<AP5%88B+"2YX?<T8AC(18!7$#]O7@4A>B\EDNHI
MS&0/@W:S@&]+F$LR-)TUW(S&"U<$C."3N##>J4)W.LGYEXWTYHYBKQ6([W3)
M!A5R90L/[8G#,?;*:&93$8LO":P412EI;\1[P\[8DJ]AM//<4IS@&!2M&$T.
MQ344(Y-ZG]_QIZ;=<YH']36$.Y!NP6[,\JR[V8E-G'C31P5#U38$A3-%_B%&
M2.@0DCK/[* C X7",L '[C"+@I.Q=U+HT.#\2\JVPQ2.?Z),<UW:MHFI"W80
MQ"/N4^8$/O?Z<;K3]3NDL(B?>]]T4#K?O^.E.SNTU+9PMZ1I@'@C&>*02N!(
MV)ZWAFQUTSJ"K[Q8-!:"'40""L!P8T@>XVA-[(F A6P],7[GZSYIPKB9>0\>
M0_C0$6C9#OK! .J;%ME$W\HSF'A1.)DV&]+<AWAW"%C"CO>TY>_4\_G3Q"(N
MXN='0[U.+>8OOJ9V-S2-+:;[O=Z'8B;M[FT0H*/6\AOFN>6O(07!>672X=6%
M?M20H1$>Q6\XDDVY[@Y^CB5!%I=!/J3YR$DS'\.[D]-F7YQVG)I1;WW^5=+5
M)3<;($&*%MYFXW-[/C@6M"%,D4SPVI@1.LM2/$#F2W>8/+Q/&'!4YY<=!L/V
MD7.T-&/:39B6EP[TYZMZ-Q=#W]5BNE7JHN#"O@NN/Y8 CPK.-\ZE#I\D56 Y
M8BF%BW(74IMD9U)X!Y.R8]1U%,Y5U)C]\KW0W0<IX&YL.BYYOJ$S;D9'=Q\F
M'=@;A5,OQY7 K0(='HY[4*XC<8!+7]K,*"<8YE9?,7?&#<G?J>5B.7\\V(EG
MB\2"O%@DY?_'CU+;\G0P*&KY=)AA2E"&_JO%=&O4>YU_0C+E'>2VE90IZMW'
M+<R=Y\IX+A6>%,DJPM/!\F:LYW!8,401(9'JB&^%&[LQTE],S$=V0M(F]6GH
M8UE,]Z#\)OV#M [7%XYSYVY3C$QO)3^5;!4)R_BNY%#BAV>\-@37J]#['RI-
M\O:0[YYQ('?KZL&0U$WJ<L2E-A(E%(P :>:!'UJ..!<_-*%ZD'-\W-!>P7@8
M":G!_B)@T[[.H#NVT3LIF/PVIB5DK!GJ)$%UJ&&%HG67%"Y0I#8T8^WAJAF'
M="%LCQD9&17;A6*A92B#3(G/<NB_64YWT/SB+TE<(*8\6?&Z\R0ITX?+$/XU
M'5_+ADYMC]-'$9+TT[6V*OBZ"T,I1@G)U9A9:$7@A )R&L/]E=%=&'5X%R8I
M;@EE[=!'.E0=1'["911%\)SP?%6%[N<F%*]]:6HM$=1G!FGTUA-<JUC@!L53
M1*<4503]@+=PHX@P0QA!1XY9 45O@M_7.>,"KCD8OGR$8M,,TNI9NM\:CQO"
M5B1R$+CAWS*,%0?%TH(4@N4:;@T-O8F7C>\W3Z@=2$.;CJ2X?9>&\.,@ 9A4
M&(TO&9;,?5\H7)NY^I7KF+?D(R"BC'L?^UK9]H93:$$QN-/+\LMHFN>G2!-%
MY8KHQ>,?Z8_QLSG<2N+&!P1[IYTLWY.4[M'L@Z<@N-#0L<S1PJAA!-_$NC6C
MI$QB(N@QV#2Q]+%ELH,6*!=@J]PI\]YE',&F:E4Z:<*AF8!,@CRF';#<D>*/
MY>!^F/I_OA^6W>U^6$P7QOMA4W9P:.1:3K=B^3;XC_KS<1=ZA^'C%HS0C,GU
M&WXKZ_@M7SUJ$BU)PCX8$<V-)G38L6B6M$4%>%[$CB?]^=3U@!"+QCJC3T9@
M"%((7,#,?4]_DF$8QP=#@Q3G\X]=[\ Z-*</3<5T0OB/$)GQ#19#9PF<4)HA
M11);/SS9)3+=W#<9DS&AH3 1%,.YJPI5)\^9 2.81G-]B&F32S*7'C&CD>8$
MA8('AM)E3(=*N^WM 3-OANOARE/2S\TMW$=*N%FLQAVC88\4:ZRW>4,;LR\^
M#?9G3^I:E+F@E<OQ3;0$\DAKSY%ULMO+<$J;Q3/>S@A9Z=OCA4RYLR17-FZ%
MD/%4>;/XAZP7KCN)2>/:A_&MLF0,O!WW%DV"&\"!8>NZ&U$P:@[T;T'YF GL
MWNYXDV@Y=!0MIQM^+DF2I<*R!M=KVO15U^:?D#M[FUYFN@J5C*.7D;]QE>ST
M*JQ_<G?,L+V.;3>WP%G&MVE"08*,3VY,$9K8)7O*33G#W#%C,JXAQRG&W6V'
M6'"X+.)3QQE"Z9D43=:5U',%4/@^P$0.C]VF\YWNBN_]3Q_LT NSG.YC^6BY
MD?9&&'WTS.XR 1_'FU9;+L>\XXYK5,@!^V(:WA^$-2&O='BU=&AE%B%P//6]
M*Q[V(0Y3%WY&"4[NS]75K8G[!KGCPY'9>&1(;M>:T;EM^\T6(+()P#N]H#HC
M7=\0=A&@'4@!&@40W7/CO==]YS.FOA7&7Z44'<\D V9U#>/EDB)%$$1FH]^3
M2S95G-C4 3O8L/!M%<A2."78=1^19'EK2801J(7.R/160>F5,? 0G=$4#2M3
M[ZKVQAA_*NU.:A DFO"&81TG5'M(%PKWN&7 DW5\"]F%-G^/?L(5TUL).G_G
M[8M;]N?H>H:]J/V$ @'\K-0QPTT_"D887>(X<.& 7 /:VHYIU</D+VW4QF[X
M[XGPQ=6FDS^Z$7^-?[/D0OY2Q_"Z_,&37[7=X+)@9=8T]'S^[,F9!'WA2]?N
M^.]VK-JN:VO^B&L,QN(%>KYNVRY\P0+Q+[F\_C]02P,$%     @ .X-<5@83
MYK1* P  $0<  !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&ULE55MC]LV
M#/Z>7T&XN&(#@G/L>]TU"9"[=F] @4/3KAB&?9!E.A:J%T^2+[U_/U)VW!N0
MNV)?9%$B'SZD2'JY=_Y+:!$C?#7:AE76QMC=Y'F0+1H13EV'EFX:YXV()/I=
M'CJ/HDY&1N?E8G&9&Z%LMEZFLWN_7KH^:F7QWD/HC1'^\1:UVZ^R(CL<?%"[
M-O)!OEYV8H=;C)^Z>T]2/J'4RJ -REGPV*RR37%S>\[Z2>$/A?OP9 \<2>7<
M%Q9^JU?9@@FA1AD90=#G >]0:P8B&O^,F-GDD@V?[@_H/Z?8*99*!+QS^K.J
M8[O*KC.HL1&]CA_<_E<<X[E@/.ET2"OL!]U+\BC[$)T9C4DVR@Y?\77,PQ.#
MZ\4S!N5H4";>@Z/$\JV(8KWT;@^>M0F--RG49$WDE.5'V49/MXKLXOICBW#G
M3"?L(PA;@XH!MFIG5:.DL!$V4KK>1F5W<.^TD@H#_/!15!K#C\L\$@/&R>7H
M[7;P5C[CK2CAO;.Q#?#.UEC_%R GZA/_\L#_MGP1\2W*4S@KYE NRO(%O+,I
M'V<)[^P9O&/Q_K6I0O14/W\?BWC .S^.QSUU$SHA<951TP3T#YBM7[\J+A=O
M7F![/K$]?PE]O:4>K7N-X!K0PCXH"Y7G9[3"(%#+@NL]2"U".$;].^ ]A4TU
MH(365!Q:LQ?&XT"BVN&L\6)'[B0.7@,(CT!)HY[%&AKO#/16-(W22D0ZB:WR
M-73"1TKK/-4;XU5](-<A@ K44#1N:J3*ZSMJVDCE*1V_1R^&+B8;CQ;W0L^(
M3NAE>_ 83N&SBBU=AXYZ'J)+YF-UOWYU7197;P+ER>^(_TAY#ON)<E+G^JPH
MEW(.ORMC'N&N=6Y.*((\L?=?/KW;;@?K&:>9W&XH<NC0$TJD2<9YLC1/@] <
M9N==W<M13(_R?5K$BE(I6%W3W PW\#^>>O8G"C]T&%!_H*G0<X_,N$>X40I>
M%K,I5"BNX02*GVBANY/9M\#'F[1<TLV0AN)BE*&XHL,A(]3;)^-"&,>*.W\R
MI@Q2N#R, Z2&&R;6=#K-^\TPYKZI#S^+]Y0M92EKV)#IXO3J(@,_#.!!B*Y+
M0Z]RD49HVK;TST+/"G3?.!</ CN8_H+K?P%02P,$%     @ .X-<5D/I73YO
M @  404  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULA51-;]LP#+WG
M5Q!:,6R 4=NRFX\N,="T*]I#@:+=QV'80;&96*@L>9)<M_]^DIVX&9!F%XN4
M^)X>:5+S5NDG4R):>*F$- M26EN?AZ')2ZR8.54U2G>R5KIBUKEZ$YI:(RLZ
M4"5"&D7CL&)<DFS>[=WK;*X:*[C$>PVFJ2JF7Y<H5+L@,=EM//!-:?U&F,UK
MML%'M-_K>^V\<& I>(72<"5!XWI!+N+S9>KCNX ?'%NS9X//9*74DW=NBP6)
MO" 4F%O/P-SRC)<HA"=R,OYL.<EPI0?NVSOVZRYWE\N*&;Q4XB<O;+D@4P(%
MKEDC[(-J;W";SYGGRY4PW1?:/C:A!/+&6%5MP4Y!Q66_LI=M'?8 T^@= -T"
M:*>[OZA3><4LR^9:M:!]M&/S1I=JAW;BN/0_Y=%J=\H=SF:W\AFE59JC@4_?
MV$J@^3P/K6/VYV&^95GV+/0=EIC"G9*V-/!5%EC\2Q Z28,NNM.UI$<9KS _
MA20.@$:4'N%+ACR3CB_Y3YZO<,5-+I1I-,*OBY6QVC7&[T,I]X3I84(_+.>F
M9CDNB)L&@_H92?;Q0SR.OAR1FPYRTV/LV:,;OJ(1"&H-_.T7'9)YE.BPS'?8
M1Z[H6*U0^\*/?.%]]>/1 VM=RUG4G D#3!:0JZI6TN&@9MH:.($X'0>3"?56
M' =)3$?77'+7EP5LE"J,"T@"ZOID.@G&$1WM]]T)T.DLF$U3CYY-@UF<PJ$:
MAGMM7J'>=,-LG)A&VK[CA]WAO;CHQ^0MO']L[IC><&E X-I!H]/)&0'=#W#O
M6%5W0[-2UHU@9Y;NS4/M ]SY6BF[<_P%PRN:_0502P,$%     @ .X-<5K5>
MKQ?8 P  60H  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&ULM59M;]LV
M$/[N7W%0@Z(%M.C%;XIK&TB:!0NP8%F==1^&?:"ELT54(EV2BI/]^ATI19$R
MUVL+](O-(^\>/L_QCN)\+]4GG2,:>"@+H1=>;LQN%@0ZS;%D^E3N4-#*1JJ2
M&3+5-M [A2QS0641Q&$X"4K&A;><N[E;M9S+RA1<X*T"794E4X\76,C]PHN\
MIXD/?)L;.Q$LYSNVQ16:/W:WBJR@1<EXB4)S*4#A9N&=1[.+D?5W#A\Y[G5G
M#%;)6LI/UKC.%EYH"6&!J;$(C/[N\3T6A04B&I\;3*_=T@9VQT_H5TX[:5DS
MC>]E\2?/3+[P$@\RW+"J,!_D_A=L](PM7BH+[7YA7_N.SSQ(*VUDV003@Y*+
M^I\]-'GH!"3A%P+B)B!VO.N-',M+9MARKN0>E/4F-#MP4ETTD>/"'LK**%KE
M%&>65XPK^,B*"D%NX(H+)E+."K@6VJB*LF\TO+ECZP+UVWE@:$<;%Z0-^D6-
M'G\!/8KA1@J3:_A99)CU 0*BVO*-G_A>Q$<1+S$]A6'D0QS&\1&\8:M_Z/"&
M_Z__DNNTD+I2J.&O\S7IIY+Y^Y#H&G)T&-*VT4SO6(H+C_I$H[I';_GZ530)
MWQTA/&H)CXZA+U?4EEE5N./:6/+WEKP/3&NDLRJ16049N)Y)*Z6XV-JZY?J0
MDJ-['59RER-L9$'=;)&-*PUPR\(,9*5@TQ91PXF)# K.UKS@AI.SR9D!IO"9
M+-G/6BQU]I*\ [$Q*3.XE8K_0V&5=A0LH39ZD'-43*7YXRG<]5:@78&<618*
M$0J\QT*[QG8YLV *G]@^VBS;*2YV%2FIK)>1U/8&%75C%_X4OO]H!ITRO*G=
MZM:CQ%#%8[E&U5;]X$X:2N[OE30$=JMX2CGE E9\*_B&ITP8^(U(J^[,X-R1
MF U6N53F)TN?8NY1FWJC$XC&H9\,AW9TYB>3R Z&H1]-1S2:GB6#:T%1% "*
MC@#TGNTT3/SI.('7KY(XBM_UK0'=FG0G"K!*4:2/5#5JSU0&^)#F3&SI+.EN
ML$U&.M-45L+J(:?F7"F9Y-.LV(G(CY*S=K.>U>2D%NG$)/XT"?MB$C^*XT;,
MK\_U./LFID*:KV,[Z>0E><&SVPTG=OFD]>V;WU(8T8\JC$GHA]&HQ_$_<]^?
MT*]*)NWHGR5QGT-_Y@>=XO#Y%(>=S0XUPYMX.(*WK7_?/'CRD9]$T0M1_9E#
M7XR@\[DO46W=HT:#XUQ_^=O9]MUT7C\7GMWK1]<-4ULN-%V#&PH-3Z=C#U3]
MD*D-(W?N\;"6AIXB;IC3VP^5=:#UC:1B:PR[0?N:7/X+4$L#!!0    ( #N#
M7%;DVOC>Q@(  !@&   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;)55
MWT_;,!!^[U]A9=,$4D02)TT;UD:BP#0DD"K8CX=I#VYR;2T<.]@.A?WU.R<E
M%*ETVD.3._ONN^_N<M?)1NE[LP:PY*D2TDR]M;7U:1"88@T5,R>J!HDW2Z4K
M9E'5J\#4&EC9.E4BH&&8!A7CTLLG[=E<YQ/56,$ES#4Q354Q_3P#H393+_)>
M#F[Y:FW=09!/:K:".[#?Z[E&+>A12EZ!-%Q)HF$Y]<ZBTUGB[%N#'QPV9D<F
M+I.%4O=.N2JG7N@(@8#".@2&KT<X!R$<$-)XV&)Z?4CGN"N_H']I<\=<%LS
MN1(_>6G74V_LD1*6K!'V5FV^PC:?H<,KE##MDVPZVV'JD:(Q5E5;9V10<=F]
MV=.V#CL.X_ =![IUH"WO+E#+\H)9ED^TVA#MK!'-"6VJK3>2X](UY<YJO.7H
M9_.YQOYJ^^R3RX>&UUAN2Y@LR35@JFLE2G)5U5H]@KLQY.@;6P@PQY/ 8G '
M$13;0+,N$'TG4$3)C9)V;<BE+*%\"Q @ZYXZ?:$^HP<1+Z X(7'D$QI2>@ O
M[DL1MWCQ/TLQ%VQ;AM>B_#I;&*OQ(_J]+_<..=F/[ ;KU-2L@*F'DV- /X*7
M?_H0I>'G [R3GG=R"#V_PT$M&P%$+0F\::+HF\AWFKB/_\$(^_G_;]@!]@NJ
M!6C7LX'KF6M<-+AV+NXW:[@HN5R1HT))K'73S2V7!$%6&-<<DX\D2L9^%(^<
M%*<H18/7'@TS/QUG9$C],$X'UWMI$.K3+,9G.*8#&H5^%&4DRD*?)AFZ&(.+
MHFBJ1C +)<XW)EQPUFT01[12VO(_W4$2^W$V(DGHC[/1 !FEJ3_"O!S+S(^'
ME.QK;[ SK17H5;N3#"E4(VTWN/UIO_;.NFE_->]VY@W3*RX-5GR)KN'):.@1
MW>VA3K&J;F=_H2QNDE9<X^H&[0SP?JF4?5%<@/[/(/\+4$L#!!0    ( #N#
M7%9.@_95/@,  + '   9    >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;*55
M;6_;-A#^[E]Q4(.B XA(I-Y3VX#=;%V!=0V:;/LP[ ,MT3912?1(*F[_?8^4
MHSB98V#H%^GN>/?<W7-\F>Z5_F*V0ECXVC:=F05;:W=786BJK6BYN50[T>'*
M6NF66U3U)C0[+7CM@]HF9%&4A2V773"?>MN-GD]5;QO9B1L-IF];KK\M1:/V
MLX &#X;/<K.USA#.ISN^$;?"_K&[T:B%(THM6]$9J3K08CT+%O1JF3A_[_"G
M%'MS)(/K9*74%Z=\J&=!Y H2C:BL0^#XNQ?O1-,X("SCWP-F,*9T@<?R _HO
MOG?L9<6->*>:OV1MM[.@"* 6:]XW]K/:_RH._:0.KU*-\5_8#[X99JQZ8U5[
M"$:]E=WPYU\//!P%%-$+ >P0P'S=0R)?Y36W?#[5:@_:>2.:$WRK/AJ+DYT;
MRJW5N"HQSL[O-*]QS+@%"/PF*V1;&.!=#9_L5FCXT%G>;>2J$; P1E@#;^XX
M:N:G:6@QO0,)JT.JY9"*O9"*,OBH.KLU\'-7B_HI0(AUC\6SA^*7["SBM:@N
M(:8$6,38&;QX)"/V>/$+>.^5JO>R:3P!_VW]6IJJ4:;7 OY>K(S5N*7^.<7#
MD"4YG<4=LRNSXY68!7B.C-#W(IB_?D6SZ.V9'I*QA^0<^OP6CVW=8]%J#?9H
MN,WQ<)4?KGSLD/L.3_5R-MOI7GZDA(D;);S7RAA85%7?]@VWHH;?\7Y:XMF>
M/&Y8>"-Q'ZUE)ZU ['O<E' !-$J)@[B UZ\*1MG;1]N3V*=Q"24LRR%+O!3%
MD_$L/'-D",7B%+*8I/BCZ)Y'T>33Z6Z>1].<%$F)4:1D%!A^B\EMO[+*\@98
MEI XI9 7)&41T"(E14PG=W[Q N*L)'$>HW1PN !61J1(8\<9_2'.:$ER^HRS
MP7:.LY@46$96."E/V8N<T:@D6<$@8X05&20YB<OL?U"6YXYHDA8%Q(06^2-E
M-,=IY3GD&2D3!B42&*<C8XZ>LB@=8\,ZFA G2G(X==#"HUNT%7KCWPH#E>H[
M.URHHW5\CA;#+?SH/KQE'[G>R,Y (]88&EWF:0!Z>!\&Q:J=OY-7RN(-[\4M
M/JE".P=<7RME'Q278'RDY]\!4$L#!!0    ( #N#7%8P?"&W\0(  "4&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;(55WV_:,!!^SU]QRJ:IE:(F
M<4* #I#HNFE[J%:U^_$P[<$D!UAS;&8[4/[[G1/(.HFR%W(^?_?Y.Y_OF.RT
M^677B Z>:JGL-%P[M[F.8UNNL>;V2F]0T<Y2FYH[6II5;#<&>=4&U3)F25+$
M-1<JG$U:W[V9373CI%!X;\ V=<W-_@:EWDW#-#PZ'L1J[;PCGDTV?(6/Z+YN
M[@VMXIZE$C4J*[0"@\MI.$^O;W*/;P'?!.[L,QM\)@NM?_G%IVH:)EX02BR=
M9^#TV>([E-(3D8S?!\ZP/]('/K>/[!_:W"F7!;?X3LOOHG+K:3@*H<(E;Z1[
MT+N/>,AGX/E*+6W["[L.FV<AE(UUNCX$DX):J.[+GP[W\"Q@E+P0P X!K-7=
M'=2JO.6.SR9&[\!X-+%YHTVUC29Q0OFB/#I#NX+BW&Q>EJ;!"MX_49DM6KCX
MPA<2[>4D=D3O07%YH+KIJ-@+5"F#.ZW<VL)[56'U+T%,NGIQ["CNAIUEO,7R
M"K(T I8P=H8OZY/-6K[L!;Y[OF^3 ZXJ:#/GTL*/^<(Z0\_CYZF<.\;\-*-O
MF6N[X25.0^H)BV:+X>S-J[1(WI[1F_=Z\W/L?7'P6)Q24S=8!WH);HVPU)*:
M2JC5]2GE9[E/*__/@<'? P.J#=8+-+X^@:^/+U(:S*LM&B<L84 *OA!2.$%$
MKR%G49:-R*  E@Z"1RYI"L"%4*5L*H]?:-5TM3$HN2,=CC_14P261BD;03J.
MQN,L>-![+EM25D2#C'E_.LB#VP9ABZK2AEZQT@[V--.$VFI18G4):3*(1L48
M\D$T3(;! SIAD,:+@T/Z%D91DJ0$C%B6$V#9D)0+@ZXQZK+/9D^P(LEAX#4%
MG^E:#)"^?$P>EA?!%^VXI#19FD4%2\E*LR(JAD,X]2+B9ZU;HUFU \K?>Z-<
MU\6]MY^!\Z[U_\*[ 7K'S4HH"Q*7%)I<#0<AF&XH=0NG-^T@6&A'8Z4UUS3'
MT7@ [2^U=L>%/Z#_9YC] 5!+ P04    "  [@UQ6G$)E*<8"  #X!0  &0
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M9C >@/=+K=U^XP-TPW[V!U!+ P04    "  [@UQ6XG:&"H0#   ;"   &0
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MT," 'IE$%P2!"^<]_)":'@ZY$C9U#N*K+$>?:"!H@ 5JU>)?"GM81?=J(CY
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M258 5YG@1,)R[$R#X:QC\FW"CPRVZE5,3"4+(1[,X',R=GPC"'*(M6%@^-K
M'/+<$*&,QYK3:98TP-?QCOVCK1UK63 %<Y'_S!*=CIV^0Q)8LC+7MV+[">IZ
M(L,7BUS9)]G6N;Y#XE)I4=1@5%!DO'JSIWH?W@.@-8!:W=5"5N4ETVPRDF)+
MI,E&-A/84BT:Q67<F'*G)7[-$*<GTS@NBS)G&A+R3:<@R5P4:&]J]GT#Y(M0
MBK3OV2('=3;R-"YI@%Y<T\\J>GJ /J#D6G"=*G+%$TC>$GBHM1%,=X)G]"CC
M)<3G) Q<0GU*C_"%S0:$EB\\P'?U6&;Z>;BOM K8V0\TIV6HUBR&L8/[I4!N
MP)F<G@1=_^*(K$XCJW.,?7*? HG1"<&!:T7$$O_?%Z>$=2I^XU1NG(H%#I0V
M^9A"EB+'4Y?QU=[Z_EM!ZU\4M'X!DP3,;T#01"@66 (:V3)&&C<#\_!;7[$3
M)2"S#3/GE61<:5D61H-+%K#*.$<V0_]L^#Z0]F! R1D&IR=]&M +C")ZF,6J
M= F'2B)[(M3M^<&.IAWA\Z@&K*!9/4#H8 >MUV_-JTTR0"T95R8V_2?YC<?Y
M8"'ML.=V.KZ5X X&/1.$ W?@1ZCG?C\/:5/?#6ED<P.$AQB%(8+Z[U+QNI1V
MU'-[W8KJ;R6MZ7O^/;0BZKI^U+5NM,.^VPDK9W8\^\Z%]ZIW%2!7MD.;WZCD
MNFICS6QS"4RKWO>27MT@UTSBKBJ2PQ*A_GDO<HBLNG(UT&)M.^%":.RK-DSQ
M(@-I$O#[4@B]&Y@%FJMQ\@=02P,$%     @ .X-<5F$#<ZS2 @    <  !D
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M?SH^"T#7(ZW>6%7Y,;)2EH:27Q;T%T#M#.@^5R2WV;@ [7\E^0U02P,$%
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M'RY1Q8N>X5V6RIQ1BEPD7TNN>/5C_^.C.4>N->3JOUW#HD9.NI$V$WY0&Y;
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M7"8Q5IHS 7-)5%445#Y/@.-V[(7>;N*.K7-M)_PD+ND:%J#OR[DTD=^R9*P
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MUCY(FV#65XAZ%]@-VH]'\@M02P,$%     @ .X-<5N09LPO !0  52L  !D
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M1?D?;:JVW;Z'IFLA6;8-5CW(DKSZ)*];(78"PLZ! +P-P.\#6@<"HFU =&I
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MEI5?EU35]KQHH'Z?,R;?-HH#U(N.1_\!4$L#!!0    ( #N#7%:$) J\1 ,
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M!OA^I;5[G?BFW'V$Y?\ 4$L#!!0    ( #N#7%9#R^@WZP8  /H[   9
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M6AV\.)C'L&#S+/XK6O+-]< ;H"5;A;N8?\KVO['F@-R2M\CBHOJ-]G7;T6B
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M-%'4 J"^!Q1-5J/U/8C>]SBI!38YT]OZ>IQQF@AJBX#2 E :A:+),K>V")G
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M-/S)E&(N>Y_@/7 !(YYE-J6Z&QM+P0'%:>EN4+BC>]P1"B,IS%S#E9C@Y#E
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M3N6:8.7A:WDC:%:<+LZH$#0I+D,D"V3*0+Y?4BHV-ZJ!^@A\^B]02P,$%
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M1'T%(-<!:C]F3.XF^H#FN\+_"U!+ P04    "  [@UQ6TIS'O7P$  !\%@
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MBX 44-*&VSNU^0Y=/6>.+U?<^"_9=+%10/+&6"4Z,&8@F&S_=-OIL >(1T<
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MNI ?=KAQ=I.EHD@AML"H#V>A-OXFIH@R3QO+L2DBH<]ALG!-%KX866C49P]
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M'Z(_-#M&3;\3,.8%NFT'=+Y/B;Z0Q(".$1(Q2UJ%*@M%7RY#1DTW% 0XTC.
M@(P'H:_OQ  9]8CM1(@J<T5_6):, E[)QZ&^O09D<D;5EWQ Q0-L.:6DRGC1
ME\N442!5%N@=-0%4E!/=5P(J$@6VWE2FC+Y<NHQ"^3* #TJ8 8"0M[,3*L-&
MGY\SHU ^C.G^#%)1K)\) "K,(HL!8,J?L>>GS1B8#S,X0)D) LD<),J>L6'3
M9@PX9/&)KZ=K(!GW/3T! ,AP$(26$RJF#!I[:MJ, =DPCY--S]X3F,*(XL X
M=0)T 0]#;&-0-HD]-6O&H%P8# $H80I Z,38^&'."R3-&) TP\S(,P$R3$-N
MK$:0#A-N.>EERE^P 9)F#$B:$1H9^7- 1]N?,A@P0-),WC2^;2I07H(-GC1C
M@!D@YJ^D@)R9IQ\7QI *>S8J91F8VS*<YMD\*_J?2+IV;.XXN^X?!HT6#Q5M
MNPV5+V$_)7?&!LV=#1HM'BK:=HLKG\1^:.Z,F3;(/*^'1-2<?@ 59L2R5^/*
M4O&7RYJY0\.=A: QQ$V7A4.]!0 1M4Q37/DP_I />[KUYX#98OKR HBP8?LA
M$;4<EW/EQOC+9="X::_V #A !=!!*BN>,FK\H43:PYL!;OHK@,(4 1" R,J@
M7!I_?L:,FRX*Z@I !5! *BO&QB^B'\J9[;:;<8?;9>( 3)Y^!@1H;+\ 5YZ-
MNSV;W79RTTX1S+F^40-DTG0:/SL#9%$46LYSN#)G_*F)-&Z>L.R!]0=T( "@
M<Q H:\3=1S9/,,WNB+L,NH$"Q7T@#H_>5<N,-QYCDN[CNGL<K$;3=@NW>L1G
M_>GZD;/C[D$K[?,3O!^O'AQ385;/L7U,JNM,NO1<7,F0WKM 5JA:/1JV>M.4
MB^YAJ<NRD1:H>SD322JJ5B"_ORK+YOY->X'U WI'_P-02P,$%     @ .X-<
M5M5,8,"&!   G1L  !D   !X;"]W;W)K<VAE971S+W-H965T-S,N>&ULQ5G;
M;N,V$/T50ET4NT W$BE;EE/;0&*FZ ))&R3=]F'1!\8:V\)*HDO2<?+WI2Z1
MK$AFX@4!O]BZS!QRSO#(1^9DQ\5WN090Z"E-,CEUUDIMSEU7+M:0,GG&-Y#I
M.TLN4J;TJ5BY<B. 1452FKC$\P(W97'FS";%M5LQF_"M2N(,;@62VS1EXOD2
M$KZ;.MAYN7 7K]8JO^#.)ANV@GM07S>W0I^Y-4H4IY#)F&=(P'+J7.!S2DB>
M4$3\'<-.[AVCO)0'SK_G)U^BJ>/E,X($%BJ'8/KK$>:0)#F2GL=_%:A3CYDG
M[A^_H/]6%*^+>6 2YCSY)X[4>NJ$#HI@R;:)NN.[WZ$J:)CC+7@BBT^TJV(]
M!RVV4O&T2M8S2..L_&9/%1%["3@XD$"J!/(Z87 @P:\2_/<F#*J$0<%,64K!
M V6*S2:"[Y#(HS5:?E"0663K\N,L[_N]$OINK//4;,XSR9,X8@HBE.EU)ED"
M$BE>#0Y"HH=GW>%5T24!B$FTY(E>+_(<?:2@6)S(3^@S^GI/T<</G] '%&?H
MKS7?2I9%<N(J/<M\+'=1S>BRG!$Y,"-,T W/U%JBJRR"J W@ZO+J&LE+C9?$
MB$AA<89\_ LB'B$]$YJ_/QWWI-/WIWN&:ORZ8WZ!YQ_ NX-'R+:Z1TO!4W3U
MI$!D+$'SNEV:=G3-L]7G:ZVH"%U("4JB;]<:!WU1D,I_^YI2#CKH'S1_^IS+
M#5O U-&/%PGB$9S9SS_AP/NUCU";8-026(OL04WVP(0^^^-%$7V4E:G#(C5_
MOC[.L!<&(T]W^7&?C6Y<.!H/7X?1;MC0'WM[8:T*AG4%0W,%7*@UNM K(UXP
M].T&T@<0O2O B'/L"K )1BV!M?@+:OZ"4\@ML$FV33!J":Q%]J@F>_3C<BM3
M@SU]#'P\[JBM&^8/![BCMFX8'OO#0VH+ZP)"8P%76Z$MF5%F1H!C.V\3C%H"
M:Q$WKHD;GT)F8YMDVP2CEL!:9&.O<7W>CPNMRFU)R/<'':7UQ)&1GN)KJ?7$
MX5";H0-:PWO>%1NKN)"Q^2?-G']L_ZVB45MH;>Y(PQTYA>"J46TQ;A.-VD)K
M,][X=FQTJF]HSN]J9$BZ7K(OCH1>5W/=N-%X=%!RC1_&9D-\$T=1 NB*2656
MGA'FZ'5@$XW:0FM3V!AR/#R)\JSZ=ZMHU!9:F_'&PF.C:7U#>4%'*>$H[ JO
M&Q;@'MUUPP9!>%!WC3'&9F<\ATP)O4KRM7'/M^]\I3.#'KTF;*)16VAM0ANC
MCL.3J-"JO;>*1FVAM1EO'#XV>MHW5#CNRFO<?;GK"1L&'6=*>\)\<O#ECC2V
MF9AM\Y]J#0+=PRK5<D1SOM6B?#8JT QX['JPBD9MH;7);-P[P:=0(+'J^:VB
M45MH;<8;ST^,#M>LP"JW]7=F]P=NWA,6=@78$Q7X'?VY>_L6NN.K8O]'HD6N
MJ_+O_?IJO<=T4>RLO+I^B<]IN5/4P)0;5S=,K.),H@26&M([&^DIB7(OJ#Q1
M?%/LCCQPI9==<;@&%H'( _3])>?JY20?H-Z1F_T/4$L#!!0    ( #N#7%8+
MGA6]_P,  !T5   9    >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;+U876_;
M-A3]*X16#"W01J*^;&>V@<1:T6 +$,1-]U#L@9&N;:T2Z9&4G?W[D9(B6Y8L
M) !3((A%ZMY#GF,>YN9.]XS_$!L B9[RC(J9M9%R>VG;(MY 3L0%VP)5;U:,
MYT2J(5_;8LN!)&52GMFNXX1V3E)JS:?EW!V?3UDALY3"'4>BR'/"_[N&C.UG
M%K:>)^[3]4;J"7L^W9(U+$$^;.^X&MD-2I+F0$7**.*PFEE7^#+"H4XH([ZE
ML!='STA3>63LAQ[<)#/+T3N"#&*I(8CZV,$"LDPCJ7W\6X-:S9HZ\?CY&?US
M25Z1>20"%BS[*TWD9F:-+93 BA29O&?[+U 3"C1>S#)1_D;[.M:Q4%P(R?(Z
M6>T@3VGU29YJ(8X2%-'^!+=.<$\3_#,)7IW@O33!KQ/\4IF*2JE#1"293SG;
M(ZZC%9I^*,4LLQ7]E.KO?2FY>INJ/#E?,"I8EB9$0H*H.F>"9""09/7BP 5*
MJ5KQ'\91S HJ>:K>$PZ("+1BF3HXXA*]CT"2-!,?T"?TL(S0^W<?T#N=^'7#
M"D%H(J:V5-O5B]IQO;7K:FONF:UA%]TR*C<"_4X32-H MN+9D'6?R5Z[@X@1
MQ!?(PQ^1Z[ANSX86+T_'/>G1R].= 39>\]5Y)9YW!F\):V5 B>YAR[A,Z1K=
MT.HBT(;Z_J<*1S<2<O%WG_85MM^/K6^;2[$E,<PL=9T(X#NPYK_^@D/GMS[=
M3()%AL!:FOJ-IOX0^OP>=D +0"O.<J2\(;FZF)0EY08M:C]\5#+'69%HP:^$
M /63H*_DJ4_D:K&@7$S?P+LY=L9A&'A3>W>L7S=N/)H$.&R'1=VPP)LXSJ0)
M:W$.&L[!(.<'FFKS+Z6Z P3Z?@OY(_#>,S.(\]HS8Q(L,@36TB]L] O?T(>A
M24U-@D6&P%J:CAI-1S_3A]5BX9%Q?-=1SCFQ83?,"[!W&A9UP_!X=!S6HCQN
M*(\'*7_FA,8PZ+]!@->>%9-@D2&PEG"31KC)&_IO8E)3DV"1(;"6IM@YU(7.
MSW1@O5K+@OZXX\#>,*?CP)XP;Q2><R ^*H;Q,.E"B)0,>G 8X;4'QBA:9 JM
MK9Y[4,]]0R/6X*:$-8D6F4)K"WLH]/%@S6O<BU[7/=XD]$^]V WS/;_KQ6X8
M]O%9+QXJ<3Q<BM=EZ1^*4:)H#WIR$.G51\<D6F0*K:WBH;;'P5MZTFC%;Q0M
M,H76%O90]./!^M>X)\/._W;>J%NA]H6-@ZXGNV&NW_W[:!_UC=1^UV7_351M
MGJJKTLPV/;ZKLK-U,G^M>W]E/^H 4S4.;PE?IU2@#%8*TKD8J3WQJA=7#23;
MEMVI1R:5:.7C!D@"7 >H]RO&Y/- +]!T1.?_ U!+ P04    "  [@UQ6W*<9
MD^T"  !""@  &0   'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6S%5FUOFS 0
M_BL6FZ966LM+ K1=@I2$;*O45E73;A^F?7#A JA@,]MYV;^?;0A+&A)U$M+R
M(=CFGN?NGK/Q#5:4O? 40*!UD1,^-%(ARBO3Y%$*!>;GM 0BW\PI*["04Y:8
MO&2 8PTJ<M.Q+,\L<$:,8*#7[EDPH N19P3N&>*+HL#L]QARNAH:MK%9>,B2
M5*@%,QB4.($9B*?RGLF9V;#$60&$9Y0@!O.A,;*O0E_9:X-O&:SXUABI3)XI
M?5&3ZWAH6"H@R"$2B@'+QQ(FD.>*2(;QJ^8T&I<*N#W>L'_6N<M<GC&'"<V_
M9[%(A\:%@6*8XT4N'NCJ*]3YN(HOHCG7_VA5V7K2.%IP08L:+",H,E(]\;K6
M80M@>P< 3@UP7@/Z!P"]&M![*Z!? _I:F2H5K4.(!0X&C*X04]:230VTF!HM
MT\^(*OM,,/DVDS@1S""1110<81*C+T 3ALLTB]!([B&.3D(0.,LYNL.,856A
M4W2&GF8A.GE_.C"%#$#1F%'M;%PY<PXXLQUT2XE(.9J2&.)= E-&WH3O;,(?
M.T<90XC.4<_^B!S+<5H"FKP=;K? P[?#K2/9])IB]#1?[P#? RR!+("C.:,%
MFJX%,()S--'; %A5I!M*DK,;68H8C3@'6;H?-Y('70LH^,^VHE1.^^U.U7?E
MBI<X@J$A/QP<V!*,X,,[V[,^M0G:)5G8$=F.V/U&[/XQ]HW8E=:P+BD3B.,<
M>)N$%96KJ=27=!G8UH7G6^HW,)?; NV;7OB7;HMEN&_I]BZM7<N=U-PF-?=H
M:D]WUX_3$,T>1X_365LZ1^'_NB.Z) L[(MN1S6MD\_['\?.Z%+M+LK CLAVQ
M_49LO[OCY^\?/^_2;CM]+9:.Y[2=OGU+WW;;#I^Y=;O*;9#H+H6CB"Z(J&ZJ
M9K5IA$;Z_G^U/I8-4M7/_*6INJM;S)*,<)3#7%):Y[X,BU4=2S41M-1W^#,5
M<B_J82J;/&#*0+Z?4RHV$^6@:1N#/U!+ P04    "  [@UQ6X_49(.,"  !2
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6RM5LMNVS 0_!5"#8H$
M:*VW7+NV@#AJ41\"!''2'HH>:&EM"9%(E:0?_?LN)5GU0W9SR,7F4C/#G:6\
MZ]&&BQ>9 BBR+7(FQT:J5#DT31FG4%#9XR4P?++@HJ *0[$T92F )A6IR$W'
ML@*SH!DSPE&U]R#"$5^I/&/P((A<%045?R:0\\W8L(W=QF.V3)7>,,-129<P
M _5</@B,S%8ER0I@,N.,"%B,C5M[& 4:7P&^9["1>VNBG<PY?]'!-!D;EDX(
M<HB55J#XM88[R',MA&G\;C2-]DA-W%_OU+]6WM'+G$JXX_F/+%'IV/ADD 06
M=)6K1[[Y!HT?7^O%/)?5)]DT6,L@\4HJ7C1DS*#(6/U-MTT=]@AV<(;@- 3G
MF."=(;@-P7TMP6L(7E69VDI5AX@J&HX$WQ"AT:BF%U4Q*S;:SYB^]ID2^#1#
MG@J?4B Q+TK.@"E)^()D#&,@<\!W"G:1HEN0",3KEDJC%/(6/,>W)F/+(;F.
M0-$LES?D(WF>1>3ZZH9<(9D\I7PE*4ODR%28KC[4C)O4)G5JSIG4;(?<<Z92
M2;ZP!))# 1-]MF:=G=F)<U$Q@KA'7/L#<2S'Z4CH[O5TNX,>O9YN77#CME?G
M5GKN&;UI?35/=$NB3,8YERN\L)^W<ZD$_IQ^=56\5O2Z%76+&<J2QC VL(=(
M$&LPPO?O[,#ZW%6MMQ2+WDCLH))>6TGODGKXW)OU"'92074OZGQ5:P&_$M"M
M=!WZEN/C-:[W*W**<KV^YQRBHE/4P._W6]"!!;^UX%^T@$T06QS[CXM:(]@[
MV?;<03 XLM$!LP-G+\7:QRG,'_3[3K>1H#427#0R/=M^N@P%)Z6T!YYC'QOJ
M@/FV=0R+3F'!P/4&1X;,O6Y;@%A64TLWQQ53=2]J=]O!>%O-@Z/]"0[,>K[]
MDZFG[3T5RXQ)DL,"):U>'W,2]02K \7+JJ?/N<()42U3'/H@- "?+SA7NT ?
MT/Z-"/\"4$L#!!0    ( #N#7%8O2!\#I0,  .,,   9    >&PO=V]R:W-H
M965T<R]S:&5E=#<W+GAM;*U778^;.!3]*Q9;53/2=L#F(S";(,T,6VT?*HTZ
MT_:AV@<';@(JX-1VDME_OS8P3(*=:-3V)<%PSO$YU\:YF>\9_RY* (F>FKH5
M"Z>4<G/MNB(OH:'BBFV@54]6C#=4JB%?NV+#@18=J:E=XGF1V]"J==)Y=^^>
MIW.VE775PCU'8MLTE/]W"S7;+QSL/-_X5*U+J6^XZ7Q#U_  \O/FGJN1.ZH4
M50.MJ%B+.*P6S@V^SC#1A [QI8*].+A&.LJ2L>]Z\*%8.)YV!#7D4DM0];6#
M.ZAKK:1\_!A$G7%.33R\?E9_WX578994P!VKOU:%+!=.[* "5G1;RT]L_P\,
M@4*ME[-:=)]H/V ]!^5;(5DSD)6#IFK[;_HT%.* @*,3!#(0R)00G"#X \%_
M+2$8"$%7F3Y*5X>,2IK..=LCKM%*35]TQ>S8*G[5ZG5_D%P]K11/IH\EH UG
MNZI;2+6/U*2<0RL1;0M=0%"C E5MSAI DCXA>%)[3@"Z6$(+JTI>HIRI;2"D
M0&R%I-);L5IMIZI=7Z.+#"2M:G&)WJ'/#QFZ>'.)WB@U]%BRK5!3B+DK50QM
MQLT'R[>]97+",B;H(VME*=#?;0'%L8"K\H]%(,]%N"5G%3/(KY"/_T3$(\1B
MZ.[U=&RA9Z^G>V?2^..2^IV>?T+O0[]6CVJMLDKD-1-;#NC;S5)(KEZS?VT5
M[Q4#NZ(^>Z[%AN:P<-3A(H#OP$G?_H$C[R];M7ZG6/:;Q(XJ&8R5#,ZII^^A
M $YK6\%Z8M@1]=FZ2Z.8)'-W=U@($Q3$)#P&928(1_$+Z,AX.!H/SQI_D%1"
M]P;7++<'Z 6BPP!A//%O8D(\P60F)O'LYJ/1?'2^ZHRKT[JUF8Z,R?PD,&Q;
M4!&.@HEQ$X5G'@GLWF>C]]E9[W?#X6F>E[8X,\-"$*D\DS@6% Z]V22.B<+Q
M+$GL<>(Q3ORS+T!LS/<N]LC$N@F:KH)%AN 3NS\972>_NOL3<]I@^O::&(PG
M[DU(<&(#8>_E!]G[V>T_,(^KE>!IU6VPT/<FWBVH6>B?<'_03N"S[K/3'8,U
M$3:M^K/(GR:RP$(\/4DMJ# F)Q*1ET3D;*)')FG]VCC$//%]'!L+9(%Y24*F
M>4P83OP83Q*Y!]U? WS===%"=67;5O8]T'AW[-1ONOYT<O]6=_!=5_DBT[?_
M'RE?5ZU -:R4I'<U4YYXWU'W \DV78^Y9%)UK-UEJ?Z% -< ]7S%F'P>Z G&
M_S7I_U!+ P04    "  [@UQ6I( 20&P$  #)#P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970W."YX;6RM5]MNXS80_15"710)L(Y$W9W:!IJD1?>A;;!)ML^,
M/+:)4**7I.VD7]^AY,@74<(6R(LM2C-'9X:<.9K)3JH7O0(PY+44E9YZ*V/6
MU[ZOBQ643%_)-53X9"%5R0PNU=+7:P5L7CN5P@^#(/5+QBMO-JGOW:O91&Z,
MX!7<*Z(W9<G4VPT(N9MZU'N_\94O5\;>\&>3-5O" YBG];W"E=^BS'D)E>:R
M(@H64^]7>GU+<^M06WSCL--'U\2&\BSEBUU\F4^]P#(" 86Q$ S_MG +0E@D
MY/%]#^JU[[2.Q]?OZ+_7P6,PSTS#K13_\+E93;W<(W-8L(TP7^7N#]@'E%B\
M0@I=_Y+=WC;P2+'11I9[9V10\JKY9Z_[1!PYT+C'(=P[A#_J$.T=HCK0AED=
MUATS;#91<D>4M48T>U'GIO;&:'AEM_'!*'S*T<_,'E= #'LEL%A@8C61"V*@
M7$N%>TKF'.\JJ K0Q*R8(4M,.5%<HX\DFB\KON %JPQ!![LKC3]"8B)!*9C7
MV$QK0&A6S4_O"\Z>N>"&(SQ3@'9D(04>+'U-+N[ ,"[T)1F1IX<[<O'IDGPB
MO"*/*[G1"*4GOL'X;11^L8_UIHDU[(GU#HHK$M'/) S"T.%^^^/N]-3=QZRW
MJ0_;U(<U7M2#]Q<6J2-/UZ[ &J38C61+_5JO60%3#VM9@]J"-_OY)YH&O[C"
M_""PDZ"C-NAH"'V&M8>559$*@\=>I)CAU9((J34IF%)O(^Q,.Z;<V]M )S6T
M[4_;69+$$W]['%S7AH;CL#4Z(1VWI.-!TE^J+51&8D78,\R*0FXJ/- *"N!;
M]BS 1;:!3(^(1'D>G+'M&L5)D+O9)BW;9)#MO9(+;HA>,86Y=5%+.F\-\XR>
M4>L:15F>N:FE+;5TD-J#D<4+[GO=P0M9HAAI9A<NEFF'0$;3,Y(.FZAGL[.6
M8S;(\;>Z$]I&QMMM7S<I!<&Q!?<2SCIDQE$<GC'N&B64]E#.6\KY(.6_L>4J
M%Z.\N]'I>0J[-G'0L\WCEL]XD,^C-$R0I;)5[>APGVWUN^B..U1HEH;C,\(.
MJR2/>HJ&!@<A# 9)?V-BPYI/"ZM!#%7/*3%!Y_6C;A=R645)WK//]$BMZ2#)
M'LUP$J6.; 99<L[481:&2=K#]"!N=%C=[OJ4_D+(:CDRH,I+I]31#]6ZCT([
MS<)![>BPW-ULN)A;A8-7V^O O5-1][#0*#DO5*=9T'NF#N)&A]7M4;$YS@8X
M-]3R)GC1S[2K5Z,0DW7.U&66)+2'Z4'8Z+"R/54XJ0C^+YZJ)4XH!&O5\L8O
M1=1@ M\WW+P1#<5&U4?-&4%7UD8TBSM5X3"+H[ZB.,@?'=:_WD9-NT(V2I,.
M*X=5V)O6@^#18<5KVG7?I[F3;E?%1LFXH\XNLS@*@Q["![FCPWKW?[I@WOT>
MI#0YUQ2'63;N[+=_-&?9(?=/II8<AQX!"W0+KC+T5\W<V"R,7->CU[,T.,C5
MERN<M4%9 WR^D-*\+^PTUT[OL_\ 4$L#!!0    ( #N#7%;%4*C=J0,  (P,
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;*U776_;-A3]*X2&#AU0
M6!]V_)'9 F*KQ?)0+*B7]F'8 RU=V40HTB/I./WWNZ04U58DV0/Z8HO2/4?W
M')*75_.C5$]Z!V#(2\&%7G@[8_:WOJ_3'114#^0>!#[)I2JHP:':^GJO@&8.
M5' _"H*Q7U FO'CN[CVH>"X/AC,!#XKH0U%0]7T)7!X77NB]WOC"MCMC;_CQ
M?$^WL ;SN']0./)KEHP5(#23@BC(%]Y=>)N$@06XB*\,COKDFE@I&RF?[. ^
M6WB!S0@XI,924/Q[AA5P;IDPCW\K4J]^IP6>7K^R?W+B4<R&:EA)_HUE9K?P
MIA[)(*<';K[(XQ]0";JQ?*GDVOV28Q4;>"0]:".+"HP9%$R4__2E,N($$(X[
M %$%B)J 40=@6 &&UP)&%6#DG"FE.!\2:F@\5_)(E(U&-GOAS'1HE,^$G?>U
M4?B4(<[$"<MS4"!2T&0#Y@@@B-D!>13,0$;6AAI\DD,&BG*B<7@P4GTG3*2R
M &+H"U$80JC(' Z0SDWEFX@COH90Y)(<%YN^)>\3,)1Q_=O<-ZC$YN.G5=;+
M,NNH(^LP(I^E,#M-/HH,LG,"'RVH?8A>?5A&O8P)I ,R##^0*(BBEH16U\/#
M%GAR/3SH43.L9W7H^(8=?/>E]W^A]PG3*9?Z@.;_?;?11N%.^Z?-\9)QU,YH
MR\^MWM,4%A[6%PWJ&;SXUU_"<?![FUL_DRSY261G3HYJ)T=][/&Z7O%V$>LV
MXTJ"F2.P9?8Y#@9V$3R?&G)-4'(AZ$S 32W@YJ* <GMRF>(6QOT(^@,1>*3(
MG'RJ-O8&!.3,M,DKZ;&RGV85!%%#8$?8L"'Q(MN9R'$M<MPK\AL364YYK8/D
M2A8$7D"E3(,5BH4T?2)R;P^;UEGL?\'[8# *WK55JM5%X*P=F%P$CM\ S\R9
MU.9,>IF6E2=VNJ7"@U"0!!26Z(S<"T/%EFTXD+)DM#G3SXYY3CN<N0A\*[!T
MYB+P[5R<.3.MG9GV,GUTAY4U)J^,<;N#;+&#,J#P0*."/ [6@Y.#K[,,3%M7
M]K!9"-K#)J/&/ND(NVG?)[-:\*Q7\)]X1*NVY/MAW8MX=1$8=LSQ['\5@C#X
MT<\$5\RI;4 Z9ZIB:+P[BIHEK2-NTBS;77&SAA;_I$TK0&U=NZM)*@_"E)U*
M?;=NJ>]<(]FXO[2MMFO_?M"4??IGJK9,:,(A1\I@,,%ZJ\K6MQP8N7?-X$8:
M;"W=Y0X_%T#9 'R>2VE>!_8%]0=(_!]02P,$%     @ .X-<5HS;@]K@ @
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M=K!'VP_(K>!ZJL@USR#;%G QT#K:8!UM/SBHF$!Z3D+_(PF\(&@(:/!ZNM]
M3UY/]PYD$];>AU8OW*LWQI&,](%C2Y,AHYPDN4J94',)Y/$;3I,;#87ZW>1^
MJ1XUJYOSXE+-: H]!P\$!7(!3OSAG=_V/C<Y=TRQY$AB6ZY&M:O1(77C*DB)
MMN*Y@+N>D^<E3JY7>%PJ(">5Y8V+NI1O67ES:B[BL^#"QW,4__EBT[(&8"OT
M=G#)+JYC<35L*\]6G6?K8)[K]!*0N%$S3%-3/LE'#-89/]Y",0+9N'8.:O_O
MVCFF6'(DL2U/V[6G[3?=D>UCNGI,L>1(8ENN=FI7.V^[(SL[&\AO>;L;;;"+
MNVB );NP<!M69NENW*H%R(FM3A1)Q9SK\LJJ1^L"Z,K>^R_&^U@8E77,LTQ9
M5=U2.<FY(@S&*.F==S H658J94>+F;V[1T)C)6";4RSN0!H SH^%T.N.^4!=
M+L;_ %!+ P04    "  [@UQ6.-<19ST$   T$@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970X,2YX;6R]6%UOVS84_2N$5@P)D$:?EJW,-N!8&Q:@V8PFW1Z*
M/=#6M:55(EV2LI-_/U)29,NB-;<0^F*+U+V']YQ+4I<<[RG[PF, @5ZRE/")
M$0NQO3--OHHAP_R6;H'(-VO*,BQDDVU,OF6 H\(I2TW'LGPSPPDQIN.B;\&F
M8YJ+-"&P8(CG68;9ZSVD=#\Q;..MXV.RB87J,*?C+=[ $XA/VP63+;-&B9(,
M"$\H00S6$V-FWX6VIQP*B[\2V/.C9Z2H+"G]HAH/T<2P5$20PDHH""S_=C"'
M-%5(,HZO%:A1CZD<CY_?T'\KR$LR2\QA3M._DTC$$V-DH C6.$_%1[K_'2I"
M X6WHBDO?M&^LK4,M,JYH%GE+"/($E+^XY=*B",'VS_CX%0.SJF#=\;!K1S<
M2QV\RJ&0VBRI%#J$6.#IF-$]8LI:HJF'0LS"6])/B,K[DV#R;2+]Q/0Y!K2B
MV982(((CNI:96.59GF(!$:(B!E:\9Q"K9.\ I91SV24;7"A[:8+6-)43*"&;
M.W05@L!)RJ_1>_3I*417[Z[1.Y00]!S3G&,2\;$I9.!J>'-5!7E?!NF<"=)V
MT",E(N;H5Q)!U 0P)>.:MO-&^][I1 QA=8M<^P8YEN-H II?[FYKW,/+W:T.
M-FZ=1+? <\_@S8Y2]F>1LGDC90]$IA#0U0>9NFOT^8-T1P\",OZ/+A?E6)Y^
M++4/W?$M7L'$D"-P8#LPIC__9/O6+SH=^P0+>P)K:.S5&GM=Z V-SRT+G9HE
MZJ! 59OP;OI^X%L#?VSNCG72F+DCSW6:9J$.+0B&M56#VJ"F-KB86@AK^39"
M]T#DDT"+%!.._I ?H!!8LL.BG$]<L#PK=HS/CY M@6EG4N>PWSJ3^@0+>P)K
MR.W7<OL_<+7Z?6K<)UC8$UA#XV&M\;!S2JL)&QTF;'*8L#=H"9N$$/FQ4E^O
M5\!,)VL)[Q\OM" X68WSSACT#)%.J?9@ T>_I$<U_]'W\4<;60NB*[5;7=\@
M N4G'+_H-!BUPG*&EGVB0=NH+52H,3K',*@9!M^=82!15VZ#5C3VT I.>+6-
M-+PZ0[QH C2XV]:A:K,NWK)E_2NK6X+F.6- 5J]H%OTK"\<BVS,A6++,!5ZF
M@ 1%"\Q4=]>FW3WRM^XHO:*%?:$U53^JE>T?N'-7@_4E=)]H85]H3:&=@]!.
MY_2>ES(K3063!8AZ5H?$>F)?NHU7XS26L3OT/.MDM>OL&H55)8L.+@BL@7XO
MLP\%O-U9NTZ?]2RUE-QV#([E.H-32AH[U_8\]Y13V\YU VMTAM*A7K:["^9+
M<O@_&[6M*W>'0[]%55<]M[,<:O':Y;-Y=)S.@&V*:PEUYLV)*(^8=6]]]3$K
M#OPG_??J2J0XIA]@RON41\SD[.4HA;6$M&Z',B967E&4#4&WQ:%]286@6?$8
M Y8?/&4@WZ\I%6\--4!]433]#U!+ P04    "  [@UQ6K-4@,QL#  " "0
M&0   'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6RM5MMNVS ,_17"*XH-6.M+
MTO2R)$!;;]@>6A3-NCT,>U!L.A9F2YXD-]W?CY(=+VF=(,#ZDNC"<T0>T:3&
M2ZE^Z1S1P%-9"#WQ<F.J"]_728XET\>R0D$[F50E,S15"U]7"EGJ0&7A1T$P
M\DO&A3<=N[4[-1W+VA1<X)T"79<E4W^NL)#+B1=ZJX5[OLB-7?"GXXHM<(;F
MH;I3-/,[EI27*#27 A1F$^\RO(A'UMX9?..XU&MCL)',I?QE)U_2B1=8A[#
MQ%@&1G^/>(U%88G(C=\MI]<=:8'KXQ7[)Q<[Q3)G&J]E\9VG)I]X9QZDF+&Z
M,/=R^1G;>$XL7R(+[7YAV=H&'B2U-K)LP>1!R47SSYY:'=8 X6@+(&H!T7/
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M&7BWP#R($_8>7( O#POP[NP]. -Q!O[=DIP)+S;5N)A5@:V%]0SFU0S0@1E
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M?MQJF#=@8'D@T\O6&M]MO$)VUP&VI[LJ!)LI7HG83/&U!L2];L"(8_=N8WF
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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M<+R057$)I0[^B2.-DG02]Y NFJKZ!,>^FPLKR^V?AVW_M.W#OU!+ P04
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M4$L! A0#%     @ .X-<5K#Y)EON    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ .X-<5IE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  [@UQ6<.3D^%<'  "1,   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ .X-<5@!?9Q\'!P  (AT
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M965T-BYX;6Q02P$"% ,4    "  [@UQ62,C@K\H(  #K*0  &
M    @($;+P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M.X-<5J-M:7#5%0  H3L  !@              ("!&S@  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( #N#7%9S+JI@^P4  "P-   8
M          " @29.  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  [@UQ623#8FH8&  "\$   &0              @(%75   >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( #N#7%9Y(J^IE (  )0%
M   9              " @11;  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ .X-<5A<)1;'<!   #@T  !D              ("!WUT
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  [@UQ6'CGD
M[]0%  !'#P  &0              @('R8@  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( #N#7%9I<N'!W (  'H&   9
M  " @?UH  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M.X-<5@9>B2[&!   6 L  !D              ("!$&P  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  [@UQ6&H0]R.P"   7!@  &0
M            @($-<0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( #N#7%8X,@,Z @,  *$&   9              " @3!T  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ .X-<5L]OO>()!
MV@@  !D              ("!:7<  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  [@UQ68%M*V.H%   =#0  &0              @(&I
M>P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( #N#7%;!
M[$;^00D  #\6   9              " @<J!  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ .X-<5BR#W\XN!   ' H  !D
M     ("!0HL  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #N#7%8T6=W-GP(  *,&   9              "
M@2^D  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ .X-<
M5A&<MJ [!   0 H  !D              ("!!:<  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  [@UQ6DP=;##,7  #510  &0
M        @(%WJP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( #N#7%8&$^:T2@,  !$'   9              " @>'"  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ .X-<5D/I73YO @  404
M !D              ("!8L8  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  [@UQ6M5ZO%]@#  !9"@  &0              @($(R0
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( #N#7%;DVOC>
MQ@(  !@&   9              " @1?-  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ .X-<5DZ#]E4^ P  L <  !D
M ("!%-   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  [
M@UQ6,'PAM_$"   E!@  &0              @(&)TP  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( #N#7%:<0F4IQ@(  /@%   9
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M970S.2YX;6Q02P$"% ,4    "  [@UQ69#M\[?,%  "I#P  &0
M    @(&Q[0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M #N#7%;-,#QP^ (  "8'   9              " @=OS  !X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ .X-<5F$#<ZS2 @    <  !D
M             ("!"O<  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  [@UQ6[%X@)J("  !C!@  &0              @($3^@  >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( #N#7%8E5SRO$00
M *H)   9              " @>S\  !X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ .X-<5M:6G]1] P  (!(  !D              ("!
M- $! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  [@UQ6
MZYXKL](&  #0,   &0              @('H! $ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( #N#7%;:SJ!-# D  ,1"   9
M      " @?$+ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ .X-<5APL/-QY @  3P8  !D              ("!-!4! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  [@UQ6B3I$#W$"  !(!@
M&0              @('D%P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( #N#7%;D&;,+P 4  %4K   9              " @8P: 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ .X-<5O5Y:3%\
M @  +P8  !D              ("!@R ! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  [@UQ6\T6#@&4#  #/#@  &0
M@($V(P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( #N#
M7%970QM^AP(  , &   9              " @=(F 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ .X-<5B% B?NS!   AAH  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( #N#7%;\(%%Z@00   X7   9
M  " @19# 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M.X-<5MS0""KY @  & @  !D              ("!SD<! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  [@UQ6-^_BFV #  #@"   &0
M            @('^2@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( #N#7%9JO9.^Q@,  ,4/   9              " @95. 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ .X-<5@ZK5UQZ P
MP@X  !D              ("!DE(! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  [@UQ67.S6470#  !?"P  &0              @(%#
M5@$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( #N#7%94
MU\NM]0,  .L.   9              " @>Y9 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ .X-<5G2J=W4" P  A D  !D
M     ("!&EX! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #N#7%8'^LOUL (  .X&   9              "
M@79X 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ .X-<
M5BV@0FD&"0  K#<  !D              ("!77L! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    "  [@UQ6U4Q@P(8$  "=&P  &0
M        @(&:A $ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( #N#7%8+GA6]_P,  !T5   9              " @5>) 0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ .X-<5MRG&9/M @  0@H
M !D              ("!C8T! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    "  [@UQ6X_49(.,"  !2"   &0              @(&QD $
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( #N#7%8O2!\#
MI0,  .,,   9              " @<N3 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ .X-<5J2 $D!L!   R0\  !D
M ("!IY<! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  [
M@UQ6Q5"HW:D#  ",#   &0              @(%*G $ >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( #N#7%:,VX/:X (  #H*   9
M          " @2J@ 0!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#
M%     @ .X-<5CC7$6<]!   -!(  !D              ("!0:,! 'AL+W=O
M<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    "  [@UQ6K-4@,QL#  "
M"0  &0              @(&UIP$ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM
M;%!+ 0(4 Q0    ( #N#7%9*$.'TB (  -H%   9              " @0>K
M 0!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ .X-<5MYY
M8#.]!0  H1P  !D              ("!QJT! 'AL+W=O<FMS:&5E=',O<VAE
M970X-"YX;6Q02P$"% ,4    "  [@UQ6KSM&UU0#  #0%   #0
M    @ &ZLP$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #N#7%:7BKL<P
M !,"   +              "  3FW 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M #N#7%;I9^R8V08  %XW   /              "  2*X 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  [@UQ6DS&\_8 "  "3,0  &@
M@ $HOP$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  [
M@UQ6]S F!B<"   R,   $P              @ '@P0$ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     7 !< #L9   XQ $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>258</ContextCount>
  <ElementCount>393</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>82</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Changes in Shareholder's Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholder's Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - The Company and its Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies</Role>
      <ShortName>The Company and its Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Impact of COVID-19 Pandemic</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic</Role>
      <ShortName>Impact of COVID-19 Pandemic</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Recent Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/RecentAgreements</Role>
      <ShortName>Recent Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Property, Equipment and Leasehold Improvements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements</Role>
      <ShortName>Property, Equipment and Leasehold Improvements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets</Role>
      <ShortName>Trademarks, Licenses and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Loans Payable ??? Banks</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/LoansPayableBanks</Role>
      <ShortName>Loans Payable ??? Banks</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. Common Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Segments and Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/SegmentsAndGeographicAreas</Role>
      <ShortName>Segments and Geographic Areas</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows</Role>
      <ShortName>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies</Role>
      <ShortName>The Company and its Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables</Role>
      <ShortName>The Company and its Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Inventories</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables</Role>
      <ShortName>Property, Equipment and Leasehold Improvements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables</Role>
      <ShortName>Trademarks, Licenses and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/AccruedExpenses</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Long-termDebt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CommitmentsTables</Role>
      <ShortName>Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Commitments</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Equity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Segments and Geographic Areas (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables</Role>
      <ShortName>Segments and Geographic Areas (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/SegmentsAndGeographicAreas</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables</Role>
      <ShortName>Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails</Role>
      <ShortName>Schedule of lanvin brand name for our class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>The Company and its Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Recent Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative</Role>
      <ShortName>Recent Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/RecentAgreements</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Schedule of inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfInventoriesDetails</Role>
      <ShortName>Schedule of inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Inventories (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/InventoriesDetailsNarrative</Role>
      <ShortName>Inventories (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/InventoriesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Schedule of fair value, assets measured on recurring basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative</Role>
      <ShortName>Derivative Financial Instruments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails</Role>
      <ShortName>Schedule of equipment and leasehold improvements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative</Role>
      <ShortName>Property, Equipment and Leasehold Improvements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails</Role>
      <ShortName>Schedule of trademarks, licenses and other intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>Trademarks, Licenses and Other Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Accrued expenses consist of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails</Role>
      <ShortName>Accrued expenses consist of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Long-term debt consists of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails</Role>
      <ShortName>Long-term debt consists of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Loans Payable ??? Banks (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative</Role>
      <ShortName>Loans Payable ??? Banks (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/LoansPayableBanks</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Long-Term Debt (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/Long-termDebtDetailsNarrative</Role>
      <ShortName>Long-Term Debt (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/Long-termDebtTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails</Role>
      <ShortName>Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails</Role>
      <ShortName>minimum annual royalties and other commitments as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Commitments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/CommitmentsDetailsNarrative</Role>
      <ShortName>Commitments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/CommitmentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details</Role>
      <ShortName>The following table sets forth information with respect to nonvested options for 2022: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails</Role>
      <ShortName>The effect of share-based payment expenses decreased income statement line items as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details</Role>
      <ShortName>The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails</Role>
      <ShortName>The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails</Role>
      <ShortName>Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details</Role>
      <ShortName>The following table summarizes additional stock option information as of December 31, 2022: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/EquityDetailsNarrative</Role>
      <ShortName>Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/EquityTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails</Role>
      <ShortName>The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative</Role>
      <ShortName>Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Information on the Company???s operations by segments is as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails</Role>
      <ShortName>Information on the Company???s operations by segments is as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails</Role>
      <ShortName>Consolidated net sales to customers by region are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails</Role>
      <ShortName>Consolidated net sales to customers in major countries are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative</Role>
      <ShortName>Segments and Geographic Areas (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails</Role>
      <ShortName>The components of income before income taxes consist of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails</Role>
      <ShortName>The provision for current and deferred income tax expense (benefit) consists of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails</Role>
      <ShortName>The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails</Role>
      <ShortName>Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://interparfumsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails</Role>
      <ShortName>The components of accumulated other comprehensive loss consist of the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails</Role>
      <ShortName>Schedule of net income attributable to transfers from the noncontrolling interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details</Role>
      <ShortName>The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="g083417_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails</Role>
      <ShortName>Schedule of Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 37 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:SecurityExchangeName, us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension, us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife, us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths, us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments, us-gaap:LineOfCreditFacilityExpirationDate1, us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebtTerm, us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1, us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, us-gaap:WeightedAverageNumberOfSharesOutstandingBasic -  g083417_10k.htm 29, 32, 49, 50, 51, 52, 53, 54, 55, 76, 77, 78, 79, 80, 81, 82, 83, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 98, 99, 100, 101, 102, 107, 108, 109</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="g083417_10k.htm">g083417_10k.htm</File>
    <File>g083417_ex21.htm</File>
    <File>g083417_ex23.htm</File>
    <File>g083417_ex31-1.htm</File>
    <File>g083417_ex31-2.htm</File>
    <File>g083417_ex32-1.htm</File>
    <File>g083417_ex32-2.htm</File>
    <File>ipar-20221231.xsd</File>
    <File>ipar-20221231_cal.xml</File>
    <File>ipar-20221231_def.xml</File>
    <File>ipar-20221231_lab.xml</File>
    <File>ipar-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img001_v1.jpg</File>
    <File>img002_v1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1114">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>106
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "g083417_10k.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 2,
    "http://fasb.org/us-gaap/2022": 1114,
    "http://xbrl.sec.gov/dei/2022": 36
   },
   "contextCount": 258,
   "dts": {
    "calculationLink": {
     "local": [
      "ipar-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ipar-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "g083417_10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ipar-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ipar-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ipar-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 630,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 82,
    "http://interparfumsinc.com/20221231": 3,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 91
   },
   "keyCustom": 21,
   "keyStandard": 372,
   "memberCustom": 36,
   "memberStandard": 43,
   "nsprefix": "ipar",
   "nsuri": "http://interparfumsinc.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://interparfumsinc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Recent Agreements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://interparfumsinc.com/role/RecentAgreements",
     "shortName": "Recent Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://interparfumsinc.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://interparfumsinc.com/role/FairValueOfFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Derivative Financial Instruments",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://interparfumsinc.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Property, Equipment and Leasehold Improvements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements",
     "shortName": "Property, Equipment and Leasehold Improvements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets",
     "shortName": "Trademarks, Licenses and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Accrued Expenses",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://interparfumsinc.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Loans Payable \u2013 Banks",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://interparfumsinc.com/role/LoansPayableBanks",
     "shortName": "Loans Payable \u2013 Banks",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://interparfumsinc.com/role/Long-termDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Commitments",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://interparfumsinc.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://interparfumsinc.com/role/BalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Equity",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://interparfumsinc.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Segments and Geographic Areas",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreas",
     "shortName": "Segments and Geographic Areas",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://interparfumsinc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Accumulated Other Comprehensive Loss",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows",
     "shortName": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts",
     "shortName": "Schedule II - Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies",
     "shortName": "The Company and its Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables",
     "shortName": "The Company and its Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://interparfumsinc.com/role/BalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://interparfumsinc.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables",
     "shortName": "Property, Equipment and Leasehold Improvements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables",
     "shortName": "Trademarks, Licenses and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://interparfumsinc.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://interparfumsinc.com/role/Long-termDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Commitments (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://interparfumsinc.com/role/CommitmentsTables",
     "shortName": "Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Equity (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://interparfumsinc.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Segments and Geographic Areas (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables",
     "shortName": "Segments and Geographic Areas (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://interparfumsinc.com/role/StatementsOfIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://interparfumsinc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables",
     "shortName": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails",
     "shortName": "Schedule of lanvin brand name for our class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "The Company and its Significant Accounting Policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Recent Agreements (Details Narrative)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
     "shortName": "Recent Agreements (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Schedule of inventories (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails",
     "shortName": "Schedule of inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - Inventories (Details Narrative)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://interparfumsinc.com/role/InventoriesDetailsNarrative",
     "shortName": "Inventories (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails",
     "shortName": "Schedule of fair value, assets measured on recurring basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_ForeignExchangeContractMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative",
     "shortName": "Derivative Financial Instruments (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_ForeignExchangeContractMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails",
     "shortName": "Schedule of equipment and leasehold improvements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative",
     "shortName": "Property, Equipment and Leasehold Improvements (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
     "shortName": "Schedule of trademarks, licenses and other intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative",
     "shortName": "Trademarks, Licenses and Other Intangible Assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedAdvertisingCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - Accrued expenses consist of the following: (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails",
     "shortName": "Accrued expenses consist of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedAdvertisingCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - Long-term debt consists of the following: (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
     "shortName": "Long-term debt consists of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31_custom_DomesticSubsidiariesMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - Loans Payable \u2013 Banks (Details Narrative)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
     "shortName": "Loans Payable \u2013 Banks (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31_custom_DomesticSubsidiariesMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - Long-Term Debt (Details Narrative)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative",
     "shortName": "Long-Term Debt (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Consolidated Statements of Changes in Shareholder's Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity",
     "shortName": "Consolidated Statements of Changes in Shareholder's Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails",
     "shortName": "Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails",
     "shortName": "minimum annual royalties and other commitments as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ipar:OperatingLeaseOfRelatedToRentalExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - Commitments (Details Narrative)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
     "shortName": "Commitments (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ipar:OperatingLeaseOfRelatedToRentalExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details",
     "shortName": "The following table sets forth information with respect to nonvested options for 2022: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
     "shortName": "The effect of share-based payment expenses decreased income statement line items as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details",
     "shortName": "The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails",
     "shortName": "The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails",
     "shortName": "Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DeferredTaxExpenseFromStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
     "shortName": "The following table summarizes additional stock option information as of December 31, 2022: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - Equity (Details Narrative)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://interparfumsinc.com/role/EquityDetailsNarrative",
     "shortName": "Equity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://interparfumsinc.com/role/StatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
     "shortName": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative",
     "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - Information on the Company\u2019s operations by segments is as follows: (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
     "shortName": "Information on the Company\u2019s operations by segments is as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
     "shortName": "Consolidated net sales to customers by region are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_srt_NorthAmericaMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails",
     "shortName": "Consolidated net sales to customers in major countries are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_custom_UnitedStatesMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative",
     "shortName": "Segments and Geographic Areas (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_country_US",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails",
     "shortName": "The components of income before income taxes consist of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails",
     "shortName": "The provision for current and deferred income tax expense (benefit) consists of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails",
     "shortName": "The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails",
     "shortName": "Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - The Company and its Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies",
     "shortName": "The Company and its Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredForeignIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - Income Taxes (Details Narrative)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income Taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-012022-12-31_custom_ForeignDerivedIntangibleIncomeMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredForeignIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails",
     "shortName": "The components of accumulated other comprehensive loss consist of the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails",
     "shortName": "Schedule of net income attributable to transfers from the noncontrolling interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details",
     "shortName": "The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails",
     "shortName": "Schedule of Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_AllowanceForCreditLossMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ImpactOfCOVID19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Impact of COVID-19 Pandemic",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic",
     "shortName": "Impact of COVID-19 Pandemic",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "g083417_10k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ipar:ImpactOfCOVID19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 82,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r709",
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r709",
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r709",
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r709",
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r709",
      "r711",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents accumulated defined benefit plans net derivative instruments member.",
        "label": "Accumulated Defined Benefit Plans Net Derivative Instruments [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents accumulated other comprehensive income loss net of tax.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "periodEndLabel": "Net derivative instruments, end of year",
        "periodStartLabel": "Net derivative instruments, beginning of year"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax1",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents accumulated other comprehensive income loss net of tax.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax [Default Label]",
        "periodEndLabel": "Cumulative translation adjustments, end of year",
        "periodStartLabel": "Cumulative translation adjustments, beginning of year"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax2",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_CashHeldInEscrowIncludedInOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash held in escrow included in other assets.",
        "label": "Cash held in escrow included in other assets (see note 3)"
       }
      }
     },
     "localname": "CashHeldInEscrowIncludedInOtherAssets",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_CentralAndSouthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents central and south america member.",
        "label": "Central and South America [Member]"
       }
      }
     },
     "localname": "CentralAndSouthAmericaMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ChangeInFairValueOfDerivatives": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents change in fair value of derivatives.",
        "label": "Change in Fair Value of Derivatives",
        "negatedLabel": "Change in fair value of derivatives"
       }
      }
     },
     "localname": "ChangeInFairValueOfDerivatives",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_CoachMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents coach member.",
        "label": "Coach [Member]"
       }
      }
     },
     "localname": "CoachMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_DeferredTaxAssetsInventoryAndAccountsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents deferred tax assets inventory and accounts receivable.",
        "label": "Inventory and accounts receivable"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventoryAndAccountsReceivable",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_DeferredTaxLiabilitiesBuildingExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents deferred tax liabilities building expenses.",
        "label": "Building expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesBuildingExpenses",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents deferred tax liabilities unrealized gain on marketable equity securities.",
        "label": "Unrealized gain on marketable equity securities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_DisclosureImpactOfCovid19PandemicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impact Of Covid-19 Pandemic"
       }
      }
     },
     "localname": "DisclosureImpactOfCovid19PandemicAbstract",
     "nsuri": "http://interparfumsinc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows",
        "verboseLabel": "Following Table Summarizes Cash And Cash Equivalents As Of December 31 2021"
       }
      }
     },
     "localname": "DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract",
     "nsuri": "http://interparfumsinc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "ipar_DomesticSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents domestic subsidiaries member.",
        "label": "Domestic Subsidiaries [Member]"
       }
      }
     },
     "localname": "DomesticSubsidiariesMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_DonnaKaranAndDKNYMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents donna karan and dkny member.",
        "label": "Donna Karan and DKNY [Member]"
       }
      }
     },
     "localname": "DonnaKaranAndDKNYMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_DueVendorsNotYetInvoiced": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents due vendors not yet invoiced.",
        "label": "Due vendors (not yet invoiced)"
       }
      }
     },
     "localname": "DueVendorsNotYetInvoiced",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents effective income tax rate reconciliation at federal statutory income tax rate1.",
        "label": "Effect of foreign taxes greater than U.S. statutory rates"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ipar_EliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for eliminations.",
        "label": "Eliminations [Member]"
       }
      }
     },
     "localname": "EliminationsMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_EmanuelUngarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents emanuel ungar member.",
        "label": "Emanuel Ungar [Member]"
       }
      }
     },
     "localname": "EmanuelUngarMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents employees member.",
        "label": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_EuroInterbankOfferedRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents euro interbank offered rate member.",
        "label": "Euro Interbank Offered Rate [Member]"
       }
      }
     },
     "localname": "EuroInterbankOfferedRateMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents exercise price range four member.",
        "label": "Exercise Price Range Four [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents exercise price range one member.",
        "label": "Exercise Price Range One [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeOneMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents exercise price range three member.",
        "label": "Exercise Price Range Three [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents exercise price range two member.",
        "label": "Exercise Price Range Two [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ForeignDerivedIntangibleIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents foreign derived intangible income member.",
        "label": "Foreign Derived Intangible Income [Member]"
       }
      }
     },
     "localname": "ForeignDerivedIntangibleIncomeMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ForeignSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents foreign subsidiaries member.",
        "label": "Foreign Subsidiaries [Member]"
       }
      }
     },
     "localname": "ForeignSubsidiariesMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_FranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents france member.",
        "label": "France [Member]"
       }
      }
     },
     "localname": "FranceMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_GUESSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents g u e s s member.",
        "label": "G U E S S [Member]"
       }
      }
     },
     "localname": "GUESSMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ImpactOfCOVID19PandemicTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents impact of c o v i d19 pandemic text block.",
        "label": "Impact of COVID-19 Pandemic"
       }
      }
     },
     "localname": "ImpactOfCOVID19PandemicTextBlock",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ipar_InterparfumsSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents interparfums s a member.",
        "label": "interparfums S A [Member]"
       }
      }
     },
     "localname": "InterparfumsSAMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_InterparfumsSASubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents interparfums sa subsidiary member.",
        "label": "Interparfums SA Subsidiary [Member]"
       }
      }
     },
     "localname": "InterparfumsSASubsidiaryMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_JanvinMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents janvin member.",
        "label": "Janvin [Member]"
       }
      }
     },
     "localname": "JanvinMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_JimmyChooMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents jimmy choo member.",
        "label": "Jimmy Choo [Member]"
       }
      }
     },
     "localname": "JimmyChooMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents less imputed interest based on2.6 weightedaverage discount rate.",
        "label": "Less Imputed Interest Based on2.6 Weighted Average Discount Rate",
        "negatedLabel": "Less imputed interest (based on 2.6% weighted-average discount rate)"
       }
      }
     },
     "localname": "LessImputedInterestBasedOn2.6WeightedaverageDiscountRate",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents lessee operating lease liability payments due net total.",
        "label": "Net Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNetTotal",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_LoansPayableOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents loans payable one member.",
        "label": "Loans Payable One [Member]"
       }
      }
     },
     "localname": "LoansPayableOneMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LoansPayableThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents loans payable three member.",
        "label": "Loans Payable Three [Member]"
       }
      }
     },
     "localname": "LoansPayableThreeMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LoansPayableTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents loans payable two member.",
        "label": "Loans Payable Two [Member]"
       }
      }
     },
     "localname": "LoansPayableTwoMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_LondonInterbankOfferedRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents london interbank offered rate member.",
        "label": "London Interbank Offered Rate [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_MontblancMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents montblanc member.",
        "label": "Montblanc [Member]"
       }
      }
     },
     "localname": "MontblancMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_NetDerivativeInstrumentLossNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents net derivative instrument loss net of tax.",
        "label": "Net derivative instrument loss, net of tax"
       }
      }
     },
     "localname": "NetDerivativeInstrumentLossNetOfTax",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_NumberOfInstallment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents number of installment.",
        "label": "Number of installments"
       }
      }
     },
     "localname": "NumberOfInstallment",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ipar_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents operating lease member.",
        "label": "Operating Lease [Member]"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_OperatingLeaseOfRelatedToRentalExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents operating lease of related to rental expenses.",
        "label": "Operating lease of related to rental expenses"
       }
      }
     },
     "localname": "OperatingLeaseOfRelatedToRentalExpenses",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_OtherSegmentCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents other segment country member.",
        "label": "Other Segment Country [Member]"
       }
      }
     },
     "localname": "OtherSegmentCountryMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_PercentageOfIncreaseInAnnualDividend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents percentage of increase in annual dividend.",
        "label": "Percentage of increase in annual dividend"
       }
      }
     },
     "localname": "PercentageOfIncreaseInAnnualDividend",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ipar_ProductSalesConcentrationRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents product sales concentration risk member.",
        "label": "Product Sales Concentration Risk [Member]"
       }
      }
     },
     "localname": "ProductSalesConcentrationRiskMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ProvisionForDoubtfulAccounts1": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents provision for doubtful accounts1.",
        "label": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts1",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents reconciliation of cash and cash equivalents to the statement of cash flows text block.",
        "label": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows"
       }
      }
     },
     "localname": "ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ipar_RochasFashionBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents rochas fashion business member.",
        "label": "Rochas Fashion Business [Member]"
       }
      }
     },
     "localname": "RochasFashionBusinessMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_RochasFashionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stans for rochas fashion.",
        "label": "Rochas Fashion [Member]"
       }
      }
     },
     "localname": "RochasFashionMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_RoyaltyExpenseNetSalesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents royalty expense net sales percentage.",
        "label": "Royalty expense, percentage of net sales"
       }
      }
     },
     "localname": "RoyaltyExpenseNetSalesPercentage",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ipar_RussiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents russia member.",
        "label": "Russia [Member]"
       }
      }
     },
     "localname": "RussiaMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents schedule of maturities of lease liabilities subsequent table text block.",
        "label": "Maturities of lease liabilities subsequent to December 31, 2022 are as follows:"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ipar_StockOptionOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents stock option one member.",
        "label": "Stock Option One [Member]"
       }
      }
     },
     "localname": "StockOptionOneMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_SubtotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents subtotal member.",
        "label": "Subtotal [Member]"
       }
      }
     },
     "localname": "SubtotalMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_SupplementalDisclosureOfCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalDisclosureOfCashFlowInformationAbstract",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents transfer of subsidiary shares purchased to treasury shares.",
        "label": "Transfer of subsidiary shares purchased"
       }
      }
     },
     "localname": "TransferOfSubsidiarySharesPurchasedToTreasuryShares",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ipar_UnitedKingdomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents united kingdom member.",
        "label": "United Kingdom [Member]"
       }
      }
     },
     "localname": "UnitedKingdomMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ipar_UnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The element represents united states member.",
        "label": "United States [Member]"
       }
      }
     },
     "localname": "UnitedStatesMember",
     "nsuri": "http://interparfumsinc.com/20221231",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Asia.",
        "label": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leader of board of directors.",
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r294",
      "r527",
      "r528",
      "r531",
      "r532",
      "r585",
      "r649",
      "r653",
      "r750",
      "r753",
      "r754",
      "r791",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r294",
      "r527",
      "r528",
      "r531",
      "r532",
      "r585",
      "r649",
      "r653",
      "r750",
      "r753",
      "r754",
      "r791",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "minimum annual royalties and other commitments as follows:"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r476",
      "r593",
      "r624",
      "r650",
      "r651",
      "r678",
      "r686",
      "r697",
      "r755",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r476",
      "r593",
      "r624",
      "r650",
      "r651",
      "r678",
      "r686",
      "r697",
      "r755",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of North America.",
        "label": "North America [Member]"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r362",
      "r595",
      "r679",
      "r695",
      "r747",
      "r748",
      "r756",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r362",
      "r595",
      "r679",
      "r695",
      "r747",
      "r748",
      "r756",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r468",
      "r476",
      "r486",
      "r487",
      "r488",
      "r590",
      "r593",
      "r624",
      "r650",
      "r651",
      "r678",
      "r686",
      "r697",
      "r746",
      "r755",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r468",
      "r476",
      "r486",
      "r487",
      "r488",
      "r590",
      "r593",
      "r624",
      "r650",
      "r651",
      "r678",
      "r686",
      "r697",
      "r746",
      "r755",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r302",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "Schedule II - Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r363",
      "r364",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r652",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r680",
      "r696",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r363",
      "r364",
      "r632",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r652",
      "r654",
      "r680",
      "r696",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r744",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r300",
      "r301",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r16",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable - trade"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedAdvertisingCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Advertising liabilities"
       }
      }
     },
     "localname": "AccruedAdvertisingCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r20",
      "r666"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r20",
      "r666"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Salary (including bonus and related taxes)"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r106",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r33",
      "r34",
      "r257",
      "r617",
      "r629",
      "r630"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r270",
      "r271",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r30",
      "r34",
      "r174",
      "r582",
      "r625",
      "r626",
      "r725",
      "r726",
      "r727",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r28",
      "r34",
      "r174",
      "r271",
      "r272",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "License agreement renewal term"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "License agreement term"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition costs, period cost"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r8",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r739",
      "r740",
      "r741",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionsToOtherAssetsAmount": {
     "auth_ref": [
      "r719"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of significant additions in the period in other assets (current, noncurrent, or unclassified).",
        "label": "Additions to Other Assets, Amount"
       }
      }
     },
     "localname": "AdditionsToOtherAssetsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising and Promotion"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r258",
      "r372",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowances for sales returns and doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r61",
      "r89",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive securities excluded from computation of earnings per share, amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r61",
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Impairment charge"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r211",
      "r230",
      "r255",
      "r289",
      "r346",
      "r352",
      "r358",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r527",
      "r531",
      "r548",
      "r694",
      "r751",
      "r752",
      "r780"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "negatedLabel": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r247",
      "r262",
      "r289",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r527",
      "r531",
      "r548",
      "r694",
      "r751",
      "r752",
      "r780"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r524",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r524",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
        "label": "Description of recent agreement"
       }
      }
     },
     "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Recent Agreements"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r68",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Business of the Company"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r63",
      "r250",
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents per balance sheet"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents and Short-Term Investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r57",
      "r63",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and cash equivalents per statement of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r57",
      "r63",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents \u2013 end of year",
        "periodStartLabel": "Cash and cash equivalents \u2013 beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r57",
      "r203"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.",
        "label": "Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:"
       }
      }
     },
     "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r109",
      "r400",
      "r401",
      "r634",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "License Agreements"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Dividends declared per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r739",
      "r740",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.001 par value. Authorized 100,000,000 shares: outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r35",
      "r266",
      "r268",
      "r278",
      "r613",
      "r621"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Inter Parfums Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r167",
      "r168",
      "r178",
      "r266",
      "r268",
      "r277",
      "r612",
      "r620"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss), net of tax, atributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income attributable to noncontrolling interests:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r166",
      "r178",
      "r266",
      "r268",
      "r276",
      "r611",
      "r619"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r47",
      "r275",
      "r610",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r71",
      "r72",
      "r198",
      "r199",
      "r366",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r71",
      "r72",
      "r198",
      "r199",
      "r366",
      "r631",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r71",
      "r72",
      "r198",
      "r199",
      "r366",
      "r633",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r71",
      "r72",
      "r198",
      "r199",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r71",
      "r72",
      "r198",
      "r199",
      "r366",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet": {
     "auth_ref": [
      "r120",
      "r175",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the total net income attributable to the parent for the period and the effect of net changes during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not result in a deconsolidation of the subsidiary from the consolidated financial statements.",
        "label": "Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet": {
     "auth_ref": [
      "r120",
      "r175",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not arise in a deconsolidation of the subsidiary from the consolidated financial statements.",
        "label": "Decrease in Inter Parfums, Inc.\u2019s additional paid-in capital for subsidiary share transactions"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r175",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Schedule of net income attributable to transfers from the noncontrolling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy": {
     "auth_ref": [
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Issuance of Common Stock by Consolidated Subsidiary"
       }
      }
     },
     "localname": "ConsolidationSubsidiaryStockIssuancesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiability": {
     "auth_ref": [
      "r757"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.",
        "label": "Contract with customer, refund liability"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRightToRecoverProduct": {
     "auth_ref": [
      "r757"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to recover product from customer on settling refund liability.",
        "label": "Contract with customer, right to recover products"
       }
      }
     },
     "localname": "ContractWithCustomerRightToRecoverProduct",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r42",
      "r595"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of sales",
        "verboseLabel": "Shipping and handling costs"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldOverhead": {
     "auth_ref": [
      "r728"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indirect cost incurred related to good produced and service rendered.",
        "label": "Cost of Goods Sold, Overhead"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldOverhead",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk that a borrower will fail to pay interest or principal on a loan or debt security when due.",
        "label": "Credit Risk [Member]"
       }
      }
     },
     "localname": "CreditRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r732",
      "r762",
      "r764"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r732",
      "r762"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r508",
      "r516",
      "r732"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current income tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r732",
      "r762",
      "r764"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r70",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.",
        "label": "Refund (return) liability"
       }
      }
     },
     "localname": "CustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r287",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r431",
      "r438",
      "r439",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Loans Payable \u2013 Banks"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r212",
      "r214",
      "r228",
      "r294",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r569",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Basis spread over variable interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r205",
      "r207",
      "r415",
      "r569",
      "r674",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt instrument, face amount",
        "verboseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r22",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Interest per annum",
        "verboseLabel": "Variable rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateTerms": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.",
        "label": "Description of debt instrument interest rate terms"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r23",
      "r294",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r569",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r23",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Installment amount (in Dollars)"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r23",
      "r115",
      "r116",
      "r117",
      "r118",
      "r204",
      "r205",
      "r207",
      "r226",
      "r294",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r569",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss recognized in earnings from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) to investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Transfer from other comprehensive income into earnings",
        "negatedLabel": "Transfer from other comprehensive income into earnings"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTransferToTradingLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r124",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Straight line basis over the requisite"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r732",
      "r763",
      "r764"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r732",
      "r763"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "verboseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative",
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r496",
      "r497"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred tax assets",
        "verboseLabel": "Deferred Income Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r61",
      "r157",
      "r509",
      "r515",
      "r516",
      "r732"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r4",
      "r5",
      "r213",
      "r227",
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred income tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r732",
      "r763",
      "r764"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Profit sharing"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Total gross deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Effect of inventory profit elimination"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "verboseLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Foreign net operating loss carry-forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Stock option compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.",
        "label": "Tax benefits"
       }
      }
     },
     "localname": "DeferredTaxExpenseFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities (long-term):"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r155",
      "r761"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "negatedLabel": "Trademarks and licenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r61",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r61",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r61",
      "r341"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and amortization including impairment loss"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r189",
      "r190",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative",
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r194",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r184",
      "r186",
      "r189",
      "r190",
      "r192",
      "r193",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Loan amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r191",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DistributionMadeToLimitedPartnerUnitDistribution": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of units distributed for payment of a unit distribution to unit-holder of limited partnership (LP).",
        "label": "Number of share distributed"
       }
      }
     },
     "localname": "DistributionMadeToLimitedPartnerUnitDistribution",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r119",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedLabel": "Dividends"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends payable, amount per share (in Dollars per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r279",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r316",
      "r318",
      "r320",
      "r321",
      "r322",
      "r326",
      "r538",
      "r539",
      "r614",
      "r622",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income attributable to Inter Parfums, Inc. common shareholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r279",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r318",
      "r320",
      "r321",
      "r322",
      "r326",
      "r538",
      "r539",
      "r614",
      "r622",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share attributable to Inter Parfums, Inc"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective rates"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r291",
      "r499",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Statutory rates"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends": {
     "auth_ref": [
      "r759",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend paid to employee stock ownership plan.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent",
        "negatedLabel": "Windfall benefit from exercise of stock options"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r759",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Benefit of Foreign Derived Intangible Income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r759",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r759",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State and local taxes, net of Federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of plan compensation cost recognized during the period.",
        "label": "Aggregate cost"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity:",
        "verboseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r114",
      "r243",
      "r270",
      "r271",
      "r272",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r315",
      "r329",
      "r376",
      "r456",
      "r489",
      "r490",
      "r491",
      "r511",
      "r512",
      "r537",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565",
      "r582",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r219",
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Cash held in escrow is included in other assets"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r540",
      "r541",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset."
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r429",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r541",
      "r587",
      "r588",
      "r589",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r540",
      "r541",
      "r543",
      "r544",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis": {
     "auth_ref": [
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit or market risk.",
        "label": "Concentration of Credit or Market Risk [Axis]"
       }
      }
     },
     "localname": "FairValueConcentrationOfRiskDisclosureItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueConcentrationOfRiskDisclosureItemsDomain": {
     "auth_ref": [
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the general information items required or determined to be disclosed with respect to all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties."
       }
      }
     },
     "localname": "FairValueConcentrationOfRiskDisclosureItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r429",
      "r469",
      "r474",
      "r541",
      "r587",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r429",
      "r469",
      "r474",
      "r541",
      "r588",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r429",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r541",
      "r589",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r429",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r587",
      "r588",
      "r589",
      "r674",
      "r675",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r253",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r95",
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Gross Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the entity's intent or ability to renew or extend the arrangement related to an intangible asset and how that affects expected future cash flows.",
        "label": "License agreement, expiration description"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r90",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets [Member]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r95",
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Net Book Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign currency contracts, liability, fair value disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value",
        "verboseLabel": "Foreign currency forward exchange contracts not accounted for using hedge accounting"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.",
        "label": "Foreign currency forward exchange contracts accounted for using hedge accounting"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.",
        "label": "Foreign currency forward exchange contracts not accounted for using hedge accounting"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r549",
      "r551",
      "r553",
      "r555"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedLabel": "Loss (gain) on foreign currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r667",
      "r681",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Net derivative instrument gain (loss), net of tax"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r41",
      "r289",
      "r346",
      "r351",
      "r357",
      "r360",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r548",
      "r671",
      "r751"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentChargeOnReclassifiedAssets": {
     "auth_ref": [
      "r101",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.",
        "label": "Impairment Charge on Reclassified Assets"
       }
      }
     },
     "localname": "ImpairmentChargeOnReclassifiedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLeasehold": {
     "auth_ref": [
      "r61",
      "r102"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.",
        "label": "Impairment loss"
       }
      }
     },
     "localname": "ImpairmentOfLeasehold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r290",
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r290",
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Foreign operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r346",
      "r351",
      "r357",
      "r360",
      "r671"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r38",
      "r61",
      "r84",
      "r220",
      "r237",
      "r343"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Share of income of equity investment"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r291",
      "r500",
      "r501",
      "r507",
      "r513",
      "r519",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r292",
      "r314",
      "r315",
      "r344",
      "r498",
      "r514",
      "r520",
      "r623"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income taxes",
        "terseLabel": "Total income tax expense",
        "verboseLabel": "Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r269",
      "r494",
      "r495",
      "r501",
      "r502",
      "r506",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r58",
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r219",
      "r236",
      "r720"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r729"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Income taxes, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r729",
      "r777"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedLicenseAgreements": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.",
        "label": "Indefinite-Lived License Agreements"
       }
      }
     },
     "localname": "IndefiniteLivedLicenseAgreements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Member]"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Trademarks, Licenses and Other Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r88",
      "r93"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Trademarks, licenses and other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r206",
      "r223",
      "r273",
      "r340",
      "r568"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r281",
      "r284",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.",
        "label": "Interest Rate Derivative Liabilities, at Fair Value",
        "negatedLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateDerivativeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet": {
     "auth_ref": [
      "r181"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivatives designated as interest rate fair value hedging instruments.",
        "label": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateFairValueHedgeDerivativeAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r721"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r260",
      "r665",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r249",
      "r259",
      "r328",
      "r378",
      "r379",
      "r380",
      "r594",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r722"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Raw materials and component parts"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserveMember": {
     "auth_ref": [
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve to reduce inventory to lower of cost or net realizable value.",
        "label": "SEC Schedule, 12-09, Reserve, Inventory [Member]"
       }
      }
     },
     "localname": "InventoryValuationReserveMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r86",
      "r723"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "negatedLabel": "Interest and investment income",
        "negatedTerseLabel": "Investment Income, Interest and Dividend"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Gross Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r578",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Operating Leases"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r216",
      "r234",
      "r694",
      "r731",
      "r745",
      "r774"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity [Default Label]",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r248",
      "r289",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r528",
      "r531",
      "r532",
      "r548",
      "r694",
      "r751",
      "r780",
      "r781"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r3",
      "r214",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of credit, maximum borrowing amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r214",
      "r231",
      "r428",
      "r442",
      "r674",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Loan payable"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Current portion of long-term debt",
        "verboseLabel": "Less current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtDescription": {
     "auth_ref": [
      "r23",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.",
        "label": "Long term debt maturity, description"
       }
      }
     },
     "localname": "LongTermDebtDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r111",
      "r294",
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long\u2013term debt, less current portion",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-term debt, term"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r23",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails",
      "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of risks inherent in servicing assets and servicing liabilities.",
        "label": "Servicing Assets and Servicing Liabilities Risk [Axis]"
       }
      }
     },
     "localname": "ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketingExpense": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.",
        "label": "Customer incentives cost"
       }
      }
     },
     "localname": "MarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MiddleEastMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Middle East.",
        "label": "Middle East [Member]"
       }
      }
     },
     "localname": "MiddleEastMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r26",
      "r215",
      "r233",
      "r289",
      "r375",
      "r406",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r548"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Ownership percentage in Interparfums SA",
        "verboseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r57",
      "r59",
      "r62"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r39",
      "r62",
      "r221",
      "r238",
      "r246",
      "r264",
      "r267",
      "r272",
      "r289",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r319",
      "r346",
      "r351",
      "r357",
      "r360",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r539",
      "r548",
      "r671",
      "r751"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income attributable to Inter Parfums, Inc.",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Inter Parfums, Inc.",
        "verboseLabel": "Numerator for diluted earnings per share (in dollars)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r171",
      "r177",
      "r264",
      "r267",
      "r314",
      "r315",
      "r727"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Less: Net income attributable to the noncontrolling interest",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r120",
      "r170",
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "negatedLabel": "Purchase of subsidiary shares from noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r164",
      "r456",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets [Default Label]",
        "verboseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses (income):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r346",
      "r351",
      "r357",
      "r360",
      "r671"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing operating income (loss).",
        "label": "Operating Income (Loss) [Member]"
       }
      }
     },
     "localname": "OperatingIncomeLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r573",
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Noncash additions to operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Lease liabilities, less current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r572",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r576",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average cost of capital",
        "verboseLabel": "Operating lease, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r575",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r261",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r254"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Total"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueAfterFifthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "OtherCommitmentDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInFifthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "OtherCommitmentDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInFourthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "OtherCommitmentDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "OtherCommitmentDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInSecondYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "OtherCommitmentDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInThirdYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "OtherCommitmentDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r29",
      "r31",
      "r550",
      "r552",
      "r557"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "negatedLabel": "Translation adjustments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r27",
      "r32",
      "r550",
      "r554",
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Foreign currency translation adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r85",
      "r275",
      "r558",
      "r563",
      "r565",
      "r610",
      "r618",
      "r725",
      "r726"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other comprehensive income (loss), before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax": {
     "auth_ref": [
      "r263",
      "r533"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Net derivative instrument income (loss), \u00a0net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Translation adjustments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r27",
      "r32",
      "r554",
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r166",
      "r167",
      "r173",
      "r265",
      "r268"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Net derivative instrument income (loss), \u00a0net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "negatedLabel": "Other loss (income)"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Receivables, other"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Dividends paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Payment for intangible assets acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r280",
      "r766",
      "r767",
      "r768"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Purchase price, period cost"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property, equipment and leasehold improvements"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchase of subsidiary shares from noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": {
     "auth_ref": [
      "r2",
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.",
        "label": "Retirement reserves"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r6",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r6",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.001 par value. Authorized 1,000,000 shares: none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r52",
      "r148"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of options",
        "verboseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r246",
      "r264",
      "r267",
      "r282",
      "r289",
      "r306",
      "r314",
      "r315",
      "r346",
      "r351",
      "r357",
      "r360",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r526",
      "r529",
      "r530",
      "r539",
      "r548",
      "r615",
      "r671",
      "r690",
      "r691",
      "r727",
      "r751"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity",
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r637",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Equipment and Leasehold Improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r105",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Equipment and leasehold improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r107",
      "r235",
      "r616",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, equipment and leasehold improvements, net",
        "verboseLabel": "Property, Plant and Equipment, Net, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property, Equipment and Leasehold Improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of equipment and leasehold improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Depreciated over a range"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForLoanLeaseAndOtherLosses": {
     "auth_ref": [
      "r60",
      "r82",
      "r222"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.",
        "label": "Lease expense"
       }
      }
     },
     "localname": "ProvisionForLoanLeaseAndOtherLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r34",
      "r36"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedLabel": "Transfer of OCI into earnings"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r475",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r475",
      "r583",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepurchaseAgreementsCollateralPolicy": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy with regard to collateral required and collateral rights on securities sold under agreements to repurchase.",
        "label": "Treasury Stock"
       }
      }
     },
     "localname": "RepurchaseAgreementsCollateralPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Package Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r119",
      "r232",
      "r628",
      "r630",
      "r694"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r243",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r315",
      "r376",
      "r489",
      "r490",
      "r491",
      "r511",
      "r512",
      "r537",
      "r625",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r337",
      "r338",
      "r350",
      "r355",
      "r356",
      "r362",
      "r363",
      "r366",
      "r465",
      "r466",
      "r595"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Net sales",
        "verboseLabel": "Revenue from Contract with Customer, Including Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAllowances": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue recognition for sales allowances.",
        "label": "Payments to Customers"
       }
      }
     },
     "localname": "RevenueRecognitionAllowances",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionSalesReturns": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for sales returns.",
        "label": "Sales Returns"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturns",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r274",
      "r289",
      "r337",
      "r338",
      "r350",
      "r355",
      "r356",
      "r362",
      "r363",
      "r366",
      "r375",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r548",
      "r615",
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenue from export sales",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The nature of risks inherent in servicing assets and servicing liabilities."
       }
      }
     },
     "localname": "RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesReturnsAndAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers.",
        "label": "Sales Returns and Allowances [Member]"
       }
      }
     },
     "localname": "SalesReturnsAndAllowancesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r366",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Accrued expenses consist of the following:"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r34",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "The components of accumulated other comprehensive loss consist of the following:"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r159",
      "r160",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "The following table summarizes cash and cash equivalents as of December 31, 2021:"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "The provision for current and deferred income tax expense (benefit) consists of the following:"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r23",
      "r115",
      "r116",
      "r117",
      "r118",
      "r204",
      "r205",
      "r207",
      "r226",
      "r674",
      "r676",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Long-term debt consists of the following:"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Long-termDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of fair value, assets measured on recurring basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r90",
      "r94",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CommitmentsDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails",
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.",
        "label": "Schedule of trademarks, licenses and other intangible assets"
       }
      }
     },
     "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "The components of income before income taxes consist of the following:"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r13",
      "r14",
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "The following table sets forth information with respect to nonvested options for 2022:"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative",
      "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Consolidated net sales to customers in major countries are as follows:"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r40",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Consolidated net sales to customers by region are as follows:"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r37",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails",
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Information on the Company\u2019s operations by segments is as follows:"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r138",
      "r140",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "The effect of share-based payment expenses decreased income statement line items as follows:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "The following table summarizes additional stock option information as of December 31, 2022:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r135",
      "r140",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "The assumptions used in the Black-Scholes pricing model are set forth in the following table:"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r69",
      "r71",
      "r72",
      "r73",
      "r198",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedule of lanvin brand name for our class"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r334",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r366",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r398",
      "r399",
      "r672",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r346",
      "r349",
      "r354",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segments and Geographic Areas"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/SegmentsAndGeographicAreas"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Noncash stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based compensation arrangement by share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Weighted-average dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Weighted-average expected stock-price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Weighted-average risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Adjusted for stock splits (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Weighted average exercise price of options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Nonvested options granted",
        "verboseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details",
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted Average Grant Date Fair Value, granted",
        "verboseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative",
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options shares under option - end of year",
        "periodStartLabel": "Options shares under option - beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price shares under option - end of year",
        "periodStartLabel": "Weighted average exercise price shares under option - beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Weighted average exercise price options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Weighted average exercise price options forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Weighted average exercise price options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average expected option life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Aggregate intrinsic value of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining contractual life of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "periodEndLabel": "Nonvested options - end of year",
        "periodStartLabel": "Nonvested options - beginning of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "negatedLabel": "Nonvested options vested or forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited.",
        "label": "Weighted Average Grant Date Fair Value, vested or forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, end of year",
        "periodStartLabel": "Weighted Average Grant Date Fair Value, beginning of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Fair value of shares vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Exercise price range (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Options outstanding weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r217",
      "r218",
      "r229",
      "r724"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r68",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "The Company and its Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r245",
      "r334",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r366",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r396",
      "r398",
      "r399",
      "r672",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r25",
      "r114",
      "r243",
      "r270",
      "r271",
      "r272",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r315",
      "r329",
      "r376",
      "r456",
      "r489",
      "r490",
      "r491",
      "r511",
      "r512",
      "r537",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565",
      "r582",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r329",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails",
      "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details",
      "http://interparfumsinc.com/role/InventoriesDetailsNarrative",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r133",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Recognized as compensation cost"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r114",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Shares issue"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r7",
      "r114",
      "r119",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockSplits": {
     "auth_ref": [
      "r6",
      "r7",
      "r114",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of a stock split.",
        "label": "Shares adjusted for stock splits"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockSplits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r25",
      "r114",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Shares issued for license acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r114",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Shares value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r6",
      "r7",
      "r119",
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r114",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Shares issued upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r83",
      "r694",
      "r731",
      "r745",
      "r774"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Inter Parfums, Inc. shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter Parfums, Inc. shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r164",
      "r165",
      "r176",
      "r243",
      "r244",
      "r271",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r376",
      "r456",
      "r489",
      "r490",
      "r491",
      "r511",
      "r512",
      "r537",
      "r558",
      "r559",
      "r565",
      "r582",
      "r626",
      "r627",
      "r731",
      "r745",
      "r774"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets",
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r288",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r566",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r566",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r566",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Schedule of Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r370",
      "r371",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r24",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r24",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r24",
      "r121",
      "r122"
     ],
     "calculation": {
      "http://interparfumsinc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r330",
      "r331",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Management Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r295",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "Charged to other accounts describe"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "Deductions describe"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Stock options"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r317",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Denominator for diluted earnings per share",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r316",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average shares",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails",
      "http://interparfumsinc.com/role/StatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=SL5742995-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2459-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569618-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13572-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13587-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.11)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r699": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r701": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r702": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r703": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r704": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r705": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r706": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r707": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r708": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r709": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r711": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r712": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r713": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r714": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r715": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r716": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r717": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>107
<FILENAME>0001753926-23-000213-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001753926-23-000213-xbrl.zip
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MITXW#/PS_L#M:O:1[%:GKZ;.ZQ;4\[9@^K8G4/& 5CB'RO.7W@6B)8D->&,
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MF-8G8$ 'OEA^B,2++!C.^ RG@$;!8'(83 &-@J$,J35[+BS+YL?,7_!2PR-
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MFDLTO3(7&A" "UC,.RQ>H__6$"6\ ,A< F3.->\\"W.!IKE$TRN;E8<89 J
MS"5 %L,*T\^\;IC-_6L>A)Z#6QWO^_L$U(CM>+>:=@&3>8;)8NK;!:;F&5-O
MK'47X%@0<+RM[EW 9)YALI@:>(&I><;4W.CA!4SF&2:+J8V?.@^P3-?K1;NO
M-OQ]8FK$=KQ;;;R R3S#9#&U\0)3\XRI-];&"W L"#C>5ALO8#+/,%E,;;S
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MR=O3EPRZ6\D9=/<E@VY/?]!J96,&,]W8S!ZT6GD)^'-P^J)!MW(.ZD6#[N2
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M<$4_M;CI>B0H[!DA/ /*D\,'<?2Y#T=79*TXEK:,;"!Y=?;;Y8Y_W_[\]U2
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M#K>__WYIKAD!/O?S6G0*\@KH@:9 >OKG).V\L($W@6O>EXS_E"N5JM%EGO'
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M$]!]QS)^K,D%-C@'C(2-OV'Z^#P]"C^B*:B!J'\QVL[E%)D?&+L5PV(]?V^
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M$S*$5!:+!>)EP9G"!15-4#F<N*8K=@!J2A?01X"6HL/(1V47(8LCBEW%>6'
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MSN78CGW7MK2W'\VQ.&-?V8,;/1WKGO#D:0*H8[Q75_I)(46UR9J9,-U<DG,
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M1S'>Z!F;6:^]Y68.KB(.K5JXQ60@(TI^'+V4P2R_*6]M?[CUY+M;G;/=/<&
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M+*\X\!;O/$Z8@%%-J.[N /E0^TW$@JC2WQP$@4@2T4Y<&84%2@>Z1$$G N*
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M@HB785P[9D5RS*A$>[HO[3P-3"3O<D_F83 T'I"7!Q7%>^EDBG.&=3HEZLK
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M1Q,Z66A',G"*4\/M'D#B_-%CXV+PC1-#;K6^HZ!(*XS]7K2W][A9-32G0P=
M9/W8P4>S>-.T<'=4F3C+#9N=[DHH!%06F$P\?C0'>/#HQ_F\8!2D!4.@,&]K
M6F9IY^!$.':TRTBSV G=<&;"/G,+$NV?G??_U X8YS9-D4@%S6X (7:X6K-,
MO#F"ZN7;*M)O*,!A\"!K^G5.V3@PGR1U.8+!P _F%8.1H_9SX_4%4W#K)-!K
MFF;+HIT  QN_;=#D@LFX?KBA!P E**Z:EN9)Y/[V!4C$"Y))2X/42Y!TNP%:
M47%+]W?NP2)N0[[TAXLYL/FQRAM_^/DWG_1OMI77'Y_&Y/W=#]I[<%T?=* ]
M ;TD,R9II;^DY6*L_.>\CONJ[C6>S-IX];_K2$Z3E?^.,'#^+K &F@^[$O25
MOHB^8,0UBE"E>?$D*D;]K?W=>[W]NX]Z^_?OW[E86UXX#7_STWW8Y/'>I6MS
M;>]]\&#GX7=Z\^.=^]_MFR\'GU_?FW>_VVS?W[G['6' =_>^FPGI7MT*2%CU
M:#8WEKFY#4J8#?LJKZ0]5;_=NR/C>OABP,ZEP =;3J-W& 6YB1YGZ 4^!I(#
MZ,A?$)4!#*2$0JMRTD;1ULM?7OI_W?'-[\BU(5U6NM@/>2EF8IFC7DNQ2T$J
M5\ANTA6';[\$JM+_>1]0E7X#56EZX?FX_S/0>A[RI!B&M]#:/KSW5# N +),
MZWYJ$_:Z^[%$O?R@A0Y?JZ#BL]A*CJ _"S%W!P)FH3G8W #6+A]Q,Y+WP/1*
MDYNM@^=';X[N?%MWZ)IDF?_KGLW9]L,YB7L2_:O_,\UQ[_'=W:@Z?+MOHJ]:
MNMT:P7JD1IRW=D%J9.\1__)K)49:R\912I+3&2_;W;W]Z-<1K]F4_)I__N/1
MW0?W2+ 0F96.>>3KGQDTC<*:;FD,!>R?W,=HOBCWSHHF,ZZ:D+L,8O6@@U@Q
MQ.KNK818?9Z@7I/VNC 4\SD5HL[#:3CT7F5R@N/X;D[AH!.MUS1+J<IH$-!'
M__O#OO^D4 #9=I2S9=ESOO"Q'PS^7/K@3_IE,A-_TS73"7\X7R\)HQA<\4AM
M[45;HU@;*M>&K*?,%*.9ML&>PI:X<]$1\>.5>.'VEKZ\/;OSM^S/W>/69__!
MA6/Y_)=\\^'O]O8^:_@_?K&,?!C;RGR"[C04AOUHBUO=%C91,O0%(;@R*^IE
M$[5L;1]?=M&RAUW72'9[NY\>RI>OS17V[T7+=#?:DFZ,9//8 D4^SGTHKWV=
M8&4_>'C_IBS6X\>]*PC.U]])/[^'Z_LM)IM<FILRV71R?_[>^"HVN'="=3F.
MS>!:+.^K6:7M8?S+3D91623_^P/]97=W[_\_V]OY<SKZ@8S'ZG]_V'IY?/#N
MEU>'=WZ(?OKZ09[KF Y]N!:(#VU1 @00ERZLS*U^DZ+F'&U9F6DDUK)O""HL
M3NRA:6BH*F(DDM&984ELB(MO7+',B -  \/0!<? I15VL9VX@MXDM8!-;F>F
MIH>GB(_L[][?_7KQCN\)T7I#LXG4?V^A&%BJ&%U;WNC52;2__W#O@5[HXVLG
M+K[&8;*70%2]:2&JWCE$52\@0P.VM6'#F8=@"53 =9"0JDPT#M,JB"(^#X"L
M[=9?_N>]^;Y$<VU7&!S%O#BZ]I"8%C1 ?EZ0?-$8*L_6([Q2)&T%@%W@57-M
M2)M1 #@E9>3X//?F@:\P;S<*?G7R5N;6!RN9]8T<9L.PL\T-D'OAR\#!.<U+
M5Q<+M!7&QCVQ25A-AITCY;S-8+2(%_,!.@4.^-F,NPS' H%+@0GE9]):F5CQ
M.QKVM)@! 7M8='P^2%/YOJCYJ4!."G-FS;DA+[-9KK!5ZQ77K24-O>8:@<S-
M+2,SW&$B"C-E.-S 3!BDQX%CGHF+$"?DU?%#- H:4M0U*[(HT)L;[^8P@@%!
M7Z\]A2&_72,FVLDTD,^&N8KY$:#V@*FSF6[".07V.[HR%PJ7 7Z'>5^/&QV6
MHQ('E-7RU%YT)%E[_OM!78WSPOX5^ZUQ; "D]*C&0\\JZ+@5CH\.#G]Q[ I:
MA+RY(917+0I#(^"S,AYZ CW/40C10:AM-&9BO[A%$-KCB!R(X9?E @3>V*YX
M$G%0A% Y!_[!7,]/'7]$P]^0<.&3+@T8*!@-+QL+?0GIOH+K-'0.3NI^60GY
M*EWTAREFFQN_ /UY*)?Z\@]?F&FY;ZPAP_EC]/^]^@.W\1AVHM]R/]8E>"L>
M7CPXXYIU*[@J)G>E\2WA>&2&+Z4,9.H$)69D]D:ZZ+8@*B\ '3L)D8(RTM<>
M=*NG#S90T=J. 6@.$SIW/#FP,0L5VIS0YB^%<D:IF3G<E9IXH+W4)8X,10HH
MF>Y;1J0Y[:6]DG006G7W9VW1.X&[86K_ ^:<(P'HYS@EN-W 1;TOF864V4I;
ML&22%F$KX525#ACUA('XTX" G#;E,@I281]U$&'IL"O5ATZSU\P1K3M0F$1)
M9X #(2A1E.W+!2W^67.IEIVHL4Z@.)F4+TWR<9[*.^A\G5]MJYOYS(R8#844
M'4U+M 5&%EIGAF7S!7UCJO(;)ZV^^]ZX4F3_81?9Y\C^O5L9V5])<5XAX*>/
MX]__H;V?/AMOXL3FT04@E&4YU9 AZ%]]]-PF=X*-6HQOOGZEH?5*9VT4=-/C
MU>,3OB+QX6?CWUK$A]\>)WM9#.P+O^S:QWZYC$B:JEG?]?N\_37^O/>D5TVE
M'[6^GRELNY^IA+X,@GH]BNIZ]?T;<82>R#?IOR2@T(+#EP[F$C1DOS[9N=YO
M5MRR#%H(2!_<!QOKM>Z';_]-#W8>"L?L&GW4/T?5TX>[^"PY7U=XR>B<N?]5
M--1%6?855DNOI%C8J%YR_V3%].[P6,(?OL"0^R$UUN>J"L2]AS+>'U?X$QZL
M_"<\V%WY3_AJFN4RV^="GW4E%0[YO:\TB^ <7\X@;R]DD/^6=[LB:KL]85^>
MPCYF:B+&!X"BJ!3$7R_:[T5W)=,N_!<CQ)6;&@0/T/8]<+_M_OL,N=F^^^-/
MLSE7XZ8IBVN,1%SOIOQ-P!4L"#=W>C^EB^_M=G[H)Z?IT#' F-5=ZN=F:#/U
M5C@M!2:M:6&!T2B,-/"3+-^H0-X,.6[7]&UUO_JM^^3[0C#DOB@:\'0,;O*7
MW6#-N 2E'R 9U[]1YU='$X;D]M=+<G_C,F+V9U^B+Q DYNK=W ![6< 5<?NX
MZ ZJR-#Q.P/&;N0 =)L;VM0ZQ!TN8 I*8TX%3:.H4Z/42H8)SX2<3;H!DBG+
M"#MI^>?!7WA=:B>6F99<K3#]K,XR@W?& !,E>:EM46)%2W ]HE[>L1*O5!7J
M,LAZFS(6HL#+W)L#V"BWMR!PE)5/D4F]L$[&%X$;*5U5NB]<NKF1VJ'YUD2N
MG;1<D[2 OA?B,DSC\Z;S,LN#8Q9V0A. V" _G0BLB0A,8ZOHP]14E30;LT&H
MW!81MCP>>7LH=N</:D7LH[^YQP5KD2ETY7DLS9D:#8JBMB3FZQI>RVE>!EW=
M@6,4(D/+I-W\-#,<VL2:++&FU2Y8SGGR H!<1^^G6/CC<:9;8(<RX3[AS:S)
M5X6?.H98MA L3@5FZ/X8HY64$(?S7-"OSW"+(KV':7XN1H/<&GN?#-AW $X1
MCBNC<"CA_4S[>$X&#LA<;QD:\H, ZFU /ME#VPNN/Y(R#Q0Z<#,TDHZ:1#YF
MU0$"F;K(N+UY*@QE*@0-S^\YR+<=Z;\\K(I/&79<5[ 2(P8):F\?5Y#!-FGS
MD(H>@$@"H@>DX??V0._RX.EAM'5?__HB'A<FH_U?W7%88I71DLF3PS[II8<9
M^V^4FA GCHS.M:[W!@U!D?2%2?/80WY=V2Y^=4I*!T47 HW.\FQ[2A^EM^I/
MN9LC9JFG)C%^R!5;P4Z4+H.3^*.=U!-F\]Q_M-O;W=V-3C]$8!0W,1LY#W;]
M3X/'#^(9P,)9-6:@FE2"T%,OJ#"6I852+<"#&KNV(4''$:8FINE(9W\9!2?7
MI:H#[)G@:3U9:VZMF4#=LD'',0-N9@D(=I(7KEXC3K0[?1G<(O320>D;3\%B
M@7S# 6UP8BC0_,PX0O_@>R%7*+?G'<XT)F1L"B6JMG"D87.+\T6]R TZ,4]*
M^S8P,$#,0+<:=L!.]$+^TG.R7TYI:2OI$]IP/&,*YFBE6U56P9Q+6TU::WHL
M"(!I>4ZUFHJ+;2IE8T%A"XD?M"1_==]RLP/92EXZ:;['/-H1)DKFG$'I\:WK
M*OD,7B]32JOV2O-$LU^H;VCTC4YQ4M 16-"6U^.OFB^66EZE(V?-(!I85RB#
MNU$!(54V)!E#TD;EN+%A;]M*O'&*MV%MY_(=QA+W\T)+4%VE5[ RTD>7=#<J
M]DJ>U:D4SG'/32FNU)TXI//?G)-V=FYAR,3,1$?2:X3?)LWG_"+U376.LMC
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M?XLJ^SVSR#F>5*3^2LY)<RH2W'$#^OFS(L_^(KU(OZY9_7%<E3&03IAVHK<
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MY'45 "HYF+A@-VC(#!#A94]2<_S)#5BD!N0?@OKG0?]? O(7?/ZG$/R<*%B
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M(K:0G=.I<S3#\%7S;5BXW.<$W'*9,@J!LUG.9#&,Q@Z&R(R2?R_T&6GDD[^
MWFV&0]]GKI$=[0S"K'AI2DYU.'!A+"*97-]^(,O??$1R)%+:4V3"YL9B"Y:\
M&,69_0NABO.<A Z)6]!6@\G6B>* #B'I%T';!WM*F]!)2I\E4CN@Z?U-ZS*&
M:OAP%S<ETIYI_#"(AR[4/__Q:'_OX=/2=5C3YJ1*,]:" 6C["WOKNE"\'YO
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MR%NDC;.2\U52DVP&=:)_%:>CY\MJ.!AKK#22H]GI25=@[[)/D2# C9*8'R+
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MN-586)ZZ*+T M]EZ0H^NU WUV^$K:B&5I07/(>Q43+U9P,/U ^*J+DOVP"\
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M+6FUSHS=,DM1X1E#[*!MVW-.G+I]DP[HG&_LVC;(/)]K,I.SX/:FI(O>-I=
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M%C2HH/C!(.Y+3P!/!SVI!<0Y-T4?%B?@U#%E6:"T%749Y'/A\D: Q!8TS!%
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ML.6!<&92.QRB2D%=+1UP"O#5%"A5;E(H#M@D(.=%8V@WG^#3=IR(+#"^C=[
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M[.3-U%]^6/KKR[F[V@&/2MJZ9MM;S*.O)W.S;Z6EY: +YHK%WZZ&/?,09SH
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MZ)H8Z.O5*[PPV:+50P<]'=7*A/T,;15)4XEVKC%LXZW+X@873%BFF$J4=6J
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M?:1F+\DM3)I?\&8Q^;_&]\,N)HY1/+0I=(O4,:O8Q%#)#>/@?>MBJ93\D/R
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MS-,I8T.FD1VHKV'Y!\WN16;,+/KO9+[X-CHI%[:,Y>\D;=&/R;DI9R;3OLF
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MLU6[0L_8WJ)EH9U-T3(4&(A+^K=_@,N,:]*2%2\WB>?-FJ8U@VZBFQ$K:V1
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M=DK6D^5Q8%N*R83\:#F9;+'IV\NT>ML*_ZN?+08<[MV)_N',W/ZJ0?1]XS@
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M\Q!SE.;JQ8:_8;UME/NBF!=(F<'9RQ-V,S1S@3',"EKW0?176Z@+O4<;15X
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M=(ZVJ;H@].5)6RQ((&6YWG540X9:BYNG9UMD$:K\6-;O6HBB/S"-+ PDM@'
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M=3TD;CZ6#T96RZ%6KJ&I2R$=:OLCSAN(E 3('U:7^J?H#WX&T9#^C4V/Z8#
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M"*V\Q%5I)[FX"O5SA+]>B[8@;& - 3,^62(2CU\0H:7[=YO_JA*03R\@Q^.
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M(J[NDF!5GS8^@YJC:"=QFBJ6;3O:M/':6*AUX;1H2.6U]H611\>\N05_= A
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MJKCJXEJB258PS#!5*$,N(+U/A:,5R%,?;V;#ALAB.,K6.8+/1AMF3:A$E'Y
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M&9[<4#MM;5%-(K=",<1()9:W]00Z392++H@RO@'4>">@68-%%M)E('Q=L<R
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MHE6L=%5\6LM@$UQL@97%^?5!9+$\]C4B-A "1?F4 ?(AS3>Z:Y&.:"H$C0*
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MN>G(ZZ^20HX=U9? ;(3:=N !$-3HZ[3/J*^,$T11PU.MY#HR#%J:AGBEY1>
MBA:L/9@HN5NC*;39]L[Y4O G3XS0'S1X&CM6<%[2MC[,*5Y&3_)I12BP->Y-
MRSKI7'@<7R<1)&3^$KL&B6D)P#Q" @HXA/@;7^J\H5ZC&PBF^4W*06YR8_>X
M&+O)J_C(PI3#<B:LU\@M'TH&_\#D( K-Q6FF,3B<S;9I0==Q1EDB$S:;D)SA
M7<R!U/.6CG)?L@<>R\0<+B3/N5M)"[<<VC8W\)X^*5\,&WTM2X3-( Y1-54G
M0+8M4/>TLU<D":F(2FBAHU.?=!:,*K%-<H&0$A+ELT ]$CUN^#/S$B\-^@$<
M1:\[)!@4,\U*=7KT,3\K [1LIU5,/&7.=Q3C"7P=I"S'2'AYCE%!HM&YAY$+
MR#BQ\6;D>>:">BT-_M;)NH+!'-RR*YH,7]XF[[VLT3R);KI@05['NC]TJ:6>
M4_0=O ?2Z6\B)X_Q*B:$8',W3;G<"]1SCH8Y#9EN)4<$HLS7_J"'SGRXNE %
MN%$J@#-!CF6JZD2,-%#A'A4XJN1:Y8YP] #M!0!B#1-.H1[@T<M0LW$(@N^[
MD0*7QNKKZ>??W[_9:AR#E1518AH6#0P&('$PD0OCCVDR'-C4SRL9#ZC/+4+(
MP%C].*"DDC;W0**B7"-\=&M4FANWBG7J:XO8'2JE@9]C58YR"#Q'^?=5Y@2E
M$+K5MFI+2#VC*EZ,>"JUPK9B98/ ;5&!9<>%PM#J4GX,I^B9=<\5/-[K["5=
MI#=XV2Z[,:T+[86\G\=H[X'KW;%N8. 5Z^ A/ @W[161JP8B,*8;:E.Y#'.J
M&1%<1ZV$0;U68F0H[:PMTA[[A94V9=U!DKJ+6J\0&V4I9>9K+8<L.2PRZ1+D
M5G\01YKA73(HO\&$.T7;E^D$-Y6O[E[*%$X'^#1#S?D(2A&&/'&W-8>]AQT'
M/<V>G)1)@H%G:W3J.FA]8;A^KC&MT9DX!_E3G8^*RNJ87[XP"T+0"\.QZ\RR
M!=SNG/'".JBUO,=L>=U><II?P[T'R8ET5S^(XU\,(HL,80WY,C^-4)IR%N@F
M1ZZ?=5,5X&DQ_;TJID\Q_485TU\5=EZP/<>)>&5N, K^$/B/R84D*:?$WH0\
M2$RF>M'8>:D=ZDXP$AW')]D--J_&)"C$E5(FA<4_Q@0GUWFAS)W)_D9VX[DP
MK<XD8;RTY+?6\>XY?G<2W[K$K>A>GYC .<U7[N<]HUA#CI[L2:YEGTH=ZS5R
M&75%'P&%$DOX^=SB1I$9NR.5-85 W@DUX>(O39@JE5=T^TXU9!,T9%/.U^-)
MV\M-U<IU&-RV; ITISE*$'JS'G?1E87VY&Y35O8,3X%R@_O#A<<#N(^E!WKD
MB*$#,':LRE[C8=@QT=L23B(U#JZCGNJ+J*HL2]H>!I+=ILIL<"T#MV&*!CJR
MB'*M84:QCE!U^%7&PT#FO%7H\10DZDS-M"KU=EFZ7J/*B/S3*!N51<&YH=O>
M6VW;^%XBG$2/0$XYEL8Q4HRZ%-1H.*&#.,4N5>@$ X%LC)#\FL9\)TH?-EY?
MV(BAZB& ".ZZB-(U)OX[[) \(=J:HA9"L5!9OMG$O"#/3M0-\#']^RA?3!QW
MJH!FK#@;S^1(:&G4[X3Q[7RNZ%&LXB7#<!K=O0Z8E,@AUGU-&3E2Y_9&V*$K
M^::3A1&7+@D08BG Y+["_J"1Y=I4-B_B77RC.SD6:Z8U&C-&!57E/"5N6 *Q
MC[1-!0O$=>>RE0RI!!]NX!WTXB77<D3[S.<IS]]<;J3_16,Z[EP%(*#0RH._
M%>&IJ)]89&IDCXK?G4KSKC#]71,4Z)Q10[W5',;>,$OH,G\6R2,Z@1_I9,(K
MX"O.LS$W9 YPA4%;V "'?2)+U1:WY>]H!DM$,QV$*_ OOH J^*:&VU61F'&G
M,C8/%KF2"YL[K]&QL+-R2NRI %\#-0(GX)-.@3.P30&]D8*W'(PUM<&Y C:-
M'%'H")BKI;,5_/G:97).%UOZHC0U%33PQ#<&)"@K_2EU&=RW66Z^.RTV#9YO
M>]JQUL4]#:5'=L)8-UCB!9(;XWUD/:>-;+%CK&H5.X8OK( UU ;JY B5]X)S
ML7SG=C!7&+1*UY^&OUOL+G,_W-I\MD&]=@?PVO%609LESWX)J/@'C"6\M3;/
MV_W:]5-[N;0D-TLET4E4Z.AV@NQPH4HLWF6K365O6AM).;-)457MH%62@<H_
MRIM-><M3Q;E:6-?4E0D]Y&8[E2CON?E[H ,08N>4-7JY);(NR,@_E(>'VC"E
MR@0:I]O-=:*,@ FDF)AUZ2NUW09V)]J+1CB01+GI2:6"@U(G*!]!D6P2R>T+
M"2V$2K4ZFW:^GV!,5-\S1F9I@0[MT_9-\0S-X-?1O[ZC?X<R@NJU)_3O>-:]
M ^I!T:OC.G(Z\W+D3%I<O38W1TZ>GS>!IY^PA+Y47I.F-_G,$)[0,/RF1&%@
M7!O%O"#TZMI<_#O$:4<<",S;_D9I3]!)D)#'.4-%CEZ0FZYC2$^XD1#39_Q@
MN]-ETPMCSFC1I'W$B$^0YS&FHS*4RHWX/Y1Y1NM#A(Z;F7YHTIK@3%%<W*6=
MF^)[ZRJ86MRA0'GO82$1XN*CBH&].,!B+_UI#]OZ(5(1/%BOT3)ZHD--"A@2
ML0O6/Y]L]E=-%ZUE0Y R,,0THBYI'@BM0#Z^2:\"2HQNB^.62FG'(41^'W6?
M@^G)K!ODUUNZ2M^\&DZ%0R=-&3)<-4&X_$6]AK(&QG8XE[EL-YCF5_:+U,"(
MY;>&;#3,M$>,/+"",?DM@K.$YK'&6L2F>6[NI2XH\KJA_*[DLY/6%G1-HA6R
M:)Z?2@B,*7,J21QGF[)/9^2]$%=D=)KIF$1U,ZL)DWE)PB4J(43.EE.G9\PY
M@H[DEN0#IW*ST;*GR-4- DL*X+@V*8TYTF.DB!RQP&<Z9=LM"2S)VN8])AB!
MVXXUZ=G.4>9LR8)0\'.9")R9CGT%U5$ED8OO8$JJ1H.L09=4"MQH4BBQM:EZ
MZ;2,@OTJHX R"II51L$3LO,2:)_G"F\Q -F#I:F8C*DS@">7,Q"N3W.'I!O\
MI>&KB@D0[UQE<\("E#%O\$4(] (+V?J/TT,L;2L5Q>/ CX9SK==VX8W\7F[B
MK4 2?.^7UFV "81)=A>4 ?4#,&MPS>^)#H1DADU"5"4UJ$\ZVE=PFV"A4+!I
MH8KS6*=U.$H6MYVE%B.Y*ER\&I\?[A_X.SL[OO="N[09Y%]%LN"1?_[C:/=@
M[^=&$Y^CF*R"TU-:L81I*3BN-H9O(X+VBQ5F'5:[]^(;#;0LL*"$7WV#*@5'
MLCA<AWSUTB_&#$ULM6"+V+XISYO[.S0WTNRU4EI(66<MMEXKT8A=9F(*D*DN
MPO8P-(%<ZD[I:B>7A,B'W?/<N(FJR2$UD*:32^.IUW2.J\WGZ6$'8V4.H")*
M9=SD)'/:S%GL8^R^2F%=4^YZ"YWT^C22,MMP&NC)<?HQ<I&>G-)HBB%24*1U
M:7II]ZQ'$L!/?J) PF'#7XR>,&RY]DH9+N0X<%_FE<H4(2$Q2JT$,[<Y5=\2
MA#OIOBR\IAVF1.B.3@0A]_QH9X]X7M5>@-15,]W)G7W/.?K8YB'-[-DN^ %0
M&C3XI;"[SP^/CO'O&R9 IR72Z+1FT[H\#$FP(0$)<,*)GHLA,$O"'0S@S'"Q
M5#S+>:7/FS^/^U4H=6-BIL68<T%G:6A&*$E=X,9]&F>PX^(,$IB+&\Q5W1/9
M+:\AH;E$T 5>;QD_/[-T?@;."ZD'>BATO\@[3 6,; ZQ3BVCWRRVQ31,A]*$
M+9MRUKS9'17S+B2DYKQ68VGT^-(B3,!4K,T2# &#MVFO]@D0H7>"\;3P$!)3
M)\*1K@@OE*&X-83J@7'G@<)&0)Z5<*A]=B31+0[D#./VMS23@PUC*JM,:C^'
M\6J,5^NHT P%>=Q-I4M.J9![NTW6-04UV!M3,9MT^YB;K&$'MG>45:'N,O#.
MD1HX1??7>.C&WI+1:.(%26HO)__HYB'*.C-IT<423<?CG5^*"EG>M@;6&AKL
MH=.J CE>9]05\'>4'/)\[VAWHL(P*TD=&/5H5CUB[W"'=_6]>I[N1P<41BT.
MZYQD1[6GP1:&E*A(@!J,083"JRQ0K\S6(/%,.TVZ$1'377M'/SM^[C;(D6N.
MF3D3(B*I7#Y%/(E-;J.K=%HQU9A64*QV0JJZ@"Z37;GX:R3(6'Z,D>#V9G5=
MOSD'.%ZYM_.4JYTP<=7>J>2QS9)S)S;FP8EVP"+4[0XKUJ-;$EQ52;D*\Y*Y
MJV)25):(>74Z<!%2LU R!JD':Q<[3V3Y6%S*5B,:[28^H-#)%-X.@Y<IO+G4
MR4&U\5Q. DDI#Y9-:PSLX$-FYOP[01.$472INT<Y)9@, D*&RRNW@> ,G#:6
M8I$[@A-)Q#F1-&'.1]8F;.J]T#:5C2G:)B",YPNJ9]'P9X3]4J,XWS-H#H8N
M*=VNI?M2'4_3I("&A#62^6]C)GC,L'4M=F-Q Q?YS18ZIF"L=(("2+TAIXBC
MX^^O8=#^QO(004FXB4Q$>9Q2]:SP9'0=)'&$--BTPYN#:N<L?FJE0[%+;'WK
MP?9R^[ICWG"%U71UA=6@65[!T,%O&^.VF16AZMV(QTX_1\'*,<=4GRH,ZC7L
M#$T92!A=>GZPN\-:B&TLE@Y;V*=1)9F1[NDP)5<6M[5O$R] )U>\3?KPN"ZC
M]0MV]-"R7[15RP[JQHX#J$9#IV>?51J@=\%O5DV%7O*E-_Z],R6#P:,I2EV0
M.M2E'0U1K#; %^32T K)[2_D=YU]@&]BDO->O&3%X'G3/]K?\P_V#VB YPU_
M?T_1T>;9A IC!!X^V-GS=_<..$T9GCY4SD'34F-*WKQ;@>&^G(K'\6:_B@)M
MDQ90/BS#Z.8OBBT4HF,T*C1U0T4'O8Q4PHZ3([@JRP\Y_2J2F:.81!1 AM?*
MG*Y0NB1[$/9T6C7Q!"JDPR(#.JW_7"PE,B=]"A:HT@5OS^<X@W*UJJ0F+#G$
MO &M7TA5N6W/F@5[-&L;$_VY PE\__Q@9\>HDXWMYJ[7AZL.MT%RX)C[P !=
M=4,3#E*P)4%5%DTG(&)W2E>/*+5VFO)?U;$M3XCXH H14XAXMPH1+SD[WQ.)
MU'%WC55+^ZY'_SEK%!--<0W,Q Y]O@@)S<KHPBBC/9WLC44F6B9R=3J6*!9J
MV[K&.4,!O$)<S"@_I/$<-I7M_\6H:$"!'J=HC4=.9ER.CFXWCNE>+BO(TRIA
MWL97X,,*3<35]D_'4%W&G/RZ=M#U\F,Q"ED@>*?8W&8GQ&/&_XD^M<HDV3>S
M)B&/(<44/ 1YIX/Q1I7GY6V8@?!4O0<9B0%/28QI@6UD\!+ON,F6',>59(AC
MWE_$V.^K>JH<LW%;-V)$%@G[2EER#$[MMLW#;K,3 I/NR!].;CNM:*%F3W";
M[(PHS P69S,F338>OD#IVC>Z9,TX,TQ#8%J9=G>9UVZ9[Y''XXZR/N9P1!G@
MB#OL%9S)!)('^B*23AH,7[,8!TY#R]'B(79S[=-)AYBL"3K&7-SC9-LS3&V6
M1U\<@U'D&DF% >]@*MY#!IA83*7/+JS4COC)9>4?3U2*Z'N#7+]Y17A/,6;>
MB#=M4(NI0HC+*1)$O+%896QIIA,#/?? XE1-^)1M6H#45%^I"CSG(AB/+DQ&
MY)X&G&"*^% N@K0OR1E![Z21[,U&@U6Y$Y#K/E=TY_PAI0MHH*\KQ.$$-<HV
M"IJEY_S 31]$K*E0?R[$\BS$:AP<Y"*9.^.@_NR]T^C*A#Z?L,>NM&:" 3FD
MK2*=#$IH@28XR6RD]89<64))%)P.Q//&KMKH-[<\[NE:($T)D_A&=^[WH,](
M,,VC'WQO=^<'FGKC\(>2;#K#[N2L:6AG3<'%5]U9BY*26K?SO:*E1%C BM<H
M[-*Q9WI< W&YPS*N&Z3MBXZ<)6BITDT+HIK0%]J$J($R(8EOLAZ,.(%5;QF"
M+%YCOCII'[Z*!BN?O8Y4B_R!4@$S.O][NX?LH7Z^>WBDM'%T3A\?*/M6"?<I
MS.XC&LWQ 1R=PR,^.@>[/YC*OJ)5G/5B5/.Y0^YFL>M"H[>IDRG$A<Z45UD2
MT36I,C:DZ\T[HCMQ7?@*;'4_,;JKL7,WC%>>2)PJ38YR].HUZR=BL[[CZQSA
M7"RB[+HF?U<^&[G@>IHEI&%8T\GCGSVER<QVZDRYMH"] 3BF4^F>OR:L%C[!
M6U58H/%*3!YV=]^1LDKT.D% -P5?9<PJR:FRDM >EUD\/Q_$%#>A.H<_U6N3
M/0L+\0Y6GH'U7^U"W9).F +O1G/IN(Y&D(;O@F(=KX4Y9Q\BND@R#'WW@CY=
MGM.<=OK-!5>G\6SR@U8B(9*9S@?4C3'Z8+&F61QA[E.^H$JY \W2\,R:5^=7
MZ4H=4"&VN$+-Q<"AY[ V*Q0.N.5<7*(436$!E),_-I%2R1U*YW>]I,K!2;!'
M;HBH) J^"2?FZ>3#6*-$ D\>!UGH44ISYN4RF&U[!.L&R->:;:KB-RVOX+#*
M*Z"\@KTJKV#)V?D$J\+^&J+Q@,Z3<ZP  (,O%#=^L8;' 'JDU-,*$2K9HJ4,
M+RI/"P6;R0B1P:]RK=&>\HS@)1U*SOM#,=*'5?:XL1/GI^<Z7);7%V&*6QGV
M3 '$_I[=3[<1!5(A="":C:[@Y0P';8*( N9/)KY30B GU)6\EKW*H-^W]3UM
MJ>.\5]V0]1I>TWWQ/>@/^SJY6%?-PLA<5C]@JYQ[AF,><,YC^GRWZ>\=[6^8
MC#[-%UQ3I4T69T8/L? KK@L1J4=.1-/_VI:F:YL,52YX\T]K0$_^+[ZZ= [/
M7AVP@_U%D8F=G%$$A4M3K[F]3X^Z[2V58U4W4=)0/?;'N4J5EUY&4Q<8K&Y;
MAW&$:+X"E4]XO:FNO\'.X+YMYP-DB@E1NO"<,QA?)'A$O7_Q[^%/^!<F#CLR
M0ST-7[R$[Q4@)1YU9 "&B_T7'L4D,TFQ:"Y'*7VA.\AZ^K/YG;M;=^L)3YM[
MAG*MUH$X1KX%*2,_T0D#$86E9:+@T G<'/E\LK=FE V39+\$KSY@/[)+[$=6
M!?D73OR++ ;%_#.'BY'JVYAKX>4:T=]P$F(81 @<;MO'F;YQ!FJ_I)F$R:1'
M!B?KF@0I#1L/5$<#4_D9Q5BBY^#RZVPM'2/706)4+;C4RI[ *9"/WJ1@L4C+
M6\FY#>2X,E1RW8IQ'I!S-<D8&%Z73A7+OG+N&M6.E4LD<EE>OJ?*0^[F\!V/
M.3I^#EM8D">]R!&?$/^&2;N'3F]V!M,EEQ)2N./(41/L"I!AJGJ":AT\Y:K&
MAK#X>A['(0YZ2<IX9ALVBR[7K&=*3(#M&%A5-_% &O!T379HSKUT@SY=TKD)
MJB^Z"E!W5-J/3DG! K8! UM>]H8*_E,M7Y5M!*E%DC5!)9NV1^HZSYLO !,E
M*'-"VS=@T1TJJM1_E]$93-4(04 KM+U<.\(_"@5S,NKA%QV\B34#.$>/GE&8
MD($M->Y,.HXRXH8?P\!TG1G!!HU$B%"*8-?R><@Q"6VJ1DND"R[3SY7C[3)3
M6QM'!Y1_Q?-G,TH,7H+&N*P<Z@N2^P6=%\&><+]SLN0+6+N;>!,'K\AY?XZF
M^P4*PWH-24&%@(W&SQZ2Y#.R,8A-KW'@.\@/KV,LPB\QC%^H*L+W7RY.=-T@
MI32I&#6+S:,C?P]#;SBR$L,H-/#HJ5(U=2[1M\\]1G%4_5)*R;/W(2?#:B'@
M-M.CZ)MIF'>@'12IC.#:1VM&27N>%8IV9:R[,T._ </8!&DZY#OZUV$DD1S[
M<,?!AQK GG(NW-^Q6DRN  6[JDQ95U3!9<L"F$H,&0"'BHQQ:C#('BU<%?NA
M#KV_\X.)5JJQ.&%DSP';+QAG+5#"4>QN%H\3X71;+(.:H/2- %@8;V^JHQ8I
MMA['QTR7&VLUZOK,$&=F,=BL=T)US@56Z.N,Q%1Y&](G\3&8,2E-Q6O+,!S@
M/1]=_?O9SC/Z=SK JXC_?>=YW02=K(>/[OQ0XHLN]3MGB1X&M '*TM0K@1\^
M>X5S[>@GU.MWMIMJ-5GGU>2OMXK?EQK6'['5$0<1T:S'5%-2195"EV:BVZ5$
M7]16U(EO-'_P^>4_9@G^!ZGYP,V\C4[5SA5W[K?4%(/#,L$2$$F(R <@;CL^
MM[ :WU=7PM(>\XX>H>S430$CBM(( M"QM=1'.]M'I0^-2=?MI^*-!;?&Z6AJ
M4((;1HB-H&-]@)VRQH.6"V!SDAEY9<F2XCK W6U3L[UA=]()*3O&+MYM<(IS
ML[HGED/:'.SZS:.&HY>2$G'*>BG'&F?Z/[(T4*,;P'LD9UL V^\8J *R,K53
MPF3G@XR)M)]@+,R$I^D.4\!SMPDRZGG#(2L!PK$DHM1 KD(!^KT 51C!(LR3
MUFY/8\IPRB6BO]PPN?1D-FCCF$QP-#?K-6U\YEV'C:/Q*#8G*%$V&=TOQKK$
M2G:#+@+GMWG@'UA_'QN:UK[,9UG7:U%<;ISI\#HJ&JJLJ#!.8W<W[UATVJHA
M#@[I*>AH3H>M_X*>@D_H!#-CO^:*P!W3D'.]^-6Y-]AN$@SX2NM*!V&0Z>Y7
M!CHU;[LVT3-)V>?VBH[J-?.U7VRWY>OL(RZ2\%21A&W"91*.]EPZ4'+MBWW_
M:/_0F*NIFK;"K7,G_;)RCBTJ"5UO]<Y8-S[",%2<IUNH=;@5K32=68X/[.&A
M0HB"6N-9P,YH2!_JT++&!78XTU=)I#"#KF1<=L>W,9%;?,<1#.]L'#;]W;U=
M/BQNDKMY%R@4P4!?I_DI\$(SD"%I5R8$K\R>=7S+,!F9E[#3J"B/*".;1V9B
MM862&^BSYK/'$13V6J<FH9[%%I[E?,['WO9!O;:92O),V7E'578>9>?M5]EY
M2\[.XY@TG/!BE!_N4J*Z7N@RLLC&O_A^1G56IJC$!VF/$_V*4H@P[912D0L9
MYQ[\,/P^Q/K$UPSACAD)VX[O_L-K[;LOJET@]\4 />KV8?NA<?A3MV7\G6YE
MK4:X)!P>5;9LU@8J#RV.6F%AXK(*46IYB_U%0#6BSF?\T!47&5%.LZEFUBC>
M>F;F_6I:^(3ZBNHUS6PQLHAR-DFP.,?QJE/(L4A@5U\,0ZWS,/Z)JPWN-?W&
MWHX><= #$1_W]534 !927%60&@  WS;SL-5!')O7Q:94DTU7*F*13AO'IR#*
MC#ICO:9P8%78NUN\E0Z._:/=XTV[CW0*R0D00X+VRWD+7X.K7K:!L<//PT+D
M'$\PEH[H9 R%5LN:#3\I',IY"1&.*IHO3KZB^HA_6F<)9A#2,XSYS66%Y(%T
MWZ+[&E!'1&QL0Y$=FU2AYW@M=1 LE9:OJ;;FY"N(I9AB?RH#Z)H;)1K\I&A$
M4U3=K?#EM-AM[P_"L2@B+Q"XIZ[!(21VA+_LQ)*+,HJF:OG+84$9; Y"7<08
M4H0?=&+06@P2$+?9*,_-X:OEMN2<S6)8.+]?)6KZ;<Z; K;8O%/[%&/^X1PI
M="_HRB-?-2- OLZ!"RK6IF-@#TIB-\]X;O"TC*?E.%EV-P\YH%:4,8!S87QU
M3*?@KDP^OF!73CN_L^76H0A6I1DV+(78O4$G(& W5W'QJ75+3Q$&VP5C^A)L
M6\9>(9"W#B0NZ*23TF1PR@6\@\I?LR@)]IDRT=Q-V3P99JMO"QU*J-+'P,J4
M-RDAE^T0]..XA9+!% -PF7##WSUL;MZ]^"E6I_WS303RLQ<,ZK6W0["_PB#:
MQ SU/\R=I#S^'K6Y[P<1U6\9X 6E6VJBH3&.-X520,LNIA,,.Y#O45GX'R<#
MM6'V&+XGA%7 W8.%^9CL2V$JMSQ'MPZ@E>EV5KI^126L$XR\ ][>4DY1W4%[
MPEU#[:_1]QE'W/>"/9R;Q0VD.!I, TKFQ:YTJ$9L:-[H'](4D )_[.TT7GQ[
MJ5PX4]OO4<X^Z"N</N-];F>QJ@O 9E9X,K!-!Z*EM'LZWZ<;)"FVR="NCER9
MGT%NT2X9W8J0E<DB0A]Q?8[!L_A*TI7*'@\'-X)\)@CA-,3#2YT<W53T6$,T
M,0@31D5,(*1>^SRAI-6AVH!YR!;:H@;F9+26%?."*+AA] E]\UG$, L8)@GK
MRL$U-!+EM@Y>Q2:_SQM(]@,?_G+H'Q[NJEX;A_[^>*.-0)=]D7%-XW>T0S-'
M<M- :UW/#$B,UJMB5VM;K<)-MG4[Z\>>RI,*"06>AT8-@U36:]9RH!/G9.Z-
M%?A,: 3.ON&4SI-*RM8=F@/57GIR.W,&TYS<RUP'+9L&F1 =GR.^M(VWE I>
M!FTL5#4]G+ +$Q6[Y&MGX?39[+F D%W(QE,-3=4"R>]D*J)TK7)+I]AW0 PP
M;I3IKC,3I<8B"D M78\_$[F*H%$/)<;Z'OES1.6.@9CO9!"VDCB*'EW(//+[
MOPAT=WSS3GOQ/__1W-W_F2#%5GU5OTO8F^"OH80KL"6"K2]!E'X;K8,4GC%B
M?EQ%S"EB?E!%S)=(6;C,07-D;&RF,J-J)XI%IL-^7S62Q5!FWDQ5\= L]DF]
M9)T9^\JIAGQH_JKPZ*1.U[X.F"*VC3*]P:9)X+8,!I397OB%S[$:\T#7H.3%
M;F=K%UA28^2 0=,+KGJ(8ZZ743HG-Y:%Q:L8/B<,6TK4QIA6JN*ZJA6E;5W-
M_24=12>=I.GXXQE;-'']:;VVZW9.&Z>^3O4'LRW#&:%:$\9./K/>NKSEA8M0
M) I3>8/PFA[_5PP&8=!6WU.##-7X4$/F2C"MG,@Y-SE6"5V_;5]L>QU@)5RR
M;D7(C0=-H8_\SAT8Z5VX/\L"1V%3\-V4^V)*_D-2\#E[?F)^/0NK9UH 96B[
MX5RB?S]K'#^;<$6TZ(IHV"MB7'"#Y,.WN%/?ZHI^$(Y^NFWR]&P:_ VB]IA$
M:.O5Q6\?/YY\_9,G>?KYXY>S3Q<GE^\_?_(N3UY_.&.["L?C<@"SF/E-0N^;
M'832Z^](VYG(.5_2X3W($R!'EI%>7^(TX'#"!-J5%4S,?6_'R7I'8CT^[_T)
MHJ(BTFT'E&#/B$RMQ/M13[#UZL7SEQ7Q;B$>=2JH:'<_QN.TCC':G:"&6!'U
M?D1ES*0[4O5%HR+LK9=Q'&V=$:A>"0T-1!AG!^=C_J44;U84OXWBIZ3W\[2"
M,CJJT![[2$J^)Q?8V*>PD7\A*#:6QY1\_4;Y84N^NF5;SU2PI))<]]KNDU"5
MZU+>S-W)CZ=JMR+S;62^Q-K_U6#16<VTG[T6$/&*&OYM@0T<)S]Y_S@]/3L[
M/R^QX)2!W6S^\+.G+/6M4'8S3:)YK0=!Q7APKL.<2EEM]?^P6&94PQ[\\,A\
MA[ZK)5[_86']E,H^QYDT_"8WQEYB&A1Y8-XTV-K9JE9?K7X)5]_8J99?+7]#
ME[])5]_CZ)./J4.""1P@Q -G<RPX2K)8]1]CF<NUQ,4>A;59YB1Y5RVP6F"U
MP&J!U0*7^[)812VIT B7O,B<E[5<7/(86M.:JQ.5UE0ML%I@M<!J@=4"E_BR
M>$!*Z6.J1E/V8WV4H&5<Y+PYNUICM<9JC=4:JS56:UR1-:Z>(^DKHAV$H<5P
M]7GX%WLOEXM#%I>@M3:'X'"_\B)5"ZP66"VP6F"UP*6\*E9/8>+(V[E&4\A%
MWJJ<I74X"LT-T)H.-V"-:R^TJP56"ZP6^,2"]+A2G&9;@TE6\GX'7<G[DL@T
M0+"AY>*/*EVI4IC*AM_=7_\UKKVPKA98+;!:X%-[FIY&DE;92E6VTAI&G*LU
M5FNLUEBML5ICM<8U48D^!NV>#+V3[":..]Z+_2H1:=7YNW'0\)N-HS5?9)5M
MM08+;.PT_*/&WGHO<NUWL5K@JB]PK['K[^PN_EY<4IUH6M;1<C%"Y3RJUEBM
ML5ICM<9JC=4:UW>-2ZHH+>..5RI1M<9JC=4:JS56:ZS6N+YK7+V<["^]( P&
M ^F]EA$V=%7%_R8WVWN/FLMR,4L5?[M7SMW>WIJ'IIJ-'?^@BK]5"ZP6^,3!
M?G]GYV#-U]CP=P_7_-(X/M[U]YX@:6,%M2B1=(=]^/Y]U-[V/8K5\01,S=MR
ML4J%"G#GX8]V=OW]G37/"VD<[/O[AVN>I[7V%W"UP%5?8./0/]S=7?,U-OW#
MPS67I\?'Q_[^T7&E0MVZ!@V@%'?9Y31@E8KG<'&R7&Q2803<W0-U=.0?[:RY
M9M'8W?$/#M=<;J_]Y5LM<-47".K3_KH[@D%]VMM==_5I[]C?:^POK?I4I395
MJ4W5&JLU5FNLUEBML5KC&J]Q]3Q*)K7I0D19X!?B<81!N5R<4N4UW;U(='_/
M/SI>\UR#O=T#__AX\590Y9.H%E@M<+/RFM9^$X]W#N'&.*STI]OU)Y,#+J*.
MF]-D0 B6BU.JG*:[:Q9'37]_;\UUQ-W#(W_O8,T]Y6LOMZL%KOH"-R&G:>TW
M\0B$Z>%NE= T<T*37Z4S+<,2YZXY'1S#.5CS13:/]_W]=?>NK;W(KA:XZ@O<
MA'2FM=_$0["UCYJ+%Z95+E.5R[2&\>AJC=4:JS56:ZS66*UQ_9U)Y\D__]'<
MW?VYPW\D09N'?RN2=B"VOLA0C&)_N9BE2F>JTIFJ=*9J@=4"EW.!FY#.M!$P
M38UCOWE0A>1N7T,^^=N"7/(D1-19+D:I$IJJA*8JH:E:8+7 Y5S@)B0T;0)(
MT]%QP]]O+'XC5T^!XB9TGP<R$1F,P6-KY"8WSZE*<5K]8U&E.*W+(M?^)JX6
MN.H+W(04IR/_^&C-EW@(JM31$S@5M2KU8R9:H82_P=\'>JB^2*Z":"N+!S]Y
M.S][ZI^L6\$G]GT#_N'_VMKRS@,9=G[ROH@K^3-,XZ^AC-HP_"'\_G<1#N&O
M#6]K2R^N$USKP5IQTI&)>?OK$%0WKSG(O#0.@XX9G29S,,C&IG- "MO )1.,
MM0,ON(5(N57BB\?5G_&UTV#.>O5*?_8N1P-8Y$DB6D'[9^^3Z$NFQJ<8UWUP
MZ/[J1_TS_ K)^,N/0)$2X@S@!5NM1(IO6RW9C1-XIPAOQ"B],UWX6[4"NW^Y
M@=T9XM1YP_*\<5?ZTH@E///P%Y:QW]=A*+?TU%U"NGN+BGZ>?KLE]-LE^HTS
M*OV N;1AN=0Y<0U\V4W0R7H_><V='^S*D=+JORZE<W-^'&+3(0>>#D.0 &TP
M1/[];.<9_5L9/_3O.P^J%MG8P55.M<N :"66ER;2WN [7&BW"]__#M,LZ(Z>
MO3KI@VF7I5XBNZ%L9[+C@:4'%M7G01;$D7=R(Y(.?CM(9(KUN%E/>E>)@+]U
M1":]K@@2[QJE4NH%D8=A<A__VZ#"7314P(!,X:WP+ORI?1[1=M,LAKV/>2C!
M0PU3(*(GF"^V+MJ].(1WJV<&28 T]_IQ1X;;WB6\4:3IL$_?XF]AI !'"E)^
MQA.)]#HR$T'(7YW'<1;%,//&+I"2YB2&G0 7WH97( L*_$=7%QK#).&#OD0B
MP>_C8>*=1-$0OO@J!W&2X<K.XZ0/>[?U'V#>A-XYDB+Q)%"RX[V1;=EO 4EW
M&T2:)I&F2Q.Z";(>/7]Q=KH]Y]MD)5BU>1=613[\:Q@D0+C6R#M/0.SWO%#<
M^$7['R@31+#GP!(!;%M\@YP3=P.0,3V1( ,-0E '<+-$&.HWR?X@C$<2UG[3
MB[V>N ;BQ?"91'[(>HF4P%-1UDN)=65R';2E#SS1#H=(34^:$$_,;@EZ$!GF
M;)C$ PDCQNR^0%Z-8=N15^#3C\FVZ8%&W,"^#ALRF@!0#2NE'\HNKA(Y'8C?
M'H;$P'SLA@,\61X,B]<P2D9X1R:^$VO U..^+'DK<2B^#Z@3M^EU<%8L?9QW
MIR(4R8B/8E]\#_K#OB=(IG@#,:)A8' ^#W HQ0 V IZ"=X8C[_ENT]\[VI_
M^0\6WGD]1/&1^C"(,/H&#V[O!]'<K]0[C'RJM@S%&^Y-G(FP7A,L8EIZ<T$V
M94G0&M)C*-Q$!W:GW8:+%%E/2;)N#/MU@Q\ :_?AK3\]Q8KF3$M\:>GHST 5
M_ %I]J+(OI',%'/[]1I<'ZG7W-ZG1_'\2[A2X(I+__F/HV;C\&</94HV(ED<
M#S/GQSEI_M++:-+"ZR:BC?O 9S4:]O%,QW0Z;WH!"!+8GQLX:K >.$?U&CX%
M!(K[<*44GW,&8ZT4#Z?W+_X]_ G_@C]?.,)"/0U?O(3O\2IEWL&C>@-7%OT,
M3B"(XK_IFWI-?A_(**4O J243#-/?[:]B'UZPM/EGALX)?!U<!UTAGC&K#R#
MC0 "1WRJ0$!YL*'"E7+P+>@M]L<L]@+XJ<LB\Z/E'$[;K;K""JFT>:-@ISRN
MX'Y;'E"9HEW<>83+G+AE$E)"1]!%MG@1O,1[#R1+"KIE:K(\U+4/7Z5QY IX
MX#I@+;YH466(P.KME*D4H(-V@Q2HIY1M?.E?0Z$'!AF6RIR>!*HE#Y\,49.&
M][>D_46'7O B@/FB*L330[4'I ,+%I Z&9Z0PCMSKTLE2%^^TPT1.OFI=;:G
M.DWN[S)90_:=%/1\%+'R[!7JGV]!O8W 2KF"?<YHFX'1+N0@(]N%YX#_ATRW
MS>Z.F<*(Y<096['>T]QZG0_G-M!TPD_*#'Y$PI]D-W'<00L;#%X@>VXS+-UC
M9S>\ S8DM[UW 2OC2@T'M8$D2<(F;!+WO>?[.SO^#OR_QRIE.!K?/<?6O-\-
M<N^SNXJWU<22U8+[M95W;-W&>K^T7J&GDX3F%[!1V\$ 9/R7&.X/D,*__-AZ
M=>> <]FA MF.A(O^_:SY;+:)EWES9UC,%WO[N9-O)=Z/>C:WO<+<E_=]P1=U
MS=[W]]JVON_O7SQ_.;^-6^*-?A"13X8PF;@5A/*^;SAC6Z;:I2F+_!!W0*)>
M521^/!)?HNOF"2GT.#E=ZF+<;_YP&PE^10_G1]$1";8A%D$"UZQW9UI,\'U.
M)8R^O'^8SC%W>^SXASP?3(Q7N[.?E"SQJ#.M%E0MZ*X+FE58.!+A5B-M^H=3
M<D >]N)JM-E'F^\=<0MG?AVF*=AEUIQ5[>G'49QGOAUT) Q-@_)^&C._RI1@
ME=O\\]B-^QW<Q^..:CZ//9]*K&[D: L5JZ:YD,D9L'#Y.I9_=[W["X=/,9>B
MO6UA]ZV4O;>L'L\OJ"0NSV=:B?@2"[DE)%$E=S=RM*>1N]S4[>XB=A(&@)6V
M=WZET:2]4LSO2M96\ZFTVVJT%9*RXW!S!:2Y.<O=>SJH32&R%;QW?E,EJ2NM
M>"%:\1(D>,PW<>:7UJM? I@>_G^KM'QIK'JN457/4?7<T0I7SSTN.^G)%)CJ
M4<?\@G4HKRG1F$NM%C7\(LYI><)R2>9LO99*+'( K4($F.*.Y0N<?9K(D*]9
M+$ 1[9XJ/HN[<'ESR1AG;;=&E#:+F:LB&NF"B,DE.?K!,$@SV:G7 JY/NQCV
M^YA(=^IFP%Y2REEG2)5#^-1 I)G.PEV6Q._'SXL#]8Y%)*AVH1BD( /TW^Z:
M,H?<K^??&LNVG/S=M$R(^[[2IH<</"P_I/7J+?(FL1B>ZZW\N;[+I&:<\+T7
MO:+OOX?].=N.FO3+N;'</#C)>R.R.<[(T+VQ\U!&/P.YU*<DX_-A-DS I@++
M; BL_QL5#]/@R@Q"PL;1UAD76;V/\"THD.GFFW0V'DCTE:',:E#%YLU->,5)
M&'J?J7+D@BJZ>0$_C?'!D++703Q>8!D>"4K^09RLY&IS1?+3E@M:2!)D6)]#
M;!".3"KF2JSX[+M,VD$*6E1"RBHFJ+>I<)@IL$)+.0WC= [$?\!-M""2//D&
MW%. 7O9 ,F"%KF=28M=C7:#FRZPH(]9KC1\5 ,!ZK<KAR'^LU;J8(]=K488%
MUVI5OT6Z"LD1'6NU0E8DUGN-"DQI[ KX\:*W3LMDY?!15CG?2*1^A\F^=VM8
MRJ=YMWS^@Q_*B?3I9!YOG_&Q_?*B @II+6P2U5Q7<:[[*S375:)K-=?UG^M"
M9?PBIWH/U\=X)= ]DR,F7:!S2;D8XZ['R^ZHAJJ&VIBA[G]8YSG20TR'Y*KU
MHKFSYS=WC_SF_OY+5[3QW^A?#P<;_ABT>S+DF/X<7SOW%S)HD9N]\R!QOG/X
M8[/Y(_?8G3M3-!@ Z=%Y4"]F4>,M>'EK+:(6.92WELM:+2%?"?#Y"O!&\\?=
M'13@J\W$U5#54$\[U/XB[_+GQX?;1WN+&^U@>W^*@'B(@EY2952LDG^@A*L\
M#M50U5 K,M3J*J/Y&O-*9E5#54-MQE"K);-F5,)N*^:N!%PU5#749@RU7 )N
MP[J,_1(4T2;J-2Z]R56Z8OD15R _>3WK(HDS"WY L\(/(/R XPH_8,G9^=$*
M[(MM]A9<9.^I:DFA>])BHTL]B=14%!8[9"Z!+*MJ\ZO:_'5__SV\7;/MZ+.J
M-K^JS:]J\R>>TUM>4=7F5[7Y*[*4JC9_R2O[JMK\U5UC59N_4NNJ:O-79555
M;?XZK+&JS7_*VOQI!3;S+<D_G%"2O_MCX^#'8OW)_8:8\;&CU:D;W5N=J39V
M5F>N$SA@*:N<)[# 4LYUE>A:A A1<]T=SP-?AMFN 657::Y[Q_[1L??/?QSM
M'NS=:9Q[N$"J&OUJJ&JH31UJN9*SJAK]IRWQ5%D)QKH\*L\JJF1\-50UU,H,
MM5HR_A%K.4M]/6M$XE4=:3V/W0*'*O$:K,6ZEH/9'TL[G6O-9R7;EG.D]10X
M"QSJ8$UEVP*'FN).G)N&-@\9AFA"C4J(S7SK-_V]H_TUY-=JJ-49:CD.UF.I
M:(]<QUXI;<LYTGH>U4II>_!0#WOQ$NEMCRS8*DVNTN2JH59KJ.4X6+]L)D['
MIQ.O+T64>E&<>6(P"$%\P_J7H8C]B=%*OB1Q-\BH.A$1 C83J>0D3&-/I%XG
M2-N8KM7Q1"N^EO6:B#I>(O\:!@E\UAIYYXF,VCTO%#<^ R)X7YB6/@(W]$40
M(1!$Z@58$G\3>0.F;JJH.\!2UVZ<>"(,];MD?Q#&(PG+NNG%7D]<2\)W""5!
M.V2]1$JO#Q3H4>UH*I/KH"U]+XC:X1"S":;@1)P-DWB :=[PWX3@(. KJN+,
M>IC\G6SKR)]/8 ^GO4!VO3/SOL_\OGI-PS^XJZ7?RBZN5"0P9Q&VAR%5 ;<(
M V XB"-/># R:BV(%@)OR<1WPFR V<=]60(KX2'%@3IQFUZ%X!F:/O6:\^)4
MA"(9;7L(RM%7]2^B#W9GY@W$B,: D0G@@OZBW^(%*9[_)/Y.)<OAR'O.VL&&
MB8)3M5U8RXO[$F<B1':/AB+T6GICVS"/)&@-Z3&@'"&6B'8[3CH*VB3+@:(@
M_ F\]:?-HN7!X0](PQ<N*]=KP,N1S!2G^UXHT]1K;N_3HX2J@N5U>%@E%\3?
M!%DO'F;.CTA2((&1BU]Z&<U>>-U$M'%#^,Q&PSZ>[9B*KF]Z 4@4V*@;.&^I
MS_(+GX+YQOT@&GO.&8SQ@_"$>O_BW\.?\"_X\X4C--33\,5+^/Y:A$-F(CRS
M-R)JT\_@)(*%]#=]4Z_)[PA'0U\$2"*99I[^;,..W=PPA$"1B;:D ]QS;S2A
M>BT/)^0M'$T(S\J&\<%,T&B[%30:KOMPIX)&>WIV=@H4P8SX/,S2#"X7% /J
MP*M*3Y$!'5 <U&M_@CS8.HLZ;$^T'LNFT#-;1JD.?)?U;I7ML4--F1.?2I$_
M51*Z!PR&,GZ"0,\)<)"JDR6XH%>_D6U)>"V[#=_#-F'+((4?']3MKLAMQ?3M
M4'9AT/W!71S6#M[2X7SJQB>#K#W,=SWKY$JH,1%0[!:2/+C\VL .N178-$SK
ME04B*OFR $U4_%(J$*!.R;>J>M^@+N2_5?!!R,N_I,/!JQ<-> K_,B-Q-H]B
MYK=$L^6@4A&KK&3:#GK93R5?/P6=X5N11#-MP=.3V$'3*CU!I30GM(52Q)V[
M.]#G/^]!P,ZVDB_+T0WGE6HQWBF@4,[:W/VA5'!/HX_^Z7SK=W?+*W/G.,)\
M'VO>>[YS)MRCSW?5Z/O($RE:%[,/\3@G>>+IG83G,I>08K.L@1XK-DVCV,Q]
MU"<?\/%23W:WC^X]V"V9(<WC'YN[B[Y@'F(;W9D9RSHS/SIO+,4)>+R,LOWM
MYKTS9&Y+5=KYL3FE'>;J,V3C27BC\23'8&$<>;B[O7/\B!PYA=L?X#59)-LM
M-ENR&NT^S';;2Q8F_.X#0[3.F[;.HZT$0R[V-GZTT7Y!/Y@;CMCJBGX0CGZ:
M'I"@BQ1_>N\[>FDO[GM31!E%#Z+*IMM&"^7]A0Y6F4(5_\UB :T^ U:6SSHI
M8^L\VE,IFE-JBBMVW-S15HL=&?#28SS)5;ZOUE,-/#[</IJBJCWX%CZJ;N%J
MM)46>\MA<:S23JWS:"O$A?? /;TK+:N$B?D.5"5,/(09JX2)N0]4>0D?0+PJ
M8>(1!JK<ANND3JWS:"ND*BX=[:K1-I +[PP#?.>KT6^NH0NOLDY601X>+8[S
M%CC4XGCO8/MX9PJ#/(#Y?FP<K;DATO3W%L<2S;6,DU2&\$,.[R)98J&#E<*G
M8/^\'8/T4-G%E5U<C;::%LG2T:X:;0.Y< XPZTNM,:[?0)6EO!KF:V4I5Y;R
MTQD/E:5<6<H;8REO4H#XD=M.+ 8$]-FK__M+\.H\CK,HSN!5W23N,^HGMPU
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M&2!7MI5TOMQ[BY2- &V^\VUW!L6-CR*6>ZCW"907R?C_'A!7+(RQS<.0U@S
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M@PE1D45J9F3%P'N3N1?95!&MD^DBNV,HAF8\J$ *^! <-0_W!+UA<0Y(*?Y
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M%]-[O0^;/-!'"BP=D,^:ZZ7R_A9)WB=XI=G>$H?N,/"QX7L,@UFC"+IAYX
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MD'2JN"^#SM7__&]9*N:_LL^Q9[=D^L"A]J[/D*MNDJ_"T_$6'AX )=5&@1=
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M?F@>0\\8'$W/A"GD:&]OC3W; &I'CS#\#SY<C(ONZ(C8)W0HB+&]Y<NI2J8
M0^D(!+<(/(?LYU-[= (/3"Y[0#I>D(:/'OX[Z@7.ZZVN>@$7LOPJR:3)>UP5
M#IHZRIOM+9<^[K@TI$RB-6JWZ<&?]6B&)3_(R20CF<8=S7_5;S.>3L@6!DXH
M'*TU.5G8CN\3#""0.&;1%V*%;T+ 9[K>W"V.%,U:H/=4?(FE8^6Q9%GCSGW
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M1*QM$O_/MYC ._<CT'U GZ$XB)QGTP043WR>3+P4JK_<CXPJP.VMJ6?PE4"
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M)3?Y[;(UY"43K,]@==7V%MT9.%6!BB@H4\)<)C7$4)AL$F5#$YDDFD;7:Z'
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M?RCV-.N@]D-L)B>"[BMWOHT"](X1Q<60Z@@U30?N5KDR24]+?@//*J,196*
M1FF3\*$)G_R'3/AD0A.F.]3AW^;0M UNS+"-U.KVO)6D_/@@ZE/.0WV: /N\
MVON=B%:=ZIL_P:6Y8S@6?I]%2AE 'W9(1SEM0J/_VMZ">\#GI4XM29J7T7*R
MKE\C";E[413O>[JD2_?OEP^_C\O[%U?EZZ<=SJ+#M\@'OP0@)W>Y"2(;(]T[
M=ES(0"9XRNP0JK5#0!Q#)F6$&:I07%KV41<"<C<,!7ORJ]S'ND9%[(T!$1T8
M5N)R)U_9#SB5!^^'Q</OYY6^WMJ9:/U%W_I'VGV"^TF7&D= #9'=\JQ>Y:#9
MO7DY1-FEA@\\ZFU"V+]'CK7[(,L]?)D@::5JT[)-N67?J_OW[T97D1^__[S]
M4RSL9$/8Z2)38V^RO*,SB3,IQXEO5$Q+1,41$:W10*DOJ8*(9;7]H_'^I_W\
MY_FA.456PP9^F@_-3SDAS^>D,I\K%#Y'&J,TF^BR9;/T[1>77I$QA^$MX^1B
M,CKT# _,TFJF*2P 7P?T_!=9@V1VU:ZQDAIR2<5BD:O?=^5J[3VGE._?KX^/
M^JWJXR_EH1-#/NXZJHU"A((Y!:7\WX,G(UQ I-)$ 8'<B >9B/R=C:D*$Z--
MUQ)#EK;S[:]Q#Q6&/NZ.LJ(QG2.3MGBRB!#CQ9?)K-@9B#-5K8MV,+9$LQW_
MW5'?["^ZTU4,6T$MM2MK.QS[P?KOSJZ$F88YA=^)?X+B:O*LV\;!SC<1G]N2
M*+EA)W>)XXKIPND1+J!K06DQ.4H7*GPQ24J''?%2X(@W.H9IWR"S6]=?D&63
MHI7A@_W=V7\\Z5R?F>^/RU+\D\\UV<0NI$.AT,7=1MH:=[(8A1$V[6-:$/BR
M-%UXEF6B$B)8@J>M*/""F)^38&%'+!?TJ5CCW36TQ;_ A?T<V<Q7&3YJZLG-
MJ76@26J_G* -G?=\N3N@G?UD"U"J8R]78";1->V35BGQA?*\@K,RA$O6ON7*
M8@HGKA8X<:!!=-LP^WA?PR>L>Z7F[EHO3ZWO#^D8L]F.EKM4%2W97@5IEO+I
MR94K?&5E3\]40B5X6BIEOI**?<H'3LL%%-OXNL :;YV>3V[ZG1\'=P\HSME)
MRSH%EL[3(JSE"LAX>J9^KOBRL*KNWXQ42_"0";PDE%,X8_O#9VP@N#9\MEKU
MGG16?7LJ/,;Q_!9PR2);\&HHY8$P\1)%9H"HJ5^P^&)!6.4#-IU:R1VLG,AC
MB4KY8-'!K3?R&PJXL\-GJU+O_SP__B'U'Y.,3(X_4('P^ZRGC VBM6%#@>O6
M,-&BYR0BYB&BBMTLSXGH3H4P,/5S7)I9+&?*(GU$]B2I.&;7L8FE9WWS+-Y@
M'6(S'8*5R7M=O;E_+S9,4:V]G!U=R<NQT^+>)/UQ8]B H9DA*[U( UTJE_A2
M;E5OEHLTSB6API?$-*QS(7"D+DWHY;'[EYJLVU5=@;Q*#R*[-# CUOUS]?)8
M?;TKOM1^YK2%WBTGIY3=#? D6]CS $<!G8A,8X,.-M-X<8'"EAX4G43QM*UJ
ML8@/7VY%#]_,A$OP!IJO\%)A7L*%G<5J\ KJ=M6=@NQ> TTNVK<6(EIGZ# ^
M/5>T\K6D/TC%;)9ZD.7O&NU=QW+;]3-P^":2..W@3XFO%%?5\LU.N.1.GR1A
MK95&_"<W<$UUP26HD<=*Y?"-M44?&X;RJFK:T!D\,7[F'^P_K8/B4X8,XHV'
M)\F[$)"T7YMVOXZ :&3@5$:A?=J'LR+PY<*JAF9C$S#)*V&>%_*SW]JGG])R
MX)0>L+&BWJ77V^_0V;SNG4@_'@SY]&E:V>Z2[..!-R!5?LO$+7 \:=/V2D5>
M+%16].3-2+4$KX=\12JF?-H" >ES0V_Y<9? 07NHWO[0;X][SZ7*\B.WDX\<
MS8_(H>7SZQ,/#&5:VM8SSXNY5$*"'YM#"?K0 E\HSZXO8@9MBR-!VWN5QFJI
MTGA7'CNJ_/.PHBR\4<'=1VZO,*I!HD1NH^D/\O@8\DF^QRF&@WVY2)74,SYE
MAC!GVF8?DOI\(3][5&4,,Z,JCG5E38+A+E[,%W@I1K B$FO"-,910&.<LDEI
M*K*JNM*PC=83!'*1:4'(S^X/].?5KFM*\7>Y]+T;)]LSSO^8IW%OYUM@ W0(
M-%EVVH[J>G8[Y<,%([P!SI UY:)_:1WEEE:B$ZT!3O-WLNF"BR47E:!<&/H#
M]"4<H.9P8>1I[?WVI7?_7C9:1T_GA8/FI92APDA7',C(# JBJ.&]T$89!>\F
M)C=&3-',=B:$I.G71A;FCA]EF%))ENCS%3&-"OW"V&24JWG[XXY75_M1>K=?
MBWJ<^JT%U$:&G3386% 39RG#,DSPE ]?@<]5YHTFK1#ADCN+Q93:TXHA[6F7
M<A]JN\8<P8=:[UFO]\XNBXLMSXC8F-:CB^=VZ<"S)=?QA%(TY3-6+O-2>=XT
MY@I0++G#51;Y2GG>:NZPTR4,GB[30<KHW6+X@%6=PL_'=O'IXCBC3=9L)W2@
ML[5L>S:6KFG[D:+$%W/SND>K0;4$?4JIR!=+::1OI6#Z5B6XW,H44_;<.OGQ
MPQ)*9R>EY>>49N@&8#9N?3,78_B7MN&,50?[09-+L[ H.?61YZ48%5HQLTN5
MB2%!KR^ :1.L5JJ-PW?QX=?]>RG_/2]:#?WA9.&M 1-TS"S] B'7U5648?H@
MCCUO<GQET0Z$E,_SA>*F_RAJ_&O1KDH.\Z>RN :DZIA \VA%C*]G+D_?JZ_F
MP]'Q^V+NXG,4Q<"6R&09\:L7=>;IG,;68,QLC44XE*VIMSB*?+Z21(KU8ZB9
MZ#Q*\E:4XRM"$A4*,SLV8Z*:D[3.X9'Y&ZN<IS]:G!Q76M[-5 4T'(;_:-IG
M*J?3+]Z3I,W]*E5N)>C]5/A<.J66TS"[AHMO2,6%\K+_Z[G2N2S^$!/T=&;3
M('1AFSJ*N4/ADTJMA!SF=J-^]]MIZ<\GO3B!N06$P.M0E\5=RF;;Z6)#4M=;
M>W2T!-L5FZ%(>H4W(A-39$H#_>.L 8+(CHLZ+8%C@MV2DWU(3+Z67R3KHE$[
M4^=3$1,4Q.0.<;?5QH(U\MQ?P[/$:F,WA"7IPB2C-A2RMTMD-D"<[M7Z?4]5
M[AVLDR_);RPR>8P-0SC/'U_V<A</[[^:.YRMVK!D?QD-N@S\;,XPZ2 /A4Z5
MXO#S.?*XT8%GN<06R>97W+8N7K\C]*/S7IS>>AWE?0E8OOKYT:#!8^M.<8&S
M.5+C%RCL"4)8UFGD%VPH(?D?K-Y,,J,3[7%5Q^X8IOJ.A6&8]_FQO*=O][_J
M\7Q4*&]-Z>JR)52K-10BE.QLR-Z31B5P_+F/L@HF=;7.^>O#T45^_V?45<S
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ME85?!3)#T&0L=("@!0DFXZ51QRI-5W;,%QG9_ZBZ>SJ_.<]]UYT_:AQUETC
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M-E"'5355"^\Z&*F^D=\6[X/</3E%\^5.1ET?$R0&D><XA$G3<%;LFV4<S)S
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M9C..MQJ"FV78K5#!/3@3F\ZS\Z"WGE9><+,9'IM)<#<IT!5).F9K-8MWL5/
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M[-&BI[]&!98O?*&$W7H.(IK<:2R;7@(__'N?1"0  (E8)K$ZC[DPRRD!.O1
MA(^N%5$U8?.(B-G#CP2[*'>7@]/VF=I6M->OX:*@V.]Q&L0H<C#=/2VGH?6C
M'4V1<*22K@W(UJB#10VGJ5RPSC1F*I;+A-4$.T-XA><9B39))V+)W X*[A..
M,R*5%$]L9L%H>G;,S135MHR54':O78!6JQB7I?;-]9UUO4S@;;,<&T8!/''P
M8>S-\Z8[0614D;[B)1D_ZO4V<^=W:(EK/,9(-%8LD]Z=X?K.,!(U%4M^=@/L
M%"UU,DM+31_C$J"L'H;5][)*GFX?HARLM687[ ,C6[8_H^]]TH%!F@?R^T%'
MEH#J_PC /4GYO:$K\6PBBYO()Q/)?QWJ?/-:B+"4R^TH]S&)_MF#4A*I6"%T
MB>SG2?;P!2DHV]VR2A3LOK+*URKYDWX;-A.WT:+PK[.PL@^T0,#DH#*5;R3N
MYUR]\"ST&1W>B50RELMN=#OPCD'64*LYC3WR.?"$-SJ(NV./-52 3@5PCZ5"
MS\7\O"CB%!*69554F]/+2HOJ6>5-K WO\M$Y9NLO*FW9N]X5E7Y24:D7$>&&
M]+AI7FU=:&K[ENC=8]*8S-8^]O[4K=SK^;-:ZS_UA\M@'6Q47-O9.$8+%-@Y
M*].18.]?(((V[5C7649: ,V]JT.,_/0BP2)-Q>*[U'GT9Q=19./3H?ZF*)[B
ME +2BF'TP28@DRK(J1>EZB=S9MSED\F+&RG*WM"U5XO*?/O;J8G"E\4%'_,Z
MARXD8^G"=YI-N@SI(TF%9G*Q5.BJ]N]*^8BT03IT-\^"_6C>BE=3:[Y6>[3&
M]>2=Z$T9/-Q) 7[\KFNZ6I5NALUM]Q_\(ISP/:,(UQ@9OI;L#CS@-8KN;"P>
M&C3R2\F/\(2/I)DLEEJFU?H[D3T*J9V,Y7*KF[9:#"@5J;:.90Q&JI)1TKI=
M3:4;#H[ZO"O9W.GU\.WI/+W=9K>S9:$GRE^I9C'X--<IGL'I3&]T%N\KG6$4
MDCZ5B&4+NX%T:SK!2)1&/):/;V;@)ZBDWD.M2UG5L%>N G32B3$E^:!73E]Z
MZG/ALKV,&MHHY\&OB 13$^#$D$UT35$P-29S2FR%%['X]1@_\'6F);*[T/::
M#S(*=56(Y5.[4USG*4:ALE+)3V[H6\!CNM5L,M4ZHD[;>(D^65)/5=7Y:^HL
MG;M*E.0O KQ$P2SZ#4.69%$?"092@(>^/JZYOGH%U6P.6J/N2\?2FSUY9>LY
M(6P#0;JP:R!8CG*9^,*4FR+DRTM5Z/GK[%':^^KL*W_Z\>3O/V>E[C)X%IM9
M9^\%,/[)B^[_#JSC^T8W?;FJV0"&^I2Y:IE8)KO1&'];SQ^1LD<4'E4N'TNL
M/M>S]><8[3V/=D1H/I;][ [T$+KWI-4B3;/:.GD'5T-MDQO1)%45J8K_AXV"
M ]@HV,\WX%;H<M,D$OZAJ$K^7W@^R2L//'KYZOSBH=:]']3TS!;7TC-2T?YF
M3BQ!!VH)[-^& .R)&OL;B=DYUS,"WOH4?1U:,.^4]19S4;2M=(E8,AYVKN".
MC59O\ZV+BR(I(TS&DJ%-B<4ZD#Y$@&LX"000&)_<U%3ZJ)B]I&;DM]UWCVF0
M+S5)ZMHJW]:BG-ZP-I==YL00?DJ<'']CDSSUY!&$DOZ#N"3\ BF-];+09Q@
MV50LNP,_W%;FB%:OQY*%'6<LH8\W@#$BR:EF8\GL$K#;4U3UT:I4M4.;8]GH
M:8:HG((>[<$WX&<DC:SVB<3G2FDJN/"UNB6-DA>]VV/Y\6(9U)I-\=I+TU2O
M0!,9"5@[:<NJBK%T<.U'1-1W1O,J+NF"+.>_HD6CVEIM$U0V'TOE5S[9?<<
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MREPP@J Q4/Q1T>GR F@?"<GE2B50%OUN7W$I83"W#,51MZ>IJ,2P,1AA33K
M(V 8\Q9;.GO#'(432L=U*V_U]9-:YKQ02VZ_4.*@\>-3YF8*H..Q\2]SOU^W
M2B43O)&BFHGG/D_8@)7])]DW!N+CV:.1\4Q@H?_P+)_9-K4.F 4'MZA9*^J
M<&;[/E((7:&.W.Z _:#(0!R\5PX9]O=Z?1UN,IH!S)A#.Z*/WB?SUW5"A"ZL
MK .W7A<4"B?AMT] Y#3(Q/0;M.4\OKYB:&"G@+-/#X.:.;Y5<)L(GVK0"][$
M1"R:3US>2&#=&;+)4 5HD ^O#?J:3)S:RT:9V :3"5$UP$)2_5O ;XLHKFC[
M.1IC&/=#@KX2&D7=WV-2!,1.DS_.OQ-XD&QJ.IJ$GN Q0^4':L *:2L&2&NM
MR6 1Z.I<\PDDHBF;??8M^C>V=T]HA$98*, &'=II6Y$VD()_00WP5<D #4FT
M4SU+ "\:5 JZ[Z@\?*$7,--ARS)PA/,B!Z6!Z2:*5H#@"8IR *<$I)&-CL\,
M].X#K-T).(FI X,I_[@KZ!"%:IC@)X.6[)O(:9.> SM,>!:<ML3W0M/W>+3@
M\OLU86BU\'S]UK]M5O_<*.*7"Y![%1 H</2*?LT$?4RM"_31/H)DJE"WNDJ6
M7"1+]T^ORVOFM<%!)N*+X4&Z.RW7K4SZ\3C^=DMN\VY$_/.1(ND5L?EC@E^\
MAP6^73+5S"0N^Z?MY#K-J,DE?L[E&2/&X^N1>=>3$T=ZZZ/$6 EZY4(G^9K*
M#&Y+W;>35#::Q<\ZOFGKRH*A?IK4;@87VKT4S;(6P\(,OW1PBIO-1NKLMP27
M\\/*9!9)PZ!<KO[&S(&\G$:65-VZR9WE6M77W_+#AX&N5@:,&?Y<<W7K[OFL
MF#ZMR*?==I3G.N?"K-B'O,54"SB!532O>3+7N '6 LL-;"KF#([YD-XQ2*&^
M7[?*Z8O!DW%[4R;C,G*] :M&[^JQ]2=S]Z2"8VPO5W#7^XT\1'OSNK-YMW@"
M/$1QQ.(S4I^,H:Y1%PHC0#+<-3#!X0$:."R6MZ@B!K\%'P-^U:">@39DV(+X
M59S%9[;ZBB=)K#L9.N88@1,/M]:.H-ON9E]%9"_2I-9^C+M08AL\OS;]U'_&
ML\=>1BW:BRAK^C%?P22_LM@ES1]+74_6V+JZJSR92O=8/&DZF=^B?U\,"DXG
MX)+R -C$3N<E@1=:Y K&D<:=]&YV8E;!X62)-?B6BN)&<^D>)XA^M *BL[)/
MZ\&,UZK9 9&UEXTF^F(3(F80/7DXF5*?(#J-.P1H?Z[X$S$;+5$>$&5TN+\7
M=-6=^X87;:C+IDG4 ZW5@ON$\5N>9;,I,^7>#CN$9I$P($&CRKX;>HAR50/O
M7.89/S%@'6-R1,>47? 2F-?//Q*4U7-R5$@?F86YZ0K9ZX@$I'@@GAPE EV:
M=OBD0<-A%*$2 0Q%551&O$J(OHF651#=@79T0Q<T1@4'1",N&#S!__7LRQ-*
MV=]K].F$AYX(! >.=2(4:W9GYN3NR'VWU5":YV_B%RAHP "P:FKZG.*V@F]H
M4O!7ZM;E[:N82EQ6WX[SGPJG?)1M6B?IN]_7^0;B";/ERN0;A;@]F_96D/6
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M@@) 69I"L<D8<#>671)-O/!.Y_GK 5YD"_)=5GL]S/1M>#*H0$Q6O1^X+UI
MX),"H2%AK(0ZK-92JOCV!<JJ;O"6]@E^O<2[TG%4?8D7F\UVO+UC=A=[$"(%
M]RX?_N0;?^+CS9=K=+ZS=4O-&<,_I4(*F.C'+[X)6O+=5N7OA?FROC=Y/7$#
M; RFD%U+ .ZFA-@IK+ )&$C'5X&ITJ*<CS^@_03"%.$.Z)]YTT07E5"3%;Y@
M)$L5>8WFL*.!N &CB&=(03:Q2B30!X="%:27SL_> 6? TC/>222@^Z;0JAAJ
M+E+[I0&[X@XBS5N"K>0U:&B1EU.S*5#87IIH1)?>^5!C1+_DK-P+ML/ZA[P
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M<G1#7KUF)PHQI8G!0M0?^WL4SC!FC]V@S@D->=E,[,"2>M]+,^6TVH&F5UF
MJD-0I79I?Q+&&OL.++>@T&0LA6S R28LR0Z;U=0VT>&6\*&"!MQLV"J.)WD@
MGG0\\!,<D,'V*7/M"H3#( 'NS"4_N][@@300&5H"J0*_I-ESF9:#V:DOE7!
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MA@X:L;$1A\0N5YTUR\[I<2?2<1_+:AA )>O\ ^:G?S(HOEV?_3)8_4I$QJE
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MLBE7T@>S'.A9V&V;]M"BKM7T?P2]W?B9C*=CR50^ELQD_@Y@2ZZ!<^F__+1
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MGLDQ503<X42H-C ZCOZO32PJPOTD2GXW$O'MWZE:&/*D5D*>H!(I+P@+X]V
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MG-)2-\T56IF+W(-YO<>+=/W3A+N=4_[J;?]3CW:C#,=,/I8+1')?5)1_'\"
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MIT03EUJ9+  7WAS[B8_^6P@T/_VOHZ7.OC?N[WE>R2+9['T_\5%_CUO:KN_
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M#C9-GB[(<\.G3#3?RP,TA__5&-^D$:V9XIXRX%#TOPEC'31%BYJU8:[J98F
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MPI&FO?+]4S=M:WI&LD$UV%,6YZHSX2=BL+<0%9: 4!R0&9TCBQQ2R(-9N%/
M-]J6KOH"%CVAKIR:C9Z:4E.!Y8E.=_?1B'ZGA'B68U5?%8<V2M!;[/JOOI&7
MC9?!;>\DX\2$Z H$&]QE07(LU48PCQRABA)#[7@5P?]X)A8/D2N:P2 +29R-
M8N)D.";V2&2O*%X;6^=.'Y*YXSOR6DX[;.U9DT\_K(S%0TUR2<33\7F37+XD
MYY3"<0[/0*Z%2U[*R>=R0<S>G3M,8NM1@<]!_&3I-R?S_45E7P15'9,\ZC4D
M HV(*(IFH]?[,]Y@L_U1]X241R6C?YU<O@)T)2I[[F)747R4B"6SBQ<?156W
MF_]D!1J&/P8OS;/2':F]?Z!8>_&];0S'9!<?)AL5MX24'2M1FB$X8_C[^C3U
M]OB[:A8BX8RPZFY=<B.^>!O29Q:9__CE!'BC56DAO8 P*FWZMX]&E^*+I@>Q
M*MLF#H?"V3#^AJ:67FLV&S=')^E/5FY3%[F*;A2PPY*IR6*;SY)3F2BUVJI9
MY*0H#>.%X]-6*QHI]A']%B739%.QS ;Q3,AXV'S=MFK^>&DKK?-B,]_.R9^J
MY:+DA02HMUP\_GGJ+:RC-L5=K ;GO:;HO4UH58E_LLZD%)MFV(F_DY?PT]G9
M:SYTS.-SM.J,;:SB6N1B^24Z"[>F7RJW<7IZ)EMVB/+2&!9U,1L>=F]3-'G$
MC)J.%9*K&+&^H8P:,DP2D7$PDRDS1DI\^5VHBI7TIS!E6/,A6@9, O]-5F!_
M;DM?")<YX/7NFNSZD4225I#4^@T3NY@VZ5ZL)8G<[!NPT(,#FP .YU]T1G?O
MQ4[K\7/$\7PK@:V\[E_X*KC]_V?O6Y\39;I]OZ<J_P-GSGE//4^5R>8J./.>
MJ?*:F(L:-1?S)86"BD$P7#3ZUY_N!A0%%1209&;7WL^>) K=JU>O^_JM+)VA
MF&\L;ZG3A*6W<5KAX;;)3D61YJ4OH_CCXCV6RS!D>$_MR[ >'7^,>QN;5=16
M^8-O-%OD:=R>?:H\+I8B.";#!8#(3$?NUK=GUJNULY;6;@=1V4DV7@?D[ZTJ
M>W$]-26IV#*4%VHWEQ[94'V,YHV *:EL+D.Q40"_I;8'/V -3 @MN\CQ:FG$
MR?BH_GXJYCA 6:9)+::66XY3C(N>V*D\5EK=EKS'AHJ/,^('[B!S>(9C8A(:
MIT)BB+E!\Y3X"NOO_D/:1Z*8WI!8^PCV1_>/8']Z PGVMX,DM274AY?=;"((
M1UA$_7+S4IK/U"YW37RU#I)-W.#$JJB)7(8E_M .DH!Y\$ ^4(QLW9@^<?)S
MKG%E$JGK(,D2?V0'R:$%0S%RR7U_=&V4N]TKG?QJ+23?6_A]KQ:2PVN'#N']
M (7@X^KUN_IN- 26CZ5$+KC.3J04G,IP!X2:XBJ<+)Q8@P;A#Y)3.69T-S:&
ML?!'F)#C*3@F&[XT(BYN.32*&!-G$'E9>29?YM,9%0MG!%5W"<D-]@"4V#^B
MA>3PK)B',:.N_V:U#TJ0IR_M8CSUWR$&V<19 8[#277'<F?B/46':;6H660X
M?9JK5R^J.652I]]B;2$A,R1W[!B[Q"VA_;HM:O[@[E\>KAM7=Z(LGE3+Q<D+
M-)NA<B<<:?C'=9 <7OL9#;_OK(JNM%X7M[G&5&CD3E)*%5RIQMY!PK+AF^R^
M3+4>D3HUO9,M7^;/SU-:?"QW!ZDO)$V84>D,P\52P9\.1LV?U#;8R93]/E]M
MZ5*Y_D*<A"F#6@_Q,B"5(;BT#87Z SI(LDG$DK<57!<+)=:L=X1J-VT=)$3<
M)=<LD2'9;SR*+\H.D@@X[?U!KVLM3IV2_)=1_+%UD&0S.3J6D<7I8+T$$L/;
MV*Q1>"3$Y_;XDQZE4I7'Q5(Y.D,=@"7RMX'D@#KP8S7VHJX+[.-K[6GRT=W-
MI*=H((EN*A^L!<]Q4: WI+8E($KT0)LYC)?Q$ZZ.C-ES_U3,<8"N3)-63"VW
M!$RI;-&+"[E]_T[F)Z_-[A[=EGP#281"@Z S.!V%79Y  \E1/1:[YGN"TQ8?
M\-R\=_=DS%<IK>_7?Y)<E\V/WWF?48IP;NCYV<Y9CNZOU?N;-V+K*%&I(/7:
M3U?39FWOO,;=;TAN7&AV_PQ'GW&AN="T\@P0;;8&_% M+)I"'+2*84@H<^DU
M:P(-"<5#$\LS-E337A6E7A]DR\,8B!7#:%#FTML/N',TZ+;)H)CO#99T],\>
MK (W5(R?3#3U$ZS*$'TN=E"#S?6BLO6>&B!4>R;*4_$>4&V(+'OA\\[=X?FB
M]UY?-.51?9>6U<?@K]3/GR^EEY\_61S]3_"Z<HZ"(WSQ94VY12J;<C;)*)\;
M&33TX]UD1^2U]DQ%>QN[MW8OX(4[HE48?(KNK=''6)E;7Q]!C^H.=B2HP/Q(
M[YF.?,#NAIHH>LF;*S<?VQ^W-S>=-?(R,9 7+B!F I.!"<SX$#A@]&C+_BJJ
MJ7GIRW=O<^/K^O55;>BF;W9S/EP.KQSW=O!9[]NYYU>.%MOUFPKO?CL;_>G"
MW<=[N)&O&'PV9G;$?::@[^//=3;-.AJ)O<3:0V THI9+H&_XJ:C!4;[K,^DG
MP#I5!;CPT(,"L9ED##%WR0L&AY$>)N$?=;%ORG=27UQIJ@TS]=B\ZJKEPHG
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MHFA8M@/*KO'VH1@K\IR? 8?7\G6!Y:=9^3?H]VK^)K#U9=M7!F=C'0>X2+(
MGP+M$4T""['/VUD//$6+A\ "EG&-[U:=<+*Z"R!MQ$]XO\7?__U?%Q=811)E
MX2?6 .+R%WCTARF"JP170/VR()3 O[&+"Z=.2I"FNXN15H6V;M35K _J:A:A
MKD8!Y^I%5/2'>*U<N+?L;/87!M743RRO\5VI]PNK 05C$:2FPIV3N/M;_^-\
M#?X)4O6__P-HXD.>"7C 11?<[_>+K@CN*7@F+\_XN1Z:,JZ3=C/.VHO=*X1+
MMU;G.FS/X:\*D$BJ]+:XOAKW<K6^*BGO,1<@K>\AZ!)QX#M>=5YK4O:54<5C
ME^B/POG?[N]JK5UN8HU\L_)XW\I@U5KQ$LO72ECKL="JEJKY9K7<^N__='^'
M6SR$D<=;L]H+5ZUJ7#R+/Y"HA2'=,SJ5!B?DXEE7334LI5X$\AQ*!@3@5Y$4
MH+.A^&\!76,E2OS7?JQHW'+4?O+031KN;7$GFL6'2K5:%8EX2./8=M@6TR[<
M85;>%HO)/&O2;.Y!.[J*<#O9@J^H\+9@^_7%:/C!%OM\/"OZIZH .T,U=4 T
M:!5!:Q#3A]"V@F0$EH3UT_D98#S^7]\-[-@"#;R1ZOR&KG*M_$W_I)(QD4R+
M8]#[9;*ME%GP5+:D SO/SI? A#"X]MTY,@IU\'CHJ0%C50&6H @.$#P8)F;@
M7\&YCM$:AJ++MW&6<7YFF];>)2S#7*L<2E^T[4X-N@Y87U/''F<X&!A2D 2I
MKAD7%TWX)LOK13_?@T>.S?$RZGXU+4^?1W3OLQLD8TX%3Q42!/WCMP$K?C:R
MA4#X;NXY6'_VX7OF/]U[QD=9AJA(Q.<T&V3/)!YFTUFPZ1F0!G,K*[J^]TNL
MNF0D28!^#PJ7(I]WQ:U]T9M21+)$!#)% IRU3/VA;R//1G$<1/!1P.G0AUKR
M^;I;Z<U:;K\S?>CGQIFQQ'P2EM_7[=F*$7I^-M& K- D&9[/!' 'I/8=KTP!
M6;L:%'0PT&3%-%QY'/BC%7Y0K+"*=8: V)*&34P-)A  ?]@/@BG@ 7@8*E:%
M3 B%'KB.YV?@G?:'T1]VO!&\XL8$J[1,!!:Y_/_W?W-4EO[%XLORT']<A;#@
MPYYLDEO&K7(BZ,[;D'.K@A6K'26K9-U5;2SYTLM=JTWC=F\$?-_SHQA*DMV>
M:/'&0L_/F(URVG^Q?]8%PK_P5/D>#&:@6!(Z54!!L#%%0#=1!YQE95B@C7:)
M%<0>;]K'YQ4NZPHJH$A9ER8;NO,R2"L)D0?VRMW#O-<DKAA:2-!>.8'T6"-#
MX+8)$?#-!+84:1 >>B/EV$-Q7KW!SZ%@S"L"^ WX'.!AOBO)DB&).@P&RRJ,
M#[?!ZPJRVGO_L78&:W?MP">^+?J5R373F'R(I6&BIWC8.!@XC2+0PI8XV_A_
M? (YOG-YMO<B@R]:HV(V8:MAU;T_H+4]7^:?W I2<UU4<B0P^0OZPT+F:E<C
M&8TG@>>%V56L^AKF.VPQ<S>8Q3:=*';6;_6&HF#*8KWO9= VW-\6;L^YJY&"
M/P2*J2))#N6:_)2-G<$WCK@ 7.5W6I%;"[8RIL35&=LI"QVE%R3;$QH"\=U7
M95F= =;_N3S^[VHR?;NI4$E-!XIV(I#O*QP.IG.TJ]14[DAC[;%1ZI2#@ZT<
MLXKO\0KW,*<570NN/L6/N\?[1:MY3U%"C'0-PZD!T3E.> F65 V.,!609.Y@
MZ7<F7.2SQ:"@^".&J$4TZ\_%+$NYL&G30VLA+R F@L5Q12MM#QWG,9^_*R[>
MQ>G;XIJM9Y]&9>G>7$7CXQB_QM*^0WQ<Z\/DE1VV==++;E$<<%[0QJ</&J>S
ME;XQ3S.ER0Q%[<?DW$F)/8.<OBB-HP/\ ,*;)/8C5P6FL=]=);UWM<7+O :8
MW_^BFI.G4JL!_)9[ZH"+&GQB$5K%',X]M NLP%,5TXKXH9)?&";D/R.;]W H
M]+D_T>*>)4QD"/+4@UL2H%AT=XG(97*Y\,.7]U\@RGN!FNJ<EXVM-\B0"D7Z
M4:S</[/1JKK?RQ>GXH WR1#WG<AF&.K40T*2(%FDEX)@O U QU\*H%6<#I>2
M*3Z)BJ!J>DTU.J)15::JU!.%C4O1JK3R]]I-];TPB%6M@.5@4VL]V#\P<S"'
M201[32=2)=*$UWYNHU/,MX; F0R7#8]$>-IK$YYBT5T:FLFP>'@4MG"F6 ,V
MQJM*7A%0(WA#U0U--"2KSA[\%OY"'$]D=0Y_41 5L2\9#9E7=%<4V5_]M(@.
MT;]^&;7H;CR>EG?GS>728?9/U*:GUE!1DC?F"\IE<)SX8M<S,3)'J IQP-)Q
MJ$)W4U\1Z411 Z\%5\K9X]S_GEZ]EKG.O#U7R&RL&M%:#,SQ&Z:F_+L,?\Q/
MRSN[:17[I<OBQS+#%R)<=->(B< O];M%;C0 )$N\.5/_6S2A&*F@/Q>[V5X\
MVF[[Q*[3X\X?\)Q ++;[!.*V6#,$'05R=JHF!*3HI*(4!B0=?NK>@4D'GT#F
M%N%@+(5#N6 H1"W;-_!#D@Y!,?S1\O_;=?XL2/I$YN<_,4 4\1<VE73)DM _
M,:MB=XGKW_70*@'&](3.(^?)4PD.DJ R63*\+9TVT9&V$XK0"*>RF6P\DX=.
M@V\>$-.<?5M0G8?\:/ID4,W>L15>>Y',[0_ /FAE53"T43NUJW 6 OH*8ELK
M=L2'<C<=ZXV^RJ\D=HW]!:QN=(@MWX#H4=/KAJC3SVS$G5V'4NM/*%LE\.UU
MJ]3;XDEOZM33^&E1[O_X?:?RBH[9A<>P98 DB%]8@5?>TU'#&KN<L@@PV2!
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ME5^;I<%=>X6R[:SD $;9184@@BPM#$+[3![8 I^UA%CXU^K-W9![EJ ;PNE
M/$0F,C5P/AB$JO #-=RG^\J?$\D","HA&24(D[V0VJ=AK'KUZO,VFQ^R<W83
MI1I.&X''3C#!>[$9VE6G33"(XM1Z0W9F<X(+ZD56Q!GX"8*2P?]58"ME%TJS
M2VRI:<%QF@9L=4:%<Q-3TTU>@<VTZ"SA89^?.:<)X9<7HJ9N8X(E[.MW;GU>
M67O(]&5_H>YR$7P*<]MZYV<;QIY-1$15%Q@<IL,^='0PRCM26H+&]PVL;S&]
MA$!>#+ *:%_M;D;.)F<[5JP=^_)^^Z/S?/L\OIOO[6B.VA+<NJIX#,&-YF<D
M ?7U@SX_@U;>FI%7?FQ6"_6F9:MU16,FBHI'%%9.9K.534T]7"ANYXM (![J
MJYQ_OIM<-:3>%S'J]I!K'V-"*KRM$2$:%8Y?^F53'!7N@UQ:_E,8;AU!A:F3
M]=<'HU+J?A4O(A*&<Q,A*H;; ;GZCR/SH%<QEA0?)Y4[A6\1%^LM/EX^"T/N
MDS2K4AH<BR-Y)BH.8=A=0LGP=2KVV*GG9\!0-9#:W6X__;5;X=Q6"+^+YJ?
M_RCJ*FRW1ED(J;*;1AG[.0A.Q0M>OR8BH>NA#U4@>!'XF.N5.]YR?K9^%+O2
M2R4(_&44FXTB/NG*"2-Z@+7MA'JEMT*]KH#PRL#H:>3G#Z^?C^V'?1.IOR$(
M+!$.!'8-6[5&LO6RKM98<P4D>7IXV&6Z> WT\MJ<E8NM\B<^7S4MK-':2U4?
M&;%Z)/.VZ,AW9DYZ()GAT4@?D>"V>M9( V=P:LP?S%EK4(T)!G4'B0CP^ENC
M32KT(Y-/ PBK9X6%MT7VY;HNO30K3_<1)\<]B*P;+^[>ZY,BK9I")::3"8+"
MZEE8\6W!9I]:PPZC+W)QL;7?B\$5;9?Y&WKZ8#3G,>'2'H"INH)1C;ABX4Y5
M!FV@DZ&AN:U>P0UFZ?OYM\5+J<CF6N9HQ/4.%FM_1($!L;W (/NVF-R:S7JM
M^IE_XF!^71E<0%ICD-BIJ"F($Q=KW=71M^%AL;YX6-N^#(R#9VX\_FS>X:7H
MK$(OXA4XN[ZAS[N+EP>!S]EGAVQ= :S,*8?0,9]RB+CPKF)T+?X,%*M5B:#S
M?()<N01.L=2%_>N_<#_?@,Q_P8'2 PZ4-*)/6#[TI-VVARXK?$_,HYHH*\7&
MK*?8UHPKPS&NO+.]4,&=77#H1!CS[R\+5AD7BY-1N%CB:DV!)N1YWQTTE\9L
MSZ4QU/8*@R7TLE-@*'FS8_0*,Z"&9FW5^W"#O"R/[<X-&!0V:U$16^Q*<KLX
M6)AS81G.K2V'?$FK5^L[N]!]UAKO&:"([)+TM1^_:;^&.XOLX@>L#AB#U0SE
M^=J>?,>HDEN9OH$PYZ4>6# ZC;W35 \XD-*,;@.3N3O65E/-751U<-G_ ;Q3
M@@:$IO\;[I9L;"+D=-3#+\VJXR'GZ7BX]/:C;)8B=D5@%BDP0 YW[JAZR_F&
MB6CK+ZM<M*J(%^C(L;*I24 E^%<0;L]&'YV<.>#P-;;_B==?&]J[X#I\>U/0
MB8:5+N.$,BS1W-%=61..],/ULK(F\0*B+1F 8[=$ N 11W2J,Z.6NRD.R&%O
M-<L"?L[1 S\V%W\0/IM[\3'KOUW=CF0&S^[O+CLY(MZ* 7)[&&!SU.PA,KTM
MWF8[CQR_X .?=<#Z.8Z"Y.  E_Y:"Z<<!8P7&\["T08I&Y-!NJJ<7)U>75D>
M8&&4-=_GS_4<OG<N\$$FZ;)*UN?M$1BE!,5LKV$(8I4RT5NE>RC^65CPQ?R-
M:':I).W2" ["8YD2.^KK0IJFV\O4(S)-]YQ*[J[4:3RT\!*Y=\QR%$9G%-<B
M2K,S/]$DV:X4.,+FS"9M<^XYU:%8ON\P+%M_Z"?=%7#D-=ME7++[;<OCH&E6
M)@03B0VYYY2>!R\CXZFEE&Y_^"TQ6ALQVIOG@S-%9UCFU-"MJP/D(K$!]QS@
MX+99;Q-3JMLA8CQ!(J$3).D,Y7O%#@,Y2@*"[VCKDPEL?6:/MC[;,]5A''E4
MH>X7^KVAA93/AUN?R[='T%Y ,)=[&PQV&9]<,L:GB^"=9Z5<FYO5EWKVQ,9G
MV'/P&I]^ &YNV]/NG=IK>E*G,#U=9S*A/Y^'K\Q5_79X(M,S])V(TO2\X<$Q
M:7-47N3JL%I:G])X8J):5<-S?[;[S F:FZZ3?)TS]Y\M29>:XNF#G%'=N5TM
MIW[A,+LT?+G=J"T:.C:3U'62Y3G%<:^=U]FM<!J;](@KZ;%H<ADNYZ>G3F.1
MDK%9I*[S6["EU]=AH\5^4*>Q2*,\/P+/,$=#>*<N!KJEON"(P&@$IBD<&+X$
M&J"5VZ><.N;[(4-"1QBGJ_='89[Z(:T%-DZ+"1FG;I*S,RT_' WGV1OZU.9I
MZ)/P&JC[@J-!#=3MF=PX#53WN0SJ5>+%*#_4&MRI3-3P-V.GD>J]&CN-U'K/
M4.VL/!'22(T1@.7 T]3N:]/ZL#!X44?I-%,/NWL[P'.VN^D^ANKI4()71A(>
MGY'KY@3EJ4ZTWN?94E?:G;^/'(+T*-OX&%G@ TJ:H0Z8*Y0VU-BMK+2O#.0(
M>]O-2N3C-,\_$A3>#E[^G*Q%'C77<$PL,.7Q1HZ/*=^.R@,D @FWQ5R^J>+J
MF+HCV/A]\"A8@L,S.'WJ62[! R7V9.=[M4ZQ\VH[>]V/WU6.@LPTE^'PZ$;]
M)>@.4VQH=_A.U'6L9Z%S.V!L/H-K3ZE@MN6(79C\KEN='_#/QGPQ*G16+MZ6
M32:C1Q("I^<R#!T+\GDZF&";P;K!!+;,>64GZH2Z?:@/J/0S082BB\GDB%@&
M%"1I-!"7H:)ZY"4#5VO/O-C-L?9G0_,L^AXFJ":P\X)6QV:W<&Q-57J^DDN7
M;GLWK45VULPMF1;M:@\ R-:UA>;2U=+B-F48(D/GPD_(VGKZP016DL=?"G3\
M@HU5:LLM;EB8="MB?CZA-R%""8K,X7LZ]?:S0K#::)+(0@^$S' Y<DMM]$$G
M$_L0C8#S,KBW!7,]GO+"3>FZO,+7B0 @:#5&(7DPI^3>5/7T$1DJUD< )^+Y
M&0K537BM;XYUK)5? J+RO0]3TB4D@^S6]SN^!T<X8H;&0QAT[1WA2"V!\U$[
MJ2C ,*@*<?%AB^ RM0"QSJDL_2MX/-0OGV,">51^;$;5L/+0YCK70U9_?6=3
MVH&Y-9\#J/#C-[.WWNA?\!Y3NYB+O'9^)L-8'C_01(1G<[D3P,\M!$NBWM.D
M"7Q^]'V *BZH<H5_K1*#I1"%7P=46+YU>3C[X2L"4G^[5BVY7XOPL->HY@/Y
M;R,C7A!6?3M"3=.MBFC>OJKP!J$VL/] A%E)7\%1(H@U!#0Q@Q#;^HR?3, =
M MRQ!;+2_K $7L0OYS=H-APWZ0I@7WJ$JLT:<%/P/1#^C<>&HC  +P3J29KR
MAC0540;*8G-K%@98%H*+@U!<F";VH"Y#N8T^+\%5RJ8%?M,;0J!.2)NUOZ O
M]64+U1J2 CX,G.!XHHE#.#(6O1+\+%ZNX'*^EP1.6K=4UTOX5^(>RNOSLPW1
MODT#]$W@=8G@I+2)BAAL*/+"A\EKX./Z;M%_:'^]G;$D<)K"CRU#YBHZ5Z+Q
MNM(."=6Y1[@#*4-?@.5%4'B,[\C6DYQ/FFHS*[E-JVZ?%[)/JT9"^OSH^?FA
M.3<+4S*MI-^C67?U,CFJ%8A%44&JU<$+7^G67=C,NU0K(+^M6B,Y"/Z5?Y*;
M#?&UM4.W8ON5*R(\4J[!CB"@>LVO@^%SC(_!R.&7^,J:L2U1?_6)^6G/\[-M
MZC.4\L3LTU]7GKNT)K9/:0)!'%QKPEWSO9XE;V&Q0<\-5Z@O00JMRI@U;?K]
M]-O],AX(MRNO 799X[H0""D:@>&#3PO!^G:/8=B6)5V]N"E.K"(6()D:&J"X
M-.'EJE(#RVW/1'DJWD-;4'<I-3MN]-*ZO<9?<J_//.-*LCL[@"_)8*O76("+
M8:)"H9<80?!HAQZC\$MOX&A3C0'^AN-0T,7QG,6VOO5]7LGB5:@UZ=>V6KP?
MK5$:6X&[.?-L,@=Z&^M@>0&E'M#L[*KD#G F4B%(6O!]L#;P3TTU!T- $XK:
M9L4'@E9FWQ;-/GN]&,]SM"DE#*V<H &_$\*9V0KA_*<!-9/A@)I3!<=\ B6V
M0I8%]^CQ3GYZO:DS GOT/8H'J1FL<5$:CD>DK-3*1\.HAT9JKKPMLJ./SP^%
MZ=*/_7A>?Q!4<\SPPR>&7?Z"NTL3A')1'8\E [%,7A$ 6QG M 9"$5A/^V=!
MNRL=PCWH;=&>:6R39\7;>M):^8^ :B:W0S63;XMIMB*TZZ+&S-@?OUTGEPJ<
MYHW72'!N7"_X$>SFC>68<$BF.Y'7Q:VB,L87GW*ZLXPVC08\J_V^U ,//3^;
M 7$#)1+X Q1!4W$H]63X.NA*&CRXS+P,W$3P'^AO6A,QH;SJR;RN2WT)>O;@
M>4!T\08:'8Q>8HW3=%YLIY'!8X8\&KL"?4\-JJV^,Q7X_,SOBX((_14TR%'J
MHRF0F@9#!BC4@*(0Z%LPM@!\/!$Y&9=8?7TQ8'VZ:%C;4[N /F@&IV['&7KJ
M0)$6<%:Q/<'8^DX/7 UH(:(WH8F?7?!K-(P2?FBBB3K\BQ6Q@(XX^I;C=%IS
MMU9/@[OXQC&)JK(\J0VJ6P3*H"S*BAT@K#AP.W1P_)^0IJY\CTU!1#&P'$!G
MAZ9HZ"3XAS2%ZT2'.;$.$EA%8%6B@IYD+0,<&/1K)Z(U;TE5K!6@E5UB33A9
ME)<SRP^C;( &QS+UAG#MSI/Y?E_L&1L'B9FZ'6?;N6GP4@CW9 7MK >>GP&>
M!=Z$KBI@LX 00.SS,,"%YIV*GZ+6D\"SU^\ 4*5PP";XN.G<7D (#7$FG+NY
M'%^NK7&II%CA"[BUY13/O4P.=X7^KO:LKX+567=^]2VPAR%P4N"?W 0(<"V^
M\17(^P^$REA9)\^8*7!\O)MO$%_Y#:UV#[%8RC6DO9[M9^:M1S:=)Z(_PN +
M@0)PAC-CV H,=9[KTP^!>V=?EW&AYR"+LVM[&DPG=T]PI> %.A3]XS=SR:V/
M^T5A'TLB0[;QD$< =B."P$4\C>X;N"-+;6!?J34I#Q0(D"!H!JLO(=F@A"S9
M[X;]6W;G5J 6-."+289X!\234 4W4QE(X,+ED>HIS._YD:H5H<I<SUVLK\1)
M78S'%>U>:U$/#ZNBT VEEME#M'UAT[ D"-*9Y+>9J-K6MH_>0^(<2D(X/EK1
M(?O*O#U%>M,L09SA-WC8_SSJ_:;UK+9JO:-LO4+?UEZZ*(VOAG6I-6H4NMM.
M#LH)UQ*UM<7O[N8-N+I=O:7K_N&Q$6[&YUPV MP9+[V+!].;6-+;+D.L3UX&
MAODISG-,RNA-+&MRPE5-[Z V=^EMSO-0VS>/4#J8XOB2XKA%\:Q(F3Q-=QI"
MVBB.+RF.1T7Q['Z*+TTF2Z4!@Q/Z$OO"6!E %1U.NP?J0IY[79:E(V%U6-O5
M0\L/]7A]B/5E=69/5Q=]SKRX5>'9+>C;I5A]WLN3'^/Y4YO;>L;."L,I&N?5
MR8DHV@<5=^,(K60T^  B*XP,+?T*U=^5W$KT[>9:4=6WHA(LBNK[:W'T(#WW
M5@,!:L'7$^X,X$J2HS_N,RMC@_ZG<PNBBZHBZ;4:[+7*1-?[B.AWMG$*?M-:
MYNC;J!O7/\2:<T'B'??<M\6T<TVI\YN7:IZ,/>3J,V+LYK65U^J5'D^\>^H7
M$!?+JTT$+&'0[5ED>HR3R)+V+#?2 __&\HHO/%QM;6H:;QIJD'EKC"L<KUDC
MG>!7?]@KC75>$Y7UQ>.'Y1XIGI6PU@TF OTBKJL/1^+,'5U>,D6_TA]7T.'C
M[IUZD#I]JKFJ1H%4B&@HQH&+C+ESC,FPY/[>[#1-;D"L29^J21\_@.\ZP.9N
MS]0-=EN\9N]>Z,*T6Z+=[$8?T=0?;CVQ<U:./19<(5E49L19S*DXBSF4LR!.
MR@9O36ZUB7BM5C7"S5I,0JP%%Q0S<]$9[H#N_-/(JNQ7DU45U=0V&.J]H%\3
MCWP_QW?=')5-AJ/@@F)G*)P^(63G41CR:R@#@"KL:5$J$I!Y%6FZ*?)FG6*Y
M52Z-NRSEYM!CH(A"+BA^#LV&1P6.%XLB/+3.VBK6LG-HH*TN+43+ST)%(7:]
M]<$]\RD%7RD>P/9Y2(@MO#]_+=YIYMU8%OHKI(LE]6)$9#ED[3%?DVPF1X0'
MFSHY9,M1O/QE+P)WP$78X/V^<5VZZ1:N6Z_O2]Z_TE1=QP)@O23!_#'S.T5D
MF&S:&/XHO1!V.,YN+;+[KPC$R@$#7K8A_N/4)UD;("^S_W'R:$X]PX5O/<._
MWTU3D:OP/B15U:*4 QY<@&2J*X ^3FD&[RW->)-JU3=!<M]9XNIYSH]&W0=V
MM XGMOTDT"'LH_XQE_V?'?G>0[<>-^I3)A<=$.Z_Z=!R._&GOC!\U<9%"A8)
M-I *VU!XV>O.\VM=_AAWY%465C2"J+L#H<V6=R#,JN/&9\QELE04T'Q;8;72
M *Q5 K9]#J^)KU)WUF/CRHHZC8PG -OR>[4[[RU^HL*2W[L;2+-;&TA7[6_E
MM\6+7G]EG@ICD^WNN2??L+64"M=:NB)<\6TA-;A9PS0>.]**!T_?=(INCL,@
MB7.IMT9CR:ONKDOF;2&0MQ_YWLL]S5'Q=%V&;$R-GFZ!>E&W48A]6XQNM/MG
MY0;O58EX*!2N+S4I NTE3>%M,:U?W10G@V?MG8F'-$%:65-#$/IM463POM0K
MD8U/,1Z"'-#]ZJ'/:651@@V*4@\5L^<=6*44-"M&5RVG:\9/V"@,C4N3E^O+
MKKR*!,U2&-"TZ\3F3NW;SEHYXDT$CX2MR$<\\VU1:_9&U[?W0B<O)%PGMUXY
MNJ.5!'K)BE'7\I9[@ JCQ5E=*Z,&N/RJ/=*_T%0C&+4QU3J&YD+@L5EMB>"5
M@;7:DF8U@$4/#A/%[M8;6R4=.!^:,<<0 I^"9IZ=G\'R0F=KL#<082\N-ZDO
M"[=-JV)]B>QJ]24AOPU!4X%=*J+EM2'L+/@=</QF'S*:+;MTX$LA^"GPE8FF
M"F;/T,_/$!EAL2YOH Y'(/I0FYT>".8&JWK?[70,6EA@J'1RX_ VT D!:72S
M.T)=C"H&6_7&YA@6/*.!:[R @A"Z!:JU; ;/8#Y5G'>WE8>67)\5I>Z/W_:#
MG,%MFCKG9533N:*TZWG?L%Z3W?9";S"5]*GMQ$Z^GI20Y:L5C?XM&?4)P;G'
M,M;AY5\!2Y1,T1\9SA5WNQGHY6OM2<U?]6(H#PVRH+A#:@2;X9C] >6_Q:!^
M,PG\#K E@@,3H$VWP4NU.[HN/C5>;SM21+6?NU\?-^>00&K@?XL]@W-.>0_G
MM(>2YL<X[Z72S:)R*^K=]X@J.W>^/7:)PV7POW6<8:KD_(X+ED<:0Q]N>;II
M]HHXR9680415F[M?'W>^D\IE*)K[>F)F;T%F7)S#[>,<J>_+./?X\_VH>_W>
M;;U'5$RY\^VQ\PV98?#PF?(3B!EWS>,W*2&A=_(@*@W<QH9CGGIO#1?$?;F7
M:%WCOF7&S*\Y+INAJ2BF>9VXB/$;UG'@V[EYTU^\G1LCC;ZY+1,)CI_;6%/\
M%4C A*.XF";/Q3O?[/ HT*Z2C<+;XN,9'SR^WCUV6WP<*:J-Y=$X)-QI1Z55
MK$$T6P*UYV<P>2:"SXY1WG59TS>1>46!*'76UV%X>A7P=F+&"&,/_(8WL!D0
M_3#6+5J =^ W/ME+&(%636.)W\=;F';PL1,5!NYAPE>SL/5@-D]2!1O/D>^J
M4Q'K2P.P&!U<04Q1#6?& UH2C*5;*P$F+ZP]-#2I:QJJIML)0OAK-Q%<0(Z7
MYV=-%'^>+R&@W*@INBC+X!L9!TC/@LCA!1C"!J_AT00+!YP&_'$PT,0!HJ8?
M4-121-FOM!%IMB)[W-!/,XZ[J5>$I:C:6.P^N;/^HN2 .SAV_Q >'W G?"^-
M/"!.Y<K5;?.V4\-OY1B)% ,@4Y;;#R[C#\A4V$LE#_#2;9M\:?'B7<G(QDBE
M&$"4:.+2&\#:9"0XJF8_4))U=S71QID$=]0GC>I4@Z[OMB8:+2@%;3P[?B#Z
M0/IMWMX13PYS]( U1^_;:)Z!DLY^(DS+*:)AB=N=-9_[UA;Q-=\#K^<W;LN!
MU]O,!1Y)8L_E[U^U@1O0N+XW4T#A0V7$'OJREWZA%8N^B*-]P"H/)[%'<N2K
MG_/W]ATUUK?*UP1I?*B$V4OC[1"1:SOR VSSLW8@$UC(8#Z ;2=+7V\:R-'/
M!6@9:N]]J,H0H+G\84K&'-;X[1\)0+E46N!GO"WPS_)K>]@<-5KQU]S\B>,
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MCR/<4MYO]4_:KV:U6!'XT<YHBXN4L?9T)1E^B41!9+D,2X57$*35R!0T%',
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M>J5_I7R(/D-0_Q"!&DN^E6&_KSB-LO<GN#CU^OL?N8?WZ^95<49^:W$:;<"
MR&;P+RI.(PUD1B%.O=7K=)T:&1^Z>I_]XD(Q^B@#PUU2^XM0#A"*I\H:;XRR
MCJR-V#U=?!]Y @QK]Y_D#+^'":K9E<50LC]446OX#I'R_M)G1NX;='=>OGTE
M C;0^4UK#TF5]+2:1!*CH&DBPP1(@Q\TM?TH;HTK@1Y5\TDY6*!"N.79G%YX
M>ESDCNRQ\V/>K]2Z$F6,(L \G.0Y]HO+5X]+^-"FVI_S25\:!L5O^%[R-4E
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M.E8Z]!OAK]=2$>@^?F/?!T'E\Y*VBJ6NXBE#7C@_ZXJB A@0\,P8$$G 4+@
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M2SW+N'1N"K;EHAC _54U8+A@NJE#9>HRS>WU]7A]>'[F'"Q::$7L:B;\$DS
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MU_(8T%]7=K5M2_.6]2JA$CZK?E+_N>P8^_8F:TQ>OFV_]F#T;*(#\\SYUS(
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MX=6X[S??)VT1#VGRH&7>RPB&2A#(9#;_39E=IY'N],;,=,, ;^5W.J/K55W
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M?!"U:@P%]B5]SU;U]VZ\X("CPA_EU=&A1#]CBX9 =TLCW5/K,LM+V5<N7FC
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M)6C4XTU7?'U;F&J5N:X)9ZR2QWL'BDMNKC0,%S(4P#QY5"//^&T \-<WRPD
MBE !P]'%ZVVM<Q  ./?)P@( )I5,4,<% 'H; /SUNG("P.VDR^HZI8US[8,
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MX3.]ON !!2GXE&A0P*.A4E2"_%0HX Z,@@W;2.Y]U,KU7.&RTG*/ I9GDE&
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M3N$%.]-JP2.M:U5H%(DC=(EJ&*.67GV1J:FD'4J-[)0)B^6;5V%AM@%"7>P
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M/66HP8UJ!)BT !+B/4&UQA4/($7,/WW_!C$A_&-K'QM^V\FR*"NJJ$]+:&E
MT_.BUH)7AZ&ZM<\J:S-177R[89"5YE67?LQF7PZJ\K]$K]7TSEZKMX-W^DT1
M:NIKVJK$M,QS(J/KJM@<6A2"$LED)]2[:F?8AYN$GSHWD6DZ,3M U:S)KZB9
M9D61$0Q519)0#N(<"+N;M.+H%3R7H=#*OP&:5N\)\E,/KFJ*AERV:\.FA@P
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M3/F=>]5>1:Q>Y-GTT]-=,Y;.L.BU'T4EDLR.U@8QN+J?<CT#87["OHZ*+54
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M9$TR#3A":*,G]R%V(@(.G3SGOS1TH-V2:=5N'UJ%YXOBFP?H@"UV"TLSD]R
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M.:<RR& R]IRQ#Y,AN&/;F3KXP,^9<^%ZOC-S;)A>]T?NX*#2&PPFUV/?'5_
MT)U=[8G7MSQ3+%[M.?MME'^&7^U^I;"@D@8K" 7/4%Y0 M2" N.AD$LAB6*"
M \Y+&J,A#_446K ,Q>4\)PG,*-HI0+.AD"FR,#Z#B,'5:P53(N,\Q?@N#X^!
M\ BR/,A8Q(ADR%,/>+L#L9!%_!4E$BB/: 0V#6D:(%:K48-FO=G4Z"*7!Q59
M1,X@(@KMAC20.9$K:)X5=BV=1))K"*3,T&Y&YRQ3FYP\A5XIIIQMJ7O&&1R.
MQ3&T6BVCT3K]='96,"R'FHW3C_63HT?Q#BK;@)(F",[GI8I:5)&PM7W,..$A
M0\6RA] :_B4KR,(%C?)DHQ?3PG(T0#\E18(K4:JF%I*NM<LVXA5Z)9CU6@47
M$:%Q<DB.#IM'QV4AO8EB?5W+^;W^R(&!,QIYT]X ^_Z\6J\6W].>;9???\WD
MED5JH4WK[SL0"!E1:80B2<@RH[@O;=[T7F_YLQ+^)Y6*A20I.2NQK&Y.&<NW
M2ZL-=.OD 3D02HFT#4%"PN_00'I%?3RK0 =T%D;&[NDZ%91\.,'=<"='(R8I
M2U;ME[)\@F1F)ER1>UU.UUX/4$3+U.#Z=+3_F,JI3N4)5KE0Z(B/67&P%JO5
M?>O[L7:^$?)[#<JW_^.<>;*A/K]?[-QHMHS>&08,&4VB-IX <]K!L#]R?7H@
M.S",LG1L]\OO* ;V"!;04I4,M[U0C#WJCW[1'\VR/S#^4U*[I3=%@ABRC+Y#
MTM0LU\1>2LW4M\#UM5#?'G\!4$L#!!0    ( #N#7%:XH@EMS@8  .$:   2
M    9S X,S0Q-U]E>#,Q+3$N:'1MU5E=3^-&%'V/E/\PC=0*)(?P4:J*9",!
M"=VT+" V6VD?)_8X&6%[S,PX(?WU/7?&3@()2]H%:>$AP<Z=^WGNN3-VY^/P
MTV6W7NM\[)_V\,WHKS,<#"_[W4[+?^/75OESY^RZ]Y5]'GZ][']HQ"JS)^Q@
M/[=L*%-AV)68L5N5\BSP-P+V66@9-[ 02V^J=2G78YF=L/U&]Y=L9/)VIW7S
M1&1;U6VV4 ;1_3:SXL$V>2+'N*7E>&(;W<Y9M_\PD2-IV='!WD&G==9]6X-O
M&E0H,BNTBZKSI7O>OQT.+@;GI\/!]=7G3NM+]PW#JTR_<GR-[B!@?PJ>L4\\
MXCJ '6UE/&=VPNW)*YIY=;\/]MB 3?A4,"VF4LQ$!)^E83S+"I[@9JZT92IC
M%TJG,-#\BZF8#2B+]=H-UW&10O<@"_=>TZM7#_-PCYUQ@^ 023IG=YF:)2(:
MB\!'6X89*:C,E&4A['"9(0MS5F16%Z)>,Y9;D0(_E  . TB!1(IB'N*69BI%
M=UK%G-R:0"9"80S7<Q))^9V 8<$6.@WN1? &-A/J0+)! J'4(3)L>8;E]5J1
M14*SV42&$V8*^E@JF DM2BT40BI-(G@DLS&;23M!B"87H?.0%.?P344(=(IE
M$1O-5Q/Q0Y?RZ!NE%"R6&7)%:5^F)D =(8Z?@=FE@,QB8)I;"44R"Y,B@E(4
M8!W_ 6HH=3)G.;)(""!H),FRQ&5RS1,7 *-(DOZ )(K$HH0HK$+RG5GC' NY
MF; X43-355V+L316<UCB=-,' &^#E=J9RIL5K]]!^7[=8\-'(?ZBS7VAVL87
MJ&).PJV*8XG+';/KXA_4:UP+EVND3HX202EA H4>)=),: G)I>A<ZEZZCJ0)
M$V4*K*.>UBKQ.<^U"D6$VX;M(,610-%\'OL/X81G8\%.T2RW10*)@R/>/#C>
M$;MP &L/CB-_Z=V2Q(69KS898-12*R#P-2%GMK84>\VEH1B&*%"DIUY;A09$
MB+E_X/GB/_>.9=;H\EW6$P93&-$[[GJY-@':!8C@A=E^#1'<2"#/I2E/F:K0
M4(#&F4KC^A%2(G-Z:$0O.WF5%+1(.!6N7BM)<YG\H&0,*JM$W\,9HQ(9<>L\
M'1D92:XEY45Z;G=$E9'=PA#=.K0;Q\VN>Y41\,B"+FA1S@&9L$@XL0[B\EXL
M>1M+_!18'5_X;R3((Q #%(CH;0KYAA@9/<7(ULVU#I47VW%KH !<4QE1^;E1
M&2?BX0;8H:%,F. Z6M0'F)%\)!-IY\3FF^P27ETI794\U!Z)K@QU1W /90[R
M0N> B7'C)PR5CIP';KR/18:ADB1S<%08BIQP2#+8O7A$ *\R!\>\.TR$NZP_
MY4GA6HOR)N(8LU9.$;'9,#*K>5*O;4$6_G+S&'58P$+TN?'#>J0*^[P+&\SY
M@;%J;R$M:$L2O[P78R.WV2DP\SRNA4\&/&J3^^^MG!%:W"=J/>&TW2YGHOME
M<UFW'[B.VE48%IKRZFGT&;4L5<;B/AT0H<N$4'1?@(6A>N<Y3V(@!+U7R<%G
M[.6$.Q]DCW>0N]Z7"3>+40-BYPY&(@KH_.#24!+,'*> .Y&4AX4G\L'W9^;=
M(*?1/?Z>_:([V$85W(*REXAOT=JK%5\V%55O^ZG#UG8&"_<X=@=6Z9(#2,C=
M@<X4)T4K'$XVK!LIS!/Z+9)PCC2P'< #)&&(A/!-.Y0*R>*^D/#=H;;(0G>J
MV'T_.T(Z1='\E:@<[6EI>QQ*@327Y+S8F,T$OR.V%0[GGG#=Z'9G[^I$M:EZ
MYGF"\'LH?ZK8T'H\PD(C%IWW;.-5$Q]K4#,,YL"3OD$63)$B _(?X>(IF6[C
M*?3==.63+1O1=JR![@ )%:XK41/W$**L7N#I3V93E4RI@K# Q^73%%UVLDCS
M1,T%O)A-E'\FQ1^! [7\QF#8OFOWWD..&]T>DG?"+L1(%_3<Z/#W@!WN'QZ]
M76\/3\\N^^R\?WGY^>;T?'#UQX?&?L-=WYSV>M7U?S8ZDY&=D.C^SVVPF\8V
MNQFJ).&Y07S5?_2$O3.\K=1/B=8QA*L'MU;EC?+9?F?8JZ1*U4?'2\TC9:U*
M3]@HX>$=.X![[F#69N1PTZ /O=>-;N?B^FJX&DXSYJE,YB<O!;2FJ658:_GT
MM],BQ?3JH?>LQ[^1QVMZJGI@(3YN_T]&WC#*U>?;YQ,I8M9_$&%!VV!V[4?O
M-T/?)MR6PZ"#XS.O6Q9H_:G99!=2)-$)NP&7M.'W?8')0>I9LUG9[PW^?JRE
MB<2A +FMVF$!&7?O"8S.'(P.*QC!_KI3^:,7)IT63%;65YQLD9?>L9=":]$K
M*O_.BEYM_0M02P,$%     @ .X-<5HOI;WO'!@  WAH  !(   !G,#@S-#$W
M7V5X,S$M,BYH=&W565MOXC@4?D?B/WB1=M1*H?2R7:V 06H'NH.V,U-UT$KS
M:!('K"9Q:CM0]M?O=^R$2Z%3=J>5IGV )AR?ZW>^8R?=CZ-/U[UZK?MQ<-''
M-Z._[F@XNA[TNBW_C5];Y<_=RR_];^SKZ-OUX'TC5IEMLY/CW+*13(5AG\6<
MW:J49X&_$;"O0LNX@858>E.M2[F>R*S-CAN]=]G8Y)UNZ^:1R+ZJ.VRI#*+'
M'6;%@VWR1$YP2\O)U#9ZW<O>X&$JQ]*RLY.CTV[KLO>Z!E\XJ$9O&+!/,IR*
MA%W8N5)1P$*AK8P7S$ZY;;^@I1=W_>2(#=F4SP338B;%7$3P61K&LZS@"6[F
M2ENF,G:E= H#S;^8BMDPLT+7:S=<QT4*W<,L/'I)KUX\S-,C=LD-@D,DZ8+=
M96J>B&@B A]M&6:DH#)3EH6PPV6&+"Q8D5E=B'K-6&Y%*C)+"> P@!1(I"CF
M(6YIIE( V"KFY+8$,A$*8[A>D$C*[P0,"[;4:7 O@C>PF1!(R08)A%*'R+#E
M&9;7:T46"<WF4X"-F8(^5@KF0HM2"X602I,('LELPN;23A&BR47H/"3%.7Q3
M$0*=85G$QHOU1/S4I3S[3BD%BV6&7%':5ZD)4$>(XV=@=B4@LQB8YE9"D<S"
MI(B@% 78QG^ &DJ=+%B.+!(""!I)LBIQF5SSR 7 *)*D/R")(K$H(0JKD'QG
MUCC'0FZF+$[4W%15UV(BC=4<ECC=] ' VV"M=J;R9LWK-U"^WX[8:"/$=]K<
M%ZIC?($JYB3<JCB6N#PPAR[^8;W&M7"Y1NKD.!&4$B90Z'$BS926D%R*SJ7N
MI>M(FC!1IL ZZFFM$I_S7*M01+AMV %2' D4S>=Q\!!.>381[ +-<ELDD#@Y
MX\V3\P-Q" >P]N0\\I?>+4E<F/EJDP%&+;4& E\3<F9O2['77!J*88@"17KJ
MM75H0(28^R>>+_[SZ%QFC1X_9'UA,(<1O>.NYVL3H%V "%Z8_=<0P8T%\ER:
M\I2I"@T%:)R9-*X?(24RIX=&]*J3UTE!BX13X>JUDC17R0]*QJ"R2O0]G#$J
MD1&WSM.QD9'D6E)>I.=V1U09V2T,T:U#NW'<[+I7&0&/+.B"%N4<D F+A!/K
M("[OQ8JWL<1/@?7QA?_&@CP",4"!B%ZGD*^(D?%CC.S=7-M0>;8=]P8*P#63
M$96?&Y5Q(AYN@!T:RH0)KJ-E?8 9R<<RD79!;+[++N'5E=)5R4-M0W1MJ#N"
M>RASD!<Z!TR,&S]AJ'3D/'#C?2(R#)4D68"CPE#DA$.2P>[%(P)XE3DXYLUA
M(CQD@QE/"M=:E#<1QYBU<H:(S8Z16<V3>FT/LO"7N\>HPP(6HL^-']9C5=BG
M7=AAS@^,=7M+:4%;DOCYO1@;N\U.@9GG<2U\,N!1A]Q_:^6,T.(^4=L)I^UV
M.1/=+[O+NO_ ==2NPK#0E%=/HT^H9:DR%O=#VM[%<!"*[@NP,%0?/.5)#(2@
M]RHY^(R]G'#G@VQS!WGH?9ERLQPU(';N8"1P7D2;NS24!+/ *>!.).5AX9%\
M\..9>3/(:?3.?V2_Z ZV406WH.PEXENT]GK%5TU%U=M_ZK"MG<'2/8[=@56Z
MY  2<G>@,\5)T0J'DQWKQ@KSA'Z+))PC#>P \ !)&"(A?-,.I4*RN"\D?'>H
M+;+0G2H.VR]>A=?=%])9BJ:P1/UH9TN;Y% *)+NDZ.7V;"[X'7&N<&CWM.L&
MN#N!5^>J734T3].$WTGYL\6.!N01%AJQ[+\GVZ^:^UB#RF$\!Y[Z#;)@BA09
MD/\(%T_)=SO/HF^F-Q]MW(B\8PV,!TBH<+V)FKA'$67U D^",INI9$85A 4^
M*9^IZ+*?19HG:B'@Q7RJ_),IO@$.U/([XV'_WCUZ"SEN]/I(7IM=B;$NZ.G1
MZ1\!.ST^/7N]WAY=7%X/V(?!]?77FXL/P\]_OF\<-]SUS46_7UW_9Z-S&=DI
MB1[_V@'':6RVFZ%*$IX;Q%?]1X^BNZ/;2OV,R!VCN'J :U7>*!^"=T?]2JI4
M?7:^TCQ6UJJTS<8)#^_8"=QSQ[,.(X>;!GWHO6[TNE=?/H_6PVG&/)7)HOU<
M0%N:6H:U-AX#=UNDFQ[3]Y]T^G=R>DM551(LQ,?M_TG**P:Z$22KHKQT;KZ8
MD0]3*6)VM>S;+WZX._I\)9,W_I $8Q>KDU-I][NUW*=^+==7KL6>>->R[,!?
MFDT$+I*HS6[ CQTX?%]@&I)ZUFQ6]OO#OS>U-($$("JW58LOV\#=>]0:EZXU
M3JO6@/UMI_*-MR7=%DQ6UM><;)&7WK'G0FO1^RG_PHK>:_T+4$L#!!0    (
M #N#7%;,6 =1P ,  ,4,   2    9S X,S0Q-U]E>#,R+3$N:'1MU5=1C]HX
M$'Y'XC_,(?74DP@)T.VUD"(!@98[NB#(G=1')W&(=8F=VLZRW*^_<4)8=F]7
M;:5EI?( Q![/]\V,_8WC?O(_+T?-AOMI-O;P%\S']1?^<C9R[>H79^WCM#M9
M>5]@ZW]9SCZT8L'U +I.KL%G&55P3?>P$1GA[6J@#5LJ6=S"A;AT7:_+B-PQ
M/@"G-?J5!RH?NO;Z@<GWNA["R1F:.D/0]%9;)&4['))LE^C6R)V,9K<)"YB&
M?J_3=>W)Z+* %PTJI%Q3648UG6W\Q7PQ'?N+U?4%PZHA+Q,7XQ$UZYW.%>.M
MD9]0*'!(*L2F$214TN" '*1F,3.^& <2AD)&A(>TV=@SG4#W'?S5V7:F'>CV
MKYPV$ 4D$KE&!WDA54&X!BV01JB9X/#>>0LB!HU86R(#PJFR5K<I/< XU&:F
MYSB]$BEA"D*2DY#I0^F5XW3,D(XQ6YC$-!MK(N,B0VH+'G;:Z);HTO>8\X*D
ML*&YD/ID#_?, >G,A<PP?]:?$ M9KCQ0(H%B&B+P:$BS )?UNVWDU4-><9&F
MF!*1Y2EFY)@"LTS2KP63-,.$*H-7Q]OMOR:_G2*F82&9QI4PNPT3PG>T#KO[
MOO\&0XSN0F <*66D]!)BG0DS1<'$J"),$,]$UFS$A$EDE$NJ#'15HS3%>F.\
M#%. $SER4>W2:<PXULZ,H\N(E<X-*EH5:<5<Y%16J(^G[<*[\,%6]\>3Y0RF
ML^5RNQY/%]<?/[2<5OF\'GM>_?S#1/8LTHDQ=5X-(< =3:45BC0EN:)X[([_
MC'RZ_J9V?V-.0DC2^G1JD;>.PNWZ7FUU='WEO$*IF*^N_7-V5DPREAX&W^)7
MVBKV+ZW":8T\K.< YC20!9$'Z+TK=V3?M0V"Z1?>DTSZSTID<AA\#^B;W^\2
M&PBM13: ("7A/]#%ZBB1LN@Y6=G*AC\H2L1G$A%Y3A"_-C]2QM,&/ _N\<'G
MHW]'O?W3<9\FC,:H9ZAMFMU06%4B_5@<=GF:1R^E'9<!&<.Q/PJ\=*"<II6Z
M8[?:H[9KB@*M\;":3M!L'-M"!-A(SUM@@@TMH&B;2W'#3+/!'OE8CS+BO&<H
MZ('I,<<F@,Z>LHT+R9E**H>H^,W&6=,Q!J?&,Q59QI0JA5X"0_%'WG$,18XC
MAC=5^H7%_C(@)_>_6!;,&4VC 29N1X?H Z/$JPQ"@675I\-;_'W_OFSA*1O
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M0=(V+"MB7PO--J\SU?N->0WZ%U!+ P04    "  [@UQ6.V8:B'J]  "TS@
M#0   &EM9S P,5]V,2YJ<&?L>G50'$Z4YN#N+H.[!1L<,@1W=W<=W D)[N[N
M[FX#">X0W"&XNP="<K_=NMO=VZK;VG_VO_NZJJM??^U=[[VN[OZ[^G<'@"TO
M+2<-@($% "S_"8"_%P <24\+!U\ #  > /C7K"L IKBEL[D5P++OGQR8OQN
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MU?XV#N&Q\_3O?;=S&[FBSE2%T\6#F_@ZNZNCW6,=[@%VB (F8F]%X#L#TD/
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M";<YG I$Q+OH9J[N096@:8)#7WL_,A'OEX<D7?OW0)V>.XQR&^(:US[MC:2
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M4<EGT*<&)EDTSUODU0K/L]8= :6<L94AE++RO%C'X-[!M&Q>(_S%1<$A@*1
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M!Y1 <V/G$MI'I6F(A2':S;WD2%%.?.]/6<^!5\-S9Q!_,@_NW+88<J AD%W
M1ZME]L/ M[@Y]I'!SD@GNL,_N_SH90'-U]FCTJ,C$D!7W0.E$NF=YFO"6<%%
MKJ%BZKZRJ?RGM[L5Z,*\Z0*07'6]:7>5DS>9+/7^:T+TBK?X\]?9M]*E*Y!
M 5T'-V<K'FL^DU%.A W1GG&CMRQ,S &V(DQY\:?S(1%$9K![L46[+6R]+SLE
M\L+=!PFQ3=FKM=K(E*D.2G>$26H  $X90"[\\7"RSD4LDNH+!6Y0_>][D\$A
M L5_O\-3U1*[D5#C1&*.IH(E1<:R14;&[(+<\GT"JE,LJ$E!EJ8_P<1&$T3O
M\2G8L#YUK(PI-6R<Q/0$DENRWWJ\(/+I%+L>J<Z4YXS2O;LS.3'@,='0YIS'
M]3<8Z6$(&4 CUH/ HZ+#K2=%=!I]G8??5M:UO6<6Z]B*(/>=/7 F*$.W)F(%
M1/G!0FUG6'X.!A&M:AS/A-FZY;.7-:>ZJRVB0IJ:LN$^N8HE(\C%2W.?R\B+
MK3#5F-P!/J)VS[[7PM#>B@[&A6<PX7H5'!Z%ERQ<*4.H=5%)-G-0H;'0V_CS
MA^WPAY7+MKS:DX*B"%Q2)WAG*ST"%G($5XN;FLX&G7:_7:+9!$D#U03MC"<U
M7/\ -0@6),_M=O&FX<-/J%>NIM_E@M'%Q*5^+BY3*M;TU@DB-N#'QW-2?^CP
M->R#8XW9J@JS!X1.DCL\NJ#4M\Q6%G[Q >'4"$_UC>?J:OQMQ(T^G(H"S)V=
MC" 4-XK;CE<Q4\[G7,UB:O(DOS>_I<>:P.M5#3%N3DSPH"J*7I86O%/:;-+<
M43:_!P1-D/-$7"E5=/&E%[_SNTBNEE5AE&3?JGWRFZ(S13Z>XK!J]T[?VO9S
M6>05W&(CD8C3?<)&82<6+,S5]_%@>YRB/*QWW1XQ3OO^PV'^<\14;O\?_?VF
MC#*>]8<"ZGM&SJ_IG1=6IXI/O8QCGR>:S6'5%D9_!R4[&,[)N.J06M">O%,.
MEFF.,_\GW3;'N%@?NSPNEK]\J$WI+'=S,LVOO$U66M;CD9CJR%3B4IIG+;3,
M9:: %R NJ?)Q 2+QO3*TN!?:8RQ>9I/OC'9@8W#B4VE:1 \LL14M/D#C^-3!
M^=NZTQA"S9PM<5AR!Y\5$IS7?6HLC'H59A:C%)PO:]DAZN9S\&/O"\A13*T;
MU0E,.'0$)%RJO\O@B!4*B>&,G%>=6*&^]>$<5I=-%M6VX$OB6PEU:;8*$0S"
MY'N(W7,['U^H.JO<&JVR0+H$G>Z.PVDNDP#<?C^/$;,25'U.(W2SK;#=^)[W
M==B^N,+(ON=UGKOY6W8:A,!-;VTE/N8KC07YN&]W-#XF'?4$24>([QKW-LHC
MF1I#'<0YF1L%XZP]: 9FD0/_EL+*/GX>VMZ3;D3HU3RS\TYK%$65HKH^(KOW
M55 SX]0I .J@9>#,K^1'L6&,[_8T;JC<!N3A34V95:3+!>O2$5)*MR5>_07T
M2$F?IQ:;'>"&2__TTY?CY3EK/W)X656TQ)T(4>>Q\D2!*../9NEP>)4=RLV6
M.VK? =;@FJI@XR>S^=5;R=^'E4W*],J,1$(;KCX4M4],[1'*WVMH5P%I>029
ML;7+A#,GF7/QYICD?+,0+-_"//;'Z%<XO@:L3I)[>S^5O9:RNU.YT $6;@(]
M48 "N/7BK=>\8QCE&<)Z\*.G+>8JROJC$:"MY6[_CLN%YR2H1E=Y.62H=6_A
MSM,;9%M5%=Z,I<72+(Y@%O"3;KKFGB@*W[ZQHO*.N"ON*Y3W?$7ZW7YK_J>7
MAYT9NQUYB]I>Z@V<9H*=O1#]H/GZ?3,K$?D\"K(KW>VD;@(EL>%6_^GI5FM.
MI&V, >(';YQIV[LB\XKAM55>9V.G%K-[OGA"6[HOW4[PIYW,CU*J<-APXC!=
M%<Y,=7J.SR/^PEZ"M1.& LFN@.AX2=)H-Y;MMC:E7WFW8Z)6-]'Y@.Q;H,I8
M_63^>$>G*O.CYJ5[DQ<IZ8V;9TQQ86QHBMT8'6J*]QT*%$;JE4,BLX;.%4;(
M&GM1V-V@_/Q8>>EH,0L.B'[I;[QBCD:I'\BC24J.NKH%^0LPF+ML?:M"*R"S
M<&>R6[&00CG;8QU2,_LEEN+(GP/+=SFS=;SL^W2F*=P44C6@79C-5ZD;9>D4
MHSO/S+ S\<T#3'/&5#5E^4*4Z,'I_/#MIFA^[<P/&**'Y'C<]<,]=\\(;>^8
M@Z*  TVM\L*L>MG(2_67,.+([$(J8"V+@S=69U:/WZ4=T$%&>UZK-:#<XB'E
MM_]:.NB%84)MF-@ RK>4J"$_EBS3D^-M$I*;1Q($GY*#T<7O6C1*KQ3B.%86
M_?F^*WVUM;1H8A0PY055]A>'FF-20T!Y4.?:HRY76HVPMLA@_3GY)+74D&7R
M\W"TI@W1HE:M:SZEP5XGTI5)J>P&X]KZ&%WDB4T1 _FW*L:H4$E_BTX][BY]
MS;V&S[O&3NHO$H;Q#9T>EPKB$9\6+J&L HP>:5-[QP)'!)XJ$E6*=N*?ZDY>
M$2L@]3PN]NZ@9^/R$R8!Q*Z+KX"1_0<+2M*!IV^Q.%#=R_1)^LUX:\O:Z=I'
M7NSJ3T5&H5_Z.7:[[]M*F$H#BE[K^G#U/ '1+*J+,IF2@]U-VZ/*X4RU>R4E
M$;3C'!R@W=3EXL#=3\R!^ !VZ9+&W@9?=_:'MKB[B)'E[D!2U"-8,:<&TENC
M%HJDC:PVR&7\6-^3 .N0U-I@=X!0KU*XCP\5%_%P,BY]<@Q! _5H[@1'=; 3
ME?F3M6C[KV02B@W=34@L[HC$. >#^"=[XPL9^OHE:,?3G[PSO]0X7.X]$EU=
MMZ!5$1$XV=O=@<R'L&29BN@B_FP)OTEJX=,N9.HHTN>"KV]&C!.E'OA-1>@H
MQ/D%:EG0$@$\=^\O*N@+@YT53S+-<$PC.,L[9^ANBQ1HV2:05:>VF !;80[M
MQQQ#%-Z1+)5]W>2$>4B&;2]#^8S3V^M$>\4\YI6$L%9T,Z&<C9N;.OO6<'%3
M5CJ#>!1=?)(FQ2,/@_H]@QF&.Z3:V0?TL@ZJY$'DY:.9J;(%H.+EX 2)G)O
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MNU"^\KQ)T6Z)MKFN\$M]/9>YP$<J>@6[8IR=M6+L4Y3P8YD4S),0>1?YR.B
M-[*^GR(_OWTJ>9*S5E+NZ#K_"]#]:%KV3%T6GWUMHY4K_/&6K//S1\8W"?;X
M!Q G$R]&K\JK^WWJ#X]VR2.A[9/IA?.0)U3ZDR^QE+_MSQKAP9X+E=,#&)Z7
M*S)_R#.O^4Y:D2[?NZ[64JZ?HMFOTN>%GORVCVUIPC,"-3TH"W>*1;'G?>QZ
M\[3/5&>_O\1M?J1#:H5[+^I#8F;T[7"R5NMXVB78/4O]"QC1FMNRU((_WZ@N
M5/U:MR/T46VPKRI!,C4X$WYC:TE-D8$)D*#V%HJ(1Z9*A=A,>H_\9/6]=4LZ
MZVO'T^7'TQ\SJF_T+=.9#OXE_*2O.PU_ =2*0.SYP4AG&ZW CXQJT'!@7L$M
M%J+8@B?6GY\;WR?_ H[4@8OK@?J@K874:,K'$IS=5W2-?VQ*>?Z&4.U"!);/
MUN!">+?+0T2(84#Y&4'#TY^MAG?!7Q,AW?[@V;EZI\"YR16IC[]086;?F03"
M'Q^UX?8Q2_C1A?V_WO\%8*IM'=EC/K3_V1(3_OI[HJ0[1]4=P]OC2.3=XTL_
MQAP&HPJKOU#-+/S'O$6G75NX_\7>6T;'T63;@F4QD\7,+%G,+(LL9F966<QH
M@<7,S,P6,S,S@X4E9K)X[*^[[^W[IOOUFC7S:];[FSO.B;U/G!.1D561N746
M<S;B76PE\0ZX>^UX:7D<YBUNY%>LLDG[MAB]3!W]F2W?GN#TN&+5[2ERG7G:
MZ1VP2$B?<\&I:)&S]NR$_'NX8C?FM=KFECBEKC9_&SQ'S_2S<]PY:_#X6I'-
MFVU'Y1"DO0.J[Z%2/01NSG=M<*'6+?F^S1)YW?N7(9UG+6PH5]DX; :X"1KD
M\:/.2HP@GA_72SRN>@Z=$QD$I1T=(</8#6?=V/@6:'^SGD_;MDS>J'(H.C\F
MM@.3=75*BL+HV-YY0D#/G8&DYN6L+NO>K4;*=T7@NMKM%6V*TGZ6G1=\_F;S
M#F#T<<C(7!1E9#E9*QUL&+QOGDT<)&3K[<"V$SKT"2-(7UC0@(&FJ3]FM6L7
M(07/?P>@!O^"_A1URW@]?<CK2"AX!+L[V"45Z7Y;;MZ:8IF\UE9,02.OVYM!
M\Q2%GR#[NTP]?W?>LUW\IP!^@ LAL1#2?^\ ;?+O"/].LN3B!1@^FB%N/B;5
M9UK?.8ZV5KOMMZ;@\,._:(,+;7:6=8/K G@BUYD 2[+?=@@)6(@L5T/0\;[9
MS+UEO.R#;U"$^T%KK^\1"IY "0CF#$BLA\4!!.]7%@P 47F$5\_?/U1'?%NZ
M%K34BF6_Q_13?N%^/ 9OE93(K[;)W>GXO4J1>)#GIWR[:"NK(1!\&[9!#9;[
M"1'4:I)_07K,>IM&^--@_RTA^QT00Q-U9&3#N.2J*("W2?36ZQDS&USGR5.!
M,I?PIU*_31!!/_?]$*7V'._,!3HAMAI3/=@(X)K?E!(>,TCW1RUQREO-"'D[
MJ2#Y>L+YA?;U_J[T F@BZTQ5 #2B]ZXK#-M23W4!EQ59@JN[ZSF U]9Z%AIN
M[1M(B7]NC<N4!W1$'/ .Z-A!)OI%J/) 6A#4=;^VH)9;U?4K:IV1(.WD;?I1
M]& TZH8=ZHGWFTWT.Z#*QX&W-=S5=PF87E!O5WGFX>8-'?U3E7_8XLDAZNY.
M>^BQYP*OV0,F.H*?9$BG=?.F2@S?";&9D/D=$$^^-+1J?WDCO*%C)##2>G^,
M\D*DVYO%V!LF>BLHAJ1G?7Q< B&1T/XJ;H.%.BT[JFO"%16X)!^/?,%Q-SY&
M&-#4/+_?P'"I\DIR"6G=,;N:Y**WMD&0PI[3CEXMRPOG67HN(47M^VQS7 '1
M"H/<[K(-2([*(1:(W>YW,^.^('SM#1::AGD'% ORZSQ3!R2UM-:POP,R0=QO
M^2'J;PM."Q\:%AL8[+7C.QN3)2*=T2PZ>C?IO$'ML-RJ%($]Q,4Z%0-4PW!"
M*DG$C@E%*!^F)=A:.\^:%TE.R6=OQX05'+4'5MK@;DJ[;[0[.FKRIO?.]$M/
MDFW*?[1FU]NP'1EL/Y:;M4 W*2Z];(@F@Z[,T4Z#+5<=#W6N*\>2_,.J]!3_
M-[]BXG]CZO %6'_N!;-1 ,-WG@:(-@UMC:+LS"[B\D4@$26JH.$S06:<S,CI
MX<ZMESV>'E_L:I/,):NPXA%IKDJ&.PL$DZ#TGIG'U8RR).M*0:2V>E5\Y"BA
M'_\8]75/"&ZK&$/E$AU<\2[95=_%LLEE,MI.[V=(81;2C"\A.*/-C]/'>8,E
MITNZP5?0ZW%Z35-%NM+BP)0_SK@\1<5 SR-/06=]SW*:0U_^0GJ7U"O3'<M;
M9AM>:ET#GFE(38T#:NT-LU2:PNEST10.<Z("(.>Q39&&6UD!02G$;CL3NOAB
M8[?^3#__<.E&>P6:)])& J ;$#(^]V6W;VC @TKK_,;X@D V/5A];K>Y<W2R
M;6SUF,W9SOC(?_7PUV#-U[4AB<:O(P%L:%\G\E5"PA"U285DT5$^!])\E&(;
M!0 (?'%Z]-?6.QY<6;@?9IM;+KB2/T8)'/$E<S8U!<U2:FO75#9$YE9:;$TS
MH3]@&8X:($TO#:ULOZ3J5*/N5^I4AYE50JD*Z/S?!R5,F#JT8;LHS:N3J!C=
MEFCJ2($_UYF6E\=.:VSA0>[MMH/WW&P0,6$!XY,]PRI[-IVH)/G +BRETOCX
M70BM;XM)?A$%;2&X[S52;DE0P.@]TDFZR;FG]>"O%<YRJ10X).QK8CB_WF9"
M#(RR;>UW@%F=YYGV1JTI4^TYVO@"EUIP2"D^]R<& 3Q]A#5SD?3 YN>#]N=,
MY?,)Y?BR.F,DYU610FT12QQUS#:(>M\&J1^I;:0.Y.3[0N@<Q=M#'6TW%VV?
M+ZQZIX!G;=R!(W:?)J>7L%3G@>"$U\"YA>TON-L'>ML"%T_%CJ[JGO$.^FNM
M"X4#19P=W9S$UOI9U-T'O1U\ZC_6+#O7/K532S$T:.>*K3MMZ\!;.BK33R^B
MAFF,XA>(?(ZMUJ&>$=Y#0;)#LH:6=9SDJ0HO/2O9-:L#/]/0 G=<# ;8<5T3
MWT[O="CFVS! VT^0:S&LJ[.*TU[V6M$I]@:DD*UK.L$)GR)/I!7)D?-_B9T;
ML7'P&VRX2E0H! OR>W0P65#SM5,<_9]5,[16MK,Z9G,VBVX94H+W68?L2*.%
MN\29*A]-B?FC@"J5HJ5 I&(/ ;%?W'PYNB05:+<HP*]T?<34F.+4B3\<_QKY
M *H^HV%?RWXP$YY3KBGJ_(E.BDY*;Q%,D*T]*-C-0M9R*E"MQ.EU05H3E_(G
M5:>ZAKIVIE?.IW9XSO)9<\-R9^_VBZRA\)525#TS'NYX'!@)4]8FFQ@,.:.8
M@J7D=* ==@]V1$O!FAA9,VZJ!GD?DG!/_4%2^R'[/$/JU;#C1W<^5#\__N^9
ML7SN:5RW9D5LI6.R/ W+["^W4S9EZFB6Z 5/C-9W8_QB!?U@5@7!12?1](JH
ME5\5#S2-8HI,G">-L0'P);Z(14-\L;#&X\=I $#I _\ 9T,$&W$2:"Q%+;54
MIY,YFE$Z'':A:%BSTII:AO)KY/DL"II:<UK%YD]] TK*\M@P# P0*=ZXNN;W
M=(R(4DB2ST,LA5RPTMU.X1F:^+.-,AL!K/R5@&8$N]R<*NA,/MH6S54Q0N+1
MEYSY:7Q(^0 BY% C@KI?OM:025WXG*0:90_F7XN*UE52IJMGH[07\R@)!^E,
M-";*RQ(KE,3,3+%4C5%* 4CY?2SGUE1- 8MZN\>/QN33!B86CEIVMR5B0B67
MB6!&9P28E&8MO8GL)$6!?3L!<Z);FJU-"V8#VH1%HY2;+9+'./M!M'):36;5
MW5.B$A0_)275#P[RC U!,2;9+P?I%?;4EW,Z S$IV(\4SA!"6.!"0O8Y5(,*
M*7UY0&'^!E&82ECLV'/(.>X3NF*+>YL],T86)M1A">YDD[>^+ZT]K#_$ZE"@
MY<O.*8AQBTV$"0W> ;EA@TSVU##V8RLF.7P;W8ZTOP)8Q\A.3#'(/PKOJG4\
M5'AW!JZE3XSFS YP\JM6<=;5E(TIV<34UOTX'T_%F1 ?:/]N2_V$*G<+H2[&
MBIY#3)8# S1SY5E_Y?;TZ*G_4. OB?]B:0UNLPXA$2Y=0YE@#?R5Y&'=LN"B
M[8S5<G_07ZJ^L;A+1=2287-.';M-/%)7S:G8MJ?H!.]:[FH9(PE79@TH1$59
MO%LC,N9N3'S<)&?H34F+]<L1V*E!DEI>P<;'!9GU9T#21=&I<U97KEISVH"^
MLJDYRIU;XR^-8.BT6M]O]](><_BH9A@#612*PT+34ZK\-K%2U?)LJ?MI6CX/
M@(M3X9B$80;CF#+FNS=1VW/7="LV*[5+M-"(D@0ODK_*VCG+PAX2"&XU,FYT
MW/)7%,V>KN6R,>5;.\/J&R#0)7$"1[4IC-1BY$@96R<**D,YD28G'/)6/H]O
M^>N)/@J1!9MC,=8#4OVXD P<"<%'1*C$Z/F;V:+AYC.0A7=#0)4XC%4NF$CI
M5AT:]-<+PU9\@0Z,Z[-]TLU]&EMZ:UEQ K7Q9?7?<3$Q1G@.7RI5;%9,%M%2
MX S14L B[),LMD) <5+PD (HQEG"[P#G0*D5C0/8#Q9 UCBI(B50/1&=[X.J
M*[_ZUWRL0F,2&LMH%LM^0L6UCM9.*AQMOAN..)2)2I; JBR!YK-GJA%JE8V2
MV'B:6^48(2&:K*S442^^*28^XBTO$G5J8DRP+2TDB"T8B(_13,(:0UX\*VNZ
MS84KQ4!:OII.?V<"PD7- :53[Q9WQKL3EUQTSN$0YRUT-T#7C;*#D=\M=50[
MRWI\(W['#SLD3RTNE61<\*%@^1U-CB2SQ_,H,-I%[L'"^0]Y!88Z'GQT3/7'
MGZP4U@:U(S^9V@RVMH];:XY=,R>HHC,@)UA-&WU)J<<* W- "HNA&28G<%Z2
M&6V)O%]":'1A$9#QSZ#3LF?K0[[4F*ZI[2,?AR97/&"G"J0+HL+ R2KDR,+U
M^-)<?L(77B*&*C) HINC1[]P/'LN*=HDTF/LZQO[/4Q7A!:,7-&.18B8]@,[
MHOT17::(M)0E:?T0 U".'U)U(K)=7AN!%KC(1A1I_,5<O3Y5]%SIOF0-PSV3
MSE'[K!U (=LB*:6-Z8V*\,0U<Q5IB.5V+[86"NY+ZH= '(/^!)5?^#:RLXGG
MN_-YI6068#<J1#Z7Q!=ZZ5M*C*K3N2JT=<_&%2>GK" )CKN$9, 04G=N39BJ
MB#>1IW'9,'D6.KI]^S4,>4%)]O-,A-%WW$AIKO:*\,20.(3A=5W:4M]"&0EZ
M*>HPN>&TD6E$%8/"[G*MK<TX2:)(J\X]Y[7Z.ZW.?9\I$JMO+?/\M9XM16O<
MK^U=0IJ($.H"D=&)WKA/']IJ15IC%5D>1W6W/Y!\](U*,]4@O&9I.3C:#?'%
ME=:E"]?6F@,((^U($*N)6O>MX\[U<P4H?^%(O%Y"'FYDM'6_?\L4"UK'JRA9
M,*0:PT_00HL@CTGV9J".19B$XH$X [,2MUSU-1 N0YRL;<^C8$REBS]V%2BG
MNY'5^A#$AM&;"59PJVBLD:2O[;$N/!&6 B)7QF_>$:<*XIJG Y,H?\O>.I&W
MQM0&/M5)CD%@Z,DQ#B@U#&KN@DY/<'!/.-E-22;X2#B,\"949,&+FJC]9"@_
M(%04]).Z%HQDX?9R8>$ZNQLKBWEP9=(5&FLY]O8^P%T:5&M'(V 9%:NLT7ZG
M3^A/C%)"F9FMR%'USRC1RK-!HJ30QE@7A3D&#IN<7C.:IN&7-4)H9;=+NO]"
M+T(;B#[#)@_!8HMCVO\2H$]:BF@)6"*"U45:<,;O<W9U>!7V"W.)H."HTTK6
MG-^#+*HV%='[6IXZ;I)!D<7#KC:2$V?*C"02*@.U9=@GE/:13C>!;3J*W.WD
M0I%18QD</FTW(TUA*9!KAT>UNTFEC7*UVV.M'*&//;Z6Y@O?3:O80B5],OGF
M$U]#]IHY$\R"N&I?)"3:XT^74@11]!TXJBFNU0>H#T]#=:RX=HXK"6V\$G H
MB,S5?F)7>Q#3,:MJW[>5DX()V7>:>6G:;K1+[39+#IC>@OW7VEHL%4)X*M>,
MS70),HS-X]"BB\R>4[C9"+B="&W2(4+7"W!+'+&E0T*2)I)],6O.W4:]B36%
MA $Q7-NABI[&44>+OB!/C24T^-H[OYS2W"JH9L]RC7-O:[E%NF1WM*4M]/2
MUO-*VC:]R.AVS6S)8N'&.2!SH_FP<).JD2@GO"1"G"DZAJ)QG@H&M6.*M; ]
MPK0H+WBM+$J,>@B4Z]JNZ)>#R*&44>%2=HLVUZ]?"YU8=D!QB/C'/A526WM"
M5[^8M3E\BEUJ&[>QX;U#AXJ-9@/%CSXA2[0EY2HEI'R=4;,^K0T3ZP#*8(E<
ML0988A'7H2?*3T;(&:7,&GC-I>3;E\0,TB5%N;DH+<9J36_K.<,-S=S3-Y^8
M>(H&4=83X]M?EC^X6G.6O>KZMQFJF-LU3&CDY*1BRLY& J<93)?0UU=/OW!H
M8IWT]#8NJ*)9\3\'.!1E)Q@,,P\UG>K(H\%RL1=PLL-BSX<!J.WMMON1],8[
M(ATS W&1-78^%!$;P-J7$J@U7^4(N&[P;/\LZ[%>B+?.VF1P7'NH-LJ6X<3K
M&^4 R35@'\"KW2^L*7,X$O%BP/TZST8]22:T0<2D(@ X[-DXQ;((P4Q0RA2'
M8(#SMI@,-D"D@0?:*:56!!TM-C R1/-FP(XR49%4(GE1B]'H.0W8JLL]9 ZL
M:QF'FVT-J)%$TO!2L^TL*F:(P7[1@B*U_Q@U]X.QKK:2ECBO-%3HN^('DF[P
M%*%/&]HB4PLM0T7M_.->8_CK8ZPE0_A9*#._RAJ1$U;? ;S!X2\![)D)#3LL
M;X20R8KR<-DL*LK_[H"S[SWR'M'.*"'<=Q6%2SW,%PD?^D:?"$Z/\H:V;TTQ
M:G>ON+,^H*?A^@"5N2B[Y@32O ]Q(>^ :NI0!)M?6T;H0N#"\TZW#P[?7,<(
MKUW.%CM*-L:L\4R8!Y?39GEE&B 7]@=SX+)BNQ_INFS;(X></(/&;(\XF'5A
M-<ACA@_ X^KM+ #XZ]32I8.5('Z9-9 VS;RW,I G1!UXK%0;?S<,-!5W69.O
M'M8^*1UFISVD7-4<D[#%X;*@0O.+U0"PS>?A'DA:3:VW<;R] RS@5W:#:++1
MQ\,T\1 "BX(J(:#!Y8P'.^#S$:L[ZL]X/3A&-S4I_>*%R:<'C_*1K<7PA1TE
MH3*5=[21,\0<T?_=^>\<DA(8TQ8-\H@?ER0J!FKMSJ)S=ZZE9['M7Q,+QX9_
MM64868\P]L-\(ME+:1/_0BO;H@I.GKLJ8"&,A@]11!,<Y%"9W';>J'=>OU29
M>\8+#>*'4/"GU1+J\SNZ9$3M<M'M?%E)3E<[UAOE3;E>3 3-];%Z\*AG$"![
M,1WJ(Y_H5GO;/+>[/[*H$?:DWN9B"ZF6VP%'2(_4I;FT)^;M]D=PB!5Y\GBP
M(>!P+3-K-I<VP94NL$3"A9THX=6^Z"<+?+4<AJI'L*?,\"HO;DM];K7LF#]Q
M./XQ2>FY@X!$/S:P$L6]T5N_N[?5X5FR0:N^[-)(JQM%. =Q.(K17H\0H"D.
M3_#1@5:DQ:RLU&].$!S=B0DY@ >,8R\"&>QV4&G6JJI#=/\Q^'"TC#+W^J7O
MUO"CPJ./X1-3:(E7%],K]N=Y ?T4GPA2*Z)/XX+BJ.S(R2"B?)BTX+$;Y)GO
MLG]9]O[=$*/%MG)(!_@Q4=.6^];D!5A2O&E1FMYRHQZ:BM$6V%V$KKK'=&CP
M8=J1\)QQ<U'2YZ.DNC7(N?TTM7Y\"3RL5Z95?[6 =+VO/2P^(\R] 8'#_E1E
M/"]JF;]87/++:(/8"&\>]JR/.[T]EO[4=.'V7I <)29'<"3>!7/E2UB?,""^
MOV5HGWOHNIS/@W6M%*8X)FE-?'_3$"-$#HD%;<C$*,($'/,<K]6H0LEYF M2
M+3%"M\Q,>'?&:0O@J\@4I/>A8&8=XS#+.(;/'KZNPJE0V7=]]?S\RZ:KVIE]
MJ1H%S<("0Z/%$BKJPJ.J@JY++BPR.#1^6QQ!BY-=+M)63S7W1)5)>G1^%HG0
M6@[X #?<)=$%A@F8ILU,+YD^ ]<C%FGEK-F2"@5YX?;@PH%2O91NA^.!<AD7
ML3J(2%+0#29AHJ_-#7ZD?*/T';"0+(0TWN1HSS"82IFL=H^<1'6S^U%4>S(#
MK!'G[8><._ONJ)1N1K#TFCYM)DY[N%3QA,M3)9U<@-6Q?*=-/=N</IN7E!(!
M\MT2U&? EQQ8&64 ,GY_"YJ\N[W'L4L3:DU47[RLA.!@4;>V+;Y$@(Y\ AW-
M3W%T2XT[D@K7L\W:[D)<9D4F^=/+<;+M5->03!9.-D0SFOFPB='UTJ+\FS;N
MCXCLE_MC(B?VP1B"_;6(:T6OK>O@90TA\06:5CSI/L4IX^%*@=Z&0BI@U[D]
MCX$MWSH!2WN[R<2>NRU>?6@[A=DTT%MQ7GEAI\VGKRS/38%KO'SV>R?DYF@3
MY#VK)0(V3(5"9$2<,9*\MP6:)<MA& J([F,E^RWBGEGSEWF9[?ZD\/)00;=/
M7/0<)_EE;%=1YP_VZZ]]*6+QV"6AY6)Q]+4HBJBS$?OA>&@6/*>L9GLQSH31
MF15.BPY;WP$\J?28[+N>SNMW6+7Q;=UX_$0?F>D H_&MJ%@TH2&PV[ZU+*88
MD 9&*QJN>3-/<%42US!A(65QH14IV,4T 4J1*=KQ2EA4OE$9?%:,46GNOD]B
MW8]8FG2S%&AC6":1;5J<A)?72Q1R"<EU&O05H2:R/.@SQ>4H]E3!02&A8?Y
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M'(ES+=#!2BL_I<8WBPD &LG,8F_;FE9J([OH&#*[ZYA::>,3PZ3$H=RCN#>
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M3G[L)LEHD\G"8>C3NF]Y X/=UP.*N2)$V#NF@.HS:&%V>[X2!E0;W(-&@-3
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M;,L=N8QPM][1#QOFK;6L%IZ5<2TW2J )]E(QZ8^T9/<E"@M%33+%*FYH>6)
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MA0YP4)$IE [3',@1T]^F?$UW3AJ6)[H+\)F!W/+Q6SM4O%=<^QI@Z[AV^'W
M8S+6XGL0U=(O81K;PT-%/!5?S,XZ</87L'OIE6?72U*K/4:(_%X@C&?J;T!4
M<N:OHQJ7R@U_=;1%*-[ TX-'N$#7\U^"?"OVF.RUESE$MC9B\NP&$;KI[9]A
M(X\G7S7T.XO_JR>VZ!X9Y1O:;D$L/VY3FX$@GIT,]2#!K>9DEBP&@M2<[O6K
M8-6(G?2(>!G4<YK+_$4:QNX'C+U- 3?F=MMGZ,_:,QV>['O1<S'E5HZ[BYZ
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M';*"JG2,XZ&!%'LFF-%VPQ_R-*+(\N0*72,1W3?Q%1T)[ ;Y'_<[9VYV-Z9
M=Z=>[)?'IJ1?8[Z@8]<:(4-<;"@^OK1T;K*N<S^W5#U!HNH*OA)?,^@2&@%<
M&)T7M:-@2M5+5@+A1T7W2%FRXIV!9'YK9C-/=W8N9=T=%PO2F&Y"-_7N[8&H
MT<5TZ,J\D6FJ1/G UX7 QT=4QX):0[;D*]G]/N=7$\D$OUQ+"S>;X=*BF\I
M1\J*$+$=(O$((,GV>&*1V&3FTJL@@@*')1?D\-Q5N9L/T8 S2T\P##+G[I"
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MW(&.*@L5[Q?9N*:.;Y]48KP([>?@!' FG,\]U\:JYU;FK&C5^O5]4ZZD>]O
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M\.:%]!72<<-YR3MW3-[&9A.WGAK"6DU4Z0?X$"'[F/QA/7F^7GAOH,#?4^J
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MMH:[O/4_%@4N[C,KI#BQ/N5YM7RL(\)_910Q9F< 7IR1PZ&I(J?B8KJ45WF
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MO-M2O,'!W-D'I$8/JNE"5PL^I,9>;1\$4S"_^,K^,O8B4D?/^N<Q3,J_/VD
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M*7BXW<V1V\NNB>8GC-T#\N61W7*&V?0KZPB\8*GJ=%K-3Q5!F/'XAS<EMP\
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MR"(G([%,9M?+7$.IO8C<W>W4KD*6<A3=]#//8_TFC*:1EY-O\,@;DD5:Y6+
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MA/6T6%KS?N228YWAIJFMY2E"'@#GRNHO\3-V#H("+,GYM%% '4=B=80HJ\=
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M9R7MLQ ![2$KT=16O6>6! H[R6,1K0WS#C L),F'T2O@$48.T_KY>,)=IG.
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M,;&X0R8V M61RBU^AA<::WM1C?\KQCWT7UD(+DILX ,5M>X<5CO6/)ET2NU
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M;XB%O\<D)VDP%26JW;)+B=C7V[2@>Y+SRH7H>]H(XAJK@@=I5<NIM'[D_V^
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MY.3^3QC[ZHG:'6U/URA!;TMB7&H83)[;'%UI[]</"]@6-I;Y.!G"J$7*HOH
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M;V7'EJ+517Q3CP@H_U@49M!*1#0<;,W)-!C_NSM-I,K^GK5CK*)=4X=(=<<
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M52S##+7< <^%BJCP<O!^E#6P@9_OF<H<**\$?6% >0KJLP*<8M[N++S9@PJ
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M1RVZ<JXP0YUYXP4TQ]"G<P,T@;8UA0T5T_H795D'J,E%B#YPLN85MKI+V?4
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M1?F,2?X$?L03VP5CL]Z](GPC@Q63T1IMW@J'@1E[R<![05L(LT&"1V&$>V=
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MN09=!^)K'C,FL<<5>!ZQA)53@+QC*4%+3VC(N_-\-[@'W#/L*J+=H TDM=;
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MPO@J H,![QG(2U*Y/N/P$:#KP5Q;T.@3*-\M^'O@!6ZV(V_ 249CB?Y.0A"
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MJFQ,[^P>3,Y@D8O.HM/AANHFFJ5O0JI4-G,O7 <-#HYRB=AT+[QO(*U4EX<
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M"YGB0=1M5MP6"'$W$0X[AG9V%>&*<1AX9Q\,"BMW\Z[@&C32_[SD.[Z=%FN
M<#,15QH^G%5M]",]!OA^P4%WF#OJI;^:G8<^?(1^X@;\[853=,1[BY#Y[C)\
M=P-,FBPZ2-.?+>#J#K&!N!8M<=J-#+\%B3$08*4F#].;D@D8;=V^>H)ZV*MK
MRU6 U@#PLWBR*PG54D:VK+83!DG8X&]<W9I )1/K"+G8OYJ=0 P\TF)TO' A
M7KI\4P"I)*YS/_DT.I04F>)B]FG0P\;54P@P98I_R-@J,N+#12.SPC<J!@1
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M3DQ^"C<$.6[H.WZ))/I*/2WR0 E+?TU)<TZO;QVO1)P#(_JJ_2REK_R0?0%
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M)5-LN^1S0:V9+RY2QF,N-PMW2B[19N21E/4ZSP4]&8=<'$L*@8'X#$+?K1L
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MJNA+EZH6NK=M+'0P=):T.\?+^[/-5)?-LANPHM$7-)GGYOJ-@EE.K;9I$YR
MRLV%)66[FT9CUAC;=$#F&M:TI6C&FJ8S0G+E^2@AZP:(HOSRFN3-&7$U"ZQL
M^E!M9S=1$(Q%$789>=*'3:K%#+TUHR1;)")\(--:SP!8:5+K"J1!7RZC>4.
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M  #]VP< %0   &EP87(M,C R,C$R,S%?;&%B+GAM;.2]>W/D-I8O^/]&['?
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MQD,AZITN=OB&Y*FE44?\L&$O5^L@W>+D4[H*B#K412;E++Q%#;$):1%%O!-
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MT'-0OOM"?UANU_GC0OV5Y7+./K4.9O.]94(P/KH&V?#+QQU1](@6?@<-YUE
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MYT"73'H-,*RR@BG0BRJA((U0R'[ K;IWHCV^9*1XPG3BEK[2B;CLY)1>U.G
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M:FDPU#-"%.),*P4VSH<RFNO,;#_2;VB[C-"5];22(,)5+":T@F"HHT,G7U(
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MLQ'TRO2^18MM\9*1^%]4YNSD^^^_9_]?<BW_$:59BE',;@*;-S_UI#/>;4)
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M+9Z7=R?*BUXJ"F\L:P(J?@H^*F)71U8:Z.M*Q]<2?SE)DJYY\B?P"GV 2UB
MY(^AEJ:7EMZB-%7MN+DTW>QS1%',]Y^?LKOB!9,2EG[[0JOB=%?" GR/*AIY
M, ,]"Y#BH<U*A4T!N5*U1'."%C 6^^DT(=P2-C?M5^3A-%@0<TDG%<C>*L)
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MK>?K4R\;=7.A8QANU]N$K17R@28[L$KP"T79C!!8%@U=WSG.A-,+'R<XU[L
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MX/;M?$%W>P]DQ-SR>=E)8?**\_-RJ*_H[BQU70Y,1KG3'8!8*4(*&Y@"7#B
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M2K[*52/9*@A%;+QDWY:B;MYBZ&3< 4"*G GB*@75'"BU"H+32;D*2"?CO>?
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M=GQ/J=VFMKL\WF/JEEM1107T7:8.AHY'T?=DE$3S=VDS%\#&"&G%Q\@Z(G^
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MN$=KK6-?-E3F,S7OY %5D=)S5."JGW<SI$X!M^#&\@>,8C.[!YA/_/VLDD+
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M\)K.>N%=K^UP%%-_=-OB0<=2TG6U?/8I$]Z[LX7/YD2W/5.4=SAVR;@OTXH
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MDC1>$G9/9EDTK1Y6-2J#J1ZVY\P>7I@DT &3NE?8?YO1:ZJ'[0RS!PPF"73
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M6FA#'#\T?>./"U($+?)^O52^K25$RS_D77MTW;?WRCOW6-Z[N (>E?U[<4Z
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MQ2Y,S:_J ON(F^5>Q& '\F'OH[= \)"T=W.=O1LE;?6)_7JO0[JHP,,-E1O
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M-U\Q,&LN:'1M4$L! A0#%     @ .X-<5N)@9M3P @  +18  !
M     ( !DD@# &<P.#,T,3=?97@R,2YH=&U02P$"% ,4    "  [@UQ6PK_P
MV1X#  !$"@  $               @ &P2P, 9S X,S0Q-U]E>#(S+FAT;5!+
M 0(4 Q0    ( #N#7%:XH@EMS@8  .$:   2              "  ?Q. P!G
M,#@S-#$W7V5X,S$M,2YH=&U02P$"% ,4    "  [@UQ6B^EO>\<&  #>&@
M$@              @ 'Z50, 9S X,S0Q-U]E>#,Q+3(N:'1M4$L! A0#%
M  @ .X-<5LQ8!U'  P  Q0P  !(              ( !\5P# &<P.#,T,3=?
M97@S,BTQ+FAT;5!+ 0(4 Q0    ( #N#7%:8,WCWY0,   T-   2
M      "  >%@ P!G,#@S-#$W7V5X,S(M,BYH=&U02P$"% ,4    "  [@UQ6
M.V8:B'J]  "TS@  #0              @ 'V9 , :6UG,# Q7W8Q+FIP9U!+
M 0(4 Q0    ( #N#7%8)5Y""(K0  "7!   -              "  9LB! !I
M;6<P,#)?=C$N:G!G4$L! A0#%     @ .X-<5J+J$]U4&   V $! !$
M         ( !Z-8$ &EP87(M,C R,C$R,S$N>'-D4$L! A0#%     @ .X-<
M5@3I::54'   L3X! !4              ( !:^\$ &EP87(M,C R,C$R,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( #N#7%9_#$ _J#H   *. P 5
M  "  ?(+!0!I<&%R+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    "  [@UQ6
MZ8_'FL6*  #]VP< %0              @ '-1@4 :7!A<BTR,#(R,3(S,5]L
M86(N>&UL4$L! A0#%     @ .X-<5OM-E@:Z7P  DRT& !4
M ( !Q=$% &EP87(M,C R,C$R,S%?<')E+GAM;%!+!08     #@ . 'H#  "R
%,08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
